{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s outstanding principal on the 5.000 % senior notes due April 2030 was $606 million in FY2022 and remained $606 million in FY2023 (as of Oct 29 2023) and FY2024 (as of Nov 3 2024)【page_81】. The unchanged balance over three years shows the company has kept this modest, fixed‑rate tranche stable while using other financing actions—such as issuing new senior notes and repaying term loans—to reshape its overall debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states the balance was $606 million in FY2022, FY2023, and FY2024 (unchanged), but the ground truth clearly shows the balance was $1,086 million in 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. This is a major quantitative accuracy failure - the LLM missed the $480 million reduction that occurred between 2022 and 2023 ($1,086M - $606M = $480M). The LLM's claim of 'unchanged balance over three years' is factually incorrect and contradicts the actual debt reduction strategy. While the LLM correctly identifies the note details (5.000% senior notes due April 2030, $606M in later years) and provides some contextual reasoning about debt management, the core numerical progression is wrong. The LLM's interpretation that the company 'kept this modest, fixed-rate tranche stable' misses the significant $480 million principal reduction that occurred in 2023, which is the key indicator of the company's deliberate debt reduction strategy mentioned in the ground truth. The multi-hop reasoning fails because it doesn't synthesize the complete three-year progression correctly. The answer demonstrates partial understanding of the debt management context but fails on the most critical factual elements - the actual numbers and the progression that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 398,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block has stayed essentially unchanged – the 2022 10‑K disclosed that 59.25 % of the closed block was reinsured under a modified‑coinsurance agreement, and the 2023 and 2024 filings each report roughly 59 % of the closed block transferred (see 2022 page 214; 2023 page 227; 2024 page 204). The steady‑state proportion of risk transferred shows that MetLife is pursuing a deliberate, long‑term reinsurance strategy that consistently off‑loads a sizable slice of the closed‑block exposure while retaining enough risk to preserve capital flexibility and policyholder dividend objectives.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core quantitative facts: 59.25% in 2022, ~59% in 2023, and ~59% in 2024 for the modified coinsurance agreement's reinsurance of the closed block. The percentages are accurate and properly formatted. The answer correctly identifies the consistency of this arrangement across the three-year period and appropriately characterizes it as a deliberate, long-term strategy. However, there are notable omissions compared to the ground truth: (1) The LLM does not mention the deposit method of accounting or the right of offset/deposit recoverable combination, which are important technical details about how MetLife accounted for this arrangement. (2) The LLM does not reference the significant growth in total net ceded reinsurance recoverables ($6.3B in 2021 to $17.6B in 2024), which provides important context for understanding the scale and evolution of the reinsurance program. (3) The LLM's explanation of the strategy's purpose is somewhat speculative (\"preserve capital flexibility and policyholder dividend objectives\") rather than grounded in the filing data about capital optimization. The multi-hop reasoning is sound in connecting the consistent percentages to strategic intent, but the answer lacks the depth of financial context that would demonstrate complete understanding of the reinsurance strategy's evolution. The page references provided (2022 page 214; 2023 page 227; 2024 page 204) add credibility but cannot be independently verified. Overall, the answer captures the essential narrative but misses important supporting details that would elevate it to a more comprehensive response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 450,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply – it was $1.494 billion at 12/31/2022, $800 million at 12/31/2023 and $491 million at 12/31/2024 (a drop of about $1 billion over the two‑year span)【page_102】【page_99】.  The steep decline implies the company is netting more of its derivative positions or scaling back exposure, so less margin is needed to support its investments, advances and long‑term receivables, indicating tighter, more efficient derivative‑risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The calculated decline of approximately $1 billion over the two-year span is accurate ($1,494M - $491M = $1,003M ≈ $1 billion). Number formatting is appropriately varied ($1.494 billion vs $1,494 million in ground truth, which are equivalent). (2) COMPLETENESS: The answer addresses all parts of the multi-part question - the change from 2022 to 2024, the intermediate 2023 data point, and the trend interpretation regarding derivative exposure management. (3) ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is accurately referenced, and all three fiscal years are correct. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly interprets the declining collateral trend as indicating either improved netting efficiency or reduced derivative exposure, which aligns with the ground truth's characterization of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' The interpretation that 'less margin is needed' logically follows from the declining collateral amounts. (5) SEMANTIC EQUIVALENCE: The LLM's conclusion about 'tighter, more efficient derivative-risk management' is semantically equivalent to the ground truth's assessment of the trend. Minor differences in wording ('steep decline' vs 'consistent decline') are stylistic and do not affect factual accuracy. The inclusion of page references adds credibility. No calculation errors detected, and all financial metrics are precisely accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 484,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO reported $622 million of the 3.625 % senior notes due October 2024 outstanding at the end of FY 2022, the same $622 million at the end of FY 2023, and by FY 2024 the balance was removed (shown as “‑”) indicating the notes were fully repaid or matured【page_81】. This pattern shows the company kept the notes on its books until they reached maturity and then let them expire rather than refinancing, reflecting a disciplined debt‑reduction strategy for this instrument.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. QUANTITATIVE ACCURACY: All financial figures are accurate - $622 million for FY 2022 and FY 2023, with the balance removed by FY 2024. The note designation (3.625%, October 2024 maturity) is correct. COMPLETENESS: The answer addresses all three fiscal years requested and traces the evolution of the debt instrument. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three fiscal years to show the progression and draw conclusions about debt management strategy. REASONING QUALITY: The interpretation that the notes were \"fully repaid or matured\" is sound, though there is a minor interpretive difference from the ground truth. The ground truth states the debt was \"either fully repaid or refinanced ahead of its maturity,\" while the LLM answer suggests the company \"let them expire rather than refinancing.\" This is a subtle but meaningful distinction - the ground truth leaves open the possibility of refinancing, while the LLM answer more definitively states the notes matured without refinancing. However, both interpretations are reasonable given the data showing the balance went to zero by FY 2024. MINOR ISSUE: The LLM's characterization of \"let them expire rather than refinancing\" is slightly more definitive than warranted by the data alone, which could indicate either repayment or refinancing. The ground truth's more cautious \"either fully repaid or refinanced\" is technically more accurate. STRENGTHS: Clear presentation, accurate numbers, proper identification of all entities and years, logical flow of analysis. The inclusion of the page reference adds credibility. OVERALL: The answer demonstrates strong understanding of the multi-hop question and provides accurate financial data with sound reasoning about debt management strategy, with only a minor interpretive nuance distinguishing it from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 525,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems segment earned $2.56 billion from surface‑ship contracts in 2022, which rose to $2.70 billion in 2023 and to $2.82 billion in 2024 【page_9】. The steady year‑over‑year increase (≈5 % each year) shows the company’s growing share of Navy surface‑combatant and auxiliary ship work, underscoring its strengthening position as a premier U.S. naval shipbuilder.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All financial figures are correct - $2.56B (2022) matches $2,561M, $2.70B (2023) matches $2,698M, and $2.82B (2024) matches $2,819M. The format variation (billions vs millions) is acceptable and properly converted. The stated year-over-year growth percentages (≈5% each year) are mathematically accurate: 2022-2023 growth = (2,698-2,561)/2,561 = 5.3%; 2023-2024 growth = (2,819-2,698)/2,698 = 4.5%. ENTITY ACCURACY: Correctly identifies General Dynamics, Marine Systems division, surface ships, and the three-year period (2022-2024). MULTI-HOP REASONING: Successfully synthesizes the revenue trajectory across three years and draws appropriate conclusions about the company's strategic positioning in naval shipbuilding. The interpretation that steady growth indicates 'sustained growth and strategic emphasis' aligns with the ground truth. COMPLETENESS: Addresses all aspects of the question - the evolution of revenue (three data points showing progression) and what this indicates about positioning (strengthening position as premier U.S. naval shipbuilder). MINOR CONSIDERATIONS: The LLM adds interpretive context about 'Navy surface-combatant and auxiliary ship work' which, while reasonable and not contradicted by the ground truth, goes slightly beyond the specific data provided. This represents appropriate contextual enhancement rather than error. The citation reference [page_9] adds credibility. Overall, the answer is factually sound, mathematically accurate, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 456,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 to 2024 Mastercard’s Class A shares kept the same voting structure – each share continued to carry one vote – and retained full dividend rights 【page_96】.  The cash dividend per share rose each year, from $2.04 in 2022, to $2.37 in 2023, and to $2.74 in 2024 【page_99】【page_92】.  The unchanged “one‑vote‑per‑share” rule together with a steadily increasing dividend shows a stable governance framework that preserves voting power while enhancing shareholder returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core governance fact (one vote per share remained constant across 2022-2024) and properly concludes that this indicates a stable shareholder structure. However, there is a critical factual discrepancy regarding dividend amounts. The LLM provides specific dividend per share figures ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) with page citations, but the ground truth states MA had 'standard dividend rights' with 'no changes to these rights over the period.' The ground truth does not mention increasing cash dividends per share, suggesting the LLM may have conflated dividend payment amounts (which can vary annually) with 'dividend rights' (which are structural/contractual rights attached to the share class). This is a significant distinction in the context of governance structure stability. The LLM's interpretation that 'steadily increasing dividend shows a stable governance framework' is reasonable logic, but it appears to introduce information not confirmed in the ground truth about the actual dividend progression. The answer correctly addresses the multi-hop synthesis requirement (combining voting rights + dividend rights + 3-year progression), and the governance conclusion aligns with the ground truth. The page citations suggest the LLM attempted to verify its claims, but the specific numbers provided cannot be confirmed against the ground truth. The qualitative reasoning about stability is sound, but the quantitative claims about dividend amounts introduce uncertainty without clear validation against the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 436,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine‑Systems revenue from surface ships rose from **$2.56 billion in 2022** to **$2.70 billion in 2023** and to **$2.82 billion in 2024**【page_9】—a roughly 5 % increase each year.  This steady, double‑digit‑plus growth signals that GD is deepening its foothold in U.S. Navy surface‑combatant and auxiliary ship programs, capturing new contracts and expanding capacity to meet rising naval demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the three-year revenue trend for General Dynamics' surface ships business, with numbers in the correct ballpark ($2.56B, $2.70B, $2.82B vs. ground truth $2,561M, $2,698M, $2,819M). The answer appropriately addresses the multi-hop question by synthesizing revenue evolution and drawing conclusions about naval defense positioning. The qualitative reasoning about deepening foothold in U.S. Navy programs is sound and relevant.\n\nCRITICAL ERRORS: (1) GROWTH RATE CALCULATION IS INCORRECT - The LLM claims \"roughly 5% increase each year\" but the actual year-over-year growth rates are: 2022-2023: (2,698-2,561)/2,561 = 5.3%, and 2023-2024: (2,819-2,698)/2,698 = 4.5%. While 5% is approximately correct for the first year, the statement \"roughly 5% increase each year\" is misleading as the second year is closer to 4.5%. More problematically, the LLM then contradicts itself by claiming \"steady, double-digit-plus growth,\" which is factually incorrect—neither year shows double-digit growth. (2) NUMBER PRECISION - The LLM rounds to $2.56B, $2.70B, $2.82B, which loses precision from the ground truth values of $2,561M, $2,698M, $2,819M. While rounding is acceptable for presentation, the subsequent growth rate claims should reflect actual calculations from precise figures.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across three years and draws appropriate conclusions about naval defense positioning. The connection between revenue growth and market positioning is logical and well-articulated.\n\nSEMANTIC ISSUES: The phrase \"double-digit-plus growth\" is a significant factual error that contradicts the numerical data presented. This undermines the credibility of the analysis despite the correct underlying revenue figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 489,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s Business Overview in each of its 2022, 2023 and 2024 10‑K filings notes that the majority of its industrial‑gas sales are under long‑term contracts【page_17】【page_19】【page_17】. Maintaining this contract‑heavy mix shows the company’s intent to lock in predictable cash flows and to pass energy‑ and feedstock‑cost swings onto customers, cushioning earnings against volatile energy markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Linde consistently relied on long-term contracts for industrial gas products across 2022, 2023, and 2024; (2) these contracts provide cash flow stability; (3) they allow pass-through of energy and feedstock costs to customers; (4) this strategy cushions against volatile energy markets. The answer accurately synthesizes information across three years and correctly identifies the multi-hop connection between contract strategy and financial resilience. No quantitative errors are present (no specific numbers were claimed). The answer is semantically equivalent to the ground truth, conveying that Linde maintained an unwavering, deliberate approach to risk management through contractual stability. Minor deductions: (1) The LLM answer is slightly less explicit about the 'consistency' or 'unwavering emphasis' aspect - it says 'maintaining this contract-heavy mix shows the company's intent' rather than emphasizing the consistency across all three years as strongly as the ground truth does; (2) The phrase 'prioritization of financial resilience and operational certainty over short-term pricing flexibility' from the ground truth is not explicitly captured, though the concept is implied; (3) The LLM answer doesn't explicitly state this was 'without deviation' or emphasize the deliberate nature as strongly. These are minor semantic/emphasis differences rather than factual errors. The multi-hop reasoning is sound - correctly connecting contract strategy to cash flow stability to risk management across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 436,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "General Dynamics has kept the same approach each year – its ROIC formula expressly **excludes goodwill impairments and any non‑economic accounting changes** because they “are not reflective of company performance” (2022 10‑K p. 47; 2023 10‑K p. 50; 2024 10‑K p. 49). By consistently stripping out these accounting adjustments, GD signals that it wants ROIC to measure the underlying operating return on capital, not the effects of accounting‐only items, reinforcing a focus on core business performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core finding that GD consistently excluded non-economic accounting changes from ROIC across 2022-2024, matching the ground truth's assertion of 'stable methodology'; (2) Accurately cites specific page references (2022 10-K p. 47; 2023 10-K p. 50; 2024 10-K p. 49) that support the claim, adding credibility and verifiability; (3) Provides the actual quoted language ('are not reflective of company performance') which reinforces the consistency finding; (4) Correctly identifies goodwill impairments as a specific example of excluded items; (5) Synthesizes the multi-hop reasoning effectively by connecting the consistent exclusion methodology to GD's strategic intent (measuring core operational performance); (6) Uses appropriate financial terminology and maintains semantic equivalence with ground truth language about 'underlying business performance' and 'core operational performance.' MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (includes page citations and direct quotes), but this represents added value rather than error. The phrase 'accounting-only items' is semantically equivalent to 'non-economic accounting changes.' The answer fully addresses the question's three components: (1) how treatment evolved (consistently applied), (2) what this reveals about approach (focus on core performance), and (3) the consistency aspect (stable methodology). No numerical errors, calculation errors, or factual inaccuracies detected. The multi-hop synthesis across three years of filings is sound and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 465,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s guarantees for service‑level performance were reported as immaterial in each of the three most recent years – the 2022, 2023 and 2024 Form 10‑K all state that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material” (see Note 4, page 81 of the 2024 filing, which references all three years). The unchanged, immaterial impact suggests the company’s risk‑management controls effectively contain exposure and that its contractual performance has been consistently reliable across this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies the three-year period (2022, 2023, 2024) and accurately states that service level guarantee amounts were consistently immaterial across all years; (2) Provides the exact quote from the filings ('none of the amounts accrued, paid or charged to income for service-level guarantees were material'), demonstrating proper source verification; (3) Correctly cites Note 4, page 81 of the 2024 filing as the reference; (4) Accurately synthesizes the multi-hop reasoning: immaterial amounts → effective risk management controls → consistent contractual performance; (5) Uses appropriate financial terminology and maintains semantic equivalence with the ground truth answer. Minor considerations: (1) The LLM adds slightly more specificity than the ground truth (citing specific note and page number), which enhances credibility but goes marginally beyond the original answer's scope; (2) The phrase 'unchanged, immaterial impact' is a reasonable inference from the consistent pattern but represents a minor interpretive addition. The answer fully addresses both parts of the question: the evolution (showing consistency/no material change) and what this pattern suggests about risk management effectiveness and contractual performance. No numerical errors, calculation errors, or factual inaccuracies detected. The reasoning is sound and properly synthesizes information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 409,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems revenue from surface‑ship construction rose from **$2.56 billion in 2022** to **$2.70 billion in 2023** and **$2.82 billion in 2024**【page_9】.  The steady double‑digit growth each year signals that the company’s investments in ship‑building capacity, workforce and supply‑chain expansion are translating into larger contract wins, reinforcing its strategic positioning as a primary supplier of U.S. Navy surface‑combatant and auxiliary platforms.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core financial numbers that are the primary focus of the question. (1) 2022 Revenue: LLM states $2.56 billion, but ground truth is $2,328 million ($2.328 billion) - an error of approximately $232 million or 10% overstatement. (2) 2023 Revenue: LLM states $2.70 billion, ground truth is $2,698 million ($2.698 billion) - essentially correct with minor rounding. (3) 2024 Revenue: LLM states $2.82 billion, ground truth is $2,819 million ($2.819 billion) - essentially correct with minor rounding. The 2022 figure is materially incorrect, which undermines the entire analysis of the revenue progression. The LLM also claims 'steady double-digit growth each year' which cannot be verified from the provided numbers and appears to be an unsupported assertion. QUALITATIVE ASSESSMENT: The reasoning about strategic positioning, capacity investments, and Navy supplier role is reasonable and contextually appropriate, but is built on partially incorrect foundational data. The multi-hop synthesis (connecting revenue growth to strategic positioning) is logically sound in structure but compromised by the quantitative errors. ENTITY ACCURACY: General Dynamics and Marine Systems segment are correctly identified. The characterization of surface ships/combatants is appropriate. OVERALL: While the answer demonstrates understanding of the question's intent and provides relevant strategic context, the material error in the 2022 baseline figure (off by ~$232M) is a critical failure for a financial analysis question where precision is paramount. This is not a minor rounding difference but a substantive discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 465,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In 2022 GE described Electric Insurance Company (EIC) as its captive property‑and‑casualty insurer that provided coverage to GE and its employees and held net claim reserves of roughly $0.2 billion (2021) (page 47).  In the fourth quarter of 2022 the subsidiary was re‑classified as a “held‑for‑sale” business, with $541 million of assets and $378 million of liabilities and a $109 million loss recorded in 2023 as the sale process progressed (page 50).  The divestiture was completed in the second quarter of 2024 when GE sold EIC to Riverstone International Holdings for $120 million, eliminating the related assets and liabilities from its balance sheet (page 48).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about GE's relationship with Electric Insurance Company from 2022-2024. STRENGTHS: (1) All key financial figures are correct: $0.2 billion net claim reserves (2021), $541 million assets, $378 million liabilities (2023), $109 million loss, and $120 million sale price (2024). (2) Timeline is accurate: 2022 disclosure, Q4 2022 reclassification as held-for-sale, 2023 loss recognition, Q2 2024 completion of sale. (3) Entity names are correct: Electric Insurance Company (EIC) and Riverstone International Holdings. (4) Multi-hop synthesis is sound: the answer correctly traces the evolution from operational captive insurer → held-for-sale classification → completed divestiture, showing the strategic progression. (5) Classification terminology is precise ('held-for-sale' business). (6) The answer captures the key business context (captive insurer serving GE and employees). MINOR OBSERVATIONS: (1) The LLM notes the loss was 'recorded in 2023 as the sale process progressed' while ground truth states it was 'recorded in connection with the expected sale' - these are semantically equivalent and both accurate. (2) The LLM includes page references which add credibility but aren't in the ground truth (not a negative). (3) The phrase 'eliminating the related assets and liabilities from its balance sheet' is a reasonable inference about the divestiture impact and is accurate. QUANTITATIVE VERIFICATION: All numbers match ground truth exactly with appropriate format variations. No calculation errors detected. The answer successfully synthesizes information across three fiscal years and multiple financial metrics without contradiction or omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 477,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips sold its remaining 91 million CVE common shares in the first quarter of 2022 and directed the cash from that one‑time monetization to buy back 87.7 million of its own shares that year【page_110†L15-L22】.  The company kept the buy‑back momentum, repurchasing 48.6 million shares in 2023 and 49.1 million shares in 2024, and in October 2024 the board raised the total repurchase authorization to $65 billion【page_112†L1-L9】【page_112†L10-L13】.  This evolution shows the CVE sale was used as an initial cash source to kick‑start a larger, ongoing share‑repurchase program, reflecting a capital‑allocation strategy that prioritizes returning excess cash to shareholders through sustained buybacks.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate information on several key points but has notable gaps in completeness compared to the ground truth. CORRECT ELEMENTS: (1) The 91 million CVE shares sold in 2022 (Q1 timing added by LLM, not contradicted by ground truth); (2) The 87.7 million shares repurchased in 2022 from CVE proceeds; (3) The 48.6 million shares repurchased in 2023; (4) The 49.1 million shares repurchased in 2024; (5) The October 2024 board approval raising authorization to $65 billion; (6) The overall narrative that CVE monetization kick-started a larger buyback program. SIGNIFICANT OMISSIONS: (1) The ground truth states 383 million total shares repurchased by end of 2023 at $29 billion cost—the LLM only mentions the 2023 annual repurchase (48.6M) without cumulative totals; (2) The ground truth states 433 million total shares repurchased by end of 2024 at $34.3 billion cost—the LLM only mentions the 2024 annual repurchase (49.1M) without cumulative totals; (3) The ground truth mentions the original $45 billion authorization, while the LLM jumps to the $65 billion total without explaining the progression; (4) The LLM does not provide the cumulative cost figures ($29B through 2023, $34.3B through 2024). QUANTITATIVE ACCURACY: The annual repurchase numbers (87.7M, 48.6M, 49.1M) and the $65B authorization are correct, but the answer lacks the cumulative metrics that are essential to understanding the full scope of the capital allocation strategy. QUALITATIVE ACCURACY: The reasoning about CVE monetization funding the buyback program is sound, and the characterization of the strategy as prioritizing shareholder returns is appropriate. However, the answer doesn't fully capture the 'expansion' aspect of the strategy mentioned in the ground truth (the $20B increase to the authorization). CONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and capital allocation strategy, though it could be stronger by including the cumulative repurchase totals and cost figures that demonstrate the scale and consistency of the program.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 557,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged: the 2022 filing notes that **≈ 59.25 % of the closed block** was reinsured under a modified‑coinsurance agreement and “**accounts for this agreement under the deposit method of accounting**” (page 214); the 2023 filing reports **≈ 59 %** of the closed block reinsured with the same **deposit‑method accounting and offset of the deposit liability with the deposit recoverable** (page 229); and the 2024 filing repeats the **≈ 59 %** figure and the same **deposit‑method treatment with offset** (page 204). This consistency shows MetLife is maintaining a stable, long‑term risk‑transfer strategy for the closed block, using a steady‑percentage modified‑coinsurance structure and a uniform accounting approach to preserve capital efficiency and balance‑sheet clarity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All percentages are correct - 59.25% (2022), 59% (2023), and 59% (2024) match the ground truth exactly. The answer correctly identifies these as approximate percentages of the closed block reinsured. (2) ENTITY AND ACCOUNTING ACCURACY: The LLM correctly identifies MetLife as the company, the modified coinsurance agreement as the instrument, and accurately describes the accounting treatment (deposit method of accounting with offset of deposit liability and deposit recoverable) across all three years. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate years (2022, 2023, 2024) and correctly identifies the consistency pattern - showing that the percentage remained stable at approximately 59% throughout the period. (4) REASONING QUALITY: The LLM properly interprets what this consistency reveals about MetLife's strategy - a stable, long-term risk transfer approach focused on managing longevity risk through structured reinsurance. The conclusion about capital efficiency and balance-sheet clarity is a reasonable inference from the consistent approach. (5) COMPLETENESS: The answer addresses all parts of the multi-part question: the evolution (or lack thereof) of the percentage, the accounting treatment consistency, and what this reveals about long-term strategy. The inclusion of page references adds credibility. Minor note: The answer uses approximate symbols (≈) which is appropriate given the slight variation from 59.25% to 59%, showing nuanced understanding. No calculation errors detected. The semantic meaning aligns perfectly with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 466,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "Target’s filing shows that the share of purchases paid with its credit‑card products (the “Target Credit Cards,” which include the Target MasterCard Credit Card) slipped from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024【page_27】. Because the “Target Credit Cards” category explicitly comprises the Target MasterCard Credit Card【page_23】, this steady decline indicates that consumer engagement with Target’s branded credit offering has been weakening over the three‑year span.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match the ground truth exactly. (2) The LLM correctly identifies the Target MasterCard Credit Card as part of the Target Credit Cards category and accurately traces the three-year downward trend. (3) The multi-hop reasoning is sound - the model correctly synthesizes that the decline indicates weakening consumer engagement. (4) Citation references (page_27, page_23) demonstrate proper source attribution. WEAKNESSES: (1) The LLM answer omits important contextual information present in the ground truth - specifically the rebranding from RedCards to Target Circle Cards in 2024 and the significance that this rebranding did not reverse the decline. (2) The answer does not mention the 5% discount incentive that Target offers with these cards, which provides important context about the company's efforts to maintain engagement despite the declining penetration. (3) The phrase 'consumer engagement with Target's branded credit offering has been weakening' is accurate but less specific than the ground truth's characterization of this as 'a potential challenge in sustaining customer loyalty through financial offerings.' (4) The answer addresses the 'how did it evolve' part of the question well but provides minimal insight into what the trend 'suggests about consumer engagement' - it states engagement is weakening but doesn't explore the implications as thoroughly as the ground truth. The answer is factually accurate on all numbers and core reasoning but lacks the completeness and depth of analysis present in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 454,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. has been listed in PMI’s peer group in every filing – it appears in the 2022 peer‑group table (page 21) and the identical peer‑group listings in the 2023 and 2024 10‑Ks (pages 26 of each) 【page_21】【page_26】【page_26】. The fact that its inclusion never changed shows PMI uses a stable benchmarking set based on global presence, consumer‑product focus and comparable size, treating Colgate‑Palmolive as a consistent reference point for its consumer‑product peers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that Colgate-Palmolive remained consistently in PMI's peer group across 2022-2024, matching the ground truth assertion of 'remained consistently included'; (2) Accurately cites specific page references (page 21 for 2022, pages 26 for 2023 and 2024), demonstrating document verification; (3) Correctly identifies the four benchmarking criteria: global presence, consumer-product focus, comparable net revenues, and market capitalization (though the LLM slightly abbreviates this as 'comparable size'); (4) Properly synthesizes the multi-hop reasoning that consistency across three years indicates a 'stable benchmarking methodology,' which aligns with the ground truth's conclusion about 'stable benchmarking methodology'; (5) Appropriately characterizes Colgate-Palmolive as a 'consistent reference point,' semantically equivalent to the ground truth's emphasis on 'ongoing strategic alignment.' Minor observations: The LLM's phrasing 'identical peer-group listings' is slightly informal compared to ground truth's more formal tone, but this is a stylistic difference, not a factual error. The answer could have been marginally more explicit about the three-year span (2022, 2023, 2024) being the evaluation period, though this is clearly implied. No calculation errors, no incorrect dates or entities, and the multi-hop synthesis correctly connects consistency of inclusion to strategic benchmarking approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 414,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s policy for development‑service + IP‑licensing contracts has been unchanged from 2022 through 2024. In the 2022 filing (p. 59) AMD states that when a license is not distinct it is combined with the development services and revenue is recognized over time; when the license is distinct, revenue is recognized at a point in time, and standalone IP licenses are always recognized at a point in time. The same language appears in the 2023 filing (p. 63) and again in the 2024 filing (p. 64), showing that AMD has applied a consistent accounting approach to these arrangements over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that AMD's policy remained unchanged from 2022-2024, matching the ground truth assertion of consistency; (2) Accurately describes the three-part policy framework: non-distinct licenses combined with development services (recognized over time), distinct licenses recognized at point in time, and standalone IP licenses recognized at point in time; (3) Provides specific page references (p. 59 for 2022, p. 63 for 2023, p. 64 for 2024) showing multi-hop synthesis across three years of filings; (4) Correctly notes the consistent application across all three years. MINOR WEAKNESSES: (1) The answer does not explicitly mention the absence of variable consideration estimates across the three years, which the ground truth specifically highlights as evidence of stable and uniform accounting policy - this is a notable omission that slightly reduces completeness; (2) The answer could have been more explicit about the two-part test for distinctness (capable of being distinct AND distinct in context), though the substance is captured; (3) Does not explicitly state what this consistency 'reveals' about AMD's accounting approach, though the implication is clear. QUANTITATIVE ACCURACY: No numerical errors; page references appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years and properly identifies the policy framework. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with the main substantive difference being the omission of the variable consideration detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 464,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. appears in PMI’s peer‑group list in every filing – it is named among the benchmark companies in the 2022 filing (see page 21), again in the 2023 filing (see page 26), and once more in the 2024 filing (see page 26). The fact that the peer group has remained unchanged, with Colgate‑Palmolive retained each year, shows that PMI deliberately frames its competitive set as a stable cohort of leading global consumer‑product firms, reinforcing its strategic positioning as a peer to major consumer brands beyond the tobacco market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive Co. was included in PM's peer group across all three years (2022, 2023, 2024), matching the ground truth; (2) Accurately conveys the consistency of the peer group across the reporting periods; (3) Provides specific page references (page 21 for 2022, page 26 for 2023 and 2024) which adds credibility, though these cannot be independently verified; (4) Correctly synthesizes the multi-hop information about strategic positioning and competitive framing; (5) Uses appropriate terminology ('PMI' for Philip Morris International, though the question uses 'PM'); (6) Semantic meaning aligns well with ground truth regarding the strategic implications of consistency. MINOR ISSUES: (1) The LLM uses 'PMI' while the question and ground truth use 'PM' - this is a minor notation difference but technically PMI is the correct ticker/abbreviation for Philip Morris International; (2) The LLM adds interpretive language about 'deliberately frames' and 'reinforcing its strategic positioning as a peer to major consumer brands beyond the tobacco market' which goes slightly beyond what the ground truth explicitly states, though this interpretation is reasonable and not contradicted; (3) The ground truth emphasizes 'similar revenue and market capitalization' as selection criteria, which the LLM answer does not explicitly mention, though this is a minor omission. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects the consistency finding to strategic implications about competitive positioning. The logic is sound and the conclusion appropriately reflects the data pattern. QUANTITATIVE ELEMENTS: No calculations required; the factual claims about years and consistency are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 508,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "AMD’s policy for contracts that bundle development services with an IP licence was unchanged from 2022 through 2024. In each filing the company says it first decides whether the licence is a distinct performance‑obligation; if the licence is not distinct it is combined with the development services and revenue is recognized over time, whereas a distinct licence is treated as a separate obligation and revenue is recognized at the point in time the customer can benefit from the licence (2022 p. 59; 2023 p. 63; 2024 p. 64). Thus the approach to performance‑obligation identification and timing of revenue recognition remained consistent over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that AMD's policy remained unchanged/consistent across 2022-2024, matching the ground truth assertion of 'no material changes'; (2) Accurately describes the two-criterion framework for assessing distinctness (capable of being distinct AND distinct in context of arrangement); (3) Correctly states the revenue recognition timing: over time for non-distinct licenses combined with development services, and at point in time for distinct licenses; (4) Provides specific page references (2022 p. 59; 2023 p. 63; 2024 p. 64) that demonstrate multi-hop synthesis across three years of filings; (5) Uses semantically equivalent language ('unchanged,' 'consistent') to convey the same meaning as ground truth's 'remained consistent' and 'no material changes.' Minor considerations: (1) The LLM answer does not explicitly mention the ground truth's detail about 'no variable consideration estimates associated with these arrangements,' though this is a relatively minor omission that doesn't affect the core accuracy of the response; (2) The LLM uses slightly more concise phrasing than the ground truth but maintains all essential information. The answer successfully synthesizes information across three years of SEC filings and correctly identifies the stable nature of AMD's accounting policy. No numerical errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 407,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips completed the monetization of its CVE stake in early 2022, selling the remaining 91 million CVE common shares and applying the cash to its buy‑back program, which repurchased 87.7 million of its own shares that year【page_141】. The company kept the repurchase engine running, buying back 48.6 million shares in 2023【page_110】 and 49.1 million shares in 2024【page_112】, and even raised its total repurchase authorization to $65 billion in October 2024【page_112】. Together, these steps show that the CVE sale acted as a catalyst for a larger, ongoing capital‑allocation strategy that prioritizes returning excess cash to shareholders through systematic share repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. CRITICAL ISSUES: (1) The LLM reports 87.7 million shares repurchased in 2022, 48.6 million in 2023, and 49.1 million in 2024, which sum to only 185.4 million shares. The ground truth states 383 million cumulative repurchases by end of 2023 and 433 million by end of 2024. This represents a massive discrepancy - the LLM is missing approximately 197.6 million shares from the 2023 total and 247.6 million from the 2024 total. (2) The LLM fails to report the total repurchase costs ($29 billion by end of 2023, $34.3 billion by end of 2024), which are critical metrics for understanding capital allocation strategy. (3) The LLM correctly identifies the 91 million CVE shares sold in early 2022 and the $65 billion authorization in October 2024, but these correct facts cannot compensate for the massive understatement of actual repurchase volumes. REASONING ASSESSMENT: The LLM correctly identifies the multi-hop connection between CVE monetization and share repurchases, and appropriately characterizes this as part of a capital allocation strategy. However, the incomplete repurchase data severely limits the ability to assess the 'multi-year progression' requested in the question. The LLM appears to have captured only a subset of annual repurchase data rather than the full cumulative picture. COMPLETENESS: The answer addresses the basic structure of the question but fails to provide the comprehensive financial picture needed to evaluate the 'evolution' and 'trajectory' of the strategy over the three-year period. The missing $34.3 billion total cost figure and the dramatic undercount of shares repurchased represent fundamental gaps in answering a question specifically about multi-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 488,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a clear escalation in competitive‑landscape exposure. In 2022 the company only warned that “future growth … depends on developing new technologies … in increasingly competitive markets” and that rivals could erode returns with after‑market services (2022 p.33). By 2023 the narrative had broadened to a segment‑by‑segment warning that each business – Aerospace, Building Technologies, Performance Materials & Technologies, and Safety & Productivity Solutions – faces “changes in the competitive landscape, including new market entrants and non‑traditional players” (2023 p.31) and the firm highlighted licensing settlements, repositioning actions and acquisition plans to counter those pressures (2023 p.34). In 2024 the same competitive‑risk language persists (2024 p.31) but is now paired with a structural response – a realignment of reportable units, the spin‑off of Advanced Materials and the planned separation of Aerospace and Automation (2024 p.31‑32) – indicating that market pressure has intensified and Honeywell is reshaping its portfolio and pursuing strategic transactions to protect margins and growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core trend of escalating competitive landscape concerns from 2022-2024 and appropriately synthesizes information across multiple years. It accurately captures the evolution from general competitive warnings to segment-specific risks to structural portfolio responses. The mention of specific strategic actions (spin-offs, separations, realignment) is relevant and shows good multi-hop reasoning. The semantic understanding of intensifying market pressure is sound.\n\nWEAKNESSES AND ERRORS: (1) ENTITY ACCURACY ISSUE: The LLM lists 'Aerospace, Building Technologies, Performance Materials & Technologies, and Safety & Productivity Solutions' as the segments facing competitive pressure in 2023. However, the ground truth specifically mentions 'Honeywell Building Technologies and Safety and Productivity Solutions' in 2022, and 'Building Automation and Industrial Automation' in 2024. The LLM appears to have included segments not explicitly mentioned in the ground truth (Aerospace, Performance Materials & Technologies) or used different segment naming conventions. This is a material discrepancy in entity identification. (2) QUANTITATIVE SPECIFICITY: The LLM cites specific page numbers (2022 p.33, 2023 p.31, 2023 p.34, 2024 p.31-32) which cannot be verified against the ground truth and may be hallucinated. The ground truth does not provide page citations. (3) INCOMPLETE ALIGNMENT: The ground truth emphasizes the specific language evolution ('new market entrants and new technologies' → 'product commoditization' concern), while the LLM uses slightly different phrasing ('non-traditional players' instead of 'new market entrants'). (4) MISSING DETAIL: The LLM does not explicitly mention the 'product commoditization' concern that the ground truth identifies as a 2024 development, which represents a qualitative shift in the nature of competitive pressure.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects competitive landscape disclosures to strategic responses (portfolio restructuring). However, the segment identification errors undermine the precision of this synthesis.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the overall trend and strategic implications but contains entity accuracy issues and potentially fabricated page citations that reduce confidence in the factual foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 646,
        "total_tokens": 2197
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "Across 2022‑2024 Mastercard’s Class A shares always carried “one vote per share” and the right to receive dividends (MA 10‑K 2022 p. 96; 2023 p. 99; 2024 p. 92).  The cash dividend per share rose each year – $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024 (same pages).  The unchanged voting entitlement together with a steadily higher payout shows a governance strategy that preserves a stable, one‑share‑one‑vote framework for public owners while progressively enhancing shareholder returns.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUE - FACTUAL ERROR ON CORE QUESTION: The LLM answer introduces dividend per share amounts ($2.04, $2.37, $2.74) that are NOT present in the ground truth answer. The original answer explicitly states there were 'no changes in the description of these rights over the three-year period' and focuses on the CONSISTENCY of voting rights and dividend rights (not the actual dividend amounts paid). The LLM has conflated two different concepts: (1) the structural rights associated with A Class shares (which remained constant), and (2) the actual cash dividend amounts paid per share (which may have varied). The ground truth answer is about the GOVERNANCE STRUCTURE remaining stable, not about dividend payment amounts. The LLM's introduction of specific dividend per share figures represents a factual addition not supported by the ground truth, and potentially contradicts the core finding of 'consistency' by suggesting changes occurred in actual payouts. STRENGTHS: The LLM correctly identifies that voting rights remained 'one vote per share' across all three years and correctly cites the document pages. The reasoning about governance strategy is logically sound. WEAKNESSES: (1) Introduces unsupported numerical claims about dividend amounts, (2) Misinterprets what 'consistency' means in the context (structural rights vs. payout amounts), (3) Adds interpretive analysis ('progressively enhancing shareholder returns') that goes beyond the ground truth's focus on governance stability. The answer partially addresses the question but fundamentally misrepresents the nature of the consistency being discussed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 445,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return‑swap‑deferred‑compensation exposure grew each year – the contracts covered $651 million of notional amount in FY 2022, $792 million in FY 2023 and $985 million in FY 2024【page_92】【page_91】.  The operating‑expense impact shifted from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024【page_92】【page_91】, indicating that the larger exposure moved from a loss‑making position to a profit‑generating one.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key financial figures are correct: (1) Operating expense impacts: $92 million loss in FY2022, $58 million gain in FY2023, $91 million gain in FY2024 - all match ground truth exactly. (2) Notional amounts provided: $651M (FY2022), $792M (FY2023), $985M (FY2024) - these are additional contextual details not in the ground truth but appear to be accurate supplementary information. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the evolution across three fiscal years and identifies the trajectory from loss to gains. (4) Entity accuracy is perfect: Cisco correctly identified, fiscal years correct, Total Return Swaps-Deferred Compensation metric correctly identified. (5) The semantic meaning matches ground truth - both convey the same narrative of reversal from net cost to net benefit. The LLM answer actually provides MORE information than the ground truth by including notional amounts, which enhances understanding without introducing errors. The only minor distinction is that the LLM provides additional context (notional amounts) beyond what was in the original answer, but this is supplementary and accurate rather than contradictory. The answer directly addresses how the financial exposure evolved and explains the gains/losses trajectory clearly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 373,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "By 2022 Johnson & Johnson had set aside roughly $2 billion to fund a trust for LTL Management LLC, the spin‑off created in the 2021 restructuring that filed a Chapter 11 petition and obtained a stay of all talc litigation. In 2023 the original LTL case was dismissed, LTL re‑filed as “LTL 2” (later dismissed as well), the company renamed the entity LLT Management and increased its funding commitment to about $9 billion (covering settlements over 25 years), while pursuing parallel litigation and appeal strategies. In 2024 the firm finalized a multi‑state settlement with the 42‑state/​DC group (agreement in principle in January, closed in June) and advanced a pre‑packaged bankruptcy plan for the successor “Red River” entity that proposes a $6.5 billion present‑value payment, continuing to fund the talc‑liability trust.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth, particularly regarding entity names and financial figures. CRITICAL ERRORS: (1) Entity naming: The LLM claims the company was 'renamed...LLT Management' and later became 'Red River' - the ground truth makes no mention of these name changes. This is a major factual error. (2) Financial figures: The LLM introduces a $9 billion funding commitment and $6.5 billion present-value payment that do not appear in the ground truth. The ground truth only confirms the $2 billion reserve established in 2022. These new figures appear to be fabricated or confused with other information. (3) Timeline accuracy: The LLM correctly identifies 2022 ($2B reserve, Chapter 11 filing), 2023 (dismissal and LTL 2 re-filing), and 2024 (multi-state settlement with 42 states/DC) - these align with ground truth. (4) Multi-state settlement details: The LLM adds specificity about 'agreement in principle in January, closed in June' which is not contradicted but also not confirmed by ground truth. (5) Strategy evolution: The LLM correctly captures the shift from bankruptcy protection to dual strategy of appeals and settlements, matching the ground truth narrative. STRENGTHS: The answer correctly identifies the core timeline, the bankruptcy filings and dismissals, the multi-state settlement scope (42 states + DC), and the strategic shift. WEAKNESSES: Introduction of unsupported entity names (LLT Management, Red River), unsupported financial figures ($9B, $6.5B), and claims about 'pre-packaged bankruptcy plan' not mentioned in ground truth. The answer demonstrates partial understanding of the multi-hop synthesis but introduces significant fabricated details that undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 486,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an unchanged $495 million principal in FY 2022, FY 2023 and FY 2024 – the 2022 filing listed $495 million and the FY 2023 and FY 2024 tables both show $495 million for this tranche【page_81†L31-L38】. The flat balance indicates the company has chosen to keep this low‑cost, fixed‑rate debt on its books rather than prepay or refinance it, reflecting a deliberate strategy of preserving cheap financing until the notes mature.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS: All factual information matches the ground truth - the $495 million principal balance is correctly stated for all three fiscal years (2022, 2023, 2024), and the constancy of this amount is accurately identified. The company name (Broadcom/AVGO), debt instrument (3.125% notes due January 2025), and time period are all correct. (2) QUANTITATIVE ACCURACY: The $495 million figure is precisely correct across all three years, with no calculation errors. The answer correctly identifies that the balance remained unchanged (flat/constant) throughout the period. (3) QUALITATIVE ACCURACY: The LLM provides sound multi-hop reasoning by synthesizing information across three fiscal years and correctly interpreting what the constant balance indicates about debt management strategy. The interpretation that the company chose to preserve low-cost, fixed-rate debt rather than prepay or refinance is a reasonable and logical inference from the data, though slightly more interpretive than the ground truth's more neutral statement about 'consistent approach.' (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - that the principal remained constant at $495 million across the three-year period and this reflects a deliberate debt management strategy. The wording differs but the meaning is equivalent. The LLM adds slightly more strategic interpretation ('preserve cheap financing') which is reasonable inference but goes marginally beyond the ground truth's more neutral characterization. (5) MINOR CONSIDERATIONS: The citation reference【page_81†L31-L38】appears to be a formatting artifact but doesn't detract from accuracy. The answer is comprehensive, addressing both the evolution (constant) and the strategic implications of the debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 503,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50 % senior note due June 15 2025 showed a sharp rise in its effective cost: in FY 2022 the note carried an effective rate of **≈ 3.2 %** (July 30 2022 table)【page_89】; the prior‑year column of the FY 2024 table shows the same note’s effective rate was **≈ 6.4 %** as of July 29 2023【page_89】; and by FY 2024 the effective rate had climbed to **≈ 6.7 %** (July 27 2024 table)【page_89】. This progression indicates that Cisco’s borrowing cost on this fixed‑rate debt more than doubled over the three‑year span, reflecting rising market interest rates and higher financing expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key percentages match the ground truth: FY 2022 effective rate of 3.20% (LLM: ≈3.2%), FY 2023 effective rate of 6.38% (LLM: ≈6.4%), and FY 2024 effective rate of 6.66% (LLM: ≈6.7%). The use of approximation symbols (≈) is appropriate given the rounding, and the format variations are acceptable. The calculation that borrowing costs 'more than doubled' is mathematically sound (3.2% to 6.7% represents approximately a 109% increase). ENTITY ACCURACY: Correctly identifies Cisco, the specific 3.50% June 15, 2025 maturity note, and all three fiscal years (2022, 2023, 2024). MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years and correctly traces the progression of effective interest rates. The interpretation that this reflects 'rising market interest rates and higher financing expenses' is logically sound and consistent with the ground truth's assessment of 'deterioration in financing terms.' COMPLETENESS: Addresses all parts of the question - the evolution of rates across the three-year period and what this indicates about borrowing costs. MINOR NOTES: The LLM provides slightly more specific detail (citing page numbers and table dates) than the ground truth, which adds credibility. The phrase 'more than doubled' is a reasonable characterization of the 109% increase. The only minor difference is the ground truth mentions 'changes in the company's credit profile' as a possible factor, while the LLM focuses on 'rising market interest rates' - both are plausible explanations and not contradictory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 448,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s senior‑plus‑subordinated debt stayed roughly flat over the three‑year span – $30.8 bn at year‑end 2022, rose modestly to $31.2 bn in 2023, then slipped to $30.7 bn in 2024 【page_178†L31-L38】【page_188†L31-L38】. The near‑steady level signals a deliberate “maintain‑capacity” capital‑structure approach, using modest net issuance in 2023 and a slight deleveraging/refinancing in 2024, while the weighted‑average rate on this debt climbed from about 4.48 % in 2022‑23 to roughly 4.84 % in 2024 【page_178†L23-L30】【page_188†L23-L30】, indicating a strategic tilt toward higher‑yielding fixed‑rate notes to lock in rates and manage interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the entire response. (1) MAJOR NUMBER ERROR - 2022 baseline: Ground truth states $27.219 billion, but LLM claims $30.8 billion. This is a $3.6 billion discrepancy (13% error) on the starting point. (2) INTEREST RATE ERROR - 2022 rate: Ground truth clearly states 2.76% for 2022, but LLM claims 'about 4.48% in 2022-23,' conflating 2022 and 2023 rates. The 2023 rate of 4.48% is correct, but attributing it to 2022 is factually wrong. (3) 2023 and 2024 numbers appear approximately correct ($31.2bn and $30.7bn match ground truth), but the 2022 baseline error cascades through the entire analysis. (4) REASONING FLAW: The LLM characterizes the progression as 'roughly flat' and 'near-steady level,' which is semantically incorrect given the ground truth shows a $4.029 billion increase from 2022 to 2023 (14.8% growth), followed by a $552 million decline. This is NOT 'roughly flat' - it's a significant capital raise followed by modest deleveraging. (5) STRATEGIC INTERPRETATION: While the LLM correctly identifies the shift toward fixed-rate financing and interest rate risk management, this insight is undermined by the incorrect baseline numbers and mischaracterization of the magnitude of the 2023 capital raise. (6) MULTI-HOP SYNTHESIS: The model failed to correctly synthesize the 2022 baseline figure across the three-year period, which is fundamental to answering the question about 'evolution' and 'progression.' The answer demonstrates partial understanding of the capital structure strategy but fails on core quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 468,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "In 2022 roughly 40 % of the U.S. pension‑plan fixed‑income portfolio was invested in U.S. Treasury or agency securities; that share fell to about 30 % in 2023 and remained near 30 % in 2024 (CL 10‑K 2022 p. 102; CL 10‑K 2023 p. 101; CL 10‑K 2024 p. 100). The decline signals a deliberate move away from the safest government bonds toward a broader mix of other government and corporate debt, suggesting the pension fund is seeking higher yields or greater diversification rather than relying solely on Treasury/agency exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All percentages are correct - 40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. The page references (CL 10-K 2022 p. 102; CL 10-K 2023 p. 101; CL 10-K 2024 p. 100) provide appropriate sourcing. ENTITY ACCURACY: Colgate-Palmolive correctly identified, U.S. pension plan and fixed income portfolio correctly specified, years 2022-2024 correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes data across three years and correctly identifies the trend (40% → 30% → 30%), demonstrating proper multi-hop synthesis. INTERPRETATION: The LLM's characterization of the shift as 'deliberate move away from the safest government bonds toward a broader mix of other government and corporate debt' aligns with the ground truth's description of 'strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds.' The LLM adds slightly more specific language about 'seeking higher yields or greater diversification' which is semantically equivalent to the ground truth's 'shift in risk tolerance or yield-seeking behavior.' MINOR DIFFERENCES: The LLM uses slightly more detailed language ('safest government bonds,' 'broader mix') compared to the ground truth, but this represents enhanced clarity rather than factual deviation. The reasoning about market conditions and strategic intent is sound and well-supported by the data presented. No calculation errors, no missing key information, and all facts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 437,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In 2022 GE described Electric Insurance Company (EIC) as a captive property‑and‑casualty insurer that primarily insured GE and its employees, reporting net claim reserves of about $0.2 billion (and $0.3 billion a year earlier) [page_45].  By the end of 2023 the subsidiary had been re‑classified as a “held‑for‑sale” disposal group – with $541 million of assets, $378 million of liabilities, a $124 million valuation allowance and a $109 million loss recorded – and a binding sale agreement was signed [page_50].  In the second quarter of 2024 GE completed the sale to Riverstone International Holdings for $120 million, eliminating all EIC assets and liabilities from its balance sheet [page_48][page_46].  This progression shows GE systematically exiting non‑core, run‑off insurance businesses, converting them to cash and sharpening its focus on core industrial operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All key numeric values are correct: $0.2 billion net claim reserves (2021), $541 million assets, $378 million liabilities, $124 million valuation allowance, $109 million loss (2023), and $120 million sale price (2024). (2) Timeline is accurate: 2022 disclosure, 2023 held-for-sale classification with loss recognition, Q2 2024 completion. (3) Entity identification is precise: Electric Insurance Company (EIC), Riverstone International Holdings, GE. (4) Multi-hop synthesis is sound: correctly traces the evolution across three years, connecting classification changes to valuation adjustments to final disposition. (5) Strategic interpretation aligns with ground truth: correctly identifies this as part of GE's broader restructuring to exit non-core insurance and focus on industrial operations. (6) Additional detail provided (prior year $0.3 billion reserves, specific balance sheet line items like $541M assets/$378M liabilities) adds credibility and demonstrates deeper filing analysis. MINOR CONSIDERATIONS: The LLM provides slightly more granular balance sheet detail than the ground truth answer, but this is supplementary rather than contradictory. The characterization of the progression as 'systematic' and 'sharpening focus' is semantically equivalent to the ground truth's 'deliberate move' and 'focusing on core industrial and aerospace operations.' The answer fully addresses all components of the multi-part question: classification evolution, valuation changes, ultimate disposition, and strategic implications. No calculation errors detected. All dates and amounts verified as accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 470,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple’s 10‑K filings have treated the 4.45 % Notes due 2044 exactly the same way each year. In the 2022 filing Apple lists the notes in Exhibit 4.4 – an Officer’s Certificate dated May 6 2014 that “includes … 4.45 % Notes due 2044” (see 2022 10‑K, page 56) ; the 2023 filing repeats the identical description in Exhibit 4.4 (page 53) ; and the 2024 filing again shows the same Exhibit 4.4 wording (pages 56‑58) . The unchanged, multi‑year disclosure shows Apple has kept this long‑dated, low‑coupon bond on its balance sheet without amendment or refinancing, signalling a deliberate strategy of locking in cheap, long‑term debt and maintaining a stable capital structure over many years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All numeric values are correct - the 4.45% coupon rate, the 2044 maturity date, and the May 6, 2014 Officer's Certificate date are all accurate. (2) The multi-hop synthesis across three years (2022, 2023, 2024) is sound - the answer correctly identifies that the same disclosure appears in Exhibit 4.4 across all three filings with no material changes. (3) The specific page references (2022 page 56, 2023 page 53, 2024 pages 56-58) demonstrate detailed verification, though these cannot be independently verified from the ground truth. (4) The reasoning about what the pattern suggests is logical and well-articulated - the answer correctly interprets the unchanged disclosure as indicating a stable capital structure and deliberate debt strategy. (5) The answer goes slightly beyond the ground truth by adding interpretive detail about 'cheap, long-term debt' and 'locking in' rates, which is reasonable inference but adds analytical depth. MINOR CONSIDERATIONS: The ground truth uses more neutral language ('no material changes or retirements'), while the LLM adds strategic interpretation ('deliberate strategy of locking in cheap, long-term debt'). This is not incorrect but represents a slightly more analytical stance. The LLM's characterization of the 4.45% rate as 'low-coupon' is contextually reasonable given historical interest rate environments but represents added interpretation. Overall, the answer demonstrates strong multi-hop reasoning across three years of filings, accurate fact synthesis, and sound logical conclusions about Apple's debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 448,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior‑ and subordinated‑note balances were essentially flat over the three‑year span – $30.8 billion at year‑end 2022, rising modestly to $31.2 billion in 2023 and then slipping slightly to $30.7 billion in 2024 【COF_10k_2023.pdf page 178】【COF_10k_2024.pdf page 188】.  The company kept overall debt levels stable while reshaping the mix of its notes: the floating‑rate senior tranche (≈$1.6 billion in 2022) was eliminated and the share of higher‑coupon fixed senior debt grew, pushing the weighted‑average interest rate on its senior‑note portfolio from roughly 4.5 % in 2022‑23 to about 4.8 % in 2024 【COF_10k_2023.pdf page 178】【COF_10k_2024.pdf page 188】.  This suggests a capital‑structure strategy focused on maintaining a steady debt base but locking in higher fixed rates as market rates rose, thereby managing interest‑rate risk without expanding total leverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine the entire response. (1) MAJOR NUMBER DISCREPANCY: The LLM states 2022 carrying value as '$30.8 billion' when the ground truth clearly shows $27,219 million ($27.2 billion). This is a $3.6 billion error - approximately 13% off. The LLM's 2023 figure of $31.2 billion aligns with ground truth ($31,248 million), and 2024 of $30.7 billion matches ($30,696 million). (2) WEIGHTED-AVERAGE INTEREST RATE ERROR: The LLM claims the rate was 'roughly 4.5% in 2022-23' when ground truth shows 2.76% in 2022 and 4.84% in 2024. The LLM's 4.5% figure for 2022 is off by approximately 1.74 percentage points - a material misrepresentation of the interest rate environment. The 4.8% for 2024 is approximately correct. (3) FLOATING-RATE DEBT CLAIM: The LLM states floating-rate senior debt was 'approximately $1.6 billion in 2022' and was 'eliminated,' but provides no verification against ground truth data. This claim cannot be validated from the provided ground truth. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the overall trend (debt levels relatively stable with a shift from floating to fixed-rate), the foundational numbers are wrong, which corrupts the analysis. The reasoning about capital structure strategy and interest-rate risk management is sound in concept but built on incorrect data. (5) SEMANTIC ISSUES: The characterization of the debt evolution as 'essentially flat' is misleading given the $3.5 billion net increase over three years (12.8% growth from 2022 to 2024), which is not 'flat.' The ground truth explicitly notes this as a 'notable shift' and 'strategic move,' whereas the LLM downplays the magnitude. STRENGTHS: The LLM correctly identifies the strategic intent (locking in fixed rates, managing interest-rate risk) and the general direction of change. The document citations are provided, though the accuracy of the underlying data is questionable. OVERALL ASSESSMENT: This response fails on quantitative accuracy due to the 2022 baseline error and interest rate misstatement, which are fundamental to answering the question about capital structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 590,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K Adobe introduced Frame.io as a “cloud‑native creative collaboration platform” that lets creators upload, review and comment on video, still‑image, design‑file and PDF assets, is directly integrated with **Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and offers “Camera‑to‑Cloud” uploads; it is also made available in **Adobe GenStudio** alongside Express and Firefly Services【page_98】.  \n\n- The 2023 filing repeats the same positioning, emphasizing the same real‑time, frame‑accurate commenting and Camera‑to‑Cloud capabilities and the same set of Creative Cloud apps (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront) while still highlighting its role in GenStudio【page_12】.  \n\n- The 2024 filing keeps the description unchanged, continuing to present Frame.io as a core collaboration hub tightly woven into the Creative Cloud ecosystem and GenStudio, showing Adobe’s consistent strategy of using Frame.io to extend collaborative workflows across its video‑and‑design applications【page_12】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) CHRONOLOGICAL MISALIGNMENT: The LLM claims Frame.io was introduced in the 2022 Form 10-K with full integration into Photoshop, Lightroom, Workfront, and GenStudio. However, the ground truth explicitly states that in 2022, Frame.io was only 'listed as a registered trademark' with no detailed feature descriptions. The detailed positioning as a 'cloud-native creative collaboration platform' with specific integrations (Premiere Pro, After Effects) only appeared in 2023. (2) INTEGRATION TIMELINE ERROR: The LLM incorrectly attributes the expanded integration (Photoshop, Lightroom, Workfront, GenStudio) to 2022, when the ground truth clearly indicates this expansion occurred in 2024. The LLM states these integrations were present in 2022 and remained 'unchanged' through 2023-2024, which is factually incorrect. (3) EVOLUTION NARRATIVE FAILURE: The ground truth describes a clear three-year trajectory of increasing integration and strategic emphasis. The LLM's claim that 2023 and 2024 filings 'repeat the same positioning' and show 'unchanged' descriptions contradicts the ground truth's explicit statement that 'Frame.io's role expanded further' in 2024 with 'deeper integration.' (4) MISSING PROGRESSION: The LLM fails to capture the key distinction that 2022 showed minimal positioning (trademark only), 2023 showed initial detailed positioning with limited integrations, and 2024 showed expanded ecosystem integration. Instead, it presents all three years as having identical comprehensive integration. (5) SOURCE ATTRIBUTION ISSUES: The LLM cites page numbers (page_98, page_12) but the factual content attributed to those pages appears incorrect based on the ground truth's description of what was actually disclosed in each year's filing. The multi-hop reasoning required to synthesize the evolution across three years was fundamentally mishandled.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 534,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s 10‑K exhibit tables for 2022, 2023 and 2024 all list the “Fifteenth Supplemental Indenture … a form of 4.550 % Notes due April 5, 2049” (see Exhibit 4.16 in the 2022 filing [page 82]​, the 2023 filing [page 75]​, and the 2024 filing [page 75]​). By keeping this long‑dated, fixed‑rate tranche in its capital structure, Lowe’s is deliberately extending its debt maturity horizon, locking in moderate borrowing costs and smoothing out refinancing needs, which signals a long‑term strategy to maintain a stable, well‑distributed debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of the question. STRENGTHS: (1) All quantitative data is correct - the 4.550% interest rate, April 5, 2049 maturity date, and consistent inclusion across 2022, 2023, and 2024 filings are all accurate. (2) The specific exhibit references (Exhibit 4.16) and page numbers provided add credibility and demonstrate proper sourcing. (3) The multi-hop reasoning is sound - the model correctly synthesizes information across three years of filings to identify the pattern of consistent inclusion. (4) The strategic interpretation aligns well with the ground truth: both answers recognize that consistent inclusion without modification indicates deliberate capital structure management, stability prioritization, and interest rate risk management. (5) The semantic meaning is equivalent - phrases like 'deliberately extending debt maturity horizon,' 'locking in moderate borrowing costs,' and 'smoothing out refinancing needs' convey the same strategic intent as the ground truth's 'prioritized stability' and 'deliberate approach to managing interest rate risk.' MINOR DIFFERENCES: The LLM answer provides slightly more specific operational detail (mentioning 'Fifteenth Supplemental Indenture' and specific page numbers) which adds value without contradicting the ground truth. The ground truth emphasizes 'absence of disclosures suggesting modifications' while the LLM focuses on the positive strategic intent - both perspectives are complementary and correct. No calculation errors, no factual inaccuracies, and the answer fully addresses the multi-part question about capital structure strategy and debt maturity profile management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 461,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried an outstanding principal of $495 million in fiscal 2023 and the same $495 million in fiscal 2024 (see the senior‑notes table on page 81) [page_81]. The balance has not changed over the three‑year span, indicating the company is retaining this low‑coupon, near‑term debt as a stable source of financing rather than accelerating repayment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $495 million outstanding principal balance for the 3.125% notes due January 2025. (2) The numeric values are accurate and properly formatted. (3) The LLM correctly notes that the balance remained unchanged between fiscal 2023 and 2024. (4) The interpretation about the company retaining low-coupon, near-term debt is reasonable. WEAKNESSES: (1) CRITICAL OMISSION - The question explicitly asks about evolution 'from fiscal 2022 through 2024' (three fiscal years), but the LLM only explicitly addresses fiscal 2023 and 2024, stating 'the balance has not changed over the three-year span' without actually providing the fiscal 2022 figure. While the LLM claims consistency across three years, it fails to explicitly cite the fiscal 2022 balance of $495 million. (2) The LLM provides a page reference (page 81) but doesn't fully document the multi-hop synthesis across all three years as required by the question. (3) The reasoning about debt management strategy is somewhat superficial - the LLM mentions 'retaining this low-coupon, near-term debt' but doesn't fully explore the strategic implications of maintaining the same balance across three years (no early repayment despite approaching maturity). (4) The ground truth emphasizes this was 'consistent across all three fiscal years' and suggests deliberate strategy; the LLM acknowledges consistency but with less emphasis on the deliberate nature of the strategy. CALCULATION VERIFICATION: No calculations required; the $495 million figure is correct. MULTI-HOP REASONING: The LLM should have explicitly synthesized data from three separate fiscal years (2022, 2023, 2024) but only explicitly mentions two years. The claim that 'the balance has not changed over the three-year span' is correct but insufficiently documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 495,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.950 % Notes due 2025 are shown only in the securities‑registration schedule (see page 32), treated as a routine listed debt without a separate instrument reference. The 2023 filing adds a specific incorporation‑by‑reference to the governing indenture (Exhibits 4.1 & 4.2 to Form 8‑K filed May 22 2017) on page 20, giving investors explicit detail on the notes’ rights. The 2024 Form 10‑K again lists the notes in the securities‑registration table (page 1) while retaining the prior instrument reference, indicating IBM’s continued reliance on ultra‑low‑coupon, long‑dated financing and a clear trend toward more granular, transparent disclosure of its capital‑structure components.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 0.950% Notes due 2025 across all three years (2022-2024), accurately references the May 2017 Form 8-K filing date, and correctly notes the incorporation-by-reference to Exhibits 4.1 & 4.2. The answer appropriately characterizes the notes as ultra-low-coupon, long-dated financing. The general progression narrative about increasing transparency is reasonable. WEAKNESSES: (1) The LLM answer introduces specific page numbers (page 32 for 2022, page 20 for 2023, page 1 for 2024) that cannot be verified against the ground truth and may be inaccurate or fabricated. (2) The LLM answer describes the 2022 treatment as 'routine listed debt without a separate instrument reference,' which contradicts the ground truth stating that IBM referenced the May 2017 Form 8-K filing in 2022. (3) The LLM answer characterizes the 2023 change as 'adds a specific incorporation-by-reference,' implying this was new in 2023, when the ground truth indicates the reference existed in 2022 as well. (4) Most significantly, the LLM answer completely omits the critical 2024 development mentioned in the ground truth: IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under ticker IBM25B, representing a major shift from disclosure to active market tradability. This is a substantial omission that weakens the answer's ability to address the question about evolution and capital structure strategy. (5) The LLM answer's conclusion about 'granular, transparent disclosure' is somewhat generic and doesn't capture the strategic significance of the NYSE listing. The multi-hop reasoning is partially sound but incomplete due to the missing NYSE listing information, which is central to understanding the progression from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 482,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "The Form 10‑K for 2022, 2023 and 2024 each states that KPMG LLP’s Public Company Accounting Oversight Board (PCAOB) firm identification number is **185**【page_13】. That same number appears in every filing, showing the PCAOB identifier for KPMG LLP has remained unchanged across all three years【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all parts of the multi-part question. (1) CORRECTNESS: The core factual claim is accurate - KPMG LLP's PCAOB firm identification number is 185 across all three years (2022, 2023, 2024). The answer correctly identifies this number and confirms consistency across the three-year period. (2) QUANTITATIVE ACCURACY: The numeric value (185) is correct and matches the ground truth exactly. No calculations are required for this question, so quantitative accuracy is perfect. (3) ENTITY ACCURACY: All entities are correctly identified - KPMG LLP (correct company name), PCAOB (correct regulatory body), and the three fiscal years (2022, 2023, 2024) are all accurate. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings to demonstrate consistency of the identifier. The reasoning is sound: the same number appears in each filing, therefore it remained unchanged. (5) COMPLETENESS: The answer addresses both parts of the question - it identifies the specific PCAOB number (185) and confirms it remained consistent across all three years. The citation references (page_13, page_14) add credibility, though they are not verifiable in this context. Minor note: The answer uses citation brackets which are stylistic choices that don't affect factual accuracy. The semantic meaning is equivalent to the ground truth - both convey that 185 was the consistent identifier across 2022, 2023, and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 411,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One kept the amount of its fixed‑rate senior unsecured notes roughly flat (≈ $27 billion) but moved the debt to longer maturities and higher coupons. In 2022 the notes spanned 2024‑2034, carried a 0.80 %‑7.62 % coupon range and a weighted‑average rate of about 4.45 % (carrying value $24.1 bn)【page_178】; the same profile persisted in 2023 with the weighted‑average still 4.45 % and a slightly larger balance of $27.2 bn【page_178】. By 2024 the issuance window shifted to 2025‑2035, the low‑end coupon rose to 1.65 % (still up to 7.62 %), and the weighted‑average rate climbed to 4.84 % while the balance was $26.9 bn【page_188】. The trend of modest net issuance combined with higher rates and longer maturities shows Capital One accepting higher funding costs in a rising‑rate environment while extending its debt profile to lock in financing and mitigate refinancing risk, a capital‑structure move aimed at preserving liquidity and stability amid tighter macro‑economic conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CRITICAL NUMBER ERRORS: The LLM claims 2022 weighted-average rate was 4.45%, but ground truth shows 2.91%. This is a massive discrepancy (1.54 percentage points). The LLM also states 2022 carrying value was $24.1bn, but ground truth shows $19,975 million ($19.975bn), a difference of ~$4.1bn or 20%. (2) INCOMPLETE TREND ANALYSIS: The LLM correctly identifies the 2024 weighted-average rate of 4.84% and balance of $26.9bn, matching ground truth. However, the 2022 baseline is fundamentally wrong, making the entire trend analysis invalid. The ground truth shows an increase from $19.975bn to $26.930bn (a $6.955bn or 35% increase), but the LLM's starting point of $24.1bn understates the magnitude of growth. (3) REASONING QUALITY: While the LLM provides sophisticated reasoning about maturity extension, coupon ranges, and macroeconomic response, this reasoning is built on incorrect foundational numbers. The narrative about 'roughly flat' amounts is contradicted by the actual 35% increase shown in ground truth. (4) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize year-over-year changes but fails to correctly establish the 2022 baseline, which cascades through the entire analysis. The claim that amounts stayed 'roughly flat' at ~$27bn is inconsistent with the ground truth showing growth from $19.975bn. (5) PARTIAL CREDIT: The LLM correctly identifies the 2024 endpoint (4.84%, $26.9bn) and correctly notes the strategic shift toward longer maturities and higher rates in response to macroeconomic conditions. The qualitative interpretation about capital structure decisions is reasonable, but it's built on incorrect quantitative foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 483,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "Across AMD’s 2022 (p. 59), 2023 (p. 63) and 2024 (p. 64) 10‑K filings, the revenue‑recognition policy for development‑and‑IP licensing agreements did not change – the company still evaluates whether the license is distinct, treats a non‑distinct license as part of a single performance obligation and recognizes revenue over time, and treats a distinct license as a separate obligation recognized at the point in time the customer can benefit, with no variable consideration. This continuity reflects a deliberate, long‑term strategy to monetize its IP portfolio through a predictable, ASC 606‑aligned framework, emphasizing stable, transparent treatment of IP as a separate revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and accurately cites specific page numbers from 10-K filings (p. 59, 63, 64), showing precise document referencing. (2) Accurately captures the core revenue recognition methodology: the distinctness evaluation framework, the treatment of non-distinct licenses as combined performance obligations recognized over time, and distinct licenses as separate obligations recognized at point in time. (3) Correctly notes the absence of variable consideration across all three years. (4) Properly synthesizes the multi-hop reasoning by connecting the consistent methodology across three years to strategic implications about IP monetization. (5) Uses appropriate technical language (ASC 606-aligned) demonstrating understanding of accounting standards. (6) The conclusion about 'deliberate, long-term strategy' and 'mature and well-defined policy framework' aligns semantically with the ground truth's characterization of 'stable and deliberate strategic approach' and 'mature and well-defined policy framework.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrasing 'predictable, ASC 606-aligned framework' adds helpful context about standards compliance without contradicting the ground truth. No quantitative errors detected. The multi-hop synthesis correctly combines information across three years to draw conclusions about strategic consistency. The answer fully addresses both parts of the question: the evolution (or lack thereof) of methodology and the implications for long-term strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 473,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from $27.2 billion at year‑end 2022 to $31.2 billion at year‑end 2023, then slipped modestly to $30.7 billion at year‑end 2024【page_188】【page_178】【page_188】. The 2023 increase signals a capital‑raising push to support growth, while the slight 2024 decline points to modest refinancing or repayment; concurrently, the weighted‑average rate on senior debt climbed from roughly 2.8 % in 2022 to 4.5 % in 2023 and 4.8 % in 2024, showing a shift toward higher‑cost, longer‑dated fixed‑rate funding as market rates rose【page_188】【page_178】【page_188】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the key financial progression and strategic insights. STRENGTHS: (1) All major dollar amounts are correct and properly formatted: $27.2B (2022), $31.2B (2023), $30.7B (2024) match the ground truth values of $27,219M, $31,248M, and $30,696M respectively. (2) Interest rate progression is substantially correct: 2.8% → 4.5% → 4.8% in the LLM answer vs. 2.91% → 4.45% → 4.84% in ground truth. The minor rounding differences (2.8% vs 2.91%, 4.5% vs 4.45%, 4.8% vs 4.84%) are within acceptable tolerance for financial reporting. (3) The multi-hop synthesis is sound: the answer correctly connects the debt amount changes with interest rate movements and draws appropriate conclusions about capital structure strategy. (4) The reasoning about the shift toward fixed-rate debt and away from floating-rate exposure is logically sound and matches the ground truth narrative. WEAKNESSES: (1) The LLM answer omits a critical detail from the ground truth: the specific reduction in floating unsecured senior debt from $1,709M (2022) to $349M (2023) to complete retirement by 2024. This is a significant strategic indicator that the ground truth explicitly highlights. (2) The explanation for the 2024 decline as 'modest refinancing or repayment' is somewhat vague compared to the ground truth's more definitive statement about the strategic pivot. (3) The phrase 'roughly 2.8%' introduces slight imprecision where the ground truth provides 2.91%. ENTITY ACCURACY: All entities correctly identified (Capital One/COF, senior and subordinated notes, weighted-average interest rates, floating vs. fixed debt). CALCULATION VERIFICATION: No explicit calculations required, but the progression logic is correct. The answer successfully synthesizes information across three fiscal years and connects debt structure changes to interest rate environment changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 519,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from $24.1 billion at year‑end 2022 to $27.2 billion at year‑end 2023, then slipped slightly to $26.9 billion by year‑end 2024, while the weighted‑average interest rate rose from roughly 4.45 % in 2022‑23 to about 4.84 % in 2024【page_178】【page_188】. This pattern shows the firm expanding its fixed‑rate senior borrowing, then modestly trimming the balance and accepting a higher average cost, indicating a focus on managing its long‑term debt profile and adapting to a higher‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics. (1) CARRYING VALUE ERRORS: LLM states 2022 value as '$24.1 billion' when ground truth shows '$19,975 million' ($19.975 billion) - this is a $4.125 billion overstatement (20.6% error). The 2023 and 2024 values are approximately correct ($27.2B and $26.9B match $27,168M and $26,930M). (2) WEIGHTED-AVERAGE INTEREST RATE ERRORS: LLM claims the rate was 'roughly 4.45% in 2022-23' when ground truth clearly shows 2.91% in 2022 and 4.45% in 2023 - this is a major error conflating two different years and missing the critical 2022 baseline of 2.91%. The 2024 rate of 4.84% is correct. (3) MULTI-HOP SYNTHESIS: The LLM failed to properly track the year-over-year progression. The ground truth shows a dramatic increase from 2.91% (2022) to 4.45% (2023) to 4.84% (2024), which is a key insight about the debt strategy. The LLM's statement 'roughly 4.45% in 2022-23' obscures this critical trend. (4) REASONING QUALITY: While the LLM's interpretation about 'managing long-term debt profile and adapting to higher-rate environment' is reasonable and somewhat aligned with ground truth's conclusion, it is built on incorrect foundational data. The LLM correctly identifies the slight decrease from 2023 to 2024 in carrying value and the upward trend in rates, but the 2022 baseline errors undermine the entire analysis. (5) COMPLETENESS: The answer addresses all parts of the question (carrying value evolution, interest rate evolution, strategic implications) but with material factual errors in the data itself.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 445,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed from the 2022 filing (page 59) through the 2023 filing (page 63) to the 2024 filing (page 64). In every year the company says it first determines whether the licensing component is distinct; if the license is not distinct it is combined with the development services and revenue is recognized over time, whereas a distinct license (or a standalone IP license) is recognized at a point in time when the customer can benefit from the license, with no variable‑consideration estimates. The wording of this distinction is identical in all three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about AMD's revenue recognition policy evolution from 2022-2024. Strengths: (1) Correctly identifies that there were NO material changes to the policy across the three-year period, which is the core finding; (2) Accurately describes the key distinction mechanism: non-distinct licenses combined with development services recognized over time, while distinct licenses recognized at point in time; (3) Correctly notes the absence of variable consideration estimates in both combined and standalone arrangements; (4) Provides specific page references (59, 63, 64) for the three filings, demonstrating source verification; (5) Accurately states the wording remained identical across all three years. The answer demonstrates proper multi-hop synthesis by comparing policies across 2022, 2023, and 2024 filings. Minor considerations: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information; (2) The ground truth mentions 'evolving market conditions and ongoing customer arrangements' as context for why the policy remained stable, which the LLM answer doesn't explicitly include, though this is a minor contextual detail rather than a factual error; (3) Both answers convey the same semantic meaning regarding the consistency and mechanics of the policy. No quantitative errors detected. The answer correctly synthesizes information across multiple years and filing documents as required for this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 421,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "COF’s short‑term borrowings fell sharply after 2022 – $883 million at year‑end 2022, $538 million at year‑end 2023 and then edged up to $562 million at year‑end 2024 (Table 8.1, 2022‑2023 → page 178; Table 9.1, 2024 → page 188).  Its long‑term debt rose modestly from $47.8 billion in 2022 to $49.3 billion in 2023, then declined to $45.0 billion in 2024 (Table 8.1, 2022‑2023 → page 178; Table 9.1, 2024 → page 188).  The three‑year pattern shows COF deliberately cut reliance on short‑term funding – likely to reduce refinancing risk and exposure to volatile short‑term rates – while managing the size and composition of its long‑term debt, even as the weighted‑average interest rate on that debt rose from roughly 4.5% in 2022 to about 4.8% in 2024, indicating a modest increase in overall interest‑rate exposure despite the lower total debt level.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth across multiple key metrics:\n\n1. TOTAL DEBT FIGURES - MAJOR DISCREPANCY:\n   - Ground Truth: $43.086B (2022) → $48.715B (2023) → $45.551B (2024)\n   - LLM Answer: ~$48.7B (2022) → ~49.8B (2023) → ~45.6B (2024)\n   - The LLM's 2022 figure of ~$48.7B is approximately $5.6 billion HIGHER than the correct $43.086B. This is a massive error representing a ~13% overstatement.\n   - The LLM correctly identifies the 2024 figure (~$45.6B) but misses the 2022 baseline entirely.\n\n2. WEIGHTED-AVERAGE INTEREST RATE - SIGNIFICANT ERROR:\n   - Ground Truth: 2.76% (2022) → 4.48% (2023) → 4.84% (2024)\n   - LLM Answer: \"roughly 4.5% in 2022 to about 4.8% in 2024\"\n   - The LLM completely misses the 2022 rate of 2.76%, instead claiming it was ~4.5%. This is a 1.74 percentage point error (63% higher than actual).\n   - This fundamentally misrepresents the magnitude of rate increase and the interest rate exposure trajectory.\n\n3. SHORT-TERM BORROWINGS - PARTIAL ACCURACY:\n   - Ground Truth: Included in total figures but not separately detailed\n   - LLM Answer: Provides specific breakdowns ($883M, $538M, $562M)\n   - While these figures may be correct from detailed tables, they represent only a small portion of total debt and don't align with the ground truth's focus on combined short-term and long-term debt totals.\n\n4. MULTI-HOP REASONING FAILURE:\n   - The LLM fails to correctly synthesize the 2022-2024 trend because it starts with an incorrect 2022 baseline.\n   - The ground truth shows debt INCREASED significantly from 2022 to 2023 (up $5.6B), then declined in 2024. The LLM's narrative misses this critical expansion phase.\n   - The interpretation of \"deliberately cut reliance on short-term funding\" may be reasonable, but it's built on incorrect foundational numbers.\n\n5. INTEREST RATE EXPOSURE ANALYSIS - FUNDAMENTALLY FLAWED:\n   - Ground Truth reveals a dramatic rate increase from 2.76% to 4.48% (1.72 percentage points) in one year, then modest further increase to 4.84%.\n   - LLM's claim of \"modest increase\" from ~4.5% to ~4.8% (0.3 percentage points) completely misses the severity of the 2022-2023 rate shock.\n   - This undermines the entire analysis of COF's interest rate exposure strategy.\n\n6. MISSING CONTEXT:\n   - The ground truth explicitly states COF \"initially expanded its debt footprint amid rising rates\" - a key strategic insight the LLM misses due to incorrect 2022 baseline.\n   - The LLM's narrative about reducing refinancing risk is reasonable but not grounded in the correct debt trajectory.\n\nCONCLUSION: While the LLM demonstrates some understanding of debt structure and provides reasonable strategic interpretation, it fails on the most critical requirement: factual accuracy of the core financial metrics. The 2022 debt figure error ($48.7B vs $43.086B) and interest rate error (4.5% vs 2.76%) are disqualifying errors that invalidate the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 796,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s policy for development‑service and IP‑licensing contracts has not changed from the 2022 filing through the 2024 filing. In each year the company says it evaluates whether the licensing component is distinct; a non‑distinct license is combined with the development services as a single performance obligation and revenue is recognized over time, while a distinct license—whether part of a combined arrangement or a standalone IP license—is recognized at a point in time when the customer can benefit. No revisions to this approach were disclosed in the 2023 or 2024 10‑Ks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core finding that AMD's revenue recognition policy for development and IP licensing agreements remained consistent from 2022 to 2024. The answer accurately identifies the key framework: (1) evaluation of whether licensing components are distinct, (2) non-distinct licenses combined with development services as single performance obligations with over-time revenue recognition, and (3) distinct licenses recognized at a point in time. The LLM correctly synthesizes the multi-hop information across three years and properly identifies that no material changes occurred. Quantitative accuracy is perfect—no numbers, dates, or calculations are present in either answer, so no errors exist on this dimension. The LLM's wording differs slightly from the ground truth but conveys semantically equivalent information. Minor differences: (1) The ground truth explicitly mentions 'variable consideration' consistency across years, which the LLM omits—this is a notable detail about the completeness of the policy description. (2) The ground truth references 'increased emphasis on the Gaming segment in 2023 and 2024' as contextual business information, which the LLM does not include. (3) The LLM's phrasing 'when the customer can benefit' is slightly less precise than the ground truth's distinction between 'distinct in capability and context.' These omissions are relatively minor and don't undermine the core accuracy of the answer. The LLM successfully demonstrates multi-hop reasoning by synthesizing policy information across three fiscal years and correctly concluding consistency. The answer directly addresses the question's focus on evolution (or lack thereof) and the distinction between combined arrangements versus standalone licenses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 488,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The fact that Visa’s 10‑K for 2022 lists the “Certificate of Designations of Series B Convertible Participating Preferred Stock” as Exhibit 4.5 (page 111) and the 2023 and 2024 filings again include the same certificate as an exhibit (shown on page 109 for both years) indicates that this preferred‑stock series remains an active part of Visa’s capital structure. The repeated, unchanged disclosure across three consecutive years signals that the instrument is stable and continues to be relevant to the company’s financing framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core concept that the Certificate of Designations of Series B Convertible Participating Preferred Stock appears consistently across Visa's 2022, 2023, and 2024 filings, and appropriately concludes this signals stability and ongoing relevance. However, there are significant quantitative accuracy issues: (1) The LLM states the 2022 filing lists it as 'Exhibit 4.5 (page 111)' and 2023/2024 as 'page 109' - the ground truth specifies Exhibit 4.5 for 2022 and Exhibit 4.4 for 2023/2024, indicating a change in exhibit numbering that the LLM failed to capture. (2) The LLM does not mention the critical filing date of June 21, 2016, which the ground truth emphasizes as consistently referenced across all three years - this is a key detail supporting the 'static but integral' characterization. (3) The LLM's statement that the certificate is 'shown on page 109 for both years' provides page numbers not mentioned in the ground truth and may be inaccurate. The reasoning about stability is sound and semantically equivalent to the ground truth's conclusion, but the LLM missed important exhibit number changes (4.5 to 4.4) and the specific 2016 filing date that anchors the stability argument. The answer demonstrates partial understanding but lacks the precise documentary evidence that supports the ground truth's more nuanced analysis of 'static but integral' status with unchanged terms and conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 399,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "Across 2022, 2023 and 2024 RTX’s Pratt & Whitney consistently owned a **61 % program‑share interest** (and a **49.5 % equity stake**) in International Aero Engines AG, which after accounting for sub‑collaborator shares gave it a **net economic exposure of about 57 % of the V2500 program** (and 51 % of the related IAE LLC)【page_110】【page_99】【page_101】. The unchanged, majority‑owner position over three years signals that Pratt & Whitney is deliberately maintaining a leading, long‑term strategic foothold in the V2500 engine program, preserving both influence and upside.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE VERIFICATION: All key percentages are correct - 61% program-share interest, 49.5% ownership interest, 57% net program share interest, and 51% of IAE LLC are all accurately stated and match the ground truth. The consistency across 2022-2024 is correctly identified. COMPLETENESS: The answer addresses all major components of the question: (1) RTX's stake evolution (correctly showing consistency), (2) economic exposure metrics (all three key percentages provided), (3) multi-year progression (2022-2024 explicitly covered), and (4) strategic positioning implications. ENTITY ACCURACY: RTX, Pratt & Whitney, International Aero Engines AG (IAE), V2500 engine program, and IAE LLC are all correctly identified and contextualized. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects RTX's ownership structure to Pratt & Whitney's operational role, synthesizes the relationship between program-share interest and net economic exposure, and draws appropriate strategic conclusions about maintaining a 'leading, long-term strategic foothold.' The interpretation that unchanged positioning signals deliberate strategic maintenance is reasonable and well-supported. MINOR CONSIDERATIONS: The LLM answer includes slightly more interpretive language ('deliberately maintaining,' 'preserving both influence and upside') compared to the ground truth's more neutral framing ('did not alter its strategic positioning'), but this represents appropriate inference rather than factual error. The inclusion of page references adds credibility. The answer is semantically equivalent to the ground truth while being slightly more interpretive in tone, which is acceptable for strategic analysis questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 498,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic’s 10‑K shows the Non‑Employee Director Deferred Unit Award Agreement appearing in every recent filing – it is listed as Exhibit 10.52 under the 2008 Stock Award and Incentive Plan in FY 2022【page_117】, and re‑appears (renumbered as Exhibit 10.41) in both the FY 2023 and FY 2024 reports【page_115】. The unchanged presence of this deferred‑unit award across three years signals that the company relies on a stable, long‑term director‑compensation framework that uses deferred equity to align non‑employee directors with shareholder interests.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT NUMBERING: The LLM answer contains a fundamental factual error that undermines the entire response. The ground truth states that the agreement was listed as Exhibit 10.41 in 2022 and Exhibit 10.52 in both 2023 and 2024. The LLM answer reverses this, claiming it was Exhibit 10.52 in FY 2022 and renumbered to Exhibit 10.41 in FY 2023 and 2024—the exact opposite of what the ground truth indicates. This is a critical quantitative/factual error that directly contradicts the source material. Additionally, the LLM answer fails to address key aspects of the ground truth: (1) it does not mention the explicit tie to the 2008 Stock Award and Incentive Plan across all three years, (2) it does not note that broader updates occurred to other award agreements under the 2013 plan while this one remained unchanged, (3) it does not explain the significance of the deferred unit award NOT transitioning to newer plan versions. While the LLM correctly identifies that the agreement appeared consistently across all three years and correctly interprets this as indicating a stable compensation strategy, the exhibit numbering errors are severe factual mistakes that cannot be overlooked. The reasoning about stability and long-term alignment is sound, but the specific documentary evidence cited is inverted, making the answer fundamentally unreliable despite capturing the general conclusion about consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 396,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin uses variable‑interest‑rate swaps as **fair‑value hedges** to turn fixed‑rate borrowings into floating‑rate exposure (i.e., “For fixed‑rate borrowings, we may use variable interest rate swaps… designated as fair‑value hedges”【page_66】).  The aggregate notional amount of those swaps was **$1.3 billion in 2022** (reported in the 2023 filing) and remained **$1.3 billion in 2023**【page_95】 and **$1.3 billion in 2024**【page_52】.  The flat notional amount over three years shows that the company has kept a steady, calibrated hedge position rather than expanding or reducing its interest‑rate risk exposure, reflecting a consistent risk‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 notional amount. The ground truth states that in 2022, the notional amount was $500 million, which then increased to $1.3 billion by 2023 and remained at $1.3 billion in 2024. However, the LLM claims the notional amount was $1.3 billion in 2022, which is incorrect. This is a major quantitative error that undermines the entire analysis. The LLM states 'The aggregate notional amount of those swaps was $1.3 billion in 2022' when it should be $500 million. This error cascades through the interpretation: the LLM concludes there was a 'flat notional amount over three years' showing a 'steady, calibrated hedge position,' when in fact there was a significant 160% increase from 2022 to 2023 (from $500M to $1.3B), followed by stabilization. The ground truth explicitly identifies this as 'a strategic shift toward more active interest rate risk management' and 'a tripling of exposure,' which the LLM completely misses due to the incorrect 2022 figure. QUALITATIVE ISSUES: While the LLM correctly identifies that LMT uses fair-value hedges to convert fixed-rate borrowings to floating-rate exposure, it fails to capture the key insight about the evolution and strategic shift in the company's approach. The LLM's conclusion about a 'steady, calibrated hedge position' is contradicted by the actual data progression. The answer does address the question's components (use of swaps, notional amounts, risk management strategy), but reaches incorrect conclusions due to the data error. POSITIVE ASPECTS: The LLM correctly identifies the mechanism (fair-value hedges), the purpose (hedging fixed-rate borrowings), and provides citations. However, these positives cannot overcome the fundamental quantitative error that makes the core answer factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 505,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s charter and by‑law language has remained unchanged – the 2022, 2023 and 2024 Form 10‑K each state that stockholders “may only remove directors for cause” (2022 p.46; 2023 p.27; 2024 p.27). Maintaining this provision for three consecutive years signals a deliberate, steady posture to reinforce its anti‑takeover defenses by limiting shareholder‑initiated director removal and preserving board stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the consistent provision across all three years (2022, 2023, 2024) that stockholders may only remove directors for cause; (2) Accurately cites page numbers (2022 p.46; 2023 p.27; 2024 p.27) which demonstrates proper multi-hop synthesis across three separate 10-K filings; (3) Correctly interprets the strategic implication—that this consistency signals a deliberate anti-takeover defense posture; (4) Properly synthesizes the multi-hop requirement by comparing governance language across three years and drawing conclusions about strategic intent. MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth and omits mention of other complementary anti-takeover provisions (staggered board terms, supermajority voting requirements) that the original answer explicitly references as part of the 'broader set of anti-takeover provisions.' While the LLM correctly identifies the director removal provision as part of anti-takeover defenses, it doesn't elaborate on the ecosystem of related provisions that reinforce this strategy; (2) The phrase 'steady posture' is slightly less formal than the ground truth's 'stable and deliberate governance strategy,' though semantically equivalent. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references are correct. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years of filings and correctly identifies the consistency pattern, then draws appropriate conclusions about strategic intent. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 465,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market funds and time‑deposit holdings fell from **$21 million in 2022 to $10 million in 2023 and stayed at $10 million in 2024** (see the fair‑value tables for 2022/2023 on page 79 and for 2024 on page 84). The roughly 50 % cut and the subsequent flat level, even as total cash rose to $12.8 billion in 2023 and then dropped to $5.5 billion in 2024, indicate the company keeps only a modest, steady cushion of ultra‑short‑term assets for liquidity while using the bulk of its cash for operations, investments or debt‑management purposes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) REVERSED SEQUENCE: The LLM states money market funds/time deposits fell from $21M in 2022 to $10M in 2023 and stayed at $10M in 2024. The ground truth shows the OPPOSITE progression: $12M (2022) → $21M (2023) → $10M (2024). This is a complete reversal of the trend direction. (2) INCORRECT 2022 BASELINE: LLM claims $21M in 2022, but ground truth shows $12M in 2022. (3) INCORRECT 2023 VALUE: LLM claims $10M in 2023, but ground truth shows $21M in 2023. (4) CASH BALANCE ERRORS: LLM states total cash rose to $12.8B in 2023, but ground truth shows $9,201M ($9.2B). The $12.8B figure is not supported by the ground truth data. (5) MISCHARACTERIZATION OF TREND: The LLM describes a 'roughly 50% cut' from 2022-2023, when the ground truth shows a 75% INCREASE from $12M to $21M. The LLM's interpretation of the trend as 'flat level' for 2023-2024 is correct only for that specific period, but the overall narrative is inverted. (6) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year progression and its relationship to overall cash positions. The ground truth narrative of 'initially favored slightly higher placement' followed by 'retreating' is the opposite of what the LLM describes. The only correct element is the 2024 value of $10M and the general concept that the company maintains modest liquidity in these instruments. The answer demonstrates a fundamental misreading or misremembering of the data sequence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 431,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s charter and bylaws have consistently required that stockholders may remove directors **only for cause** – the 2022 Form 10‑K states this provision (page 46) and the same language appears unchanged in the 2023 Form 10‑K (page 27) and again in the 2024 Form 10‑K (page 27). The lack of any amendment to this rule over three years shows that AbbVie is maintaining a stable, long‑term anti‑takeover framework, using the cause‑only removal restriction to make board turnover difficult and thereby deter hostile takeover attempts. (ABBV 2022 p.46; ABBV 2023 p.27; ABBV 2024 p.27)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies the core governance provision across all three years (2022, 2023, 2024) - that stockholders may remove directors only for cause. (2) Accurately cites specific page numbers from each filing (2022 p.46; 2023 p.27; 2024 p.27), demonstrating proper multi-hop synthesis across three separate documents. (3) Correctly characterizes the consistency of this provision as unchanged across the three-year period. (4) Properly interprets the strategic implication - that this stable provision functions as an anti-takeover defense mechanism. (5) Accurately explains the mechanism (making board turnover difficult to deter hostile takeovers). (6) The reasoning is sound: unchanged provision over time → deliberate strategy → anti-takeover defense. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth in some respects (e.g., doesn't explicitly mention 'insulate the board from abrupt changes' or 'discourage activist interventions'), but these are minor omissions that don't affect the core correctness. The answer fully addresses both parts of the multi-part question: (1) how the provision evolved (it didn't - remained consistent), and (2) what this consistency suggests about strategy (anti-takeover defense). All factual claims are verifiable and accurate. No calculation errors or date inconsistencies. The semantic meaning aligns perfectly with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 408,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as an “industry‑first implementation of backside power delivery” that would debut in the future Intel 20A node, promising up to a 15 % performance‑per‑watt gain over Intel 3 (see page_14).  \n- By the 2023 filing the roadmap had shifted, with PowerVia now slated for the upcoming Intel 18A node as the first high‑volume commercial use of backside power (alongside RibbonFET) (see page_12).  \n- The 2024 filing confirms that Intel has cancelled the Intel 20A node and is positioning PowerVia as a core feature of Intel 18A, emphasizing backside power delivery as a key differentiator for performance‑per‑watt and scaling in its advanced‑node strategy (see page_10).  \n\nThis evolution shows Intel moving PowerVia from a distant future concept to an imminent, flagship technology in its near‑term node, indicating a strategic focus on backside power delivery to drive efficiency and competitiveness in its leading‑edge processes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims PowerVia was first announced in 2022 for Intel 20A, but the ground truth states it was 'first introduced' in 2022 as part of future technologies without specifying 20A as the initial target. The LLM's claim that 2023 shifted PowerVia to Intel 18A contradicts ground truth which states 2023 positioned it for Intel 20A. The LLM incorrectly states Intel 20A was cancelled - the ground truth shows a 'strategic pivot' and 'realignment' but doesn't confirm cancellation. (2) TIMELINE MISALIGNMENT: Ground truth shows 2023 emphasized Intel 20A as the introduction point, but LLM claims 2023 shifted to 18A. Ground truth shows 2024 integrated PowerVia into Intel 18A for 2025 HVM, which the LLM partially captures but with wrong prior positioning. (3) MISSING CONTEXT: The LLM adds unsupported details like '15% performance-per-watt gain' and 'RibbonFET' pairing that aren't in the ground truth. The LLM also cites specific page numbers that cannot be verified against the ground truth. (4) MULTI-HOP REASONING: The LLM fails to correctly synthesize the evolution across three years - it misidentifies which node was targeted in which year. The ground truth clearly shows: 2022 (introduction), 2023 (20A positioning), 2024 (18A integration). The LLM reverses the 2023-2024 node assignments. (5) STRATEGIC INTERPRETATION: While the LLM's conclusion about moving from 'distant future concept to imminent flagship technology' aligns directionally with ground truth's 'practical implementation' focus, the factual errors undermine this conclusion's validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 460,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "Medtronic’s Black‑Scholes inputs show volatility rising each year – 23.04 % for fiscal 2022, 24.05 % for fiscal 2023 and 24.29 % for fiscal 2024【page_83】【page_82】. The upward trend signals that the company is progressively using a higher‑volatility assumption, reflecting greater perceived stock‑price uncertainty and resulting in a more conservative (higher) valuation of its non‑qualified stock options over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the ground truth answer and provides incorrect information. CRITICAL ERRORS: (1) The LLM focuses on volatility percentages increasing (23.04% → 24.05% → 24.29%) but this is NOT what the ground truth addresses. The ground truth is about the METHODOLOGY CHANGE in how volatility is calculated, not the numerical values themselves. (2) The LLM completely fails to identify the key evolution: from purely historical volatility (2022) to a blended approach using both historical and implied volatility (2023-2024). This is the central insight of the question. (3) The LLM's interpretation that 'higher volatility = more conservative valuation' is a reasonable financial statement, but it misses the actual story: MDT shifted from a backward-looking (historical only) to a forward-looking (market-based implied) methodology. (4) The LLM provides specific percentage numbers (23.04%, 24.05%, 24.29%) which may or may not be accurate, but even if correct, they distract from and obscure the actual methodological evolution that is the heart of the question. (5) The question explicitly asks about 'how assumptions...evolved' and what this 'suggests about the company's approach' - this is asking about methodology and philosophy, not just numerical trends. The ground truth correctly identifies the shift from historical-only to historical+implied volatility. The LLM answer addresses only the numerical progression of volatility values, not the methodological shift. MULTI-HOP REASONING: The question requires synthesizing information across three years (2022, 2023, 2024) to identify a pattern in methodology. The LLM identifies a numerical pattern but misses the methodological pattern entirely. This represents a fundamental failure in understanding what the question is asking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 494,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "- In the 2022 Form 10‑K Intel first introduced PowerVia as a “future process and packaging technology” – a backside‑power delivery innovation slated for its upcoming Intel 20A node (page 7).  \n- The 2023 filing then positioned PowerVia as one of two breakthrough technologies for Intel 20A, promising up to a 15 % performance‑per‑watt gain over Intel 3 (page 14).  \n- By the 2024 filing Intel had cancelled Intel 20A and folded PowerVia into the Intel 18A node, which is slated for high‑volume production in 2025, indicating that PowerVia has moved from a planned concept to a core component of Intel’s advanced‑process roadmap to drive performance, power efficiency and signal‑routing improvements (page 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the 15% performance-per-watt improvement figure is accurately cited, and the timeline (2022 introduction, 2023 reiteration, 2024 cancellation of 20A/adoption in 18A, 2025 HVM) matches the ground truth precisely. ENTITY ACCURACY: All entities correctly identified - Intel, PowerVia, Intel 20A, Intel 18A, RibbonFET (implied through context), and Panther Lake (mentioned in ground truth but not explicitly in LLM answer). MULTI-HOP REASONING: The LLM successfully synthesizes the three-year evolution across multiple filings, correctly tracing PowerVia's progression from future technology concept (2022) through strategic emphasis (2023) to core component status (2024). The logical connection between node cancellation and PowerVia's retention is sound. COMPLETENESS: The answer addresses all major aspects of the question - development trajectory, strategic positioning, and implications for the advanced process roadmap. The conclusion that PowerVia 'moved from a planned concept to a core component' accurately captures the significance of the evolution. MINOR CONSIDERATIONS: The LLM answer does not explicitly mention RibbonFjet as a complementary technology (mentioned in ground truth as integrated with PowerVia), and does not name Panther Lake as the first processor on Intel 18A. However, these are minor omissions that don't materially affect the core answer's accuracy or completeness. The page references in the LLM answer (pages 7, 14, 10) appear to be specific filing citations, which adds credibility though cannot be independently verified here. Overall, the answer demonstrates excellent synthesis of multi-hop information with accurate facts and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 498,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "- 2022 (10‑K): expected option life 6.0 years, risk‑free rate 0.90 %, volatility 23.04 %, dividend yield 1.95 %【page_84】  \n- 2023 (10‑K): expected life unchanged at 6.0 years, risk‑free 2.70 %, volatility 24.05 %, dividend yield 2.92 %【page_84】  \n- 2024 (10‑K): expected life modestly lengthened to 6.1 years, risk‑free 4.16 %, volatility 24.29 %, dividend yield 3.18 %【page_84】\n\nThe progression shows Medtronic gradually raising both the volatility input and the assumed option‑life (expected life) – a higher volatility estimate reflects a blend of historical and implied market volatility that the company now views as slightly riskier, while the longer expected life signals a more conservative view of when employees will exercise their non‑qualified options.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer provides specific numerical data for Black-Scholes assumptions across all three years (2022-2024), including expected option life, risk-free rates, volatility percentages, and dividend yields. The numbers appear internally consistent and are presented with proper formatting and page citations. The answer correctly identifies that volatility increased from 23.04% (2022) to 24.05% (2023) to 24.29% (2024), and that risk-free rates rose from 0.90% to 2.70% to 4.16%, reflecting realistic market conditions. The observation about expected life lengthening from 6.0 to 6.1 years is noted.\n\nWEAKNESSES: The LLM answer diverges significantly from the ground truth on a critical point. The ground truth explicitly states that in 2023, MDT 'began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility,' and that this method was 'retained in 2024.' This represents a methodological shift in HOW volatility is calculated. The LLM answer mentions 'a blend of historical and implied market volatility' but does not clearly articulate this as a 2023 methodological change or explain the significance of this shift. The ground truth emphasizes this as a key evolution showing 'a shift toward aligning internal assumptions more closely with external market signals,' which the LLM answer only vaguely references.\n\nThe LLM answer characterizes the volatility increase as reflecting 'a higher volatility estimate reflects a blend of historical and implied market volatility that the company now views as slightly riskier,' but this interpretation may conflate the numerical increase with the methodological change. The ground truth suggests the shift to implied volatility was a deliberate strategic choice for more market-informed estimation, not necessarily a view that the company sees the stock as riskier.\n\nMULTI-HOP REASONING: The LLM answer provides year-over-year comparisons but fails to synthesize the key insight from the ground truth: the methodological evolution from pure historical volatility to a hybrid approach incorporating market-traded option data. This is a critical multi-hop element requiring synthesis across the three years to identify the turning point (2023) and its implications.\n\nNUMERICAL VERIFICATION: The specific percentages and rates provided cannot be independently verified against the ground truth, which does not provide these exact figures. However, the ground truth does not contradict them either. The progression logic (increasing volatility, increasing risk-free rates, slightly increasing expected life) is plausible and consistent with 2022-2024 market conditions.\n\nOVERALL ASSESSMENT: The answer provides useful numerical detail but misses the core analytical insight about the methodological shift in volatility estimation that the ground truth emphasizes as the key evolution in MDT's approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 775,
        "total_tokens": 2200
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply from **$1.494 billion in 2022** (see 2023 filing, page 102) to **$491 million in 2024** (see 2024 filing, page 99), a reduction of roughly $1 billion. This decline—recorded against the “Other assets, including intangibles – net” line—suggests the company has been tightening margin requirements or scaling back its net derivative positions, reflecting more efficient and disciplined management of its derivative exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the 2022 starting value ($1.494 billion/$1,494 million) and 2024 ending value ($491 million), matching ground truth exactly. (2) The directional trend is correct—a significant decline over the period. (3) The qualitative interpretation about derivative exposure management and margin requirements is sound and aligns with the ground truth's assessment. (4) The answer appropriately addresses the multi-hop question about changes and what they suggest. (5) Contextual relevance is high—the answer directly addresses the question asked.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely omitted the 2023 intermediate data point ($800 million), which is explicitly stated in the ground truth. This is a significant gap in completeness for a three-year trend analysis. The ground truth specifically notes the progression: $1,494M (2022) → $800M (2023) → $491M (2024), showing a two-step decline. The LLM only shows the endpoints. (2) The calculation of \"roughly $1 billion\" reduction ($1.494B - $0.491B = $1.003B) is mathematically correct, but this calculation obscures the actual trend pattern by skipping the intermediate year. (3) The LLM's interpretation, while reasonable, doesn't capture the nuance that the decline occurred in two distinct phases (2022-2023 and 2023-2024), which could suggest different strategic decisions in different periods.\n\nQUANTITATIVE ACCURACY: The two numbers provided are correct, but the omission of the 2023 figure represents incomplete data presentation for a multi-year trend question. The calculation shown is accurate but doesn't fully capture the trend complexity.\n\nQUALITATIVE ACCURACY: The reasoning about derivative exposure management and margin requirements is sound and well-articulated. The interpretation aligns with ground truth conclusions about strategic reduction and active management.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information about collateral amounts and their implications for derivative management, but fails to fully synthesize the complete three-year trend that would strengthen the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 573,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra’s Level‑3 gas‑option fair‑value stayed near $100 million on the asset side, with the liability side moving from an undisclosed amount in 2022 to $97 million in 2023 and $102 million in 2024. The implied‑volatility assumptions widened from a 17%–295% range (36% weighted‑average) in 2022 to 20%–233% (50% average) in 2023 and then narrowed to 15%–150% (52% average) in 2024, indicating the company is assuming higher, more concentrated gas‑price volatility while keeping net exposure roughly constant—signalling a more aggressive risk posture in its gas‑derivative portfolio【page_84】【page_84】【page_86】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) ASSET VALUES INCORRECT: LLM claims assets 'stayed near $100 million' throughout, but ground truth shows $356M in 2022, dropping to $100M in 2023-2024. This is a critical factual error - the LLM missed the significant $256M decline from 2022 to 2023. (2) LIABILITY VALUES PARTIALLY CORRECT: LLM correctly states $97M (2023) and $102M (2024), but claims 2022 was 'undisclosed' when ground truth clearly shows $347M in 2022 liabilities. This is another major omission. (3) VOLATILITY DIRECTION REVERSED: Ground truth states volatility DECLINED from 36% (2022) to 50% (2023) to 52% (2024), indicating 'reduction in perceived market volatility.' LLM incorrectly interprets this as 'higher, more concentrated gas-price volatility' and 'more aggressive risk posture' - this is a fundamental misreading of the data trend. The volatility percentages themselves are correct (36%, 50%, 52%), but the interpretation is backwards. (4) VOLATILITY RANGE DATA: LLM provides volatility ranges (17%-295%, 20%-233%, 15%-150%) that are not mentioned in the ground truth, making it unclear if these are accurate or fabricated. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the evolution of both asset and liability values across the three-year period, missing the dramatic 2022-2023 decline. (6) RISK POSITIONING CONCLUSION WRONG: Ground truth concludes 'reduction in perceived market volatility and risk,' while LLM concludes 'more aggressive risk posture' - these are contradictory interpretations of the same data. The LLM's conclusion is unsupported by the volatility trend shown.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 443,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "Across the three filings the Unsecured Notes – 35A shows no change – a $750 million face amount (shown as $750,000 in the “thousands” tables) and an annual debt‑service cost of about $19.9 million (shown as $19,875) in the 2022 table (page 50), the 2023 table (page 51) and the 2024 table (page 51). The unchanged figures indicate that Simon Property Group has kept this tranche static, using it as a long‑dated, low‑rate anchor in its debt mix and signaling a deliberate strategy to maintain a stable, diversified long‑term unsecured‑debt profile rather than expanding this particular issuance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental and severe quantitative mistake that undermines the entire response. The LLM states the face amount is '$750 million (shown as $750,000 in the thousands tables)' - this is INCORRECT. The ground truth clearly states the face amount is $750,000 (in thousands), which equals $750,000 total, NOT $750 million. This is a 1,000x magnitude error. The LLM appears to have misinterpreted the filing convention where amounts are shown 'in thousands,' incorrectly converting $750,000 (thousands) to $750 million. Similarly, the annual debt service is stated as '$19.9 million' when it should be $19,875 (in thousands) or approximately $19.875 million - a minor rounding difference, but compounded by the major error above. The ground truth values are: Face amount: $750,000 (in thousands), Annual debt service: $19,875 (in thousands). The LLM's interpretation of these numbers as $750 million and $19.9 million represents a catastrophic misunderstanding of SEC filing conventions. While the LLM correctly identifies that the figures remained stable across 2022-2024 and provides reasonable strategic interpretation about SPG's debt management approach, the foundational numerical errors are disqualifying. The reasoning about debt strategy and stability is sound, but it is built on incorrect financial data. The multi-hop synthesis across three years is logically correct, but the base numbers are fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 404,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments has kept embedded‑processing as a cornerstone of its strategy throughout the period – the 2022 MD&A states that its “great business model … is focused on analog and embedded‑processing products” [page 20]; the 2023 and 2024 MD&A sections repeat that “our strategic focus is on analog and embedded‑processing products” and that the company places extra emphasis on the industrial and automotive markets [page 19 (2023)]; [page 19 (2024)].  Nevertheless, the financial contribution of that segment has shifted: embedded‑processing revenue was $3.26 bn in 2022, rose modestly to $3.37 bn (+3 %) in 2023, then fell sharply to $2.53 bn (‑25 %) in 2024, with operating profit dropping from $1.25 bn (2022) to $1.01 bn (2023) and $352 m (2024) [page 20 (2022)]; [page 20 (2023)]; [page 20 (2024)].  This three‑year progression shows TI’s long‑term commitment to embed‑processing as a strategic growth engine, while also revealing that the business is now confronting market headwinds that have compressed revenue and margins – underscoring the need to leverage its broad portfolio and manufacturing scale to sustain its competitive position in the semiconductor industry.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a comprehensive response that addresses the multi-hop question effectively. STRENGTHS: (1) Correctly identifies the consistent strategic emphasis on embedded processing across 2022-2024, matching the ground truth's core finding. (2) Properly synthesizes information from multiple years' MD&A sections with appropriate citations. (3) Adds valuable quantitative analysis showing revenue and operating profit trends that the ground truth doesn't explicitly provide but are relevant to understanding the 3-year progression. (4) Correctly identifies the shift from growth (+3% in 2023) to decline (-25% in 2024), demonstrating sound multi-hop reasoning. (5) Appropriately contextualizes the strategic commitment alongside market headwinds. WEAKNESSES/CONCERNS: (1) The specific financial figures provided (embedded-processing revenue of $3.26bn, $3.37bn, $2.53bn and operating profit of $1.25bn, $1.01bn, $352m) cannot be verified against the ground truth, which does not provide these specific numbers. While the LLM cites page numbers, the ground truth does not confirm these exact figures. This introduces uncertainty about quantitative accuracy. (2) The ground truth emphasizes the 'consistency' and 'stability' of the strategy, while the LLM introduces a narrative of 'market headwinds' and 'compressed revenue and margins' - this is a reasonable interpretation but goes beyond what the ground truth explicitly states. (3) Minor: The LLM uses 'embed-processing' (hyphenation inconsistency) in one instance. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects strategic positioning to financial performance, which is sound reasoning. The conclusion about leveraging portfolio and manufacturing scale is a logical inference from the data presented. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - embedded processing remained a strategic cornerstone with consistent emphasis, though the LLM adds financial performance context not in the ground truth. The quantitative data, while unverified, appears internally consistent (3% growth, then 25% decline) and supports the narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 580,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "In 2022 Comcast’s wireless service was sold only as part of a qualifying broadband bundle and customers could choose between an unlimited‑data plan, a shared‑data plan, or a pay‑per‑gigabyte option【CMCSA_10k_2022.pdf page_5】. By 2024 the bundled‑‑only positioning remained, but the company added a prepaid unlimited‑data option under the NOW brand, expanding the menu of payment and plan choices while still offering unlimited, shared‑data and per‑gigabyte options【CMCSA_10k_2024.pdf page_5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about CMCSA's shared data plan strategy evolution from 2022 to 2024. Strengths: (1) Correctly identifies the three plan types available in 2022 (unlimited, shared data, per-gigabyte), (2) Accurately notes the bundled-only positioning remained consistent through 2024, (3) Correctly identifies the 2024 introduction of prepaid unlimited data plans under the NOW brand, (4) Properly synthesizes multi-hop information across 2022 and 2024 filings, (5) Cites appropriate source documents with page numbers. Minor omissions: (1) The answer does not mention 2023 data, which the ground truth explicitly includes as a middle year showing maintenance of the structure. The ground truth states 'In 2023, the company maintained this structure' with 'similar device financing terms,' providing a more complete three-year narrative. (2) The ground truth mentions '24 months' device financing options in 2022 and 2023, which the LLM answer omits. (3) The ground truth emphasizes that shared data plans remained 'a core part of bundled offerings across all three years,' while the LLM focuses primarily on 2022 and 2024. The LLM answer is accurate in what it states but less comprehensive in covering the full 2022-2024 period. The characterization of the evolution as 'strategic expansion' in 2024 while 'maintaining shared data plans' aligns well with the ground truth's framing. No factual errors detected; the omission of 2023 and device financing details represents incompleteness rather than incorrectness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 431,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew from a $51.4 billion negative balance at year‑end 2022 to $60.4 billion at year‑end 2023 and $71.4 billion at year‑end 2024【page_71†L31-L38】【page_71†L39-L46】【page_70†L31-L38】.  The company’s annual purchases of treasury stock also rose, from $8.8 billion in 2022 to $9.1 billion in 2023 and $11.0 billion in 2024【page_72†L31-L38】【page_73†L31-L38】【page_70†L43-L50】.  This expanding repurchase activity shows Mastercard is increasingly allocating cash to buy back shares, reflecting a capital‑allocation focus on returning excess capital to shareholders and signaling confidence in its valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The treasury stock balances are correctly stated as $51.4 billion (2022), $60.4 billion (2023), and $71.4 billion (2024). These match the ground truth values of $(36,658) million, $(60,429) million, and $(71,431) million when converted to billions ($36.658B ≈ $51.4B discrepancy noted - see below). The annual purchase amounts of $8.8B (2022), $9.1B (2023), and $11.0B (2024) are provided with appropriate detail. CRITICAL ISSUE: There is a numerical discrepancy in the 2022 figure. The ground truth states $(36,658) million = $36.658 billion, but the LLM states $51.4 billion for 2022. This is a significant variance of approximately $14.7 billion. However, the 2023 and 2024 figures align well ($60.4B and $71.4B respectively). The LLM may be using a different reporting basis or including additional components. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple years and connects the treasury stock evolution to capital allocation strategy. The logic is sound: increasing buybacks → confidence in valuation → shareholder value return. COMPLETENESS: The answer addresses both parts of the question - the evolution of treasury stock AND what it suggests about capital allocation strategy. The inclusion of annual purchase amounts adds valuable context beyond the ground truth. SEMANTIC EQUIVALENCE: The interpretation that growing treasury stock balances reflect 'stock buybacks' and 'returning excess capital to shareholders' aligns with the ground truth's characterization of 'growing emphasis on stock buybacks' and 'desire to return value to shareholders.' MINOR WEAKNESS: The 2022 balance discrepancy (51.4B vs 36.658B) prevents a perfect score, though this could reflect different accounting treatments or reporting methodologies not visible in the ground truth. The overall narrative and trend analysis remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 526,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics’ “Repair and other services” line fell from **$1.169 billion in 2022 to $1.132 billion in 2023 and stayed at $1.132 billion in 2024** – a total drop of $37 million (about 3 %)【page_9】. The modest decline in 2023 followed by a flat result in 2024 suggests the service business experienced a slight contraction but then stabilized, indicating a plateau in its growth trajectory over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.169 billion (2022), $1.132 billion (2023), and $1.132 billion (2024) match the ground truth exactly. The calculated decline of $37 million is accurate ($1,169M - $1,132M = $37M), and the percentage decline of approximately 3% is correct (37/1,169 ≈ 3.16%, rounded to 3%). The format variation ($1.169 billion vs $1,169 million) is acceptable and properly handled. COMPLETENESS: The answer addresses all parts of the multi-part question - it provides the specific revenue figures for all three years, calculates the change, and interprets the pattern. ENTITY ACCURACY: General Dynamics is correctly identified, the metric 'Repair and other services' is accurate, and all fiscal years (2022, 2023, 2024) are correct. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified the 2023 decline followed by 2024 stabilization, and drew a logical conclusion about the service business trajectory (contraction followed by plateau). The interpretation that the business 'stabilized' after the initial decline is a reasonable inference from the flat 2024 result. SEMANTIC EQUIVALENCE: The LLM's characterization of 'slight contraction but then stabilized' is semantically equivalent to the ground truth's 'stagnation or potential contraction' - both convey a negative or flat trajectory. The only minor difference is the LLM's slightly more optimistic framing of 'stabilization' versus the ground truth's 'stagnation,' but both are defensible interpretations of the same data pattern. No material errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 455,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "In 2022 CVS held residential mortgage‑backed securities (RMBS) with a fair‑value of about $757 million and an unrealized loss of $89 million 【page_148】; by the end of 2023 the fair‑value had risen to roughly $810 million while the unrealized loss had narrowed to $60 million 【page_148】【page_149】. In the separate‑account portfolio the RMBS holding grew from $51 million at 12/31/2023 to $71 million at 12/31/2024 【page_160】, and the prior decline in unrealized losses suggests the market value of the securities continued to improve. Together, the higher fair‑values, the shrinking loss cushion and the modest increase in exposure indicate that CVS has been able to reduce the risk profile of its RMBS positions and is maintaining a cautiously expanded, but more comfortably‑priced, exposure to this asset class.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all three years examined. (1) QUANTITATIVE ERRORS - 2022: LLM states fair value of $757M and unrealized loss of $89M, but ground truth shows $629M fair value and $10M unrealized loss (differences of $128M and $79M respectively). 2023: LLM claims fair value rose to $810M with unrealized loss of $60M, but ground truth shows fair value dropped to $614M (LLM is off by $196M in the wrong direction). 2024: LLM correctly identifies $71M in the separate-account portfolio but this represents only a portion of total holdings. (2) DIRECTIONAL ERRORS - The LLM fundamentally mischaracterizes the trend. Ground truth shows a clear de-risking strategy with RMBS holdings declining from $629M (2022) to $614M (2023) to $71M (2024), with unrealized losses worsening from $10M to $60M before the sharp reduction. The LLM incorrectly claims fair values 'rose' in 2023 and interprets the trajectory as 'cautiously expanded' exposure, which is the opposite of what occurred. (3) REASONING FAILURE - The LLM's conclusion that CVS is 'maintaining a cautiously expanded' exposure contradicts the actual 88.4% reduction in RMBS holdings from 2022 to 2024. The statement about 'shrinking loss cushion' and 'more comfortably-priced exposure' misinterprets the data. (4) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize the three-year trajectory, instead presenting disconnected observations that don't form a coherent narrative of the company's actual de-risking strategy. The answer demonstrates a fundamental misreading of the source documents and arrives at conclusions opposite to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 462,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "Linde’s on‑site contracts for atmospheric gases stayed fundamentally the same from 2022 through 2024 – they are long‑term (10‑20 year) total‑requirement agreements that contain minimum‑purchase obligations, price‑escalation clauses and a variable‑consideration element tied to external price indices, which the company consistently characterises as “constrained” under ASC 606 (2022 p.96; 2023 p.100; 2024 p.87). The only material shift was the size of the future revenue pool tied to those minimum‑purchase commitments, which rose from roughly $48 billion in the 2023 filing to about $58 billion in the 2024 filing, reflecting growth in on‑site supply arrangements (2023 p.102; 2024 p.89).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core contractual structure (10-20 year on-site contracts with minimum purchase requirements, price escalation clauses, and variable pricing tied to indices). It accurately characterizes these as 'constrained' under ASC 606 and correctly notes the consistency of this structure across 2022-2024. The answer appropriately addresses the multi-hop synthesis of contract evolution and pricing mechanisms. The page citations (2023 p.100, 2024 p.87, etc.) demonstrate specific sourcing.\n\nWEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific dollar figures ($48 billion in 2023, $58 billion in 2024) that cannot be verified against the ground truth. The ground truth does not mention these specific revenue pool figures, and the LLM's claim about a $10 billion increase appears to be unsupported or potentially fabricated. This is a critical error for a financial question. (2) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes a key evolution: in 2023, Linde 'explicitly noted' variable pricing details that 'were not detailed in 2022,' representing a shift in transparency/disclosure. The LLM mentions variable consideration but doesn't capture this 2022-to-2023 disclosure evolution as clearly. (3) MISSING ASC 606 CONTEXT - The ground truth highlights growing emphasis on 'transparency in pricing mechanisms and contract performance under ASC 606' and the 'practical expedient for measuring progress toward performance obligations.' The LLM mentions ASC 606 but doesn't fully capture the evolution in how Linde disclosed these mechanisms. (4) CITATION CONCERNS - While page numbers are provided, the specific figures cited ($48B, $58B) lack corroboration in the ground truth, suggesting potential hallucination of supporting data.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across three years but relies on unverified quantitative claims that undermine the analysis. The qualitative reasoning about contract structure is sound, but the quantitative pivot (revenue pool growth) introduces factual uncertainty.\n\nVERIFICATION: The ground truth does not mention $48B or $58B figures. This represents a significant quantitative accuracy failure, as these specific numbers cannot be confirmed and may be incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 616,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "- At 12/31/2022 NEE’s net notional exposure to forward natural‑gas contracts was **‑1,307 MMBtu**【page_85】.  \n- At 12/31/2023 the exposure widened to **‑1,452 MMBtu**【page_85】, indicating a larger net short (forward‑sale) position.  \n- By 12/31/2024 it had been trimmed to **‑1,131 MMBtu**【page_87】.  \n\nThe three‑year pattern shows the company increased its gas‑market hedge (or short exposure) in 2023, then reduced that exposure in 2024, suggesting a shift toward a more moderate risk posture in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 2,
      "detailed_feedback": "CRITICAL MISMATCH: The LLM answer reports notional exposure in MMBtu (physical quantity units) while the ground truth provides net exposure in millions of dollars (financial value). These are fundamentally different metrics measuring different aspects of gas market exposure. The LLM's numbers (-1,307 MMBtu, -1,452 MMBtu, -1,131 MMBtu) are completely incompatible with the ground truth's dollar values ($160M, $300M, $250M). While the LLM correctly identifies the directional trend (increase then decrease), it answers a different question entirely - reporting notional contract volumes rather than net financial exposure. The ground truth specifically asks about 'net exposure' which is calculated as assets minus liabilities in dollar terms ($191M - $31M = $160M in 2022, etc.). The LLM's interpretation of 'net short position' in MMBtu terms is a valid financial metric but does not address the question as posed in the ground truth. The LLM does correctly identify the three-year pattern (2023 increase, 2024 decrease) and provides reasonable qualitative interpretation, but the quantitative foundation is entirely wrong for the specific question asked. This represents a fundamental failure to provide the correct financial metric requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 350,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across all three years Broadcom kept industrial‑fiber‑optics as a core line‑item of its “Industrial” segment, listed alongside optocouplers, motion encoders, LEDs and Ethernet ICs. In the 2022 filing it appeared under a generic “Industrial End Markets” description, while the 2023 and 2024 filings moved it into a more focused “Factory Automation, Renewable Energy and Automotive Electronic Solutions” section and added “industrial and medical sensors” to the product set—yet the cited end‑use markets (industrial automation, power generation/distribution, medical, defense/aerospace, and vehicle subsystems such as EV power‑train, infotainment and ADAS) remained the same. Thus the positioning of industrial fiber optics stayed stable, with only a slight re‑grouping and modest expansion of the surrounding industrial product portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AVGO's Industrial Fiber Optics positioning across the three-year period and correctly identifies the core narrative: stable strategic role with modest organizational/grouping changes. STRENGTHS: (1) Correctly identifies Industrial Fiber Optics as a consistent core product line across 2022-2023-2024; (2) Accurately notes the shift from generic 'Industrial End Markets' description to more focused 'Factory Automation, Renewable Energy and Automotive Electronic Solutions' framing in 2023-2024; (3) Properly identifies companion products (optocouplers, motion encoders/control, LEDs, Ethernet ICs, sensors); (4) Correctly lists end-use markets (industrial automation, power generation, medical, defense/aerospace, automotive/EV); (5) Reaches the correct conclusion about stability with modest re-grouping. MINOR ISSUES: (1) The LLM states 'added industrial and medical sensors to the product set' which slightly overstates the change—the ground truth indicates sensors were listed in 2023 alongside other products, not necessarily a new addition; (2) The phrasing 'moved it into a more focused section' is interpretive and not explicitly confirmed in ground truth language, though the characterization appears reasonable; (3) The answer could be more explicit about the 2022 description being broader/more generic versus the later years' more structured categorization. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the evolution pattern (stable core with organizational refinement). The logic connecting product groupings to market positioning is sound. ENTITY ACCURACY: Company correctly identified as Broadcom (AVGO), years correct (2022, 2023, 2024), product names and markets correctly cited. No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy is based on factual correctness of categorical/descriptive information rather than calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 545,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "- In the 2022 10‑K, the Unsecured Notes – 31B carried a 3.25 % rate, a $750 million face amount and $24,375 thousand of annual debt service (interest)【page_48】.  \n- The 2023 filing shows the same figures – $750 million face and $24,375 thousand interest expense【page_50】.  \n- The 2024 filing again reports the note unchanged at a $750 million face amount with $24,375 thousand of annual interest cost【page_51】.  \n\nThe note’s face amount and interest obligation have stayed flat over the three years, indicating Simon Property Group is maintaining this low‑to‑moderate‑rate tranche of long‑dated unsecured debt rather than expanding or refinancing it, a sign of a deliberate strategy to preserve stable, low‑cost long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - face amount of $750 million (consistent across 2022-2024), annual debt service of $24,375 thousand ($24.375 million), and interest rate of 3.25%. The format variations ($750 million vs $750,000,000) are appropriately handled. COMPLETENESS: The answer addresses all three years (2022, 2023, 2024) and covers both the face amount and interest obligations as requested. ENTITY ACCURACY: SPG (Simon Property Group) is correctly identified, the specific instrument (Unsecured Notes - 31B) is properly referenced, and all fiscal years are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the pattern of stability - no changes in any metric across the three-year period. STRATEGIC INTERPRETATION: The LLM provides sound analysis of what the stability reveals about debt strategy, noting the deliberate preservation of low-cost long-term financing rather than refinancing or restructuring. This interpretation aligns with the ground truth's conclusion about a 'stable long-term debt strategy.' MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('low-to-moderate-rate tranche' vs ground truth's simpler 'stable long-term debt strategy'), but this represents semantic enrichment rather than error. The citation references to specific pages add credibility. No calculation errors detected, and the logical flow from data presentation to strategic conclusion is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 436,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ U.S. defined‑contribution‑plan expense grew from $70 million in 2022 to $75 million in 2023 and to $76 million in 2024【TXN_10k_2023 page_44】【TXN_10k_2024 page_43】. The upward trend shows the company is steadily increasing its funding of employee retirement benefits, reflecting a stronger commitment to supporting workers’ retirement savings.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all three years' expense figures ($70M in 2022, $75M in 2023, $76M in 2024) and accurately describes the upward trend. The numbers match the ground truth exactly. However, the answer has one notable omission: it does not calculate or mention the 8.6% total increase from 2022 to 2024 that was included in the original answer. The LLM provides appropriate source citations (TXN_10k_2023 page_44 and TXN_10k_2024 page_43), which adds credibility. The qualitative interpretation is sound - the answer correctly characterizes the trend as showing steady growth and increased commitment to employee retirement benefits. The reasoning about what the trend indicates is logically sound and semantically equivalent to the ground truth's interpretation. The main weakness is the incomplete quantitative analysis - while the LLM describes the trend qualitatively, it fails to provide the specific percentage calculation that would fully address the question's request for what the 3-year trend 'indicates.' This is a minor but measurable gap in completeness for a financial analysis question where numerical precision is expected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 328,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD’s 10‑K disclosures show the same treatment each year: the ROIC metric “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” in 2022 (p. 47), 2023 (p. 50) and 2024 (p. 49). The unchanged exclusion of non‑economic items indicates that GD uses a stable performance‑evaluation methodology that isolates pure operating returns on capital and avoids distortion from accounting adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies GD's consistent treatment of non-economic accounting changes across all three years (2022, 2023, 2024), matching the ground truth assertion of stability; (2) Provides specific page references (p. 47, p. 50, p. 49) that add credibility and demonstrate source verification; (3) Accurately quotes the exclusion rationale ('not reflective of company performance'), showing direct evidence from filings; (4) Correctly synthesizes the multi-hop requirement by comparing treatment across three years and drawing the appropriate conclusion about methodology consistency; (5) Uses semantically equivalent language to the ground truth ('stable methodology,' 'disciplined approach,' 'isolates pure operating returns') while adding specific supporting details. Minor considerations: (1) The LLM provides page numbers which, while helpful, are not explicitly required by the question and could be subject to variation depending on filing format; (2) The answer is slightly more detailed than the ground truth but this represents added value rather than error. The core factual claim—that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022-2024—is correct and well-evidenced. The reasoning about what this consistency reveals (stable, disciplined methodology) is sound and matches the ground truth interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 396,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS’s “Separate Accounts assets” were $3,313 million at year‑end 2022, slipped slightly to $3,250 million in 2023, and then rose to $3,311 million in 2024【page_157†L13-L20】【page_108†L31-L38】.  Because these assets are carried at fair value and are set aside to meet the obligations of long‑term insurance contracts【page_156†L1-L9】, the three‑year pattern of essentially flat levels – a modest dip in 2023 followed by a rebound in 2024 – suggests CVS is maintaining a steady investment positioning for its long‑duration insurance products rather than expanding or contracting its separate‑account holdings dramatically.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth states CVS's Separate Accounts Assets were $5,087 million in 2022, but the LLM claims $3,313 million. This is a $1,774 million discrepancy (35% understatement) - a massive error that invalidates the entire trend analysis. The 2023 ($3,250M) and 2024 ($3,311M) figures are correct, but the missing 2022 baseline completely changes the narrative. TREND INTERPRETATION ERROR: Because the LLM used the wrong 2022 figure, it incorrectly characterized the trend as 'essentially flat levels' with 'modest dip' and 'rebound.' The actual trend is a dramatic 36% decline from 2022 to 2023 ($5,087M to $3,250M), followed by marginal recovery in 2024 ($3,311M). This represents a 'significant decline' followed by 'stabilization' (per ground truth), not a flat pattern. The LLM's conclusion about 'steady investment positioning' is semantically opposite to the ground truth's assessment of 'strategic reduction or market-driven devaluation.' POSITIVE ELEMENTS: The LLM correctly identified the 2023 and 2024 values, properly explained that separate accounts are carried at fair value for long-term insurance obligations, and attempted multi-hop synthesis. However, these strengths are overwhelmed by the critical 2022 data error that undermines the entire analysis. The reasoning quality is reasonable, but it's applied to incorrect data, making the conclusion fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 414,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement with TD Bank USA, N.A. was originally executed on October 22 2012 and, as disclosed in the 2022 and 2023 Form 10‑K exhibit lists, had a First Amendment (February 24 2015) and a Second Amendment (November 19 2019) (see page 69)【page_69】. The 2024 Form 10‑K expands that list to include a Third Amendment dated November 1 2022 and a supplemental Letter Agreement dated March 8 2023 (see pages 74‑75)【page_74】【page_75】, showing the agreement’s continued amendment and refinement through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims a 'Third Amendment dated November 1 2022' and a 'supplemental Letter Agreement dated March 8 2023' exist in the 2024 Form 10-K. However, the ground truth explicitly states that by 2024, only the Second Amendment dated November 19, 2019 was listed - no Third Amendment or supplemental Letter Agreement from 2022-2023 are mentioned in the original answer. This is a major factual error. (2) INCOMPLETE/INCORRECT SYNTHESIS: The ground truth clearly documents the evolution as: Original agreement (October 22, 2012) → First Amendment (February 24, 2015) → Second Amendment (November 19, 2019). The LLM fabricated additional amendments not present in the ground truth. (3) DATE ACCURACY: While the LLM correctly identifies October 22, 2012 (original), February 24, 2015 (First Amendment), and November 19, 2019 (Second Amendment), it adds unsupported dates (November 1, 2022 and March 8, 2023) that are not in the ground truth. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022-2024 evolution. The ground truth shows the agreement remained in effect with the same amendments across all three years, not expanding with new amendments as the LLM claims. (5) CITATION ISSUES: The LLM provides page references (69, 74-75) that cannot be verified against the ground truth provided, and the claim about 2024 Form 10-K showing additional amendments directly contradicts the ground truth statement that only the Second Amendment (November 19, 2019) was 'explicitly listed' in 2024. The core narrative of 'continued amendment and refinement through 2024' is unsupported by the ground truth, which indicates the relationship was sustained but not expanded with new amendments in 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 505,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "In 2022 Linde’s rare gases (krypton, neon and xenon) were described as co‑products of its market‑leading non‑cryogenic air‑separation platforms, with the company stressing proprietary VPSA and membrane technologies that set its atmospheric‑gases business apart【page_4】. By 2023 the firm was already leveraging its engineering capability to support gases production – inter‑segment sales from Engineering to the industrial‑gases business rose to $1.5 bn in 2023 (up from $1.0 bn in 2022)【page_98】. In the 2024 filing Linde positions rare‑gas (noble‑gas) production within its Engineering segment, supplying dedicated plant components and integrating those assets across the full value chain—from production and storage to distribution and clean‑energy applications—thereby deepening its technological differentiation and tying rare gases more tightly to its broader product lines【page_5】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Linde's rare gases strategy from 2022-2024, accurately names specific rare gases (krypton, neon, xenon), and correctly identifies technological innovations (VPSA and membrane separation). The answer appropriately emphasizes the shift toward integration with broader product lines and the Engineering segment's role. The multi-hop reasoning connecting Engineering segment sales to rare gases production is sound.\n\nWEAKNESSES: (1) QUANTITATIVE ERRORS: The LLM cites specific inter-segment sales figures ($1.5bn in 2023, $1.0bn in 2022) that are NOT present in the ground truth answer. These numbers appear to be fabricated or sourced from unreliable data, as the original answer makes no mention of these specific dollar amounts. This is a critical factual error. (2) INCOMPLETE COVERAGE: The LLM answer omits important details from the ground truth about 2022-2023 positioning, specifically: the description of rare gases as 'primary atmospheric gases' in 2022, the three core distribution methods (on-site, merchant, packaged), and the emphasis on long-term contracts with price escalation clauses in 2023. (3) STRUCTURAL SHIFT: The ground truth describes a progression from 'product-centric to technology- and integration-driven approach,' while the LLM answer jumps more directly to the 2024 positioning without clearly establishing the 2022-2023 baseline.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years and segments (Engineering to industrial gases), which is appropriate for the question. However, the introduction of unsupported financial figures undermines the credibility of this synthesis. The connection between Engineering segment sales and rare gases production is logical but not explicitly supported by the ground truth.\n\nNUMBER VERIFICATION: The $1.5bn and $1.0bn figures cannot be verified against the ground truth and appear to be hallucinated or incorrectly sourced. This is a significant accuracy issue that prevents a higher score despite otherwise reasonable qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 564,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply – $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024 (2023 10‑K Note 13; 2024 10‑K Note 13). The decline indicates that the company’s net exposure to derivative liabilities tied to its advances/receivables from equity‑company partners is diminishing, suggesting reduced reliance on margin collateral and a lower overall risk profile for those relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three collateral values are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The format variation ($1.494 billion vs $1,494 million) is acceptable and properly handled. The declining trend is accurately captured. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) how the collateral evolved from 2022-2024, and (2) what this trend suggests about derivative liability exposure. ENTITY ACCURACY: Company (ExxonMobil), metric (collateral under master netting arrangements), relationship type (equity company advances), and time period (2022-2024) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral values to reduced derivative liability exposure and interprets this as de-risking/portfolio optimization. The interpretation that lower collateral indicates 'reduced reliance on margin collateral and a lower overall risk profile' is logically consistent with the ground truth's characterization of 'strategic reduction in exposure' and 'de-risking.' MINOR DIFFERENCES: The LLM provides slightly more specific interpretation ('reduced reliance on margin collateral') compared to the ground truth's more general 'de-risking or portfolio optimization efforts,' but this represents appropriate elaboration rather than error. The citation references (2023 10-K Note 13; 2024 10-K Note 13) add credibility though they cannot be independently verified from the provided context. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the question's multi-hop requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 471,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s net‑generating capacity covered by long‑term bilateral contracts rose from roughly 92 % in 2022 (the 2022 filing) to about 94 % in 2023 (the 2024 filing) and stayed near 94 % in 2024 (the 2024 filing)【page_19】【page_18】【page_19】.  The modest increase and subsequent plateau show the company is deliberately locking in a larger share of its output through long‑term contracts to hedge price risk and reduce exposure in competitive wholesale markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct percentages (92% in 2022, 94% in 2023 and 2024) and proper identification of the trend (steady increase then plateau). The multi-hop synthesis across years is sound, correctly extracting data from multiple filings and comparing them chronologically. The reasoning about risk mitigation and hedging strategy is logically sound and semantically equivalent to the ground truth. Minor weaknesses: (1) The LLM answer uses slightly less precise language ('roughly 92%', 'about 94%', 'near 94%') compared to the ground truth's definitive percentages, though this is a minor stylistic difference that doesn't affect factual accuracy. (2) The LLM answer omits one detail present in the ground truth - the explicit mention that 'the company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place' - which provides additional context about the complete risk mitigation strategy. (3) The phrase 'modest increase and subsequent plateau' accurately captures the trend but uses slightly different terminology than 'consistent rise' in the ground truth. All numeric values are correct, the entity (NEER) is properly identified, the time period (2022-2024) is accurate, and the interpretation of what the trend suggests about risk mitigation strategy is appropriate and well-reasoned. The answer successfully addresses both parts of the multi-part question: the evolution of reliance on long-term contracts AND what it suggests about risk mitigation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 428,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an outstanding principal of **$495 million in fiscal 2022, $495 million in fiscal 2023, and $495 million in fiscal 2024**【page_101】【page_81】.  The balance did not change over the three‑year period, indicating that the company has chosen to keep this low‑coupon, fixed‑rate instrument on its books rather than repaying or refinancing it early – a clear sign that AVGO is preserving cheap, long‑dated debt until its scheduled maturity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. QUANTITATIVE ACCURACY: All financial figures are accurate - $495 million is correctly stated for all three fiscal years (2022, 2023, 2024), and the instrument details (3.125% notes due January 2025) are correct. The consistency of the balance across all three years is accurately captured. COMPLETENESS: The answer addresses the core question about how the balance evolved (remained constant) and provides interpretation of the debt management strategy. ENTITY ACCURACY: AVGO ticker, fiscal years, note terms, and maturity date are all correct. REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop information - tracking the same instrument across three fiscal years and drawing a logical conclusion about debt management strategy. The interpretation that AVGO is preserving cheap, long-dated debt until maturity is reasonable and aligns with the ground truth's suggestion of refinancing or using cash reserves. SEMANTIC EQUIVALENCE: The LLM's characterization ('preserving cheap, long‑dated debt until its scheduled maturity') is semantically equivalent to the ground truth's assessment ('planning to refinance or use cash reserves to settle the obligation rather than amortizing it'). Both convey that the company is not reducing principal and is managing the debt strategically. MINOR DIFFERENCES: The LLM's interpretation emphasizes 'preserving cheap debt' while the ground truth emphasizes 'refinancing or cash settlement' - both are valid interpretations of the same underlying strategy, though they frame it slightly differently. The LLM's answer is slightly more specific about the rationale (low-coupon advantage) while the ground truth is more neutral about the mechanism. Both are reasonable debt management interpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 491,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "- 2022 (10‑K as of 12/31/2021) the unsecured notes 37B carried a 2.25 % coupon, a $700 million face amount and a maturity of January 15 2032【page_50】.  \n- 2023 (10‑K as of 12/31/2022) the same notes were reported with identical terms – 2.25 % interest, $700 million face, maturing 01/15/32【page_51】.  \n- 2024 (10‑K as of 12/31/2023) the notes still show a 2.25 % rate, $700 million face amount and a Jan 15 2032 maturity【page_51】.  \n\nThe three‑year consistency shows Simon Property Group deliberately locked in low‑cost, long‑dated unsecured debt, preserving liquidity and shielding the balance sheet from rising rates and refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700,000,000 face amount, and January 15, 2032 maturity date are accurately reported for all three years (2022, 2023, 2024). The date format variations (01/15/32 vs January 15, 2032) are acceptable and semantically equivalent. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) interest rate evolution, (2) face amount evolution, and (3) maturity date evolution, plus the strategic interpretation requested. ENTITY ACCURACY: Simon Property Group is correctly identified, the specific debt instrument (unsecured notes - 37B) is properly referenced, and all three fiscal years are correctly mapped to their corresponding 10-K filings. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate annual filings and draws a logical conclusion about the company's debt strategy. The interpretation that the consistency reflects a deliberate strategy to lock in low-cost, long-dated debt while managing refinancing risk is sound and aligns with the ground truth's assessment of maintaining predictable financing costs. MINOR OBSERVATIONS: The LLM answer includes page references (page_50, page_51) which add credibility but are not required. The strategic interpretation is slightly different in wording from the ground truth (\"shielding the balance sheet from rising rates and refinancing risk\" vs \"extending liability durations to align with real estate portfolio\"), but both interpretations are valid and complementary perspectives on the same underlying strategy. No calculation errors detected. The answer fully satisfies the question requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 480,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in the property tables of the 2022, 2023 and 2024 Form 10‑K as a principal manufacturing/design location marked only for **Analog** (an “X” under Analog and no mark under Embedded Processing) – in 2022 it is noted with footnote † and in 2023‑2024 with footnote ** (both indicating a mix of owned and leased space)【page_18】【page_16】【page_16】. The classification never changed, showing that over the three‑year span TI kept Melaka dedicated to analog production and did not expand any embedded‑processing capability there.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and the consistent pattern of Melaka being marked only for Analog with no Embedded Processing designation. (2) Accurately notes the footnote changes († in 2022, ** in 2023-2024) indicating owned/leased space mix, which adds valuable contextual detail. (3) Properly synthesizes the multi-hop information: identifies the location (Melaka, Malaysia), the company (Texas Instruments/TI), the product categories (Analog vs Embedded Processing), and the temporal progression across three years. (4) Correctly concludes that the operational footprint remained stable and analog-focused with no expansion into embedded processing. (5) Provides appropriate page references to source documents. (6) The reasoning is sound: the consistent 'X' marking for Analog across all three years combined with the absence of any Embedded Processing marking clearly demonstrates a targeted, stable strategy. MINOR CONSIDERATIONS: The LLM answer includes slightly more technical detail (footnote references and page numbers) than the ground truth, but this represents added value rather than inaccuracy. The semantic meaning is fully aligned with the original answer - both convey that Melaka maintained an analog-only focus throughout 2022-2024 without diversification into embedded processing. No numerical errors, calculation errors, or factual inaccuracies detected. The answer fully addresses all components of the multi-part question regarding evolution, consistency, and strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 438,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "In 2022 Mastercard’s 10‑K described a multi‑layered security program that protected its core network from cyber and information‑security threats while supporting real‑time payment capabilities in 12 markets. By 2023 the firm added dedicated Security Operations Centers, Fusion Centers, an Intelligence Center and technical‑standard collaborations (e.g., EMV) to secure the expanding real‑time payment flows, and in 2024 it further hardened the ecosystem with third‑party assessments, public‑private partnerships, real‑time fraud‑scoring and tokenization, extending its real‑time clearing and settlement infrastructure to 13 markets worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but contains a critical chronological error and incomplete synthesis. CORRECT ELEMENTS: (1) 2022 baseline of 12 markets with multi-layered security is accurate; (2) 2023 expansion to 13 markets is correct; (3) Mention of EMV, fraud-scoring, tokenization, and public-private partnerships aligns with ground truth; (4) General evolution narrative is sound. CRITICAL ERRORS: (1) The LLM states 2023 added 'Security Operations Centers, Fusion Centers, an Intelligence Center' but the ground truth does not mention these specific entities in 2023 - this appears to be either fabricated or misplaced chronologically; (2) The LLM reverses the market count progression by stating '13 markets worldwide' at the end of 2024, but ground truth shows 12 markets in 2022 and 13 in 2023, with no explicit expansion number given for 2024. INCOMPLETE SYNTHESIS: (1) The LLM fails to address the China joint venture expansion mentioned in ground truth as a key 2024 development requiring security framework scaling; (2) Missing the explicit connection between China market entry and the need to maintain network integrity while processing domestic transactions; (3) Does not adequately explain how the security framework evolved specifically in response to this new market entry. QUANTITATIVE ISSUES: The market count progression is muddled - the answer suggests 13 markets by 2024 but doesn't clarify whether this represents growth from 2023 or if additional expansion occurred. The ground truth clearly shows 12→13 progression from 2022→2023, but 2024 status is ambiguous in the LLM response. REASONING QUALITY: The multi-hop synthesis is partially successful in connecting security measures to market expansion, but fails to fully integrate the China market entry as a pivotal 2024 evolution point. The answer reads more as a list of security features rather than a coherent narrative of how security evolved in response to specific market expansions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 535,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics built 360 new LAVs for the Canadian Army in 2022, increased production to 399 units in 2023, and further raised output to 449 units in 2024 (GD_10k_2022.pdf p.11; GD_10k_2023.pdf p.11; GD_10k_2024.pdf p.10). The steady rise in volumes shows a clear strategic emphasis on expanding its LAV business and deepening the partnership with the Canadian Army.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. All quantitative data is correct: 360 units (2022), 399 units (2023), and 449 units (2024) match the ground truth exactly. The progression is accurately presented with proper chronological ordering. The LLM correctly identifies General Dynamics as the company and the Canadian Army as the customer. The reasoning about strategic emphasis is sound and semantically equivalent to the ground truth - both convey that the upward trajectory indicates growing strategic focus and commitment to the LAV program. The LLM adds specific document citations (GD_10k_2022.pdf p.11, etc.) which enhances credibility, though these cannot be independently verified. The phrase 'deepening the partnership with the Canadian Army' is a reasonable semantic equivalent to 'deepening commitment to fulfilling international demand for armored mobility platforms.' The answer fully addresses both parts of the question: (1) how production evolved (the numbers and trend), and (2) what this indicates about strategic focus (expanding LAV business and deepening partnership). Minor note: The LLM uses 'built' rather than 'produced' and 'expanding its LAV business' rather than 'expanding defense contracts,' but these are stylistic variations that don't affect factual accuracy. The multi-hop synthesis across three years of data is executed correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 390,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS’s pension plan held about **$225 million of hedge‑fund limited‑partnership interests in 2022**, which rose to **≈$252 million in 2023** and **≈$280 million in 2024**【page_174†L31-L34】【page_173†L31-L34】【page_167†L31-L34】. Over the three‑year period the hedge‑fund slice grew roughly 24 % (≈$55 million) and the plan’s target hedge‑fund allocation rose from 3 % to 4 %【page_175†L1-L4】【page_169†L1-L4】, indicating CVS is deliberately increasing its exposure to hedge‑fund alternatives to diversify the pension portfolio and pursue higher return potential.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth: (1) WRONG NUMBERS: LLM states 2022=$225M, 2023=$252M, 2024=$280M, but ground truth shows 2022=$214M, 2023=$225M, 2024=$252M. The LLM has shifted all values upward and misaligned them to wrong years. (2) WRONG CALCULATION: LLM claims 24% growth (~$55M increase), but ground truth shows 17.8% growth ($38M increase from $214M to $252M). The LLM's calculation is mathematically incorrect for the stated numbers and doesn't match the actual trajectory. (3) YEAR MISALIGNMENT: The LLM appears to have the 2023 and 2024 values swapped or shifted, creating a false narrative of acceleration. (4) MISSING BASELINE: The LLM fails to identify the correct 2022 starting point of $214M, which is crucial for understanding the three-year trajectory. (5) INCORRECT INTERPRETATION: While the LLM correctly identifies an upward trend and mentions diversification strategy, the underlying numbers are wrong, making the entire analysis unreliable. (6) ALLOCATION PERCENTAGE CLAIM: The LLM mentions target allocation rising from 3% to 4%, which cannot be verified against the ground truth provided and appears to be unsupported. The answer demonstrates a fundamental failure in multi-hop synthesis - it has conflated or misread the year-to-year data points, resulting in a completely different financial narrative than what the source documents actually show.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 404,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The share of purchases made with Target’s MasterCard‑based credit product fell each year – it was about 20.5 % of all RedCard purchases in fiscal 2022, slipped to 19.8 % in 2023, and dropped further to 18.6 % in 2024【page_27】. This steady decline signals that, while the card still commands a sizable portion of spend, consumer adoption and engagement with Target’s branded credit offering is gradually weakening.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN KEY METRIC: The LLM provides 18.6% for 2024, but the ground truth states 17.8% for 2024. This is a material discrepancy of 0.8 percentage points on a key financial metric that directly answers the core question. The 2022 (20.5%) and 2023 (19.8%) figures are correct. STRENGTHS: (1) The LLM correctly identifies the three-year trend of consistent decline; (2) The interpretation that this signals weakening consumer adoption is accurate and aligns with ground truth reasoning; (3) The contextual framing about RedCard purchases is appropriate; (4) The semantic understanding of the trend's implications is sound. WEAKNESSES: (1) The 2024 figure of 18.6% is factually incorrect - should be 17.8%; (2) The LLM answer is less comprehensive than ground truth - it omits important context about why the decline occurred (RedCard sales increased in dollar terms but total sales grew faster, diluting proportional use); (3) Missing discussion of potential causes (shifting consumer preferences, increased competition, reduced sensitivity to discount incentive); (4) The phrase 'about 20.5%' for 2022 introduces unnecessary vagueness when exact figures are available. MULTI-HOP REASONING: The LLM successfully synthesizes the three-year trend and connects it to consumer behavior implications, but the factual error on the final year undermines the reliability of the analysis. The error appears to be a data retrieval or transcription mistake rather than a reasoning failure. For a financial question where precision is paramount, a 0.8 percentage point error on the most recent year is significant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 441,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "NextEra Energy’s fair‑value exposure for FPL Cost Recovery Clauses grew from $2 million in 2022, to $12 million in 2023, and $38 million in 2024 (NEE_10k_2023.pdf p55; NEE_10k_2023.pdf p53; NEE_10k_2024.pdf p55). The makeup shifted from a $5 million negative contribution from significant other observable inputs offset by $7 million from significant unobservable inputs in 2022, to a larger $12 million negative other‑observable offset by $24 million unobservable in 2023, and finally to a positive $4 million other‑observable plus $34 million unobservable in 2024, showing a move toward greater reliance on unobservable inputs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 total fair value figure. Ground truth states $1 million for 2022, but LLM claims $2 million. This is a fundamental error that undermines the entire analysis. Additionally, the 2022 component breakdown is incorrect: Ground truth shows -$5 million (other observable) and +$6 million (unobservable), but LLM states -$5 million and +$7 million. The $7 million figure is wrong; it should be $6 million. These are not minor rounding differences but actual data errors. The 2023 and 2024 figures are correct ($12M and $38M total, with accurate component breakdowns for those years). The qualitative analysis and reasoning about the shift toward greater reliance on unobservable inputs is sound and well-articulated. The multi-hop synthesis across years is logically structured. However, the quantitative errors in 2022 (both total and components) are serious factual mistakes that significantly impact the credibility of the answer. The answer correctly identifies the trend and provides appropriate context, but the foundational data errors prevent a higher score. The citation references provided appear reasonable but the underlying numbers extracted are inaccurate for 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 357,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s filings from 2022 through 2024 all list Anta as a principal global rival and repeatedly stress that Nike’s edge comes from “continuous technical innovation” – citing the rollout of Nike Air, Zoom, Flyknit, FlyEase, React and related platforms in each year’s product‑research section (2022 p.6; 2024 p.6) – and from a “consumer connection, engagement and affinity” built on digital commerce, social‑media interaction and high‑profile athlete, influencer and event partnerships (2022 p.8; 2024 p.8). The language has become marginally more integrated, but the core positioning—out‑innovating and out‑engaging Anta through superior product technology and digital brand experiences—remains unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) FACTUAL ERRORS - The LLM claims specific product platforms (Nike Air, Zoom, Flyknit, FlyEase, React) appear in 'each year's product-research section (2022 p.6; 2024 p.6)' with page citations. This is problematic because: (a) the ground truth does not mention these specific product platforms at all, (b) page citations cannot be verified and appear fabricated, (c) the claim that these appear 'in each year' contradicts the ground truth's narrative of EVOLUTION and CHANGE across years. (2) INCOMPLETE EVOLUTION NARRATIVE - The LLM states positioning 'remains unchanged' which directly contradicts the ground truth's core finding that NKE's emphasis EVOLVED from 'quality, performance, reliability' (2022) → 'innovation and development' elevated ahead of performance (2023) → further solidified innovation focus with digital engagement emphasis (2024). The ground truth explicitly describes a 'strategic shift' and 'multi-year strategic effort,' not stasis. (3) MISSING KEY DETAILS - The LLM omits the specific 2023 strategic shift where 'innovation and development' was elevated in importance, which is a critical turning point in the competitive positioning narrative. (4) SEMANTIC MISALIGNMENT - While the LLM correctly identifies Anta as a named competitor and mentions innovation/digital engagement, it frames these as 'unchanged' rather than 'evolved,' fundamentally misrepresenting the temporal dimension of the question. (5) CITATION CONCERNS - The specific page references (2022 p.6; 2024 p.6; 2022 p.8; 2024 p.8) cannot be verified against the ground truth and appear to be hallucinated details. WHAT WAS CORRECT: The LLM correctly identifies Anta as a principal competitor, correctly emphasizes innovation and digital engagement as key differentiators, and correctly notes these are core to Nike's positioning. The general framing of 'out-innovating and out-engaging' is semantically aligned with the ground truth. However, the failure to capture the evolution/shift across the three-year period is a fundamental error in answering a question explicitly about 'how has...evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 566,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The Form 10‑K tables for 2022, 2023 and 2024 all list the remaining shares only for the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan, with **no shares shown as available under the 2003 Director Compensation Plan** (see footnote (c) in the 2022 filing [TXN_10k_2022 p.63], the 2023 filing [TXN_10k_2023 p.61] and the 2024 filing [TXN_10k_2024 p.61]). This consistent lack of any remaining pool indicates that the 2003 plan’s share reserve has been fully exhausted and TI is no longer using that plan for new director compensation, relying instead on newer plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM claims that 'no shares shown as available under the 2003 Director Compensation Plan' across all three years (2022, 2023, 2024), and that the plan's share reserve has been 'fully exhausted.' However, the ground truth explicitly states that 'In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it.' This is a critical discrepancy. The LLM's assertion that there were zero shares available in 2022 contradicts the ground truth's indication that the plan was still active with shares being issued in that year. The LLM also misses the key evolution described in the ground truth: the plan transitioned from being active in 2022 to being phased out by 2023-2024. The LLM's conclusion about 'consistent lack of any remaining pool' across all three years is factually incorrect based on the ground truth. While the LLM correctly identifies that TI shifted to newer plans (2024 LTIP, 2018 Director Plan) and correctly cites the relevant filings and page numbers, the core claim about the 2003 plan's availability trajectory is wrong. The answer fails to capture the actual evolution from 2022 (active) to 2023-2024 (phased out), instead presenting a static picture of zero availability throughout. This represents a failure in multi-hop reasoning and factual accuracy on the primary question being asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 400,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "CMCSA’s advertising business started in 2022 by already providing “technology, tools, data‑driven services and marketplace solutions” to media‑industry customers (Advertising p. 10). In 2023 it layered those capabilities onto new digital properties – launching the NOW streaming service and extending data‑driven ad targeting through the rollout of DOCSIS 4.0 and multigigabit broadband that expanded network capacity for richer audience data (Advertising p. 6; Network & Technology p. 7). By 2024 the firm further upgraded its stack with advanced proprietary wireless gateways and an expanded Xumo Stream Box (formerly Flex), while continuing to offer enhanced technology, tools, data‑driven services and marketplace solutions across X1, Sky Q, NOW and other platforms (Advertising p. 8; Xumo Stream Box p. 5).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) DOCSIS 4.0 and multigigabit broadband are network infrastructure improvements, not advertising service enhancements - this conflates network technology with advertising data-driven services. (2) The NOW streaming service launch is mentioned but is not directly relevant to advertising offerings evolution. (3) Xumo Stream Box and wireless gateways are hardware/platform products, not advertising technology enhancements. (4) The answer lacks the core ground truth elements: no mention of cloud-based platforms, integrated search functionality, or strengthened representation agreements with third parties. (5) The answer provides specific page citations that cannot be verified against the ground truth, suggesting potential hallucination of sources. (6) While the answer correctly identifies 2022-2024 timeline and mentions data-driven services, it fundamentally mischaracterizes the nature of CMCSA's advertising evolution by mixing unrelated product launches and network infrastructure improvements with advertising service enhancements. The ground truth emphasizes integration of data-driven services into the advertising ecosystem and enhanced targeting precision through representation agreements, while the LLM answer focuses on streaming services and network hardware. The multi-hop reasoning fails because it doesn't properly synthesize how advertising capabilities specifically evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 427,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "In 2022 CVS reported commercial‑mortgage‑backed securities (CMBS) with a fair‑value of **$1.018 billion** and **$155 million** of unrealized losses (page_147). By year‑end 2023 the CMBS position had slipped to **$975 million** fair‑value and **$100 million** of unrealized losses (page_148). The 2024 filing shows the only disclosed CMBS holding – in its Separate Accounts – was **$3 million** (down from $6 million a year earlier) and no unrealized loss was reported (page_160), indicating CVS has dramatically trimmed its CMBS exposure and is moving to a much lower‑risk stance in this asset class.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors across all key metrics. QUANTITATIVE ERRORS: (1) 2022 CMBS fair value: LLM states $1.018 billion vs. ground truth $574 million - a 77% overstatement. (2) 2022 unrealized losses: LLM states $155 million vs. ground truth $12 million - a 1,192% overstatement. (3) 2023 CMBS fair value: LLM states $975 million vs. ground truth $675 million - a 44% overstatement. (4) 2023 unrealized losses: LLM correctly states $100 million (matches ground truth). (5) 2024 CMBS fair value: LLM states $3 million vs. ground truth $6 million - a 50% understatement. The LLM's claim that 2024 holdings were 'down from $6 million a year earlier' contradicts its own 2023 figure of $975 million. MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution across three years. While it correctly identifies the general trend of declining exposure and de-risking, the underlying numbers are dramatically wrong, making the quantitative analysis unreliable. The narrative about 'moving to a much lower-risk stance' is directionally correct but built on false premises. ENTITY/METRIC ACCURACY: The company (CVS) and asset class (CMBS) are correctly identified, but the financial metrics are severely misstated. The reference to 'Separate Accounts' in 2024 appears to be an attempt to explain the dramatic drop but is not supported by the ground truth data. CONTEXTUAL RELEVANCE: The answer addresses the right question about CMBS exposure evolution and risk positioning, but the factual foundation is so compromised that the conclusions, while directionally reasonable, are based on incorrect data. This is a critical failure for financial analysis where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 470,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings show the same “merchandise discount” language each year – it is listed as part of the employee compensation‑and‑benefits package in 2022 (p. 6), 2023 (p. 7) and 2024 (p. 7) – but none of the disclosures provide a specific percentage or dollar amount for the discount. The unchanged, non‑quantified description across the three years indicates that the discount is a stable, non‑cash perk rather than a growing monetary benefit, reflecting a consistent strategy of offering modest, ongoing employee perks rather than expanding the discount’s value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the ground truth and the question's intent. CRITICAL ERRORS: (1) The LLM claims merchandise discounts were 'unchanged' and 'non-quantified' across all three years, but the ground truth explicitly describes significant evolution in how the benefits were framed and contextualized—from 2022 (basic listing with $15/hour minimum wage) to 2023 (expanded wage range $15-$24/hour with enhanced financial wellness components) to 2024 (integrated into expanded ecosystem with mental health and virtual healthcare). The LLM completely missed this multi-year progression. (2) The LLM's conclusion that the discount represents a 'stable, non-cash perk' and 'consistent strategy of offering modest, ongoing employee perks rather than expanding the discount's value' directly contradicts the ground truth's finding that the strategy evolved to preserve foundational offerings while layering in new, modern benefits. (3) The LLM correctly notes that specific percentage/dollar amounts for the discount itself are not disclosed, but this observation is tangential—the question asks about the SCOPE AND VALUE EVOLUTION, which the ground truth addresses through contextual framing, wage expansion, and benefits ecosystem changes. The LLM conflates 'no specific dollar amount for the discount' with 'no evolution in the discount's strategic role.' (4) The LLM fails to synthesize the multi-hop information across years: it should have identified how merchandise discounts were repositioned within increasingly comprehensive benefits packages, not merely noted their consistent mention. (5) The LLM's interpretation that unchanged language = unchanged strategy is a logical error; the ground truth demonstrates that the strategic significance evolved through the surrounding benefits context. The answer demonstrates poor multi-hop reasoning and misses the qualitative evolution that is central to answering the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 526,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In the 2022 Form 10‑K Linde mentioned “cultural challenges associated with integrating employees from the acquired company into the existing organization” only as one bullet in a long list of integration‑risk items (2022 p. 10‑12). By the 2024 filing the same bullet is retained, but it is now reinforced by a separate paragraph that explicitly calls out “integration of operations across different cultures and languages” as a unique risk for foreign acquisitions and joint‑ventures (2024 p. 10‑11). This shift from a simple checklist item to a highlighted cross‑border risk shows Linde has sharpened its strategic focus on cultural integration, treating it as a key lever for managing the complexities of international acquisitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific page references and correctly identifies that Linde's treatment of cultural challenges evolved from 2022 to 2024, with a shift from a simple checklist item to a more highlighted cross-border risk. The page citations (2022 p. 10-12 and 2024 p. 10-11) appear reasonable for 10-K filings. However, the answer has significant gaps compared to the ground truth: (1) It completely omits the 2023 filing, which according to the ground truth showed an important intermediate evolution where Linde 'expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks.' This is a critical gap in the multi-hop analysis across the three-year period. (2) The LLM answer focuses primarily on the structural presentation change (from bullet point to separate paragraph) but misses the ground truth's key insight about the strategic reframing from 'operational hurdles' to 'strategic risk management and financial outcomes.' (3) The ground truth emphasizes that by 2024, cultural challenges were framed in terms of 'potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel,' but the LLM answer doesn't capture this financial/outcomes-focused reframing. (4) The LLM's conclusion about 'sharpening strategic focus' is directionally correct but lacks the nuance about how the framing evolved from operational to strategic/financial. The answer demonstrates partial understanding of the evolution but fails to synthesize the complete three-year progression and misses the deeper strategic shift in how risks were being characterized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 450,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell from **$1,494 million in 2022** to **$491 million in 2024** – a drop of roughly **$1.0 billion** (see 2022 $1,494 m and 2024 $491 m in the fair‑value tables)【page_102】【page_99】.  The steep decline suggests the company’s derivative exposure (or the amount of margin required) has been shrinking, reflecting more efficient netting, lower derivative usage or stronger counter‑party risk controls in its risk‑management program.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures (2022: $1,494 million, 2024: $491 million) and accurately calculates the decline of approximately $1.0 billion. The answer properly addresses the main question about the trend and provides reasonable interpretation about derivative exposure management. However, there is a notable omission: the ground truth specifically mentions the 2023 intermediate value of $800 million, which represents an important data point in the three-year trend analysis. The LLM answer jumps directly from 2022 to 2024, missing this intermediate year that would strengthen the 'consistent decline' narrative. The calculation of the decline ($1,494M - $491M = $1,003M ≈ $1.0B) is accurate. The qualitative interpretation about derivative exposure, netting efficiency, and counterparty risk controls is sound and semantically equivalent to the ground truth's assessment. The answer correctly identifies ExxonMobil and the relevant metric (collateral under master netting arrangements related to Notes and accounts receivable). The reasoning about what the trend suggests is logical and appropriate. The main weakness is the incomplete temporal coverage (missing 2023 data point) which slightly diminishes the completeness of the multi-hop analysis, though the core answer remains substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 374,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "Across the three filings Broadcom’s Security Insights Platform is described in essentially the same way. In the 2022 filing it is positioned as a main‑frame‑focused security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” and the output “is available for use with in‑house tools for security‑information‑and‑event‑management.” The 2023 and 2024 filings repeat that language verbatim – there is no new claim of integration with third‑party or external SIEM tools, no shift to automated or intelligent remediation, and the platform remains listed under the mainframe software portfolio while being referenced as part of Broadcom’s broader enterprise‑security suite. Thus, from 2022 to 2024 the platform’s positioning and described capabilities stayed consistent: internal‑tool integration, ad‑hoc remediation guidance, and alignment with the company’s overall cybersecurity strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the platform's positioning EVOLVED from 2022 to 2024, with key changes: (1) 2023 saw more explicit ties to AVGO's broader cybersecurity portfolio with emphasis on proactive risk response, and (2) 2024 showed the platform contextualized within an expanded mainframe software suite including Cybersecurity, AIOps, and DevOps. However, the LLM answer claims the platform description remained 'essentially the same' across all three years with 'language repeated verbatim' and 'no new claims' or 'no shift.' This is a direct contradiction of the ground truth's core assertion about evolution. The LLM correctly identifies the 2022 positioning and accurately quotes the mainframe security posture language, and correctly notes the internal-tool integration aspect. However, it completely misses or denies the documented evolution in 2023 (broader portfolio alignment) and 2024 (expanded suite contextualization). The LLM's conclusion that positioning 'stayed consistent' is factually incorrect according to the knowledge graph. While the LLM demonstrates some understanding of the platform's basic functionality and correctly identifies AVGO/Broadcom, it fails the primary task of explaining how the positioning EVOLVED. This is a critical failure in multi-hop reasoning and synthesis, as the question explicitly asks about evolution/change, and the LLM answer denies that change occurred. The quantitative accuracy score is higher because there are no specific numbers to verify, but the qualitative accuracy is very low due to the fundamental mischaracterization of the platform's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 470,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "SPG’s Unsecured Notes ‑ 32B carried the same $750 million face amount and a 3.38 % coupon in each filing – $750,000 k at 3.38 % in the 2022 table【page_50】, unchanged at $750,000 k and 3.38 % in the 2023 table【page_49】, and again $750,000 k at 3.38 % in the 2024 table【page_51】.  This steady‑size, low‑rate tranche (maturing 15 Jun 2027) shows SPG’s strategy of locking in modest‑cost, medium‑term debt to keep interest‑rate exposure stable and maintain a predictable long‑term financing profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three fiscal years (2022-2024). QUANTITATIVE VERIFICATION: All numeric values are correct - $750 million face amount (correctly formatted as $750,000k in thousands notation), 3.38% interest rate, and June 15, 2027 maturity date are all accurate across all three years. The notation variation ($750M vs $750,000k) is acceptable and correctly handled. COMPLETENESS: The answer addresses the core question about how face value and interest rate exposure evolved, correctly identifying that both remained unchanged across the three-year period. The multi-hop synthesis across 2022, 2023, and 2024 filings is sound. ENTITY ACCURACY: SPG is correctly identified, the specific debt instrument (Unsecured Notes - 32B) is correct, and all fiscal years are properly referenced. REASONING QUALITY: The LLM correctly interprets the stability of these metrics as evidence of a deliberate debt management strategy focused on maintaining predictable financing. The characterization of the debt as 'modest-cost, medium-term' is reasonable given the 3.38% rate and 5-year maturity window. MINOR OBSERVATIONS: The original answer provides slightly more explicit context about 'no principal reduction or refinancing activity' and 'despite potential shifts in market interest rates,' which the LLM answer touches on more implicitly through 'locking in modest-cost' language. The LLM's phrasing is semantically equivalent and appropriately captures the strategic intent. Page references are included appropriately. No calculation errors detected. The answer fully satisfies the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 462,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "In the 2022 filing Comcast warned that Lumen was already building out fiber‑based network infrastructure that let it offer speeds beyond DSL and that it was using bundled service packages to compete with Comcast’s broadband (2022 p.9). The 2023 report repeated that Lumen’s fiber rollout was ongoing and that its higher‑speed, bundled offerings continued to pressure Comcast’s broadband business (2023 p.9). By the 2024 filing Comcast still identified Lumen as a key competitor expanding its fiber footprint and leveraging bundled broadband‑plus‑other‑services strategies, indicating the threat has persisted and grown as Lumen’s fiber reach and bundling capabilities have increased (2024 p.9).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies Lumen as a consistent competitive threat to CMCSA across all three years; (2) Accurately captures the evolution of Lumen's strategy from fiber infrastructure deployment to bundled service offerings; (3) Properly synthesizes multi-hop information showing escalation of competitive pressure over time; (4) Correctly identifies the two key competitive dimensions: fiber network expansion and service bundling; (5) Uses appropriate page references (p.9) consistently across filings, suggesting accurate source documentation. MINOR WEAKNESSES: (1) The LLM answer includes specific page citations (2022 p.9, 2023 p.9, 2024 p.9) that cannot be verified against the ground truth provided, though this adds specificity rather than detracting from accuracy; (2) The phrase 'the threat has persisted and grown' in the 2024 section is slightly more assertive than the ground truth's 'possibly intensifying,' though both convey similar meaning; (3) The LLM answer could have been slightly more explicit about the 'escalation' aspect mentioned in the ground truth, though the progression is clearly implied. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this qualitative question, so this dimension scores high based on correct year identification and temporal sequencing. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings and correctly identifies the pattern of competitive evolution, meeting the multi-hop requirement. The semantic equivalence between 'fiber-based infrastructure' and 'fiber network expansion' is maintained throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 480,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded‑payment‑card usage fell each year – the “RedCard/Target Circle” penetration was about 20.5 % in fiscal 2022, slipped to 19.8 % in fiscal 2023 and declined further to 18.6 % in fiscal 2024【page_27】【page_29】. The modest but consistent drop indicates that, while the loyalty‑driven card program still drives a sizable share of purchases, its incremental impact is weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the 2024 penetration rate was 18.6%, but the ground truth shows it was 17.8%. This is a material discrepancy of 0.8 percentage points. For financial metrics, this level of precision matters significantly. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUANTITATIVE ACCURACY: The error in the 2024 figure (18.6% vs. 17.8%) is a significant factual mistake that undermines the quantitative accuracy score. The year-over-year trend direction is correct (declining), but the magnitude of the final decline is misrepresented. QUALITATIVE ACCURACY: The reasoning about the trend is sound - the LLM correctly identifies the consistent downward trajectory and appropriately interprets it as indicating weakening effectiveness of the loyalty-driven payment strategy. The synthesis of information across fiscal years is logically sound. The characterization that 'incremental impact is weakening over time' aligns with the ground truth's assessment. COMPLETENESS: The answer addresses both parts of the question - it describes the evolution of penetration rates AND provides interpretation about what the trend suggests. However, the interpretation is slightly less explicit about the 'shift in consumer payment behavior' aspect mentioned in the ground truth. ENTITY ACCURACY: Correctly identifies Target, the RedCard/Target Circle program, and fiscal years 2022-2024. CONTEXTUAL RELEVANCE: The answer is highly relevant and appropriately addresses the multi-hop nature of the question by synthesizing data across three years and drawing conclusions about strategy effectiveness. The inclusion of source citations adds credibility. The primary issue is the factual error in the 2024 figure, which prevents a higher score despite otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 488,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "In 2022 Chevron expanded its Congo footprint by extending deep‑water licences in the Republic of Congo, which added roughly 36 million barrels of oil‑equivalent to its African reserve base. In 2023 the company kept that interest and spent about $0.7 billion on offshore development and natural‑gas projects in the country, maintaining a non‑operated working stake. By 2024 Congo accounted for roughly 20 % of Chevron’s net oil‑equivalent production in OPEC+ nations, but the 2024 filing disclosed that Chevron will sell its 31.5 % non‑operated interest in the Haute Mer permit and its 15.75 % interest in Lianzi in early 2025, signalling a strategic move to reduce its exposure in the region.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and figures, but includes some unverified claims and minor inconsistencies with the ground truth. STRENGTHS: (1) Correctly identifies the $0.7 billion investment in 2023 for offshore development and natural gas projects in Congo; (2) Accurately states the 31.5% nonoperated working interest in Haute Mer and 15.75% interest in Lianzi that were sold; (3) Properly characterizes the strategic shift from investment to divestiture; (4) Correctly notes the 2024 divestiture timing. WEAKNESSES: (1) The claim about 'extending deep-water licences in 2022' and adding '36 million barrels of oil-equivalent' to the African reserve base is NOT mentioned in the ground truth and cannot be verified; (2) The statement that 'Congo accounted for roughly 20% of Chevron's net oil-equivalent production in OPEC+ nations' in 2024 is not present in the ground truth and appears to be an unsupported addition; (3) The ground truth simply states Congo was 'listed among Chevron's key operational countries' in 2022, not that it 'expanded its Congo footprint' with specific reserve additions. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years (2022-2024) and properly connects the investment phase to the divestiture phase. However, it adds details not in the ground truth, which suggests either hallucination or reliance on external information not validated against the knowledge graph. QUANTITATIVE ACCURACY: The $0.7 billion figure and the two specific percentage interests (31.5% and 15.75%) are correct. However, the 20% production figure and 36 million barrels claim lack ground truth support. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution of financial and operational engagement, asset ownership, investment levels, and strategic positioning. The narrative flow is logical and comprehensive, though it exceeds the ground truth scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 536,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "NextEra’s gas‑option book stayed roughly the same size – about $100 million of option assets each year – while the liability side moved from $102 million in 2022 to $97 million in 2023 and back to $102 million in 2024, leaving the net position essentially flat (‑$2 m, +$3 m, ‑$2 m)【NEE_10k_2022.pdf page 84】【NEE_10k_2023.pdf page 84】【NEE_10k_2024.pdf page 86】.  At the same time, the weighted‑average implied volatility used to price the options rose modestly from roughly 50 % in 2022‑23 to about 52 % in 2024, and implied correlation jumped from ~57 % to ~99 % in 2024, indicating that the company now assumes higher gas‑price uncertainty and stronger co‑movement, reflecting a more risk‑aware (and potentially more hedged) stance in the gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that contradict the ground truth across all key metrics:\n\n1. ASSET VALUES - MAJOR ERROR: LLM claims assets stayed 'roughly the same size – about $100 million of option assets each year' but ground truth shows: 2022: $356M assets (not ~$100M), 2023: $100M assets, 2024: $100M assets. The LLM completely misses the dramatic $256M drop from 2022 to 2023.\n\n2. LIABILITY VALUES - SIGNIFICANT ERROR: LLM states liabilities moved from '$102 million in 2022 to $97 million in 2023 and back to $102 million in 2024' but ground truth shows: 2022: $347M liabilities (not $102M), 2023: $97M liabilities, 2024: $102M liabilities. Again, the LLM misses the massive $250M reduction from 2022 to 2023.\n\n3. IMPLIED VOLATILITY - MAJOR ERROR: LLM claims volatility 'rose modestly from roughly 50% in 2022-23 to about 52% in 2024' but ground truth shows: 2022: 36% (not 50%), 2023: 50%, 2024: 52%. The LLM incorrectly states 2022 volatility as 50% when it was actually 36%.\n\n4. MISSING CRITICAL CONTEXT: The LLM completely fails to capture the strategic de-risking narrative - the sharp 70%+ reduction in both assets and liabilities from 2022 to 2023, which is the most significant finding. Instead, it incorrectly characterizes the position as 'essentially flat.'\n\n5. MULTI-HOP SYNTHESIS FAILURE: The LLM appears to have confused or misread the 2022 baseline figures, fundamentally undermining the entire temporal analysis required by the question.\n\n6. ADDITIONAL ERRORS: The mention of 'implied correlation jumped from ~57% to ~99% in 2024' is not mentioned in the ground truth and appears to be unsupported information.\n\nThe answer demonstrates poor document reading accuracy and fails to correctly synthesize the multi-year evolution of NextEra's gas options exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 499,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "In Nike’s 2022 filing the company grouped FlyEase with a long roster of emerging technologies – “Nike Air, Zoom, Nike Free, Flywire, Dri‑Fit, Flyknit, **FlyEase**, ZoomX, Air Max, Nike React and Nike Adapt” – presenting it as one of many new innovations it was developing 【page_6】. By the 2024 filing the same language appears, but the list is trimmed and FlyEase remains highlighted alongside core platforms such as Air, Zoom, Flyknit and React, underscoring that FlyEase has become an established, recurring pillar of Nike’s product‑innovation pipeline 【page_6】. This shift signals that FlyEase has moved from a peripheral experiment to a sustained, strategic technology that Nike relies on to differentiate its products and advance its broader innovation agenda.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core narrative arc - FlyEase's evolution from a newly introduced technology to an established pillar. (2) The 2022 and 2024 comparisons are appropriately framed, showing the progression from a longer list to a trimmed list where FlyEase remains prominent. (3) The conclusion about FlyEase moving from 'peripheral experiment to sustained, strategic technology' aligns with the ground truth's characterization of evolution from 'newly introduced concept to foundational element.' (4) The citation format and page references add credibility.\n\nWEAKNESSES: (1) MISSING 2023 DATA: The ground truth explicitly mentions 2023 as a critical middle year where 'the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications.' The LLM answer completely omits 2023, jumping directly from 2022 to 2024. This is a significant gap in the multi-hop synthesis across three years. (2) INCOMPLETE PROGRESSION NARRATIVE: The ground truth presents a three-stage progression (2022: initial positioning, 2023: expansion/scaling, 2024: full embedding), while the LLM only captures a two-stage progression (2022 to 2024). (3) MISSING CONTEXTUAL DETAILS: The ground truth mentions FlyEase's 'integration into various categories and consumer applications' in 2023, which provides important context about how the technology was being deployed. The LLM doesn't capture this intermediate scaling phase. (4) VAGUE CHARACTERIZATION: The LLM describes 2022 as presenting FlyEase 'as one of many new innovations' but doesn't clearly establish it as 'newly introduced' in the same way the ground truth does.\n\nMULTI-HOP REASONING: The question requires synthesizing information across three years (2022, 2023, 2024) to show evolution. The LLM only synthesizes across two years, missing the critical middle year that demonstrates the scaling phase. This is a material gap in multi-hop reasoning.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are provided in either answer, so quantitative accuracy is based on the correct identification of years and the general accuracy of the characterization. The years mentioned (2022, 2024) are correct, but the omission of 2023 is a factual gap.\n\nSEMANTIC EQUIVALENCE: While the LLM's conclusion about FlyEase becoming 'an established, recurring pillar' is semantically equivalent to the ground truth's 'foundational element,' the incomplete temporal coverage undermines the overall answer quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 677,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "SPG’s Unsecured Notes 35A carried a $750 million face amount, a 2.65 % coupon and $19.9 million of annual debt service in each of the three filings – the 2022 table shows these figures (page 50), the 2023 table repeats them (page 51), and the 2024 table lists the same amounts (page 51). The note’s size, rate and July 15 2030 maturity have not changed, signalling that the company is keeping this low‑cost, long‑dated unsecured tranche unchanged and using it as a stable source of financing rather than expanding or refinancing it, consistent with a long‑term debt strategy focused on maintaining inexpensive, predictable borrowing capacity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental and severe quantitative error that undermines the entire response. (1) MAJOR FACTUAL ERROR - Face Amount: The LLM states the face amount is '$750 million' when the ground truth clearly indicates it is '$750,000' (or $750 thousand). This is a 1,000x magnitude error - the difference between $750 million and $750,000 is enormous and completely changes the financial significance of this debt instrument. (2) ANNUAL DEBT SERVICE ERROR: The LLM states '$19.9 million' when the ground truth shows '$19,875' (approximately $19.9 thousand, not million). Again, this is a 1,000x error in the same direction. These are not minor formatting differences - they represent fundamental misreading of the financial data. (3) CORRECT ELEMENTS: The LLM correctly identifies: the 2.65% interest rate, the July 15, 2030 maturity date, the consistency across 2022-2024, and the strategic interpretation about stable long-term financing. (4) MULTI-HOP REASONING: The reasoning about SPG's debt strategy is sound and matches the ground truth interpretation, but this is undermined by the massive quantitative errors. (5) SEMANTIC ISSUES: While the LLM's narrative about maintaining a 'low-cost, long-dated unsecured tranche' is qualitatively reasonable, it becomes nonsensical when applied to a $750 thousand obligation rather than $750 million. The strategic significance of a $750K debt instrument is vastly different from a $750M instrument. The answer demonstrates good understanding of the question structure and strategic implications, but fails catastrophically on basic numerical accuracy - the most critical requirement for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 463,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments repeatedly stressed that its growth engine is built on analog and **embedded‑processing** products, with embedded processing singled out each year as a core segment and a focus for the industrial and automotive markets (2022 – page 19; 2023 – page 19; 2024 – page 19). That unchanged positioning, coupled with the company’s explicit statement that **free‑cash‑flow‑per‑share** is the ultimate performance metric (2022 – page 18; 2023 – page 16; 2024 – page 18), reveals a long‑term strategy to leverage the high‑margin, cash‑generating nature of embedded‑processing to sustain and grow free‑cash‑flow‑per‑share for shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Texas Instruments' strategic evolution. STRENGTHS: (1) Correctly identifies embedded processing as the core strategic focus across all three years (2022, 2023, 2024); (2) Accurately notes that free cash flow per share is the ultimate performance metric; (3) Properly synthesizes the connection between embedded processing products and long-term FCF per share growth strategy; (4) Correctly identifies the industrial and automotive markets as key application areas; (5) Page references are provided (though not verified against actual filings, they appear reasonable and specific); (6) The reasoning about high-margin, cash-generating nature of embedded processing is sound and matches the ground truth's characterization. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention the 'four competitive advantages' framework that TI used in 2022, though this is a minor omission; (2) The ground truth emphasizes the 'broad portfolio of analog and embedded processing products' offering 'more opportunity per customer and more value for investments' - the LLM mentions analog but doesn't elaborate on this value proposition as thoroughly; (3) The ground truth notes TI 'reiterated' and 'maintained' the narrative across years, emphasizing consistency - the LLM uses 'repeatedly stressed' and 'unchanged positioning' which conveys similar meaning but with slightly different emphasis. QUANTITATIVE VERIFICATION: No specific financial numbers, percentages, or calculations are provided in either answer, so quantitative accuracy is based on the correct identification of years (2022, 2023, 2024) and metrics (free cash flow per share), both of which are accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects the strategic emphasis on embedded processing to the long-term FCF per share objective, demonstrating sound multi-hop reasoning. The semantic equivalence is strong - both answers convey that TI views embedded processing as foundational to its growth strategy and FCF per share maximization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 592,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "In the 2022 filing Disney listed Marvel only as an indefinite‑life intangible (a trademark) on its balance sheet (see 2022 Intangible‑asset table, page 110), but by the 2023 10‑K the company was already promoting Marvel as one of the “top‑level selections or ‘tiles’” on the Disney+ home screen alongside Disney, Pixar, Star Wars and National Geographic (see Direct‑to‑Consumer description, page 7). The 2024 filing again treats Marvel trademarks as a core indefinite‑life intangible (page 114), showing that Disney has turned the brand from a passive balance‑sheet asset into a front‑line UI feature to drive Disney+ subscriber growth and to justify the capitalized production costs and valuation of its high‑value IP.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative of Marvel's evolution from 2022-2024 as a strategic asset, accurately noting: (1) Marvel's status as an indefinite-lived intangible in 2022 and 2024; (2) the 2023 transition to a top-level 'tile' on Disney+ alongside other branded content; (3) the strategic shift from passive balance-sheet asset to active UI feature. The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and connecting balance-sheet accounting to product strategy. However, there are notable omissions: (1) The LLM does not mention the specific Disney+ subscriber count of 123 million as of September 28, 2024, which the ground truth includes as evidence of the strategy's impact; (2) The LLM does not reference the ESPN+ tile launch plan for early fiscal 2025, which the ground truth cites as part of the broader branded-content strategy; (3) The LLM does not explicitly discuss Marvel's role in 'subscriber retention and growth' as a strategic outcome. The answer is factually accurate on the core points (indefinite-life intangible status, tile placement, years) and correctly identifies the strategic pivot. The page references provided (110, 7, 114) appear reasonable for 10-K filings but cannot be independently verified. The reasoning about leveraging brand strength for platform differentiation is sound and aligns with the ground truth's conclusion. The omission of the 123 million subscriber figure and ESPN+ context represents incomplete synthesis of the multi-hop question, which asked specifically about 'financial strategy in driving subscriber growth' and referenced 2024 subscriber data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 458,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has consistently covered roughly 59 % of the closed block—59.25 % in the 2022 filing (page 214) and about 59 % in both the 2023 (page 227) and 2024 (page 204) filings.  The associated reinsurance recoverable balances rose from the $1.8 billion of deposit assets disclosed in 2022 (page 216) to $10.3 billion of total recoverables (including $5.1 billion of deposit assets, page 229) at year‑end 2023, and then to $4.6 billion of deposit assets (with $17.6 billion of net ceded recoverables overall, pages 204 & 206) at year‑end 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth across multiple dimensions:\n\n1. PERCENTAGE ACCURACY: The LLM correctly identifies the percentages (59.25% in 2022, ~59% in 2023-2024), which matches the ground truth. This is the only correct quantitative element.\n\n2. REINSURANCE RECOVERABLE BALANCES - CRITICAL ERRORS:\n   - Ground Truth 2022: $3.6 billion in unsecured reinsurance recoverable balances\n   - LLM Answer 2022: $1.8 billion of deposit assets (INCORRECT - wrong number and wrong metric)\n   - Ground Truth 2023: $4.4 billion in unsecured balances\n   - LLM Answer 2023: $10.3 billion total recoverables with $5.1 billion deposit assets (INCORRECT - significantly overstated)\n   - Ground Truth 2024: $4.2 billion in unsecured balances\n   - LLM Answer 2024: $4.6 billion deposit assets with $17.6 billion net ceded recoverables (INCORRECT - wrong numbers and conflates different metrics)\n\n3. METRIC CONFUSION: The LLM conflates multiple different metrics (deposit assets, total recoverables, net ceded recoverables) rather than focusing on the unsecured reinsurance recoverable balances that are the core of the question. This suggests misreading or misinterpretation of the source documents.\n\n4. TREND ANALYSIS: The ground truth shows a clear trend: $3.6B → $4.4B → $4.2B (increase then slight decline). The LLM's numbers show: $1.8B → $10.3B → $4.6B (highly volatile and incorrect), which would lead to completely different conclusions about the evolution of the arrangement.\n\n5. MULTI-HOP REASONING: While the LLM attempts to synthesize information across three years, the synthesis is based on incorrect numbers, making the overall analysis unreliable.\n\n6. CONTEXTUAL RELEVANCE: The question specifically asks about 'unsecured reinsurance recoverable balances,' but the LLM provides deposit assets and net ceded recoverables instead, suggesting a fundamental misunderstanding of what metric to extract from the filings.\n\nThe only correct element is the percentage reinsured across the three years. All balance sheet figures are materially incorrect, which is a critical failure for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 587,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s residential mortgage‑backed securities fell from roughly **$721 million at year‑end 2022** to **$614 million at year‑end 2023** (fair‑value totals in the unrealized‑loss tables)【page_149】, and the amount held in its Separate Accounts dropped to **$71 million by year‑end 2024** (up from $51 million in 2023)【page_160】. This steep three‑year contraction shows the company is actively reducing its exposure to agency‑guaranteed RMBS—likely to curb interest‑rate and credit‑risk volatility—and repositioning capital toward other, higher‑quality fixed‑income assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figure. Ground truth states CVS held $629 million in RMBS in 2022, but the LLM claims $721 million—a $92 million discrepancy (14.6% overstatement). This is a material error that undermines the entire analysis. The 2023 figure of $614 million is correct, and the 2024 figure of $71 million is correct. However, the LLM also introduces confusion by mentioning Separate Accounts with $51 million in 2023 and $71 million in 2024, which appears to be a different metric or subset not clearly distinguished from the main RMBS holdings discussed in the ground truth. The ground truth does not mention these Separate Account figures, suggesting the LLM may be conflating different data sources or metrics. MISSING KEY INFORMATION: The LLM answer omits the unrealized losses data entirely ($10 million in 2022, $60 million in 2023), which the ground truth identifies as important context for understanding risk exposure evolution. This is a significant omission that weakens the analysis of risk exposure trends. REASONING QUALITY: The LLM's interpretation of the trend (de-risking, reallocation strategy) is reasonable and aligns with the ground truth's conclusion, but it's built on incorrect foundational numbers. The mention of 'interest-rate and credit-risk volatility' and 'repositioning capital toward other, higher-quality fixed-income assets' shows sound reasoning, though these specific mechanisms aren't explicitly stated in the ground truth. MULTI-HOP SYNTHESIS: The answer attempts to synthesize data across three years and connect it to strategic positioning, which is appropriate for the question. However, the factual errors in the 2022 baseline figure compromise the validity of the entire trend analysis. The inclusion of page citations suggests source documentation, but the numbers don't match the ground truth baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 522,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged. In the 2022 filing (p. 214) the company said it reinsured 59.25 % of the closed block under a modified coinsurance agreement and accounted for it using the deposit method, offsetting the deposit liability against the deposit recoverable. Both the 2023 filing (p. 227) and the 2024 filing (p. 204) report the same approach – roughly 59 % of the closed block is reinsured and the agreement continues to be recorded under the deposit method with the deposit liability offset by the deposit recoverable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: (1) 2022 percentage of 59.25% matches ground truth exactly; (2) 2023 and 2024 percentages reported as 'roughly 59%' correctly reflects the ground truth's 59% reporting for these years; (3) all three years correctly identified. Multi-hop synthesis: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the evolution (or lack thereof) of the arrangement. Accounting treatment: The LLM correctly identifies the consistent use of the deposit method with offset of deposit liability against deposit recoverable across all three years, matching the ground truth's statement about consistency. Entity accuracy: MetLife correctly identified, modified coinsurance agreement properly characterized, closed block correctly referenced, and unaffiliated third-party reinsurer concept implicitly understood. The LLM's characterization of the arrangement as 'essentially unchanged' and 'stable' aligns with the ground truth's conclusion. Minor note: The LLM uses 'roughly 59%' for 2023-2024 while ground truth states exactly '59%' - this is a reasonable characterization given the shift from 59.25% to 59%, and the word 'roughly' appropriately captures this minor variation. Page citations (214, 227, 204) add credibility though cannot be independently verified. The answer directly addresses all components of the multi-part question regarding percentage evolution and accounting treatment consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 425,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra’s net notional volume of gas‑forward contracts fell from ≈ (1,307) MMBtu at 12/31/2022 to a larger short position of ≈ (1,452) MMBtu in 2023, then eased back to ≈ (1,131) MMBtu in 2024【page_83】【page_85】【page_84】. The peak in 2023 shows the company had expanded its gas‑price hedge (a larger net short exposure), while the reduction in 2024 indicates it trimmed that hedge, suggesting a move toward a more modest risk posture in the natural‑gas market.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect and addresses a completely different metric than the ground truth. (1) WRONG METRIC: The LLM discusses 'net notional volume of gas-forward contracts' measured in MMBtu (physical volume units), while the ground truth clearly addresses 'net exposure to forward contracts for gas' measured in DOLLAR AMOUNTS ($160M, $300M, $250M). These are entirely different financial metrics. (2) WRONG NUMBERS: The LLM provides MMBtu volumes (1,307, 1,452, 1,131) which are not comparable to the dollar-based net exposure figures in the ground truth. (3) WRONG TREND INTERPRETATION: The LLM claims 2023 showed 'a larger short position' and 2024 showed a 'reduction,' but the ground truth shows net exposure INCREASED from $160M (2022) to $300M (2023), then DECREASED to $250M (2024). The LLM's directional interpretation is partially aligned with the 2023-2024 decline, but the 2022-2023 movement is completely mischaracterized. (4) MISSING COMPONENT BREAKDOWN: The ground truth provides detailed asset/liability components ($191M/$31M in 2022, $377M/$77M in 2023, $296M/$46M in 2024), which the LLM entirely omits. (5) SEMANTIC MISMATCH: While both answers attempt to discuss risk positioning, they're analyzing different underlying data entirely. The LLM appears to have pulled data from a different section of the filing (possibly derivative notional volumes) rather than the net exposure figures requested. This is a fundamental failure to answer the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 417,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "In the 2022 10‑K Broadcom listed industrial fiber optics as one of a broad assortment of industrial‑ and automotive‑market products that serve many different end‑uses – from factory automation and power‑generation to medical, defense and electric‑vehicle subsystems【page_10】. By the 2023 filing the company reorganized its industrial segment, placing industrial fiber optics together with motion‑encoders and Ethernet ICs in a distinct “Industrial” product family and highlighting the synergy of these components for factory‑automation, renewable‑energy and automotive electronics【page_5】【page_7】. The 2024 filing reinforces that integration, positioning industrial fiber optics alongside motion‑control encoders and Ethernet PHYs/switches as a cohesive suite that now underpins an even wider range of applications, including renewable‑energy systems, EV powertrains and advanced driver‑assist systems【page_5】【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of AVGO's Industrial Fiber Optics positioning; (2) Accurately captures the 2022 baseline positioning alongside optocouplers, motion encoders, LED devices, and Ethernet ICs with correct application domains (industrial automation, medical, defense, EV subsystems); (3) Properly synthesizes the 2023 reorganization showing the grouping of fiber optics with motion encoders and Ethernet ICs in a distinct product family, with correct emphasis on factory automation, renewable energy, and automotive electronics; (4) Accurately describes the 2024 evolution linking fiber optics with motion-control encoders and Ethernet PHYs/switches, with correct expanded applications including renewable energy, EV powertrains, and ADAS; (5) Successfully captures the strategic narrative of evolution from standalone components to integrated, intelligent systems. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different terminology in places (e.g., 'motion-control encoders' vs 'motion encoders', 'Ethernet PHYs/switches' vs 'Ethernet PHYs, switch ICs') but these are semantically equivalent and represent acceptable variations; (2) The LLM answer includes page references which add credibility but are not required; (3) The answer is slightly more concise than the ground truth but captures all essential information without omission. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings, correctly identifying the progression and evolution of product positioning and integration strategy. The logical flow from 2022 baseline through 2023 reorganization to 2024 integration is sound and well-articulated. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 512,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "From fiscal 2022 through fiscal 2024 Nike’s redeemable preferred stock – the $0.3 million‑par series owned solely by Sojitz America – continued to carry a $0.10‑per‑share cumulative dividend payable each May 31, and common‑stock dividends could not be declared until that preferred dividend was paid in full. The stock’s terms, redemption rights and the prohibition on issuing any additional preferred shares remained unchanged, indicating that the capital‑structure relationship with Sojitz America stayed stable over the three‑year span.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all quantitative details correct: the $0.3 million par value, $0.10 per share annual dividend, May 31 payment date, and the three-year period (fiscal 2022-2024) are all accurate. The multi-hop synthesis correctly identifies the stable relationship between Nike and Sojitz America across the three-year span, properly noting that terms, redemption rights, and the prohibition on additional preferred shares remained unchanged. The answer accurately captures the dividend priority constraint (preferred dividends must be paid before common stock dividends). However, the LLM answer is slightly less complete than the ground truth in two respects: (1) it does not explicitly mention that Sojitz America 'has not sought redemption of the stock despite having the option to do so,' which is a meaningful detail about the stability of the relationship, and (2) it does not explicitly state that the dividend obligation 'remained consistent' across all three years, though this is clearly implied by the statement that terms remained unchanged. The answer's emphasis on structural stability and the unchanged nature of the relationship aligns well with the ground truth's core message. The wording differs appropriately (e.g., 'cumulative dividend payable each May 31' vs. 'dividend obligation remained consistent at $0.10 per share annually'), but the semantic meaning is equivalent. The reasoning is sound and the multi-hop synthesis across the three fiscal years is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 421,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "- In the 2022 filing (as of 12/31/2021) the Unsecured Notes‑31B carried a 3.25 % rate, a $750 million face amount, $24.4 million of annual debt service and matures on 11/30/2026【page_50†L31-L35】.  \n- The 2023 filing (as of 12/31/2022) shows the same terms – 3.25 % interest, $750 million face, $24.4 million annual service, maturity 11/30/2026【page_49†L31-L35】.  \n- The 2024 filing (as of 12/31/2023) again reports identical terms for the 31B note【page_51†L31-L35】.  \n\nBecause the face amount, rate and maturity have not changed over three years, SPG is treating the 31B note as a stable, fixed‑rate, medium‑term source of unsecured financing, indicating a long‑term strategy that relies on predictable, non‑refinanced debt rather than frequent restructuring.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts about SPG's Unsecured Notes-31B: (1) 3.25% interest rate is correct, (2) maturity date of 11/30/2026 is correct, (3) the stability of terms across 2022-2024 is correctly identified, (4) the reasoning about SPG's financing strategy (stable, non-refinanced debt) is sound and matches the ground truth interpretation. The answer appropriately synthesizes information across three years of filings.\n\nCRITICAL ERROR - QUANTITATIVE ACCURACY: The LLM states the face amount as '$750 million' while the ground truth specifies '$750,000' (in thousands). This is a significant discrepancy - the LLM inflated the amount by 1,000x. The ground truth clearly states '$750,000' not '$750 million'. This is a major quantitative error that undermines credibility, even though the relative stability claim remains correct.\n\nMINOR ISSUE: The LLM references filing dates as 'as of 12/31/2021', 'as of 12/31/2022', and 'as of 12/31/2023' for the 2022, 2023, and 2024 filings respectively. While these are technically the balance sheet dates within those annual filings, the phrasing could be clearer about whether these are fiscal year-end dates or filing dates.\n\nVERIFICATION OF OTHER NUMBERS: The $24.4 million annual debt service figure is consistent with a $750,000 principal at 3.25% interest (approximately $24,375 annually), which validates the calculation logic, though the principal amount itself is wrong in the LLM answer.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the pattern of consistency. The conclusion about SPG's financing strategy is logically sound and matches the ground truth assessment.\n\nOVERALL: The answer demonstrates good reasoning and mostly correct qualitative analysis, but the fundamental error in stating the principal amount as $750 million instead of $750,000 is a critical quantitative mistake that significantly impacts the accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 536,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The value of TI common stock in the U.S. defined‑contribution plans fell from $940 million (6 million shares) in 2022 to $873 million (5 million shares) in 2023 and to $852 million (5 million shares) in 2024【page_44】【page_43】. The downward trend reflects a modest decline in the company’s share price and a reduction in the number of shares employees hold—likely because the TI stock fund has been frozen to new contributions—indicating relatively flat‑to‑downward stock performance and limited new employee investment in the retirement plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($940M in 2022, $873M in 2023, $852M in 2024). The share counts (6 million shares in 2022, 5 million shares in 2023 and 2024) are provided and appear consistent with the valuation trend. The year-over-year declines are accurately captured. COMPLETENESS: The answer addresses the core question about the 3-year evolution of TI common stock value in U.S. defined contribution plans and provides interpretation of the trend. ENTITY ACCURACY: Correctly identifies TI (Texas Instruments), the specific investment vehicle (U.S. defined contribution plans), and the correct time period (2022-2024). REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) tracking the value across three years, (2) noting the consistent downward trend, (3) identifying the frozen stock fund since 2016 as a contributing factor, and (4) connecting this to employee investment behavior. The reasoning that the decline reflects both share price changes and reduced share count is sound. SEMANTIC EQUIVALENCE: The LLM's interpretation that the trend indicates 'modest decline in company's share price' and 'reduction in number of shares' aligns well with the ground truth's mention of 'strategic reduction in stock allocations' and 'freeze on new contributions.' The conclusion about 'relatively flat-to-downward stock performance' is a reasonable interpretation of the data. MINOR CONSIDERATIONS: The LLM provides additional detail (share counts) not explicitly mentioned in the ground truth, which adds value without contradicting it. The phrasing 'limited new employee investment' is a reasonable inference from the frozen fund status. No calculation errors detected. The answer is well-structured and directly addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 510,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "In fiscal 2022 Disney reported roughly 220 000 employees – about 166 000 in the United States and 54 000 abroad – with its workforce made up of ≈78 % full‑time, 15 % part‑time and 7 % seasonal workers, and a large share covered by collective‑bargaining agreements while overseas staff were represented by works councils, trade unions or other employee associations【page_5】. By fiscal 2024 the headcount had risen to about 233 000 (≈171 000 U.S. and 62 000 international), the mix shifted slightly to ≈76 % full‑time, 16 % part‑time and 8 % seasonal, and the same patterns of collective‑bargaining coverage in the U.S. and employee‑association representation abroad persisted【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop question about Disney's workforce evolution from 2022-2024. QUANTITATIVE VERIFICATION: All key numbers match the ground truth precisely: (1) 2022 total: 220,000 employees ✓; (2) 2022 U.S.: 166,000 ✓; (3) 2022 international: 54,000 ✓; (4) 2024 total: 233,000 ✓; (5) 2024 U.S.: 171,000 ✓; (6) 2024 international: 62,000 ✓; (7) 2022 seasonal percentage: 7% ✓; (8) 2024 seasonal percentage: 8% ✓. The employment composition percentages (78% full-time, 15% part-time, 7% seasonal in 2022; 76% full-time, 16% part-time, 8% seasonal in 2024) are also accurate. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple dimensions: temporal evolution (2022→2024), geographic distribution (U.S. vs. international), employment type breakdown (full-time, part-time, seasonal), and employee representation structures (collective bargaining agreements, works councils, trade unions). COMPLETENESS: All sub-questions are addressed: total employees, U.S. vs. international distribution, seasonal workforce percentages, and employee association representation. MINOR OBSERVATIONS: The answer includes additional context about employment composition percentages and representation structures that enhance understanding, though these weren't explicitly requested. The formatting with approximate symbols (≈) and citation markers is appropriate for SEC filing context. The semantic equivalence is maintained throughout—the answer conveys identical information to the ground truth despite different wording. No calculation errors detected. All entities (Disney, fiscal years, geographic regions) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 468,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD’s filings show no change in how it treats non‑economic accounting changes in its ROIC metric. The 2022 10‑K (p. 47) states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance,” the 2023 10‑K (p. 50) repeats the same exclusion, and the 2024 10‑K (p. 49) again notes that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance.” This consistency indicates that GD deliberately strips out accounting‑driven items to keep ROIC focused on the underlying operating returns of the business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that GD maintained consistent treatment of non-economic accounting changes across all three years (2022, 2023, 2024), matching the ground truth assertion of consistency; (2) Provides specific page references (p. 47 for 2022, p. 50 for 2023, p. 49 for 2024) that demonstrate multi-hop synthesis across three separate 10-K filings; (3) Accurately quotes the exclusion rationale ('not reflective of company performance') consistently across years; (4) Correctly identifies the specific items excluded (goodwill impairments and non-economic accounting changes); (5) Properly interprets what this consistency reveals about GD's approach—that the company deliberately maintains a stable framework focused on economic/operating performance rather than accounting volatility. The reasoning is sound and demonstrates proper multi-hop synthesis across three years of filings. Minor consideration: The LLM answer provides slightly more granular detail (specific page numbers and direct quotes) than the ground truth, but this adds value rather than detracting. The semantic meaning is fully aligned with the ground truth conclusion that GD's consistent exclusion indicates a stable performance evaluation framework emphasizing economic performance. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 390,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In the 2022 filing Linde treated rare gases (krypton, neon, xenon) as a co‑product of its standard cryogenic air‑separation plants, simply part of the broader “atmospheric gases” portfolio (page_94). By the 2024 filing the company positions rare‑gas production as a strategic, technology‑driven capability – highlighting its market‑leadership in non‑cryogenic air‑separation, ongoing development of proprietary production, storage and distribution technologies, and the use of its pipeline network to deliver a reliable, low‑cost supply (page_4; page_6). This shift from a by‑product focus to a differentiated, integrated rare‑gas offering underscores Linde’s competitive advantage built on superior process technology and infrastructure in the industrial‑gases market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Linde's rare gas strategy evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 positioning of rare gases as co-products within cryogenic air separation and the broader atmospheric gases portfolio; (2) Accurately captures the 2024 shift toward strategic, technology-driven positioning with emphasis on non-cryogenic air separation leadership; (3) Properly synthesizes the multi-hop information showing progression from by-product to differentiated offering; (4) Correctly identifies specific technologies (non-cryogenic air separation, VPSA implied through 'proprietary production technologies') and infrastructure advantages (pipeline network); (5) Appropriately connects this evolution to competitive advantage through process technology and infrastructure. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 filing's reiteration of rare gases positioning, which the ground truth specifically notes as part of the evolution narrative - this is a minor omission of intermediate data point; (2) The ground truth explicitly names VPSA and membrane separation technologies, while the LLM uses more general language ('proprietary production, storage and distribution technologies') - this is less specific but not factually incorrect; (3) The LLM does not explicitly list oxygen, nitrogen, and argon as core atmospheric gas offerings alongside rare gases, though this is contextual detail rather than core to the strategy evolution question. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high (9/10) - the answer correctly references years (2022, 2024) and correctly identifies the company (Linde). QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct - the answer successfully connects technological evolution to competitive advantage. The logic flow from co-product status to strategic differentiation is clear and accurate. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (strategy evolution AND competitive advantage implications) and maintains appropriate focus on industrial gas markets. The page references provided add credibility though cannot be independently verified. Overall, this is a high-quality answer with minor incompleteness regarding the 2023 intermediate positioning and slightly less technical specificity on technology names.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 668,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "In the 2022 filing NEER said that about 92 % of its net‑generating capacity was already covered by long‑term bilateral contracts (NEE_10k_2022.pdf p. 19). By year‑end 2023 that share had risen to roughly 94 % (NEE_10k_2023.pdf p. 18) and it remained at about 94 % at the end of 2024 (NEE_10k_2024.pdf p. 19). The modest increase and subsequent stabilization show NEER is deliberately locking in a larger portion of its output through long‑term contracts to hedge revenue and reduce exposure to spot‑market price swings in a volatile energy market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: 92% in 2022, 94% in 2023, and 94% in 2024. The multi-hop synthesis across three years of SEC filings is properly executed, with correct document references (NEE_10k_2022.pdf p. 19, NEE_10k_2023.pdf p. 18, NEE_10k_2024.pdf p. 19). The entity identification is accurate (NEER/NextEra Energy Resources). The reasoning about risk management strategy is sound and semantically equivalent to the ground truth: both answers identify the trend as demonstrating deliberate locking-in of capacity through long-term contracts to hedge revenue and reduce spot-market exposure. The LLM answer uses slightly more concise language ('modest increase and subsequent stabilization') versus the ground truth's 'consistent and slightly increasing reliance,' but both convey the same strategic intent. The answer appropriately addresses all parts of the multi-part question: (1) how reliance evolved (the percentages and trend), (2) what this indicates about risk management (revenue stability, hedging, market risk mitigation). Minor point: the ground truth mentions 'non-qualifying hedges' as an additional risk management tool, which the LLM answer does not explicitly include, though this is a minor omission that doesn't affect the core answer's accuracy. The LLM answer is well-structured, cites sources appropriately, and demonstrates proper multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 407,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an unchanged $495 million principal balance in FY2023 (as of Oct 29 2023) and again $495 million in FY2024 (as of Nov 3 2024)【page_81】. The 2022 filing reported the same $495 million amount, so the balance remained flat from FY2022 through FY2024. This steady figure shows the company has been holding the notes to maturity rather than accelerating repayment, reflecting a deliberate debt‑management strategy that preserves liquidity while keeping the long‑term debt profile stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All financial figures are correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024). The dates provided (Oct 29, 2023 for FY2023 and Nov 3, 2024 for FY2024) are appropriate fiscal year-end references. No calculation errors present. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the outstanding principal balance across the three-year period, (2) the specific amounts for each year, and (3) what this trend indicates about debt management strategy. ENTITY ACCURACY: Company (AVGO/Broadcom), debt instrument (3.125% senior notes due January 2025), and fiscal years are all correctly identified. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesized information across three fiscal years to identify the flat trend and drew a logical conclusion about debt management strategy (holding to maturity, preserving liquidity, maintaining stable long-term debt profile). SEMANTIC EQUIVALENCE: The LLM's interpretation that the company is \"holding the notes to maturity rather than accelerating repayment\" is semantically equivalent to the ground truth's statement that AVGO \"did not retire or refinance this specific debt instrument.\" Both convey the same strategic intent. MINOR OBSERVATION: The LLM provides slightly more interpretive detail about the strategy (\"preserves liquidity\") compared to the ground truth, but this adds value without contradicting the original answer. The citation reference [page_81] adds credibility. Overall, this is a comprehensive, accurate response that correctly synthesizes multi-year debt data and provides sound strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 485,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "In the 2022 Form 10‑K (as of Dec 31 2021) Simon listed the Unsecured Notes – 37B at a $700 million face amount with a maturity of Jan 15 2032【page_50】. The 2024 filing (as of Dec 31 2023) shows the same $700 million face amount and Jan 15 2032 maturity for the 37B series【page_51】, and the 2023 filing reported no change. Keeping the 37B tranche unchanged over three years signals that SPG is deliberately maintaining a stable, low‑cost medium‑term unsecured debt position to lock in favorable rates and manage long‑term financing needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FACE AMOUNT: The LLM states the face amount as '$700 million' when the ground truth clearly specifies '$700,000' (or $700 thousand). This is a 1,000x magnitude error - a significant factual mistake. The LLM appears to have confused the notation, possibly interpreting the $700,000 figure as $700 million. CORRECT ELEMENTS: (1) Maturity date of 01/15/32 is correct across all years, (2) Consistency of the instrument across 2022-2024 is correctly identified, (3) The reasoning about stable debt strategy is sound and appropriate. PARTIAL ISSUES: (1) The LLM references '2022 Form 10-K (as of Dec 31 2021)' which is confusing notation - the ground truth refers to 2022 and 2023 data, not 2021. (2) The LLM mentions 'three years' of stability but the ground truth covers 2022-2024 (also three years), so this is acceptable. (3) The qualitative interpretation about 'deliberately maintaining a stable, low-cost medium-term unsecured debt position' is reasonable inference but goes slightly beyond what the ground truth explicitly states. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across multiple filing years and identifies the consistency pattern, which is the core requirement. However, the magnitude error in the face amount is a fundamental factual mistake that significantly undermines the answer's reliability. The reasoning quality is good, but the quantitative accuracy is severely compromised by the $700M vs $700,000 error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 406,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in the “Properties” tables of each filing and is consistently marked only for the **Analog** segment – the Embedded Processing column is blank in 2022 (†)【page_18】, 2023 (*)【page_16】 and 2024 (**)【page_16】. Thus, over the three years the Melaka facility has remained an analog‑product manufacturing location, with no shift toward embedded‑processing work (the only change is the footnote indicating that portions of the plant are leased/owned).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) Correctly identifies that Melaka was consistently marked for Analog operations across all three years (2022, 2023, 2024); (2) Accurately notes that Embedded Processing column was blank/unmarked in all three years; (3) Properly synthesizes the multi-hop information showing no expansion into embedded processing over the period; (4) Correctly cites specific page references and footnote indicators (†, *, **) from the filings; (5) Accurately characterizes the facility as maintaining a 'stable, specialized role' focused exclusively on analog products; (6) Notes the minor operational detail about leasing/ownership changes while correctly identifying this as not affecting the core product line focus. MINOR CONSIDERATIONS: The answer could have been marginally more explicit in stating 'checkmark' or similar visual indicator terminology (as the ground truth does), but the substance is identical - the facility was marked/engaged in analog and not in embedded processing. The phrase 'appears in the Properties tables' and reference to specific page numbers demonstrates proper source verification. The reasoning correctly synthesizes across three separate annual filings to establish the consistent pattern. No numerical errors, date errors, or entity misidentifications present. The answer fully addresses both components of the question: (1) how the footprint evolved (answer: it remained stable/unchanged), and (2) the product line involvement (analog only, no embedded processing). Semantic equivalence with ground truth is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 468,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "In Disney’s 2022 10‑K the Content Sales/Licensing segment only referred to “post‑production services” in a catch‑all “Other revenue” line and did not name Industrial Light & Magic. Beginning with the 2023 filing, the segment description explicitly calls out revenue from post‑production services through Industrial Light & Magic (and Skywalker Sound), and the same language appears in the 2024 filing, indicating that Disney moved from an implicit, generic treatment of ILM in 2022 to a clearly disclosed, distinct revenue source in the Content Sales/Licensing segment by 2023‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides a different narrative than the ground truth, with both strengths and significant weaknesses. CORRECT ELEMENTS: (1) The LLM correctly identifies that there was a change in how Industrial Light & Magic was disclosed between 2022 and 2023-2024, moving from implicit/generic treatment to explicit naming. (2) The LLM correctly mentions Skywalker Sound alongside ILM, which adds relevant detail. (3) The fiscal year progression (2022→2023→2024) is correctly identified. SIGNIFICANT ISSUES: (1) The LLM's characterization directly contradicts the ground truth on a key factual point: the ground truth states ILM was 'explicitly listed' in fiscal 2022, while the LLM claims it was only in 'catch-all Other revenue' and not named in 2022. This is a fundamental factual disagreement about what the filings actually stated. (2) The ground truth emphasizes a 'stable but contextually shifting reliance' with ILM remaining part of the segment across all three years, while the LLM frames this as a move from 'implicit' to 'explicit' disclosure—a different interpretation of the same evolution. (3) The LLM misses the ground truth's nuanced point about strategic repositioning within a 'DTC-first content model' and the shift in revenue focus emphasis. (4) The LLM's answer is more transactional (focusing on disclosure changes) rather than strategic (focusing on evolving role and reliance). MULTI-HOP REASONING: The LLM does attempt to synthesize across three fiscal years and connect disclosure practices to business structure, but it appears to have misread or misinterpreted the actual content of the 2022 filing regarding ILM's explicit listing. The reasoning about moving from implicit to explicit is logical, but if factually incorrect about 2022, it undermines the entire analysis. QUANTITATIVE ACCURACY: No specific numbers are provided by either answer, so this dimension is neutral. The dates and fiscal years are correct. SEMANTIC EQUIVALENCE: The answers convey fundamentally different narratives about the same evolution, suggesting either the LLM misread the source documents or the ground truth is based on different/more detailed filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 582,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method share of earnings from its operating joint ventures (the insurance‑underwriting JVs) was $51 million in 2022, fell to $38 million in 2023, and then jumped to $175 million in 2024【page_224†L31-L34】【page_247†L31-L34】. The dip in 2023 indicates weaker joint‑venture results that year, while the large increase in 2024 signals a strong rebound and improved underwriting performance in those insurance joint ventures.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states $51 million vs. ground truth $1,305 million (96% understatement); (2) 2023: LLM states $38 million vs. ground truth $151 million (75% understatement); (3) 2024: LLM states $175 million vs. ground truth $988 million (82% understatement). These are not minor rounding differences but represent massive discrepancies in the actual equity method investment income figures. The LLM correctly identifies the general trend pattern (decline in 2023, rebound in 2024) and appropriately characterizes it as volatility, which shows some qualitative understanding. However, the quantitative foundation is entirely wrong - the numbers provided are off by factors of 10-25x in some cases. The LLM also correctly identifies the metric as 'equity-method share of earnings from operating joint ventures' and properly attributes this to insurance underwriting JVs, demonstrating entity accuracy. The reasoning about what the trend suggests (weaker performance in 2023, strong rebound in 2024) is logically sound and semantically equivalent to the ground truth interpretation. However, these correct interpretations cannot compensate for the catastrophic failure in reporting the actual financial figures. For a financial question where precise numbers are the primary deliverable, providing numbers that are 75-96% incorrect is a fundamental failure regardless of trend interpretation accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 423,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics built 360 new Light Armored Vehicles (LAVs) for the Canadian Army in 2022, raised that output to 399 in 2023, and further increased production to 449 in 2024 (GD_10k_2022 p. 11; GD_10k_2023 p. 11; GD_10k_2024 p. 11). The steady climb in LAV deliveries underscores the platform’s strategic importance—serving as a core export product and a growth engine that reinforces General Dynamics’ market‑leading position in the Combat Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. (1) QUANTITATIVE VERIFICATION: All three production volumes are correct—360 units (2022), 399 units (2023), and 449 units (2024). The progression shows consistent year-over-year increases (39 units from 2022-2023, 50 units from 2023-2024), which the LLM correctly characterizes as a 'steady climb.' (2) ENTITY ACCURACY: General Dynamics, LAV platform, Canadian Army, and Combat Systems segment are all correctly identified. The fiscal years (2022, 2023, 2024) are accurate. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) to establish the production trend and its strategic implications. The reasoning that this growth indicates strategic importance is sound and supported by the data. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth. Both identify the upward trend, the specific numbers, and the strategic significance. The LLM adds slightly more context by mentioning 'export product' and 'growth engine' in the Combat Systems segment, which enhances rather than contradicts the ground truth. (5) MINOR DIFFERENCES: The LLM provides source citations (GD_10k pages), which adds credibility but wasn't in the ground truth. The phrasing 'built 360 new Light Armored Vehicles' vs. 'increased from 360 units' is semantically equivalent. The LLM's characterization of LAV as 'core export product' and 'growth engine' aligns with the ground truth's assertion of 'increasingly central' and 'strategic role.' No calculation errors detected. All numbers are factually correct and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 463,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s hedge‑fund limited‑partnership exposure grew each year – the pension footnote shows $225 million excluded in 2022, $252 million in 2023, and $280 million in 2024 (pages 174, 173 & 167). The rising amount reflects a deliberate tilt toward alternative assets, indicating the company is incrementally increasing hedge‑fund LP holdings to diversify the pension portfolio and pursue higher‑return opportunities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. Ground truth shows: 2022=$214M, 2023=$225M, 2024=$252M. LLM answer states: 2022=$225M, 2023=$252M, 2024=$280M. This represents a systematic shift of all values upward by one year, suggesting the LLM misread or misaligned the data across fiscal years. The 2024 figure of $280M is particularly problematic as it exceeds the ground truth by $28M (11% error). MULTI-HOP REASONING FAILURE: While the LLM correctly identifies the trend direction (increasing exposure) and provides reasonable interpretation about alternative asset allocation strategy, the underlying data is wrong, which undermines the entire analysis. The reasoning about 'deliberate tilt toward alternative assets' and 'diversify the pension portfolio' is sound in principle, but is built on incorrect numbers. COMPLETENESS: The LLM does address the three-year evolution and attempts to explain strategic implications, which matches the question's requirements. However, the factual foundation is compromised. ENTITY ACCURACY: CVS is correctly identified, hedge fund LP investments are correctly identified, and the pension fund context is appropriate. PAGE REFERENCES: The LLM provides specific page citations (174, 173, 167) which adds apparent credibility but cannot be verified and may be hallucinated given the numerical errors. SEMANTIC EQUIVALENCE: The qualitative interpretation about pension strategy is reasonable and semantically aligned with the ground truth's conclusion, but this cannot overcome the fundamental quantitative errors. The answer demonstrates understanding of the question's intent but fails on the most critical evaluation criterion: factual accuracy of financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 492,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Across all three filings the company’s “Nature of Operations” note lists Sorriso among its principal global and regional trademarks in the Oral, Personal and Home Care segment – first in the 2022 10‑K [page_79] and then again in the 2023 [page_79] and 2024 [page_79] reports. This repeated inclusion shows that Colgate‑Palmolive kept Sorriso positioned as a key regional brand fully integrated into its global Oral, Personal and Home Care product portfolio, with no evident change in strategic emphasis from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies Sorriso's consistent presence across all three years (2022, 2023, 2024) in the company's trademark portfolio; (2) Accurately cites the same page reference (page_79) for all three filings, demonstrating proper source verification; (3) Correctly characterizes Sorriso as a 'key regional brand' integrated into the Oral, Personal and Home Care segment; (4) Properly synthesizes the multi-hop information showing continuity across three years; (5) Accurately concludes there was 'no evident change in strategic emphasis' from 2022-2024. The answer is semantically equivalent to the ground truth, conveying the same core message about Sorriso's stable, consistent positioning. Minor consideration: The LLM answer is slightly more concise than the ground truth, which provides slightly more contextual detail about 'regional market penetration and diversified consumer engagement,' but this omission is minor and does not affect the factual accuracy or core message. The answer directly addresses the question about how Sorriso's strategic positioning evolved (or remained stable) across the three-year period and its integration within the global portfolio. No numerical errors, date errors, or entity misidentifications present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 367,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s operating‑joint‑venture earnings rose from $51 million in 2022 to $38 million in 2023 (a modest decline) and then jumped to $175 million in 2024【page_224†L31-L38】【page_247†L31-L38】. The sharp rebound in 2024 shows the insurer is expanding its stake in operating joint ventures, positioning these equity‑method investments as a growing source of underwriting‑related income and a more prominent component of its overall investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - All numbers are wrong. Ground truth shows: 2022=$77M, 2023=$51M, 2024=$38M. LLM claims: 2022=$51M, 2023=$38M, 2024=$175M. The LLM has inverted the trend entirely and fabricated a $175M figure for 2024 that contradicts the ground truth's $38M. (2) DIRECTIONAL ANALYSIS - Ground truth indicates a consistent DOWNWARD trend ($77M→$51M→$38M), showing strategic retreat from operating joint ventures. LLM incorrectly describes a 'sharp rebound' and 'expansion,' which is the opposite of what actually occurred. (3) METRIC CONFUSION - The LLM appears to conflate different metrics or misread the data entirely. The ground truth is clear about the declining exposure pattern. (4) STRATEGIC INTERPRETATION - Ground truth correctly identifies this as a 'strategic shift away from operating joint ventures.' LLM incorrectly characterizes it as 'expanding stake' and 'growing source of income,' which contradicts both the numbers and the actual strategic direction. (5) CITATION ISSUES - The LLM provides page references that cannot be verified to support the incorrect numbers provided. The answer demonstrates a complete failure to accurately synthesize the multi-hop financial data across the 3-year period and reaches the opposite conclusion from what the data supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 380,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s equity interest in Angola LNG Limited has been steady – the 2022 filing notes a 36.4 % shareholding (​page 78​) and the 2024 filing repeats the same 36.4 % stake (​page 14​).  In 2022 the plant was simply described as being operated by the Angola LNG affiliate, with no explicit link to Chevron’s upstream assets.  By 2024 Chevron stresses that the LNG plant processes associated gas from multiple Angolan fields and that its own upstream projects now feed it – the Block 0 Sanha Lean Gas Connection Project ties Blocks 0 and 14 to Angola LNG (​page 13​) and the New G Consortium’s Quiluma‑Maboqueiro fields will connect to the plant (​page 14​) – showing a tighter integration of Chevron’s upstream gas production with the LNG operation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Chevron's 36.4% stake in Angola LNG Limited remained constant from 2022-2024, and there was a strategic evolution from passive investment to operational integration with upstream projects. The quantitative data is accurate (36.4% stake, 31% working interest in NGC mentioned in ground truth). However, there are some issues: (1) The LLM mentions 'Block 0 Sanha Lean Gas Connection Project' and 'Blocks 0 and 14' which are NOT mentioned in the ground truth answer - these appear to be additional details from the filing but represent a potential factual discrepancy or addition not in the original answer. (2) The LLM correctly identifies the New Gas Consortium's Quiluma-Maboqueiro fields connection, matching the ground truth. (3) The evolution narrative is sound - from passive equity investor (2022) to integrated gas monetization model (2024). (4) The LLM provides specific page references which adds credibility but also introduces risk if those references are incorrect. The ground truth mentions NGC with 31% nonoperated working interest, but the LLM doesn't explicitly state this percentage. The characterization of the shift from 'passive equity investor' to 'operationally integrated' is well-captured. The main weakness is the introduction of Block 0/Sanha project details not in the ground truth, which could indicate either: (a) the LLM added accurate but unrequested details, or (b) the LLM conflated different projects. This creates uncertainty about complete accuracy despite the core narrative being sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 432,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO carried $622 million of the 3.625 % senior notes due October 2024 at the close of FY 2022 and the same $622 million at the close of FY 2023, but the balance was gone by FY 2024 (shown as “‑”/zero) 【page_103】【page_81】. The company kept the exposure unchanged until the notes neared maturity and then fully retired them—using cash and the new senior‑note issuances in 2024—demonstrating a disciplined refinancing strategy that eliminated a near‑term obligation as the maturity date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($622 million in FY2022 and FY2023, zero/retired by FY2024), the interest rate (3.625%) is correct, and the maturity date (October 2024) is accurate. The progression timeline is correct across all three fiscal years. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) the evolution of exposure across FY2022-2024, (2) the specific amounts at each year-end, and (3) what this reveals about debt management strategy. ENTITY ACCURACY: AVGO is correctly identified, fiscal years are correct, and the financial instrument (3.625% senior notes due October 2024) is properly characterized. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws a logical conclusion about the company's debt management strategy. The inference that the company used 'cash and new senior-note issuances in 2024' to retire the debt is reasonable and demonstrates understanding of refinancing mechanics, though this specific mechanism detail goes slightly beyond what the ground truth explicitly states (which only says 'likely through refinancing or cash repayment'). This is a minor enhancement rather than an error. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'disciplined refinancing strategy' is semantically equivalent to the ground truth's description of 'proactively addressed its maturing obligations.' The phrase 'eliminated a near-term obligation as the maturity date approached' directly mirrors the ground truth's intent. The only minor distinction is that the LLM provides slightly more specific detail about the mechanism (mentioning both cash and new issuances), which adds value without contradicting the ground truth. The citation references (page_103, page_81) add credibility. Overall, this is an excellent answer with accurate numbers, sound reasoning, and appropriate contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 537,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The mortgage‑and‑unsecured‑debt tables show that the annual debt service for Unsecured Notes ‑ 35B was $28,500 (thousand) in each filing – $28.5 million in the 2022 filing, the same amount in the 2023 filing, and again $28,500 (thousand) in the 2024 filing【page_50†L31-L34】【page_51†L31-L34】. Because the amount did not change, SPG’s financing cost for this particular note remained flat over the 2022‑2024 period.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "In 2022 Disney began its DTC overhaul by launching an ad‑supported Disney+ tier, raising subscription prices and realigning costs, and reorganizing DMED to accelerate the streaming push (2022 p. 25‑26). In 2023 the company deepened the effort, earmarking roughly $24 billion of content spend for 2025, investing in Disney+, Hulu and a new ESPN+ flagship service, and betting that subscription‑ and ad‑revenue growth would offset rising programming costs and a crowded streaming market (2023 p. 51‑53). By 2024 Disney’s strategy shifted toward tighter cost‑containment and pricing/bundling management—consolidating its entertainment reporting unit, emphasizing churn control and competitive pricing while still making strategic DTC investments as programming‑rights costs rose and competition intensified (2024 p. 21‑24).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Disney's DTC evolution from 2022-2024 and correctly identifies key strategic shifts. STRENGTHS: (1) Accurately captures the 2022 launch of ad-supported tier and price increases; (2) Correctly identifies 2023 deepening of DTC investment with specific content spend figure ($24 billion for 2025); (3) Properly characterizes 2024 shift toward cost-containment and pricing/bundling; (4) Appropriately synthesizes multi-hop information across three years showing progression from initial overhaul to aggressive investment to cost management. WEAKNESSES: (1) The $24 billion figure for 2025 content spend is mentioned but lacks context about whether this represents total Disney spend or DTC-specific spend—the ground truth doesn't provide this specific number, making verification difficult; (2) Missing some nuance from ground truth regarding 2022 concerns about negative/low returns and uncertain business prospects—LLM frames 2022 more positively as 'overhaul' without acknowledging the cautious tone; (3) Doesn't explicitly mention the $12.25 billion in unused bank facilities cited in ground truth for 2023; (4) The ground truth emphasizes programming distributors demanding unfavorable terms (fewer linear networks but including DTC in deals), which the LLM doesn't capture. QUANTITATIVE ACCURACY: The $24 billion figure appears in the answer but cannot be fully verified against ground truth. No calculation errors detected. QUALITATIVE ACCURACY: The three-year trajectory is correctly identified, though the LLM's framing is slightly more positive in 2022 than the cautious tone in ground truth. Multi-hop reasoning is sound—correctly synthesizes information across three years and identifies the strategic evolution. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing investment strategy, competitive positioning, programming costs, and competition across the specified timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 526,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife’s deposit‑method reinsurance was relatively modest before the Global Atlantic deal – the company reported roughly $1.8 billion of deposit assets and $1.4 billion of deposit liabilities at year‑end 2021 (and similarly in 2020) 【page_216】.  The November 2023 risk‑transfer with Global Atlantic added $10.3 billion of deposit receivables and related liabilities, driving year‑end deposit assets up to $5.1 billion and deposit liabilities to $1.3 billion in 2023 【page_206】, and then they eased slightly to $4.6 billion and $1.2 billion respectively at the end of 2024 as the transaction was amortized 【page_206】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative and multi-hop synthesis across 2022-2024, correctly identifying the Global Atlantic transaction as a pivotal 2023 event. However, there is a critical quantitative discrepancy: The LLM reports deposit assets of $5.1 billion at year-end 2023, while the ground truth states $10.3 billion in reinsurance recoverables and deposit receivables were recorded in 2023. This is a significant error - the LLM's figure is approximately half the correct amount. The 2024 figures are correct ($4.6 billion assets, $1.2 billion liabilities), and the 2022 baseline figures are accurate ($1.8 billion assets, $1.4 billion liabilities). The LLM correctly identifies the 2021 comparator year and accurately characterizes the transaction's impact and subsequent amortization. The reasoning about the strategic shift and post-transaction rebalancing is sound and well-articulated. The semantic framing of the evolution is appropriate. However, the material error in the 2023 deposit asset figure (reporting $5.1B instead of the correct amount related to the $10.3B transaction) represents a significant factual inaccuracy that undermines the quantitative precision required for financial analysis. The answer would have been stronger with the correct 2023 figure, though the directional narrative and 2024 endpoint are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 383,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s CMBS holdings have been shrinking sharply. At the end of 2022 the company reported roughly $1.018 billion of commercial mortgage‑backed securities at fair value (page 148); this fell to about $975 million in 2023 (page 148) and then to only $3 million in its Separate‑Accounts portfolio by year‑end 2024 (down from $6 million in 2023) (page 160). The three‑year slide—from a near‑billion‑dollar position to a negligible amount—indicates CVS is actively divesting its CMBS exposure, likely to limit interest‑rate and credit‑risk risk and to reallocate capital toward other, more preferred asset classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2022: $574M, 2023: $675M, 2024: $3M. LLM claims: 2022: $1.018B (~$1,018M), 2023: $975M, 2024: $3M. The 2022 and 2023 figures are dramatically wrong—off by approximately $444M in 2022 and $300M in 2023. These are not minor rounding differences but represent a 78% overstatement in 2022 and 44% overstatement in 2023. The LLM also introduces confusing language about 'Separate-Accounts portfolio' and mentions $6M in 2023 for that specific account, which is not part of the ground truth answer and appears to conflate different portfolio segments. REASONING QUALITY: While the LLM correctly identifies the overall trajectory (declining CMBS exposure) and the strategic implication (de-risking/divestment), this correct conclusion is built on incorrect foundational numbers. The reasoning about interest-rate and credit-risk mitigation is sound and relevant, but it's applied to wrong data points. MULTI-HOP SYNTHESIS: The answer attempts to synthesize data across three years and connect it to investment strategy, which is appropriate for the question, but the synthesis is based on incorrect source data. COMPLETENESS: The answer addresses all parts of the question (evolution over 3 years, trajectory, strategic implications) but with wrong numbers. The dramatic overstatement of holdings in 2022-2023 fundamentally misrepresents CVS's actual CMBS exposure and the magnitude of the de-risking effort.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 426,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Colgate‑Palmolive’s 10‑K filings for 2022, 2023 and 2024 all list **“hello”** as one of the company’s global and regional trademarks (see the trademark disclosures on page 79 of each filing).  The brand sits in the Oral‑Care portfolio, which consistently accounted for roughly 43 % of worldwide net sales in 2022, slipped only to 42 % in 2023, and returned to 43 % in 2024, while Personal‑Care and Home‑Care remained near 19 %/18 % and 17 % respectively—showing that the strategic emphasis on oral‑care (and thus on “hello”) stayed steady across the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that 'hello' was listed as a trademark across 2022, 2023, and 2024 in Colgate-Palmolive's filings and appropriately notes its positioning within the Oral Care segment. The answer demonstrates good multi-hop reasoning by synthesizing trademark disclosures with segment performance data. However, there are significant quantitative accuracy issues: (1) The specific percentages cited (43%, 42%, 43% for Oral Care; 19%/18% for Personal Care; 17% for Home Care) cannot be verified against the ground truth and appear to be potentially fabricated or incorrectly recalled numbers. The ground truth does not provide these specific percentage breakdowns. (2) The citation to 'page 79 of each filing' is a specific claim that cannot be verified and may be inaccurate. (3) The LLM provides precise financial metrics that go beyond what the ground truth confirms, which raises concerns about hallucination. The qualitative reasoning is sound—the answer correctly interprets the question's multi-part nature and addresses trademark disclosures, segment positioning, and strategic emphasis across the three years. The semantic equivalence to the ground truth is reasonable (both convey continuity and stable positioning), but the introduction of unverified quantitative claims significantly undermines credibility. The answer would have been stronger if it had stuck to the verifiable facts about trademark disclosures and segment alignment without adding specific percentage figures that cannot be confirmed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 422,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s use of the deposit‑method reinsurance grew dramatically after 2022.  In the 2022 filing the company still reported only the historic “deposit assets” of about $1.8 billion and “deposit liabilities” of $1.4 billion (the amounts shown for 2021‑2020) 【page_216】.  Following the November 2023 risk‑transfer transaction with Global Atlantic, the 2023 balance sheet showed deposit assets of $5.1 billion and deposit liabilities of $1.3 billion 【page_206】, and by year‑end 2024 those figures had slipped modestly to $4.6 billion and $1.2 billion respectively 【page_206】.  \n\nThe sharp rise in 2023 reflects MetLife’s strategic shift to place a large portion of its closed‑block and universal‑life business into a modified‑coinsurance arrangement that is accounted for under the deposit method, allowing it to transfer risk while retaining control of the underlying assets; the slight decline in 2024 suggests the program is being fine‑tuned (e.g., amortizing the net cost of reinsurance) but the still‑substantial net deposit position indicates the company continues to rely on this structure to limit insurance‑risk exposure and preserve capital efficiency.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding 2023 deposit assets. The ground truth states deposit assets were $4.6 billion in 2024, but the LLM claims they were $5.1 billion in 2023. This is a material discrepancy ($5.1B vs. the correct figure implied by the ground truth progression). The LLM provides no source for the $5.1 billion figure, and this contradicts the ground truth which shows the evolution as: 2022 ($1.8B assets), 2023 (not explicitly stated in ground truth but implied to be between $1.8B and $4.6B), and 2024 ($4.6B assets). The deposit liabilities figures appear more consistent (2022: $1.4B, 2023: ~$1.3B, 2024: $1.2B), though the 2023 figure of $1.3B is not explicitly confirmed in the ground truth. REASONING QUALITY: The LLM provides good contextual reasoning about the Global Atlantic transaction and the strategic shift toward modified-coinsurance arrangements, which aligns with the ground truth's mention of the Global Atlantic transaction. The explanation of the deposit method's purpose (transferring risk while retaining asset control) is sound and relevant. However, the core quantitative foundation is compromised. COMPLETENESS: The answer addresses the evolution over time and attempts to explain the trend's implications for reinsurance strategy and risk exposure, which matches the question's requirements. The mention of fine-tuning and amortization in 2024 adds reasonable context. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across years and connect it to strategic implications, but the factual error undermines the credibility of the synthesis. The claim about a 'sharp rise in 2023' is based on the incorrect $5.1B figure. VERIFICATION ISSUE: The LLM cites specific page numbers (216, 206) but provides numbers that don't align with the ground truth baseline. This suggests either misreading of source documents or hallucination of specific figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 531,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "NEE’s Special Use Funds expanded markedly – the 2022 filing disclosed NEE‑only funds of about $5.1 billion (≈$9.6 billion when combined with FPL) with a Level‑2/Level‑3 fair‑value measurement that essentially equaled carrying amount (see page 88); the 2023 note shows NEE’s funds at roughly $7.5 billion (≈$12.7 billion combined) and the balance‑sheet line for “Special use funds” rose to $8.7 billion (page 64), then to $9.8 billion in 2024 (page 64). Throughout the period the disclosures continued to present the funds mainly at Level 2 (with modest Level 3 portions) and, while the fund base grew, the collateral posted for derivative contracts fell from $1.8 billion cash and $2.8 billion letters‑of‑credit in 2022 to $0.7 billion cash and $1.6 billion letters‑of‑credit in 2023 (page 86), indicating reduced collateral exposure despite the larger Special Use Fund assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies and some unsupported claims. STRENGTHS: (1) Correctly identifies the upward trend in Special Use Funds from 2022-2024; (2) Accurately cites the 2024 balance sheet figure of $9.8 billion and 2023 figure of $8.7 billion, matching ground truth; (3) Appropriately notes the Level 2/Level 3 fair value measurement approach; (4) Correctly identifies the collateral reduction trend (from $1.8B cash/$2.8B LOC in 2022 to $0.7B cash/$1.6B LOC in 2023); (5) Addresses multiple dimensions of the question (fair value, collateral, balance sheet presentation). CRITICAL WEAKNESSES: (1) The intermediate figures cited ($5.1B NEE-only in 2022, $7.5B in 2023) are not verified in the ground truth and appear to be unsupported extrapolations or misreadings; (2) The ground truth provides specific equity investment figures ($485M in 2022 growing to $538M in 2023) which the LLM answer does not mention; (3) The LLM answer introduces FPL combined figures ($9.6B, $12.7B) that are not part of the ground truth answer and may conflate NEE-specific with consolidated data; (4) The ground truth emphasizes the evolution of fair value disclosure methodology and the introduction of new equity investment categories without readily determinable fair values, which the LLM answer largely omits; (5) The $1.102 billion increase from 2023 to 2024 ($8.698B to $9.8B) mentioned in ground truth is not explicitly calculated or highlighted. QUANTITATIVE VERIFICATION: The 2024 ($9.8B) and 2023 ($8.7B) figures are correct, but the intermediate 2022-2023 figures lack verification. The collateral numbers appear reasonable but cannot be fully validated against ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across years and connects fair value measurement to collateral implications, but the synthesis is partially undermined by unverified intermediate figures. The answer would have been stronger by focusing exclusively on the verified balance sheet progression and the specific equity investment category evolution mentioned in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 573,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "In the 2022 10‑K Broadcom described its Security Insights Platform as a main‑frame‑focused service that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” and noted that “this data is available for use with in‑house tools for security information and event management.” By the 2024 filing the wording was refined to stress that the platform’s insights are meant to be fed directly into customers’ own SIEM or security tooling and can be woven into existing remediation workflows, but the core positioning—risk‑assessment and remediation support for mainframe environments—remains essentially the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the company as Broadcom (AVGO), the correct years (2022, 2024), and the correct product (Security Insights Platform). (2) The LLM accurately captures the 2022 positioning language about assessing mainframe security posture and making data available for in-house SIEM tools. (3) The LLM correctly notes that the core positioning remained essentially the same across the period. (4) No quantitative errors in dates or numbers. WEAKNESSES: (1) CRITICAL DISCREPANCY: The LLM claims the 2024 wording was 'refined to stress that the platform's insights are meant to be fed directly into customers' own SIEM or security tooling and can be woven into existing remediation workflows.' However, the ground truth explicitly states that 'the language remained consistent' and that AVGO 'maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.' This is a significant factual error—the LLM suggests evolution/refinement in 2024 language when the ground truth indicates consistency. (2) The LLM mischaracterizes the nature of change by implying the 2024 description added new emphasis on remediation workflow integration, when the ground truth indicates no such expansion occurred. (3) The LLM fails to mention 2023 data, which the ground truth includes as part of the three-year analysis showing consistency. (4) The phrase 'can be woven into existing remediation workflows' appears to be an inference or misreading—the ground truth does not support that this language appeared in 2024 filings. MULTI-HOP REASONING: The LLM attempts to synthesize across years but does so incorrectly by overstating the degree of evolution. The ground truth's key finding—that positioning remained stable without new integrations—is contradicted by the LLM's characterization of 'refined' and expanded language in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 515,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike’s Laakdal, Belgium site was listed as one of its most significant distribution facilities outside the United States and was owned by the company in FY 2022【page_29】. The FY 2023 filing repeats the same description—Laakdal is an owned, major non‑U.S. distribution center【page_27】—and the FY 2024 filing again notes that the Laakdal facility is owned and remains a key distribution hub for Europe【page_29】. This unchanged ownership and continued highlighting of Laakdal as a major hub indicate that Nike views the site as a strategic cornerstone of its European logistics network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. FACTUAL ACCURACY: The answer correctly identifies that Nike's Laakdal, Belgium facility was company-owned across all three fiscal years (2022, 2023, 2024) with no changes in ownership status. The characterization as a 'most significant international distribution center' or 'major non-U.S. distribution center' or 'key distribution hub for Europe' are all semantically equivalent descriptions of the facility's importance. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this question, so this dimension scores perfectly. The fiscal years cited (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal year filings to demonstrate consistency in ownership and operational status. The logical conclusion that unchanged ownership and continued emphasis indicate strategic importance is sound and directly supported by the evidence presented. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) ownership evolution (consistent ownership across years), (2) operational footprint evolution (consistent description as major hub), and (3) strategic importance implications (stable and integral to European logistics). MINOR CONSIDERATIONS: The LLM includes page references (page_29, page_27, page_29) which add credibility but are not strictly necessary for correctness. The semantic equivalence between 'most significant,' 'major,' and 'key' distribution facilities is appropriately recognized. The conclusion about strategic importance flows logically from the evidence of consistency. No factual errors, calculation errors, or entity misidentifications are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 488,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "SPG’s Unsecured Notes ‑ 32B showed no change over the three most recent filings: in the 2022 10‑K (as of 12/31/2021) it carried a 3.38 % coupon, a $750 million face amount, and a maturity of June 15 2027【page_50】; the 2023 10‑K (as of 12/31/2022) reported the identical 3.38 % rate, $750 million face amount and 06/15/27 maturity【page_49】; and the 2024 10‑K (as of 12/31/2023) again listed a 3.38 % coupon, $750 million face amount and a June 15 2027 maturity【page_51】. This three‑year consistency suggests SPG is deliberately preserving this low‑cost, medium‑term unsecured note as a stable financing source rather than refinancing, retiring, or expanding the issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACE AMOUNT DISCREPANCY: The LLM states the face amount as '$750 million' while the ground truth clearly specifies '$750,000' (a difference of 1,000x). This is a major quantitative error. The ground truth uses the notation '$750,000' which represents $750 thousand, not $750 million. (2) FISCAL YEAR CONFUSION: The LLM incorrectly references '2022 10-K (as of 12/31/2021)' - a 10-K filed for fiscal year 2022 would be as of 12/31/2022, not 2021. This creates confusion about which year's data is being reported. The ground truth correctly identifies data from 2022, 2023, and 2024 filings. (3) MATURITY DATE ACCURACY: The LLM correctly identifies the maturity date as June 15, 2027 (06/15/27), which matches the ground truth. (4) INTEREST RATE: The 3.38% coupon is correctly stated and matches across all three years. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information across three years and draw conclusions about debt management strategy, the fundamental error in the face amount undermines the entire analysis. The ground truth notes that the maturity date was 'unspecified in the 2022 report' but the LLM provides a specific date for all three years without acknowledging this discrepancy. (6) STRATEGIC INTERPRETATION: The LLM's conclusion about deliberate preservation of 'low-cost, medium-term unsecured note' is reasonable given the consistency, but this interpretation is built on incorrect quantitative foundations. The most significant issue is the $750,000 vs $750 million discrepancy, which is a 1,000-fold error in a key financial metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 440,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "In 2022 CVS’s foreign‑currency debt securities were carried at a fair value of roughly **$2.55 billion** and showed **$244 million of unrealized losses**.  By the end of 2023 the fair value had slipped modestly to **$2.51 billion**, while the unrealized loss position narrowed to **$122 million**, indicating a partial recovery in value (page 147).  In 2024 the foreign‑security component of its separate‑account assets collapsed to **$51 million** from $202 million a year earlier (page 160), suggesting the company has substantially reduced the size of its foreign‑security holdings.  This trend of shrinking exposure and lower loss‑recognition points to CVS deliberately de‑risking its portfolio against international market volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years. (1) 2022: LLM claims $2.55 billion fair value with $244 million unrealized losses, but ground truth shows $838 million fair value with $24 million unrealized losses - a massive discrepancy (205% overstatement of fair value, 917% overstatement of losses). (2) 2023: LLM claims $2.51 billion fair value with $122 million unrealized losses, but ground truth shows $1,650 million fair value with $122 million unrealized losses - the unrealized losses match but fair value is overstated by 52%. (3) 2024: LLM correctly identifies $51 million but references a prior year figure of $202 million which doesn't align with the ground truth narrative of a sharp drop from $1,650 million. The LLM appears to be confusing different categories of securities (possibly conflating foreign-currency debt securities with foreign securities more broadly, or mixing in separate-account assets). The conclusion about de-risking is directionally correct, but it's based on wrong numbers. The multi-hop reasoning about portfolio reallocation is sound in logic, but the factual foundation is severely compromised. The answer demonstrates a fundamental misunderstanding or misreading of the source data, making it unreliable despite the correct directional conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 383,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 2022 filing notes that “when … non‑agency RMBS and CMBS have not been previously evaluated by the NAIC, an internally‑developed designation is used until a NAIC designation becomes available”【page_101】. The same language appears unchanged in the 2023 disclosure【page_94】 and again in the 2024 filing【page_84】. This three‑year consistency shows that MetLife relies on the NAIC’s loss‑modeling methodology as the primary credit‑quality yardstick for these securities, resorting to internal designations only as a temporary stop‑gap until the NAIC assigns its model‑based rating.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the consistent language across 2022-2024 filings regarding internally developed designations as a temporary measure until NAIC designations become available. However, it significantly fails to address the quantitative evidence that forms the core of the ground truth answer. CRITICAL OMISSIONS: (1) The LLM completely ignores the $4.2 billion (14.5%) increase in Level 3 fixed maturity securities AFS in 2023 and the $1.6 billion (4.9%) increase in 2024 - these are essential quantitative metrics that demonstrate the evolution pattern. (2) The LLM mischaracterizes the trend as 'three-year consistency' when the ground truth reveals a clear PATTERN OF CHANGE: the growth rate slowed from 14.5% to 4.9%, indicating a shift away from internal designations toward NAIC assessments. (3) The LLM states the language 'appears unchanged' across all three years, which is technically accurate but misleading - the ground truth emphasizes that while the policy remained consistent, the ACTUAL APPLICATION evolved as more securities received NAIC designations over time. QUANTITATIVE ACCURACY FAILURE: The LLM provides zero quantitative data despite the question explicitly asking about a 'multi-year pattern' - the ground truth provides specific dollar amounts and percentages that are crucial to understanding the evolution. REASONING FLAW: The LLM concludes that consistency in policy language means 'reliance on NAIC methodology as primary yardstick,' but this inverts the actual insight - the decreasing growth in Level 3 securities (from 14.5% to 4.9%) suggests that fewer NEW securities required internal designations because more were receiving NAIC designations, indicating DECREASING reliance on internal designations. The LLM's interpretation is partially correct about NAIC being the primary methodology, but it fails to capture the dynamic evolution that the quantitative data reveals.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 520,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "Chevron’s presence in the Republic of Congo expanded from a 2022 deep‑water licence extension that added roughly 36 million barrels to its African proved reserves (page 110) to a $0.7 billion capital outlay in 2023 on offshore development and natural‑gas projects there (page 109). By 2024 the country accounted for about 20 % of Chevron’s net oil‑equivalent production (page 41), but the company also disclosed plans to sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % stake in Lianzi, signalling a shift toward reduced ownership (page 43).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERROR - The LLM claims Chevron's presence 'expanded' in 2022 with a deep-water license extension adding 36 million barrels to African proved reserves. The ground truth states Chevron 'operated' in the Republic of Congo in 2022 with no specific investment figures disclosed. The LLM introduces unsupported claims about reserve additions and license extensions not mentioned in the ground truth. (2) INCORRECT CHARACTERIZATION - The LLM states Congo 'accounted for about 20% of Chevron's net oil-equivalent production' in 2024, but this contradicts the ground truth which indicates Chevron divested its interests in 2024 (sold 31.5% Haute Mer and 15.75% Lianzi stakes). A country cannot represent 20% of production after divestiture. (3) CORRECT ELEMENTS - The $0.7 billion capital allocation in 2023 for offshore development and natural gas projects in Africa is accurate. The 2024 divestiture details (31.5% Haute Mer, 15.75% Lianzi) are correctly stated. (4) MULTI-HOP REASONING FAILURE - The LLM failed to properly synthesize the timeline: it mischaracterizes 2022 as expansion rather than baseline operation, incorrectly adds production percentage data for 2024 (post-divestiture), and creates a narrative inconsistency. The ground truth shows a clear progression from operation (2022) → investment (2023) → exit (2024), but the LLM's narrative contradicts itself by claiming 20% production in 2024 while simultaneously describing divestiture. (5) PAGE REFERENCES - The LLM cites specific pages (110, 109, 41, 43) which cannot be verified against the ground truth provided, suggesting potential hallucination of supporting evidence. The core narrative structure is partially correct but undermined by significant factual errors and internal contradictions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 488,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "Texas Instruments has kept embedded‑processing products as a core pillar of its strategy throughout 2022‑2024, positioning them within the second of its four sustainable competitive advantages – “a broad portfolio of analog and embedded‑processing products that offers more opportunity per customer and more value for our investments”【page_20】【page_18】【page_18】. The MD&A in each year’s 10‑K repeats this language, indicating that the company’s strategic emphasis on embedded processing has remained steady (even as segment revenue grew modestly in 2022‑23 before declining in 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and directly addresses the multi-hop question about Texas Instruments' strategic emphasis on Embedded Processing Products from 2022-2024. STRENGTHS: (1) Correctly identifies embedded processing as a core pillar maintained consistently across 2022-2024, matching the ground truth's conclusion about stable strategic emphasis. (2) Accurately cites the specific language from TI's competitive advantages framework - 'a broad portfolio of analog and embedded-processing products that offers more opportunity per customer and more value for our investments' - which is the precise formulation from the filings. (3) Properly contextualizes embedded processing within TI's four sustainable competitive advantages framework (specifically the second advantage), showing understanding of the structural positioning. (4) Includes appropriate citations to page numbers (page_20, page_18, page_18) indicating multi-hop synthesis across multiple 10-K filings. (5) Notes the evolution of segment revenue (growth in 2022-23, decline in 2024) while maintaining that strategic emphasis remained steady - this adds nuance beyond the ground truth. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth, providing less detail about how the narrative evolved year-to-year (e.g., 2023's emphasis on 'leveraging customer design projects and deepening market insight' is not explicitly mentioned). (2) The phrase 'even as segment revenue grew modestly in 2022-23 before declining in 2024' adds information not explicitly in the ground truth, though it appears factually reasonable and adds context. (3) Does not explicitly state that 'language evolved slightly across years' as the ground truth does, though the answer implies consistency. QUANTITATIVE ACCURACY: No specific financial metrics or calculations are provided in either answer, so this dimension is not heavily tested. The revenue trajectory mentioned (growth then decline) appears reasonable but is not verified against specific numbers. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of 10-K filings and correctly identifies the positioning within TI's competitive framework, demonstrating sound multi-hop reasoning. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth - that embedded processing remained a consistent strategic pillar - while providing slightly different framing and additional context about revenue trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 668,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s 3.50 % senior note carried an effective rate of 3.20 % in FY 2022 (as of July 30 2022)【page_89】. By FY 2023 the effective rate had risen to 6.38 % (July 29 2023) and climbed again to 6.66 % in FY 2024 (July 27 2024)【page_89】. This jump from roughly 3 % to over 6 % shows that the cost of borrowing on this fixed‑rate debt more than doubled, reflecting higher market interest rates and increasing Cisco’s overall borrowing expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - FY2022 effective rate of 3.20%, FY2023 rate of 6.38%, and FY2024 rate of 6.66%. The $500 million principal amount is correctly identified (though not explicitly stated in LLM answer, it's implied). The fiscal year dates are accurate (July 30 2022, July 29 2023, July 27 2024). The calculation that the rate 'more than doubled' from ~3% to >6% is mathematically sound (6.66/3.20 = 2.08x). COMPLETENESS: The answer addresses all parts of the multi-hop question - it traces the evolution across three fiscal years, identifies the specific debt instrument (3.50% Senior Note), and provides interpretation of what the progression indicates about borrowing costs. ENTITY ACCURACY: Cisco is correctly identified, the specific debt instrument is properly referenced, and all fiscal years are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connected the effective rates across three years and drew a logical conclusion about market rate increases and investor risk perception. The interpretation that this reflects 'higher market interest rates' is appropriate given the context. MINOR OBSERVATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The phrase 'fixed-rate debt' in the LLM answer is technically accurate and adds useful context. The citation references (page_89) add credibility. No factual errors or calculation mistakes detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 428,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "BNY Mellon disclosed in its 2022 Form 10‑K that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p. 5). The same risk‑factor language appears unchanged in the 2023 filing (2023 p. 5) and again in the 2024 filing (2024 p. 5). The consistency across three years shows that the company’s exposure to U.S. banking‑law capital‑planning constraints has remained steady, indicating a persistent regulatory ceiling on dividend and share‑repurchase decisions and limited strategic flexibility in altering shareholder‑return policies.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the three-year period (2022-2024), correctly names BNY Mellon, and accurately captures that the company's disclosures reference U.S. banking laws and capital planning constraints on shareholder returns. The citation format and page references appear reasonable. The core observation that language remained consistent across years is factually grounded. CRITICAL WEAKNESSES: (1) The LLM claims the risk-factor language appears 'unchanged' across all three years, but the ground truth explicitly states that by 2023, the company 'specifically reiterated' additional constraints (Delaware law, failure to pay full and timely dividends on preferred stock) and that by 2024, the company 'added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as well capitalized and well managed status.' The LLM's assertion of complete consistency contradicts the ground truth's documented evolution. (2) The LLM fails to capture the multi-year progression that the question specifically asks about. The ground truth reveals a meaningful evolution from 2022 (general regulatory oversight) → 2023 (specific additional constraints) → 2024 (stronger emphasis on liquidity and regulatory standards). The LLM reduces this to 'steady' and 'unchanged,' missing the documented progression. (3) The LLM's conclusion about 'limited strategic flexibility' is reasonable but is not supported by the specific regulatory evolution documented in the ground truth. (4) The LLM does not address the interplay between capital planning, liquidity risk, and shareholder returns that the ground truth identifies as a key insight. QUANTITATIVE ACCURACY: The years (2022, 2023, 2024) and page references (p. 5) are correct, but the substantive claim about consistency is factually incorrect based on the ground truth. QUALITATIVE ACCURACY: The LLM demonstrates weak multi-hop reasoning by failing to synthesize the documented changes across the three-year period and instead asserting static consistency. This represents a fundamental misreading of the regulatory evolution. CONTEXTUAL RELEVANCE: While the answer addresses the general topic, it fails to answer the specific question about how exposure 'evolved' and what the 'progression' reveals, instead claiming stasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 624,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ “Repair and other services” line fell from $1,169 million in 2022 to $1,132 million in 2023 – a $37 million (≈3 %) drop – and then held steady at $1,132 million in 2024【page_9】. The segment is comprised largely of post‑delivery maintenance, modernization and lifecycle‑support contracts for Navy ships and submarines, which generate recurring but relatively static cash flows, so the modest decline and subsequent flatness reflect a mature, stable service business rather than a growth‑oriented focus【page_9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $1,169M (2022), $1,132M (2023), $1,132M (2024). (2) Calculation of the decline is accurate: $37M difference and ~3% drop are both correct. (3) The LLM correctly identifies the segment composition (post-delivery maintenance, modernization, lifecycle-support contracts for Navy ships/submarines). (4) The characterization of cash flows as 'recurring but relatively static' is reasonable. WEAKNESSES: (1) The LLM's interpretation diverges significantly from the ground truth's analytical framing. Ground truth emphasizes 'limited growth or strategic prioritization' and suggests possible 'market saturation, resource reallocation to higher-priority programs, or operational constraints.' The LLM instead frames this as a 'mature, stable service business rather than a growth-oriented focus' - which is a different analytical lens. (2) The LLM does not address the comparative context provided in the ground truth: that the stagnation occurred 'despite overall growth in other areas like nuclear-powered submarines and surface ships,' which is important context for understanding strategic prioritization. (3) The LLM's conclusion that the pattern reflects a 'mature, stable service business' is more optimistic/neutral than the ground truth's suggestion of potential constraints or reallocation. While both interpretations are plausible, the ground truth explicitly raises concerns about growth limitations and strategic choices. (4) The LLM provides source citations (['page_9']) which adds credibility but doesn't change the analytical gap. MULTI-HOP REASONING: The LLM successfully synthesizes the three-year trend and connects it to business characteristics, but misses the comparative analysis with other business segments that the ground truth emphasizes. The reasoning is sound but incomplete relative to the ground truth's more comprehensive analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 514,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security portfolio – which is made up largely of venture‑type investments – grew from $3.7 billion at 12/31/2022 to $4.9 billion at 12/31/2024, a rise of roughly $1.2 billion【page_50】.  Its equity‑method stakes in health‑care operating businesses more than doubled, moving from about $1.5 billion in 2022 to $3.8 billion in 2024【page_52】, showing an increasingly aggressive strategy of taking direct ownership positions in health‑care businesses while still expanding its venture portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the equity-security portfolio growth trajectory. Ground truth shows: 2022: $3.7B → 2023: $4.9B → 2024: $4.9B (stable in final year). LLM states the portfolio grew from $3.7B in 2022 to $4.9B in 2024, which is technically correct for the endpoints but misleadingly suggests continuous growth when 2024 was actually flat vs 2023. More problematically, the LLM states equity-method investments moved from '$1.5 billion in 2022 to $3.8 billion in 2024' - this is INCORRECT. Ground truth clearly shows: 2022: $1.4B → 2023: $1.5B (flat vs 2022 per ground truth) → 2024: $3.8B. The LLM incorrectly uses $1.5B as the 2022 baseline when it should be $1.4B. This is a material error in the multi-hop synthesis. CALCULATION ERROR: The LLM states equity-method investments 'more than doubled' from $1.5B to $3.8B. While the percentage increase is correct (~153%), the baseline year is wrong. STRENGTHS: (1) Correctly identified both investment categories, (2) Correctly captured the 2024 strategic shift toward deeper integrated investments, (3) Appropriately characterized the strategic emphasis change, (4) Correct final values for 2024 ($4.9B and $3.8B), (5) Good contextual interpretation of what the numbers mean strategically. WEAKNESSES: (1) Incorrect 2022 baseline for equity-method investments ($1.5B vs $1.4B), (2) Omitted the intermediate 2023 data point for equity-method investments, which is important for showing the trajectory, (3) Oversimplified the equity-security portfolio narrative by not noting the 2023-2024 stabilization. The answer demonstrates reasonable qualitative understanding but fails on precise quantitative accuracy for the multi-hop synthesis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 483,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. appears in PMI’s peer‑group list in every filing – it is named as a peer in the 2022 10‑K (page 21) 【PM_10k_2022.pdf page_21】, again in the 2023 10‑K (page 26) 【PM_10k_2023.pdf page_26】, and once more in the 2024 10‑K (page 26) 【PM_10k_2024.pdf page_26】. The unchanged inclusion shows that PMI applies a stable, criteria‑driven benchmarking framework (global presence, consumer‑product focus, comparable size) year after year, using a fixed set of peers to consistently gauge its performance and strategic positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) Correctly identifies Colgate-Palmolive Co. as appearing in PMI's peer group across all three years (2022, 2023, 2024) - this matches the ground truth exactly. (2) Provides specific page references for each filing (page 21 for 2022, page 26 for 2023 and 2024), demonstrating document-level verification. (3) Accurately captures the four criteria for peer selection: global presence, consumer-product focus, comparable net revenues, and similar market capitalization - all mentioned in ground truth. (4) Correctly synthesizes the multi-hop reasoning: consistent inclusion across years → stable benchmarking framework → strategic lens for competitive positioning. (5) Appropriately notes that PMI excludes direct tobacco industry peers, showing understanding of the strategic context. (6) The conclusion about 'fixed set of peers' and 'consistently gauge performance' aligns with ground truth's emphasis on 'stable peer benchmarking framework.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no material information. The ground truth explicitly mentions 'unchanged year-over-year' and 'broader consumer products sector,' while the LLM emphasizes 'stable, criteria-driven benchmarking framework' - these are semantically equivalent. The LLM's inclusion of specific page numbers adds value beyond the ground truth. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; all page numbers are accurate; no calculations required. QUALITATIVE ACCURACY: Multi-hop synthesis is sound - correctly connects consistent peer inclusion to strategic benchmarking stability. CONTEXTUAL RELEVANCE: Directly addresses all aspects of the question regarding evolution (or lack thereof), consistency, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 497,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s risk disclosures show a clear widening of abuse exposure as its credit franchise grew and its reliance on unaffiliated banks and other partners deepened. In the 2022 filing the company already warned that its consumer‑ and merchant‑credit products and the use of third‑party lenders created “additional risks” and that “measures to detect and reduce the risk of fraud…may not be effective…particularly new and continually evolving forms of fraud” (2022 p. 25‑28). By 2023 the language was expanded to link the growing portfolio of PayPal‑branded credit, BNPL and working‑capital loans to higher non‑payment and fraud risk, noting that any interruption in a partner‑bank’s ability to lend could limit product growth and that fraud‑detection remains “complex…and may not be effective” (2023 p. 24‑26). The 2024 filing repeats and intensifies these points, stressing that the expanding credit suite and continued dependence on third‑party chartered institutions “expose us to additional risks” and that “measures to detect and reduce the risk of fraud…require continuous improvement” (2024 p. 22‑24‑25). Overall, exposure to abusive behavior has risen alongside credit‑product expansion and third‑party reliance, and while PayPal is incrementally strengthening its controls, the disclosures suggest its fraud‑mitigation framework is still catching up to the heightened risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's evolving fraud and abuse exposure across 2022-2024, with accurate synthesis of the multi-hop narrative. STRENGTHS: (1) Correctly identifies the core trend of increasing exposure tied to credit product expansion and third-party reliance across all three years; (2) Accurately captures the progression from 2022 warnings about fraud detection limitations, through 2023 expansion of credit offerings and partner-bank dependencies, to 2024 intensification of these concerns; (3) Properly synthesizes the key insight that fraud mitigation effectiveness has lagged behind risk growth; (4) Appropriately cites specific page ranges (2022 p. 25-28, 2023 p. 24-26, 2024 p. 22-24-25) showing document-level specificity; (5) Correctly references the €40 billion BNPL receivables agreement context (though not explicitly quantified in this answer). MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the €40 billion multi-year BNPL receivables sale agreement that the ground truth highlights as a specific 2023 milestone, which is a notable omission of a concrete quantitative detail; (2) Does not explicitly address regulatory uncertainty regarding loan receivables post-sale validity mentioned in ground truth; (3) Page citations appear plausible but cannot be independently verified as exact matches to actual 10-K filings. QUANTITATIVE ACCURACY: The answer avoids specific numbers except for page ranges, which limits quantitative verification but also avoids errors. The omission of the €40 billion figure represents a gap in quantitative completeness. QUALITATIVE ACCURACY: The reasoning chain is sound—correctly linking credit expansion → third-party dependencies → increased fraud exposure → lagging mitigation effectiveness. Multi-hop synthesis is well-executed. CONTEXTUAL RELEVANCE: Directly addresses all aspects of the question: evolution of exposure, credit products, third-party risk, and fraud mitigation effectiveness trends. The answer is appropriately scoped and relevant throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1670,
        "completion_tokens": 555,
        "total_tokens": 2225
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume rose from 214 million mmBtu in 2022 to 339 million mmBtu in 2023 (see 2023 filing, p. 117) and then fell to 176 million mmBtu in 2024 (see 2024 filing, p. 114). The increase in 2023 shows the firm added options when gas‑price volatility spiked, while the subsequent reduction in 2024 indicates it scaled back the hedge as market conditions eased—demonstrating a flexible, responsive risk‑management approach to natural‑gas price risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 BASELINE: The LLM states 214 million mmBtu for 2022, but the ground truth clearly indicates 253 million mmBtu. This is a significant factual error (39 million mmBtu discrepancy, ~15% understatement). The 2023 figure of 339 million mmBtu is correct, and the 2024 figure of 176 million mmBtu is correct. QUANTITATIVE ACCURACY: The 2022 number is materially wrong, which undermines the entire 3-year trend analysis. The LLM correctly identifies the 2023 increase and 2024 decrease, but the starting point is incorrect, making the percentage changes and trend interpretation inaccurate. QUALITATIVE ACCURACY: The reasoning about market volatility response and hedging strategy is sound and aligns with the ground truth interpretation. The LLM correctly identifies the pattern of aggressive hedging in 2023 followed by de-risking in 2024. However, the incorrect 2022 baseline weakens the overall analysis. COMPLETENESS: The LLM addresses the 3-year trend and provides interpretation of risk management strategy, which matches the question requirements. The mention of alternative hedging instruments (swaps) is absent from the LLM answer, though this is a minor omission. MULTI-HOP REASONING: The synthesis across three years is logically sound, but built on an incorrect foundation. The connection between market conditions and hedging decisions is appropriately made. ENTITY ACCURACY: Southern Company is correctly identified, years are correct, and the metric (natural gas options in mmBtu) is correct. The page references provided (2023 filing p. 117, 2024 filing p. 114) cannot be verified but appear plausible. The fundamental issue is the 2022 number discrepancy, which is a critical factual error that significantly impacts the evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 480,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ U.S. defined‑contribution plan expense rose from **$70 million in 2022** to **$75 million in 2023** and **$76 million in 2024**【page_44】【page_43】.  At the same time the company notes that its **non‑qualified defined‑benefit pension plan is unfunded and closed to new participants**【page_44】, indicating a strategic shift toward expanding and funding defined‑contribution benefits while moving away from legacy defined‑benefit obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is correct - the three-year progression ($70M in 2022 → $75M in 2023 → $76M in 2024) matches the ground truth exactly. (2) Numbers are properly formatted and cited with page references. (3) The company identification (Texas Instruments) and time period (2022-2024) are accurate. (4) The observation about the non-qualified defined benefit pension plan being unfunded and closed to new participants is factually correct. WEAKNESSES: (1) The LLM answer lacks important contextual detail from the ground truth - specifically the mention that the defined benefit plans were closed to new participants in 1997, which provides historical context for understanding the strategic shift. (2) The reasoning about 'strategic shift' is somewhat incomplete - the ground truth emphasizes that the trend reflects 'growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan' and highlights the company's 'long-standing structure of offering flexible retirement options.' The LLM's framing of this as a 'strategic shift' is reasonable but less nuanced than the ground truth's explanation that this reflects support for employees who have 'opted out of the defined benefit plan and are participating in the enhanced defined contribution plan.' (3) The multi-hop synthesis is present but somewhat superficial - the LLM correctly connects the increasing defined contribution expenses to the closed defined benefit plan, but doesn't fully articulate the relationship between the two in terms of employee choice and benefit flexibility. CALCULATION VERIFICATION: No calculations required; all stated figures are accurate. MULTI-HOP REASONING: The answer does synthesize information across the expense trend and pension plan status, but the connection to 'long-term employee benefit strategy' could be more thoroughly developed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 525,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "GM’s assumed long‑term return on its U.S. defined‑benefit pension assets rose from 5.38 % in 2022 to 6.30 % in 2023, and was further increased to roughly 6.5 % for 2024 【page_86†L45-L52】【page_88†L1-L4】. This upward trend shows GM is becoming more optimistic about future investment performance and is willing to tolerate a slightly higher risk profile, reflected in a more aggressive asset mix for its pension plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a critical discrepancy in the 2022 figure. The ground truth states 5.4% for 2022, but the LLM reports 5.38%. While these are very close (likely rounding variations), the ground truth explicitly states 5.4%, not 5.38%. More problematically, the ground truth indicates the 2023 rate 'remained unchanged at 6.3%' - implying it was already 6.3% in 2022 - but the LLM shows progression from 5.38% (2022) to 6.30% (2023). This represents a fundamental contradiction: the ground truth suggests the 2022 rate was 5.4% but also that 2023 remained at 6.3%, which is internally inconsistent in the ground truth itself. The LLM's interpretation (5.38% → 6.30% → 6.5%) appears more logically coherent as a progression. However, the LLM should have reported 5.4% not 5.38% to match ground truth exactly. The 2024 figure of 6.5% matches correctly. COMPLETENESS: The LLM addresses the core question about the evolution of rates and provides interpretation of the trend. However, it omits some contextual details from the ground truth such as 'capital market assumptions,' 'funded status objectives,' and the specific mention of 'strategic asset mix and risk mitigation approach.' REASONING QUALITY: The LLM correctly identifies the upward trend and provides reasonable interpretation about increased optimism and risk tolerance. The conclusion about 'more aggressive asset mix' aligns with the ground truth's mention of 'greater tolerance for market exposure.' ENTITY ACCURACY: Correctly identifies General Motors, U.S. pension plans, and the metric (long-term rate of return on assets). SEMANTIC EQUIVALENCE: The LLM's interpretation of the trend and its implications is semantically equivalent to the ground truth, though less detailed. The main issue is the quantitative discrepancy in the 2022 figure (5.38% vs 5.4%) and the internal inconsistency in how the ground truth presents the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 522,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return‑swap hedge of deferred‑compensation exposure turned a $92 million loss in FY 2022 into a $58 million gain in FY 2023 and a $91 million gain in FY 2024, while the notional amount of the swaps grew from $651 million (2022) to $792 million (2023) and $985 million (2024)【page_92†L13-L20】【page_91†L31-L38】. The swing from a loss to increasing gains, despite larger swap notional amounts, shows that Cisco has sharpened its economic hedging of equity‑price risk linked to deferred compensation, using total‑return swaps to smooth compensation‑related expense volatility and reinforce its risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FY2022 loss of $92 million, FY2023 gain of $58 million, FY2024 gain of $91 million, and the notional amounts ($651M, $792M, $985M respectively) are all accurate. The multi-hop synthesis is sound—the answer correctly traces the evolution across three fiscal years and connects the financial performance to the growing notional amounts. The reasoning about improved market conditions and strategic adjustments is well-supported by the data progression. The LLM goes beyond the ground truth by providing additional context about notional amounts and explicitly explaining the hedging mechanism (total-return swaps smoothing compensation-related expense volatility), which adds valuable insight without contradicting the original answer. The semantic equivalence is strong: both answers convey the same core message about the turnaround from loss to gains and what this indicates about risk management strategy. Minor point: the LLM's interpretation that the company 'sharpened its economic hedging' is a reasonable inference from the data but represents a slight elaboration beyond the ground truth's more cautious 'potentially reflecting improved market conditions or strategic adjustments.' This elaboration is logical and well-reasoned rather than speculative. All entities (Cisco, fiscal years, financial metrics) are correctly identified. The answer fully addresses all parts of the multi-part question regarding evolution, realized gains/losses, and implications for risk management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 438,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across all three years PayPal’s margin‑risk profile did not change – the company continues to act as the **principal** on each payment, set fees at its own discretion and therefore **bear full margin risk**. In 2022, 2023 and 2024 the 10‑K notes state that PayPal “controls the service of completing payments…has full discretion in determining the fee…independent of the costs we incur when we may utilize payment processors…We therefore bear full margin risk…These fees paid to payment processors … are recognized as transaction expense”【page_80】,【page_75】,【page_75】. Thus, PayPal’s exposure to margin risk remained consistent, with pricing under its control, third‑party processor costs recorded as transaction expense, and no reduction or increase in that exposure over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies PayPal's consistent principal role across all three years (2022-2024) with no structural changes; (2) Accurately captures the core margin risk exposure - PayPal bears full margin risk consistently; (3) Properly synthesizes the multi-hop relationship between pricing control, third-party processor costs, and transaction expense recognition; (4) Correctly states that fees paid to processors are recognized as transaction expense across all three years; (5) Accurately notes that tiered/volume-based pricing does not constitute a future material right (implicit in 'no reduction or increase'); (6) Provides appropriate citations to filing pages; (7) Uses precise financial/accounting terminology (principal, margin risk, transaction expense). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information; (2) The ground truth explicitly mentions '2023 clarified that tiered pricing based on volume did not constitute a future material right' while the LLM answer implies this through 'no reduction or increase' - this is semantically equivalent but slightly less explicit; (3) The LLM answer doesn't explicitly mention 'adoption of new segment reporting disclosures' in 2024, though this is a minor contextual detail that doesn't affect the core answer about margin risk evolution. QUANTITATIVE VERIFICATION: No specific dollar amounts, percentages, or calculations are required for this question - the answer correctly focuses on qualitative consistency and structural stability. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly links pricing control → margin risk → transaction expense recognition as an integrated concept. The conclusion that exposure 'remained consistent' is well-supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 531,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola LNG gas output was essentially flat – 49 million cubic feet per day (MMCFD) in 2022, slipping to 48 MMCFD in 2023 and holding at 48 MMCFD in 2024 【page_9】. The footnote confirms these figures represent Chevron’s share of production from Angola LNG 【page_9】. This stable, only‑slightly‑lowered volume signals that Chevron is preserving a steady feedstock supply for its LNG business, positioning itself as a reliable, long‑term LNG producer rather than pursuing rapid expansion in that market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core quantitative facts. The ground truth states Chevron's natural gas production volumes associated with Angola LNG were: 592 MMCFD (2022), 596 MMCFD (2023), and 609 MMCFD (2024). The LLM reports dramatically different numbers: 49 MMCFD (2022), 48 MMCFD (2023), and 48 MMCFD (2024) - off by a factor of approximately 12x. This is not a minor formatting difference or rounding variation; these are completely different values. The LLM's numbers are approximately 1/12th of the actual figures. The ground truth shows a clear upward trend (592→596→609), while the LLM shows a flat-to-declining trend (49→48→48). The LLM's interpretation of the trend is also inverted - it characterizes the volumes as 'essentially flat' and 'slightly-lowered,' when the actual data shows steady increases. The LLM's strategic interpretation about 'preserving steady feedstock' and being a 'reliable, long-term LNG producer' contradicts the actual upward trajectory that suggests growing operational emphasis. The multi-hop reasoning fails because the foundation (the numbers themselves) is incorrect. While the LLM correctly identifies the metric (natural gas production in MMCFD) and the entity (Angola LNG), the quantitative values are entirely wrong, making the entire answer factually incorrect and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 375,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "Across the three filings Southern Power kept outdoor‑lighting arrangements classified as operating leases, but the disclosed contract horizon grew—from “initial terms of up to seven years” in the 2022 10‑K (page 268) to “initial terms of up to ten years” in both the 2023 and 2024 filings (pages 240 and 232). The reporting of scheduled payments also changed: the 2023 filing still presented modest maturity‑analysis figures (e.g., $36 m due in 2024 and $29‑$30 m in each of the next four years, page 239), whereas the 2024 filing listed a much larger undiscounted cash‑flow schedule for operating leases—including the outdoor‑lighting payments—of $142 m in 2025, $148 m in 2026, $150 m in 2027, $161 m in 2028, $164 m in 2029 and $506 m thereafter (page 233). This escalation in term length and disclosed payment amounts reveals that outdoor‑lighting contracts have become increasingly material and a more structural element of Southern Power’s lease portfolio over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific page numbers and detailed financial figures that cannot be verified against the ground truth knowledge graph provided. The original answer establishes a clear three-year progression: (1) 2022 - immaterial undiscounted cash flows noted, (2) 2023 - scheduled payments included in maturity analyses, (3) 2024 - explicit integration into lease income reporting framework. The LLM answer attempts to support this narrative with concrete data points (contract term lengths increasing from 7 to 10 years, specific payment schedules for 2023-2024), but these specific numbers and page references are not confirmed in the ground truth. The LLM correctly identifies the core thesis that outdoor lighting contracts became increasingly material over time, and the reasoning about escalating term lengths and payment amounts logically supports this conclusion. However, without verification of the specific dollar amounts ($36M, $29-30M, $142M, $148M, etc.) and page numbers cited, the quantitative accuracy cannot be confirmed as correct. The qualitative reasoning is sound - the progression from immaterial to material status is well-articulated, and the multi-hop synthesis across three years is logically structured. The answer is contextually relevant and addresses the evolution question directly. The main weakness is the introduction of specific financial figures and page citations that go beyond what can be verified in the provided ground truth, creating uncertainty about factual accuracy despite the coherent narrative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 429,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across all three years the Melaka, Malaysia site was listed only under the Analog segment. In the 2022 Form 10‑K (Item 2, page 16) the Melaka facility has an “X” in the Analog column and no mark for Embedded Processing; the 2023 Form 10‑K (Item 2, page 16) shows the same pattern; and the 2024 Form 10‑K (Item 2, page 16) again lists Melaka with an “X” only for Analog. Thus the operational footprint in Melaka remained unchanged – it supported Analog products and did not expand to the Embedded Processing segment during 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Correctness assessment: (1) WHAT WAS CORRECT: The LLM correctly identifies that Melaka, Malaysia was listed exclusively under the Analog segment across all three years (2022, 2023, 2024) with no expansion into Embedded Processing. The answer accurately conveys the key finding that the operational footprint remained unchanged. (2) SPECIFIC VERIFICATION: The LLM provides specific document references (Form 10-K Item 2, page 16 for each year) and describes the marking pattern ('X' in Analog column, no mark for Embedded Processing), which aligns with the ground truth's statement that operations were 'exclusively for the Analog segment' and 'limited to the Analog segment' across all three years. The numeric/factual claims are verifiable and consistent with the ground truth. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and two business segments, correctly identifying the pattern of consistency and lack of expansion. The reasoning is sound: examining each year's filing, noting the consistent marking pattern, and drawing the logical conclusion about unchanged operational scope. (4) MINOR CONSIDERATIONS: The LLM answer is slightly more detailed than the ground truth (providing specific page references and describing the marking system), but this adds clarity rather than introducing errors. The semantic meaning is fully equivalent - both convey that Melaka remained an Analog-only operation throughout 2022-2024. No calculation errors, date errors, or entity misidentifications are present. The answer directly addresses all aspects of the multi-part question regarding evolution (or lack thereof) across the three-year period and both segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 482,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "Across the 2022, 2023 and 2024 filings the 1.600 % senior notes always carried a $700 million aggregate principal (with only modest reductions of roughly $1‑$3 million), paid interest semi‑annually on April 15 and October 15, and retained a par‑call date of March 15 2026【page_48】【page_110】【page_113】. This consistency shows AMT’s strategy of locking in low‑cost, long‑dated fixed‑rate funding and keeping the tranche largely untouched, emphasizing financing stability and flexibility while minimizing amortization.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts about AMT's 1.600% Notes: (1) $700 million aggregate principal amount maintained across 2022-2024, (2) semi-annual interest payments on April 15 and October 15, and (3) par call date of March 15, 2026. The characterization of 'modest reductions of roughly $1-$3 million' aligns with the ground truth's specific adjustments of (2.6) in 2023 and (1.5) in 2024 million. The LLM correctly synthesizes the multi-year progression and identifies the stability theme. However, there are some gaps: (1) The LLM does not explicitly mention the specific adjustment amounts from the ground truth [(2.6) and (1.5)], instead using a vaguer 'roughly $1-$3 million' characterization that is less precise; (2) The LLM's interpretation of debt management strategy ('locking in low-cost, long-dated fixed-rate funding') goes beyond what the ground truth states, which more conservatively notes 'stable approach' and 'minor adjustments in administrative or accounting treatments.' The LLM adds interpretive language about 'financing stability and flexibility while minimizing amortization' that, while reasonable, is not explicitly supported by the ground truth. The answer is semantically sound and addresses the multi-hop question well, but lacks the precision of the specific adjustment figures and slightly overreaches in strategic interpretation. The page citations provided suggest proper sourcing, though they cannot be independently verified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 409,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco kept the $2 billion 5.90 % senior note unchanged in every fiscal year – it was $2,000 mm at an effective 6.11 % in FY 2022 (July 30 2022)【page_89†L31-L38】【page_89†L45-L48】, the same $2,000 mm at 6.11 % in FY 2023 (July 29 2023)【page_89†L31-L38】【page_89†L45-L48】, and again $2,000 mm at 6.11 % in FY 2024 (July 27 2024)【page_89†L31-L38】【page_89†L45-L48】.  However, the note’s share of Cisco’s debt fell dramatically as total borrowings rose from $9 bn of long‑term debt (≈$8.9 bn total) in FY 2022【page_89†L45-L48】 to $8.5 bn in FY 2023【page_89†L45-L48】 and then to $20.3 bn in FY 2024【page_89†L45-L48】 (total debt $20.1 bn)【page_89†L45-L48】—its proportion dropped from roughly 22 % of long‑term debt to about 10 % of the overall debt base.  This steady‑amount, fixed‑rate tranche combined with a surge of newer, lower‑cost senior notes and interest‑rate swaps signals that Cisco is preserving a stable long‑dated funding source while diversifying maturities and using cheaper financing and hedges to manage its overall cost of capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 5.90% Note remained constant at $2,000 million across all three fiscal years (2022-2024) with a steady 6.11% effective interest rate. The answer properly recognizes the dramatic increase in total debt and correctly notes the declining proportion of the 5.90% Note within the overall debt composition. The reasoning about diversification strategy and use of lower-cost instruments is sound and relevant.\n\nCRITICAL ERRORS IN QUANTITATIVE ACCURACY:\n1. Total long-term debt figures are significantly incorrect:\n   - Ground truth: $8,416M (2022), increasing to $19,621M (2024)\n   - LLM states: \"$9 bn of long-term debt\" (2022), \"$8.5 bn\" (2023), \"$20.3 bn\" (2024)\n   - The 2022 figure of ~$9bn is close but imprecise; the 2023 figure of $8.5bn contradicts the expected trend and ground truth\n   - The 2024 figure of $20.3bn is reasonably close to $19.621bn but still off\n\n2. Short-term debt omitted entirely - Ground truth shows short-term debt decreased from $499M to $488M, which is relevant context the LLM doesn't address\n\n3. Percentage calculations appear approximate/estimated rather than precise:\n   - LLM claims \"roughly 22% of long-term debt\" dropping to \"about 10% of overall debt base\"\n   - These percentages are not verified against actual calculations from the stated figures\n   - The comparison shifts between \"long-term debt\" and \"overall debt base\" making the trend unclear\n\n4. Total debt composition statement is confusing: \"$9 bn of long-term debt (≈$8.9 bn total)\" - unclear whether this means total debt or just long-term\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and connects the stable 5.90% Note to broader debt strategy. However, the quantitative foundation is weakened by the debt figure inaccuracies.\n\nSEMANTIC EQUIVALENCE: The core insight about Cisco's strategy (preserving stable long-dated funding while diversifying with cheaper instruments) aligns with ground truth, but the supporting numbers undermine confidence in the analysis.\n\nOVERALL: The answer demonstrates good understanding of the strategic narrative but contains material quantitative errors that prevent a higher score. The 2023 debt figure of $8.5bn is particularly problematic as it suggests a decrease rather than the expected increase in total debt.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 634,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics’ Land Systems unit was building 360 new LAVs for the Canadian Army in 2022, increased to 399 new LAVs in 2023, and rose again to 449 new LAVs in 2024 (GD_10k_2022 page 11; GD_10k_2023 page 11; GD_10k_2024 page 11). The step‑wise growth shows a clear strategic push to expand its LAV manufacturing capacity and deepen its partnership with the Canadian Armed Forces, reinforcing its market‑leading position in light‑armored vehicles.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All core production volume numbers are correct: 360 units (2022), 399 units (2023), 449 units (2024). (2) Numeric progression is accurately captured and correctly identifies the step-wise growth pattern. (3) Company and unit identification (General Dynamics' Land Systems) is accurate. (4) Document citations provided (GD_10k pages) add credibility. (5) The characterization of growth as 'strategic push' and 'market-leading position' is reasonable inference from the data.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM answer completely fails to mention the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) program introduced in 2024 with 66 specialized LAVs. This is a material detail from the ground truth that directly supports the answer to 'what does this progression indicate about the company's strategic focus.' (2) The LLM answer focuses on 'partnership with Canadian Armed Forces' but the ground truth emphasizes the LRSS as evidence of 'deepening commitment to land systems and armored vehicle capabilities' - a more specific strategic indicator. (3) While the LLM mentions 'expand its LAV manufacturing capacity,' it doesn't capture the full strategic picture that includes the specialized surveillance variant expansion.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the three-year production trend across multiple 10-K filings, but incompletely addresses the second part of the question about what the progression indicates strategically. The ground truth provides a more complete answer by including the LRSS program as concrete evidence of strategic focus evolution.\n\nNUMERIC VERIFICATION: All three production volume numbers are correct (360, 399, 449). No calculation errors present.\n\nCONTEXTUAL RELEVANCE: The answer addresses the production volume evolution well but provides incomplete strategic context. The question specifically asks 'what does this progression indicate about the company's strategic focus' - the LRSS program is a key indicator that was omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 547,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 2022 filing warned that CMS can change the methodology for Medicare Advantage risk‑adjustment payments, creating funding volatility, and the company answered by selectively adjusting members’ benefits and premiums, pulling plans from certain counties and tightening both medical‑ and operating‑cost management【page_20】【page_25】. The 2023 and 2024 reports repeat that CMS’s risk‑adjustment mechanisms (including periodic RADV audits) remain a continuing exposure【page_21 (2023)】【page_21 (2024)] and UnitedHealth has persisted with the same cost‑control, benefit‑premium adjustments and heightened compliance efforts to mitigate the ongoing funding pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core issue: CMS's ability to change Medicare Advantage risk-adjustment payment methodologies creating funding volatility; (2) Accurately captures the three-year evolution from 2022 through 2024, showing consistent exposure; (3) Properly identifies strategic responses: selective benefit/premium adjustments, county withdrawals, cost management intensification, bid recalibration, and compliance efforts; (4) Mentions RADV audits as an additional specific mechanism in 2023-2024, which adds appropriate detail; (5) No quantitative errors or incorrect dates; (6) Successfully synthesizes information across multiple filing years. MINOR WEAKNESSES: (1) The answer is slightly more concise than the ground truth and could have elaborated more on the 'sustained operational agility' concept mentioned in the original; (2) While the answer mentions 'heightened compliance efforts,' the ground truth emphasizes 'beneficiary health status data submissions' as a specific 2024 focus area - this detail is not explicitly captured; (3) The phrase 'selective market participation' from the ground truth is implied but not explicitly stated in the LLM answer. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate filing years and demonstrates understanding of how the company's strategic responses evolved in parallel with CMS's changing methodologies. The logical flow from problem identification to strategic response is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information and meaning of the ground truth, with only minor omissions of specific details rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 489,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s “fixed‑rate 2.850 %” notes (maturing 10 Oct 2029) were carried at **$1.5 billion in 2022, $1.5 billion in 2023, and $1.5 billion in 2024**【page_107】【page_104】.  The unchanged $1.5 billion balance over three years shows the company is keeping a steady, low‑cost, long‑dated tranche of debt in its capital structure, using it as a stable financing backbone while issuing newer, higher‑rate notes for additional funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All three years' carrying values are correctly stated as $1.5 billion (2022, 2023, 2024), matching the ground truth exactly. The maturity date (10 Oct 2029) and interest rate (2.850%) are correctly identified. No calculation errors present. ENTITY ACCURACY: PayPal/PYPL correctly identified, fiscal years 2022-2024 properly referenced, and the specific debt instrument properly characterized. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (constant at $1.5B), and (2) what this indicates about long-term debt strategy (stable, low-cost financing backbone). MULTI-HOP REASONING: The synthesis is sound - the model correctly identifies that the constant balance across three years indicates strategic consistency, and appropriately contextualizes this within the broader debt portfolio dynamics (newer, higher-rate notes issued for additional funding). SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents a \"steady, low-cost, long-dated tranche\" and \"stable financing backbone\" conveys the same strategic intent as the ground truth's \"consistent long-term debt strategy\" and \"strategic intent to preserve this liability structure.\" MINOR CONSIDERATIONS: The LLM provides slightly more operational context (mentioning newer higher-rate notes) which adds value without contradicting the ground truth. The citation references (page_107, page_104) suggest proper source documentation. The only minor distinction is that the ground truth emphasizes \"despite broader changes in its debt portfolio\" while the LLM emphasizes the contrast with \"newer, higher-rate notes\" - both perspectives are complementary and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 484,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron kept a steady 36.4 % equity stake in Angola LNG Limited—the on‑shore plant that can process 1.1 billion cf/d of associated gas—through 2022‑2024 [page_14].  Its carrying investment fell from $2.18 bn in the 2022 filing [page_78] to $1.96 bn in the 2023 filing and $1.76 bn in the 2024 filing [page_82], while equity earnings jumped to $1.86 bn in 2023 before moderating to $0.51 bn in 2024 [page_82].  This shows Chevron maintaining a stable minority position, trimming capital exposure, and relying on the LNG plant (and upcoming gas feed from projects such as the New Gas Consortium) to monetize Angola’s associated gas over the long term.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Chevron's consistent 36.4% ownership stake in Angola LNG Limited across 2022-2024, matching the ground truth. (2) The carrying investment values ($2.18bn in 2022, $1.96bn in 2023, $1.76bn in 2024) appear reasonable and show a declining trend that is logically presented. (3) The mention of the New Gas Consortium as a future gas feed source is accurate and relevant. (4) The LNG plant capacity (1.1 billion cf/d) is a specific technical detail that adds credibility.\n\nWEAKNESSES: (1) The LLM answer focuses heavily on financial metrics (carrying investment, equity earnings) rather than the strategic evolution requested in the question. The ground truth emphasizes the STRATEGIC POSITIONING EVOLUTION—specifically how the investment transitioned from a 'standalone LNG export facility' to an 'integrated hub for gas monetization.' (2) The LLM mentions equity earnings ($1.86bn in 2023, $0.51bn in 2024) but these figures are not verified against the ground truth and appear to be specific claims that require validation. (3) The LLM answer does not adequately address the upstream expansion through Blocks 49 and 50 exploration acreage, which is a key element of the strategic evolution described in the ground truth. (4) The LLM answer does not explicitly discuss the Quiluma and Maboqueiro (Q&M) gas fields and their direct connectivity to the Angola LNG plant, which is central to understanding the integrated hub strategy. (5) The answer lacks the narrative arc of strategic evolution—it presents financial data but doesn't synthesize how this reflects a shift from standalone facility to integrated hub.\n\nMULTI-HOP REASONING: The LLM partially synthesizes information across years (2022-2024) but fails to connect upstream development (Blocks 49/50, Q&M fields) with the downstream LNG facility to show the integrated strategy. The ground truth requires understanding how upstream and downstream assets work together; the LLM answer treats them somewhat separately.\n\nQUANTITATIVE VERIFICATION: The 36.4% stake is correct. The carrying investment figures ($2.18bn, $1.96bn, $1.76bn) show a logical declining trend but cannot be independently verified from the provided context. The equity earnings figures ($1.86bn, $0.51bn) are specific claims that require source verification.\n\nCONCLUSION: The LLM answer is partially correct on the ownership stake and provides relevant financial context, but it significantly underaddresses the strategic evolution question by focusing on financial metrics rather than the integration of upstream and downstream assets that characterizes Chevron's long-term natural gas monetization strategy in Angola.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 713,
        "total_tokens": 2110
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "Southern Company’s trust holdings have risen each year. Domestic‑equity assets grew from $829 million in 2022 (651 + 178 = $829 m) to roughly $973 million in 2023 (Alabama Power $651 m + Georgia Power $322 m) and to $1,099 million in 2024 (849 + 250 = $1,099 m)【page_283】【page_281】【page_273】. Private‑equity exposure also increased, moving from $161 million in 2022 to $169 million in 2023 and $181 million in 2024【page_283】【page_281】【page_273】. The consistent upward trend shows a deliberate long‑term capital‑allocation strategy that expands equity positions and adds private‑equity exposure, reflecting the company’s focus on building diversified, long‑duration assets to support future obligations and generate stable returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that contradict the ground truth across all three years:\n\n1. DOMESTIC EQUITY - MAJOR DISCREPANCIES:\n   - 2022: LLM states $829M, but ground truth is $1,016M (error of -$187M or -18.4%)\n   - 2023: LLM states $973M, but ground truth is $829M (error of +$144M or +17.4%)\n   - 2024: LLM correctly states $1,099M ✓\n   The LLM has essentially shifted all values down by one year, creating a systematic misalignment of the entire timeline.\n\n2. PRIVATE EQUITY - SIGNIFICANT ERRORS:\n   - 2022: LLM states $161M, but ground truth is $150M (error of +$11M or +7.3%)\n   - 2023: LLM states $169M, but ground truth is $161M (error of +$8M or +5.0%)\n   - 2024: LLM correctly states $181M ✓\n   Again, values are systematically shifted, though the 2024 figure is correct.\n\n3. NARRATIVE CONTRADICTION:\n   The LLM claims \"trust holdings have risen each year\" but the ground truth shows domestic equity DECREASED from 2022 ($1,016M) to 2023 ($829M) before rebounding in 2024. This is a fundamental mischaracterization of the trend.\n\n4. MULTI-HOP REASONING FAILURE:\n   The LLM failed to correctly synthesize the three-year progression. The correct pattern is: 2022 ($1,016M) → 2023 ($829M, decline) → 2024 ($1,099M, rebound). The LLM's pattern is inverted.\n\n5. STRATEGIC INTERPRETATION:\n   While the LLM's conclusion about diversification and long-term strategy is reasonable, it's based on incorrect data. The ground truth indicates a more nuanced pattern with a dip in 2023 followed by recovery, not a consistent upward trend.\n\n6. CALCULATION ERRORS:\n   The LLM shows work (e.g., \"651 + 178 = $829m\") but these component breakdowns don't match the ground truth totals, suggesting data extraction or calculation errors from the source documents.\n\nThe answer demonstrates a systematic misalignment of years and values that undermines the entire response, despite correct identification of the general strategic direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 538,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "- 2022: Eliminations/Reclassifications subtracted **$107 million** from total net sales and revenue (‑$107 m)【page_69】.  \n- 2023: The same line reduced total net sales and revenue by **$151 million**【page_70】.  \n- 2024: The impact grew to a **$296 million** reduction【page_68】.  \n\nThe increasingly larger negative adjustments indicate that GM’s internal inter‑segment eliminations and reclassifications have become more material over time, reflecting greater complexity and more extensive internal transactions as the company consolidates its automotive, financial and Cruise businesses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM reports: 2022=$107M, 2023=$151M, 2024=$296M. Specifically: (1) 2022 figure is WRONG - LLM states $107M but ground truth is $105M (off by $2M); (2) 2023 figure is WRONG - LLM states $151M but ground truth is $107M (off by $44M, a 41% error); (3) 2024 figure is CORRECT at $296M. The LLM got 1 out of 3 years correct. MULTI-HOP REASONING: The LLM correctly identifies the trend direction (increasing eliminations over time) and provides reasonable interpretation about increasing complexity and inter-segment transactions. However, this qualitative reasoning cannot compensate for the fundamental quantitative errors. COMPLETENESS: The answer addresses all three years and attempts to explain the trend, but the incorrect numbers undermine the entire analysis. The interpretation about 'greater complexity and more extensive internal transactions' is reasonable but is based on partially false data. ENTITY ACCURACY: GM is correctly identified, years are correct, and the metric (Eliminations/Reclassifications) is correctly identified. The page references provided (page_69, page_70, page_68) cannot be verified but appear to be citations. SEMANTIC EQUIVALENCE: While the wording about trend interpretation is reasonable, the core answer fails because the numbers are materially incorrect. This is not a minor formatting difference but actual data errors that fundamentally misrepresent the financial information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 435,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "Netflix’s Performance Bonus Plan was originally disclosed in the 2022 filing as a legacy “Performance Bonus Plan” referenced in a Def 14A proxy filing (Exhibit 10.6†, dated April 28 2014) 【page_66】.  In the 2023 10‑K the company filed an **Amended and Restated Performance Bonus Plan** as an 8‑K (Exhibit 10.5†, filed December 9 2022) 【page_68】, and the same amended‑and‑restated document is again attached in the 2024 10‑K (Exhibit 10.5†) 【page_69】.  By 2023‑2024 the plan is presented together with other executive‑compensation exhibits (e.g., the Executive Severance and Retention Incentive Plan, stock‑option and RSU award agreements), indicating it has been formally incorporated into Netflix’s broader compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All dates are correct - April 28, 2014 for original plan, December 9, 2022 for amendment/restatement filing, and proper year attribution (2022, 2023, 2024). (2) All exhibit numbers are accurate - Exhibit 10.6† for 2022 original plan, Exhibit 10.5† for 2023-2024 amended/restated versions. (3) The multi-hop synthesis is sound: correctly traces the evolution from historical exhibit (2022) → amended and restated (2023) → carried forward without changes (2024). (4) Properly identifies the integration with broader compensation frameworks (Executive Severance and Retention Incentive Plan, stock options, RSU agreements). (5) Correctly notes the filing type progression (Def 14A proxy for original, 8-K for amendment). MINOR CONSIDERATIONS: (1) The LLM answer specifies the 2023 amendment was filed via 8-K, while the ground truth simply states 'filing date of December 9, 2022' without specifying the form type - this is a reasonable inference but adds detail not explicitly in ground truth. (2) The LLM answer uses slightly different phrasing ('legacy' vs 'historical') but conveys the same meaning. (3) The ground truth emphasizes 'strategic update in 2023 followed by stabilization in 2024' while the LLM answer focuses more on the documentation status and integration aspects - both are valid interpretations of the evolution. The answer fully addresses all parts of the multi-part question regarding documentation status and integration with other compensation frameworks, with accurate synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 449,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK’s Item 13 consistently states that the “Business Relationships and Related Party Transactions Policy” is included in the proxy and incorporated by reference, and that it is presented together with the Director Independence discussion and the same set of committees (Audit, Corporate Governance/Nominating & Social Responsibility, and Human Resources & Compensation) in each filing — 2022 (see page 11)【page_11】, 2023 (see page 13)【page_13】 and 2024 (see page 13)【page_13】. The wording and committee references are unchanged across the three years, showing that BK’s corporate‑governance disclosures on this policy, director independence and committee structure have remained stable and consistent.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the consistent disclosure of the 'Business Relationships and Related Party Transactions Policy' across all three years (2022, 2023, 2024); (2) Accurately specifies Item 13 as the location; (3) Correctly names all three committees (Audit, Corporate Governance/Nominating & Social Responsibility, Human Resources & Compensation); (4) Properly synthesizes the multi-hop relationship between the policy, director independence discussion, and committee structures; (5) Accurately conveys the key finding that disclosures remained stable and consistent across the three-year period; (6) Provides specific page references (page 11 for 2022, page 13 for 2023 and 2024) which add credibility. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page citations with formatting markers【page_11】【page_13】 that, while helpful, are not explicitly mentioned in the ground truth answer, though this represents added value rather than error; (2) The ground truth mentions 'Corporate Governance and Board Information' as the broader context, while the LLM focuses on Item 13 specifically - these are semantically equivalent and both correct; (3) The LLM's phrasing 'incorporated by reference' and 'included in the proxy' adds slightly more specificity than the ground truth but remains accurate. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; page numbers appear reasonable for SEC filings. QUALITATIVE ACCURACY: The reasoning correctly identifies the multi-hop synthesis required (policy → director independence → committee structures) and properly concludes that consistency indicates a stable governance framework. CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question by demonstrating that there was no material evolution - consistency itself is the key finding, which is appropriately emphasized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 529,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt portfolio has been shrinking: at 12/31/2022 the securities were reported at a fair value of **$679 million** (carrying $696 million); at 12/31/2023 the fair value fell to **$596 million** (carrying $603 million); and at 12/31/2024 it declined further to **$508 million** (carrying $512 million). The parallel drop in both fair‑value and carrying amounts suggests the company is deliberately reducing the size of its HTM holdings—likely by letting securities mature or selling them—while continuing to value them close to amortized cost using observable market inputs, reflecting a conservative valuation stance and a strategic shift toward a smaller, more liquid investment mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect fair value figures for 2022 and 2023. Ground truth shows: 2022 fair value $643M (LLM claims $679M - error of $36M or 5.6%), 2023 fair value $596M (LLM correct), 2024 fair value $508M (LLM correct). For carrying values: 2022 carrying $641M (LLM claims $696M - error of $55M or 8.6%), 2023 carrying $603M (LLM correct), 2024 carrying $512M (LLM correct). The LLM gets 2 of 6 data points correct. CALCULATION VERIFICATION: The LLM correctly identifies the downward trend (643→596→508 for fair value and 641→603→512 for carrying value per ground truth), but this is obscured by the incorrect 2022 baseline numbers provided. MULTI-HOP REASONING: The qualitative interpretation about strategic reduction and shift toward observable market inputs is reasonable and aligns with ground truth conclusions, but is undermined by the factual errors. The reasoning about deliberate reduction through maturity/sales and conservative valuation stance is sound. ENTITY ACCURACY: Company (UnitedHealth), metric (Debt Securities HTM), and years are correctly identified. SEMANTIC EQUIVALENCE: The narrative about portfolio shrinking and strategic shift is semantically aligned with ground truth, but the foundation is built on incorrect numbers. The statement about 'observable market inputs' aligns with ground truth's mention of shift away from Level 3 inputs. MAJOR ISSUE: Starting with wrong 2022 baseline numbers (off by 5-8%) propagates through the entire analysis and violates the strict requirement for numerical accuracy in financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 441,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In its 2022 filing PayPal warned that its credit‑product portfolio – which includes buy‑now‑pay‑later (BNPL) loans – left it vulnerable to defaults, charge‑offs and “bad transactions” that could increase loss rates (2022 10‑K p. 25‑26).  In June 2023 the company entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables and to forward‑flow future originations, thereby off‑loading the bulk of that exposure (2023 10‑K p. 25).  By the 2024 filing PayPal stresses reliance on third‑party funding and continued forward‑flow arrangements as part of its risk‑mitigation strategy, showing a clear shift from holding BNPL receivables to transferring them to external partners to limit loss risk (2024 10‑K p. 21‑22).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) All key numeric values are correct: €40 billion BNPL receivables sale agreement in June 2023, correct fiscal years, accurate characterization of the transaction as a multi-year agreement with forward-flow arrangements. (2) Quantitative accuracy is excellent - the €40 billion figure matches ground truth exactly, and the timeline (2022 → June 2023 → 2024) is precise. (3) Multi-hop reasoning is sound: the answer correctly traces PayPal's evolution from acknowledging BNPL risk exposure in 2022, to executing the strategic sale agreement in 2023, to emphasizing third-party funding and forward-flow arrangements in 2024. (4) Entity identification is accurate throughout (PayPal, BNPL, U.K./European receivables). (5) The answer correctly identifies the risk mitigation strategy shift from holding to transferring receivables. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than ground truth in one respect - it doesn't explicitly mention that the 2024 filing noted the sale was \"subject to certain conditions\" that could delay benefits, which was highlighted in the original answer as an important caveat about ongoing challenges. (2) The ground truth emphasizes continued acknowledgment of fraud and abuse risks in the digital payments ecosystem, while the LLM answer focuses more on the structural shift to third-party funding without explicitly restating the persistent fraud/abuse concerns. These are relatively minor omissions that don't affect the core factual accuracy but represent slightly less complete contextual coverage. The answer is well-structured, cites appropriate filing pages, and demonstrates clear understanding of the multi-year evolution of PayPal's BNPL risk strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 507,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s Myanmar output fell sharply: in 2022 the asset produced about 17 k bbl oil‑equivalent per day (≈94 MMCFD of gas) 【page_9】; in 2023 it slipped to roughly 15 k bbl (≈87 MMCFD) 【page_9】; and by 2024 it had dropped to only 4 k bbl (≈22 MMCFD) 【page_9】. This decline reflects Chevron’s strategic decision announced in January 2022 to begin an orderly transition out of Myanmar, culminating in its withdrawal from the country in April 2024 【page_15】【page_9】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2024 production figure of 4 k bbl (≈22 MMCFD), but the ground truth states Chevron completely withdrew from Myanmar in April 2024, meaning there should be NO production in 2024 after the withdrawal. The LLM's claim of 4 k bbl production in 2024 directly contradicts the complete exit. (2) The 2022 (17 MBD) and 2023 (15 MBD) figures are correct and match ground truth. (3) MULTI-HOP REASONING - While the LLM correctly identifies the January 2022 announcement and April 2024 withdrawal, it fails to properly synthesize that a complete withdrawal in April 2024 means zero production for the remainder of 2024, not a partial year production of 4 k bbl. (4) STRATEGIC SHIFT - The LLM correctly identifies this as a strategic transition/withdrawal but undermines this by reporting continued production through 2024. (5) The ground truth is clear: 17 MBD (2022) → 15 MBD (2023) → complete exit (April 2024). The LLM's intermediate 4 k bbl figure for 2024 appears to be either a misinterpretation of partial-year data or a fabrication not supported by the ground truth. This is a fundamental factual error that significantly impacts the answer's reliability, as it misrepresents the timing and completeness of the strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 363,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "In 2022 the Personal Electronics segment made up about 15 % of TI’s total revenue and PC & Notebooks was listed as the second‑largest sector within that segment (after mobile phones) 【page_5】. By 2024 the segment’s share had risen to roughly 20 % of total revenue while PC & Notebooks remained the second‑largest category 【page_5】. The unchanged ranking together with the growing share of Personal Electronics indicates TI is steadily strengthening its strategic focus on the consumer‑computing market, especially PC and notebook applications.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect percentages. Ground truth states Personal Electronics was 24% in 2022, declining to 15% in 2023, then rising to 20% in 2024. The LLM claims it was 15% in 2022 and rose to 20% in 2024, missing the 2023 data point entirely and misrepresenting the 2022 baseline by 9 percentage points. This is a major factual error. (2) MULTI-HOP REASONING - The LLM fails to synthesize the complete three-year trend. Ground truth shows a decline from 2022-2023 followed by a partial recovery in 2024, suggesting strategic de-emphasis. The LLM only compares 2022 to 2024, missing the critical 2023 inflection point. (3) STRATEGIC INTERPRETATION - The LLM's conclusion is directly opposite to ground truth. Ground truth indicates TI shifted AWAY from PC & Notebooks toward higher-growth Automotive and Industrial markets. The LLM concludes TI is 'steadily strengthening its strategic focus on the consumer-computing market,' which contradicts the documented strategic shift. (4) ENTITY/RANKING ACCURACY - The LLM claims PC & Notebooks was 'second-largest' in both years, but ground truth indicates it appeared 'lower in the list of priorities' by 2024 compared to mobile phones and portable electronics, suggesting a relative decline in importance. (5) COMPLETENESS - The answer addresses the revenue contribution evolution but fundamentally misinterprets the trend direction and strategic implications. The 2023 data point is entirely omitted, which is critical for understanding the segment's trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 434,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "- 2022 – GM disclosed that its wholly‑owned seller had agreed to indemnify Stellantis for any post‑sale emissions, product‑liability or recall claims, and that GM had entered into a guarantee of that obligation, but it could not estimate any loss and recorded no accrual for the indemnity 【page_90】.  \n- 2023 – GM added that it had already paid an **immaterial** amount to cover certain legacy Opel/Vauxhall recalls (including Takata‑inflator recalls) and still could not estimate any material loss, noting that any further Takata‑related indemnification was “remote” 【page_93】.  \n- 2024 – The filing repeats the 2023 language: the known liability remains immaterial, no material accrual is shown, and future exposure to additional Stellantis indemnification (especially for Takata recalls) is still considered remote 【page_94】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of GM's indemnification obligations to Stellantis across 2022-2024 and correctly identifies key themes (immaterial amounts, inability to estimate losses, remote Takata exposure). However, there are significant gaps and inconsistencies when compared to the ground truth:\n\n1. MISSING CRITICAL DETAILS (2023-2024):\n   - The ground truth explicitly mentions 2023 disclosure of indemnification for \"pre-sale representations and warranties, emissions claims, product liabilities, and recalls\" - the LLM answer does not clearly articulate these specific categories in 2023\n   - The ground truth specifically identifies \"European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era\" with accruals in 2024 - the LLM answer completely omits this regulatory investigation detail, which is a material omission given the question's focus on \"legacy Opel/Vauxhall matters\"\n   - The ground truth notes GM \"reiterated that while further indemnification for Takata-related recalls was possible\" in 2024 - the LLM answer says exposure is \"still considered remote\" which is less precise than the ground truth's nuanced \"possible but remote\" characterization\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - Both answers correctly identify amounts as \"immaterial\" but the LLM answer lacks specificity about what changed between years\n   - The LLM answer does not distinguish between \"immaterial amount already paid\" (2023) vs. \"accruals of an immaterial amount\" (2024) - these represent different liability recognition\n\n3. MULTI-HOP REASONING:\n   - The LLM answer correctly synthesizes information across three years but misses the key evolution point: the emergence of specific regulatory investigation exposure (EC/CMA) in 2024, which represents a material shift in the nature of obligations\n   - The answer fails to connect the \"legacy Opel/Vauxhall\" aspect of the question to the specific regulatory investigations mentioned in ground truth\n\n4. STRUCTURAL ISSUES:\n   - The 2022 description in LLM answer mentions \"wholly-owned seller\" and \"guarantee\" which adds detail not in ground truth, but this detail is not problematic\n   - The LLM answer's statement that 2024 \"repeats the 2023 language\" is partially incorrect - the ground truth shows 2024 added new information about EC/CMA investigations\n\n5. WHAT WAS CORRECT:\n   - Correct identification of immaterial amounts across all years\n   - Correct characterization of inability to estimate losses\n   - Correct identification of Takata-related exposure as remote/possible\n   - Correct year-by-year progression structure\n   - Correct identification of companies (GM, Stellantis)\n\nThe answer is partially correct on the surface but fails to capture the most important evolution: the emergence of specific regulatory investigation liabilities related to Opel/Vauxhall end-of-life vehicle practices in 2024, which directly addresses the question's focus on \"legacy Opel/Vauxhall matters.\"",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 800,
        "total_tokens": 2257
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower first disclosed the 1.450 % senior notes due 2026 in a supplemental indenture dated September 27 2021, which appears as a new issuance in the 2022 10‑K (Exhibit 4.21) 【page_70】. The 2023 and 2024 filings still list the same notes as outstanding (Exhibit 4.25) 【page_72】, indicating the company has kept this low‑coupon, medium‑term debt on its balance sheet rather than refinancing or retiring it early. This pattern shows a deliberate debt‑management strategy of locking in inexpensive, longer‑dated financing and maintaining a stable debt profile over multiple years.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT REFERENCES: The LLM answer contains significant factual errors regarding exhibit numbers that contradict the ground truth. Ground truth states: 2022 (Exhibit 4.25), 2023 (Exhibit 4.22), 2024 (Exhibit 4.21). LLM states: 2022 (Exhibit 4.21), 2023 and 2024 (Exhibit 4.25). This is a direct contradiction—the exhibit numbers are reversed/incorrect. CORRECT ELEMENTS: (1) The coupon rate of 1.450% is correct, (2) The maturity year of 2026 is correct, (3) The supplemental indenture date of September 27, 2021 is correct, (4) The characterization of the notes as 'low-coupon, medium-term debt' is accurate, (5) The conclusion about stable debt management strategy and lack of refinancing is semantically aligned with ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes that the notes appeared across all three years (2022, 2023, 2024) and correctly infers this indicates a stable debt management approach with no refinancing. However, the specific exhibit number errors undermine the factual precision required for financial document analysis. QUANTITATIVE ACCURACY PENALTY: While the coupon rate and date are correct, the exhibit number errors are material factual mistakes in a financial context where precise document references are critical. The LLM also incorrectly suggests the notes were 'new' in 2022 when they were actually issued in 2021 (though this is a minor semantic issue since they first appeared in the 2022 10-K). OVERALL ASSESSMENT: The answer demonstrates sound reasoning about debt strategy but fails on precise factual accuracy regarding exhibit references, which is a significant flaw in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 455,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The Bank of New York Mellon kept the 2019 Long‑Term Incentive Plan as the umbrella framework, but each year it filed new unit‑grant agreements under that plan. In 2022 the plan was carried out with a 2022 Performance Share Unit Agreement (Exhibit 10.21) and a 2022 Restricted Stock Unit (deferred‑stock) Agreement (Exhibit 10.22) 【page_19】; in 2023 it was refreshed with a 2023 Performance Share Unit Agreement (Exhibit 10.26) and a 2023 Restricted Stock Unit Agreement (Exhibit 10.27) 【page_19】; and in 2024 the company introduced a 2024 Performance Share Unit Agreement (Exhibit 10.25) and a 2024 Restricted Stock Unit Agreement (Exhibit 10.26) 【page_19】. This shows a steady evolution of the 2019 LTIP through annual updates to both performance‑share and deferred‑stock unit contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) YEAR MISLABELING: The LLM incorrectly attributes 2022 and 2023 forms to those years when the ground truth indicates 2019 forms were used in 2022, and a 2019 Form of Deferred Stock Unit Agreement for Directors was introduced in 2023. The LLM claims 2022, 2023, and 2024 forms were filed in those respective years, which is factually incorrect. (2) FORM NAMING ERRORS: The ground truth specifies '2019 Form of Performance Share Unit Agreement' and '2019 Form of Restricted Stock Unit Agreement' for 2022, but the LLM calls them '2022 Performance Share Unit Agreement' and '2022 Restricted Stock Unit Agreement.' (3) MISSING KEY DETAIL: The ground truth emphasizes the introduction of the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors' in 2023, which is a critical evolution showing extension to director-level compensation. The LLM completely misses this important distinction and instead incorrectly references generic RSU agreements. (4) 2024 DISCREPANCY: The ground truth mentions '2022 Form of Performance Share Unit Agreement' for 2024, not a '2024 Form' as the LLM states. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the progression across years, misidentifying which forms were introduced when and conflating form dates with filing years. The answer demonstrates a fundamental misunderstanding of the document structure and timeline. The LLM's claim of 'annual updates' with year-matching forms is not supported by the ground truth, which shows a more nuanced evolution with 2019 forms being the baseline and selective updates/introductions in subsequent years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 468,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "From 2022 the filing highlighted OTS’s “leading position providing missile subsystems … with critical aerostructures” for both legacy and next‑generation missiles (page 12). The 2023 report reiterated that role, adding that OTS supplies those aerostructures together with control actuators, high‑performance warheads and cutting‑edge hypersonic rocket cases (page 13). By 2024 the company not only kept the aerostructure focus but also announced a strategic teaming agreement for solid‑rocket‑motor production and a major expansion of metal‑parts capacity, signaling an intensified commitment to next‑generation missile subsystems and cementing its strategic position as a premier supplier and integrator of advanced missile aerostructures.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) ENTITY CONFUSION - The LLM answer discusses 'OTS' (Ordnance and Tactical Systems) as if it were General Dynamics itself, when OTS is actually a segment/division within GD. The ground truth correctly identifies this as General Dynamics' Combat Systems segment. This is a fundamental entity identification error. (2) MISSING KEY QUANTITATIVE DATA - The ground truth provides specific revenue percentages (20% in 2023, 19% in 2024) that directly answer the question about strategic positioning trends. The LLM answer completely omits these critical metrics, which are essential for understanding the 3-year trend. (3) INCOMPLETE TEMPORAL COVERAGE - The ground truth explicitly addresses all three years (2022, 2023, 2024) with specific data points for each. The LLM answer provides qualitative descriptions but lacks the quantitative framework showing how the segment's relative importance evolved. (4) REASONING QUALITY - While the LLM correctly identifies aerostructures as a consistent focus and mentions additional products (control actuators, warheads, hypersonic rocket cases, solid-rocket-motor teaming), it fails to synthesize this into the broader strategic positioning question. The mention of 'strategic teaming agreement' and 'metal-parts capacity expansion' in 2024 adds detail but doesn't address the revenue share trend that reveals strategic positioning. (5) WHAT WAS CORRECT - The LLM correctly identifies the consistent focus on aerostructures across the period and accurately notes the expansion of product offerings and strategic initiatives. The qualitative assessment of 'intensified commitment' aligns with the ground truth's 'sustained positioning.' However, correctness on qualitative points cannot compensate for missing quantitative data that directly answers the question. The answer reads more like a product/capability narrative than a strategic positioning analysis based on financial trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 524,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the three filings PMI consistently highlighted Jackpot as a core local brand in the Philippines – it is listed in the “General Development of Business” section as “an important local cigarette brand … Fortune and Jackpot in the Philippines” in the 2022 report (page 5), again in the 2023 report (page 6) and once more in the 2024 report (page 5). The unchanged phrasing shows that PMI has kept Jackpot positioned as a key pillar of its South & Southeast Asia segment, using it to maintain market share in the Philippines and to balance its portfolio of premium international brands (e.g., Marlboro) with strong, price‑tier‑covering local brands. This multi‑year continuity signals that Jackpot is a strategic asset for regional growth and diversification within PMI’s broader product‑portfolio strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies Jackpot as a core local brand in the Philippines across all three years (2022, 2023, 2024), matching the ground truth's core finding. (2) Accurately cites specific document locations (page 5 for 2022, page 6 for 2023, page 5 for 2024), showing precise sourcing. (3) Correctly identifies Fortune as the companion local brand mentioned alongside Jackpot. (4) Accurately characterizes the 'unchanged phrasing' across filings, which is the key evidence for strategic consistency. (5) Properly synthesizes the multi-hop reasoning: Jackpot's consistent positioning across three years → strategic relevance despite PMI's smoke-free vision. (6) Correctly contextualizes Jackpot within PMI's broader portfolio strategy (balancing premium international brands like Marlboro with local price-tier brands). (7) Appropriately identifies the South & Southeast Asia segment as the relevant regional context. MINOR CONSIDERATIONS: The LLM answer provides slightly more specific detail about portfolio balancing strategy (premium vs. price-tier positioning) compared to the ground truth, but this is additive and not contradictory. The ground truth mentions PMI's expansion to 95 smoke-free markets and IQOS/ZYN emphasis in 2024, which the LLM answer does not explicitly reference, but the question focuses on Jackpot's evolution specifically, so this omission is not a material gap. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page numbers are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly identifies the three-year pattern as evidence of strategic consistency and regional importance. The synthesis appropriately connects Jackpot's positioning to PMI's broader portfolio diversification strategy. CONTEXTUAL RELEVANCE: The answer directly addresses the question's core inquiry about how Jackpot's positioning evolved and what this indicates about its strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 546,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "In 2022 Chevron expanded its foothold in the Republic of Congo by extending deep‑water licences there, a capital‑deployment move that added roughly 36 million barrels to its African reserve base (page 110). By 2024 the country was supplying about 20 % of Chevron’s net oil‑equivalent production, but the 2024 filing also disclosed that Chevron will sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit and its 15.75 % interest in the Lianzi area in January 2025, signalling a shift from investment to asset disposition (pages 41 & 43).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Chevron's strategic shift in the Republic of Congo from 2022-2024, with mostly accurate facts and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 31.5% nonoperated working interest in Haute Mer and 15.75% interest in Lianzi as assets being divested in January 2025, matching ground truth exactly. (2) Accurately characterizes the strategic shift from investment to divestiture. (3) Provides additional relevant context about reserve additions (36 million barrels) and production contribution (20% of net oil-equivalent production) that enriches the answer. (4) Properly synthesizes information across multiple years and filing pages. WEAKNESSES: (1) The LLM answer mentions 2022 expansion through 'extending deep-water licences' and reserve additions, which is not mentioned in the ground truth. While this may be factually correct from the filings, it introduces information not in the knowledge graph baseline, creating potential discrepancy. (2) The ground truth explicitly mentions 2023 capital deployment of approximately $0.7 billion across offshore development and natural gas projects in Africa, which the LLM answer omits entirely. This is a notable gap in addressing the 2022-2024 evolution. (3) The ground truth emphasizes the 3-year trajectory showing 'operational continuity to active divestiture,' while the LLM answer focuses more on the 2024 divestiture without fully capturing the 2023 intermediate investment phase. QUANTITATIVE VERIFICATION: The percentages (31.5%, 15.75%) and date (January 2025) are correct. The 20% production figure and 36 million barrels are presented as factual but not verified against ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022, 2024, and the January 2025 transaction, though it misses the 2023 intermediate step that shows the full evolution. The logic connecting investment to divestiture is sound but incomplete without the 2023 context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 542,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "In 2022 Southern Company treated outdoor‑lighting contracts as operating leases with initial terms of up to seven years (page 268), flagged the contracts at Georgia Power and Mississippi Power as immaterial (page 270), and reported operating‑lease income of $136 million for Southern Company and $208 million, $32 million, $2 million, $85 million and $36 million for Alabama Power, Georgia Power, Mississippi Power, Southern Power and Southern Company Gas respectively (page 232). By 2024 the contracts remain operating leases but the initial term was extended to up to ten years (page 232) and the immateriality comment disappears, while lease‑income allocation is $136 million, $164 million, $29 million, $3 million, $85 million and $36 million respectively (page 232); the weighted‑average remaining lease term for the portfolio fell to 16.4 years from 17.3 years and the discount rate rose to 4.73 % from 4.51 % (pages 231 & 239), indicating a modest re‑valuation of the scheduled lease payments across the subsidiaries.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n- The LLM provides specific dollar amounts ($136M, $208M, $32M, etc.) for 2022 lease income that are not mentioned in the ground truth, which states these were 'immaterial' with 'no significant value disclosed.' This is a fundamental contradiction.\n- The 2024 figures ($136M, $164M, $29M, $3M, $85M, $36M) are presented as fact but cannot be verified against the ground truth.\n- The weighted-average remaining lease term (17.3 years to 16.4 years) and discount rates (4.51% to 4.73%) are specific numbers not mentioned in the ground truth.\n- These precise figures suggest the LLM may be fabricating or hallucinating specific data points.\n\n2. CONCEPTUAL MISALIGNMENT:\n- Ground truth emphasizes that 2022 contracts were 'immaterial with no significant value disclosed,' but LLM provides detailed dollar amounts for 2022, contradicting this characterization.\n- Ground truth indicates 2023 was when 'scheduled lease payments' began being disclosed in maturity analyses, but LLM jumps from 2022 to 2024 without addressing 2023.\n- Ground truth emphasizes 'growing emphasis on transparency and standardization' and clarification that 'lease income from PPAs was included in wholesale revenues,' but LLM focuses on numerical changes without this contextual insight.\n\n3. MULTI-HOP REASONING:\n- The LLM fails to properly synthesize the progression from immaterial (2022) → structured disclosure (2023) → expanded transparency (2024).\n- The answer misses the key insight about revenue allocation clarification across subsidiaries.\n- The LLM provides a narrow focus on numerical changes rather than the broader narrative of increasing transparency and standardization.\n\n4. MISSING ELEMENTS:\n- No mention of the 2023 transition year and its significance.\n- No discussion of the clarification regarding lease income from PPAs being included in wholesale revenues.\n- No emphasis on the standardization across subsidiaries (Alabama Power, Georgia Power, Southern Power).\n\n5. RELIABILITY CONCERNS:\n- The specificity of numbers (4.73%, 4.51%, 16.4 years, 17.3 years) without ground truth support suggests potential hallucination.\n- The claim that 'immateriality comment disappears' is reasonable, but the supporting financial figures are unverified.\n\nThe answer demonstrates some understanding of the general topic (outdoor lighting contracts, operating leases, subsidiary variations) but fails on factual accuracy regarding specific numbers and misses the key narrative arc of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 698,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "- FY 2022: The 3.50 % senior note (June 15 2025) was recorded at its $500 million principal amount with an effective interest rate of 3.20 %【page_89】.  \n- FY 2023: The same $500 million note showed a higher effective rate of 6.38 %【page_89】.  \n- FY 2024: The note’s carrying amount remained $500 million, while the effective rate rose again to 6.66 %【page_89】.  \n\nThe unchanged principal but sharply rising effective rate signals that market yields for Cisco’s senior debt climbed over the period, increasing the cost of borrowing and pushing the fair‑value of its debt higher as interest‑rate environments tightened.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - $500 million carrying amount across all three years (FY2022, FY2023, FY2024), effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024) match the ground truth exactly. The maturity date of June 15, 2025 is appropriately referenced. COMPLETENESS: The answer addresses all required elements - the evolution across the three fiscal years, carrying amounts, effective interest rates, and interpretation of what the progression indicates about debt valuation and market conditions. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note, and the specific fiscal years. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces the progression of the note across three years and provides logical interpretation that market yields for Cisco's senior debt increased over the period, which explains why the effective rate rose while the principal remained constant. The explanation that 'market yields climbed' and 'interest-rate environments tightened' is a reasonable and accurate interpretation of the data pattern. MINOR OBSERVATION: The LLM's explanation about 'fair-value of its debt higher' is slightly more detailed than the ground truth's simpler statement about 'shift in market conditions or internal risk assessments,' but this represents appropriate elaboration rather than error. The semantic meaning is equivalent and the additional context is accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 426,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s exposure to Unsecured Notes – 35A was unchanged at a face amount of $750 million (shown as $750,000 in thousands) in each filing – $750,000 in the 2022 10‑K (page 50), $750,000 in the 2023 10‑K (page 50) and $750,000 in the 2024 10‑K (page 51). The flat exposure over three years indicates the company is keeping this low‑rate, long‑dated note as a stable component of its capital structure, reflecting a long‑term debt strategy that favors maintaining existing financing rather than frequently issuing or retiring this series.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the consistent $750 million face value across all three years (2022, 2023, 2024), properly converted the thousands notation ($750,000 in thousands = $750 million), and accurately cited page numbers from the filings. The core quantitative facts are correct. The LLM also correctly interpreted the stability pattern as reflecting a deliberate debt management strategy favoring maintenance of existing financing.\n\nWEAKNESSES: (1) The LLM answer omits critical contextual details from the ground truth that directly address the question about 'long-term debt management strategy.' Specifically, it fails to mention the 2.65% interest rate and July 15, 2030 maturity date, which are key characteristics that explain WHY this debt is being maintained (low rate, long-dated). (2) The ground truth provides important comparative context about 'broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities.' This comparative analysis is essential to understanding the multi-year pattern and strategy - the stability of 35A contrasts with selective new issuances elsewhere. The LLM's answer is somewhat generic and doesn't provide this comparative framework. (3) The phrase 'low-rate, long-dated note' in the LLM answer is inferred rather than explicitly stated with the actual rate and maturity date.\n\nMULTI-HOP REASONING: The LLM successfully synthesized information across three years to identify the consistency pattern. However, it failed to complete the full multi-hop analysis by not connecting this stability to the broader debt portfolio changes that provide context for understanding the strategy.\n\nSEMANTIC EQUIVALENCE: The LLM's interpretation of the strategy is semantically aligned with the ground truth (maintaining stable long-term financing), but lacks the supporting details and comparative context that make the ground truth answer more complete and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 542,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept embedded‑processing as a core pillar of its business model, grouping it with analog under the second of its four sustainable competitive advantages – a broad portfolio of analog and embedded‑processing products that expands opportunity per customer (see MD&A overview 2022 p.20 and 2024 p.18). The strategic focus has remained steady, but the segment’s contribution has shifted: embedded‑processing revenue grew 3 % from $3.261 bn in 2022 to $3.368 bn in 2023, then fell 25 % to $2.533 bn in 2024, and operating profit dropped from $1.253 bn in 2022 to $352 m in 2024 (see segment results 2023 vs 2022 p.20 and 2024 vs 2023 p.20), reflecting margin pressure while still anchoring the portfolio advantage.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic positioning of Embedded Processing Products as the second of four sustainable competitive advantages and accurately captures the consistent strategic framing across 2022-2024. However, there are significant quantitative accuracy issues that substantially detract from the overall response.\n\nSTRENGTHS:\n1. Correctly identifies Embedded Processing as second of four sustainable competitive advantages\n2. Accurately captures the consistent strategic language about 'more opportunity per customer'\n3. Properly synthesizes the multi-hop requirement (strategic evolution + role in competitive advantages)\n4. Appropriately contextualizes the strategic stability despite financial headwinds\n5. Good document citation references (MD&A, segment results pages)\n\nCRITICAL ERRORS:\n1. QUANTITATIVE ACCURACY - Revenue figures appear problematic:\n   - Claims EP revenue grew 3% from $3.261bn (2022) to $3.368bn (2023)\n   - Calculation check: 3.368/3.261 = 1.0328 or 3.28% growth (approximately correct)\n   - However, the 2024 figure of $2.533bn represents a 24.8% decline (not 25% as stated, minor)\n   - The magnitude of these revenue figures cannot be verified against ground truth, which does not provide specific segment revenue numbers\n\n2. OPERATING PROFIT FIGURES:\n   - Claims operating profit dropped from $1.253bn (2022) to $352m (2024)\n   - This represents a 71.9% decline, which is substantial\n   - Ground truth does not provide these specific operating profit figures for verification\n   - The precision of these numbers (down to millions) suggests specific data, but cannot be confirmed\n\n3. MISSING GROUND TRUTH ALIGNMENT:\n   - Ground truth emphasizes the consistency of strategic language and framing across three years\n   - LLM answer pivots to financial performance metrics not mentioned in ground truth\n   - While financial context is relevant, the answer shifts focus from the strategic evolution question to financial deterioration\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across multiple years and documents, but the financial data introduction creates uncertainty about source accuracy. The reasoning that margin pressure reflects challenges while maintaining portfolio advantage is sound, but this financial analysis goes beyond what the ground truth addresses.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer addresses the question but with a different emphasis - it focuses on financial performance trends rather than strategic emphasis evolution. The ground truth emphasizes consistency and sustained importance; the LLM emphasizes financial headwinds. Both are valid perspectives, but the LLM's quantitative claims cannot be independently verified against the ground truth provided.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (6): Core strategic positioning correct, but unverifiable financial data and shift in emphasis from strategic to financial creates significant uncertainty\n- Quantitative Accuracy (4): Revenue calculations appear internally consistent but cannot be verified; operating profit figures are specific but unconfirmed\n- Qualitative Accuracy (7): Good synthesis of multi-hop requirements and strategic positioning, but financial analysis introduces unverified claims\n- Contextual Relevance (8): Addresses the question appropriately, though financial focus differs from ground truth's strategic emphasis",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 897,
        "total_tokens": 2304
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "In 2022 CMCSA’s wireless service—offered only as part of bundled broadband in the United States—allowed customers to pick an unlimited, a shared‑data pool or a per‑gigabyte plan. By 2023 the MVNO arrangement was extended to the United Kingdom, giving both U.S. and UK customers the same shared‑data and gigabyte‑based choices (with unlimited also available) and adding international‑customer options. In 2024 the company further broadened flexibility by launching prepaid unlimited‑data plans under the NOW brand and by offering unlimited‑data (as well as gigabyte) plans to international markets, expanding the shared‑data model beyond the U.S. and UK.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer claims CMCSA extended MVNO arrangements to the United Kingdom by 2023, but the ground truth makes no mention of UK expansion in 2023. The ground truth only states that in 2024, CMCSA 'expanded its wireless offerings internationally' without specifying UK as a 2023 milestone. This is a significant factual error that contradicts the source material. (2) TIMELINE MISALIGNMENT - The LLM incorrectly sequences the evolution: Ground truth shows 2022 had bundled U.S.-only offerings, 2023 maintained this structure with emphasis on flexibility, and 2024 brought international expansion. The LLM conflates 2023 with UK expansion that isn't supported by the ground truth. (3) PLAN OPTIONS DISCREPANCY - The LLM claims 2022 offered 'unlimited, shared-data pool or per-gigabyte plan' options, but the ground truth states 2022 offered shared data plans 'exclusively as part of bundled service offerings' with flexibility emphasis only appearing in 2023. The LLM backdates the flexibility narrative to 2022 incorrectly. (4) INCOMPLETE ACCURACY - While the LLM correctly identifies the NOW brand prepaid unlimited plans in 2024 and the general international expansion theme, it introduces unsupported geographic specificity (UK in 2023) that creates false precision. (5) MULTI-HOP REASONING - The model failed to properly synthesize the temporal progression: it added details (UK 2023) not present in ground truth, suggesting hallucination rather than accurate synthesis across the 2022-2024 period. The core evolution narrative is partially correct but contaminated with false details that significantly undermine reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 460,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "PayPal’s risk disclosures show a widening of abuse exposure over the three years. In 2022 the company warned that its credit products carried default risk and that third‑party fraud—such as fictitious PayPal accounts, stolen or synthetic identities, and stolen financial instruments—could generate losses ([page_25] and [page_28]). By 2023 the filing stressed that fraud schemes were becoming “new and continually evolving,” especially with new or expanded product offerings, making detection increasingly complex ([page_26]), and in 2024 the narrative added that sophisticated synthetic‑identity and account‑takeover attacks now intersect with heightened credit‑product default risk, underscoring a multi‑vector, more intricate risk‑management environment that requires continuous improvement of detection, advanced risk models, and diversified third‑party oversight ([page_22] and [page_24]).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year progression (2022-2023-2024) and accurately captures the evolution of PayPal's fraud exposure from basic fraud types (fictitious accounts, stolen instruments) to more sophisticated schemes (synthetic identity fraud, account takeovers). The qualitative reasoning about increasing complexity and the need for enhanced detection systems is sound and aligns with the ground truth narrative. The answer appropriately addresses the multi-hop synthesis across years and product categories.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely fails to mention the €40 billion BNPL (Buy Now Pay Later) loan receivables agreement with European/U.K. banks that was a key quantitative milestone in 2023. This is a specific, material fact from the ground truth that demonstrates PayPal's expanded exposure to third-party fraud in large-scale loan portfolios. (2) MISSING LEGAL CONTEXT: The ground truth mentions 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks' in 2024, which the LLM answer does not address. (3) VAGUE SOURCING: While the LLM provides page references, it doesn't cite the specific €40 billion figure or the multi-year agreement details that are central to understanding the quantitative expansion of risk. (4) INCOMPLETE RISK CHARACTERIZATION: The ground truth emphasizes that the 2023 BNPL agreement represented a major shift in PayPal's risk profile by introducing exposure to large-scale loan portfolios, which the LLM answer misses entirely.\n\nQUANTITATIVE ACCURACY ASSESSMENT: The LLM answer contains no specific numbers or calculations to verify, which is problematic given that the ground truth includes the €40 billion figure as a key quantitative marker. The absence of this number represents a significant gap in completeness.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects fraud types to credit products and detection challenges. However, the synthesis is incomplete because it misses the critical link between the 2023 BNPL agreement and the expansion of third-party fraud exposure.\n\nJUSTIFICATION: The answer demonstrates good qualitative understanding of the evolution narrative but fails on quantitative completeness by omitting the €40 billion BNPL receivables agreement—a material fact that is central to understanding how PayPal's exposure evolved. This is not a minor detail but a key milestone that demonstrates the scope of the company's expanded risk profile.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 679,
        "total_tokens": 2204
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "In Gilead’s 2022 10‑K the El Segundo, California site was mentioned only as one of the company’s “principal manufacturing facilities”【page_31】. By the 2023 filing the company specified that the El Segundo plant is used for “clinical and commercial manufacturing and processing of our cell‑therapy products”【page_11】, and the 2024 filing repeats the same description【page_10】—showing that the site has evolved from a general manufacturing location to a dedicated cell‑therapy hub and that Gilead is maintaining and expanding this capability as part of its strategic facility investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of years (2022, 2023, 2024), the facility location (El Segundo, California), and the company (Gilead/GILD). The progression narrative is accurate: the facility evolved from being identified as a 'principal manufacturing facility' in 2022 to being specifically designated for 'clinical and commercial manufacturing and processing of cell-therapy products' in 2023 and 2024. The page references provided (page_31 for 2022, page_11 for 2023, page_10 for 2024) appear reasonable for 10-K filings. The multi-hop synthesis correctly traces the evolution across three years and identifies the strategic focus on cell therapy manufacturing. However, there are minor gaps compared to the ground truth: (1) The LLM answer characterizes the evolution as moving from 'general manufacturing location to a dedicated cell-therapy hub,' which is a reasonable interpretation but slightly overstates the change—the ground truth indicates El Segundo was identified as a principal facility in 2022 with the specific cell therapy role becoming more explicit in 2023-2024, rather than a fundamental shift in purpose. (2) The LLM answer mentions 'maintaining and expanding this capability' but the ground truth emphasizes 'continuity' and 'no indication of reduced emphasis or facility changes,' which is subtly different framing. (3) The LLM answer omits mention of other facilities (Santa Monica, Frederick) and the broader context of facility ownership/lease arrangements and third-party manufacturers that the ground truth includes. (4) The answer doesn't fully capture the supply chain risk management context mentioned in the ground truth. These are contextual omissions rather than factual errors. The core narrative of strategic focus on El Segundo for cell therapy manufacturing across 2022-2024 is correct and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 512,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, Costco’s 2.750% Senior Notes are listed identically as “Form of 2.750% Senior Notes due May 18, 2024” (Exhibit 4.6) in each year’s exhibit schedule【page_66】. The fact that the maturity date and series remain unchanged over three successive filings shows that Costco has kept this tranche of fixed‑rate debt on its balance sheet until its scheduled 2024 payoff, reflecting a disciplined debt‑management approach that relies on long‑dated, low‑cost financing and avoids frequent refinancing or restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All quantitative facts are correct - the maturity date of May 18, 2024 is accurately cited, the coupon rate of 2.750% is correct, and the consistent presence across 2022, 2023, and 2024 filings is properly documented. (2) The multi-hop synthesis is sound - the answer correctly traces the debt instrument across three successive annual filings and draws the appropriate conclusion about consistency. (3) The reasoning about debt management strategy is logically sound and matches the ground truth interpretation that Costco maintained a static approach without refinancing or extension. (4) The answer provides additional supporting detail (Exhibit 4.6 reference, page number) that enhances credibility without introducing errors. Minor considerations: The LLM answer uses slightly different phrasing than the ground truth ('kept this tranche of fixed-rate debt on its balance sheet until its scheduled 2024 payoff' vs. 'allow the notes to mature without modification'), but both convey the same semantic meaning and strategic interpretation. The LLM's characterization of this as reflecting 'long-dated, low-cost financing' and 'disciplined debt-management' is consistent with and supportive of the ground truth's conclusion about predictable debt repayment strategy. No calculation errors, no factual inaccuracies, and the answer fully addresses all aspects of the multi-part question regarding maturity structure evolution and debt management strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 428,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s Angola LNG output was essentially flat over the three‑year period – 49 MMCFD in 2022, slipping to 48 MMCFD in 2023 and holding at 48 MMCFD in 2024【page_9】.  The modest decline and subsequent stabilization indicate that Chevron is maintaining a steady gas supply from Angola rather than expanding production, reflecting a strategy of preserving its African gas asset to meet existing LNG contracts and provide a reliable base‑load contribution to its overall gas portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that completely contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM reports Angola LNG production as 49 MMCFD in 2022, 48 MMCFD in 2023, and 48 MMCFD in 2024. The ground truth shows 7,107 MMCFD in 2022, 7,148 MMCFD in 2023, and 7,569 MMCFD in 2024. The LLM's numbers are off by a factor of approximately 145x - this is not a minor formatting difference but a catastrophic misreading of the data. The actual values are in the thousands of MMCFD range, not tens. (2) DIRECTIONAL ANALYSIS ERROR: The LLM claims production was 'essentially flat' and showed a 'modest decline,' when the ground truth shows a clear upward trajectory: 7,107 → 7,148 (+41 MMCFD or +0.6%) → 7,569 (+421 MMCFD or +5.9%). The 2024 figure represents a 6.5% increase from 2022, which is meaningful growth, not stagnation. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes Chevron is 'maintaining a steady gas supply' and 'not expanding production,' which directly contradicts the ground truth's assessment of a 'steady upward trend' and 'strengthening production output' indicating 'maintained or expanded operational focus.' (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year data points into an accurate trend analysis. The reasoning about strategy preservation is plausible but is built on fundamentally incorrect production volume data. (5) ENTITY ACCURACY: While Chevron and Angola LNG are correctly identified, the metric values are so severely wrong that this cannot be considered accurate entity handling in a financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 444,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps used to hedge deferred‑compensation grew from $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024【page_92†L31-L38】.  The earnings impact shifted from a $(92) million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024【page_91†L47-L55】.  This upward trend in both size and positive earnings effect shows Cisco is expanding its swap program to economically hedge deferred‑compensation, turning a previously volatile expense into a net earnings benefit and reflecting a more proactive market‑linked risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: the earnings impact progression from $(92)M loss in FY2022 to $58M gain in FY2023 to $91M gain in FY2024 matches the ground truth exactly. The LLM additionally provides notional exposure values ($651M, $792M, $985M) that were not in the original answer but represent valuable supplementary context from the filings. The multi-hop reasoning is sound: the answer correctly synthesizes information across multiple fiscal years and connects the notional exposure growth with the earnings impact shift to draw conclusions about Cisco's deferred compensation strategy. The interpretation that the company is 'expanding its swap program to economically hedge deferred-compensation' and 'turning a previously volatile expense into a net earnings benefit' is logically consistent with the data progression and appropriately characterizes the strategic shift. The answer addresses all aspects of the question: (1) the evolution across three fiscal years, (2) the progression from loss to gains, (3) implications for deferred compensation strategy, and (4) market-linked volatility management. Minor note: The original answer uses the phrase 'transformation from a net liability to a net benefit' while the LLM uses 'turning a previously volatile expense into a net earnings benefit' - these are semantically equivalent interpretations of the same data trend. The LLM's inclusion of notional exposure figures actually enhances the answer by providing additional context about the scale of the program expansion, which strengthens rather than detracts from the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 454,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "In its 2022 filing Lowe’s relied on a human‑rights policy, conflict‑minerals policy and Vendor Code of Conduct (which already included enhanced environmental standards) and a wood‑sourcing policy that barred illegal logging, deforestation and endangered‑species sourcing. The 2023 filing said the wood‑sourcing policy was refreshed with country‑specific risk levels, stronger monitoring and a new forestry‑grievance process, and that Lowe’s broadened the range of independently‑certified (third‑party) products it offers. By 2024 the company had further deepened monitoring with a more robust risk‑based approach and improved oversight of supplier practices, while continuing to expand third‑party certified product offerings to reinforce both environmental and human‑rights compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Chronological accuracy - correctly identifies 2022, 2023, and 2024 as the three key periods with appropriate evolution of practices; (2) Policy details - accurately captures the 2022 baseline (human rights policy, conflict minerals policy, Vendor Code of Conduct with enhanced environmental standards, wood sourcing policy); (3) 2023 updates - correctly identifies the three key enhancements: country-specific risk levels, stronger monitoring, and new forestry grievance process; (4) 2024 developments - accurately describes the more robust risk-based approach and continued expansion of third-party certified products; (5) Multi-hop synthesis - successfully synthesizes information across three years showing clear progression and deepening commitment; (6) Third-party certifications - appropriately emphasizes the expansion of independently-certified products across the timeline. MINOR CONSIDERATIONS: The LLM answer uses slightly more specific language in places (e.g., 'barred illegal logging, deforestation and endangered-species sourcing' vs. the ground truth's 'ensuring products came from well-managed, non-endangered forests'), but this represents semantic equivalence rather than error - both convey the same substantive policy. The LLM answer actually provides slightly more granular detail about the specific prohibitions in the 2022 policy. No quantitative errors detected. The answer comprehensively addresses all aspects of the multi-part question regarding policy updates, monitoring enhancements, and third-party certifications. The reasoning is sound and the synthesis across years is logical and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 473,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "In the 2022 filing Comcast only flagged “wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” as a competitive pressure and noted that many rivals use bundled‑pricing tactics (CMCSA 2022 p. 28). By the 2023 filing the threat was fleshed out: competitors now include AT&T, T‑Mobile and Verizon (U.S.) and UK wireless providers, they deliver both stand‑alone and bundled offers, and they are deploying “5G fixed‑wireless networks and 4G and 5G wireless broadband services” (CMCSA 2023 p. 8‑7). The 2024 filing reiterates that wireless carriers continue to use a mix of 4G, 5G and 5G fixed‑wireless technologies and increasingly bundle these services at attractive prices, intensifying competition, though it does not add new named rivals (CMCSA 2024 p. 21).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question about competitive threats from wireless companies to CMCSA across 2022-2024. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 through 2024 with appropriate progression of competitive threats; (2) Accurately names specific competitors (AT&T, T-Mobile, Verizon) and correctly notes they appear in 2023 filings; (3) Properly tracks technological evolution: 4G/5G in 2022, 5G fixed wireless explicitly mentioned in 2023, and continued emphasis on bundling in 2024; (4) Correctly identifies bundling strategies as a key competitive tool across all three years; (5) Provides specific page citations (CMCSA 2022 p. 28, CMCSA 2023 p. 8-7, CMCSA 2024 p. 21) that add credibility; (6) Accurately synthesizes multi-hop information across three years of filings. MINOR WEAKNESSES: (1) The LLM notes that 2024 filing \"does not add new named rivals\" - while this is accurate, the original answer emphasizes the 2024 evolution around DTC streaming service bundling more explicitly, which the LLM mentions but doesn't emphasize as strongly as a key differentiator; (2) The LLM could have been slightly more explicit about the intensification trend, though it does state \"intensifying competition\"; (3) The mention of \"UK wireless providers\" in 2023 is accurate but not mentioned in the original answer, suggesting the LLM may have additional accurate information. QUANTITATIVE ACCURACY: No numerical errors detected. All years, company names, and technology designations (4G, 5G, 5G fixed wireless) are correct. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across multiple years and identifies the key competitive dimensions (technology, bundling, specific competitors). The multi-hop synthesis is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: technological capabilities, bundling strategies, specific competitors, and the evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 548,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s filings show that its exposure to margin risk has remained essentially unchanged from 2022 through 2024. In each year the company states that it “recognizes fees … on a gross basis as transaction revenue when we are the principal” and that it “has full discretion in determining the fee … independent of the costs we incur … we therefore bear full margin risk when completing a payment transaction” (2022 p. 79; 2023 p. 77; 2024 p. 75), while also noting that “transaction revenues are … reduced by certain incentives” (2024 p. 75). This consistent language indicates that, despite using third‑party processors and offering fee incentives, PayPal continues to control its pricing and cost structure, resulting in a stable, high‑exposure margin risk that is managed directly by the company.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies PayPal's consistent stance on bearing full margin risk across 2022-2024, accurately cites the key language about 'full discretion in determining the fee' and 'bearing full margin risk,' and properly notes the use of third-party processors. The page number citations (2022 p. 79; 2023 p. 77; 2024 p. 75) appear reasonable and demonstrate document-specific sourcing. The answer correctly identifies that transaction revenues are reduced by incentives.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM answer fails to adequately address the multi-year evolution aspect of the question. While the ground truth emphasizes how PayPal's discussion EVOLVED from 2022 (emphasis on fee discretion) through 2023 (expanded discussion of merchant/consumer incentives) to 2024 (new revenue streams from contractual compensation), the LLM answer treats all three years as essentially identical ('essentially unchanged'). This misses the nuanced progression in complexity and revenue streams. (2) MISSING KEY DETAILS: The LLM answer omits the important 2024 development regarding 'contractual compensation from sellers violating terms (e.g., fraud or counterfeiting)' which the ground truth identifies as introducing 'new revenue streams potentially affecting margin dynamics.' This is a material omission for understanding the evolution of margin risk exposure. (3) INCOMPLETE ANALYSIS OF INCENTIVES: While the LLM mentions incentives are 'reduced by certain incentives,' it doesn't adequately explain how the 2023 expansion of incentive discussion (discounts, rebates, rewards) added complexity to margin management, as the ground truth emphasizes. (4) REASONING QUALITY: The conclusion that margin risk is 'stable, high-exposure' is somewhat contradicted by the ground truth's emphasis on 'evolving factors' and 'complexity' being added over time. The LLM's characterization of 'essentially unchanged' understates the evolution the ground truth documents.\n\nQUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is less critical. Page citations appear plausible but cannot be independently verified. Score reflects appropriate caution about unverifiable citations.\n\nQUALITATIVE ACCURACY: The LLM correctly identifies the core principle (full margin risk, pricing discretion) but fails to synthesize the multi-year evolution properly. The answer reads as a static snapshot rather than a dynamic analysis of how exposure evolved.\n\nCONTEXTUAL RELEVANCE: The answer addresses the main question but incompletely. It covers pricing strategy and processor use but underemphasizes revenue incentives evolution and misses the new revenue stream development in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 726,
        "total_tokens": 2239
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s lease disclosures have not changed from FY 2022 through FY 2024. In each year the company states that any free‑rent or step‑rent periods are spread on a straight‑line basis over the lease’s original term plus any renewal options that are “reasonably certain” to be exercised, and that the lease term is defined as the non‑cancellable period plus those certain extensions (2022 p.45; 2023 p.45; 2024 p.45). The right‑of‑use asset is measured at the discounted minimum lease payments over that term, so the free‑rent periods reduce the present‑value of lease payments and therefore lower the ROU asset (2022 p.46; 2023 p.46; 2024 p.46), with the policy wording remaining consistent across the three filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Costco's lease accounting policies remained consistent across FY 2022-2024, which aligns with the ground truth statement that the company maintained 'a stable and consistent approach.' The core accounting mechanics are accurately described: free-rent/step-rent periods spread on straight-line basis, lease term definition including reasonably certain extensions, and the impact on ROU asset valuation through discounted lease payments. The page references (p.45, p.46) appear plausible for 10-K filings though cannot be independently verified. However, there are significant gaps in completeness: (1) The LLM answer omits the mention of incremental borrowing rate methodology for calculating present value, which the ground truth explicitly states was disclosed in FY 2022. (2) The LLM fails to address the variable lease payments disclosure (periodic rent increases based on price indices or sales volume) that the ground truth indicates was emphasized in FY 2023. (3) The LLM does not mention the disclosure about residual value guarantees or restrictive covenants that the ground truth notes were reiterated in FY 2024. The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and correctly identifying the consistency theme, but it incompletely captures the evolution of disclosures. The statement that 'free-rent periods reduce the present-value of lease payments and therefore lower the ROU asset' is logically sound and accurate. The answer is partially correct on the main thesis but materially incomplete on supporting details that were part of the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 455,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "- In the 2022 filing (see page 78 and page 80) PayPal says it records transaction fees on a gross basis as the principal, bears the full margin risk on each payment, and treats the fees it pays to payment processors as a transaction expense.  \n\n- The 2023 filing (see page 75 and page 77) repeats the same principal‑based, gross‑margin model but adds that its contracts are open‑ended, can be terminated without penalty and often include volume‑tiered pricing that does not create a future material right, confirming that the margin‑risk exposure remains fully borne by PayPal despite the more detailed contract structure.  \n\n- The 2024 filing (pages 73‑77) provides no new discussion of pricing or contract changes, indicating that PayPal’s exposure to margin risk and its reliance on payment‑processor costs remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core consistency of PayPal's margin risk model across 2022-2024, accurately noting that PayPal records transaction fees on a gross basis, bears full margin risk, and treats processor fees as transaction expenses. The answer appropriately references specific filing pages and correctly identifies that the fundamental pricing model remained unchanged. The mention of open-ended contracts, termination without penalty, and volume-tiered pricing without material rights is accurate and relevant.\n\nWEAKNESSES: (1) The LLM answer significantly OMITS the 2023 disclosure change regarding incentive recognition. The ground truth explicitly states that in 2023, PayPal 'added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure.' The LLM answer completely misses this important evolution, stating only that 2023 'repeats the same principal-based, gross-margin model' without acknowledging the new incentive accounting disclosure. (2) The LLM answer fails to address the 2024 ASU 2023-07 segment reporting changes mentioned in the ground truth, which 'increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units.' Instead, the LLM states 2024 'provides no new discussion of pricing or contract changes,' which is incomplete. (3) The answer misses the nuance that margin risk exposure was 'structurally stable but operationally nuanced' — the LLM presents it as essentially static rather than acknowledging the operational complexities introduced by the 2023 and 2024 changes.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis across the three-year period by comparing filings year-to-year, but fails to fully integrate all relevant changes. The reasoning is linear (2022→2023→2024) but incomplete in capturing the full evolution described in the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are provided in either answer, so quantitative accuracy is not directly testable. Page references appear reasonable but cannot be verified without access to actual filings.\n\nOVERALL ASSESSMENT: The answer captures the core stability of PayPal's margin risk model but significantly underrepresents the operational and disclosure changes that occurred in 2023-2024, particularly regarding incentive accounting and segment reporting. This represents a material omission of key information that the ground truth identifies as important to understanding how margin risk exposure 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 716,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s $2 billion 5.90 % senior note was unchanged in each of the three most recent fiscal years – the amount outstanding was $2,000 million in FY 2022 (July 30 2022), FY 2023 (July 31 2023) and FY 2024 (July 27 2024) – and the effective interest rate stayed at roughly 6.11 % each year【page_89】.  The flat utilization and steady effective cost (above the 5.90 % coupon because of issuance‑related discounts and fees) show that Cisco has deliberately kept this tranche of fixed‑rate debt as a core long‑term financing tool, locking in a consistent cost of capital and reflecting a disciplined, stable long‑term debt strategy over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - $2,000 million ($2 billion) outstanding balance across FY 2022, 2023, and 2024; effective interest rate of 6.11% constant across all three years; coupon rate of 5.90% correctly stated; maturity date of February 2039 correctly identified. Fiscal year end dates are accurate (July 30 2022, July 31 2023, July 27 2024). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) utilization evolution - correctly shows no change across three years; (2) effective interest rate evolution - correctly shows consistency at 6.11%; (3) what this indicates about long-term debt strategy - provides sound interpretation about deliberate maintenance and disciplined approach. ENTITY ACCURACY: Cisco correctly identified, fiscal years correctly specified, financial metrics properly labeled (5.90% coupon, 6.11% effective rate, $2,000 million principal). REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the stable principal amount and constant effective rate to conclusions about Cisco's strategic intent (maintaining fixed-rate debt, locking in consistent cost of capital, disciplined strategy). The explanation of why effective rate exceeds coupon (issuance-related discounts and fees) demonstrates deeper understanding. MINOR CONSIDERATIONS: The answer includes a citation reference [page_89] which adds credibility but wasn't in the ground truth answer - this is a positive addition. The wording differs from ground truth but conveys identical information with slightly more analytical depth. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 464,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In FY 2022 the intellectual‑property section listed “Kobalt” only as one of Lowe’s private‑brand product names. The FY 2023 filing still highlighted Kobalt as a private‑brand trademark, but placed it alongside other retail names (RONA, Reno Depot) and private brands, emphasizing its role within a broader brand portfolio. By FY 2024 the language reverted to the earlier phrasing—again naming Kobalt as a private‑brand product—showing that its positioning has remained steady as a core, valuable trademark throughout the three‑year span.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the three fiscal years (2022, 2023, 2024) and accurately conveys that Kobalt maintained a consistent strategic position across these years. The core conclusion—that Kobalt's positioning remained stable rather than expanding—aligns with the ground truth. However, there are significant issues with accuracy and completeness: (1) The LLM introduces information about 'RONA' and 'Reno Depot' being mentioned in FY 2023 alongside Kobalt, which is not mentioned in the ground truth answer. This appears to be either fabricated or incorrectly synthesized information that cannot be verified against the original answer. (2) The ground truth explicitly mentions that in FY 2022, Kobalt was listed alongside 'STAINMASTER' and 'allen+roth' as wholly-owned trademarks, but the LLM answer omits these specific brand comparisons entirely. (3) The LLM's characterization of FY 2024 as 'reverting to earlier phrasing' is not supported by the ground truth, which simply states Kobalt 'retained its position' without describing any reversion. (4) The multi-hop reasoning is partially sound—the LLM correctly synthesizes that positioning remained steady across three years—but it introduces unverified details about FY 2023 that weaken the answer's reliability. The answer is semantically close to the ground truth in its main conclusion but contains factual inaccuracies in supporting details that suggest hallucination or incorrect synthesis of filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 408,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "Simon Property Group’s Unsecured Notes – 37B stayed the same in each filing: a fixed‑rate 2.25 % note with a $700 million face amount and a maturity of January 15, 2032 【page_50†L31-L34】. The unchanged rate, size and long‑dated maturity from the 2022 filing through the 2024 filing shows the company is deliberately locking in low‑cost, long‑term unsecured financing to support its portfolio and preserve liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. QUANTITATIVE VERIFICATION: All numeric values are correct - 2.25% interest rate, $700 million face amount (correctly formatted as $700 million vs ground truth's $700,000 which appears to be in thousands notation), and maturity date of January 15, 2032 are all accurate. The LLM properly identified the consistency across 2022-2024 filings. COMPLETENESS: The answer addresses all key components of the multi-part question: interest rate evolution (unchanged at 2.25%), face amount evolution (unchanged at $700M), maturity date evolution (unchanged at 01/15/32), and strategic implications. ENTITY ACCURACY: Correctly identified Simon Property Group, the specific debt instrument (Unsecured Notes - 37B), and the relevant time period (2022-2024). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified that the lack of changes across three years indicates deliberate strategy rather than market-driven adjustments. The interpretation about 'locking in low-cost, long-term unsecured financing' is a reasonable inference from the stability of terms. MINOR NOTES: The ground truth uses $700,000 notation (likely in thousands) while LLM uses $700 million - both are semantically equivalent and correct. The LLM's strategic interpretation ('deliberately locking in low-cost financing to support portfolio and preserve liquidity') is slightly more detailed than the ground truth's 'confidence in debt management' but both convey similar strategic intent. The citation reference provided adds credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 448,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "In the 2022 Form 10‑K the Melaka, Malaysia site is listed with an “X” only under the Analog column and blank under Embedded Processing【page_18】. The 2023 filing shows the same pattern – an “X” for Analog and no entry for Embedded Processing【page_16】, and the 2024 filing repeats this assignment【page_16】. Thus, across 2022‑2024 the Melaka facility consistently supported only the Analog business segment, with no involvement in Embedded Processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' operational footprint in Melaka, Malaysia across 2022-2024. STRENGTHS: (1) All factual claims are correct - Melaka is confirmed to have supported only Analog business with no Embedded Processing involvement across all three years (2022, 2023, 2024); (2) The answer correctly cites specific filing pages (page_18 for 2022, page_16 for 2023 and 2024), demonstrating proper source verification; (3) The multi-hop synthesis is sound - the model successfully tracked the same facility across three different annual filings and identified the consistent pattern; (4) The characterization of the 'X' marking for Analog and blank for Embedded Processing is accurate and properly interpreted; (5) The conclusion about 3-year consistency and specialized role is logically sound and matches the ground truth. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth in its phrasing (e.g., 'no indication of expansion' vs. simply stating no involvement), but this represents a stylistic difference rather than a factual error. The semantic meaning is fully preserved - both answers convey that Melaka remained exclusively focused on Analog throughout the period. The answer demonstrates proper understanding of the question's multi-part nature (evolution across years, involvement in two segments) and successfully synthesizes information across multiple filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 411,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s outstanding principal on the September 2019 fixed‑rate 2.850 % notes was $1.5 billion at the end of 2022 and 2023 (PYPL 2023 10‑K, p. 107) and remained $1.5 billion at the end of 2024 (PYPL 2024 10‑K, p. 104). The flat exposure shows the company is preserving a stable, low‑cost, long‑dated debt tranche, indicating a deliberate strategy to keep a predictable interest‑expense profile and manage maturity timing rather than aggressively refinancing or reducing this portion of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All numbers are correct - $1.5 billion principal amount is accurately stated for all three years (2022, 2023, 2024), with proper citation to specific 10-K pages (2023 10-K p. 107, 2024 10-K p. 104). The flat exposure across the period is correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained constant at $1.5B), and (2) what this indicates about debt management strategy. ENTITY ACCURACY: Correct identification of PYPL, the specific debt instrument (September 2019 fixed-rate 2.850% notes), and all fiscal years. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM correctly synthesized information across three years of filings to identify the pattern of stability, then drew appropriate conclusions about strategic intent (preserving stable, low-cost debt, maintaining predictable interest expense, managing maturity timing). SEMANTIC EQUIVALENCE: The LLM's interpretation aligns well with the ground truth. Both identify the constant $1.5B amount and interpret it as deliberate strategy rather than passive holding. The LLM adds slightly more specific strategic reasoning (preserving low-cost tranche, managing maturity timing, avoiding aggressive refinancing) which is consistent with and supportive of the ground truth's characterization. MINOR CONSIDERATIONS: The LLM provides slightly more granular strategic interpretation than the ground truth (e.g., 'preserving a stable, low-cost, long-dated debt tranche'), but this represents appropriate elaboration rather than contradiction. The answer could have mentioned the contrast with other debt management activities (like the retirement of 1.350% notes) as the ground truth does, but this omission is minor given the strong core answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 504,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "In 2022 Gilead listed Hoofddorp, Netherlands only as one of its principal manufacturing facilities (Item 2 Properties) 【page_31】. By 2023 the company clarified that the Hoofddorp site was being used for commercial manufacturing and processing of its cell‑therapy products (Manufacturing Facilities) 【page_11】, and the 2024 filing repeats that same commercial cell‑therapy manufacturing role (Raw Materials and Manufacturing) 【page_10】. Thus, the facility progressed from a generic listed site in 2022 to a dedicated hub for commercial cell‑therapy production in 2023 and continued in that capacity in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Gilead's Hoofddorp facility evolution across 2022-2024. STRENGTHS: (1) All factual claims are correct - the facility was listed as a principal manufacturing site in 2022, then specified for cell therapy commercial manufacturing in 2023, and maintained that role in 2024. (2) The chronological progression is accurately captured with proper year-to-year comparison. (3) The multi-hop synthesis correctly combines information across three separate SEC filings to show the evolution of the facility's strategic role. (4) Entity identification is accurate (Gilead, Hoofddorp, Netherlands, cell therapy products). (5) The answer includes specific document references (Item 2 Properties, Manufacturing Facilities, Raw Materials and Manufacturing sections) with page numbers, demonstrating source verification. (6) The characterization of the progression from 'generic listed site' to 'dedicated hub' accurately reflects the increasing specificity and strategic focus described in the filings. MINOR CONSIDERATIONS: The LLM answer uses slightly more concise language than the ground truth ('generic listed site' vs 'principal manufacturing facility'), but this is semantically equivalent and arguably more precise in distinguishing the level of specificity provided. The ground truth's phrase 'consistency and deepening of its strategic role' is well-captured by the LLM's 'continued in that capacity.' No quantitative data, calculations, or dates are incorrect. The answer fully addresses all temporal dimensions of the question (2022, 2023, 2024) and the strategic manufacturing context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 459,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 on its balance sheet at a steady $1.250 billion in the long‑term‑debt schedule for 2022, 2023 and 2024 (page 52). The portion of total debt classified as “current” shifted dramatically – it was only $73 million in 2022, rose to $1.081 billion in 2023 (largely because the 2.750 % notes due May 2024 were still current), and fell back to $103 million in 2024 after those notes were repaid, leaving only a modest current portion of the 1.375 % notes (page 52). Meanwhile, total long‑term debt fell from $6.590 billion in 2022 to $5.919 billion in 2024, while the 1.375 % notes remained a constant component of that debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the principal amount of the 1.375% Senior Notes as $1,250 million (or $1.250 billion) across all three years (2022-2024), matching the ground truth exactly. The current portion classification figures are also accurate: $73 million in 2022, $1,081 million in 2023, and $103 million in 2024. The LLM provides additional context about the 2.750% notes due May 2024 being the driver of the 2023 spike, which is a reasonable explanatory detail. The mention of total long-term debt figures ($6.590 billion in 2022 and $5.919 billion in 2024) adds relevant context.\n\nWEAKNESSES: The LLM answer introduces information not present in the ground truth (the 2.750% notes due May 2024 and their repayment), which while potentially accurate from the filings, goes beyond what the ground truth specifies. More critically, the LLM's explanation of WHY the current portion changed is speculative—it attributes the 2023 spike to the 2.750% notes being current, but the ground truth simply states the classification changed without explaining the cause. This represents an inference not grounded in the provided ground truth. The answer also conflates the principal amount ($1,250 million) with its classification as 'long-term debt' in a way that could be clearer—the ground truth emphasizes that the principal remained constant while the CURRENT PORTION classification changed, which is the key distinction.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and connects the debt composition to maturity profiles, but the reasoning about the 2.750% notes causing the spike is an inference not validated by the ground truth provided.\n\nNUMBER VERIFICATION: All key figures match exactly: $1,250M principal (all years), $73M current (2022), $1,081M current (2023), $103M current (2024). The total debt figures provided are additional context not contradicted by ground truth.\n\nSEMANTIC EQUIVALENCE: The core message is conveyed—the principal stayed constant while current portion classification fluctuated significantly—but the explanation adds interpretive elements beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 578,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "PayPal’s Fixed‑rate 2.850 % notes (maturing Oct 1 2029) carried an outstanding principal of **$1.5 billion at year‑end 2022**, **$1.5 billion at year‑end 2023**, and **$1.5 billion at year‑end 2024**【page_107】【page_104】. Keeping this tranche unchanged shows the company is preserving a stable, low‑cost, long‑dated debt segment rather than expanding it, reflecting a disciplined strategy of locking in inexpensive financing to support its capital structure while retaining flexibility for other financing needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All key numeric values are correct - $1.5 billion principal amount for all three years (2022, 2023, 2024) matches ground truth exactly. (2) Maturity date (October 1, 2029) is correct. (3) Interest rate (2.850%) is accurate. (4) Number formatting is appropriate. (5) The core factual claim that the obligation remained unchanged across all three years is accurate. (6) Multi-hop synthesis correctly identifies this as part of PayPal's broader debt management strategy.\n\nWEAKNESSES: (1) The LLM answer omits important contextual details from the ground truth, specifically that this note was part of a $5.0 billion September 2019 issuance and had an effective interest rate of 2.96%. (2) The answer lacks the nuanced explanation that PayPal 'prioritized refinancing or issuing new debt with different maturities and rates' while maintaining this tranche - the ground truth provides more sophisticated insight into the strategic choice. (3) The characterization of the strategy is somewhat simplified - the LLM says 'preserving a stable, low-cost, long-dated debt segment rather than expanding it' which is directionally correct but less comprehensive than the ground truth's explanation of 'preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.' (4) Missing the explicit mention that this reflects active debt management decisions (other tranches were refinanced/issued) while this one was deliberately held constant.\n\nQUANTITATIVE VERIFICATION: All numbers check out perfectly - $1.5B for each year, Oct 1 2029 maturity, 2.850% rate. No calculation errors.\n\nMULTI-HOP REASONING: The answer correctly synthesizes that the unchanged obligation across three years reveals strategic intent about debt management, though it could have been more explicit about the contrast with other debt activity during the period.\n\nOVERALL: The answer is factually accurate on all quantitative measures and captures the essential finding, but lacks some of the strategic depth and contextual richness of the ground truth answer. It's a solid but somewhat abbreviated response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 579,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s gas‑option exposure moved from a net liability in 2022 (the fair‑value of net derivatives based on significant unobservable inputs was a $ (854) million liability) to a modest net‑asset position in 2023 (gas‑option assets $100 million vs. liabilities $97 million) and then to a near‑breakeven position in 2024 (assets $100 million vs. liabilities $102 million)【page_87†L1-L7】【page_84†L31-L39】【page_86†L31-L40】.  At the same time the implied‑volatility assumptions for those options fell from 20%/233% (asset/liability) in 2023 to 15%/150% in 2024, indicating a downward‑trend in perceived gas‑price risk and a more conservative risk posture in the gas market【page_84†L34-L39】【page_86†L34-L40】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that contradict the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY - MAJOR FAILURES:\n   - 2022 volatility: Ground truth states 36%, LLM provides no 2022 data\n   - 2023 volatility: Ground truth states 50%, LLM claims 20%/233% (asset/liability) - INCORRECT\n   - 2024 volatility: Ground truth states 52%, LLM claims 15%/150% - INCORRECT\n   - The LLM's volatility percentages (20%, 233%, 15%, 150%) are not only wrong but implausibly high (233%, 150% are unrealistic for implied volatility)\n   - 2022 fair values: Ground truth clearly states $356M assets/$347M liabilities, LLM incorrectly characterizes as \"net liability of $(854)M\" which appears to be a misinterpretation or conflation with different metrics\n   - 2023 fair values: LLM correctly states $100M assets/$97M liabilities (matches ground truth)\n   - 2024 fair values: LLM correctly states $100M assets/$102M liabilities (matches ground truth)\n\n2. COMPLETENESS ISSUES:\n   - LLM fails to provide complete 2022 data (missing 2022 volatility and fair values in the main narrative)\n   - LLM does not clearly present the three-year trend as requested\n   - Missing the critical 2022 baseline for trend analysis\n\n3. ENTITY/METRIC ACCURACY:\n   - Company correctly identified (NextEra Energy)\n   - Years correctly identified (2022-2024)\n   - However, the characterization of 2022 as a \"net liability\" position is misleading and incorrect\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is incomplete and contains logical errors\n   - The conclusion about \"downward trend in perceived gas-price risk\" is contradicted by the actual volatility data provided (which shows an INCREASE from 36% to 50% to 52%, not a decrease)\n   - The LLM's own volatility numbers (20%→15%) would support a downward trend, but these numbers are factually wrong\n   - The characterization of risk posture is undermined by incorrect volatility assumptions\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative differs significantly from ground truth\n   - The trend interpretation is inverted (LLM suggests declining volatility when ground truth shows increasing volatility from 36%→50%→52%)\n   - The 2022 characterization as \"net liability\" contradicts the ground truth presentation of separate asset and liability values\n\nSUMMARY: While the LLM correctly identifies 2023-2024 fair values, it fundamentally fails on volatility assumptions (the most critical metric for the question), mischaracterizes 2022 data, and draws conclusions that contradict the actual trend in the data. The volatility numbers are not merely wrong but implausibly high, suggesting a fundamental misreading of the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 732,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments moved from a modest $9 million gain in FY 2022 to a $21 million loss in FY 2023 and a $67 million loss in FY 2024 【page_46】.  Those losses helped turn other income (loss), net from a $392 million gain in FY 2022 to a $306 million loss in FY 2024 【page_46】, showing that the AFS debt portfolio became increasingly volatile – shifting from a small upside to sizable downside as market and interest‑rate conditions changed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific, verifiable numbers that align with the ground truth. The quantitative data is precise: FY 2022 AFS debt gain of $9 million, FY 2023 loss of $21 million, and FY 2024 loss of $67 million are presented clearly. The other income (loss), net figures ($392 million gain in FY 2022 declining to $306 million loss in FY 2024) are correctly cited. The multi-hop reasoning is sound - the answer successfully synthesizes how AFS debt investment performance directly impacted overall other income (loss), net across the three-year period. The answer correctly identifies the trend of increasing volatility and the shift from gains to losses. The semantic meaning matches the ground truth regarding portfolio volatility and the negative impact on non-operational income streams. Minor strengths: The answer provides specific numerical progression that makes the volatility trend concrete and measurable. Minor limitations: The answer could have slightly more explicitly addressed the offsetting gains from equity and private investments mentioned in the ground truth, though this is a minor omission. The answer is well-structured, uses appropriate financial terminology, and directly addresses both parts of the question (financial performance impact and what it reveals about volatility). The citation references (page_46) add credibility. Overall, this is a high-quality response that accurately synthesizes multi-hop financial information with precise quantitative support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 421,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Lowe’s first issued the 4.550 % notes in the Fifteenth Supplemental Indenture on April 5 2019 (maturing April 5 2049) and the 2022 10‑K lists that series in exhibit 4.16 (see p. 82)【page_82】. The 2023 and 2024 10‑Ks again reference the same 4.550 % notes in exhibit 4.16 (see p. 75) with no new issuance added【page_75】. This repeated, multi‑year disclosure shows the company is maintaining a single, long‑dated, fixed‑rate tranche of debt, locking in financing costs and extending its maturity profile as part of a deliberate long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Verification of key facts: (1) The 4.550% Notes due April 5, 2049 - CORRECT, matches ground truth exactly. (2) Fifteenth Supplemental Indenture dated April 5, 2019 - CORRECT, matches ground truth. (3) Consistent disclosure across 2022, 2023, and 2024 - CORRECT, the LLM properly identifies that the same notes appear in exhibit 4.16 across all three years with no new issuance. (4) Specific exhibit references (4.16) and page numbers (82, 75) are provided, adding credibility and specificity beyond the ground truth. (5) Multi-hop synthesis is sound: the LLM correctly traces the note from initial issuance through three consecutive years of filings and draws the appropriate conclusion about stable long-term debt strategy. The reasoning that repeated disclosure without modification indicates a deliberate, steady approach to long-term financing is logically sound and matches the ground truth's conclusion. Minor differences: The LLM provides more granular detail (specific exhibit numbers and page references) than the ground truth, which is a strength. The LLM's characterization of the strategy as 'locking in financing costs and extending its maturity profile' is a reasonable interpretation that aligns with the ground truth's assessment of 'stable long-term debt structure' and 'steady approach to long-term financing.' No calculation errors, no factual inaccuracies, and the multi-year pattern analysis is correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 412,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "Across all three filings the Unsecured Notes – 35B remained unchanged – a $750 million face amount (shown as 750,000 in thousands) with a 3.80 % coupon and a July 15 2050 maturity【page_50†L71-L78】. The fact that SPG kept both the size and the low‑to‑moderate fixed rate steady from 2022 through 2024 signals a deliberate long‑term debt strategy: locking in inexpensive, long‑dated financing to manage interest‑rate risk and preserve liquidity rather than repeatedly refinancing or expanding that tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of SPG's debt strategy. QUANTITATIVE VERIFICATION: All numbers are correct - $750 million face value (properly noted as 750,000 in thousands format), 3.80% coupon rate, and July 15, 2050 maturity date. The format variation ($750 million vs 750,000 in thousands) is appropriately handled. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) face value evolution (consistent at $750M), (2) interest rate exposure (unchanged at 3.80%), (3) time period coverage (2022-2024), and (4) strategic implications. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three annual filings to identify the consistency of this debt instrument and drew appropriate conclusions about SPG's long-term debt strategy. REASONING QUALITY: The interpretation that consistency in face value, rate, and maturity signals 'deliberate long-term debt strategy' and 'locking in inexpensive, long-dated financing' is sound and aligns with the ground truth's assessment of 'stable long-term financing approach' and 'confidence in managing long-dated liabilities.' MINOR DIFFERENCES: The LLM's characterization of 3.80% as 'low-to-moderate fixed rate' is a reasonable qualitative assessment, though the ground truth simply states 'favorable interest terms.' The LLM provides slightly more strategic detail about 'managing interest-rate risk and preserve liquidity rather than repeatedly refinancing,' which adds valuable context beyond the ground truth without contradicting it. ENTITY ACCURACY: Company (SPG/Simon Property Group), debt instrument (Unsecured Notes - 35B), and all time periods correctly identified. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 482,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "PayPal’s 10‑K risk disclosures show a consistent but deepening focus on “bad‑transaction” exposure tied to three sources: defaults on its branded credit products, volatility in cross‑border trade, and heavy reliance on unaffiliated lenders, payment processors and other third‑party partners (2022 p. 26‑28). In 2023 the filing added that a termination or interruption of a partner‑bank’s lending capacity and the need for stronger fraud‑detection controls could amplify those losses (2023 p. 24), and by 2024 the company was emphasizing concrete mitigation steps—diversifying payment‑processor relationships, selling BNPL receivables and refining credit‑risk models—while still flagging the same credit‑product, cross‑border and third‑party risks (2024 p. 22‑23). This progression from identification to active mitigation signals a maturing risk‑management approach and growing operational resilience.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three key risk sources (credit products, cross-border trade, third-party dependencies) and accurately captures the strategic evolution from 2022-2024. The narrative arc of 'identification to active mitigation' is sound and well-supported. The answer correctly references the 2023 BNPL receivables sale strategy and the 2024 emphasis on fraud/credit-risk mitigation. The multi-hop synthesis across years is logical and demonstrates understanding of PayPal's risk management transformation.\n\nWEAKNESSES: (1) QUANTITATIVE OMISSION: The LLM answer fails to include the specific €40 billion figure mentioned in the ground truth regarding the multi-year agreement to sell U.K. and European BNPL loan receivables. This is a material quantitative detail that should have been included. (2) LEGAL DOCTRINE MISSING: The ground truth specifically mentions the 'valid-when-made' doctrine for purchased loan receivables as a 2024 legal uncertainty, which the LLM answer does not address. This is a concrete risk factor that distinguishes 2024 disclosures. (3) SYNCHRONY BANK REFERENCE: The ground truth specifically mentions Synchrony Bank as the partner for U.S. consumer credit products in 2022, which the LLM answer generalizes as 'unaffiliated lenders' without naming the specific partner. (4) PAGE CITATIONS: While the LLM provides page numbers, these cannot be verified against actual filings and appear to be illustrative rather than precise.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the progression from risk absorption to risk mitigation. However, the reasoning could be more precise by including the specific mechanisms (€40B sale, legal contingency planning) rather than general statements about 'diversifying' and 'refining.'\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth—PayPal's risk management evolved from passive identification to active mitigation. However, the answer lacks specificity on key mechanisms that define this evolution.\n\nJUSTIFICATION: Score of 7 reflects that the answer captures the main narrative correctly but omits material quantitative details (€40B) and specific risk factors (valid-when-made doctrine, Synchrony Bank) that are essential to a complete answer about PayPal's risk evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 626,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco has consistently listed BJ & Sons Wholesale Club as a direct warehouse‑club rival in each of its 10‑K filings – the 2022 report notes “We also compete with other warehouse clubs, including Walmart’s Sam’s Club and BJ’s Wholesale Club” (page 7) and the 2023/2024 reports repeat the same phrasing (page 8).  In all three years Costco has emphasized its private‑label Kirkland Signature as a key differentiator, describing it as high‑quality, lower‑priced than national brands, cost‑saving and margin‑enhancing, and stating its intent to keep expanding its sales penetration (page 7 & page 8).  Thus, from 2022 through 2024 Costco’s competitive stance versus BJ’s remained stable, while its focus on Kirkland Signature as a strategic advantage was reaffirmed and reinforced each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies BJ's Wholesale Club as a direct competitor mentioned consistently across 2022-2024 filings; (2) Accurately characterizes Kirkland Signature's positioning as high-quality, lower-priced alternatives to national brands; (3) Correctly identifies the key attributes: cost-saving, margin-enhancing, and intent to expand sales penetration; (4) Properly synthesizes the multi-hop reasoning that competitive positioning remained stable across the three-year period; (5) Accurately conveys that messaging was 'reaffirmed and reinforced' rather than shifted, matching the ground truth's 'remained stable' and 'no significant shift' language. MINOR CONSIDERATIONS: (1) The LLM references specific page numbers (page 7, page 8) which adds helpful specificity but cannot be verified against the ground truth provided; however, this does not contradict the ground truth; (2) The LLM uses 'BJ & Sons Wholesale Club' while the ground truth uses 'BJ's Wholesale Club' - this appears to be a minor naming variation that doesn't affect factual accuracy; (3) The answer includes the Sam's Club reference which, while not explicitly mentioned in the ground truth excerpt, is consistent with typical competitive positioning discussions and doesn't contradict the provided information. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years (2022, 2023, 2024) and two entities (Costco and BJ's), properly identifying the stable nature of the competitive positioning and the consistent emphasis on Kirkland Signature. The reasoning is sound and logically structured. No quantitative errors detected. The semantic meaning aligns well with the ground truth's core message about stability and consistency in strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 501,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "At year‑end 2022 NextEra’s net derivative position based on significant unobservable inputs was a $854 million liability, indicating a net negative exposure that includes its gas‑forward contracts【page_85】. By year‑end 2023 the fair‑value of gas‑forward assets was $377 million versus $77 million of liabilities, yielding a $300 million net‑asset position【page_84】, and at year‑end 2024 those figures fell to $296 million of assets and $46 million of liabilities, a $250 million net‑asset position【page_86】. The progression from a net liability in 2022 to a modest net‑asset hedge in 2023‑24, coupled with the declining asset and liability values, shows the company has shifted to a more conservative, lower‑exposure stance in the natural‑gas market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023 and 2024 gas forward contract values (assets of $377M and $296M respectively, liabilities of $77M and $46M), matching the ground truth. The net position calculations for 2023 ($300M) and 2024 ($250M) are accurate. The answer appropriately addresses the 3-year progression and attempts multi-hop synthesis across years.\n\nCRITICAL ERRORS: (1) The 2022 baseline is fundamentally wrong. The LLM cites an $854 million net derivative liability position based on 'significant unobservable inputs' but fails to isolate the specific gas forward contract values for 2022. The ground truth clearly states gas forward assets were $191 million and liabilities were $31 million in 2022. The LLM conflates broader derivative positions with gas-specific contracts, breaking the multi-hop synthesis. (2) The LLM's interpretation of the trend is inverted. The ground truth indicates 'growing but increasingly balanced exposure' with 'strategic expansion,' while the LLM concludes the company 'shifted to a more conservative, lower-exposure stance.' This mischaracterizes the progression: assets grew from $191M→$377M→$296M (net growth over 3 years), and the 2023 spike to $377M contradicts a 'conservative' positioning.\n\nMULTI-HOP REASONING: The answer attempts to synthesize across three years but fails at the critical first step (2022 baseline). The comparison logic is sound for 2023-2024, but the missing/incorrect 2022 data undermines the entire 3-year progression analysis. The conclusion about 'declining asset and liability values' is partially misleading—while 2024 shows decline from 2023, the 2022-2023 trajectory shows significant growth.\n\nCALCULATION VERIFICATION: 2023 net position ($377M - $77M = $300M) ✓; 2024 net position ($296M - $46M = $250M) ✓. However, the 2022 calculation cannot be verified as presented because the specific gas forward contract values are not correctly stated.\n\nCOMPLETENESS: The answer addresses the 3-year progression but with incomplete/incorrect baseline data, limiting the quality of the risk positioning analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 564,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap activity fell sharply over the three‑year span. In 2022 the company had a large hedge in place – forward‑swap contracts with a notional amount of about $2.56 billion to lock in rates on forecast debt issuances (Note 9, 2023 10‑K, page 62). By fiscal‑year‑end 2023 those swaps were still on the books, showing a fair‑value of roughly $251 million (Fair‑value table, 2024 10‑K, page 54), but the same table shows a dash/zero for forward swaps at February 2 2024, indicating the positions had been settled or discontinued (page 54). This shift from a sizable forward‑swap hedge in 2022 to essentially no forward‑swap exposure in 2024 suggests Lowe’s moved away from locking in future borrowing costs as its debt‑issuance plans and the interest‑rate environment changed, opting for a more flexible or reduced hedging strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Lowe's forward interest rate swap evolution but contains some issues with precision and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the $251 million fair value as of February 3, 2023 (matches ground truth)\n2. Accurately captures the key narrative: swaps existed in 2022, were valued at $251M in 2023, and were absent by 2024\n3. Provides additional detail (notional amount of $2.56 billion) that adds context beyond ground truth\n4. Sound multi-hop reasoning connecting the three-year progression to strategic intent\n5. Correctly interprets the absence of swaps in 2024 as a strategic unwind\n6. Appropriately contextualizes the shift as response to changing market conditions and debt issuance plans\n\nWEAKNESSES:\n1. The date reference \"February 2, 2024\" appears to be an error - the ground truth specifies \"January 31, 2025\" for the 2024 data point. This is a factual inaccuracy regarding the fiscal year-end date.\n2. The LLM states swaps showed \"a dash/zero for forward swaps at February 2 2024\" but the ground truth indicates they were absent \"as of January 31, 2025\" - this represents a one-year discrepancy in the final data point\n3. While the $2.56 billion notional amount is provided, it's not verified against ground truth and appears to be additional detail not explicitly confirmed\n4. The ground truth emphasizes the classification under \"other current assets\" in 2023, which the LLM doesn't mention\n5. The ground truth notes these were \"cash flow hedges\" with impact on \"other comprehensive income and earnings,\" contextual details the LLM omits\n\nCALCULATION/NUMERIC VERIFICATION:\n- $251 million figure: CORRECT\n- $2.56 billion notional: Not contradicted but not verified in ground truth\n- Date discrepancy: February 2, 2024 vs. January 31, 2025 - INCORRECT for final data point\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three fiscal years and correctly identifies the strategic progression. The reasoning connecting the unwind to \"debt-issuance plans and the interest-rate environment\" is sound and matches the ground truth's interpretation.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns well: Lowe's moved from active hedging with forward swaps to no forward swap exposure, indicating a strategic shift in response to market conditions. Both answers convey this progression effectively.\n\nThe primary deduction is for the date error in the final fiscal year (2024 data point), which affects quantitative accuracy. The answer is otherwise substantively correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 694,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "In 2022 Comcast’s 10‑K noted that Lumen (along with AT&T, Frontier and Verizon) was “building … fiber‑based network infrastructure farther into their networks… and are offering services with higher speeds in many of our service areas”【page_9】.  Beginning that year Comcast launched a multiyear network‑transformation plan, rolling out 2 Gbps downstream speeds to roughly one‑third of its HFC footprint and, by 2023‑24, expanding that coverage to about half of the footprint while deploying DOCSIS 4.0 in select markets【page_7】.  By 2024 the company was also offering fiber‑to‑the‑premises services that deliver symmetrical speeds up to 100 Gbps for business customers【page_6】, allowing Comcast to match or exceed Lumen’s fiber‑based broadband in overlapping markets and broaden its residential and enterprise service bundles.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about competitive positioning evolution from 2022-2024. STRENGTHS: (1) Correctly identifies Lumen as a key competitor across all three years with fiber-based infrastructure expansion; (2) Accurately cites the 2022 10-K language about Lumen 'building fiber-based network infrastructure' and 'offering services with higher speeds'; (3) Provides specific, verifiable metrics: 2 Gbps downstream to one-third of HFC footprint in 2022, expanding to about half by 2023-24, DOCSIS 4.0 deployment, and fiber-to-premises with up to 100 Gbps symmetrical speeds for business customers by 2024; (4) Correctly synthesizes CMCSA's competitive response strategy (network transformation plan) alongside Lumen's competitive threat; (5) Appropriately contextualizes the evolution showing intensifying competition and CMCSA's strategic positioning. MINOR WEAKNESSES: (1) The answer goes slightly beyond the ground truth by emphasizing CMCSA's specific technological responses (DOCSIS 4.0, fiber-to-premises offerings) rather than focusing equally on the evolution of Lumen's competitive threat itself - though this is actually a more comprehensive answer; (2) Could have more explicitly stated that Lumen's competitive pressure 'intensified' across the three-year period, though this is implied; (3) The ground truth emphasizes 'consistent mention of Lumen across all three years' as underscoring 'growing influence,' while the LLM answer focuses more on CMCSA's response than on Lumen's growing influence per se. QUANTITATIVE VERIFICATION: All specific numbers (2 Gbps, one-third footprint, half footprint, 100 Gbps) appear reasonable and are presented without contradictions. No calculation errors detected. MULTI-HOP REASONING: Successfully synthesizes information across three years and two companies (CMCSA and Lumen), correctly identifying the competitive dynamic and market overlap. The answer demonstrates sound logical reasoning about how competitive positioning evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 554,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "In 2022 PayPal’s strategy centered on a “simplest checkout” that let shoppers fund purchases with a digital wallet, bank accounts or its emerging consumer‑credit products (BNPL in the U.S., U.K., France, Germany and Japan) and highlighted the ability to send payments in more than 200 markets and in roughly 100 currencies (with withdrawals in 56 currencies). By 2024 the company had embedded those credit products directly into the PayPal and Venmo checkout flows, expanded credit availability to additional regions, and promoted a fully omnichannel checkout—online, mobile and in‑store via Zettle and other point‑of‑sale tools—while still operating a global platform that spans about 200 markets and multiple currencies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about PayPal's evolution in seamless checkout experiences from 2022-2024, but contains significant quantitative discrepancies and some factual inconsistencies when compared to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 focus on simplest checkout with digital wallet, bank accounts, and BNPL products\n- Accurately names BNPL markets (U.S., U.K., France, Germany, Japan)\n- Correctly notes 2024 embedding of credit products into PayPal and Venmo checkout flows\n- Properly identifies omnichannel expansion through Zettle and point-of-sale tools\n- Correctly mentions Braintree as an unbranded payment processor (implied through omnichannel solutions)\n- Accurately describes the strategic evolution from global scale to integrated financial services\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERRORS: LLM states \"roughly 100 currencies\" for 2022, which aligns with ground truth. However, LLM claims \"about 200 markets\" for both 2022 and 2024, while ground truth specifies \"over 100 currencies\" in 2022 and \"approximately 150\" currencies by 2023. The LLM conflates markets with currencies and doesn't show the currency expansion progression (100→150) that ground truth emphasizes.\n\n2. MISSING EVOLUTION DETAIL: Ground truth explicitly tracks currency support evolution (100 in 2022 → ~150 in 2023 → integrated with BNPL in 2024). LLM fails to capture the 2023 intermediate step and the progression of currency support expansion, which is a key part of the evolution narrative.\n\n3. INCOMPLETE 2023 REFERENCE: Ground truth mentions 2023 as a distinct milestone with ~150 currencies and platform enhancements. LLM jumps from 2022 to 2024 without acknowledging 2023 developments.\n\n4. DEBIT/CREDIT CARD MENTION: Ground truth specifically mentions \"PayPal- and Venmo-branded debit and credit cards\" as part of 2024 integration. LLM doesn't explicitly mention these branded cards, only the BNPL products.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the three-year period and correctly identifies the strategic shift from global scale to integrated financial services. However, the synthesis is incomplete because it misses the 2023 intermediate developments and doesn't fully capture the currency support progression that demonstrates the evolution.\n\nNUMERIC VERIFICATION: The \"200 markets\" figure appears in both LLM and ground truth contexts, but the LLM's treatment of currency metrics is imprecise. Ground truth shows clear progression (100→150 currencies), while LLM presents static figures without showing evolution.\n\nOVERALL ASSESSMENT: The answer captures the main narrative arc and key strategic elements but fails on quantitative precision regarding currency support evolution and omits the important 2023 milestone. The answer is directionally correct but incomplete in demonstrating the full evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 775,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target’s debit‑card (RedCard) penetration slipped from 20.5 % of purchases in fiscal 2022 to 19.8 % in fiscal 2023 and further to 18.6 % in fiscal 2024【page_27】. The steady decline indicates that, while the card still generates incremental sales, its relative contribution to guest spend is gradually diminishing over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the penetration rate figures. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM reports: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. The 2023 figure is incorrect (19.8% vs 18.6%) and the 2024 figure is incorrect (18.6% vs 17.8%). These are not minor rounding differences but represent material misstatements of the actual data points. MULTI-HOP REASONING: The LLM correctly identifies the overall trend (declining penetration) and attempts to synthesize the implication about diminishing sales contribution. However, the reasoning is undermined by the incorrect numbers. COMPLETENESS ISSUES: The LLM answer addresses the trend evolution and provides some interpretation about its role in driving sales, but it lacks the depth of the ground truth answer which explicitly notes the 'consistent decline over three years' and the 'potential weakening in customer engagement' with the loyalty program. The ground truth also mentions Target's internal linkage between the card and increased sales, which the LLM answer does not capture. ENTITY ACCURACY: Correctly identifies Target and RedCard/debit card, though the ground truth uses 'Target Debit Card' and 'RedCards/Target Circle Cards' terminology. SEMANTIC EQUIVALENCE: While the LLM's general conclusion about declining penetration and diminishing role is directionally correct, the specific numerical errors are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 424,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy for development‑service and IP‑licensing contracts has not changed between the 2022, 2023 and 2024 filings. In each filing (2022 p. 59; 2023 p. 63; 2024 p. 64) AMD says it first determines whether the licensing component is distinct. If the license is not distinct, it is combined with the development services and the revenue is recognized over time as a single performance obligation; if the license is distinct—whether in a combined arrangement or as a standalone licensing deal—revenue is recognized at a point in time when the customer can benefit from the license, with no variable‑consideration estimates applied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that AMD's policy remained consistent across 2022-2024, matching the ground truth assertion of 'maintained a consistent revenue recognition framework'; (2) Accurately describes the two-part framework: distinct licenses recognized at point in time vs. non-distinct licenses combined with development services and recognized over time; (3) Provides specific page references (2022 p. 59; 2023 p. 63; 2024 p. 64) that add credibility and verifiability; (4) Correctly synthesizes the multi-hop requirement by comparing the approach across three years and distinguishing between combined arrangements and standalone deals; (5) Accurately notes that distinct licenses are recognized when customer can benefit from the IP, and that no variable consideration estimates are applied. The answer is more precise than the ground truth in some respects (e.g., explicitly stating 'no variable-consideration estimates applied'), which demonstrates deeper filing analysis. Minor consideration: The LLM answer is slightly more concise and structured than the ground truth, but this is a strength rather than weakness as it presents the information more clearly. No quantitative errors detected. The reasoning correctly synthesizes information across multiple years and filing sections. The semantic meaning aligns perfectly with the ground truth while being more specific about implementation details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 407,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "In Nike’s FY 2022 10‑K, FlyEase was highlighted as one of a broad “proliferation” of new technologies—listed alongside Air, Zoom, Free, Flywire, Dri‑FIT, Flyknit, ZoomX, Air Max, React and Adapt—signaling its introduction as a fresh innovation in the company’s portfolio (2022 Form 10‑K p. 6). By FY 2024, FlyEase still appears in the same “proliferation” statement, but the surrounding set of technologies has been streamlined (Flywire and Adapt are omitted and the list now reads Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, ZoomX, Air Max and React), indicating that FlyEase has moved from a newly‑launched concept to a stable, core element of Nike’s innovation strategy (2024 Form 10‑K p. 6).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) The LLM claims FlyEase appears in the same 'proliferation' statement in both FY2022 and FY2024, but the ground truth indicates FlyEase was newly introduced in FY2022, transitioned to being alongside established technologies in FY2023, and moved to mature technologies in FY2024. This is a fundamental mischaracterization of the evolution. (2) The LLM's narrative suggests FlyEase remained in a similar position across the three-year period ('still appears in the same proliferation statement'), which directly contradicts the ground truth's clear progression from novel → growing importance → mature/foundational. (3) The LLM omits FY2023 entirely, missing a critical middle point in the three-year evolution that the ground truth emphasizes as showing 'growing strategic importance and market integration.' (4) The LLM's characterization of FlyEase moving from 'newly-launched concept to stable, core element' is partially correct in direction but misses the nuance that by FY2024 it should be grouped with mature technologies (React, Air Max) rather than remaining in a general 'proliferation' list. CORRECT ELEMENTS: The LLM correctly identifies Nike's fiscal years (FY2022, FY2024) and correctly notes that FlyEase's positioning evolved over time. The citation format and page references appear plausible. However, the core analytical conclusion about the nature and trajectory of this evolution is substantially incorrect. The answer fails to capture the three-stage progression (novel → growing importance → mature) that is central to the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 456,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250% notes have been shrinking each year – $609.1 million outstanding at the end of 2022 (page 48), $551.9 million at the end of 2023 (page 110) and $517.7 million at the end of 2024 (page 113). The steady decline shows AMT is actively repaying this low‑coupon, long‑dated series, indicating a deliberate strategy to reduce overall debt and tighten its balance‑sheet leverage and maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of AMT's debt management strategy. QUANTITATIVE VERIFICATION: All three principal amounts are correct - $609.1M (2022), $551.9M (2023), $517.7M (2024). The year-over-year declines are accurately represented ($57.2M reduction 2022-2023, $34.2M reduction 2023-2024). Page references provided (48, 110, 113) add credibility. COMPLETENESS: The answer addresses the core question about debt management trends across all three years. It identifies the consistent reduction pattern and correctly characterizes it as a deliberate strategy. ENTITY ACCURACY: Company (AMT), note type (1.250%), and years (2022-2024) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the numerical trend to strategic implications (debt reduction, balance sheet leverage management, maturity profile optimization). The characterization of this as 'active repayment' and 'deliberate strategy' aligns with the ground truth's mention of 'managed amortization or repurchase strategy.' MINOR DIFFERENCES: The LLM answer omits specific mention of the consistent interest payment terms (May payments, February 2033 maturity) that appear in the ground truth. However, this is a minor omission that doesn't affect the core answer about the debt management trend. The LLM's interpretation that this represents 'tightening leverage and maturity profile' is a reasonable inference from the data, though slightly more interpretive than the ground truth's more neutral description. Overall, the answer is factually accurate, well-reasoned, and directly addresses the question with appropriate supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 462,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2040 have been a stable, long‑dated financing source over the three most recent fiscal years. In FY 2022 the notes were recorded at their $1 billion face amount (net carrying amount $1 billion) with no short‑term portion and a modest un‑amortized discount, i.e., presented as long‑term debt 【page_78】. In FY 2023 the same series was shown as a Level‑2 liability with an estimated fair value of $870 million (still classified as long‑term) 【page_67】, and in FY 2024 the fair value slipped to $851 million while the net carrying amount remained $1 billion and the entire series stayed in the long‑term portion of the debt schedule (short‑term portion $0) 【page_72】. This trajectory—steady principal amount, consistent long‑term classification, and only modest fair‑value declines as market rates rose—demonstrates NVIDIA’s strategy of locking in inexpensive, long‑maturity debt to fund growth while limiting refinancing risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) FY 2022 valuation: LLM states 'recorded at their $1 billion face amount' with 'no short-term portion' but provides no fair value figure. Ground truth clearly states fair value was $1,066 million in FY 2022. (2) FY 2023 valuation: LLM claims fair value of $870 million, but ground truth states $851 million—a $19 million discrepancy. (3) FY 2024 valuation: LLM states fair value 'slipped to $851 million' while ground truth indicates the notes were 'carried at $1,000 million with an effective interest rate of 3.54%.' The LLM appears to have confused FY 2023 and FY 2024 fair values. (4) The LLM conflates carrying amount ($1 billion) with fair value throughout, creating confusion about which metric is being discussed. The ground truth trajectory is: FY 2022 fair value $1,066M → FY 2023 fair value $851M → FY 2024 carrying amount $1,000M with 3.54% effective rate. The LLM's numbers don't match this sequence. (5) Multi-hop reasoning: While the LLM correctly identifies the long-term debt strategy concept, the underlying data supporting this conclusion is incorrect. The reasoning about 'locking in inexpensive, long-maturity debt' is sound conceptually but built on wrong numbers. (6) The LLM provides page citations that cannot be verified against the ground truth source, raising questions about data accuracy. The answer demonstrates understanding of debt strategy concepts but fails on fundamental quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 440,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "Netflix’s membership strategy shifted from adding a lower‑priced ad‑supported tier and launching games in 2022 (2022 risk factor on games and pricing adjustments – page 7) to expanding its game catalogue, rolling out live programming and consumer‑product experiences while further refining pricing in 2023 (2023 risk factor on games, ad‑supported tier and live experiences – page 6), and in 2024 focusing on scaling the service to support games, the ad‑supported plan, live programming and broader product offerings (2024 risk factor on scaling and new features – page 8). In each filing Netflix warned that if new features or pricing changes are not well‑received, they could hurt its ability to attract and retain members, slowing growth or increasing churn.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant chronological and factual errors that undermine the overall accuracy. MAJOR ISSUES: (1) CHRONOLOGICAL ERROR - The LLM states games were launched in 2022, but the ground truth indicates games were introduced in 2022 as a NEW component. However, the LLM then claims the ad-supported tier was added in 2022, when ground truth clearly states it was introduced in 2023. This is a critical factual error that misrepresents the timeline of Netflix's strategic evolution. (2) INCOMPLETE SYNTHESIS - The LLM fails to properly synthesize the three-year evolution. It conflates 2022 and 2023 actions in the opening phrase ('adding a lower-priced ad-supported tier and launching games in 2022'), when these occurred in different years. (3) MISSING CONTEXT - The ground truth emphasizes that across all three years, Netflix consistently highlighted risks around member perception of value. The LLM mentions this but doesn't adequately convey the consistent risk messaging across the full period. (4) PAGE REFERENCES - The LLM includes specific page numbers (page 7, page 6, page 8) which cannot be verified against the ground truth and may be fabricated or inaccurate. (5) CORRECT ELEMENTS - The LLM does correctly identify: (a) games as a 2022 initiative, (b) ad-supported tier expansion, (c) live programming addition, (d) the consistent risk messaging about member reception and churn. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails to maintain accurate chronological ordering, which is essential for answering 'how did strategy evolve' questions. The reasoning about risks is sound but incomplete. SEMANTIC EQUIVALENCE: While the general risk messaging is conveyed, the specific timeline errors prevent true semantic equivalence with the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 501,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture portfolio rose from $3.7 billion of equity securities in 2022 to $4.9 billion in 2023 and stayed at $4.9 billion in 2024, while its equity‑method stakes in health‑care operating businesses fell slightly from $1.5 billion in 2022 to $1.4 billion in 2023 before leaping to $3.8 billion in 2024【page_50】【page_52】.  This trajectory shows the firm expanding its overall venture holdings but, most notably, dramatically increasing direct ownership in health‑care businesses in 2024, signaling a strategic shift toward deeper integration and influence within the health‑care sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a significant factual error in the 2022 equity method investments figure. The ground truth states $1.3 billion in 2022, but the LLM claims $1.5 billion. This is a material discrepancy of $200 million. All other numbers are correct: equity securities at $3.7B (2022), $4.9B (2023-2024), and equity method investments at $1.4B (2023) and $3.8B (2024). COMPLETENESS: The answer addresses the core question about venture investment evolution and strategic positioning. It covers both equity securities and equity method investments across the 2022-2024 period. ENTITY ACCURACY: Company name (UnitedHealth), metrics (equity securities, equity method investments), and years are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the upward trend in equity securities, the dramatic 2024 jump in equity method investments, and appropriately interprets this as a strategic shift toward deeper integration. The reasoning about 'direct ownership' and 'deeper integration' aligns well with the ground truth's characterization of 'deeper engagement in healthcare innovation and operating businesses.' SEMANTIC EQUIVALENCE: The qualitative interpretation is semantically equivalent to the ground truth, capturing the strategic shift toward integrated health services. However, the quantitative error (2022 equity method investments) is a material factual mistake that cannot be overlooked in a financial analysis context. The error appears to be a data retrieval or transcription mistake rather than a calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 443,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America remained essentially unchanged from FY 2022 through FY 2024. Sojitz America continued to be the sole holder of Nike’s $0.3 million‑par redeemable preferred stock, which carries a cumulative $0.10‑per‑share dividend payable each May 31 and bars any common‑stock dividends until that preferred dividend is paid; no additional preferred shares were issued and the company’s charter bars new issuances (pages 79 & 78). Strategically, Sojitz America still provides import‑export financing for Nike and retains special voting rights on major transactions (e.g., asset sales, mergers, trademark assignments), underscoring its ongoing role in Nike’s international operations (page 7).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all quantitative facts - Sojitz America as sole holder of $0.3 million par value redeemable preferred stock, $0.10 per share cumulative dividend, and the May 31 payment date. The numerical accuracy is strong (9/10). The answer also correctly notes the charter restrictions on new preferred share issuances and mentions special voting rights on major transactions.\n\nWEAKNESSES: The core issue is the LLM's failure to capture the key evolution described in the ground truth. The ground truth explicitly states there was a SHIFT from 'purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024,' particularly regarding Sojitz America's import-export financing services since 1972 and their strategic importance amid rising global trade risks. The LLM states the relationship 'remained essentially unchanged' and treats Sojitz America's import-export financing role as a static fact rather than highlighting how Nike explicitly emphasized this role in FY 2024 as a response to trade protectionism and supply chain volatility.\n\nMULTI-HOP REASONING: The LLM fails to synthesize the temporal evolution across the three fiscal years. The ground truth requires understanding that while the financial structure remained constant, the strategic narrative around Sojitz America's role evolved - becoming more prominent and operationally significant in 2024. The LLM misses this nuanced multi-hop synthesis by treating all years as equivalent.\n\nCOMPLETENESS: The answer addresses preferred stock ownership and dividend obligations adequately but significantly underaddresses the 'evolution' aspect of the question. The question specifically asks 'how did...evolve' - implying change over time - but the LLM's answer emphasizes stasis rather than the documented shift in strategic emphasis.\n\nSEMANTIC ACCURACY: While the LLM's statement that the relationship 'remained essentially unchanged' is technically defensible regarding financial structure, it contradicts the ground truth's explicit characterization of an evolution in strategic role and emphasis, particularly the 2024 highlighting of trade-related strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 590,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s net carrying amount for the 3.50 % Notes due 2050 was $1.637 billion at the end of FY 2023 and slipped slightly to $1.604 billion at the end of FY 2024【page_67】. The FY 2022 filing showed a comparable level of roughly $1.6 billion【page_78】. This essentially flat trend – a modest decline after a stable base – signals that NVIDIA has kept its long‑term debt level steady, using only limited repayments or discount amortization to modestly reduce the liability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states FY 2023 was $1.637 billion and FY 2024 was $1.604 billion, but ground truth shows FY 2023 was $1,604 million and FY 2024 was $2,000 million. The LLM has the FY 2023 and FY 2024 values reversed/confused and provides an incorrect FY 2023 figure ($1.637B vs $1.604B). More critically, the LLM completely misses the FY 2024 increase to $2,000 million. (2) MISSING FY 2022 DATA: The LLM vaguely references FY 2022 as 'roughly $1.6 billion' without providing the actual figure of $2,147 million from ground truth. This is a major omission that obscures the full trend. (3) TREND ANALYSIS FAILURE: The LLM characterizes the trend as 'essentially flat' and 'steady,' which is fundamentally incorrect. The actual trend shows: FY 2022 ($2,147M) → FY 2023 ($1,604M, a significant 25% decline) → FY 2024 ($2,000M, a substantial 24.7% increase). This is NOT a flat trend; it's a V-shaped pattern indicating strategic repositioning. (4) REASONING QUALITY: The LLM's interpretation that NVIDIA 'kept its long-term debt level steady' directly contradicts the ground truth's correct assessment of 'temporary reduction in 2023 followed by strategic repositioning to increase long-term liabilities in 2024.' The LLM failed to synthesize the multi-year data correctly and drew an incorrect conclusion about debt positioning strategy. (5) COMPLETENESS: The answer fails to address the full fiscal year range (2022-2024) adequately, missing critical data points that are essential to understanding the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 453,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term borrowing—its commercial‑paper program—declined from $175 million at year‑end 2022 to $119 million in 2023, then jumped to $465 million in 2024 (2023 10‑K table shows $175 M for 2022 and $119 M for 2023 【page_111】; 2024 10‑K table shows $465 M for 2024 【page_101】). Across 2022‑2024 the company repeatedly emphasized that liquidity and capital are sourced from a broad mix of global markets—including equity, short‑ and long‑term debt, collateral financing, junior subordinated securities, policyholder account balances, credit facilities and a shelf registration—which it says enhances funding flexibility, limits reliance on any single market and generally lowers its cost of funds (see 2022 10‑K discussion of global funding sources 【page_127】; 2023 10‑K 【page_111】; 2024 10‑K 【page_101】).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Specific commercial paper figures are provided with proper sourcing ($175M in 2022, $119M in 2023, $465M in 2024), showing concrete quantitative evolution across the three-year period. (2) The answer correctly identifies the diversified funding sources strategy mentioned consistently across 2022-2024 filings, including equity, short- and long-term debt, collateral financing, junior subordinated securities, policyholder account balances, credit facilities, and shelf registration. (3) Multi-hop reasoning is sound: the answer synthesizes information across three separate 10-K filings to show both the quantitative trend in commercial paper usage and the qualitative consistency of the diversification strategy. (4) Page citations are provided (pages 127, 111, 101) which adds credibility. (5) The answer directly addresses both parts of the question: the evolution of short-term debt usage AND the reliance on diverse funding sources to lower cost of capital. MINOR CONSIDERATIONS: (1) The original ground truth emphasizes 'no major structural changes' and 'stable reliance,' while the LLM answer highlights the volatility in commercial paper amounts ($175M→$119M→$465M), which is actually more precise and informative than the ground truth's characterization. This represents an enhancement rather than an error. (2) The LLM answer provides specific numerical evidence that the ground truth lacks, making it more substantive. (3) The semantic meaning aligns perfectly with the ground truth's core message about diversification and cost reduction, while providing superior quantitative detail. No calculation errors detected. All entities (MetLife, commercial paper, credit facilities, etc.) correctly identified. The answer fully addresses the multi-part question about evolution from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 515,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s 10‑K notes state that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022” (Note 4, p. 81). At the same time, the balance‑sheet data show short‑term notes payable to subsidiaries rising from $8.7 billion in 2022 to $9.9 billion in 2023 and then dropping sharply to $2.0 billion in 2024, while a new long‑term notes‑payable balance of $14.4 billion to subsidiaries appears in 2024 (Condensed Balance Sheets, p. 78). This evolution indicates UnitedHealth shifted its liquidity commitments from large near‑term obligations to longer‑term financing, reducing immediate cash‑flow risk, while its contractual exposure from service‑level guarantees remained negligible throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM provides a discrepancy in the 2022 short-term notes payable figure. The ground truth states $8.1 billion for 2022, but the LLM reports $8.7 billion. This is a material difference of $600 million (7.4% variance) and represents a factual error. The 2023 ($9.9 billion) and 2024 ($2.0 billion) short-term figures are correct. The LLM correctly identifies the new long-term notes payable of $14.4 billion in 2024, which is not mentioned in the ground truth but appears to be accurate supplementary information from the filing. QUALITATIVE ACCURACY: The LLM correctly synthesizes the multi-hop relationship between service level guarantees (immaterial throughout) and notes payable evolution. The reasoning about liquidity strategy shift from short-term to long-term financing is sound and well-articulated. The LLM properly identifies that service level guarantees posed negligible contractual risk. COMPLETENESS: The LLM addresses both main components of the question: (1) service level guarantees evolution and (2) notes payable evolution. It also adds the important insight about the shift to long-term financing in 2024, which enhances understanding of liquidity strategy. However, it doesn't explicitly address the 'contractual risk exposure' dimension as thoroughly as the ground truth's emphasis on 'stable risk profile.' MULTI-HOP REASONING: The synthesis across balance sheet data and note disclosures is correct in structure. The connection between immaterial service level guarantees and changing debt structures is properly made. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—service level guarantees remained immaterial while internal debt structures shifted significantly. The interpretation of what this reveals about liquidity commitments is reasonable and consistent with the ground truth's conclusion about stable risk profiles. CRITICAL ERROR: The $8.7B vs $8.1B discrepancy for 2022 is a significant quantitative error that prevents a higher score, despite otherwise sound reasoning and analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 556,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 to 2024 American Express remained the fourth‑largest general‑purpose card network behind China UnionPay, Visa and Mastercard, but the competitive landscape grew more intense as those global networks pursued premium‑card and co‑brand deals and fast‑growing alternative‑payment platforms (e.g., Alipay, PayPal, Venmo) expanded their reach 【page_12】. At the same time, Amex’s regulatory dependency deepened: the 2022 filing already noted extensive banking supervision by the Federal Reserve, OCC and CFPB, while the 2024 filing shows the company now classified as a Category III firm subject to heightened oversight of third‑party, data‑privacy and AI practices, increased scrutiny of network‑operation rules (including interchange‑fee caps), and even forced exits from network‑licensing in the EU and Australia 【page_14】【page_34】【page_36】. In response, Amex has strengthened its risk‑management and compliance framework, adjusted its network and product strategy (e.g., focusing on its premium brand and integrated payments platform) and pursued governance enhancements to mitigate regulatory risk while preserving its competitive position.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies Amex as fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard across the 2022-2024 period. (2) Accurately names competitive threats (Alipay, PayPal, Venmo) and regional systems. (3) Correctly identifies Category III firm classification in 2024 with heightened regulatory oversight. (4) Accurately cites specific regulatory concerns: interchange fees, network routing, cobrand arrangements, third-party oversight, data privacy, and AI practices. (5) Correctly notes forced exits from EU and Australia network licensing. (6) Properly synthesizes the evolution from market-driven competition to regulatory navigation. (7) Appropriately mentions strategic responses including risk-management strengthening, compliance framework adjustments, and focus on premium brand positioning. MINOR WEAKNESSES: (1) The answer could have been more explicit about the 2023 inflection point where competitive landscape intensification became particularly pronounced, though this is implied. (2) The phrase 'integrated payments platform' is mentioned as a strategic response but could have been more specifically contextualized. (3) The answer doesn't explicitly state that regulatory scrutiny over interchange fees and network routing was 'especially in the EU' as clearly as the ground truth, though EU/Australia exits are mentioned. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no specific dollar amounts or percentages are provided in either answer, so no calculation errors exist. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across multiple years and regulatory frameworks, properly connecting competitive pressures to regulatory responses. Entity identification is accurate throughout. CONTEXTUAL RELEVANCE: The answer directly addresses all three dimensions of the question: competitive positioning evolution, regulatory dependency deepening, and strategic responses. The narrative arc from 2022 through 2024 is clearly presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1708,
        "completion_tokens": 580,
        "total_tokens": 2289
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From 2022 through 2024 ConocoPhillips consistently treated cash‑settled PSUs whose performance periods began in 2018 or later the same way: the awards accrue an “reinvested dividend equivalent” that is charged to compensation expense and paid only at the cash settlement date, rather than receiving periodic cash dividend payments during the performance period. By moving the dividend component to a settlement‑linked, reinvested payment, the company reinforces that long‑term incentives are tied directly to the firm’s stock performance and shareholder value, underscoring a tighter alignment of executive compensation with sustained corporate results.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key dividend equivalent payment structure for PSUs with performance periods beginning in 2018 or later (accrued reinvested dividends paid at settlement rather than periodic payments). The numeric/date references are accurate (2022-2024 period, 2018 threshold). However, the answer has significant omissions that reduce its completeness: (1) It fails to address the EVOLUTION aspect of the question by not contrasting the 2018+ structure with the pre-2018 structure (which the ground truth explicitly covers: 'for performance periods before 2018, no payments were made during the performance period but began after its conclusion'). This is a critical multi-hop synthesis element. (2) It omits the vesting framework details (five years or retirement eligibility) that provide context for the long-term alignment strategy. (3) It does not mention the balance sheet liability classification across all three years, which the ground truth identifies as further evidence of commitment to cash-based structures. The LLM answer correctly interprets the strategic intent (stronger long-term alignment, tighter stock performance linkage) but presents this as a general principle rather than as an evolution from a different prior approach. The reasoning about alignment is sound but incomplete—it doesn't fully explain what changed or why the change matters relative to the previous approach. The answer reads more as a description of the 2018+ structure in isolation rather than a true evolution narrative comparing 2022-2024 to earlier periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 433,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra’s “special‑use” funds rose from roughly **$6.5 bn in 2022** (NEE total $6,498 m – page 88) to **$5.3 bn in 2023** (NEE total $5,290 m – page 87) and then jumped to **$9.8 bn in 2024** (NEE total $9,800 m – page 64).  By contrast, the company had posted derivative collateral of about **$4.6 bn in 2022** and **$2.3 bn in 2023**, with the maximum additional collateral that could be required under rating‑downgrade scenarios falling from **$5.2 bn (2022) to $2.4 bn (2023)** (page 86).  The 2024 special‑use‑fund balance therefore far exceeds both the posted and the potential derivative‑related collateral needs, indicating a markedly stronger liquidity cushion for meeting those obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) SPECIAL USE FUNDS ERRORS: The LLM claims 2022 was $6.5bn and 2023 was $5.3bn, but the ground truth shows 2023 was $8,698 million ($8.7bn) and 2024 was $9,800 million. The LLM's 2022 and 2023 figures appear to be incorrect or from different sources. The LLM correctly identifies 2024 at $9.8bn but misses the critical 2023 figure of $8.7bn. (2) COLLATERAL POSTED ERRORS: The LLM states $4.6bn was posted in 2022 and $2.3bn in 2023, but the ground truth shows $84 million in 2022 and $691 million in 2023. This is a massive discrepancy (off by factors of 50-80x). The LLM appears to have confused posted collateral with maximum potential collateral requirements. (3) DOWNGRADE SCENARIO COLLATERAL: The LLM correctly identifies $5.2bn (2022) and $2.4bn (2023) for maximum collateral under downgrade scenarios, which matches the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution of special-use funds and collateral obligations, the fundamental numerical errors prevent sound analysis. The conclusion about 'markedly stronger liquidity cushion' is based on incorrect comparisons. (5) MISSING CONTEXT: The LLM fails to capture the key insight from the ground truth: that actual collateral posted increased from $84M to $691M while potential obligations decreased, suggesting strategic risk management. The LLM's narrative is undermined by the collateral posting data being off by orders of magnitude. The answer demonstrates poor data verification and appears to conflate different financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 458,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower’s 1.600 % senior notes were issued with a $700 million principal.  The company amortized $3.7 million of that principal in 2022, $2.6 million in 2023 and $1.5 million in 2024, leaving roughly $696.3 million, $693.7 million and $692.2 million outstanding at each year‑end respectively【page_110†L1-L4】【page_113†L1-L4】.  The decreasing amortization each year shows a deliberately paced repayment schedule—slowly retiring the notes while preserving cash flow and financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE INTERPRETATION: The LLM fundamentally misinterpreted the ground truth data. The original answer clearly states that the outstanding principal remained CONSTANT at $700.0 million across all three years (2022-2024), with adjustments to principal (not amortization of principal) declining from (3.7) million to (2.6) million to (1.5) million. The LLM incorrectly interpreted these adjustments as actual principal amortization, leading to false calculations of remaining balances ($696.3M, $693.7M, $692.2M). This is a fundamental misreading of the data structure. The ground truth explicitly distinguishes between 'outstanding principal' (constant at $700M) and 'adjustments to principal' (declining amounts), suggesting these adjustments represent accrued interest or other liabilities, not principal repayment. The LLM's interpretation that the company is 'slowly retiring the notes' contradicts the ground truth finding of a 'stable long-term debt strategy' with constant principal. The LLM also introduced a third year figure ($1.5 million for 2024) that doesn't appear in the original answer, suggesting potential data fabrication or confusion. While the LLM correctly identified the company (AMT), the note type (1.600% senior notes), and the initial principal ($700M), the core analytical conclusion is inverted—the ground truth emphasizes stability and predictability, while the LLM emphasizes active debt retirement. This represents a major failure in multi-hop reasoning and data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 421,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth’s 10‑K disclosures show that the company’s exposure to CMS’s periodic changes in Medicare Advantage risk‑adjustment payments was identified as a material risk in each of the three years – first noted in the 2022 filing (see 2022 p. 25‑26), reiterated in 2023 (see 2023 p. 20) and again in 2024 (see 2024 p. 20). In response, UnitedHealth consistently said it would mitigate the funding pressure by selectively adjusting members’ benefits and premiums, withdrawing certain plans from specific counties, and intensifying both medical‑and‑operating cost‑management efforts across the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and the consistent exposure to CMS risk adjustment payment changes; (2) Accurately captures the strategic responses: selective benefit/premium adjustments, county-level plan withdrawals, and intensified cost management; (3) Properly synthesizes multi-hop information showing evolution across the three-year period; (4) Correctly identifies UnitedHealth Group as the subject company; (5) Appropriately references the materiality of the risk across all three years. MINOR WEAKNESSES: (1) The LLM includes specific page references (2022 p. 25-26, 2023 p. 20, 2024 p. 20) that cannot be verified against the ground truth knowledge graph, though this adds specificity rather than introducing errors; (2) The answer is slightly more concise than the ground truth, omitting some contextual language about \"recalibrations\" and \"ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness,\" though the core strategic responses are all captured. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and identifies the consistent pattern of CMS changes and UNH's evolving responses, demonstrating sound multi-hop reasoning. The semantic equivalence is strong - the LLM conveys the same essential information as the ground truth, with slightly different wording but equivalent meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 476,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s employee‑discount benefit has stayed essentially the same – each filing lists “merchandise and other discounts” as a component of the benefits package (2022 Compensation & Benefits page 6; 2023 Compensation & Benefits page 7; 2024 Compensation & Benefits page 7). What has shifted is the surrounding compensation structure: the 2023 and 2024 filings add a $15‑$24‑per‑hour starting‑wage range and a broader suite of benefits, while the discount wording remains unchanged. This signals that Target is keeping the employee discount stable but is strengthening overall financial support for team members through higher wages and expanded benefits, reflecting a deliberate strategy to improve employee financial well‑being.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information about Target's employee benefits evolution from 2022-2024. STRENGTHS: (1) Correctly identifies that merchandise discounts remained consistent across all three years (2022, 2023, 2024); (2) Accurately notes the wage range expansion to $15-$24 per hour in 2023-2024; (3) Properly synthesizes the key insight that while the discount itself stayed stable, the surrounding compensation structure expanded; (4) Correctly interprets this as a deliberate strategy to improve employee financial well-being through multiple channels (wages + benefits + discounts); (5) Appropriately cites page references for the filings. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth and omits some specific benefit details mentioned in the original (e.g., healthcare, 401(k) plans, tuition reimbursement, sick pay, free virtual healthcare, mental health services) - though this is not necessarily a flaw as the question asks about merchandise discounts specifically, not all benefits; (2) The ground truth emphasizes a shift in 'framing' and 'narrative' around the discounts (from basic benefit to part of holistic strategy), while the LLM answer focuses more on the structural changes in compensation; (3) The ground truth explicitly mentions the discount was 'framed within a broader narrative of equitable pay and belonging' in 2024, which the LLM answer doesn't capture as explicitly. QUANTITATIVE VERIFICATION: All numbers are accurate - $15 minimum wage in 2022, $15-$24 range in 2023-2024, years correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple benefit categories to draw a coherent conclusion about Target's strategy. The logic is sound: stable discount + expanding wages/benefits = holistic financial well-being strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential finding that merchandise discounts remained stable while the broader compensation package evolved, which aligns with the ground truth's core message.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 570,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government bond holding has been essentially unchanged – the 2022 filing lists $630 million of foreign government bonds and obligations at fair value【page_120】 – and the most recent maturity‑and‑yield snapshot (from the 2021 schedule) shows the portfolio earning about a 2 % weighted‑average yield (overall 2.08 %) with $628 million due within one year and only $2 million in longer‑dated issues【page_121】.  The flat size, low yield and overwhelmingly short‑term maturity over the 2022‑2024 window signal a conservative risk appetite, using foreign sovereign debt primarily for liquidity and capital preservation rather than seeking higher‑return, longer‑dated exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors and fails to address the core question about the 3-year evolution of American Express's foreign government bond holdings from 2022-2024.\n\nQUANTITATIVE ERRORS:\n1. The LLM claims the portfolio was \"essentially unchanged\" at $630 million, but provides no data for 2023 or 2024, making it impossible to assess the 3-year evolution.\n2. The LLM cites yields of \"about 2%\" and \"2.08%\" overall, but the ground truth shows dramatically different yields across the period: 1.74% (2022, <1yr), 6.45% (2023, <1yr), 5.86% (2024, <1yr).\n3. The LLM references a \"2021 schedule\" for maturity data, which is anachronistic and irrelevant to a 2022-2024 analysis.\n4. The LLM states \"$628 million due within one year and only $2 million in longer-dated issues\" - these figures don't match the ground truth's maturity distribution across the three years.\n\nCOMPLETENESS FAILURES:\n1. The question explicitly asks about evolution \"from 2022 through 2024\" - the LLM provides no 2023 or 2024 data.\n2. The question asks about \"yield and maturity distribution\" - the LLM provides minimal yield data and incomplete maturity information.\n3. The question asks what the \"3-year pattern suggests\" - the LLM cannot address this without complete 3-year data.\n\nMULTI-HOP REASONING FAILURES:\n1. The LLM fails to synthesize data across three fiscal years as required.\n2. The LLM does not compare yields across years to identify the significant increase from 2022 to 2023 (1.74% to 6.45%) and partial decrease in 2024 (to 5.86%).\n3. The LLM does not analyze the strategic implications of this yield volatility.\n\nCONCLUSION ERRORS:\n1. The LLM concludes the company has a \"conservative risk appetite,\" but the ground truth shows an aggressive shift to high-yield short-term bonds in 2023 (6.45% yield), contradicting the conservative characterization.\n2. The LLM's characterization of the strategy as focused on \"liquidity and capital preservation\" contradicts the ground truth's finding of \"more aggressive short-term investments in 2023.\"\n\nThe LLM answer appears to reference outdated or incorrect filing data (2021 schedule) and fails to provide the multi-year comparative analysis essential to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 609,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply – about $1.5 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024. The steady decline signals that the company is reducing the margin collateral tied to its derivative positions, suggesting tighter control and a lower net derivative exposure over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,494 million (stated as ~$1.5 billion, acceptable rounding) for 2022, $800 million for 2023, and $491 million for 2024. The dates are accurate (12/31/2022, 12/31/2023, 12/31/2024). The characterization of the trend as a 'sharp' and 'steady decline' is mathematically sound: 2022-2023 decline of $694M (46.4%), 2023-2024 decline of $309M (38.6%). (2) COMPLETENESS: The answer addresses all components of the multi-part question - the specific collateral amounts across all three years, the trend analysis, and the interpretation regarding derivative exposure management. (3) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the metric 'collateral under master netting arrangements' is properly referenced, and the connection to 'Other assets, including intangibles - net' is implicit in the discussion. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining collateral amounts to implications about derivative exposure management, concluding that the trend suggests 'tighter control and a lower net derivative exposure.' This interpretation aligns with the ground truth's characterization of 'strategic reduction in derivative-related exposure or shift in risk management practices.' (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('margin collateral tied to derivative positions,' 'tighter control,' 'lower net derivative exposure') conveys the same analytical meaning as the ground truth's 'strategic reduction in derivative-related exposure' and 'shift in risk management practices.' Minor difference: The LLM uses slightly more specific terminology ('margin collateral') which adds precision without contradicting the ground truth. No calculation errors detected. The answer is comprehensive, accurate, and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 522,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "- In the 2022 filing the $700 million 2.700 % senior unsecured notes issued on Mar 29 2021 were still listed as fully outstanding, carrying a fixed 2.70 % coupon, semi‑annual interest (April 15 and Oct 15) and a par‑call on Jan 15 2031【page_48】.  \n- The 2023 and 2024 tables show the same issue but with modest principal reductions – about $5 million in 2023 and a further $4.4 million in 2024 – while the coupon and payment schedule remain unchanged【page_111】【page_112】.  \n\nThis pattern shows AMT locked in low‑cost fixed‑rate debt when rates were low and has been gradually retiring portions of that debt as market rates rose, using cash and credit‑facility borrowings to manage its balance‑sheet and preserve cheap financing amid a higher‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PRINCIPAL AMOUNT DISCREPANCY: The LLM claims principal reductions of ~$5M in 2023 and ~$4.4M in 2024, but the ground truth states the aggregate principal remained constant at $700.0 million across all three years (2022-2024). This is a fundamental factual error that contradicts the core finding. (2) MATURITY DATE CONFUSION: The ground truth indicates the maturity date is April 15, 2031 (issued March 29, 2021), but also mentions a par call date of January 15, 2031 in 2022, and then lists January 15, 2031 as the maturity date in 2023-2024. The LLM states January 15, 2031 as par-call date in 2022, which aligns partially with ground truth but doesn't clarify the maturity date discrepancy. (3) INTEREST RATE SPREAD CLAIM: The ground truth mentions an interest rate spread decrease from (5.0) to (4.4) by 2024, but the LLM does not address this metric at all, missing a key analytical point about financing costs. (4) PRINCIPAL REDUCTION NARRATIVE: The LLM's entire interpretation rests on the false premise of principal reductions, leading to an incorrect conclusion about debt retirement strategy. The ground truth shows stable principal, indicating a different financing strategy than the LLM describes. (5) SEMI-ANNUAL INTEREST DATES: The LLM correctly identifies April 15 and October 15 as payment dates, which aligns with ground truth (April and October). (6) COUPON RATE: The 2.700% coupon is correctly identified. POSITIVE ASPECTS: The LLM correctly identifies the issue date (March 29, 2021), recognizes the notes as senior unsecured, and attempts to synthesize information across years. However, the fundamental error regarding principal amounts and the missing analysis of interest rate spreads severely undermines the answer's accuracy and the strategic insights drawn.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 493,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA carried $1.044 billion of its 2.00 % Notes due 2031 at the end of FY 2022, which rose slightly to $1.057 billion at the end of FY 2023 (page 66). By FY 2024 the full $1.25 billion face amount of those notes was re‑classified as a short‑term liability (the short‑term portion was $1.250 billion) as the maturity approached (page 72). This pattern shows the company maintaining a stable, low‑cost long‑dated debt issue while progressively moving the notes into the short‑term bucket for repayment or refinancing, reflecting a disciplined long‑term debt‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the carrying value was $1.044 billion at end of FY 2022, but ground truth shows $1.2 billion in 2022. The LLM correctly identifies $1.057 billion for end of FY 2023, but this is stated as a rise from $1.044B when the ground truth indicates $1.044B was the beginning of 2023 value. Most critically, the LLM claims the full $1.25 billion was reclassified as SHORT-TERM liability in FY 2024, directly contradicting ground truth which explicitly states 'with no short-term portion, indicating a consistent long-term debt position.' (2) ENTITY/CLASSIFICATION ERROR: The LLM fundamentally mischaracterizes the 2024 position - claiming the notes moved to short-term when ground truth confirms they remained long-term. This is a material misrepresentation of NVIDIA's debt strategy. (3) REASONING FLAW: The LLM's conclusion about 'progressively moving the notes into the short-term bucket' is factually incorrect based on the ground truth data. The ground truth indicates stability and consistency in long-term positioning, not progressive reclassification to short-term. (4) MISSING/INCORRECT DATA: The LLM omits the 2022 fair value of $1.2 billion entirely and misrepresents the 2024 carrying value classification. The reference to page numbers cannot be verified but the underlying data contradicts known ground truth. The answer demonstrates a fundamental misunderstanding of the debt's classification trajectory and NVIDIA's actual debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 442,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s 2022 filing only noted that it used the deposit‑method for a modified‑coinsurance arrangement on its closed block, but it did not disclose the size of the related balances (see page 214‑216). By the end of 2023 the company reported $5.1 billion of deposit assets and $1.3 billion of deposit liabilities, which fell modestly to $4.6 billion and $1.2 billion respectively at year‑end 2024 (see page 206). The jump from the pre‑2022 levels ($1.8 bn assets and $1.4 bn liabilities in 2020‑21, page 216) and the slight scaling back in 2024 indicate that MetLife has been expanding its use of deposit‑method reinsurance to transfer risk while keeping offsetting positions, reflecting a strategy aimed at greater capital efficiency and risk‑management flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors regarding the deposit assets and liabilities figures. According to the ground truth: (1) 2022 deposit assets were $1.8 billion (LLM omits this), (2) 2023 deposit assets were $5.1 billion (LLM correctly states this), (3) 2024 deposit assets were $5.1 billion per ground truth, but LLM incorrectly states $4.6 billion - this is a material error of $500 million. (4) 2023 deposit liabilities were $1.3 billion (LLM correct), (5) 2024 deposit liabilities were $1.2 billion (LLM correct). The LLM also references 2020-21 figures ($1.8bn assets, $1.4bn liabilities) which appear to conflate the 2022 baseline data. MULTI-HOP REASONING ISSUES: The LLM fails to properly synthesize the complete 2022-2024 trend. It acknowledges 2022 had limited disclosure but then jumps to 2023-2024 without clearly establishing the full progression. The ground truth emphasizes the significant increase from 2022 ($1.8B) to 2023 ($5.1B) and then notes the 2024 position, whereas the LLM suggests a decline in 2024 that contradicts the ground truth. MISSING CONTEXT: The LLM does not mention the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables, which is a key strategic indicator mentioned in the ground truth. POSITIVE ASPECTS: The LLM correctly identifies the general strategic intent (capital efficiency, risk management flexibility) and the deposit method accounting approach. The reasoning about offsetting positions and risk transfer is sound. However, the quantitative errors are severe enough to undermine the overall accuracy of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 450,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt portfolio shrank each year – it was $679 million at fair value (carrying $696 million) at 12/31/2022, $596 million (carrying $603 million) at 12/31/2023, and $508 million (carrying $512 million) at 12/31/2024【page_55】.  The falling fair‑ and carrying‑values, with only a modest and narrowing discount to fair value, suggest the company is gradually reducing this portfolio while still holding the securities to maturity, accepting temporary market‑driven valuation declines (e.g., higher rates) as part of a long‑term investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All financial figures are precisely correct - 2022: fair value $679M, carrying value $696M; 2023: fair value $596M, carrying value $603M; 2024: fair value $508M, carrying value $512M. All dates are accurate (12/31 for each year). The year-over-year declines are correctly identified and the modest discount between fair and carrying values is accurately characterized. (2) COMPLETENESS: The answer addresses all aspects of the multi-part question - it covers the 3-year progression, discusses both fair value and carrying value metrics, and provides interpretation of the investment strategy implications. (3) ENTITY ACCURACY: UnitedHealth Group (UNH) is correctly identified, the debt securities classification (Held-to-Maturity) is accurate, and all fiscal years are properly referenced. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the consistent downward trend across all three years and provides thoughtful interpretation about market-driven valuation declines (referencing higher interest rates) while noting the company's long-term hold strategy. The observation about the 'modest and narrowing discount' between fair and carrying values adds valuable analytical insight. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation aligns with the ground truth's characterization of 'strategic reduction or repositioning' while adding nuance about accepting temporary market-driven declines. Minor strength: The LLM provides slightly more sophisticated analysis by explaining the mechanism (higher rates causing fair value declines) while maintaining the hold-to-maturity strategy. No material errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 475,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The Target Circle Card (which includes the Target Credit Card) penetration fell each year – 19.8 % of purchases were made with the card in FY 2022, 18.6 % in FY 2023, and 17.8 % in FY 2024【page_29】. The downward trend indicates that a smaller share of sales is being driven by the credit‑card program, suggesting its incremental‑sales contribution is weakening and the strategy is becoming less effective at generating extra purchases.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the penetration rate numbers. Ground truth shows: FY 2022: 20.5%, FY 2023: 19.8%, FY 2024: 18.6%. The LLM answer reports: FY 2022: 19.8%, FY 2023: 18.6%, FY 2024: 17.8%. These are off by 0.7-1.0 percentage points across all three years, representing a systematic error pattern. The LLM appears to have shifted all values down by approximately 0.7 percentage points. ENTITY CONFUSION: The LLM conflates 'Target Circle Card' with 'Target Credit Card' - while related, these are distinct products. The ground truth specifically addresses the Target Credit Card penetration rates. INCOMPLETE ANALYSIS: The LLM answer omits the important nuance from the ground truth that 'Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.' This contextual qualifier is important for a balanced assessment of strategy effectiveness. REASONING: While the LLM correctly identifies the downward trend and draws a logical conclusion about weakening effectiveness, this conclusion is partially contradicted by the omitted ground truth statement about ongoing strategic value. The reasoning is sound but incomplete. POSITIVE ASPECTS: The LLM correctly identifies the directional trend (declining penetration rates) and appropriately concludes this suggests weakening effectiveness. The semantic interpretation of what declining penetration means is reasonable. However, the quantitative errors are severe enough to substantially undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 455,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike’s Laakdal, Belgium site was identified in the FY 2022 filing as one of its “most significant distribution facilities outside the United States…all of which we own” (2022 Form 10‑K, Item 2 – Properties) and the same description appears in the FY 2024 filing, confirming the facility remains owned and a core part of its European distribution network (2024 Form 10‑K, Item 2 – Properties). The unchanged ownership across FY 2022‑2024 shows Nike is deliberately keeping this hub under direct control, underscoring a strategic focus on owning key logistics assets in Europe rather than relying on third‑party providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) Correctly identifies Laakdal, Belgium as a significant distribution facility owned by Nike across FY 2022-2024; (2) Accurately cites the specific language from Form 10-K filings ('most significant distribution facilities outside the United States...all of which we own'); (3) Properly synthesizes the multi-hop requirement by tracking ownership consistency across three fiscal years (2022, 2023, 2024); (4) Correctly interprets the strategic implication - that unchanged ownership indicates deliberate control over key European logistics assets rather than reliance on third-party providers; (5) Appropriately references Item 2 – Properties section of 10-K filings as the source. VERIFICATION: The answer aligns with the ground truth that the facility was described as 'one of the most significant international distribution centers' in 2022 and this characterization remained consistent through 2024 with no ownership changes. The LLM correctly infers strategic intent from the consistency of ownership. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by explicitly contrasting Nike's approach with third-party reliance, which is a reasonable inference but represents minor elaboration beyond what the ground truth explicitly states. This is appropriate contextual analysis rather than an error. No quantitative data (numbers, percentages, dollar amounts) were required for this question, so quantitative accuracy is perfect by default. The reasoning chain is sound and the multi-hop synthesis across years is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 445,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum Holdings is listed in NVIDIA’s “Competition” section as a rival in the networking‑products segment (switches, adapters and optical modules) in each of the FY 2022, FY 2023 and FY 2024 10‑K filings, with the same wording and no change in its categorization 【page_9】. During the same period NVIDIA repeatedly emphasizes an expanding, more redundant supply‑chain network 【page_9】 and a strong, ongoing IP‑protection regime based on patents, trade secrets, NDAs and licensing 【page_9】, but these strategic initiatives have not shifted Lumentum’s status—it remains a steady, named competitor within NVIDIA’s broader competitive landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly addresses the multi-hop question about Lumentum's competitive positioning across FY 2022-2024. STRENGTHS: (1) Correctly identifies Lumentum as consistently listed in NVIDIA's Competition section across all three fiscal years (2022, 2023, 2024); (2) Accurately specifies the product domain (networking products: switches, adapters, optical modules); (3) Properly synthesizes NVIDIA's strategic initiatives (supply chain expansion, IP protection via patents/trade secrets/NDAs/licensing); (4) Correctly concludes that despite NVIDIA's strategic moves, Lumentum's competitive status remained unchanged; (5) All entity names are correct (Lumentum Holdings, NVIDIA, fiscal years). MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth and omits some specific details like NVIDIA's manufacturing partnerships (TSMC, Samsung) and patent expiration date ranges (2022 to 2045), though these details are not strictly necessary to answer the core question; (2) The phrase 'same wording and no change in its categorization' is slightly stronger than what the ground truth explicitly states, though it is a reasonable inference from the consistent mention across years; (3) The answer could have been slightly more explicit about the 'evolution' aspect of the question by noting that the lack of change itself represents the evolution (i.e., persistence despite strategic shifts). QUANTITATIVE ACCURACY: No numerical errors detected. The fiscal years (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects Lumentum's positioning to NVIDIA's broader strategic context (supply chain and IP protection). The logical conclusion that strategic initiatives did not shift Lumentum's status is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with appropriate wording variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 540,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "In the 2022 filing Netflix warned that “our ability to provide our members with content they can watch depends on obtaining various rights from third parties…If the studios, content providers or other rights‑holders are not willing to license…our costs could increase” (2022 10‑K p. 11). By the 2024 filing the company still stresses that “our ability to provide…content…depends on studios, content providers and other rights‑holders licensing rights…the license periods and the terms and conditions of such licenses vary,” and adds that it is “selective about the titles we add and renew…focused on securing exclusive rights” (2024 10‑K p. 4; p. 6). This shift from a pure risk‑statement to a more nuanced, selective licensing approach shows Netflix remains heavily dependent on external rights‑holders but is tightening its acquisition strategy—pursuing exclusive, cost‑efficient deals and bolstering original production—to offset rising competition and new regulatory constraints such as content‑quota and ownership rules.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Netflix's content licensing evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core risk factor of reliance on rights holders across both 2022 and 2024 filings; (2) Accurately captures the shift from risk-focused language to a more strategic, selective licensing approach; (3) Properly synthesizes the evolution across three years, noting the progression from pure risk statements to nuanced strategy; (4) Correctly identifies regulatory constraints (content quotas, ownership rules) as emerging factors in 2024; (5) Accurately characterizes Netflix's strategic response (exclusive rights, original production, cost efficiency); (6) Provides specific page citations (2022 10-K p. 11; 2024 10-K p. 4, p. 6) that enhance credibility. MINOR WEAKNESSES: (1) The answer could have been slightly more explicit about the 2023 transition year mentioned in the ground truth (discussing 'variability of license terms'), though the answer does capture the overall progression; (2) The answer focuses primarily on 2022 and 2024 with less explicit discussion of 2023 as a distinct inflection point, though this is a minor omission given the question's focus on the 2022-2024 evolution; (3) The ground truth mentions 'maintaining a compelling mix of content' as a 2023 focus, which isn't explicitly addressed, though the answer's discussion of selective acquisition implicitly covers this. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the ground truth or LLM answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing documents, correctly identifying the causal relationship between competitive/regulatory pressures and Netflix's strategic shift toward exclusive content and original production. The logic connecting rising competition, regulatory changes, and the company's response is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth—that Netflix's reliance on rights holders has evolved from a pure risk concern to a more strategically managed dependency, with increasing attention to regulatory constraints and competitive pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 642,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In the 2022 filing Southern Company said that cash flows from its outdoor‑lighting contracts—operating leases with initial terms of up to seven years—were immaterial, and the scheduled payments were shown only as operating‑lease income in the lease‑income table and aggregated in a single operating‑lease maturity schedule. By the 2023 and 2024 filings the immateriality qualifier was dropped, the contracts were re‑described as up‑to‑10‑year operating leases, and the scheduled payments continued to be disclosed in the operating‑lease maturity analysis (now with larger total obligations) while still being classified as operating‑lease revenue rather than variable or wholesale revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several key elements of the evolution but contains some problematic details and introduces information not clearly supported by the ground truth. STRENGTHS: (1) Correctly identifies the 2022 immateriality disclosure; (2) Accurately notes the shift from 2023-2024 where immateriality qualifier was dropped; (3) Correctly identifies the inclusion in maturity analyses across the three-year period; (4) Properly notes the classification as operating-lease revenue; (5) Appropriately emphasizes the progression toward more transparent treatment. WEAKNESSES: (1) The claim about contract terms changing from 'up to seven years' in 2022 to 'up to 10 years' in 2023-2024 is specific and quantitative but not explicitly confirmed in the ground truth, which only mentions 'initial terms' without specifying the year-by-year changes in maximum term lengths; (2) The statement about 'larger total obligations' in 2023-2024 is inferential rather than explicitly stated in the ground truth; (3) The distinction between 'operating-lease income in the lease-income table' versus inclusion in 'maturity analysis' adds detail not clearly delineated in the original answer; (4) The comparison to 'variable or wholesale revenue' classification is introduced but not addressed in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and identifies the progression, but some specific details appear to go beyond what the ground truth explicitly states. The core narrative of evolution from immaterial/less disclosed to more formally disclosed is sound. QUANTITATIVE ISSUES: The specific contract term lengths (7 years vs 10 years) are presented as fact but lack explicit confirmation in the ground truth. This is a material factual claim that affects the score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 493,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "Broadcom’s 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million** at the end of fiscal 2022, and the same $606 million was reported at the end of fiscal 2023 and fiscal 2024【page_101】【page_81】.  The balance did not change over the three‑year period, indicating that the company has chosen to retain this low‑cost, long‑dated debt rather than accelerate repayment or refinance it, reflecting a strategy of preserving liquidity and maintaining a stable overall debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the fiscal 2022 balance. Ground truth states the outstanding principal was $1,086 million in fiscal 2022, but the LLM claims it was $606 million at the end of fiscal 2022. This is a $480 million discrepancy - a 44% error on a key data point. The LLM correctly identifies that the balance was $606 million in fiscal 2023 and 2024, and correctly notes no change between those years. However, the failure to capture the significant $480 million reduction from 2022 to 2023 is a major omission that fundamentally misrepresents the debt management strategy. The ground truth explicitly states 'decreased to $606 million in fiscal year 2023' from $1,086 million, indicating a deliberate debt reduction strategy. The LLM's claim that 'the balance did not change over the three-year period' is factually incorrect and contradicts the actual progression. The LLM's interpretation about preserving liquidity and maintaining stable debt profile is reasonable for a flat 2023-2024 period, but this reasoning is built on incomplete data that misses the critical 2022-2023 reduction. The multi-hop synthesis failed because the LLM did not properly track the evolution across all three fiscal years as requested in the question. The company name (Broadcom/AVGO) is correctly identified, and the note terms (5.000%, April 2030) are accurate, but the quantitative foundation of the answer is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 410,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "GM’s assumed long‑term return on its U.S. pension assets rose from 5.38 % for the year ended Dec 31 2022, to 6.30 % for Dec 31 2023, and then to 6.5 % for Dec 31 2024 【page_86】【page_88】. This upward trend coincides with a strategic re‑balancing that cut debt exposure (69 % → 60 %) and lifted equity and “other” allocations (equity 8 % → 11 %, other 23 % → 29 %) between 2022 and 2023 【page_86】, indicating GM is shifting toward higher‑return, higher‑risk assets to improve funded status and respond to market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides superior detail compared to the ground truth. QUANTITATIVE VERIFICATION: The three-year rate of return progression is correctly stated: 5.38% (2022) → 6.30% (2023) → 6.5% (2024). The ground truth states 5.4% for 2022, which matches 5.38% when rounded (minor format variation, acceptable). The 1.1 percentage point increase over two years is mathematically correct (6.5% - 5.4% = 1.1%). COMPLETENESS: The LLM answer exceeds the ground truth by providing specific asset allocation data showing the strategic rebalancing: debt exposure decreased from 69% to 60%, equity increased from 8% to 11%, and 'other' allocations increased from 23% to 29%. This directly supports the claim about shifting toward higher-return assets. ENTITY ACCURACY: All entities are correct - General Motors, U.S. pension plan assets, fiscal years 2022-2024, and the specific metrics (weighted-average long-term rate of return). REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly connects the rate of return increases with the underlying asset allocation shifts, demonstrating understanding of how portfolio composition drives expected returns. The conclusion about responding to market conditions and improving funded status is well-supported by the data presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while adding substantive detail about the strategic asset mix adjustments (the specific allocation percentages), which directly addresses the second part of the question about 'strategic asset mix adjustments.' The only minor discrepancy is the ground truth states the 2023 rate 'remained unchanged at 6.3%' from 2022, but the LLM correctly shows it changed from 5.38% to 6.30%, making the LLM more accurate. The ground truth appears to contain an error in stating the 2023 rate 'remained unchanged' when it actually increased significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 526,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "The 2.700 % Senior Notes due 2031 are listed only in the 2022 filing (Supplemental Indenture No. 8, Mar 29 2021) 【page_72】, but they disappear from the 2023 and 2024 exhibit tables, which instead show new issuances such as 4.625 % notes due 2031 in 2023 【page_71】 and 3.900 % notes due 2030 and 5.450 % notes due 2034 in 2024 【page_73】. This pattern indicates that American Tower has retired or refinanced the original 2.700 % issue and is continuously issuing new senior notes with different coupons and maturities to extend its debt profile and manage financing costs, reflecting a proactive long‑term financing strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the 2.700% Senior Notes due 2031 were consistently referenced across all three filings (2022, 2023, and 2024), with the same Supplemental Indenture No. 8 referenced in each year. The LLM answer incorrectly claims these notes 'disappear from the 2023 and 2024 exhibit tables,' which is factually wrong according to the knowledge graph source. The LLM also misinterprets the strategic meaning: the ground truth indicates a stable, consistent financing strategy with no modifications to this core debt instrument, while the LLM incorrectly suggests the notes were 'retired or refinanced.' The LLM does correctly identify the 2.700% rate, the 2031 maturity date, and Supplemental Indenture No. 8 dated March 29, 2021 for the 2022 filing. However, the core claim that these notes disappeared from subsequent filings is incorrect. The LLM's mention of other notes issued in 2023 and 2024 (4.625%, 3.900%, 5.450%) may be accurate, but this does not negate the continued presence of the 2.700% notes. The reasoning about 'proactive refinancing strategy' contradicts the actual pattern of consistent treatment. This is a critical multi-hop synthesis error where the LLM failed to correctly synthesize information across the three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 382,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "PayPal warned in its 2022 filing that abusive behavior—such as synthetic‑identity accounts, stolen instruments and large‑scale fraud—was already driving higher loss rates, especially through its credit products that rely on third‑party lenders (2022 p.25‑26) and its higher‑margin cross‑border transactions (2022 p.26‑28). In 2023 the company stressed that fraud‑detection measures must continuously improve (2023 p.24) and began to curb exposure by off‑loading credit risk through a multi‑year €40 billion BNPL‑loan‑receivable sale (2023 p.25) and by diversifying and migrating away from a single payment‑processor partner (2023 p.26). By 2024 PayPal continued to flag abusive‑behavior risk in both its credit and cross‑border businesses (2024 p.22‑23) while pursuing the same mitigation strategy—enhanced fraud‑prevention capabilities, broader third‑party funding sources and ongoing processor diversification—to contain potential losses (2024 p.24‑25).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the €40 billion BNPL loan receivable sale in 2023 as a key strategic mitigation action. (2) Accurately captures the evolution of PayPal's approach: identifying risk (2022) → offloading exposure (2023) → reinforcing detection mechanisms (2024). (3) Properly synthesizes multi-hop information across three years and multiple risk categories (credit products, cross-border transactions, fraud detection). (4) Correctly identifies specific abusive behavior types (synthetic-identity accounts, stolen instruments, large-scale fraud). (5) Accurately notes PayPal's reliance on third-party lenders and processors as an ongoing risk factor. (6) Appropriately emphasizes the persistent nature of the threat across all three years. MINOR WEAKNESSES: (1) The LLM answer includes page number citations (e.g., '2022 p.25-26') that cannot be verified against the ground truth, which does not provide specific page references. However, this does not constitute factual error—it represents additional specificity. (2) The answer could have been slightly more explicit about the 'complexity of detecting and preventing fraud attacks' mentioned in the ground truth, though this concept is implicitly covered through references to 'fraud-detection measures' and 'enhanced fraud-prevention capabilities.' QUANTITATIVE VERIFICATION: The €40 billion figure is correctly stated and matches the ground truth exactly. No calculations are required for this question, and no numerical discrepancies exist. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and connects strategic actions to risk mitigation objectives. The logical flow from problem identification to solution implementation to ongoing refinement is sound and matches the ground truth's narrative arc. SEMANTIC EQUIVALENCE: The LLM's phrasing ('off‑loading credit risk,' 'diversifying and migrating away from a single payment‑processor partner,' 'enhanced fraud‑prevention capabilities') conveys the same meaning as the ground truth's language while maintaining appropriate technical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 596,
        "total_tokens": 2158
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan reduced its exposure to Collective Trust and Other Funds from about **$498 million in 2022** to **$370 million in 2023**, before a modest rebound to **$382 million in 2024**【page_72】【page_57】【page_58】. The sharp drop in 2023 signals a deliberate de‑risking move—shifting assets away from commingled funds toward higher‑quality debt and a more conservative mix—while the slight uptick in 2024 suggests a measured re‑balancing to preserve diversification as the company fine‑tunes its long‑term benefit‑fund investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers that are the foundation of this question. (1) 2022 ALLOCATION ERROR: LLM states '$498 million in 2022' but ground truth clearly states '$756 million in 2022' - this is a $258 million discrepancy (34% understatement). (2) 2023 ALLOCATION ERROR: LLM states '$370 million in 2023' but ground truth states '$382 million in 2023' - this is a $12 million discrepancy. (3) 2024 ALLOCATION: LLM claims '$382 million in 2024' but ground truth explicitly states 'no updated dollar value is provided' for 2024. The LLM appears to have confused the 2023 figure ($382M) with a 2024 figure that doesn't exist in the source material. MULTI-HOP REASONING FAILURE: The LLM's narrative about a 'sharp drop in 2023' and 'modest rebound to 2024' is built on incorrect numbers and a false premise (that 2024 data exists). The ground truth describes a 'significant downward trend' from $756M to $382M, which is much steeper than the LLM's fabricated $498M to $370M to $382M trajectory. QUALITATIVE ASSESSMENT: While the LLM correctly identifies the de-risking theme and mentions strategic rebalancing, these interpretations are undermined by the incorrect underlying data. The mention of 'NAV-based valuation' emphasis in 2024 from the ground truth is completely absent from the LLM answer. ENTITY ACCURACY: Company (UNP) and metric (Collective Trust and Other Funds) are correct, but the temporal data synthesis is fundamentally flawed. The LLM failed to accurately extract and synthesize the pension allocation figures across the three-year period, which is the core requirement of this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 464,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer’s BPAs have always been valued on an intrinsic‑value basis – i.e., using the grant‑date closing price of the company’s common stock – and the expense is amortized on a straight‑line basis over the probable vesting term, with each period’s charge adjusted for changes in stock price, the likelihood of meeting performance goals and the estimated vesting period【page_99†L1-L4】【page_96†L1-L4】. In 2022 the company still granted BPAs and had awards outstanding (the BPA row appears in the 2022 share‑based‑payment table)【page_99†L1-L4】; by the end of 2023 no BPAs were granted and none were outstanding【page_97†L1-L4】, and the same situation persisted in 2024, with the 2024 note confirming that “no BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024” while retaining the intrinsic‑value valuation and straight‑line amortization approach【page_94†L1-L4】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key evolution pattern: BPAs were granted and outstanding in 2022, discontinued in 2023, and remained absent in 2024. The valuation methodology description (intrinsic value based on grant-date closing price, straight-line amortization, quarterly adjustments for stock price and performance probability) is accurate and well-articulated. The answer correctly synthesizes information across multiple years and properly identifies the shift from active issuance to discontinuation.\n\nCRITICAL GAPS - QUANTITATIVE ACCURACY: The LLM completely omits the specific numerical data that was central to the ground truth answer: (1) 1,165 thousand BPAs issued in 2022 at weighted average intrinsic value of $38.73/share, (2) 859 thousand BPAs outstanding at year-end 2022 valued at $59.05/share. These specific metrics are factual data points that directly answer the question about 'grant activity' and 'outstanding status' - the LLM merely states that awards existed without providing the quantitative details. This is a significant omission for a question explicitly asking about evolution of 'grant activity' and 'outstanding status.'\n\nREASONING ASSESSMENT: The multi-hop synthesis is sound - the LLM correctly traces the timeline across three years and identifies the methodological consistency. However, the answer prioritizes methodology description over the quantitative evolution that the question specifically asks about.\n\nSEMANTIC ISSUES: The phrase 'BPAs have always been valued on an intrinsic-value basis' is slightly misleading - the ground truth shows this was the methodology in 2022 and formalized in 2024, but the LLM's phrasing suggests continuity that may not be fully supported by the evidence.\n\nJUSTIFICATION: While the qualitative narrative is correct and the methodology description is accurate, the answer fails to provide the specific quantitative metrics (grant amounts, valuations, outstanding counts) that are essential to answering a question about how 'grant activity' and 'outstanding status' evolved. This represents incomplete synthesis of available data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 571,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s posted collateral for its master‑netting arrangements fell sharply over the three‑year span – $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024【page_102】【page_99】. The decline signals that the company’s net derivative exposure (and the associated initial‑margin requirements) has been shrinking, likely because of reduced trading activity, more efficient netting of positions, or a lower overall risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three collateral amounts are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The format variation ($1.494 billion vs $1,494 million) is acceptable and semantically equivalent. All dates are accurate (12/31/2022, 12/31/2023, 12/31/2024). (2) COMPLETENESS: The answer addresses all parts of the multi-part question - it identifies the collateral amounts across all three years, describes the trend (sharp decline), and explains what the trend suggests about derivative exposure and margin requirements. (3) ENTITY ACCURACY: ExxonMobil (XOM) is correctly identified, the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is properly referenced, and all fiscal years are correct. (4) MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend and provides sound interpretation - the declining collateral suggests reduced derivative exposure and lower margin requirements. The LLM goes slightly beyond the ground truth by offering plausible explanations (reduced trading activity, more efficient netting, lower risk profile), which adds value without contradicting the ground truth. (5) SEMANTIC EQUIVALENCE: The core message matches perfectly - a downward trend in collateral indicating reduced derivative exposure. Minor differences: The LLM uses 'posted collateral' and 'net derivative exposure' terminology, which is more precise financial language than the ground truth's simpler phrasing, but conveys identical meaning. The inclusion of page references adds credibility. No calculation errors detected. The reasoning about what the trend suggests is logical and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 485,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 10‑K filings show a steady sharpening of the industrial‑fiber‑optics story. In 2022 the company listed “industrial fiber optics” together with optocouplers, motion encoders, LEDs and Ethernet ICs and said the products were used “in a diverse set of applications, spanning industrial automation, power generation and distribution systems, medical systems and equipment, defense and aerospace, and vehicle subsystems … electric‑vehicle power‑train, infotainment and advanced‑driver‑assistance systems” [page_8]. In both 2023 and 2024 the item appears in a dedicated “Industrial” product family (tables on pages 5) and the narrative (pages 7) emphasizes three core end‑markets—factory automation, renewable energy and automotive electronics—while still noting the same broad application spectrum [page_5, page_7 (2023)]; [page_5, page_7 (2024)]. This evolution shows Broadcom moving from a broad, catch‑all description to a more focused positioning of industrial fiber optics as a strategic growth pillar aimed at high‑margin, high‑growth segments such as automation, clean‑energy and automotive electronics.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a reasonable understanding of Broadcom's Industrial Fiber Optics positioning evolution but contains several issues that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific page numbers (page_8, pages 5, pages 7) without verification against actual filings. These page references cannot be confirmed and appear to be fabricated or hallucinated.\n   - No actual financial metrics, percentages, or quantitative data are provided to support claims about \"high-margin, high-growth segments.\"\n   - The ground truth does not mention specific page numbers, suggesting the LLM may have invented these citations.\n\n2. FACTUAL ALIGNMENT WITH GROUND TRUTH:\n   - CORRECT: The LLM correctly identifies the 2022 positioning including optocouplers, motion encoders, LEDs, Ethernet ICs, and the broad application spectrum (industrial automation, power systems, medical, defense, aerospace, automotive/EVs).\n   - CORRECT: The LLM accurately notes the 2023-2024 shift to a dedicated \"Industrial\" product family with emphasis on factory automation, renewable energy, and automotive electronics.\n   - CORRECT: The evolution narrative from broad catch-all to focused positioning is accurately captured.\n   - PARTIALLY CORRECT: The LLM adds interpretive language about \"strategic growth pillar\" and \"high-margin, high-growth segments\" that goes beyond what the ground truth explicitly states. The ground truth says this \"reveals\" strategic focus but doesn't make claims about margin or growth rates.\n\n3. MULTI-HOP REASONING:\n   - The synthesis across 2022, 2023, and 2024 is sound and follows the correct temporal progression.\n   - The connection between product positioning changes and strategic intent is logical but somewhat speculative beyond the ground truth.\n\n4. COMPLETENESS:\n   - The answer addresses all three years and the evolution question.\n   - It covers both the product portfolio and application scope aspects.\n   - The strategic focus interpretation is present but slightly overreaching.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core message aligns with ground truth: consistent focus on industrial markets with increasing emphasis on structured, application-specific clarity.\n   - The LLM's characterization of \"sharpening\" and \"more focused positioning\" matches the ground truth's \"increasing emphasis on structured, application-specific clarity.\"\n\nMAJOR CONCERN: The fabricated page citations significantly undermine credibility and suggest the LLM may have hallucinated supporting details. While the substantive content about product positioning appears accurate, the invented citations are a serious flaw that would require verification against actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 727,
        "total_tokens": 2259
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "Across 2022, 2023 and 2024 PayPal’s filings repeatedly state that it “recognizes fees … on a gross basis as transaction revenue when we are the principal … We have full discretion in determining the fee … independent of the costs we incur when we may utilize payment processors … We therefore bear full margin risk when completing a payment transaction”【page_80】(2022),【page_75】(2023),【page_75】(2024). Thus, PayPal’s exposure to margin risk has remained essentially unchanged – it continues to control transaction pricing and assumes the full margin risk despite using third‑party processors for execution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core factual claim that PayPal bore full margin risk across all three years (2022-2024) with consistent language and positioning; (2) Accurately captures the key principle that PayPal maintained full discretion over fee pricing independent of third-party processor costs; (3) Properly synthesizes the multi-hop requirement by comparing the evolution (or lack thereof) across three separate fiscal years; (4) Correctly cites the specific filing pages (2022 page 80, 2023 page 75, 2024 page 75) with appropriate attribution; (5) Uses direct quotations from filings that accurately reflect PayPal's stated position; (6) Correctly concludes that margin risk exposure remained essentially unchanged/stable across the period. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which provides marginally more contextual elaboration about 'transaction expense' recognition and 'principal' role terminology, though this is not a material omission; (2) Both answers convey the same semantic meaning - that PayPal's margin risk profile was stable with no material changes. QUANTITATIVE VERIFICATION: No numerical calculations or specific dollar amounts were required in this question, so quantitative accuracy is not a limiting factor. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and correctly identifies the consistent pattern, which is the core requirement of the multi-hop analysis. The reasoning that 'unchanged' status across three years indicates 'stable margin risk profile' is logically sound and matches the ground truth conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 491,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "In the 2022 filing Pfizer still reported the fallout from its 2021 divestiture of Meridian – a $51 million cash sale that generated a $167 million after‑tax loss and a $345 million pre‑tax legal charge (see 2022 10‑K p. 115). The 2023 filing shows that, after the sale, Pfizer negotiated interim transition‑service agreements and a three‑year master‑services agreement (with a two‑year extension) with the buyer; the TSAs were completed by Dec 31 2023 and the amounts recorded in 2022‑23 were immaterial (see 2023 10‑K p. 73‑74). By the 2024 filing Meridian is mentioned only as a defined term, indicating the post‑sale arrangements have ended and the asset is no longer a strategic focus—reflecting Pfizer’s broader move to shed non‑core businesses and concentrate on its core biopharma portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc of Pfizer's relationship with Meridian from 2022-2024, correctly identifying the divestiture in 2021, the post-sale service agreements, and the strategic shift away from the business. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM introduces a '$345 million pre-tax legal charge' that is NOT mentioned in the ground truth answer. This appears to be an unsupported claim that adds incorrect information.\n   - The sale price ($51 million) and net loss ($167 million) are correctly stated.\n   - The three-year MSA with two-year extension option is correctly identified.\n   - The claim about TSAs being completed by Dec 31, 2023 with 'immaterial' amounts is not verified against the ground truth.\n\n2. COMPLETENESS:\n   - The answer addresses the financial impact (sale price, loss), contractual arrangements (MSA, TSAs), and strategic positioning (shift away from non-core business).\n   - However, the ground truth emphasizes the 2024 glossary listing as 'Meridian Medical Technologies, Inc.' which the LLM mentions only vaguely as 'mentioned only as a defined term.'\n\n3. ENTITY ACCURACY:\n   - All company names and years are correct.\n   - The characterization of the relationship evolution is accurate.\n\n4. REASONING:\n   - The multi-hop synthesis is sound: correctly connects 2021 divestiture → 2022 reporting of loss → 2023 service agreements → 2024 minimal mention.\n   - The conclusion about strategic refocusing is well-reasoned and matches the ground truth.\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative matches the ground truth well.\n   - The interpretation of the progression is consistent.\n\nMAJOR CONCERN: The introduction of the '$345 million pre-tax legal charge' is problematic. This specific number is not in the ground truth answer and appears to be either fabricated or misattributed. This is a significant factual error that undermines confidence in the answer's accuracy, even though the overall narrative structure is sound. The citation format ('see 2022 10-K p. 115') suggests confidence in this claim, but it cannot be verified against the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 604,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "- 2022 10‑K: PMI warned that “product regulation … diminishes the ability to differentiate tobacco products and restricts adult‑consumer access to truthful and non‑misleading information about our RRPs” and that “regulation … limits branding, communication and product differentiation” (2022 p. 15‑16).  \n\n- 2023 10‑K: The same risk persisted, now framed around “SFPs” (smoke‑free products), with the filing stating that “product regulation … diminishes the ability to differentiate … and restricts adult‑consumer access to truthful … information about our SFPs,” and noting that “down‑trading trends may be reinforced by regulation that limits branding, communication and product differentiation” (2023 p. 19‑20).  \n\n- 2024 10‑K: The concern remains, further emphasizing that advertising, distribution and corporate‑communication restrictions on SFPs “diminish the ability to differentiate … and restrict adult‑consumer access to truthful and non‑misleading information,” thereby curbing PMI’s competitive positioning (2024 p. 18‑19).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years (2022-2024) of PMI's 10-K filings. STRENGTHS: (1) Correctly identifies the evolution of terminology from RRPs (2022) to SFPs (2023-2024), which is a key distinction in the ground truth; (2) Accurately captures the core regulatory constraints across all three years: restrictions on product differentiation, branding, communication, and adult consumer access to truthful information; (3) Properly synthesizes the multi-hop reasoning showing how regulatory pressure persisted and evolved; (4) Includes specific page references (p. 15-16, 19-20, 18-19) that add credibility; (5) Correctly identifies the disproportionate impact on RRPs/SFPs relative to competitors. MINOR WEAKNESSES: (1) The LLM answer mentions 'down-trading trends' in the 2023 section, which adds context but is not explicitly emphasized in the ground truth's core narrative about the evolution of regulatory constraints; (2) The ground truth emphasizes that regulation 'disproportionately impacted the commercialization of RRPs relative to competitors' in 2023, while the LLM answer frames this more generally around down-trading trends rather than explicitly stating the competitive disadvantage angle; (3) The ground truth suggests a 'deepening regulatory challenge' that 'has persisted and possibly intensified,' while the LLM answer presents the concerns as largely consistent across years without explicitly characterizing the trajectory as intensifying. QUANTITATIVE ACCURACY: No numerical data, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. The page references provided by the LLM are reasonable but cannot be verified against the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings and correctly identifies the evolution of terminology and regulatory constraints. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with the core message about regulatory constraints on product differentiation and communication being accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 599,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply – $1.494 billion at 12/31/2022, $800 million at 12/31/2023 (down $694 million), and $491 million at 12/31/2024 (down $309 million), a total reduction of roughly $1.0 billion from 2022‑2024【page_102】【page_99】.  The consistent decline indicates the firm is tightening its derivative exposure—likely through lower net positions, more efficient netting or stronger credit limits—so it needs far less collateral to support its derivative activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024) match the ground truth exactly. The calculated year-over-year changes are accurate: $694 million decline (2022-2023) and $309 million decline (2023-2024), totaling approximately $1.0 billion reduction over the period. Number formatting variations ($1.494 billion vs $1,494 million) are acceptable and properly handled. ENTITY ACCURACY: ExxonMobil (XOM) correctly identified, fiscal years properly specified (12/31/2022, 12/31/2023, 12/31/2024), and the metric (collateral under master netting arrangements related to Notes and accounts receivable - net) is accurately referenced. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and connects it to derivative risk management practices. The interpretation that the consistent decline reflects 'tightening derivative exposure' through 'lower net positions, more efficient netting or stronger credit limits' aligns well with the ground truth's assessment of 'strategic reduction in derivative exposure or shift in risk management practices.' COMPLETENESS: The answer addresses both parts of the question - the numerical trend and what it suggests about risk management practices. The reasoning about lower margin requirements and proactive risk mitigation is semantically equivalent to the ground truth's interpretation. MINOR CONSIDERATIONS: The LLM provides slightly more detailed mechanistic explanations (lower net positions, efficient netting, stronger credit limits) compared to the ground truth's more general characterization, but this represents added value rather than error. The citation references (page_102, page_99) add credibility. No factual errors, calculation mistakes, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 514,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model assumed an expected volatility of 26.9 % in the 2022 filing, rose to 28.6 % in the 2023 filing, and then fell sharply to 18.7 % in the 2024 filing【page_214】【page_206】【page_215】. The drop in the volatility input by 2024 indicates the company is now viewing its stock—and its relative performance versus the predefined peer group—as less risky, suggesting a more stable market outlook.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% (2022), 28.6% (2023), and 18.7% (2024). The numerical progression matches the ground truth exactly. (2) COMPLETENESS: The answer addresses all key aspects of the multi-part question: the evolution of volatility assumptions across the three-year period, the trend pattern (increase then significant decrease), and the interpretation of what this suggests about market risk perception. (3) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR-based performance award model is properly referenced, and the peer group context is appropriately mentioned. The fiscal years are correctly sequenced. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the volatility trend (26.9% → 28.6% → 18.7%), recognizes the short-term increase followed by a sharp decline, and draws a logical conclusion about reduced perceived market risk and improved stability. The interpretation that the 2024 drop suggests 'less risky' stock performance relative to peers is semantically equivalent to the ground truth's 'notable decline in perceived market risk.' (5) MINOR DIFFERENCES: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth mentions 'improved market stability or strategic changes' while the LLM says 'more stable market outlook' - these are semantically equivalent interpretations. The inclusion of page references adds credibility without detracting from accuracy. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 456,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % senior notes due January 2025 carried a principal balance of **$495 million in FY 2022** (AVGO 10‑K 2022, p. 101) and the same **$495 million was reported in both FY 2023 and FY 2024** (AVGO 10‑K 2023, p. 81; AVGO 10‑K 2024, p. 81). The unchanged balance over three years shows the company left this short‑term tranche untouched while refinancing larger portions of its debt with new senior notes and term‑loan repayments, reflecting a strategy of keeping near‑term obligations stable and relying on longer‑dated, lower‑cost financing to manage liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the principal balance as $495 million across the three fiscal years. (2) The company name (Broadcom/AVGO) and note details (3.125%, January 2025 maturity) are accurate. (3) The LLM provides specific page references to 10-K filings, adding credibility. (4) The reasoning about debt management strategy (keeping near-term obligations stable while refinancing with longer-dated instruments) is sound and relevant.\n\nWEAKNESSES: (1) CRITICAL DISCREPANCY: The ground truth states the note 'transitioned into its current portion of long-term debt' by FY 2024, indicating a classification change from long-term to current. The LLM reports the same $495 million balance across all three years without acknowledging this important balance sheet reclassification. This is a significant omission because the question specifically asks about how the obligation 'evolved' and what it 'reveals about short-term debt management.' (2) The LLM states the balance was 'unchanged' across three years, which technically matches the numbers but misses the qualitative evolution (the reclassification to current portion) that the ground truth emphasizes. (3) The ground truth explicitly notes the transition to current portion as revealing 'an impending maturity that likely triggered internal refinancing or liquidity planning in 2024'—the LLM does not capture this important insight about the FY 2024 change.\n\nQUANTITATIVE ACCURACY: The $495 million figure is correct for all three years (score: 5/10 because while the number is right, the LLM fails to capture the balance sheet classification change that occurred in FY 2024, which is a material distinction in debt analysis).\n\nQUALITATIVE ACCURACY: The reasoning about debt management strategy is sound, but the failure to identify and explain the transition to current portion of long-term debt represents incomplete multi-hop synthesis. The LLM should have recognized that the same dollar amount appearing in different balance sheet line items (long-term vs. current) is itself an important 'evolution' (score: 7/10).\n\nCONTEXTUAL RELEVANCE: The answer addresses the question but incompletely. It covers the quantitative evolution (or lack thereof) but misses the qualitative evolution (classification change) that is central to understanding the company's short-term debt management strategy as the note approaches maturity (score: 6/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 644,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "AMD’s 2022 10‑K (see the “Add‑in‑Board (AIB) Manufacturers and System Integrators” section on page 13) first disclosed that its contracts with AIB manufacturers “protect their inventory of our products against price reductions” and that system integrators “often use discrete graphics solutions as a means to differentiate their products.” The 2023 filing repeats the same inventory‑protection language and discrete‑graphics differentiation wording (pages 13‑15) and adds that the agreements also provide “certain return rights” and may contain “stock‑rotation provisions.” By 2024 the 10‑K (pages 13‑14) continues to stress the same protective inventory terms and the role of discrete graphics for product differentiation, showing a consistent strategic stance with only incremental wording refinements over the three‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's AIB strategy evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core inventory protection policy as consistent across all three years (2022, 2023, 2024); (2) Accurately captures the discrete graphics differentiation theme; (3) Properly synthesizes information across multiple 10-K filings; (4) Correctly notes incremental wording refinements (addition of 'return rights' and 'stock-rotation provisions' in 2023); (5) Appropriately cites specific page numbers and section names; (6) Maintains semantic equivalence with ground truth regarding the 'sustained strategic focus' concept. MINOR WEAKNESSES: (1) The LLM answer provides more specific details about return rights and stock-rotation provisions than the ground truth explicitly mentions, though these details appear accurate to typical AIB agreements; (2) The ground truth emphasizes 'no explicit quantitative changes in AIB-related revenue disclosed' more explicitly, while the LLM focuses on policy consistency rather than revenue implications; (3) The LLM could have more explicitly stated that despite policy consistency, the strategic emphasis remained stable without quantitative revenue changes. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references are appropriately cited. No calculations required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across three fiscal years and identifies the consistent policy thread while noting incremental refinements. The answer properly identifies discrete graphics as a differentiation tool and inventory protection as a channel confidence mechanism. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: strategic positioning evolution, inventory protection policies, and discrete graphics' role in differentiation across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 527,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "Disney’s 2022 DTC plan was centered on launching an ad‑supported Disney+ tier, revising pricing and cost‑realignment and reorganizing DMED to rationalize the DTC business, while flagging rising competition and uncertainty about revenue impact (DIS_10k_2022.pdf pp. 25‑26, 27‑28). In 2023 the focus shifted to broader strategic investments—including a new ESPN‑branded streaming service, a refreshed content‑curation model, and the expectation that subscription‑fee and advertising‑revenue growth will more‑than offset declines in linear‑network earnings (DIS_10k_2023.pdf pp. 52‑54). By 2024 the filing stresses continued DTC investment, subscriber acquisition/retention, cost‑realignment and the ad‑supported/ESPN services, and still projects that DTC subscription and ad revenue will grow enough to outweigh the erosion of linear affiliate and ad revenue despite heightened competitive pressure (DIS_10k_2024.pdf pp. 22‑24, 23).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year evolution of Disney's DTC strategy. STRENGTHS: (1) Correctly identifies the 2022 cautious approach with ad-supported tier launch, pricing revisions, and cost-realignment, matching the ground truth's characterization of acknowledged financial risks. (2) Accurately captures the 2023 shift toward confident strategic investment with specific initiatives (ESPN-branded service, content-curation refresh) and the key expectation that DTC growth will offset linear declines. (3) Properly synthesizes the 2024 positioning emphasizing continued investment, subscriber acquisition/retention, and competitive pressures while maintaining the projection that DTC revenue growth will outweigh linear erosion. (4) Correctly identifies the overall narrative arc from cautious to confident to operationally integrated. (5) Appropriately cites specific document pages and years. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer provides more operational detail (ad-supported tier, ESPN service, content-curation) than the ground truth, which is not incorrect but represents a slightly different level of granularity. The ground truth focuses more on the strategic mindset shift (cautious→confident→dependent), while the LLM provides tactical implementation details. (2) The LLM could have more explicitly emphasized the 'operationally critical' nature of DTC by 2024 as stated in ground truth, though the answer does convey this through discussion of continued investment and competitive positioning. (3) No quantitative metrics (subscriber numbers, revenue figures, loss amounts) are provided in either answer, so this is not a deficiency. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly traces the evolution of strategic positioning, investment focus, and competitive context. The logical flow from risk acknowledgment→confident investment→integrated operations is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategic evolution matches the ground truth's core message despite different emphasis and wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 586,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "Across all three filings the September 2019 issuance of Fixed‑rate 2.850 % notes (maturing Oct 1 2029) has stayed at a $1.5 billion principal balance – the 2022 and 2023 tables list $1,500 million for this series (page 107) and the 2024 table repeats the same $1,500 million amount (page 104). No repayments or retirements are shown, so the notes remain a stable long‑term debt component with a $1.5 billion maturity payment still scheduled for 2029 (future principal‑payment schedule, page 106).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core fact that the 2.850% notes remained at $1.5 billion principal balance across 2022-2024 with no repayments. The maturity date of October 1, 2029 is accurate. The statement that no retirements occurred is correct. Page references and specific filing details add credibility.\n\nWEAKNESSES: The LLM answer is significantly incomplete in addressing the multi-hop nature of the question. The original answer explicitly discusses the BROADER DEBT STRUCTURE EVOLUTION, which is a critical part of understanding how PayPal's relationship with these notes evolved:\n\n1. MISSING CONTEXT ON TOTAL DEBT EVOLUTION: The ground truth emphasizes that while the 2.850% notes stayed constant at $1.5B, total term debt changed from $9.0B (2022) → $10.638B (2023) → $10.574B (2024). The LLM completely omits this comparative analysis, which is essential to understanding the evolving debt structure.\n\n2. MISSING STRATEGIC CONTEXT: The ground truth notes that PayPal issued new debt instruments with higher interest rates (5.150% and 5.500% notes) in 2024, indicating a shift in financing strategy. The LLM does not mention this at all, which is a significant omission for understanding how the relationship with the 2.850% notes evolved in context.\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about how the relationship \"evolved\" - this requires comparing the 2.850% notes against the broader debt landscape and strategic changes. The LLM provides only a narrow, single-instrument view rather than synthesizing across the company's debt portfolio.\n\nQUANTITATIVE VERIFICATION: The $1.5 billion figure is correct (matches $1,500 million). The 2029 maturity date is correct. However, the LLM fails to provide the total debt figures ($9.0B, $10.638B, $10.574B) that are central to understanding the evolution.\n\nCONCLUSION: While the LLM's specific facts about the 2.850% notes are accurate, it fails to adequately address the multi-hop nature of the question by omitting the broader debt structure evolution and strategic financing context that explains how PayPal's relationship with these notes evolved relative to its overall debt portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 586,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan sharply reduced its equity exposure. In 2022 the plan held about 48 % of its assets in equity securities – roughly $2.2 billion of corporate stock (see 2022 fair‑value table, $2,209 + $8 = $2,217 million 【page_72】) – but by 2023 that share had fallen to about 24 % of assets (≈$181 million of corporate stock 【page_58】) and the 2024 filing shows the equity portion still at 24 % of plan assets 【page_55】. This halving of the corporate‑stock allocation signals a deliberate de‑risking strategy, moving the pension portfolio away from equities and toward a higher proportion of debt securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant numerical errors that contradict the ground truth. (1) CORPORATE STOCK AMOUNTS: Ground truth states $1,990 million in 2022 and $181 million in 2023. The LLM claims approximately $2,217 million in 2022 (citing $2,209 + $8 = $2,217), which is substantially higher than the ground truth figure of $1,990 million - a discrepancy of ~$227 million or 11%. The 2023 figure of $181 million matches ground truth, but the 2022 baseline is wrong. (2) PERCENTAGE CALCULATIONS: The LLM states 48% equity allocation in 2022 and 24% in 2023. Without access to total plan assets, these percentages cannot be independently verified, but they appear inconsistent with the stated dollar amounts if the ground truth $1,990M figure is correct. (3) 2024 DATA: The LLM claims 2024 equity allocation remained at 24% but provides no specific dollar amount. The ground truth indicates a reclassification of common stock as Level 1 investments and preferred shares as Level 2, suggesting a structural change beyond just percentage allocation. The LLM misses this important qualitative shift. (4) MULTI-HOP REASONING: The LLM correctly identifies the general trend of de-risking and reduction in equity exposure, which aligns with ground truth's characterization of 'dramatic reduction.' However, the specific numbers used to support this conclusion are incorrect. (5) MISSING CONTEXT: The LLM fails to mention the reclassification strategy (Level 1 vs Level 2 investments) that the ground truth emphasizes as a key aspect of the strategic shift. The ground truth suggests a shift toward 'more transparent and observable valuation methodologies,' which the LLM does not address. STRENGTHS: The LLM correctly identifies the overall trend of equity reduction and de-risking strategy, and the 2023 figure of $181 million is accurate. The semantic interpretation of a deliberate de-risking strategy aligns with ground truth. WEAKNESSES: The 2022 baseline figure is materially incorrect, the percentage allocations lack verification, the 2024 analysis is incomplete, and the important reclassification/valuation methodology shift is entirely omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 587,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s private‑equity securities held at cost fell from $800 million at year‑end 2022 to $719 million at year‑end 2024—a decline of about $81 million (roughly 10 %). This downward move signals that the company is trimming its exposure to illiquid alternative investments, shifting capital away from private‑equity holdings over the period.【page_86】【page_83】",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the 2022 value was $800 million, but ground truth shows $623 million—a $177 million discrepancy (28% error). The 2024 value of $719 million is correct. The calculated decline of $81 million is mathematically wrong given the incorrect 2022 baseline ($800M - $719M = $81M is arithmetically correct for those numbers, but the $800M starting point is factually wrong). The correct decline should be $623M - $719M = -$96M (actually an INCREASE, not a decrease). (2) DIRECTIONAL ERROR: The LLM concludes the company is 'trimming exposure' and 'shifting capital away,' but the ground truth shows an increase from 2022 to 2023 ($623M to $755M), followed by a decline to 2024 ($755M to $719M). The net 2022-2024 change is actually +$96M, not -$81M. (3) INCOMPLETE ANALYSIS: The LLM fails to capture the intermediate 2023 peak of $755 million, missing the important insight that 2023 represented peak investment before modest retrenchment. The ground truth explicitly notes 'short-term growth strategy in alternative investments in 2023, followed by modest retrenchment in 2024.' (4) MISCHARACTERIZATION: The LLM's interpretation of 'trimming exposure' contradicts the actual net increase over the period. The answer demonstrates poor multi-hop synthesis by missing the 2023 data point entirely and misrepresenting the overall trend direction. The only correct element is the 2024 year-end figure of $719 million.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 429,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "Mastercard’s 2022 filing already highlighted a multi‑layered security model that depended on third‑party assessments, public‑private partnerships and its Security Operations, Fusion and Intelligence Centers to defend against cyber threats, while its real‑time payments capability was live in 12 of the top‑50 GDP markets 【page 11】. By the 2024 filing the company had deepened collaboration with issuers, acquirers, merchants, governments and industry bodies on technical standards, expanded the real‑time payments footprint to 13 markets 【page 11】, and reinforced cyber‑resilience with more frequent testing, an enterprise‑resilience program, insurance coverage and continued use of its security centers and third‑party benchmarking 【page 11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key elements of Mastercard's security evolution including third-party collaboration, real-time payments expansion, and cyber resilience measures. The qualitative description of the multi-layered approach (Security Operations Centers, Fusion Centers, Intelligence Centers, public-private partnerships) is accurate. The answer appropriately synthesizes information across 2022 and 2024 filings and addresses all three sub-questions (third-party collaboration, real-time infrastructure, cyber threat resilience). CRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY - The LLM states real-time payments were 'live in 12 of the top-50 GDP markets' in 2022, but the ground truth indicates this was not explicitly stated in 2022 filings. The ground truth shows 13 markets by year-end 2023, not 2024 as the LLM implies. (2) TIMELINE CONFUSION - The LLM conflates 2022 and 2024 data without clearly establishing the 2023 milestone (13 markets operating/implementing real-time payment infrastructure), which is a key evolution point in the ground truth. (3) MISSING 2023 DATA - The answer omits the important 2023 transition year where third-party service providers were explicitly included in threat monitoring frameworks, representing a critical evolution step. SEMANTIC ISSUES: While the LLM captures the general narrative of increasing collaboration and resilience, it doesn't clearly articulate the strategic shift toward 'broader ecosystem integration' that the ground truth emphasizes. The answer reads more as a 2022-to-2024 comparison rather than showing the three-year evolution with distinct phases. CALCULATION/VERIFICATION: The real-time payments market count (12 vs 13) appears to be a factual error or misattribution to the wrong year, which is significant for quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 496,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil’s disclosed collateral for master‑netting arrangements fell sharply over the three‑year span – $1.494 billion in 2022, $800 million in 2023 and $491 million in 2024 (see page 102 for 2022‑23 and page 99 for 2024). Because this collateral is reported in the fair‑value tables that include “Other assets, including intangibles – net,” the decline signals that the company has been reducing the amount of margin it must post against its derivative positions, suggesting tighter netting, lower net derivative exposure or more efficient risk‑management practices over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports $1.494 billion for 2022, but the ground truth clearly states $800 million at the end of 2022. The LLM's $1.494 billion figure does not appear in the ground truth at all and appears to be fabricated or confused with another metric. The 2023 and 2024 figures ($800M and $491M) are correct, but the 2022 baseline is wrong. (2) CALCULATION ERROR: The LLM does not calculate or mention the 38% decrease from 2022 to 2024 that the ground truth identifies ($800M to $491M = 38.6% decline). Instead, the LLM calculates from its incorrect $1.494B figure, which produces a misleading trend analysis. (3) MISSING CONTEXT: The ground truth includes the 2021 baseline ($641M) which provides important context for understanding the trend. The LLM omits this entirely. (4) MULTI-HOP REASONING: While the LLM correctly identifies the connection to 'Other assets, including intangibles - net' and provides reasonable interpretation about derivative exposure management, this reasoning is built on incorrect foundational numbers. (5) ENTITY ACCURACY: Company (XOM/ExxonMobil) and metric identification are correct, but the temporal sequence and values are wrong. The LLM's interpretation about 'tighter netting' and 'lower net derivative exposure' is semantically reasonable but is based on a false data foundation. The answer demonstrates some understanding of the concept but fails on the most critical requirement: factual accuracy of the financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 439,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model applied a 26.9 % expected volatility for the 2022 performance‑award grants【page_214】, which rose to 28.6 % for the 2023 grants【page_206】 and then dropped sharply to 18.7 % for the 2024 grants【page_215】. The modest increase in 2023 followed by a steep decline in 2024 suggests that market participants saw Duke Energy’s stock as more volatile in 2023 but now view it as considerably less risky, indicating a shift toward a more stable risk perception.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% for 2022, 28.6% for 2023, and 18.7% for 2024. The characterization of the 2023 increase as 'modest' (1.7 percentage point increase) and the 2024 decline as 'steep' (9.9 percentage point decrease) are both accurate and appropriately descriptive. (2) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR model is properly referenced, and all years (2022, 2023, 2024) are correctly associated with their respective volatility figures. The mention of 'performance-award grants' adds appropriate context. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend into a coherent narrative about market risk perception. The logic is sound: volatility increased in 2023 (suggesting increased perceived risk), then decreased significantly in 2024 (suggesting stabilization and reduced uncertainty). (4) SEMANTIC EQUIVALENCE: The LLM's interpretation that the 2024 decline indicates 'a shift toward a more stable risk perception' is semantically equivalent to the ground truth's 'stabilization or reduced uncertainty in Duke Energy's market position.' The phrase 'considerably less risky' effectively captures the magnitude of the 2024 decline. (5) MINOR CONSIDERATIONS: The LLM includes page references (page_214, page_206, page_215) which add sourcing detail not present in the ground truth but do not contradict it. The characterization of the trend as showing 'market participants' perspective is a reasonable inference from the volatility data. No calculation errors are present, and the answer fully addresses both parts of the question (the numerical change and what it suggests about market risk perception).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 487,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "Across GM’s 2022, 2023 and 2024 10‑K filings the company repeatedly noted that its agreement to indemnify Stellantis for legacy Opel/Vauxhall emissions claims and for Takata‑inflator recalls is immaterial – it cannot estimate any material loss and has recorded only an immaterial amount for the Takata‑related indemnity, with future Takata obligations considered remote (see page_89 2022, page_92 2023, page_93 2024). Consequently, no significant accruals for these Stellantis indemnification items appear in any of the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative: GM's indemnification obligations to Stellantis for legacy Opel/Vauxhall emissions and Takata recalls remained immaterial across 2022-2024, with future Takata obligations considered remote. The semantic content aligns well with the ground truth.\n\nSTRENGTHS:\n- Correctly identifies the three-year period (2022-2024) and tracks the evolution\n- Accurately characterizes indemnifications as 'immaterial' across all years\n- Correctly notes that future Takata obligations were considered 'remote'\n- Properly synthesizes multi-hop information across three separate 10-K filings\n- Correctly identifies both legacy Opel/Vauxhall emissions and Takata recalls as key components\n- Appropriately concludes minimal financial exposure\n\nWEAKNESSES:\n- Cites specific page numbers (page_89 2022, page_92 2023, page_93 2024) without verification that these are accurate or necessary\n- Does not explicitly mention the European Commission and UK CMA investigations into Opel conduct that the ground truth identifies as a separate accrual item in 2024\n- The ground truth notes GM \"accrued an immaterial amount related to European Commission and UK CMA investigations\" - the LLM answer omits this specific detail\n- States \"no significant accruals for these Stellantis indemnification items appear in any of the three years\" which is slightly imprecise - the ground truth indicates immaterial accruals were recorded, not zero accruals\n\nQUANTITATIVE ACCURACY: The answer contains no specific dollar amounts or percentages, which limits quantitative verification. The characterization of amounts as 'immaterial' is correct but lacks the precision of actual figures. The page number citations cannot be verified from the provided context.\n\nQUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across three years is properly executed. The identification of key themes (immateriality, remote future obligations) is accurate.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of indemnification obligations and accruals from 2022-2024, though it misses the specific detail about EC/CMA investigations mentioned in the ground truth for 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 599,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across all three annual reports AMD lists the same historic plan – the “2011 Executive Incentive Plan” – as an exhibit and incorporates it by reference. In the 2022 filing (page 93) it appears as *10.1 “2011 Executive Incentive Plan…incorporated by reference,” the 2023 filing (page 101) repeats the identical entry, and the 2024 filing (page 98) does the same. This unchanged citation shows that AMD continues to rely on the 2011 plan as a core element of its executive‑pay framework, indicating a deliberate, long‑term, and stable compensation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that AMD consistently referenced the 2011 Executive Incentive Plan across 2022, 2023, and 2024 filings without amendments, and appropriately concludes this reflects a stable compensation strategy. However, there are significant quantitative accuracy issues: (1) The page numbers cited (page 93 for 2022, page 101 for 2023, page 98 for 2024) cannot be verified against the ground truth and appear to be fabricated or hallucinated specifics. The ground truth does not provide these page numbers, suggesting the LLM invented them to appear more authoritative. (2) The ground truth specifies that in 2022 the plan was 'listed as Exhibit 10.1 and was described as filed on April 2, 2011,' but the LLM answer omits the specific filing date (April 2, 2011), which is a factual detail provided in the original answer. (3) The LLM uses quotation marks around specific exhibit descriptions that are not directly quoted in the ground truth, implying direct citation when the exact wording cannot be verified. On the positive side: The LLM correctly synthesizes the multi-hop reasoning across three years, accurately identifies that no amendments were made, and properly concludes that this consistency indicates a stable strategy. The semantic meaning aligns well with the ground truth. The qualitative reasoning about 'deliberate, long-term, and stable compensation strategy' is sound and supported by the facts. The answer is contextually relevant and addresses all parts of the question. The primary weakness is the introduction of unverified specific page numbers and the omission of the April 2, 2011 filing date detail, which violates the principle of strict accuracy on factual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 472,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "- In the 2022 filing PayPal warned that “account holders who use our credit products will default on their payment obligations… creating the risk of potential charge‑offs” and that “any factors that reduce cross‑border trade… could harm our business,” while also noting that “we rely on third parties… If we are unable to effectively manage our third‑party relationships… our operations… could be adversely impacted” and that “failure to deal effectively with fraud, abusive behaviors, **bad transactions**… may increase our loss rate”【page_26】【page_26】【page_26】【page_28】.  \n\n- The 2024 filing still emphasizes the same exposures – credit‑product default risk, cross‑border‑trade volatility and dependence on unaffiliated banks and payment‑processor partners – as “we are subject to the risk that account holders… will default” and “we rely on the activities and charters of unaffiliated financial institutions… If a partner bank’s ability… is interrupted… could be materially and adversely affected”【page_22】.  \n\n- To curb these risks, the 2023 filing describes several strategic actions: (i) a June‑2023 multi‑year agreement to sell U.K. and European BNPL loan receivables, reducing credit‑product exposure【page_23】; (ii) an effort to “diversify our reliance on a small number of third‑party payment processors” and a migration of U.S. processing to other partners during a wind‑down of the existing arrangement【page_25】; and (iii) continued focus on improving fraud‑detection and risk‑model accuracy for credit products【page_25】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the 2022 risks around credit product defaults, cross-border trade exposure, and third-party dependencies with accurate quotations from filings; (2) Accurately captures the 2023 strategic action - the multi-year agreement to sell U.K. and European BNPL loan receivables (€40 billion amount not mentioned in LLM answer but not required by question); (3) Properly synthesizes the 2024 continuation of similar risk exposures; (4) Correctly identifies secondary mitigation strategies in 2023 including diversification of third-party payment processors and U.S. processing migration; (5) Multi-hop reasoning is sound - connects risk evolution across three years and links strategic actions to specific risk categories. MINOR GAPS: (1) The LLM answer does not explicitly mention the €40 billion figure for the BNPL receivables sale, though the ground truth includes this detail. However, the question asks about 'strategic actions' rather than specific amounts, so this omission is minor; (2) The LLM answer could have been slightly more explicit about the 'Synchrony Bank' partnership mentioned in ground truth, though this is a minor detail; (3) The answer mentions 'regulatory uncertainty, especially around the validity of loan sales post-transfer' from ground truth but the LLM answer doesn't explicitly address this regulatory aspect, though it does mention the receivables sale strategy. QUANTITATIVE ACCURACY: The dates (2022, 2023, 2024, June 2023) are all correct. No calculations are required. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across multiple years and filing documents, properly identifying cause-effect relationships between risks and mitigation strategies. CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses all parts of the multi-part question regarding risk evolution, credit products, cross-border trade, third-party dependencies, and 2023 strategic actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1635,
        "completion_tokens": 553,
        "total_tokens": 2188
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet slipped from roughly 7,007 units (about 5,979 owned + 1,028 leased) with an average age of ≈ 23.5 years in 2022 (UNP 2022 10‑K p. 22) to 7,008 units (5,971 owned + 1,037 leased) at 24.3 years in 2023 (UNP 2023 10‑K p. 19) and then to 6,893 units (5,973 owned + 920 leased) at 25.2 years in 2024 (UNP 2024 10‑K p. 19). The modest drop in total units—especially the cut‑back in leased locomotives—while the average age rises indicates the company is trimming its fleet size, leaning more on owned assets, and relying on its capital program to replace aging equipment and modernize the locomotive roster.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical discrepancies that undermine its credibility. (1) OWNED LOCOMOTIVES: Ground truth shows 6,204 (2022) → 5,973 (2024), but LLM reports 5,979 (2022) and 5,971 (2023) and 5,973 (2024). The 2022 figure of 5,979 is incorrect (should be 6,204, a difference of 225 units). (2) LEASED LOCOMOTIVES: Ground truth shows 1,038 (2022) → 920 (2024), but LLM reports 1,028 (2022) and 1,037 (2023) and 920 (2024). The 2022 figure of 1,028 is off by 10 units; the 2023 figure of 1,037 contradicts the downward trend. (3) TOTAL UNITS: LLM calculates ~7,007 for 2022 (5,979+1,028), but ground truth total should be 7,242 (6,204+1,038). This is a 235-unit error. (4) AVERAGE AGE: LLM reports 23.5 years (2022), 24.3 years (2023), and 25.2 years (2024). Ground truth shows 22.5 years (2022) and 25.2 years (2024). The 2022 age is off by 1 year; the 2023 intermediate value of 24.3 cannot be verified but appears plausible as a progression. The 2024 figure of 25.2 is correct. (5) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize data across three years (2022-2024) with document citations, which is appropriate. However, the foundational numbers are wrong, making the synthesis unreliable. (6) REASONING QUALITY: The LLM's interpretation that the company is 'trimming fleet size, leaning more on owned assets, and relying on capital program to replace aging equipment' is reasonable logic, but it's based on incorrect baseline numbers. The ground truth interpretation (cost control over aggressive modernization) is more conservative and better supported by the actual data showing increased average age despite reductions. (7) COMPLETENESS: The answer addresses the evolution question and attempts to interpret fleet management strategy, but the numerical foundation is too flawed to support valid conclusions. The answer provides more detail than ground truth (including 2023 data) but this additional detail contains errors that compound the problem.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 543,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell sharply – it was $1.494 billion at 12/31/2022, $800 million at 12/31/2023 and $491 million at 12/31/2024【page_102】【page_99】. The roughly $1 billion reduction over two years signals that the company is tightening its collateral usage, indicating a more efficient, lower‑risk derivative position and a proactive approach to managing counter‑party credit exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a significantly different starting figure of $1.494 billion for 2022, whereas the ground truth states $641 million for 2022. This is a major discrepancy ($1.494B vs $641M - a difference of $853 million or 133%). The 2023 ($800M) and 2024 ($491M) figures match the ground truth. (2) MULTI-HOP REASONING - The LLM correctly identifies the trend of declining collateral from 2023 to 2024 and interprets this as indicating more efficient derivative risk management and tighter collateral usage. However, the interpretation is based on an incorrect starting point. The ground truth describes a peak in 2023 followed by a decline, suggesting a shift in strategy. The LLM's narrative of a 'sharp fall' and '$1 billion reduction over two years' is mathematically incorrect given the wrong 2022 baseline. (3) MISSING CONTEXT - The LLM fails to address the ground truth's mention of level 3 fair value inputs for equity company receivables and long-term obligations, which is an important aspect of the derivative risk management approach disclosed across all three years. The ground truth notes continued reliance on internal models for valuation. (4) ENTITY ACCURACY - Company (ExxonMobil) and metric (collateral under master netting arrangements) are correctly identified. Years are correct. (5) SEMANTIC ISSUES - While the LLM's interpretation about risk management efficiency is reasonable, it's built on a factually incorrect foundation. The ground truth's more nuanced view of 'dynamic risk positioning in response to market conditions' is more comprehensive than the LLM's simpler 'tightening collateral usage' narrative. The fundamental error in the 2022 figure ($1.494B vs $641M) is disqualifying for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 497,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ “Other” segment – described in each filing as consisting of packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware and other items – generated **$6.89 billion (21 % of total net revenue) in FY 2022**, rose to **$7.71 billion (22 % of total) in FY 2023**, and then edged down to **$7.54 billion (21 % of total) in FY 2024**【page_86†L1-L9】【page_88†L1-L9】. The composition of the category remained the same, but its absolute revenue and share of total grew in 2023 before modestly declining in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific financial figures ($6.89B, $7.71B, $7.54B) and percentages (21%, 22%, 21%) that are NOT present in the ground truth answer. The ground truth explicitly states there is NO information about revenue amounts or composition changes - only that the category 'remained relatively stable' and 'consistent with prior years' with 'no explicit mention of new product categories or significant shifts.' The LLM appears to have fabricated specific revenue numbers and growth rates that cannot be verified against the provided ground truth. While the LLM correctly identifies the composition items (packaged/single-serve coffees, royalty/licensing, ingredients, serveware), it fundamentally misrepresents the nature of the answer by adding quantitative data that the ground truth does not contain. The question asks about 'evolution' of revenue composition, and the ground truth indicates stability with no significant shifts, yet the LLM presents a narrative of growth in 2023 followed by decline in 2024 - a direct contradiction. The citation references provided [page_86†L1-L9] and [page_88†L1-L9] cannot be verified but appear to be fabricated or misinterpreted. The LLM's answer is more detailed than the ground truth but is fundamentally inaccurate in its core claims about financial performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 374,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "In 2022 Alphabet said that ad inventory on Google Network sites—including those served through Google Ad Manager—is tracked by impressions, and brand‑advertising revenue is recognized when the ad is displayed (i.e., on an impression‑based basis) with a cost‑per‑impression metric disclosed【page_31】. By the 2023 and 2024 filings the company reaffirmed that it generally acts as the principal for these network ads, reporting the full amount billed to advertisers as gross revenue and recording the payments to network partners as cost of revenue【page_57】【page_58】【page_57 (2024)】. Thus, the impression‑based recognition model persisted, and the gross‑basis reporting approach for Google Ad Manager inventory remained consistent from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Google's advertising monetization strategy; (2) Accurately captures the impression-based revenue recognition model used in 2022 with cost-per-impression metrics; (3) Properly synthesizes the shift in 2023-2024 toward explicit gross revenue reporting with principal accounting treatment; (4) Correctly identifies that Google records full amounts billed to advertisers as gross revenue while recording network partner payments as cost of revenue; (5) Appropriately emphasizes the consistency of the impression-based model throughout the period; (6) Provides specific page references to support claims. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more technical/precise language (\"principal for these network ads\") compared to the ground truth's broader framing of \"control over advertising inventory,\" but this is semantically equivalent and arguably more precise; (2) The ground truth emphasizes \"increasing transparency and accounting clarity\" as an evolution theme, while the LLM focuses more on the consistency of the model—both perspectives are valid and complementary rather than contradictory. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple accounting concepts (impression-based recognition, gross vs. net revenue, principal vs. agent treatment), demonstrating sound multi-hop reasoning. NO QUANTITATIVE ERRORS: No numbers, dates, or calculations are present that could be verified as incorrect. The temporal progression (2022→2023→2024) is accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) how monetization evolved, (2) impression-based revenue recognition, (3) gross revenue reporting, (4) across the specified time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 518,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ’s 2022, 2023 and 2024 10‑K filings all list sales‑ and media‑marketing restrictions – especially front‑of‑pack labeling based on nutrient profiles – as a material regulatory exposure, and each year notes that extended producer responsibility (EPR) policies are already in place in “over 25” EU countries (2022) or “many Member States” of the EU (2024) and are spreading to other jurisdictions such as India, Vietnam and certain U.S. states【page_15】【page_11】【page_11】. The language is consistent across the three years, showing a steady exposure that the company continues to monitor as EPR and front‑of‑pack labeling rules expand geographically.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that MDLZ faces sales and media marketing restrictions across 2022-2024, accurately notes the 'over 25' EU countries figure for 2022, correctly identifies EPR policies spreading to India, Vietnam, and U.S. states, and properly recognizes front-of-pack labeling as a consistent concern. The quantitative references to 'over 25' EU countries and the mention of 'many Member States' in 2024 are accurate.\n\nWEAKNESSES: (1) The LLM characterizes the trend as 'steady exposure' and 'consistent across the three years,' which contradicts the ground truth's narrative of EVOLUTION and SHIFT. The ground truth explicitly shows progression: 2022 (policies 'considered'), 2023 (increased attention to labeling), 2024 (formal adoption and shift from 'contemplation to enforcement'). The LLM misses this critical temporal evolution. (2) The LLM omits specific jurisdictional details mentioned in ground truth: Indonesia and Philippines are mentioned in 2023 regarding single-use plastic bans/taxes, but the LLM doesn't capture this geographic expansion detail. (3) The LLM fails to highlight the 2024 EU Packaging and Packaging Waste Directive formal adoption, which represents a significant regulatory milestone. (4) The LLM doesn't adequately convey the shift from 'contemplation' to 'enforcement' that characterizes the 2024 evolution. (5) The characterization of 'steady' exposure misses the 'growing regulatory burden' and 'increasing specificity' emphasized in the ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails to properly identify the evolution pattern. It treats the information as static rather than dynamic, missing the key insight that regulatory burden is intensifying and expanding.\n\nSEMANTIC ACCURACY: While individual facts are largely correct, the overall narrative interpretation is incorrect. The question specifically asks 'how has...evolved,' and the LLM's answer of 'consistent' and 'steady' directly contradicts the ground truth's narrative of progression and intensification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 559,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Mastercard’s Class A shares were described the same way – each share carries **one vote and full dividend rights** (see the “Classes of Capital Stock” tables for 2022 [page 90], 2023 [page 99] and 2024 [page 92]). The unchanged voting and dividend profile over three years shows that Mastercard is deliberately maintaining a stable dual‑class structure, concentrating voting control in Class A while preserving dividend participation for all shareholders as a consistent capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) Correctly identifies that A Class shares maintained one vote per share and dividend rights consistently across 2022, 2023, and 2024 - matching the ground truth exactly. (2) Properly synthesizes multi-hop information across three years of 10-K filings. (3) Accurately cites specific page references (pages 90, 99, and 92) for the three respective years, demonstrating document-level precision. (4) Correctly identifies the company as Mastercard and uses appropriate terminology ('Classes of Capital Stock' tables). (5) The reasoning about capital structure strategy is sound - the consistency of voting and dividend rights does indicate deliberate maintenance of a stable dual-class structure. (6) No calculation errors or numeric inaccuracies. MINOR CONSIDERATIONS: The LLM answer adds interpretive detail about 'concentrating voting control in Class A while preserving dividend participation' which goes slightly beyond the ground truth's more neutral statement about 'preserving their governance and economic rights without alteration.' However, this interpretation is logically sound and consistent with the facts presented - it represents reasonable inference rather than error. The answer is more detailed and explanatory than the ground truth while remaining factually correct. All core facts match: consistency of one vote per share, consistency of dividend rights, three-year period, and the implication about capital structure strategy stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 420,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s master‑netting collateral fell sharply over the three‑year span – $1.494 billion at 12/31/2022, $800 million at 12/31/2023, and $491 million at 12/31/2024【page_102】【page_99】. The decline, reported in the “Investments, advances and long‑term receivables” line, indicates that the company’s derivative exposure (and the initial‑margin it must post) has been decreasing, suggesting either lower derivative activity or more efficient netting/hedging of its positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2022 figure of $1.494 billion, which is INCORRECT. The ground truth states $641 million for 2022. This is a massive discrepancy ($1.494B vs $641M - off by 853 million or 133%). The 2023 ($800M) and 2024 ($491M) figures are correct. (2) TREND ANALYSIS ERROR - The LLM claims the collateral 'fell sharply' from $1.494B to $800M, but this is based on the wrong 2022 number. The actual trend from ground truth is: $641M (2022) → $800M (2023) → $491M (2024), which shows an INCREASE first, then a decrease - not a continuous sharp decline as the LLM suggests. (3) INTERPRETATION ERROR - The LLM's conclusion that 'derivative exposure has been decreasing' is partially contradicted by the actual 2022-2023 increase shown in ground truth. The correct interpretation should acknowledge the 2023 spike before the 2024 decline. (4) MULTI-HOP REASONING - While the LLM correctly identifies the metric (collateral under master netting arrangements related to 'Investments, advances and long-term receivables'), it fails in the synthesis by using an incorrect starting value. (5) POSITIVE ASPECTS - The LLM correctly identifies the company (ExxonMobil), the metric category, and provides reasonable interpretations about derivative exposure and margin requirements, but these are undermined by the fundamental numerical error. The semantic reasoning about hedging strategies and market conditions is sound, but cannot be credited when based on wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 418,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ 10‑K filings show a step‑by‑step extension of its forward‑looking coffee‑supply commitments: the 2022 filing said its purchase commitments and inventory would provide an adequate green‑coffee supply through fiscal 2023 (2022 10‑K p.12); the 2023 filing pushed that outlook out to fiscal 2024 (2023 10‑K p.12); and the 2024 filing further extended it to fiscal 2025 (2024 10‑K p.12). By lengthening the horizon of fixed‑price, price‑to‑be‑fixed, forward, futures and collar contracts each year, Starbucks is deliberately locking in supply and hedging “C”‑price exposure to blunt coffee‑price volatility and reduce supply‑risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE: The LLM answer contains a fundamental factual error in the progression of supply commitments. According to the ground truth: FY2022 → through FY2023; FY2023 → through FY2025; FY2024 → through FY2025. However, the LLM states: FY2022 → through FY2023 (correct); FY2023 → through FY2024 (INCORRECT - should be FY2025); FY2024 → through FY2025 (correct). This is a major quantitative error that misrepresents the company's strategic evolution. The LLM incorrectly shows a one-year extension in FY2023 when the ground truth shows a two-year extension (FY2023 to FY2025). This error undermines the entire narrative about Starbucks' strategy for longer-term stability. CORRECT ELEMENTS: The LLM correctly identifies that Starbucks used forward contracts, futures contracts, and collars to manage 'C' price exposure across the years. The general strategic interpretation about locking in supply and hedging price volatility is directionally correct. The mention of page numbers (p.12) adds specificity but cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM attempts to synthesize information across three fiscal years, but the synthesis is compromised by the FY2023 error. The reasoning about deliberate extension and risk mitigation is sound in principle but built on incorrect data. SEMANTIC ISSUES: While the LLM's language about 'blunting' volatility and reducing supply risk is appropriate, the factual foundation is flawed. The progression should show a more aggressive two-year extension in FY2023, not a one-year extension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 435,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "In fiscal 2023 Accenture’s defined‑benefit target mix was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other assets【page_88】. By fiscal 2025 the U.S. target remains 100 % debt, but the non‑U.S. mix shifts to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other assets【page_95】. This gradual reduction in debt and added weight to insurance, cash and a modest equity increase signal a longer‑term strategy to diversify away from a pure‑bond profile, seeking higher risk‑adjusted returns and better liability matching while maintaining a conservative stance for U.S. plans.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, detailed quantitative data about ACN's target asset allocation shifts from fiscal 2023 to fiscal 2025, which is a significant strength compared to the ground truth answer. STRENGTHS: (1) The LLM provides concrete percentage allocations for both U.S. and non-U.S. plans across both fiscal years, enabling precise comparison. (2) All percentages appear internally consistent (sum to 100% for each category). (3) The identification of specific shifts is accurate: U.S. plans remain 100% debt, while non-U.S. plans show meaningful reallocation (debt decreased from 48% to 36%, insurance contracts increased from 11% to 21%, cash increased from 4% to 7%, equity slightly increased from 27% to 28%, other assets decreased from 10% to 8%). (4) The reasoning about the strategic implications is sound and well-articulated: the shift suggests diversification away from pure-bond profiles, seeking higher risk-adjusted returns and better liability matching. (5) The answer correctly identifies the conservative U.S. stance (100% debt) versus more diversified non-U.S. approach. MINOR WEAKNESSES: (1) The ground truth answer emphasizes 'continuity in strategy' and 'adaptive approach,' while the LLM answer emphasizes 'gradual reduction' and 'shift,' which could be interpreted as slightly different framings of the same evolution. However, both are semantically compatible. (2) The LLM answer doesn't explicitly mention the 'inflation-beating' objective mentioned in the ground truth, though this is a minor omission. (3) The LLM answer doesn't reference the 'duration matching' concept mentioned in ground truth, though it does mention 'liability matching' which is semantically equivalent. VERIFICATION: The specific percentages provided by the LLM (fiscal 2023 non-U.S.: 27/48/4/11/10; fiscal 2025 non-U.S.: 28/36/7/21/8) cannot be independently verified against the ground truth provided, but they are internally consistent and logically coherent. The LLM demonstrates superior specificity compared to the ground truth answer, which is more general. The multi-hop reasoning (comparing two fiscal years, synthesizing the strategic implications) is sound and well-executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 588,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen has kept Olpasiran positioned as an siRNA that lowers lipoprotein(a) to treat atherosclerotic cardiovascular disease – it appears in the “Cardiovascular disease” column of the Phase‑2 candidate tables in the 2022, 2023 and 2024 10‑K filings【page_24†L1-L5】【page_24†L1-L5】 (and is described as an siRNA for ASCVD in the narrative)【page_28†L1-L3】.  In each filing the company reported composition‑of‑matter patents for Olpasiran in the U.S. and Europe that were already issued by 2022 and are slated to expire in 2036, a protection schedule that remained unchanged through 2023 and 2024【page_26†L1-L5】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate quantitative information but has significant gaps in addressing the question's core requirement about 'evolution' from 2022-2024. STRENGTHS: (1) Correctly identifies Olpasiran as an siRNA for atherosclerotic cardiovascular disease; (2) Accurately states patent expiration date of 2036 for U.S. and European composition-of-matter patents; (3) Correctly notes the patent protection was already in place by 2022 and remained unchanged through 2024; (4) Properly identifies the therapeutic focus across all three years. WEAKNESSES: (1) CRITICAL - The LLM states Olpasiran appears in 'Phase-2 candidate tables' in 2022, 2023, AND 2024, which contradicts the ground truth's key finding that there was a 'transition from phase 2 investigation toward more advanced development or potential regulatory preparation' by 2024. The ground truth explicitly notes a progression/evolution, while the LLM suggests static positioning across all years; (2) The LLM fails to capture the strategic evolution narrative - the ground truth emphasizes 'progression' and 'transition,' while the LLM presents a static picture ('kept Olpasiran positioned'); (3) Missing the nuance that 2024 showed 'Cardiovascular disease' indication (broader than ASCVD phase 2 designation), suggesting advancement; (4) The answer doesn't adequately address 'how did it evolve' - it instead describes consistency rather than change. QUANTITATIVE VERIFICATION: Patent dates (2036) and years (2022-2024) are correct. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings but fails to identify the key evolution/transition that the question specifically asks about. The answer is factually accurate in its statements but semantically misses the 'evolution' aspect that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 494,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- In the 2022 Form 10‑K the company said it had “increasingly relied on merchant acquirers, **aggregators** and processors to manage certain aspects of our merchant relationships” (2022 p. 29) and warned that these third parties “may have business interests, strategies or goals that are inconsistent with ours” and could renegotiate terms or affect card acceptance (2022 p. 28).  \n\n- The 2023 filing repeated the same reliance on aggregators (2023 p. 29) but added that the growing use of such third‑party providers was drawing “heightened regulatory scrutiny” and created “operational‑oversight challenges” (2023 p. 28).  \n\n- By the 2024 filing aggregators were listed among a broader set of third‑party service providers, and the risk discussion shifted to the “management and oversight of an increasing number of third parties” raising “operational complexity, governance challenges, service‑disruption, data‑security and regulatory‑compliance” concerns (2024 p. 35‑31).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the multi-hop analysis of American Express's evolving reliance on aggregators from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression and captures the key evolution of risk emphasis; (2) Accurately cites specific page numbers and filing years (2022, 2023, 2024); (3) Properly synthesizes multi-hop information showing how concerns shifted from merchant behavior/card acceptance (2022) to regulatory scrutiny and operational oversight (2023) to broader third-party management complexity (2024); (4) Correctly identifies specific risks mentioned: merchant steering/surcharging implications, regulatory scrutiny, operational-oversight challenges, service disruption, data security, and regulatory compliance; (5) Uses appropriate direct quotes and maintains semantic fidelity with ground truth. MINOR WEAKNESSES: (1) The LLM answer is somewhat more granular and specific in its page citations than the ground truth, which is actually a strength but could introduce minor discrepancies if page numbers vary slightly across filing versions; (2) The ground truth emphasizes 'litigation exposure' as a 2024 concern, which the LLM answer does not explicitly mention, though it does reference 'regulatory-compliance' concerns that could encompass this; (3) The LLM answer could have been slightly more explicit about the shift from 'merchant behavior focus' to 'systemic and legal concerns' as emphasized in the ground truth, though this progression is clearly implied. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correct; page number citations appear reasonable for 10-K filings; no calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate annual filings and correctly identifies the progression of risk emphasis, demonstrating sound multi-hop reasoning. The answer appropriately connects specific risks to specific years and shows how the company's disclosure evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 546,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks repeatedly noted that green‑coffee prices are volatile and are affected by trading activity from hedge funds and commodity‑index funds, and it has relied on forward contracts, futures contracts and collars to hedge its “C”‑price exposure (2022 10‑K p.12; 2024 10‑K p.12). In the fiscal‑2022 filing the company said its purchase commitments and inventory would provide an adequate supply of green coffee through fiscal 2023; the fiscal‑2023 filing pushed that coverage out to fiscal 2024; and the fiscal‑2024 filing extended it further to fiscal 2025 (2022 10‑K p.12; 2023 10‑K p.12; 2024 10‑K p.12).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is substantially correct on the core factual claims. STRENGTHS: (1) All numeric/date information is accurate - correctly identifies the progression of supply coverage from fiscal 2023 (2022 filing) to fiscal 2024 (2023 filing) to fiscal 2025 (2024 filing). (2) Correctly identifies Starbucks' hedging instruments (forward contracts, futures contracts, collars). (3) Accurately cites commodity index funds as a volatility factor. (4) Properly synthesizes multi-hop information across three fiscal years. (5) Provides specific document citations (10-K page numbers). WEAKNESSES: (1) The LLM answer mentions 'hedge funds' alongside commodity index funds, which is slightly broader than the ground truth's focus on commodity index funds specifically - though not incorrect, it dilutes the specific focus. (2) The LLM answer is more factual/documentary in tone and lacks the interpretive synthesis present in the ground truth regarding 'strategic shift toward longer-term risk mitigation' and the significance of the multi-year extension. (3) The ground truth emphasizes the evolution of Starbucks' confidence and strategic positioning ('increased confidence,' 'stabilized hedging'), while the LLM answer is more neutral/descriptive. (4) The LLM answer doesn't explicitly address how the company's 'exposure' evolved - it documents the timeline but doesn't characterize the evolution as clearly. QUANTITATIVE VERIFICATION: All dates and fiscal year references are correct. The progression (FY2023 → FY2024 → FY2025) is accurately stated. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly traces the evolution of forward commitments. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: While the LLM answer is more factual and less interpretive than the ground truth, it conveys the essential information accurately. The core claim about the extension of supply commitments is correct and well-documented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 539,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture repurchased $4.1 billion of its Class A shares in fiscal 2022 (12.2 million shares) while retaining $3.13 billion of open‑market repurchase authority at year‑end (2022 10‑K pp. 94‑93); in fiscal 2023 it again bought back roughly $4 billion of shares and its remaining authorization slipped to about $2.9 billion (2023 10‑K pp. 37‑41); and in fiscal 2024 it increased buybacks to $4.5 billion (including $605 million in Q4) and entered the year with $2.694 billion of available authority, then added $4 billion of new authority to a total outstanding authority of $6.694 billion (2024 10‑K pp. 40‑39). This consistent, multi‑billion‑dollar repurchase activity and the maintenance or expansion of authorized capacity underscore a disciplined capital‑return strategy aimed at regularly returning cash to shareholders and supporting the stock price.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) FISCAL 2022 REPURCHASES: LLM claims $4.1 billion repurchased in FY2022 with 12.2 million shares, but ground truth shows $3,129,296 (in thousands, ~$3.13 billion) available authorization at end of FY2022 with NO specific repurchase amount stated for that year. The LLM appears to have fabricated the $4.1B figure. (2) FISCAL 2023 REPURCHASES: LLM claims ~$4 billion repurchased, but ground truth explicitly states 2,000,308 shares purchased for $605 million in FY2023 - a massive discrepancy ($4B vs $605M). (3) FISCAL 2024 REPURCHASES: LLM claims $4.5 billion total with $605M in Q4, but ground truth does not provide a total FY2024 repurchase amount; the $605M figure appears to be misattributed from FY2023. (4) AUTHORIZATION FIGURES: LLM's authorization numbers ($3.13B, $2.9B, $2.694B, $6.694B) partially align with ground truth, but the context and timing are confused. Ground truth clearly states $2,694 million available as of August 31, 2024, and $6,694 million total after the $4B new authorization. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trajectory. It invented repurchase amounts for FY2022 and FY2023 that don't match the filing data. The ground truth shows a more modest FY2023 repurchase ($605M) compared to what the LLM claims. (6) REASONING QUALITY: While the LLM's conclusion about a 'disciplined capital-return strategy' is reasonable, it's built on fundamentally incorrect numbers, making the analysis unreliable. The answer demonstrates poor data extraction and synthesis from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 458,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google’s long‑term lock‑up marketable equity holdings were $803 million at the end of 2022, rose to $1.4 billion in 2023, and then fell to $266 million by year‑end 2024 (2022 $803 M – page_63; 2023 $1.4 B – page_66; 2024 $266 M – page_67). The sharp increase followed by a steep decline suggests the company briefly expanded its exposure to illiquid, locked‑up equity positions in 2023 but subsequently unwound or re‑allocated those assets, indicating a more cautious or opportunistic approach to illiquid investments over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it substantially incorrect: (1) WRONG NUMBERS: The LLM states 2022=$803M, 2023=$1.4B, 2024=$266M, but the ground truth shows 2022=$1.4B, 2023=$803M, 2024=$1.4B. The LLM has completely reversed the 2022 and 2023 values and introduced an entirely incorrect 2024 figure ($266M vs. correct $1.4B). (2) INVERTED NARRATIVE: Because the numbers are wrong, the LLM's interpretation is backwards - it describes an increase then decrease, when the actual pattern is decrease then recovery. (3) CALCULATION/SYNTHESIS ERROR: The LLM failed to correctly synthesize the multi-hop data across the three years. The ground truth shows a clear V-shaped pattern (1.4B → 803M → 1.4B), suggesting cyclical rebalancing. The LLM's pattern (803M → 1.4B → 266M) suggests a different and incorrect strategic narrative. (4) MISSING 2024 ACCURACY: The 2024 value is completely wrong ($266M instead of $1.4B), which is a major factual error. (5) REASONING QUALITY: While the LLM's reasoning about strategic rebalancing is conceptually sound, it's applied to incorrect data, making the entire analysis invalid. The question specifically asks about changes from 2022 to 2024, and the LLM provides wrong values for all three years. This is a fundamental failure in multi-hop financial data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 377,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE’s Electric Insurance Company (EIC) was originally a captive property‑and‑casualty insurer that provided coverage to GE and its employees, with net claim reserves of about $0.2 bn at year‑end 2021 [page_45]. In the fourth quarter of 2022 GE re‑positioned EIC as a non‑core “held‑for‑sale” business, recorded a $124 m valuation allowance and a $109 m loss in other income for 2023 [page_47], and then completed its divestiture in the second quarter of 2024, selling EIC to Riverstone International Holdings for $120 m cash and removing the $541 m of assets and $376 m of liabilities from its balance sheet [page_48]. The sequence produced a $109 m write‑down in 2023 but generated roughly $120 m of cash proceeds in 2024, offsetting the earlier loss and improving GE’s liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the EIC evolution and correctly synthesizes the multi-hop information across 2022-2024. STRENGTHS: (1) Correctly identifies EIC as a captive P&C insurer serving GE and employees; (2) Accurately captures the 2023 held-for-sale classification with $109M loss; (3) Correctly states the 2024 sale to Riverstone for $120M cash; (4) Properly identifies the asset/liability removal from balance sheet; (5) Good synthesis of the strategic exit narrative and liquidity impact. QUANTITATIVE ISSUES: (1) States net claim reserves of $0.2B at 'year-end 2021' when ground truth specifies 'year-end 2022' - this is a minor temporal discrepancy but the amount is correct; (2) Reports liabilities as $376M when ground truth states $378M - a $2M discrepancy that is immaterial but technically inaccurate; (3) Mentions a '$124M valuation allowance' which is not mentioned in the ground truth answer, suggesting possible additional detail from source documents that cannot be verified against the provided ground truth; (4) The statement about the $120M proceeds 'offsetting the earlier loss' is somewhat misleading since the $109M loss was already recorded in 2023 and the 2024 proceeds represent actual cash recovery, not a reversal. QUALITATIVE STRENGTHS: The answer correctly identifies the strategic repositioning, the progression from held-for-sale to completed sale, and the financial impact across the three-year period. The multi-hop reasoning connecting the 2022 positioning, 2023 loss recognition, and 2024 monetization is sound. MINOR ISSUES: The reference to 'page numbers' (page_45, page_47, page_48) suggests citation to specific documents, which adds credibility but cannot be verified. The characterization of the $120M proceeds as 'offsetting' the loss is slightly imprecise accounting language. Overall, the answer captures the essential facts and narrative correctly with only minor numerical discrepancies ($2M liability difference) and one temporal reference issue that don't materially affect the core answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 555,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen disclosed 13 Phase 3 programs in its 2022 filing, which grew to 18 programs by 31 January 2023, to 24 programs by 31 January 2024, and to 25 programs by 4 February 2025 【page_25】【page_26】【page_26】【page_25】. The near‑doubling of its late‑stage portfolio shows a clear strategic push to broaden the pipeline—adding new Phase 3 initiations, acquiring external assets (e.g., Horizon programs), and expanding biosimilar and novel‑modality candidates across multiple therapeutic areas—indicating Amgen’s focus on diversification and growth of its R&D pipeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - MAJOR DISCREPANCY IN FINAL YEAR DATA: The LLM answer states 25 programs by 4 February 2025, but the ground truth specifies 25 programs by 2024 (end of fiscal year 2024). The LLM appears to have introduced a 2025 date that is not in the ground truth, which is a significant factual error for a multi-hop financial question requiring precise temporal accuracy. CORRECT ELEMENTS: (1) 13 programs in 2022 - CORRECT; (2) 18 programs by 31 January 2023 - CORRECT; (3) 24 programs by 31 January 2024 - CORRECT; (4) Growth trajectory and near-doubling characterization - CORRECT; (5) Mention of Horizon acquisition - CORRECT and appropriately contextualized; (6) Discussion of diversification across therapeutic areas and biosimilars - CORRECT and adds relevant detail. QUANTITATIVE ACCURACY ISSUES: The progression 13→18→24→25 is mathematically sound, but the temporal attribution of the final 25 figure to 2025 (rather than 2024) represents a factual error in a time-series analysis. The ground truth clearly states 25 programs in 2024, not 2025. QUALITATIVE STRENGTHS: The LLM correctly synthesizes the multi-hop information about pipeline expansion, strategic acquisitions, and diversification. The reasoning about what the progression reveals (strategic push, broadening pipeline, external asset acquisition) aligns well with ground truth. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about portfolio evolution and what it reveals about R&D strategy, though the temporal error undermines confidence in the analysis. The inclusion of specific dates (31 January) shows attention to detail but introduces the problematic 2025 reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 457,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In its 2022 filing American Express described its global card network as the fourth‑largest network, competing directly with Visa, Mastercard, China UnionPay and other issuers while facing intense competition from alternative payment methods (page 12). By the 2024 filing the company notes that heightened regulatory scrutiny has forced it to exit network‑licensing businesses in the EU and Australia, to confront litigation and settlement proposals with Visa and Mastercard over interchange‑fee caps and non‑discrimination/honor‑all‑cards rules, and to revise merchant contracts to meet new regulatory requirements (pages 34, 35, 13). This marks a shift from a primarily competitive positioning to a more defensive, compliance‑driven management of its relationships with global card networks.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of AXP's relationship with global card networks from 2022 to 2024, correctly identifying the shift from competitive positioning to regulatory-driven compliance. STRENGTHS: (1) Accurately identifies AXP as the fourth-largest network in 2022; (2) Correctly notes the shift from competitive to defensive posture; (3) Properly identifies key regulatory pressures in EU and Australia; (4) Mentions specific regulatory issues (interchange-fee caps, non-discrimination/honor-all-cards rules); (5) References litigation/settlement proposals with Visa and Mastercard; (6) Appropriately characterizes the evolution as moving toward compliance-driven management. WEAKNESSES: (1) The answer is somewhat narrower in scope than the ground truth - it focuses heavily on regulatory/compliance aspects but underemphasizes the 2023 intermediate period and the competitive dynamics with alternative payment platforms (Alipay, PayPal) that the ground truth highlights; (2) Does not explicitly mention the uncertainty regarding cobrand arrangements in the EU, which is a specific detail in the ground truth; (3) The answer emphasizes litigation/settlements more than the ground truth does, which may overstate that aspect relative to the broader regulatory exit narrative; (4) Page citations are provided but cannot be verified against actual filings. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings to show evolution, though it could have better integrated the 2023 intermediate period. The reasoning connecting regulatory pressures to business model changes is sound. SEMANTIC EQUIVALENCE: The characterization of the shift from 'competitive posture' to 'compliance-driven management' is semantically equivalent to the ground truth's 'direct competition to constrained environment shaped by regulatory dependencies.' The answer is factually sound but somewhat incomplete in capturing the full complexity of the evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 545,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE stake in early 2022 by selling the remaining **91 million CVE common shares** – a disposition valued at roughly **$218 million**【page_141】.  The cash was immediately applied to its ongoing share‑repurchase program, which bought back **87.7 million shares** in 2022, **48.6 million shares** in 2023, and **49.1 million shares** in 2024【page_110】【page_112】.  Repurchase spending rose to **$29 billion** through the end of 2023 and to **$34.3 billion** by year‑end 2024 (an incremental **$5.3 billion** in 2024)【page_110】【page_112】, while the board increased the overall authorization to $65 billion in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop synthesis required and correctly identifies the key narrative of CVE monetization followed by share repurchases. However, there are notable discrepancies in the share repurchase volumes that warrant scrutiny.\n\nCORRECT ELEMENTS:\n- CVE monetization: 91 million shares in early 2022 is correct\n- CVE proceeds value: ~$218 million is reasonable and cited\n- Total repurchase spending: $29 billion through 2023 and $34.3 billion by end 2024 are correct\n- Authorization increase to $65 billion in 2024 is correct\n- Overall narrative structure and multi-hop reasoning are sound\n- Proper synthesis across multiple years and documents\n\nQUANTITATIVE DISCREPANCIES:\nThe ground truth states ConocoPhillips repurchased 383 million shares in 2022 at a cost of $29 billion. The LLM answer breaks this into annual figures: 87.7M (2022) + 48.6M (2023) + 49.1M (2024) = 185.4 million shares. This is significantly lower than the 383 million stated for 2022 alone in the ground truth. The LLM appears to have misinterpreted the data, possibly confusing cumulative figures or misreading the source documents. The ground truth also indicates cumulative repurchases of 433 million shares by 2024, which doesn't align with the LLM's annual breakdown totaling only 185.4 million.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the relationship between CVE monetization and share repurchase proceeds, and properly tracks the progression across three years. The logic connecting asset sales to capital returns is sound.\n\nSEMANTIC EQUIVALENCE:\nThe answer conveys the general narrative correctly but with material quantitative errors in share volumes that undermine precision. The dollar amounts for repurchase spending are accurate, but the share count discrepancies are problematic.\n\nJUSTIFICATION:\nThe 7/10 correctness score reflects that while the narrative structure, key dates, and total spending figures are correct, the annual share repurchase volumes appear to be significantly understated compared to ground truth, representing a material factual error that would mislead readers about the scale of buyback activity in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 588,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "In 2022 the Omnibus Plans allowed issuance of up to 80 million shares (plus up to 10 million for underlying awards) – a large pool of issuable shares (HD 10‑K 2022 p.66). By January 28 2024 the company reported roughly 77 million shares still available for future grants (HD 10‑K 2023 p.66), and by February 2 2025 (covering fiscal 2024) that pool had fallen to about 70 million shares (HD 10‑K 2024 p.70). The gradual reduction in available shares indicates Home Depot is steadily utilizing its share‑based compensation capacity while still retaining a substantial pool for future awards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) 2022 BASELINE ERROR: Ground truth states 117 million shares were available in 2022, but LLM claims 80 million shares (plus 10 million for underlying awards). This is a substantial 37 million share discrepancy - a 31% understatement of the actual available pool. (2) 2023 ALIGNMENT: Both answers agree on approximately 77 million shares by 2023, which is correct. (3) 2024 ALIGNMENT: Both answers agree on 70 million shares by 2024, which is correct. (4) TREND ANALYSIS: The LLM correctly identifies the downward trend from 2023-2024 (77M to 70M), but this trend analysis is incomplete because it misses the larger 2022-2023 decline (117M to 77M, a 40 million share reduction). The LLM's characterization of the decline as 'gradual' is misleading given the substantial 2022-2023 drawdown. (5) MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the overall trend of share utilization. However, the incorrect 2022 baseline undermines the validity of the trend analysis. (6) SEMANTIC ISSUES: The LLM's mention of '80 million shares (plus up to 10 million for underlying awards)' appears to be a misinterpretation or misreading of the source material - the ground truth clearly establishes 117 million as the 2022 figure. The answer demonstrates reasonable structure and logic but is built on a factually incorrect foundation for the critical 2022 baseline year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 425,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "The 2022 Form 10‑K notes that the Amended 2010 Share Incentive Plan “authorizes a maximum of **127 million** Accenture plc Class A ordinary shares for awards”【page_91】.  By the 2024 filing the limit had been raised to **141 million** shares【page_98】 – the 2023 filing did not disclose a higher cap, implying the increase was made after 2023.  This upward adjustment shows Accenture is expanding the capacity of its equity‑based compensation program, using more share awards to attract, retain and align employees with shareholder interests.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numerical facts: 127 million shares authorized in 2022 and 141 million shares by 2024. The numbers match the ground truth exactly. The answer also correctly synthesizes the multi-hop information by comparing the 2022 and 2024 figures and drawing a reasonable conclusion about Accenture's strategic expansion of equity-based compensation. The semantic meaning aligns well with the ground truth regarding the company's strategic use of share-based compensation to attract, retain, and align employees with shareholder interests. However, there is a notable discrepancy in the treatment of 2023 data. The LLM states 'the 2023 filing did not disclose a higher cap, implying the increase was made after 2023,' which suggests uncertainty about when the increase occurred. The ground truth explicitly states that both 2023 and 2024 had the same 141 million share authorization, indicating the increase occurred between 2022 and 2023, not between 2023 and 2024. This is a meaningful difference in the progression narrative. The LLM's reasoning about the strategic implications is sound and well-articulated, matching the ground truth's interpretation. The answer appropriately addresses all parts of the multi-part question regarding the evolution and strategic implications. The minor issue with the 2023 data interpretation prevents a higher score, as it affects the accuracy of the 'progression' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 403,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted‑average yield on the company’s foreign government bonds and obligations rose from about 3.5 % in 2022 to roughly 6.1 % in 2024【page_176】. The higher yield indicates that Amex’s non‑U.S. bond holdings are now earning more interest, reflecting greater exposure to a rising international‑interest‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY - CRITICAL ERRORS: The LLM states the weighted average yield was 'about 3.5%' in 2022, but the ground truth clearly indicates it was 5.86% in 2022. This is a major discrepancy of over 2 percentage points. The LLM also states the 2024 yield was 'roughly 6.1%', but the ground truth shows it was 5.86% in 2024. These are not minor rounding differences - they represent fundamental misstatement of the actual yields. (2) INCOMPLETENESS: The LLM answer fails to address the 2023 data point entirely, which is crucial to understanding the trend. The ground truth shows a peak of 6.45% in 2023, which is essential context for understanding the volatility and trajectory. By omitting 2023, the LLM misses the critical inflection point in the trend. (3) TREND ANALYSIS FAILURE: The ground truth describes a three-year trajectory with a rise from 5.86% (2022) to 6.45% (2023) to a decline back to 5.86% (2024), indicating volatility and partial reversal. The LLM presents a simplistic one-directional increase from 3.5% to 6.1%, missing the nuanced peak-and-decline pattern that is central to understanding the company's exposure. (4) ENTITY AND METRIC ACCURACY: While the LLM correctly identifies American Express and foreign government bonds, it fails to specify that the yields refer to instruments 'due within one year,' which is an important qualifier in the ground truth. (5) REASONING QUALITY: The LLM's conclusion about 'greater exposure to a rising international-interest-rate environment' is partially correct in spirit but is based on incorrect numbers and incomplete data. The actual trend suggests more complex dynamics with stabilization or strategic adjustments, not simply rising exposure. The answer demonstrates poor multi-hop synthesis by failing to integrate all three years of data and draw accurate conclusions from the complete picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 532,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "In 2022 American Express’s foreign‑government bond portfolio was almost entirely short‑term – $628 million (about 99 % of the $630 million holding) matured within one year, with the overall weighted‑average yield on its investment‑security portfolio at roughly 2 % (1.74 % for the <1‑year segment)【page_121】. By contrast, the weighted‑average yield on this asset class rose to 6.45 % in 2023 and then eased to 5.85 % in 2024, indicating the company moved into longer‑dated, higher‑yielding sovereign debt as global rates climbed and subsequently trimmed exposure as yields moderated—reflecting a strategy of seeking higher returns when rates rise while managing duration risk as market conditions evolve.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core question and provides accurate key figures. STRENGTHS: (1) All critical numbers are correct: $630 million total holding in 2022, $628 million maturing within one year (99%), weighted average yields of 6.45% (2023) and 5.85% (2024). (2) The multi-hop synthesis is sound, correctly connecting the 2022 portfolio composition with the 2023-2024 yield progression. (3) The interpretation of market conditions and strategic implications is reasonable and aligns with the ground truth narrative about responding to interest rate changes and managing duration risk. (4) The answer appropriately addresses all parts of the multi-part question. WEAKNESSES: (1) The LLM introduces additional context about the overall investment-security portfolio yield (2%, 1.74%) that, while potentially accurate, goes beyond what the ground truth explicitly addresses and may introduce unnecessary complexity. (2) The phrase 'moved into longer-dated, higher-yielding sovereign debt' is an inference not explicitly stated in the ground truth, though it's a reasonable interpretation of the data. (3) Minor semantic difference: the ground truth emphasizes 'a shift in market conditions or a strategic adjustment' more neutrally, while the LLM presents a more definitive narrative about the company's strategic moves. (4) The ground truth mentions the 2023 yield was 'the highest among all categories,' which the LLM doesn't explicitly note, though this is a minor omission. CALCULATION VERIFICATION: All percentages and dollar amounts check out correctly. The 99% calculation ($628M/$630M) is accurate. The yield progression (6.45% → 5.85%) is correctly stated. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects portfolio composition to yield trends to market interpretation, demonstrating solid multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 514,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In the 2022 Form 10‑K the 7 % Debentures due 2029 were listed as a distinct security class in the “Securities registered pursuant to Section 12(b)” table, with its own CUSIP (718507BK1) and NYSE listing【page_1】. The 2023 filing kept the same separate‑line presentation (see 2023 Form 10‑K, page 1)【page_1】, while the 2024 filing combined the common‑stock line and the debenture line into a single entry (“Common Stock, $.01 Par Value 7 % Debentures due 2029”) but still disclosed the CUSIP and exchange (2024 Form 10‑K, page 1)【page_1】. This steady inclusion each year—with only a minor formatting consolidation in 2024—shows ConocoPhillips’ consistent commitment to transparently reporting the debt while streamlining its securities table over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE/FACTUAL ERRORS: The LLM claims the 2022 filing listed the debentures as a 'distinct security class' with separate presentation, but the ground truth states they were disclosed 'alongside its Common Stock' in the same row. The LLM also incorrectly states that 2024 'combined the common-stock line and the debenture line into a single entry,' which directly contradicts the ground truth that says COP 'maintained this structured disclosure' with the debentures in their 'own row.' (2) MULTI-HOP REASONING FAILURE: The LLM mischaracterizes the evolution pattern. Ground truth shows: 2022 (combined presentation) → 2023 (separated into own row) → 2024 (maintained separation). The LLM reverses this, claiming 2022 was separate and 2024 was combined. (3) CUSIP ACCURACY: While the LLM correctly identifies CUSIP 718507BK1, this doesn't offset the fundamental misrepresentation of the disclosure evolution. (4) INTERPRETATION ERROR: The LLM concludes the 2024 change represents 'streamlining,' but the ground truth indicates the opposite—a progression toward greater clarity and separation. The LLM's characterization of 'minor formatting consolidation in 2024' is factually incorrect based on the ground truth's description of maintained structured disclosure. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'growing emphasis on clarity and specificity' through separation, while the LLM suggests consolidation and streamlining, which are contradictory narratives. The answer demonstrates a fundamental misunderstanding of the multi-year progression pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 457,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s net carrying amount for its 2.00 % senior notes due 2031 was about $1.25 billion at the start of FY 2022 (NVDA 10‑K 2022 p. 78), fell to roughly $1.04 billion by the end of FY 2023 (NVDA 10‑K 2023 p. 67 shows $1,044 m), and rose back to $1.25 billion in FY 2024 (NVDA 10‑K 2024 p. 72 shows $1,250 m). The modest dip and rebound reflect discount amortization and short‑term re‑classification rather than new borrowing, indicating NVIDIA’s strategy of keeping a stable, low‑cost long‑term debt profile anchored by these notes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) STARTING POINT ERROR: LLM claims the net carrying amount was '$1.25 billion at the start of FY 2022' but ground truth shows $1.2 billion in 2022. (2) FY 2023 ERROR: LLM states '$1.04 billion by the end of FY 2023' which matches ground truth's $1.057 billion (acceptable rounding), but the progression narrative is problematic. (3) FY 2024 CONSISTENCY: LLM correctly identifies $1.25 billion in FY 2024, matching ground truth. (4) PROGRESSION NARRATIVE FAILURE: The LLM describes the pattern as '$1.25B → $1.04B → $1.25B' (dip and rebound), but ground truth shows '$1.2B → $1.057B → $1.25B' (consistent decline then increase). These are materially different narratives. The LLM's characterization of a 'dip and rebound' is misleading because it misrepresents the starting value. (5) REASONING QUALITY: While the LLM provides reasonable explanations about discount amortization and debt management strategy, these explanations are built on incorrect numerical foundations. The multi-hop synthesis across three fiscal years is attempted but undermined by the quantitative errors. (6) SEMANTIC ISSUES: The ground truth emphasizes 'consistent long-term debt position' and 'stable approach,' while LLM emphasizes 'dip and rebound' - these are contradictory characterizations stemming from the incorrect starting value. The LLM's interpretation of the data pattern is fundamentally at odds with the ground truth's interpretation, making this a significant analytical failure despite some correct individual numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 449,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "- In fiscal 2022 Disney treated Marvel mainly as a production banner (“Original content is generally produced … Marvel …”) and recorded the Marvel trademarks as part of its indefinite‑lived intangible assets (the $1.792 billion indefinite‑lived intangibles include ESPN, Pixar and **Marvel** trademarks)【page_108】【page_110】.  \n\n- In fiscal 2023 the company pushed Marvel to the consumer‑facing layer of its streaming portfolio, listing “Disney, Pixar, **Marvel**, Star Wars and National Geographic” as top‑level tiles on Disney+ while still naming it among its production banners【page_7】【page_5】.  \n\n- By fiscal 2024 Marvel again appears chiefly as a high‑value intangible: the indefinite‑lived intangible assets still consist of ESPN, Pixar and **Marvel** trademarks (valued at $1.792 billion)【page_114】, indicating that its brand value remains a core strategic asset even as the specific streaming‑service branding language is not restated.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies Marvel's presence in indefinite-lived intangible assets in fiscal 2022 and 2024, with accurate citation of the $1.792 billion valuation; (2) Accurately captures the 2023 strategic shift to consumer-facing branding, correctly listing Marvel alongside Disney, Pixar, Star Wars, and National Geographic as top-level Disney+ tiles; (3) Properly synthesizes the multi-hop evolution across three fiscal years, showing how Marvel transitioned from primarily production banner (2022) to prominent streaming interface branding (2023) while maintaining core intangible asset status (2024); (4) Provides specific page citations that enhance credibility. QUANTITATIVE VERIFICATION: The $1.792 billion figure for indefinite-lived intangible assets is cited consistently for both 2022 and 2024, matching the ground truth's assertion of consistent recognition. The numeric data is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and two distinct dimensions (financial reporting via intangible assets and operational/consumer-facing streaming strategy), demonstrating sound logical progression. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and structured than the ground truth, providing additional context about production banners and specific page references, but this represents enhancement rather than deviation. The semantic meaning is fully preserved and the factual content is accurate. The answer directly addresses all components of the question regarding strategic positioning evolution, branding within streaming services, and intangible asset classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 479,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "In the 2022 filing American Express explained that discount revenue – the merchant‑discount it earns – is recorded **at the moment the Card‑Member transaction occurs** and, when a third‑party merchant acquirer is used (e.g., under its OptBlue program), the **network‑rate fee is individually negotiated with that acquirer and also booked as discount revenue** at transaction time. The company’s merchant‑acceptance contracts are a mix of indefinite‑duration agreements for small‑ and mid‑size merchants and fixed‑term (typically three‑to‑seven‑year, auto‑renewable) agreements for large merchants, with payments to merchants and network partners shown as contra‑revenue. ( page 103 ; page 104 )\n\nBy 2023 the same accounting treatment persisted – payments under merchant and network‑partner contracts continue to be classified as contra‑revenue, confirming that the fee‑negotiation and discount‑revenue model remains unchanged. ( page 104 )\n\nThe 2024 filing shifts the focus to **expanding merchant coverage globally**, stressing that success will depend on “the value propositions offered to merchants and merchant acquirers… our ability to work with third‑party merchant acquirers, aggregators and processors… and continued network investments to increase acceptance in priority international cities, new‑to‑plastic industries and B2B channels.” ( page 93 )  \n\nThus, while the core revenue‑recognition and fee‑negotiation framework stayed consistent from 2022‑2023, the 2024 disclosure highlights a strategic push to broaden acceptance through third‑party acquirer partnerships and network expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about American Express's revenue structure evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core revenue recognition mechanism - discount revenue recorded at transaction time with individually negotiated network rate fees from third-party acquirers (OptBlue program mentioned accurately). (2) Accurately captures the 2022-2023 consistency in accounting treatment and fee-negotiation framework. (3) Properly synthesizes the 2024 strategic shift toward global merchant coverage expansion through third-party acquirers, aggregators, and processors. (4) Correctly identifies that payments to merchants and network partners are classified as contra-revenue. (5) Provides specific page references (103, 104, 93) showing document grounding. (6) The multi-hop reasoning is sound - comparing revenue structures across three years and identifying both continuity and strategic evolution. MINOR GAPS: (1) The LLM answer does not explicitly mention the 2023 introduction of 'processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners' - this is a notable omission from the ground truth that represents a meaningful evolution in the revenue model. (2) The answer could have been more explicit about the distinction between discount revenue and processed revenue as separate revenue streams introduced in 2023. (3) Does not mention the specific focus on 'new-to-plastic industries and B2B channels' as expansion strategies, though it does reference 'priority international cities.' QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in the question, and the LLM correctly avoids fabricating numbers. The dates (2022, 2023, 2024) are all correct. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution aligns well with the ground truth's description of 'strategic shift toward deeper collaboration' and 'optimize revenue streams.' The wording differs but conveys equivalent meaning. OVERALL ASSESSMENT: This is a strong answer that correctly synthesizes multi-hop information across three years of filings and accurately identifies the key evolution in American Express's merchant acquirer relationships. The primary weakness is the omission of the processed revenue component introduced in 2023, which represents a material addition to the revenue model not adequately captured in the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1738,
        "completion_tokens": 670,
        "total_tokens": 2408
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "In the 2022 Form 10‑K Amgen only gave a brief bullet‑point warning that “some of our products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks” (2022 p.34). The 2023 filing expanded that warning substantially, explaining that device development, supply and regulatory clearance are integral to clinical‑trial execution and product approvals, that post‑marketing commitments (e.g., REMS and a five‑year post‑marketing study for EVENITY) may be required, and that Amgen must continuously collect and assess user complaints, adverse‑event reports and FDA inspections of devices such as the Neulasta Onpro kit (2023 p.54‑55). By the 2024 Form 10‑K the discussion was further deepened: the company stresses the dependence on contemporaneous approval of drug‑delivery and companion‑diagnostic devices for trial enrollment and indication expansion, notes that failure to develop, modify or obtain clearance for these devices could increase costs, delay approvals or remove products from the market, and reiterates ongoing safety‑review obligations—including monitoring, labeling enhancements and potential regulatory actions—while highlighting reliance on third‑party suppliers for device studies and clearances (2024 p.50, 53‑55).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Amgen's regulatory risk disclosures; (2) Accurately captures the progression from brief warnings in 2022 to expanded disclosures in 2023 to deepened discussion in 2024; (3) Provides specific product examples (LUMAKRAS, EVENITY, Neulasta Onpro kit) that align with ground truth; (4) Correctly identifies key regulatory concepts: surrogate endpoints, accelerated approval, post-marketing studies, REMS, pharmacovigilance, device clearance dependencies; (5) Accurately synthesizes multi-hop information across three years and multiple regulatory themes; (6) Properly contextualizes the shift from general dependencies to specific post-marketing and safety compliance challenges. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page references (2022 p.34, 2023 p.54-55, 2024 p.50, 53-55) which cannot be verified against the ground truth but appear reasonable and add credibility; (2) The LLM provides slightly more granular detail than the ground truth (e.g., mentioning third-party supplier reliance, specific REMS requirements) but this represents appropriate elaboration rather than contradiction; (3) The mention of Complete Response Letter for LUMAKRAS in ground truth is not explicitly stated in LLM answer, though the accelerated approval and post-marketing study requirement is captured. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension focuses on date accuracy (2022, 2023, 2024 all correct) and product/metric identification (all correct). QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes regulatory concepts across years and identifies the thematic evolution. Entity identification is accurate (Amgen, specific products, regulatory bodies). CONTEXTUAL RELEVANCE: The answer directly and comprehensively addresses all aspects of the question: drug delivery devices, clinical trial dependencies, post-marketing requirements, and device-related safety reviews across the specified time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 581,
        "total_tokens": 2198
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "In the 2022 filing ConocoPhillips said its HSE audit program consisted of “HSE audits … on business units and staff groups to ensure conformance with ConocoPhillips HSE policies, standards and practices where improvement actions are identified and tracked to completion,” with audit progress “tracked and reported to our EL T and the Board of Directors.” By the 2024 filing the scope was formalized as a “Corporate HSE audit” covering the same business‑unit and staff‑group coverage, the language was tightened to state that “if improvement actions are identified, they are tracked to completion,” and reporting of audit results continued to be directed to the EL T and the Board, reflecting a more explicit corporate‑level governance structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key factual elements from 2022 and 2024 filings, including the scope of HSE audits (business units and staff groups), the tracking of improvement actions to completion, and the governance reporting to ELT and Board. The dates and entities are accurate. However, the answer has significant gaps in completeness: (1) It omits the 2023 filing entirely, which the ground truth identifies as a critical inflection point showing evolution to integrated safety systems with Life Saving Rules, Process Safety Fundamentals, and stop work policy. (2) The LLM characterizes the evolution narrowly as 'formalization' and 'tightening of language' rather than capturing the substantive strategic shift from localized conformance checks to integrated safety systems to corporate-level standardization. (3) The LLM notes the change from 'improvement actions are identified' to 'if improvement actions are identified' as a tightening, but this is a minor semantic distinction that doesn't capture the deeper evolution in scope and integration. (4) The answer misses the broader context of human capital management framework integration mentioned in the ground truth. The quantitative accuracy is high (dates, entities, and quoted language are correct), but the qualitative reasoning is incomplete—the answer provides a surface-level comparison of 2022 vs 2024 without the three-year evolutionary narrative that demonstrates the strategic maturation. For a multi-hop question asking about evolution across years, omitting the middle year and the substantive integration of safety systems represents a material gap in addressing the question's core intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 457,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From the 2022 filing (page 18) Accenture warned that “technological developments…in the case of cloud and as‑a‑service solutions…could affect the nature of how we generate revenue” and that it must “introduce new pricing or commercial models that reflect the value of these technological developments.” By the 2023‑2024 filings (pages 22‑21) the language expands to include “cloud, data and AI solutions” and “generative AI,” showing that the firm’s pricing strategy has evolved to cover a broader set of AI‑driven and data‑centric services rather than just cloud‑as‑a‑service. Across all three years the company consistently flags the same risk: if it cannot roll out these new pricing/commercial models—especially when clients delay or defer spending while evaluating emerging technologies—its revenue and results of operations could be materially harmed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Accenture's pricing model evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the progression from cloud/as-a-service focus in 2022 to broader AI/data/generative AI coverage by 2023-2024, showing genuine evolution; (2) Accurately captures the consistent risk theme across all three years regarding insufficient pricing model adoption and client spending delays; (3) Properly synthesizes information across multiple years and documents; (4) Correctly cites specific page references (18, 22-21) and uses direct quotes appropriately; (5) Maintains semantic equivalence with ground truth while using slightly different phrasing. MINOR WEAKNESSES: (1) The LLM answer is somewhat less explicit about the 2023 intermediate step focusing on 'innovation and strategic investments in AI and robotics' - it jumps somewhat directly from 2022 to 2023-2024 combined discussion; (2) Does not explicitly mention the 2023-specific concern about 'delays in client spending due to evaluation of new technologies' as a distinct intermediate evolution point, though it does reference client delays generally; (3) The phrase 'pages 22-21' appears to be a formatting issue (should likely be pages 21-22 or similar), though this is a minor citation presentation matter. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this question, so this dimension is less critical. The answer correctly identifies years (2022, 2023, 2024) and maintains chronological accuracy. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the evolution pattern and consistent risk themes. The reasoning that technological scope expanded while risk remained consistent is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution and risks aligns well with the ground truth, despite using different organizational and phrasing choices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 552,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap debt holding grew each year – it was a $900 million senior note at 12/31/2022, rose to $944 million at 12/31/2023, and increased to $982 million at 12/31/2024【page_74†L31-L34】【page_70†L31-L34】.  By selling its AerCap equity while expanding the note position, GE has shifted from an ownership stake to a larger, lower‑risk debt exposure, signalling a strategy to retain a steady‑income, non‑controlling interest in AerCap.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the core factual claims. (1) DIRECTIONAL ERROR: The LLM claims GE's AerCap note holdings GREW from $900M (2022) to $944M (2023) to $982M (2024), showing an INCREASING trend. However, the ground truth states holdings DECREASED from $993M (end of 2021, reported in 2022) to $944M (end of 2023, reported in 2024), showing a DECLINING trend. This is a complete reversal of the actual progression. (2) NUMERIC DISCREPANCIES: The LLM provides a 2024 figure of $982M, but the ground truth only provides data through end of 2023 ($944M). The 2024 figure appears fabricated or misread. The 2022 figure of $900M is also inconsistent with the ground truth baseline of $993M at end of 2021. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes GE is 'expanding the note position' and 'shifting from ownership to larger debt exposure,' which contradicts the actual declining holdings pattern shown in ground truth. The correct interpretation is a strategic REDUCTION in AerCap exposure, not expansion. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the year-over-year progression across the 2022-2024 period. The answer demonstrates a fundamental misreading of the data trajectory. (5) PARTIAL CREDIT: The LLM does correctly identify that this involves a debt note (not equity) and attempts to provide strategic context, which shows some understanding of the investment type, but the core numerical facts and directional analysis are inverted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 418,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "- In the 2022 filing Amgen reported that Bemarituzumab had just **initiated a Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma** (while still in Phase 2 for other tumors and Phase 1 for NSCLC) and listed its composition‑of‑matter patents with an **estimated expiration of 2029 in both the U.S. and Europe**【page_25†L1-L9】【page_25†L13-L17】.  \n\n- The 2023 and 2024 filings show the same candidate **still positioned in the Phase 3 portfolio** (no further progression beyond Phase 3) and the **patent expiration dates unchanged at 2029** for the U.S. and Europe【page_24†L1-L4】【page_26†L1-L7】.  \n\nThus, after the Phase 3 initiation in early‑2022, Bemarituzumab remained a Phase 3 program through 2024, and its IP outlook stayed anchored to a 2029 expiry in the two major territories.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key numeric facts: (1) Phase 3 trial initiation for gastroesophageal junction adenocarcinoma in 2022, (2) patent expiration date of 2029 for U.S. and Europe, (3) consistency of these metrics across 2022-2024 filings. The quantitative data points are accurate. WEAKNESSES: (1) The LLM answer contradicts the ground truth on a critical evolution point. Ground truth states that by 2024, Amgen 'expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC,' indicating therapeutic scope expansion. The LLM answer claims 'no further progression beyond Phase 3' and that positioning remained static, which misses this important evolution in clinical/therapeutic positioning. (2) The LLM answer focuses heavily on what DIDN'T change (Phase 3 status, 2029 expiration) rather than capturing the actual evolution described in ground truth - the shift from clinical development focus to 'broader therapeutic positioning.' (3) The ground truth emphasizes a 'shift from clinical development focus to broader therapeutic positioning and IP strategy,' but the LLM answer presents a static picture of stalled development. (4) The LLM answer states 'still in Phase 2 for other tumors and Phase 1 for NSCLC' in 2022, which adds detail not in ground truth but may be accurate; however, this detail doesn't address the question's focus on evolution. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022-2024) but fails to identify the key evolution in therapeutic scope that the ground truth emphasizes. The reasoning is sound in tracking what remained constant but incomplete in capturing what evolved. SEMANTIC ISSUE: The question asks 'how did...evolve' implying change/progression. The LLM answer emphasizes stasis rather than evolution, which is a fundamental misalignment with the question's intent and the ground truth's emphasis on 'significant evolution' and 'shift.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 539,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "In its 2022 filing, American Express noted that “alternative payment and financing mechanisms” such as digital wallets, BNPL and payment aggregators were growing rapidly and that “the speed of innovation and investment in systems, technologies, and product and service offerings” was a core competitive factor (2022 10‑K – Competition). By the 2024 filing the company stresses that pressure from large‑tech firms and proprietary digital‑wallet solutions has intensified, and it pledges to “continue to invest in technology…including open‑banking, alternative payment and financing mechanisms, tokenization, real‑time settlement, AI and machine‑learning” to stay competitive (2024 10‑K – Technology investment). This shift from acknowledging fintech rivals to committing substantial digital‑technology spending reveals a long‑term strategy to counter fintech disruption by modernizing its platform and protecting its premium network position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key competitive threats (digital wallets, BNPL, payment aggregators) and technological investments (open banking, tokenization, real-time settlement, AI/ML) across the 2022-2024 period. The multi-hop synthesis correctly traces American Express's strategic evolution from acknowledging fintech competition to committing to technology investment. However, the answer has notable gaps compared to the ground truth: (1) It omits the 2023 intermediate step where AXP expanded its list of alternative payment mechanisms to include open banking platforms and payment facilitators, which is important for showing the progression of awareness; (2) It misses the critical strategic shift identified in the ground truth—the move from 'defensive acknowledgment' to a 'dependency posture' where AXP frames these technologies as necessary for competitiveness rather than just threats to counter. The LLM characterizes the shift as 'acknowledging fintech rivals to committing substantial spending,' which is partially correct but doesn't capture the nuance that by 2024, AXP had shifted from viewing alternatives as external threats to viewing them as essential internal capabilities. The answer correctly identifies the core competitive factors and technological investments but lacks the three-year progression detail and the strategic reframing nuance that distinguishes the ground truth's more sophisticated analysis. Quantitative accuracy is high (dates and technology types are correct), but qualitative accuracy is reduced due to incomplete synthesis of the strategic positioning evolution across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 461,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of cash‑settled PSUs rose from $91.58 for the 2022 grants, jumped to $112.50 for the 2023 grants, and then eased slightly to $110.39 for the 2024 grants (2022 $91.58 [page_124]; 2023 $112.50 [page_124]; 2024 $110.39 [page_126]). This pattern shows ConocoPhillips markedly increased the monetary value of its cash‑settled long‑term incentives in 2023 to strengthen executive alignment with performance, then fine‑tuned the level in 2024 while keeping it well above the 2022 amount, indicating a strategy of enhancing and stabilizing long‑term incentive compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides a 2024 value of $110.39, which contradicts the ground truth value of $112.50 for 2024. The ground truth states the value increased from $91.58 (2022) to $112.50 (2024), with no intermediate 2023 value mentioned. The LLM introduces a 2023 value of $112.50 and claims 2024 was $110.39, fundamentally altering the trend narrative. QUANTITATIVE ERRORS: (1) The 2024 figure of $110.39 is factually incorrect per ground truth; (2) The introduction of a 2023 intermediate value ($112.50) is not supported by the ground truth, which only references 2022 and 2024; (3) The LLM's claim of a 'slight ease' from 2023 to 2024 contradicts the ground truth's simpler 2022-to-2024 progression. REASONING ISSUES: While the LLM's interpretation of the trend (strategic shift toward higher-value compensation) aligns with ground truth, the factual basis is wrong. The LLM appears to have fabricated or misread a 2023 data point and provided an incorrect 2024 value. COMPLETENESS: The LLM addresses the evolution question but with incorrect data points. The strategic interpretation is reasonable but built on faulty numbers. The page citations (page_124, page_126) cannot be verified but the numerical values are demonstrably wrong. This is a significant factual error that undermines the entire answer despite reasonable analytical framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 381,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "PayPal’s risk disclosures show a steady‑state but growing concern about abusive behavior. In 2022 the company warned that its consumer‑ and merchant‑credit products “expose us to additional risks” and that “third parties have attempted…to abuse…our services…using stolen or synthetic identities” (2022 p. 24‑26). The 2023 filing repeats the credit‑product risk and adds that “new and continually evolving forms of fraud…in connection with new or expanded product offerings” require “continuous improvement” in detection (2023 p. 24‑26), and the 2024 filing continues to flag the same credit‑product exposure while emphasizing that “behavior are complex, require continuous improvement, and may not be effective…particularly new and continually evolving forms of fraud” (2024 p. 22‑24). This progression from a general warning to an explicit focus on ever‑more sophisticated fraud suggests PayPal’s risk‑management is increasingly aware of the threat but still finds it difficult to fully contain abusive activity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc of PayPal's evolving risk disclosures across 2022-2024, capturing the progression from general warnings about third-party fraud and synthetic identities to more sophisticated concerns about evolving fraud forms. The answer appropriately synthesizes information across multiple years and correctly identifies key themes: credit products, third-party fraud, synthetic/stolen identities, and the difficulty in detection. The reasoning about PayPal's awareness increasing while containment remains difficult is sound and aligns with the ground truth's assessment of risk management effectiveness.\n\nWEAKNESSES: (1) MISSING CRITICAL QUANTITATIVE DATA: The LLM answer completely omits the €40 billion multi-year receivables sale agreement mentioned in the ground truth as a key strategic response in 2023. This is a significant omission for a multi-hop financial question, as it represents concrete evidence of PayPal's risk mitigation strategy. (2) INCOMPLETE CREDIT PRODUCT CONTEXT: While the LLM mentions credit products, it doesn't specifically reference the U.K. and European BNPL loan receivables context that the ground truth emphasizes. (3) REGULATORY DIMENSION MISSING: The ground truth specifically mentions the 'valid-when-made doctrine' and regulatory uncertainties affecting U.S. credit products in 2024, which the LLM answer does not address. (4) PAGE CITATIONS: The LLM provides page number citations (p. 24-26, p. 22-24) that cannot be verified against the ground truth and may be inaccurate. (5) QUOTE ACCURACY: While the LLM provides what appear to be direct quotes, the exact wording cannot be verified and some phrasing seems paraphrased rather than direct.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the evolution of risk disclosures. However, it fails to complete the full multi-hop analysis by not connecting the credit product risks to the specific strategic response (the €40 billion receivables sale), which is essential for understanding PayPal's actual risk management effectiveness.\n\nQUANTITATIVE ACCURACY: Score of 5 reflects the complete absence of the €40 billion figure, which is a material omission in a financial analysis. The LLM provides no quantitative data to support its claims about the evolution of risk.\n\nQUALITATIVE ACCURACY: Score of 7 reflects solid reasoning about the progression of concerns and the difficulty in managing evolving fraud, but with gaps in the completeness of the risk management picture.\n\nCONTEXTUAL RELEVANCE: Score of 6 reflects that while the answer addresses the core question about evolution and risk management effectiveness, it misses important strategic and regulatory context that would provide a more complete assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 745,
        "total_tokens": 2273
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "In the 2022 Form 10‑K Lilly listed Cyramza as a monotherapy or combination agent for **second‑line treatment of advanced/metastatic gastric cancer, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated metastatic NSCLC** (see 2022 product tables, pages 5‑6). The 2023 filing disclosed that Cyramza’s **core compound patents run out in 2026 in the U.S. and Japan and in 2028 in Europe, with data‑protection ending in 2023‑2024** (see IP table, page 11). The 2024 filing repeats the same multi‑indication positioning (see product list, page 5) but shows no new patent extensions, indicating Lilly is seeking to maximize Cyramza’s revenue across several tumor types while its exclusivity window narrows—an approach that reflects a long‑term oncology strategy of leveraging broad indication coverage of existing assets as it builds a diversified pipeline for the future.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and provides accurate core information with sound reasoning. STRENGTHS: (1) Correctly identifies Cyramza's therapeutic positioning across multiple indications (gastric, NSCLC, colorectal, hepatocellular carcinoma) in 2022-2024; (2) Accurately cites patent expiration dates (2026 U.S./Japan, 2028 Europe) from 2023 filing; (3) Correctly notes data protection ending in 2023-2024; (4) Properly synthesizes the strategic implication that Lilly is maximizing existing asset revenue while building pipeline for succession; (5) Appropriately references specific filing pages and years. MINOR ISSUES: (1) The ground truth states patents extend 'through 2026' in U.S. and Japan with data protection 'expiring as early as 2023 in Japan,' while LLM specifies '2023-2024' for data protection and adds European patent info (2028) not mentioned in ground truth—this is additional detail rather than error, but introduces information not in the original answer; (2) Ground truth emphasizes 'no new indications added' in 2024 as a key point, while LLM focuses more on revenue maximization strategy; (3) LLM's characterization of the strategy as 'leveraging broad indication coverage' is slightly different framing than ground truth's 'maintaining market presence while preparing next-generation products,' though semantically similar. QUANTITATIVE VERIFICATION: Patent dates (2026, 2028) and data protection windows (2023-2024) are accurate. MULTI-HOP REASONING: Excellent synthesis connecting 2022 positioning → 2023 IP landscape → 2024 status → strategic implications. The logic linking patent expiry to pipeline development is sound and well-articulated. CONTEXTUAL RELEVANCE: Highly relevant, addresses all aspects of the question about therapeutic positioning evolution and strategic implications. The answer goes slightly beyond ground truth with European patent data, which adds value but wasn't in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 535,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "Philip Morris kept the 3.875 % Notes due 2042 (PM42A) on its balance sheet in each filing – it appears in the 2023 securities table (PM 10‑K 2023 p. 2) and again in the 2024 table (PM 10‑K 2024 p. 2). At the same time the company continuously issued, re‑priced and retired other series of notes, moving from the 2022 lineup that included short‑term issues such as 2.375 % Notes due 2022, 2.500 % Notes due 2022 and 3.600 % Notes due 2023 (PM 10‑K 2022 p. 1) to a broader, longer‑dated set in 2023‑2024 (e.g., 2.750 % Notes due 2025, 2.875 % Notes due 2026, 0.125 % Notes due 2026, 4.375 % Notes due 2041, 4.500 % Notes due 2042, etc., shown in the 2023 and 2024 tables). This reflects a strategy of actively managing and diversifying its debt profile—extending maturities and adjusting coupon rates—while retaining the 3.875 % Notes due 2042 as a stable long‑term anchor.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 3.875% Notes due 2042 as a stable component across all three years and demonstrates understanding of Philip Morris's active debt management strategy. However, there are significant quantitative accuracy issues that prevent a higher score:\n\nCORRECT ELEMENTS:\n- Correctly identifies 3.875% Notes due 2042 as persistent across 2022-2024\n- Accurately describes the strategy of maintaining this note as a stable anchor\n- Correctly characterizes the broader strategy of active management, refinancing, and maturity extension\n- Properly identifies the shift from shorter-dated to longer-dated instruments\n- Good semantic understanding of capital structure evolution\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MISSING KEY INSTRUMENTS FROM GROUND TRUTH: The LLM fails to mention the 4.125% Notes due 2043 and 4.875% Notes due 2043 that were present in 2022 and 2023 but retired by 2024. The ground truth specifically highlights these as evidence of the refinancing strategy.\n2. MISSING 4.250% NOTES DUE 2044: The ground truth explicitly mentions the 4.250% Notes due 2044 appearing in 2023, which the LLM does not reference.\n3. INCOMPLETE SYNTHESIS: While the LLM mentions various notes (2.750% due 2025, 2.875% due 2026, 0.125% due 2026, 4.375% due 2041, 4.500% due 2042), it doesn't clearly establish the temporal progression or retirement pattern that the ground truth emphasizes.\n4. LACK OF CLEAR YEAR-BY-YEAR COMPARISON: The ground truth provides explicit year-by-year tracking (2022 vs 2023 vs 2024), while the LLM's presentation is less structured and harder to follow.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate multi-hop reasoning by connecting the persistent 3.875% note with the changing portfolio of other instruments. However, it fails to fully synthesize the specific retirement/refinancing pattern that is central to the ground truth's narrative.\n\nQUANTITATIVE ACCURACY: While the percentages and dates mentioned appear correct, the incompleteness in identifying all relevant instruments (particularly the 4.125% and 4.875% notes due 2043, and 4.250% due 2044) represents a significant gap in quantitative completeness.\n\nThe answer demonstrates conceptual understanding but lacks the precision and completeness required for a higher score due to missing key debt instruments that are explicitly mentioned in the ground truth as evidence of the capital structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 648,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 filing already warned that abusive fraud schemes—such as synthetic‑identity accounts, stolen‑instrument transactions, and defaults on its PayPal‑branded credit products—were a growing risk, and that heavy reliance on third‑party lenders and payment processors amplified that exposure【page_26】. By 2023 the company still expected third‑party abuse to increase and highlighted credit‑product default risk, but it began to curb the exposure by (i) signing a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables (agreement in June 2023, sales started in October 2023)【page_25】 and (ii) launching a diversification and migration program to move away from its primary U.S. payment‑processor toward other processors, reducing concentration in a single third‑party partner【page_25】. The 2024 filing reiterates the same credit‑product and third‑party abuse concerns (pages 22‑23) and confirms that the BNPL‑receivable sale and payment‑processor diversification/migration initiated in 2023 remain ongoing mitigation actions【page_25】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) All key numeric values are correct: €40 billion BNPL receivables sale, June 2023 agreement date, October 2023 sales start date. (2) Multi-hop synthesis is sound—the answer correctly traces PayPal's evolution across three years (2022-2024), identifying the progression from risk identification to active mitigation. (3) Entity accuracy is excellent: PayPal correctly identified, credit products and third-party risks properly characterized, BNPL and payment processor diversification initiatives accurately described. (4) The answer provides more specific detail than the ground truth, including the payment processor diversification/migration program as an additional 2023 mitigation action, which adds value without contradicting the original answer. (5) Temporal sequencing is precise (June 2023 agreement, October 2023 sales start). MINOR CONSIDERATIONS: (1) The ground truth emphasizes 'fraud prevention infrastructure' improvements in 2024, while the LLM answer focuses more on the continuation of 2023 initiatives (BNPL sales and processor diversification). The LLM does mention 'ongoing mitigation actions' but doesn't explicitly highlight new 2024 fraud detection/prevention enhancements. (2) The ground truth's characterization of the progression as 'identifying and describing (2022) → actively mitigating through asset sales (2023) → enhancing fraud prevention infrastructure (2024)' is slightly more nuanced than the LLM's framing, which emphasizes continuation of 2023 actions in 2024. However, the LLM's answer is not incorrect—it accurately reflects what was done, just with slightly different emphasis. QUANTITATIVE VERIFICATION: €40 billion figure confirmed correct, dates (June 2023, October 2023) confirmed correct. No calculation errors detected. The answer maintains semantic equivalence with the ground truth while providing additional supporting detail about processor diversification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 543,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD has listed the risk of “loss or modification of exemptions for taxes and tariffs” in its risk‑factor disclosures each year – first as a generic political‑legal‑economic risk in the 2022 filing (see page 37), then again in the 2023 filing with added language about changing tax laws, trade‑protection measures and recent sanctions (see page 41), and most recently in the 2024 filing where the same exposure is reiterated alongside evolving export‑control and sanctions regimes (see page 40). The continuity and increasing specificity of this wording indicate that AMD’s exposure to tax‑ and tariff‑exemption risk is growing, reflecting rising regulatory uncertainty across its worldwide operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's evolving exposure to tax and tariff exemption risks from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022, 2023, 2024) with appropriate temporal framing; (2) Accurately captures the evolution from generic risk disclosure to increasingly specific language about geopolitical conflicts, export controls, and sanctions regimes; (3) Provides page references (37, 41, 40) that add credibility and specificity; (4) Correctly synthesizes the multi-hop concept that increasing specificity and continuity of language indicates growing regulatory uncertainty; (5) Properly identifies AMD as the subject company and correctly frames the risk category. MINOR WEAKNESSES: (1) The LLM answer includes specific page numbers which, while helpful, are not verified against the ground truth and could be inaccurate (though this doesn't contradict the ground truth); (2) The phrase 'growing awareness of the material impact' from the ground truth is somewhat paraphrased as 'growing awareness of the material impact such changes could have' in the LLM answer - semantically equivalent but slightly different emphasis; (3) The LLM answer emphasizes 'continuity and increasing specificity of wording' while the ground truth emphasizes 'progression' and 'elevation' - both convey similar meaning but with slightly different framing. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correct; no calculations required; no dollar amounts or percentages to verify. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate filings and draws the appropriate conclusion about regulatory uncertainty trends. The logic connecting increasing specificity of language to growing regulatory concern is sound and matches the ground truth's reasoning. SEMANTIC EQUIVALENCE: The core message - that AMD's risk exposure evolved from generic to increasingly specific, reflecting heightened regulatory uncertainty - is accurately conveyed despite minor wording variations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 568,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco’s total‑return‑swap results moved from a loss to gains over the three‑year span. In FY 2022 the swaps generated a **$92 million loss**; in FY 2023 the result turned **positive at $58 million**, and in FY 2024 it rose further to a **$91 million gain** (CSCO 2022 10‑K p.92; CSCO 2024 10‑K p.91). This swing from a net loss to increasingly larger gains indicates that the swaps are now effectively offsetting the volatility of deferred‑compensation expense, showing Cisco’s growing reliance on and success with total‑return‑swap hedges to manage its deferred‑compensation exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - FY2022 loss of $92 million, FY2023 gain of $58 million, and FY2024 gain of $91 million. The progression and direction of the trend are accurately captured. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of gains/losses across three fiscal years, (2) the progression pattern, and (3) what this indicates about Cisco's exposure/strategy. ENTITY ACCURACY: Cisco (CSCO) is correctly identified, fiscal years 2022-2024 are correct, and the financial metric (total return swaps tied to deferred compensation) is properly identified. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws a logical conclusion about the reversal from losses to gains and what this indicates strategically. The interpretation that swaps are 'effectively offsetting the volatility of deferred-compensation expense' and showing 'growing reliance on and success with total-return-swap hedges' is a reasonable inference from the data pattern. SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as 'a swing from a net loss to increasingly larger gains' is semantically equivalent to the ground truth's 'notable reversal.' The inclusion of source citations (CSCO 2022 10-K p.92; CSCO 2024 10-K p.91) adds credibility. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail about the strategic implications ('growing reliance on and success') compared to the ground truth's more cautious 'potentially reflecting improved market conditions or a strategic shift,' but this represents reasonable analytical elaboration rather than factual error. All core facts are accurate and the reasoning is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 494,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From FY 2022, Disney launched an ad‑supported Disney+ tier, raised subscription prices and reorganized its DMED unit to “advance our DTC strategies” (DIS_10k_2022.pdf p25‑26); in FY 2023 it moved to broader strategic investments in its DTC platforms to grow subscription‑fee and advertising revenue while warning that an “increasing number of competitors have entered DTC businesses” and that pricing pressure, churn and cost‑containment were key risks (DIS_10k_2023.pdf p53‑54). By FY 2024 the company had committed billions to the Hulu redemption, a 20 % stake in its DTC sports business, an Epic Games investment and a Star India joint‑venture, and its filings now stress intense competition, pricing pressure, advertising‑market weakness and heightened financing and credit‑rating exposure as it scales its streaming services (DIS_10k_2024.pdf p22‑25; p52).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's DTC evolution across FY 2022-2024 and effectively synthesizes multi-hop information from multiple 10-K filings. STRENGTHS: (1) Correctly identifies the three-year progression with specific strategic actions (ad-supported tier launch, price increases, Hulu redemption, 20% Epic Games stake, Star India JV); (2) Accurately captures the shift from acknowledging DTC losses in 2022 to active investment in 2023 to scaling despite pressures in 2024; (3) Properly identifies key financial risks and market pressures (pricing constraints, competition, churn, cost containment, advertising weakness, credit rating exposure); (4) Provides specific document citations with page numbers, enhancing credibility; (5) Demonstrates sound multi-hop reasoning by connecting strategic investments to financial risks across years. MINOR WEAKNESSES: (1) The 20% stake reference appears to relate to ESPN+ DTC sports business, which is a specific detail that could be slightly clearer in context; (2) While the answer mentions 'billions' for Hulu redemption, no specific dollar amount is provided (though this may reflect filing language); (3) The answer is more detailed and specific than the ground truth but doesn't contradict it—it expands on the core narrative with concrete examples. QUANTITATIVE VERIFICATION: The 20% figure for the DTC sports stake is specific and appears accurate based on Disney's strategic investments. No mathematical calculations are required for this question, so quantitative accuracy focuses on the accuracy of specific percentages and references, which appear sound. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and multiple strategic initiatives, correctly linking them to evolving financial risks and market pressures. The progression narrative (2022 uncertainty → 2023 active investment → 2024 scaling amid pressures) matches the ground truth framework. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while providing more granular detail and specific examples, which enhances rather than detracts from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 585,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "Across all three years PayPal repeatedly states that, as the principal of each payment, it “has full discretion in determining the fee charged to our customers, which is independent of the costs we incur … we therefore bear full margin risk when completing a payment transaction. These fees paid to payment processors and other financial institutions are recognized as transaction expense” (2022 Note 2 – p. 78; 2023 Note 2 – p. 77; 2024 Note 2 – p. 75). Thus, PayPal’s exposure to margin risk has not materially changed from 2022 through 2024 – it consistently bears full margin risk because it sets fees at its own discretion while the processor‑related costs are recorded separately as transaction expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies PayPal's consistent position across all three years (2022, 2023, 2024) regarding full margin risk exposure. (2) Accurately cites the specific disclosure language about fee-setting discretion being independent of processor costs. (3) Correctly references the source documents (Note 2 in each year's filing) with accurate page numbers (p. 78 for 2022, p. 77 for 2023, p. 75 for 2024). (4) Properly synthesizes the multi-hop requirement by comparing margin risk exposure across three years and explaining the relationship between fee discretion, processor costs, and accounting treatment. (5) Correctly notes that processor fees are recognized as transaction expenses, separate from fee revenue. (6) Accurately concludes that margin risk exposure remained stable with no material changes across the period. (7) Mentions ASU 2023-07 adoption in 2024 (though not explicitly detailed in LLM answer, the ground truth notes this). MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The ground truth explicitly mentions 'adoption of new segment reporting standards (ASU 2023-07)' in 2024, which the LLM answer does not mention, though this is a minor omission that doesn't affect the core conclusion about margin risk stability. The LLM answer's direct quotation approach is actually stronger evidence than paraphrasing. All numeric references (years, page numbers) are accurate. The reasoning correctly synthesizes information across multiple years and documents to establish the consistency of PayPal's margin risk position.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 460,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "- In the 2022 filing the aerospace risk discussion focused on “lower demand for air travel … may cause our customers to delay or suspend spending on the manufacturing, repair, overhaul or servicing of aircraft” (2022 10‑K p. 32), without explicitly calling out new‑aircraft order cancellations.  \n- By the 2023 filing the risk language was sharpened to state that a downturn in global air‑travel demand “may impact new aircraft production or result in the delay or cancellation of new aircraft orders” (2023 10‑K p. 30). The same phrasing appears in the 2024 filing (2024 10‑K p. 32).  \n\nThis evolution—from a general pandemic‑driven demand slowdown to an explicit, but now routine, mention of possible order cancellations—shows that the threat of new‑aircraft cancellations has become a known, manageable risk as commercial aviation rebounds, indicating a gradual recovery and growing stability in the sector.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate citations and correctly identifies the evolution of language around aircraft order cancellations across the three years (2022-2024). The page references appear reasonable and the quoted language progression is factually sound. However, there are significant gaps in addressing the ground truth's key insights: (1) The LLM fails to capture the 2022 pandemic-specific context that the ground truth emphasizes as foundational to understanding the risk evolution. (2) The LLM does not mention the 2023 expansion to include 'regional conflicts and environmental issues' as broader macroeconomic/geopolitical triggers—a critical detail showing the shift from pandemic-specific to generalized risks. (3) The LLM omits the 2024 emphasis on 'new entrants and non-traditional players' affecting market demand, which the ground truth identifies as evidence of structural/competitive shifts. (4) The LLM's conclusion that the threat has become 'known, manageable' and indicates 'growing stability' contradicts the ground truth's assessment that the sector 'remained fragile and susceptible to both external shocks and evolving market dynamics.' This represents a fundamentally different interpretation of what the risk progression indicates about sector recovery. The LLM correctly identifies the three-year timeframe and the general evolution from implicit to explicit mention of cancellations, but misses the nuanced progression of risk drivers and mischaracterizes the implications for sector stability. The answer is partially correct on surface-level facts but fails the multi-hop synthesis required to fully address how and why the risk evolved, and what it indicates about aviation sector health.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 470,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "In 2022 PMI warned that regulatory actions could commoditise its portfolio and impede adult smokers’ ability to switch to its Reduced‑Risk Products (RRPs) – “requirements that lead to a commoditisation of tobacco products or impede adult consumer’s ability to convert to our RRPs” (2022 p.13‑15). By 2023 the same risk language still applied to RRPs but the filing added that product regulation now “diminishes the ability to differentiate … and restricts adult consumer access to truthful … information about our SFPs” (2023 p.19‑20), and in the 2024 filing the focus shifted entirely to Smoke‑Free Products, repeatedly stating that regulation limits product differentiation and truthful adult‑consumer communication for SFPs (2024 p.17‑21). This evolution shows regulatory constraints have intensified and broadened from RRPs to the wider smoke‑free portfolio, increasingly curbing PMI’s ability to differentiate its reduced‑risk offerings and to communicate with adult consumers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the evolution of regulatory constraints on PMI's competitive positioning from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with accurate temporal sequencing; (2) Accurately captures the shift from RRPs focus in 2022-2023 to SFPs focus in 2024; (3) Correctly identifies key regulatory concerns: commoditization, product differentiation restrictions, and limitations on adult consumer communication; (4) Properly synthesizes multi-hop information showing how regulatory language evolved across filings; (5) Page references (2022 p.13-15, 2023 p.19-20, 2024 p.17-21) demonstrate document-specific sourcing; (6) Accurately quotes or paraphrases regulatory concerns about 'commoditisation' and restrictions on 'truthful information'; (7) Correctly identifies the strategic product transition from RRPs to SFPs. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention the 2023 point about 'digital media spreading misleading information about RRPs' that appears in the ground truth - this is a notable omission of a specific regulatory concern; (2) The ground truth emphasizes 'regulatory asymmetries' and 'unfair competition' more explicitly than the LLM answer does; (3) The LLM answer could have been more explicit about how regulation 'disproportionately impacted' PMI relative to competitors, though this is implied. QUANTITATIVE ACCURACY: No numerical calculations required; dates and years are all correct (2022, 2023, 2024). QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information across three years of filings and identifies the logical progression of regulatory constraints. The semantic meaning aligns well with the ground truth despite different wording. CONTEXTUAL RELEVANCE: The answer directly addresses the question's core inquiry about how regulatory impact evolved and what it reveals about constraints on product differentiation and communication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 548,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s filings show that its margin‑risk exposure has been essentially unchanged from 2022 through 2024. In each year the company says it “recognizes fees … on a gross basis as transaction revenue when we are the principal … We have full discretion in determining the fee … independent of the costs we incur when we may utilize payment processors … We therefore bear full margin risk” (2022 Note 2 – page 80; 2023 Note 2 – page 78; 2024 Note 2 – page 75). Its contracts remain open‑ended with volume‑tiered pricing that can adjust fees up or down, and it continues to provide merchant‑ and consumer‑incentives (discounts, rebates, rewards, coupons) that are recorded as reductions to transaction revenue (2022 Note 2 – page 80; 2023 Note 2 – pages 78‑81; 2024 Note 2 – page 75). Thus, PayPal’s margin‑risk exposure has stayed consistent – it remains the principal, bears full margin risk despite using payment processors, and offsets revenue with incentives, with no material change over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies PayPal's consistent full margin risk exposure across 2022-2024; (2) Accurately cites the key principle that PayPal is the principal with full discretion in fee-setting independent of processor costs; (3) Properly documents the use of merchant and consumer incentives (discounts, rebates, rewards, coupons) recorded as revenue reductions; (4) Correctly references Note 2 disclosures across all three years with appropriate page numbers; (5) Accurately characterizes the margin risk as stable/unchanged across the period; (6) Properly synthesizes multi-hop information about transaction pricing models, payment processor relationships, and incentive structures. MINOR GAPS: (1) The LLM answer emphasizes 'no material change' and 'essentially unchanged' more strongly than the ground truth, which notes 'increasing detail around incentives and transaction pricing' and 'more nuanced disclosure' in later years - this represents a subtle difference in emphasis rather than factual error; (2) The ground truth mentions that incentives are 'recognized as a reduction of revenue depending on performance targets or amortized over the contractual term,' while the LLM simply states they are 'recorded as reductions to transaction revenue' - this omits the nuance about performance targets and amortization methods, though the core fact is correct; (3) The LLM could have been more explicit about the evolution of disclosure detail, though it does note the consistency of the underlying exposure. QUANTITATIVE VERIFICATION: All page numbers and note references appear accurate and consistent with typical 10-K formatting. No calculations are required for this question. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple disclosure elements (transaction pricing, processor relationships, incentives) to reach a coherent conclusion about margin risk evolution. The reasoning is sound and well-documented with specific citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 554,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s filings show a steady strategy: in 2022 it said its agreements with AIB manufacturers “protect their inventory of our products against price reductions” and that SIs “often use discrete graphics solutions as a means to differentiate their products” (2022 p13). The 2023 and 2024 reports repeat the same inventory‑protection clause (2023 p11; 2024 p11) and continue to stress that discrete graphics are a key differentiator for system integrators, with only minor wording tweaks (e.g., clearer reference to direct sales to SIs) but no substantive change in policy.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that AMD maintained inventory protection policies consistently across 2022-2024, which aligns with ground truth. (2) Correctly notes that discrete graphics solutions are emphasized as a differentiator for SIs across all years. (3) Page references appear reasonable and specific. (4) Accurately captures that the core policy remained stable with minor wording changes.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely misses the key evolution identified in the ground truth - the 2024 shift toward 'more strategic alignment with SIs' and 'deepening of the value proposition.' The ground truth explicitly states there was a 'subtle shift in language' in 2024 indicating strategic evolution, but the LLM dismisses this as 'only minor wording tweaks' with 'no substantive change.' This is a significant mischaracterization of the multi-hop synthesis required. (2) The LLM fails to capture the nuanced distinction between 2022-2023 language (AIBs selling to SIs/retailers/sub-distributors) versus 2024 language (SIs selling based on regional/product strengths and responding to new technologies). (3) The answer characterizes the evolution as 'steady' and 'no substantive change,' which contradicts the ground truth's identification of a meaningful strategic shift in 2024. (4) Missing the contextual detail about how the relationship deepened within the broader ecosystem by 2024.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting inventory protection policies across years and linking discrete graphics to SI differentiation. However, it fails at the more sophisticated multi-hop task of identifying how the strategic relationship evolved and deepened over time, which requires synthesizing subtle language changes across multiple filings to identify strategic intent.\n\nSEMANTIC ACCURACY: While the LLM's statements about inventory protection and discrete graphics are factually correct, the overall semantic meaning diverges from ground truth by characterizing the evolution as static rather than dynamic. The ground truth emphasizes evolution and deepening; the LLM emphasizes consistency and minimal change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 588,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney’s investment‑credit policy has been steady on the credit‑rating and collateral fronts – the company only trades derivatives with counterparties that have a rating of A‑minus or better and it requires collateral whenever a counterparty’s rating falls below A‑minus or the exposure exceeds the contractual limits (DIS 2024 10‑K, p. 119). The concentration rule – limiting any one institution’s exposure to roughly 10 % of total cash and cash equivalents – was in place in fiscal 2022 (no institution breached the limit) and was reaffirmed in fiscal 2023 (DIS 2023 10‑K, p. 120). By fiscal 2024, while the rating and collateral requirements remained unchanged, the company disclosed that balances with institutions exceeding the 10 % cap amounted to 24 % of total cash and cash equivalents, indicating a higher concentration within the same policy framework (DIS 2024 10‑K, p. 119).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key claims: (1) Counterparty credit rating requirement of A- or better - CORRECT, matches ground truth exactly. (2) Collateral requirements when ratings fall below A- or exposures exceed contractual limits - CORRECT, properly synthesized. (3) Concentration threshold of approximately 10% - CORRECT, the LLM appropriately characterizes this as 'roughly 10%' which is semantically equivalent to the policy framework. (4) Fiscal 2022 status: no institution breached the limit - CORRECT. (5) Fiscal 2023 reaffirmation - CORRECT, properly documented. (6) Fiscal 2024 concentration at 24% - CORRECT, matches ground truth exactly. (7) Multi-hop synthesis: The answer successfully traces the evolution across three fiscal years, correctly identifying that while the policy framework remained unchanged, actual practice diverged with the 24% concentration. The reasoning is sound - the company maintained consistent credit rating and collateral policies while experiencing a significant shift in cash concentration with a single institution. The LLM provides specific page citations (p. 119 for 2024, p. 120 for 2023) which adds credibility. Minor observation: The LLM uses 'roughly 10%' rather than stating an exact threshold, but this is appropriate given the policy language typically uses ranges. The answer fully addresses all three components of the question (counterparty credit ratings, collateral requirements, and concentration thresholds) and correctly synthesizes the evolution across the three-year period. No calculation errors detected. All entities (Disney, fiscal years, percentages) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 459,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s holding of the 2029‑maturing Fixed‑rate 2.850 % notes stayed at $1.5 billion in each of the three years – $1.5 bn in 2022【page_108†L21-L21】, $1.5 bn in 2023【page_107†L14-L14】 and $1.5 bn in 2024【page_104†L15-L15】. The unchanged amount signals a deliberate strategy to keep a stable, long‑dated debt tranche, locking in a low fixed rate and providing predictable financing while avoiding frequent refinancing or early retirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metric. Strengths: (1) All three years' amounts are correctly stated as $1.5 billion (2022, 2023, 2024), matching the ground truth exactly. (2) The interest rate (2.850%) and maturity year (2029) are correctly identified. (3) The core finding that the amount remained unchanged across all three years is accurate. (4) The reasoning about strategic debt management is sound and aligns with the ground truth interpretation. (5) The answer correctly synthesizes multi-year data to identify a pattern. Minor areas for improvement: (1) The LLM answer omits the specific context about PYPL issuing new higher-interest debt in 2023 and 2024 (5.150% and 5.500% notes), which the ground truth mentions as important context for understanding the strategic decision to retain the 2.850% notes. This omission slightly weakens the completeness of the multi-hop analysis, though the core answer remains correct. (2) The phrasing 'locking in a low fixed rate' is accurate but could have been more explicitly contrasted with the newer, higher-rate debt issuances. The quantitative accuracy is excellent (all dollar amounts and years correct), and the qualitative reasoning about debt management strategy is sound, though not quite as comprehensive as the ground truth answer. The answer successfully addresses the multi-year pattern question and provides appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 408,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s filings repeatedly flag raw‑material demand‑and‑supply volatility as a material risk for its Performance Materials and Technologies segment (renamed Energy and Sustainability Solutions in later years) – 2022: “Performance Materials and Technologies … raw material demand and supply” [page_31]; 2023/2024: “Energy and Sustainability Solutions … raw material demand and supply” [page_31]. In the 2022 report only 63% of the segment’s raw‑material supply base was under contract (as of 12/31/2021) [page_33]; the 2023 and 2024 reports state that a **majority** of the supply base is now contracted [page_31] [page_33]. This shift toward greater contract coverage shows Honeywell is trying to lock in supply, but the persistent mention of demand‑supply risk signals that the company remains exposed to commodity‑market volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) LLM correctly identifies the segment name change from Performance Materials and Technologies to Energy and Sustainability Solutions; (2) Correctly notes the persistent mention of raw material demand and supply risks across years; (3) Appropriately concludes that despite mitigation efforts, vulnerability to commodity volatility remains; (4) Contextually relevant to the question about evolution and vulnerability. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites '63% of the segment's raw-material supply base was under contract (as of 12/31/2021)' but provides no source verification and this specific metric does not appear in the ground truth answer, raising accuracy concerns; (2) The LLM introduces a specific contractual coverage metric (63% → majority) that is NOT mentioned in the original answer, suggesting either fabrication or unsupported inference from filings; (3) Missing key contextual details from ground truth: no mention of product commoditization risk (2022), no mention of oil/natural gas price volatility impact on customer investment (2023), no mention of production capacity maximization and downtime minimization (2024); (4) The answer oversimplifies the evolution by focusing narrowly on contract coverage rather than the broader risk evolution described in ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but does so incompletely and with potentially unsupported numerical claims. The reasoning about contract coverage as a mitigation strategy is logical but not grounded in the provided ground truth. SEMANTIC ISSUES: While the conclusion about sustained vulnerability is correct, the path to that conclusion relies on unverified quantitative claims that undermine credibility. The answer reads as partially fabricated rather than extracted from actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 505,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Imperial Brands PLC was named as a member of PMI’s peer group in the 2022 filing (see the list on page 21), and the same company appears in the peer‑group lists for both 2023 (page 26) and 2024 (page 26). Its continuous presence indicates that PMI’s benchmarking strategy relies on a stable set of large, globally‑present tobacco and consumer‑product firms of comparable size, emphasizing consistency in its performance comparisons over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The core claim that Imperial Brands PLC was consistently included in PM's peer group across 2022, 2023, and 2024 is accurate and matches the ground truth. The LLM correctly identifies the company name and the three-year period. (2) QUANTITATIVE ACCURACY: While the LLM provides page references (pages 21, 26, 26) which cannot be verified against the ground truth provided, these are supplementary details that enhance credibility without contradicting the core facts. The temporal consistency claim (all three years) is correct. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate filings (2022, 2023, 2024) and correctly identifies the pattern of consistency. The reasoning that this reflects a stable benchmarking strategy is sound and matches the ground truth's interpretation. (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth: Imperial Brands remained consistently in the peer group, indicating stable benchmarking focused on comparable global companies. The LLM's phrasing about 'large, globally-present tobacco and consumer-product firms of comparable size' is semantically equivalent to the ground truth's description of 'companies with similar global presence, revenue scale, and market capitalization.' (5) MINOR CONSIDERATIONS: The LLM uses 'PMI' while the ground truth uses 'PM' - these are equivalent references to Philip Morris International. The LLM provides slightly more specific detail about the filing pages, which adds value without introducing errors. No calculations are required for this question, so quantitative accuracy focuses on the consistency claim itself, which is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 492,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes (maturing 10/1/2029) was $1.5 billion in 2022, remained $1.5 billion in 2023, and stayed at $1.5 billion in 2024【page_107】【page_104】. The flat‑line exposure over three years shows that the company has been maintaining this low‑cost, long‑dated debt rather than expanding or retiring it, reflecting a strategy of preserving a stable, predictable long‑term financing structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($1.5 billion for 2022, 2023, and 2024), the interest rate (2.850%) is accurate, and the maturity date (10/1/2029) is correctly identified. The three-year progression is accurately captured with no calculation errors. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how exposure evolved (remained stable at $1.5B across all three years), and (2) what this indicates about debt management strategy (maintaining low-cost, long-dated debt with stable financing structure). ENTITY ACCURACY: Company correctly identified as PayPal (PYPL), years correctly specified (2022-2024), and the specific debt instrument properly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identified the pattern (flat-line exposure) and drew appropriate conclusions about strategic intent (preserving stable, predictable financing rather than expanding or retiring the debt). The reasoning aligns with the ground truth interpretation that PYPL prioritized maintaining this specific liability. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'preserving a stable, predictable long-term financing structure' is semantically equivalent to the ground truth's 'maintaining a consistent long-term liability position' and 'leveraging the low fixed rate as part of a broader capital structure strategy.' Minor difference: The LLM provides additional context (maturity date 10/1/2029) not explicitly in the ground truth, which adds value without contradicting it. The answer is comprehensive, accurate, and demonstrates proper multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 474,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "In 2022 ConocoPhillips said its HSE audits were performed on each business unit and staff group to verify conformance with the company’s HSE policies, standards and practices, with any corrective actions identified and tracked to completion (COP 2022 10‑K p. 18). By the 2023 filing the audit scope remained the same, but the company added that audit objectives, targets and progress are formally tracked and reported to the Executive Leadership Team and the Board of Directors (COP 2023 10‑K p. 18). The 2024 filing renamed the process “Corporate HSE audits,” kept the business‑unit‑and‑staff‑group coverage, continued to track improvement actions, and again emphasized reporting to the ELT and Board, signalling a tighter integration with corporate governance (COP 2024 10‑K p. 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) All dates and years are correct (2022, 2023, 2024). (2) All entities correctly identified: ConocoPhillips, Executive Leadership Team (ELT), Board of Directors. (3) Multi-hop synthesis is sound - the answer correctly traces the evolution across three years, identifying specific changes at each stage. (4) Key factual claims are accurate: 2022 audits covered business units and staff groups with corrective action tracking; 2023 added formal reporting to ELT and Board; 2024 renamed to 'Corporate HSE audits' and emphasized governance integration. (5) The answer correctly identifies the progression from localized conformance checks to governance-driven oversight. (6) Page references (p. 18 for all three years) are consistent and plausible. (7) Semantic equivalence is maintained - the LLM captures the same evolution narrative as the ground truth. MINOR CONSIDERATIONS: (1) The LLM uses 'renamed the process' for 2024 while ground truth says 'specifying that audits were conducted at the corporate level' - these are semantically equivalent descriptions of the same shift toward centralized oversight. (2) The LLM notes 'kept the business-unit-and-staff-group coverage' in 2024, which is a reasonable inference about continuity, though the ground truth emphasizes the 'corporate level' specification as the key change. This is not an error but a slightly different emphasis. (3) All three dimensions of the question are addressed: audit scope evolution, conformance tracking integration, and corporate governance linkage. The answer demonstrates clear understanding of the multi-hop nature of the question by synthesizing information across three separate filing years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 483,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "AMD’s 10‑K filings have kept the 2011 Executive Incentive Plan on the books each year. In the 2022 report the plan is listed as Exhibit 10.1 and incorporated by reference (see page 93); the 2023 filing again includes it as Exhibit 10.1 among a larger set of compensation‑plan exhibits (see page 101); and the 2024 filing likewise incorporates the same 2011 plan as Exhibit 10.1 (see page 98). Thus, even as AMD added newer equity‑incentive, ESPP and amendment documents, the 2011 Executive Incentive Plan remained a continuously‑referenced, foundational governance document in its executive‑compensation disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's reliance on the 2011 Executive Incentive Plan across 2022-2024. STRENGTHS: (1) Correctly identifies the plan as Exhibit 10.1 across all three years (2022, 2023, 2024), matching the ground truth exactly; (2) Accurately conveys the core finding that the plan remained a foundational governance document with no material changes; (3) Properly synthesizes the multi-hop information showing continuity across three fiscal years; (4) Correctly notes that newer compensation mechanisms were added while the 2011 plan remained foundational; (5) Provides specific page references (93, 101, 98) that add credibility and detail. MINOR WEAKNESSES: (1) The LLM answer includes specific page numbers that are not present in the ground truth, which could be either accurate additional detail or potentially inaccurate citations - this creates slight uncertainty; (2) The ground truth explicitly mentions other plans (AMD Executive Severance Plan, AMD Deferred Income Account Plan) as context, while the LLM answer is more general about 'newer equity-incentive, ESPP and amendment documents' - this is a minor omission of specific plan names but doesn't affect the core answer; (3) The phrase 'kept the books' is slightly informal compared to the ground truth's more formal language, though semantically equivalent. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) and exhibit numbers (10.1) are correct. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple filings to show the evolution (or lack thereof) of AMD's reliance on the 2011 plan. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - consistent citation, foundational role, no material changes, continuity despite other plan additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 530,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑K filings GM repeatedly noted that, under the 2017 sale of the Opel/Vauxhall business, it indemnifies Stellantis for any emissions‑related claims and legacy recalls, that those obligations are subject to time‑limits, thresholds and caps, and that the amount for the Takata‑related recalls is immaterial with no material loss estimate possible (2022 p.90; 2023 p.93; 2024 p.93). The unchanged language each year shows GM’s exposure to post‑sale liabilities from the transaction remains limited, uncertain and considered remote.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer captures some correct elements but significantly misses the core narrative of how GM's exposure evolved from 2022-2024. CORRECT ELEMENTS: (1) Correctly identifies the 2017 Opel/Vauxhall sale and indemnification obligations to Stellantis; (2) Correctly notes that Takata-related recalls are immaterial; (3) Correctly references page numbers (90, 93, 93) for the three years; (4) Correctly identifies that obligations have time-limits, thresholds and caps. CRITICAL OMISSIONS AND ERRORS: (1) The LLM states 'unchanged language each year' which directly contradicts the ground truth showing EXPANSION of geographic and legal scope - the ground truth explicitly documents progression from 2022 (general emissions/recalls) → 2023 (Germany, UK, Netherlands lawsuits + Takata recalls) → 2024 (Austria added + European Commission and UK CMA investigations); (2) Fails to capture the key evolution showing WIDENING legal exposure across multiple jurisdictions; (3) Misses the new regulatory investigations (European Commission and UK CMA) mentioned in 2024; (4) Fails to synthesize the multi-hop information showing how the complexity and persistence of post-sale liabilities increased over time; (5) The conclusion that exposure 'remains limited, uncertain and considered remote' is partially correct but misses the critical point that the SCOPE and COMPLEXITY expanded significantly despite the remote likelihood assessment. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year progression across the three 10-K filings. The ground truth shows a clear evolution pattern (geographic expansion, new regulatory actions, new jurisdictions), but the LLM treats all three years as essentially identical. This is a fundamental failure in multi-hop synthesis. The question specifically asks 'how did...evolve' and 'what does this progression indicate' - the LLM's answer that language was 'unchanged' directly contradicts the documented evolution. SEMANTIC ISSUE: While the LLM correctly identifies that further indemnification is considered remote, it misses the nuance that the INCREASING NUMBER OF LEGAL AND REGULATORY ACTIONS indicates growing complexity, which is the key insight about post-sale liability exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 600,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 Eli Lilly still owed AbCellera “tiered” royalties of roughly the mid‑teens to mid‑twenties percent of net sales on bamlanivimab (and bebtelovimab), which were recorded as a cost‑of‑sales expense 【page_72】. That year the antibody line – which includes bamlanivimab – generated about $2.0 billion of revenue ($2,008.9 m U.S. plus $14.7 m outside the U.S.) 【page_67】. By 2023 the “COVID‑19 antibodies” line showed no revenue (‑) and the same is true in 2024 【page_67】【page_68】, eliminating the royalty outlay and indicating that the product’s financial exposure has essentially vanished. This pattern shows that bamlanivimab was a pandemic‑driven, short‑term revenue driver, but its long‑term strategic importance to Lilly has faded as sales and associated royalty obligations have dropped to zero.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across Eli Lilly's 10-K filings from 2022-2024. QUANTITATIVE VERIFICATION: All numbers are correct - $2,008.9M U.S. revenue in 2022 matches ground truth exactly, the $14.7M international component is included (total ~$2.0B), royalty percentages (mid-teens to mid-twenties) are accurate, and the zero revenue figures for 2023-2024 are confirmed. The calculation of total 2022 revenue ($2,008.9M + $14.7M ≈ $2.0B) is accurate. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple filing sections: (1) revenue data from financial statements, (2) royalty obligation details from cost-of-sales disclosures, (3) temporal evolution across three fiscal years, and (4) strategic implications. ENTITY ACCURACY: Eli Lilly (LLY), AbCellera, bamlanivimab, and bebtelovimab are all correctly identified. The distinction between U.S. and international revenue is properly noted. REASONING QUALITY: The logical progression from pandemic-driven revenue ($2B in 2022) → complete phase-out (zero revenue 2023-2024) → elimination of royalty obligations is sound and well-supported. The conclusion about strategic importance fading is appropriately grounded in the financial data. MINOR OBSERVATIONS: The answer includes page citations (page_72, page_67, page_68) which enhance credibility. The inclusion of bebtelovimab alongside bamlanivimab is accurate and shows nuanced understanding. The characterization as 'pandemic-driven, short-term revenue driver' aligns with ground truth assessment. No calculation errors detected. The answer fully addresses all components of the multi-part question regarding financial exposure evolution, royalty obligations, revenue contribution, and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 493,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the three filings, PMI repeatedly lists Jackpot as one of its “important local cigarette brands” in the Philippines – 2022 (p.5), 2023 (p.5) and 2024 (p.5) all describe “Fortune and Jackpot” as key local brands. The unchanged wording shows that PMI has kept Jackpot firmly in its portfolio, using it to reinforce its presence in a core market while its global flagship (Marlboro) drives overall volume. This three‑year consistency reveals a deliberate strategy of pairing strong international brands with locally‑strong products to sustain market share in key regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies Jackpot as a key local cigarette brand in the Philippines across all three years; (2) Accurately cites the consistent pairing of 'Fortune and Jackpot' as local brands; (3) Properly references page 5 across all three filings, showing document-specific accuracy; (4) Correctly interprets the strategic implication of this consistency - a dual strategy balancing local brands with international flagships; (5) Accurately identifies Marlboro as the global flagship brand; (6) Demonstrates sound multi-hop reasoning by synthesizing information across three separate filings to identify a pattern. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth and omits some contextual nuance about PMI's 'broader strategic pivot toward smoke-free products and wellness' mentioned in the original answer - this is a meaningful strategic context that adds depth to understanding the full picture; (2) The phrase 'unchanged wording' is accurate but the ground truth provides more explicit framing about how this consistency 'highlights PMI's dual strategy' which the LLM captures but with less elaboration on the tension between maintaining cigarette brands while transitioning to smoke-free products. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correct; page references (p.5) are consistent across all three years as stated; brand names (Jackpot, Fortune, Marlboro) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the pattern across three separate filings and draws the appropriate strategic conclusion about market positioning. The logic connecting local brand consistency to market competitiveness is valid and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 515,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal warned that its credit‑product portfolio and BNPL loans were vulnerable to defaults, charge‑offs and evolving fraud schemes, and that heavy reliance on third‑party lenders and processors could amplify loss exposure (2022 10‑K – credit‑default risk [p. 26]; fraud‑loss risk [p. 28]; third‑party‑risk [p. 26]). In 2023 the company began to off‑load that BNPL risk by signing a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, while still flagging persistent fraud and third‑party disruption risks (BNPL‑sale [p. 23]; fraud‑risk [p. 24]; third‑party‑risk [p. 25]). By 2024 the BNPL exposure had largely been transferred, leaving the primary bad‑transaction exposure tied to its remaining credit products and ongoing fraud/processing‑risk concerns (credit‑product default risk [p. 22]; fraud‑risk [p. 24]; third‑party‑risk [p. 23]).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the €40 billion BNPL receivables sale in 2023 as a key risk-mitigation event; (2) Accurately captures the three-year evolution: 2022 (growing exposure/fraud risks), 2023 (partial offloading via sale), 2024 (reduced but persistent risks); (3) Properly identifies all major risk categories: fraud, synthetic identities, third-party dependencies, defaults/charge-offs; (4) Correctly notes the multi-year nature of the agreement and ongoing execution/regulatory uncertainties; (5) Appropriately emphasizes that while direct exposure decreased, underlying risks remained. MINOR WEAKNESSES: (1) The LLM answer includes specific page number citations (p. 26, p. 28, etc.) that cannot be verified against the ground truth and appear to be fabricated details—while this doesn't affect factual accuracy, it represents a minor integrity issue; (2) The answer is somewhat more concise than the ground truth, omitting minor details about synthetic identities and account takeover attempts, though these are not critical to answering the core question; (3) The phrase 'largely been transferred' in 2024 is slightly less precise than the ground truth's acknowledgment of 'uncertainty remained,' though both convey the essential point. QUANTITATIVE VERIFICATION: The €40 billion figure is correct and properly attributed to the 2023 sale. The temporal sequence (2022→2023→2024) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk dimensions (credit products, BNPL, fraud, third-party processing), correctly showing how the 2023 sale represented a strategic shift in risk management while acknowledging persistent vulnerabilities. The logic flow is sound and matches the ground truth's narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1615,
        "completion_tokens": 518,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022 the Safety & Productivity Solutions segment saw sales dip about 1 percent as weaker retail demand and the divestiture of its retail‑footwear business trimmed revenue 【page_29】. By 2024, after the realignment, that same exposure is carried into the new Industrial Automation segment, whose 10‑K risk factor warns that “fluctuations in retail markets” could depress operating results, margins and market share 【page_30】. The 2023 filing already flagged retail‑market volatility as a key macro‑economic risk for Safety & Productivity Solutions, showing that Honeywell’s industrial portfolio remains consistently sensitive to swings in retail demand across its businesses 【page_31】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year progression (2022, 2023, 2024) of retail market exposure across Honeywell's segments, properly names the Safety & Productivity Solutions and Industrial Automation segments, and accurately captures the core risk narrative about retail market fluctuations impacting demand, margins, and market share. The multi-hop synthesis across years and segments is logically sound and addresses the evolution question well. The semantic understanding of the risk progression is accurate.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR: The LLM states 'sales dip about 1 percent' for 2022 - this specific percentage is not verified in the ground truth and appears to be an unsupported claim. The ground truth mentions 'reduced investments' and 'reduced demand' but does not cite a specific 1% figure. (2) INCOMPLETE GROUNDING: The LLM cites page numbers (page_29, page_30, page_31) but these cannot be verified against the ground truth, which does not provide specific page references. (3) MISSING DETAIL: The ground truth emphasizes that this was identified as a 'key risk factor' in 2022 and 'reiterated' in 2023 as part of 'broader macroeconomic and industry risks' - the LLM captures the essence but omits the explicit characterization of these as formal risk factors. (4) DIVESTITURE MENTION: The LLM mentions 'divestiture of its retail-footwear business' which is not mentioned in the ground truth and may be an inference or hallucination.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and two business segments, showing how the same risk persisted through reorganization. This multi-hop reasoning is sound and matches the ground truth's narrative arc.\n\nOVERALL: The answer captures the essential narrative and demonstrates good understanding of the question's complexity, but the unsupported 1% figure and unverified page citations, combined with the divestiture claim not in ground truth, reduce confidence in factual accuracy despite strong conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 551,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 to 2024 the Incyte‑LLY deal kept the same royalty framework – Incyte receives tiered double‑digit royalties (up to 20 % of worldwide net sales) plus an extra low‑teens royalty on COVID‑19 sales – but the large milestone payments that were capitalized in earlier years ($260 million and $210 million) have become non‑material, with Incyte now only eligible for up to $100 million of additional sales‑based milestones each year (2022‑2024)【page_72】【page_73】【page_73】.  At the same time Olumiant’s contribution to LLY’s top line has grown, rising from $830.5 million of net product revenue in 2022 to $922.6 million in 2023 and $957.4 million in 2024, underscoring its increasing strategic importance【page_73】【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - CRITICAL FAILURES: The LLM states milestone payments of '$260 million and $210 million' but the ground truth specifies $260.0 million in 2022 with up to $200.0 million in contingent payments (not $210M). More critically, the LLM claims Incyte is 'only eligible for up to $100 million of additional sales-based milestones each year (2022-2024)' - this contradicts the ground truth which states $200.0 million in contingent payments were available. The LLM provides Olumiant revenue figures ($830.5M in 2022, $922.6M in 2023, $957.4M in 2024) that are NOT mentioned in the ground truth answer, making them unverifiable against the source material. (2) INCOMPLETE SYNTHESIS: The LLM fails to address key elements from the ground truth: (a) the specific tiered royalty structure details (up to 20% on general sales PLUS additional low-teens royalty for COVID-19 sales threshold), (b) the evolution from capitalized milestone payments in 2022 to ongoing revenue recognition in 2023, (c) the strategic shift toward Olumiant's expanded use including EUA and follow-on compounds by 2024, (d) the characterization of the partnership's maturation from 2022-2024. (3) REASONING ISSUES: The LLM oversimplifies the evolution by claiming the 'royalty framework' stayed the same while missing the strategic evolution in how LLY recognized and positioned these obligations. The statement about milestones becoming 'non-material' is not supported by ground truth language. (4) ENTITY/METRIC ACCURACY: While company names and years are correct, the financial metrics are either incorrect (milestone amounts) or unverified (Olumiant revenue figures). The ground truth emphasizes strategic positioning evolution; the LLM focuses narrowly on revenue growth without addressing the broader strategic alignment and therapeutic expansion mentioned in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 512,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "In the 2022 filing Altria already owned UST LLC outright and recorded the MST and snus trademarks it acquired with UST as $8.8 billion of indefinite‑lived intangible assets (the bulk of its $11.4 billion indefinite‑lived intangible‑asset pool)【page_64】.  The 2023 and 2024 reports continue to list UST (through its wholly‑owned subsidiary USSTC) as a 100 %‑owned subsidiary【page_60】, and the intangible‑asset balance still reflects those UST trademarks, while the business description now places USSTC in the oral‑tobacco segment as the “leading producer and marketer of MST products” and frames it as a key pillar of Altria’s Vision to transition adult smokers to a smoke‑free future【page_4】【page_5】.  Thus, from 2022‑2024 Altria’s financial exposure to UST remained a fully‑owned, trademark‑driven intangible asset base that is explicitly integrated into its broader smoke‑free transition strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numbers are correct: $8.8 billion in MST/snus trademarks, $11.4 billion total indefinite-lived intangible assets, 100% ownership structure. (2) Correctly identifies UST as wholly-owned subsidiary through USSTC across all three years. (3) Accurately captures the strategic evolution from 2022-2024, noting the shift toward smoke-free transition framing. (4) Properly synthesizes multi-hop information: ownership structure + intangible asset valuation + strategic positioning. (5) Correctly identifies USSTC as the operating entity for MST production. MINOR GAPS: (1) The LLM answer does not explicitly mention the newer alternatives (Helix oral nicotine pouches and NJOY e-vapor) that the ground truth identifies as part of Altria's broader diversification strategy. While the LLM notes the 'smoke-free transition strategy' framing, it doesn't detail how UST's traditional MST business was 'increasingly complemented by newer, potentially less harmful tobacco alternatives.' (2) The answer could have been more explicit about the 'strategic evolution' aspect - the ground truth emphasizes that while UST remained a core asset, it was being strategically diversified around. The LLM captures this implicitly but doesn't articulate it as clearly. QUANTITATIVE VERIFICATION: All dollar amounts ($8.8B, $11.4B) and percentages (100%) are accurate. No calculation errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (ownership, valuation, strategic positioning), though it could have more explicitly connected UST's role to the broader portfolio strategy. The reasoning is sound and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 494,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50 % senior note showed a sharp rise in its effective cost: in FY 2022 the note carried an effective rate of about 3.2 %【page_89】; by FY 2023 the effective rate had climbed to roughly 6.4 %【page_89】; and in FY 2024 it was about 6.7 %【page_89】. The more‑than‑doubling of the effective rate signals that borrowing costs on this fixed‑rate debt have risen sharply as market interest rates have increased, reflecting tighter capital‑market conditions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: FY2022 effective rate of 3.2% matches ground truth (3.20%), FY2023 rate of 6.4% matches ground truth (6.38% - minor rounding acceptable), FY2024 rate of 6.7% matches ground truth (6.66% - minor rounding acceptable). All three fiscal years are correctly identified and the progression is accurately captured. The LLM correctly synthesizes the multi-hop information by: (1) identifying the specific debt instrument (3.50% Senior Note), (2) tracking the effective interest rate evolution across three fiscal years, and (3) interpreting the trend's implications for borrowing costs and capital market conditions. The reasoning is sound - the observation that effective rates more than doubled reflects tightening capital market conditions is logically consistent with the data presented. The answer appropriately addresses both parts of the question: the evolution of interest rate exposure AND what it indicates about borrowing costs and capital market conditions. Minor deviations from ground truth are negligible: the LLM uses 'about 6.4%' and 'about 6.7%' which are reasonable approximations of 6.38% and 6.66%, and this level of rounding is standard practice in financial reporting. The semantic meaning is fully preserved - the answer conveys the same critical information as the ground truth regarding the significant upward trend and its market implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 401,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s unsecured senior “2017 Notes” fell from $16 billion at 12/31/2022 to $15 billion at 12/31/2023, and then to $13 billion at 12/31/2024【page_58】【page_57】. The consistent drop—$1 billion in the first year and $2 billion in the next—shows Amazon is actively repaying or redeeming this tranche, indicating a disciplined debt‑reduction strategy aimed at lowering leverage and interest costs while preserving balance‑sheet flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $16 billion (2022), $15 billion (2023), $13 billion (2024). The year-over-year reductions are accurately stated ($1 billion decline 2022-2023, $2 billion decline 2023-2024). Dates are correctly formatted (12/31/2022, 12/31/2023, 12/31/2024). ENTITY ACCURACY: Correctly identifies the instrument as 'unsecured senior 2017 Notes' and properly attributes to Amazon. MULTI-HOP REASONING: The answer successfully synthesizes the evolution of this specific debt instrument across three years and connects it to Amazon's broader debt management strategy. The observation about accelerating repayment ($1B then $2B) is accurate and insightful. COMPLETENESS: Addresses both parts of the question - the balance evolution AND what it indicates about debt management strategy. The answer goes slightly beyond the ground truth by noting the acceleration pattern and mentioning specific strategic benefits (lowering leverage, interest costs, balance-sheet flexibility), which adds valuable context without contradicting the ground truth. MINOR DIFFERENCES: The ground truth mentions the broader context of total long-term debt reduction ($67.2B to $52.6B), which the LLM answer does not include. However, this is a minor omission that doesn't significantly detract from the core answer about the 2017 Notes specifically. The LLM's focus on the specific instrument is appropriate given the question's primary focus. SEMANTIC EQUIVALENCE: The phrase 'actively repaying or redeeming' accurately captures the debt reduction mechanism, and 'disciplined debt-reduction strategy' is semantically equivalent to the ground truth's 'deliberate debt management strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 480,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 have shown no change over the three‑year period – the notes carried an outstanding principal of $606 million and an effective interest rate of 5.18 % in fiscal 2023 and fiscal 2024 (as shown in the 2024 10‑K table) and the 2022 filing reported the same balance and rate (AVGO 10‑K 2022, pp. 101‑105). This flat trajectory signals that the company has chosen to keep the instrument on its balance sheet as a stable, low‑cost, long‑dated source of financing rather than accelerating repayment or refinancing it. 【page_81】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $606 million principal balance, 5.18% effective interest rate, April 2030 maturity date. The three-year period (fiscal 2022-2024) is correctly identified. COMPLETENESS: The answer addresses all key aspects of the question: (1) outstanding principal balance evolution, (2) interest rate progression, (3) multi-year comparison across all three fiscal years, and (4) interpretation of debt management strategy. ENTITY ACCURACY: AVGO correctly identified, fiscal years 2022-2024 properly referenced, note characteristics accurately described. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the pattern (no change) and its strategic implication (static approach, stable financing). SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'keeping the instrument on its balance sheet as a stable, low-cost, long-dated source of financing' is semantically equivalent to the ground truth's 'maintained a static approach...neither accelerating repayments nor issuing additional tranches.' Minor note: The LLM references specific page numbers (pp. 101-105 for 2022 filing, page_81 for 2024) which adds credibility but wasn't in the ground truth. The answer is slightly more concise than the original but captures all essential information with appropriate analytical depth. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 419,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- In the 2022 Form 10‑K the Performance Bonus Plan was disclosed only as the original plan (exhibit 10.6, a 2014 Def 14A filing) and was not restated or tied to any new executive‑agreement language【page_66】.  \n- In the 2023 filing Netflix filed an **Amended and Restated Performance Bonus Plan** (exhibit 10.5, filed December 9 2022), which superseded the 2014 plan and was incorporated by reference into the executives’ compensation agreements for the co‑CEOs and other officers【page_69】.  \n- The 2024 Form 10‑K continues to reference the same amended‑and‑restated plan (exhibit 10.5, same December 2022 filing) and lists it alongside the signatures of the co‑CEOs, showing that the restated plan has become the formal, integrated component of Netflix’s executive compensation framework【page_68】【page_70】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) All dates are correct - the December 9, 2022 filing date for the Amended and Restated Performance Bonus Plan is accurate; (2) The chronological evolution is properly traced: 2022 (original plan referenced), 2023 (amended and restated plan introduced), 2024 (continued integration); (3) The multi-hop synthesis is sound - the answer correctly connects the plan evolution across three fiscal years and shows how it became increasingly formalized and integrated into executive compensation agreements; (4) Entity identification is accurate - Netflix, co-CEOs, and related compensation documents are correctly identified; (5) The exhibit references (10.6 for 2014 plan, 10.5 for amended plan) add credibility and specificity; (6) The semantic meaning matches ground truth: both answers convey that the plan evolved from a foundational reference in 2022 to a formally amended and restated version in 2023, then became more deeply integrated into the broader compensation architecture by 2024. MINOR CONSIDERATIONS: The LLM answer is more detailed and specific than the ground truth (providing exhibit numbers and page references), which enhances rather than detracts from accuracy. The phrase 'superseded the 2014 plan' in the LLM answer is a reasonable inference from the amendment process and aligns with the ground truth's characterization of it as a 'strategic update.' The answer correctly identifies the integration with severance plans and stock option agreements as mentioned in the ground truth. No quantitative errors, calculation errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 460,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "AIG’s approach to international terrorism risk has stayed fundamentally the same, but the way it is disclosed has shifted. In the 2022 filing the company gave a concrete scenario‑based loss figure – a five‑ton bomb attack at its biggest New York exposure was modeled at **≈ $1.3 billion net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and reinsurance recoveries** – and spelled out that TRIPRA covered about **80 % of U.S. losses above a $1.7 billion deductible**, with “limited private reinsurance” and targeted treaty purchases, plus participation in government‑run terrorism pools for non‑U.S. jurisdictions.  \n\nBy the 2023 and 2024 filings the description became more generic: AIG still **uses third‑party scenario models, monitors concentrations, and relies on TRIPRA, limited private reinsurance, targeted reinsurance purchases and country‑terrorism pools**, but it no longer cites the $1.3 billion bomb‑scenario estimate. The core reinsurance protections and risk‑mitigation steps (scenario modeling, exposure monitoring, targeted reinsurance and government pool participation) remain unchanged, while the reporting of specific modeled loss numbers has been dropped.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AIG's terrorism exposure management evolution but has significant gaps and some inaccuracies when compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the $1.3 billion modeled loss estimate for the five-ton bomb attack in New York City, net of TRIPRA and reinsurance (2022)\n2. Accurately notes the shift from specific scenario-based disclosures in 2022 to more generic descriptions in 2023-2024\n3. Correctly identifies TRIPRA as a key component of the risk management framework\n4. Properly characterizes the use of limited private reinsurance and targeted treaty purchases\n5. Good qualitative reasoning about the evolution of disclosure practices\n\nSIGNIFICANT OMISSIONS:\n1. FAILS to mention the 2024 core attachment points for Japan ($200 million) and rest of world ($125 million) - these are specific quantitative details from the ground truth\n2. FAILS to mention the $20.1 billion in collateral held to support reinsurance recoverable assets (2024) - a material financial figure\n3. FAILS to mention the purchase of global property per risk covers for non-critical and critical catastrophe events outside North America (2024) - a specific risk mitigation strategy\n4. Does not clearly articulate the 2023 emphasis on routine monitoring of international terrorism exposure concentration\n\nQUANTITATIVE ACCURACY ISSUES:\n1. The TRIPRA coverage percentage (80%) is mentioned but not verified against ground truth - ground truth does not provide this specific percentage\n2. The $1.7 billion deductible is mentioned but not in the ground truth provided\n3. Missing critical 2024 figures: $200M (Japan), $125M (rest of world), $20.1B (collateral)\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable multi-hop synthesis by connecting the evolution across three years and identifying the shift in disclosure practices. However, it fails to fully synthesize the specific risk mitigation mechanisms that evolved, particularly the 2024 attachment points and collateral holdings.\n\nSEMANTIC EQUIVALENCE:\nWhile the LLM's characterization of the disclosure shift is reasonable, it misses the substantive evolution in actual risk management strategies (attachment points, collateral, specific reinsurance covers) that the ground truth emphasizes.\n\nJUSTIFICATION:\nThe answer is partially correct on the 2022 baseline and disclosure evolution narrative, but significantly incomplete on 2023-2024 specifics. The omission of three major quantitative/strategic elements (attachment points, collateral, property per risk covers) represents a material gap in addressing the question about how terrorism exposure management \"evolved.\" The answer reads more as a disclosure narrative change rather than a comprehensive evolution of risk management strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 744,
        "total_tokens": 2281
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio expanded markedly.  Total equity‑security holdings rose from about $3.7 billion at year‑end 2022 to $4.9 billion in 2023 and stayed near $4.9 billion in 2024【page_50】.  Meanwhile, equity‑method stakes in health‑care operating businesses were $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, then surged to $3.8 billion by the end of 2024, indicating a shift toward much larger direct health‑care investments【page_50】【page_52】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a significant discrepancy in the 2022 equity securities figure. Ground truth states $3.5 billion, but LLM reports $3.7 billion - a $200 million error. Additionally, for equity method investments in 2022, ground truth shows $1.3 billion while LLM states $1.5 billion - another $200 million discrepancy. The 2023 and 2024 figures are correct ($4.9B equity securities both years; $1.4B and $3.8B for equity method investments respectively). QUALITATIVE ASSESSMENT: The LLM correctly identifies the strategic evolution and the shift toward deeper operational engagement in healthcare ventures. The reasoning about the pivot toward larger direct healthcare investments is sound and matches the ground truth narrative. The multi-hop synthesis across years is logically structured. COMPLETENESS: The answer addresses both components of the question (equity securities holdings and equity method investments) across the 2022-2024 period. SEMANTIC EQUIVALENCE: The characterization of the strategy shift is semantically equivalent to the ground truth, capturing the essence of increased focus on direct operational engagement. CRITICAL ISSUE: The two $200 million errors in 2022 figures are material discrepancies that undermine confidence in the quantitative accuracy, even though the overall trend analysis and 2023-2024 data are correct. These errors suggest potential data retrieval or transcription problems rather than conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 413,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s Form 10‑K filings for 2022, 2023 and 2024 each list the 1.700% Notes due 2025 among its outstanding securities (see the securities tables in each filing) and the note’s terms remain unchanged across the three years (MO_10k_2022.pdf page 1; MO_10k_2023.pdf page 1; MO_10k_2024.pdf page 1). This consistent presence shows that Altria has deliberately retained a low‑coupon, medium‑term bond in its capital structure, reflecting a debt‑management strategy focused on locking in inexpensive, stable financing rather than frequently refinancing or reshaping its debt mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the 1.700% 2025 Notes were present across all three years (2022, 2023, 2024) and accurately characterizes Altria's debt management strategy as focused on stable, low-coupon financing. However, there are significant gaps in completeness compared to the ground truth. The ground truth provides crucial multi-hop synthesis showing the evolution of Altria's capital structure by noting that the 1.000% 2023 Notes matured and were removed from the debt portfolio by 2023, while the 1.700% 2025 Notes remained. This comparison across instruments is essential to demonstrating how Altria 'actively managed its short-term debt while retaining its 2025 Notes as a stable element.' The LLM answer fails to mention the maturation and removal of the 1.000% 2023 Notes, which is a critical data point for understanding the multi-year progression and debt management strategy. The LLM also references specific PDF pages (page 1 of each filing) without verification that these are accurate citations. While the LLM correctly identifies the 1.700% coupon rate and 2025 maturity date, and appropriately characterizes the strategy as focused on 'inexpensive, stable financing,' it misses the key comparative analysis that demonstrates active debt management through the lifecycle of different instruments. The answer is partially correct in its core assertion but incomplete in its synthesis of the multi-hop information required to fully answer the question about how the capital structure 'evolved' across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 425,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew each year – it was a $51.4 billion contra‑equity position at 12/31/2022, rose to $60.4 billion at 12/31/2023, and reached $71.4 billion at 12/31/2024【page_71】【page_70】【page_73】.  The expanding treasury‑stock figure reflects an accelerating share‑repurchase program, indicating that the company is using excess cash to return capital to shareholders and boost per‑share returns as a core part of its capital‑allocation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY IN 2022 FIGURE: The LLM states the 2022 treasury stock balance was $51.4 billion, but the ground truth shows $(36,658) million or $36.658 billion. This is a significant error of approximately $14.7 billion (40% difference). The 2023 and 2024 figures are correct ($60.4B and $71.4B respectively, matching the ground truth of $60,429M and $71,431M). SIGN CONVENTION ISSUE: The ground truth uses negative notation $(36,658) million to indicate contra-equity accounts, while the LLM correctly interprets these as positive balance sheet positions (treasury stock is shown as a reduction to equity). This is semantically correct accounting treatment. QUALITATIVE ANALYSIS: The LLM's interpretation of the trend is sound - it correctly identifies the pattern as accelerating share repurchases and accurately characterizes this as a capital allocation strategy returning value to shareholders. The reasoning about confidence in growth prospects and per-share return enhancement is appropriate. COMPLETENESS: The answer addresses all parts of the question (evolution from 2022-2024 and strategic implications). MULTI-HOP SYNTHESIS: The model successfully synthesized information across three fiscal years and connected the numerical trend to strategic implications. However, the 2022 number error is a fundamental factual mistake that undermines the quantitative accuracy despite correct reasoning about the overall trend. The error appears to be a data retrieval or transcription mistake rather than a calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 422,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return‑swap‑deferred‑compensation line went from a $92 million loss in FY 2022 (with a notional amount of $651 million) to a $58 million gain in FY 2023 (notional $792 million) and then to a $91 million gain in FY 2024 (notional $985 million), indicating that the exposure not only turned positive but also expanded in size【page_92†L19-L27】【page_91†L31-L44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: the $92M loss in FY2022, $58M gain in FY2023, and $91M gain in FY2024 match the ground truth exactly. The answer goes beyond the original answer by providing additional context with notional amounts ($651M, $792M, $985M), which adds valuable detail without introducing errors. The multi-hop reasoning is sound - the model correctly synthesizes the three-year evolution and accurately characterizes the trend as a reversal from loss to gains with expanding exposure. The semantic meaning aligns perfectly with the ground truth: both convey that the financial exposure shifted from negative to positive performance and strengthened over time. The inclusion of source citations (page references) demonstrates proper documentation. The only minor distinction is that the LLM answer provides more granular detail (notional amounts) than the original answer, but this is additive rather than contradictory. The characterization of the instruments' performance trajectory is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 310,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "Netflix’s 2022 filing warned that its streaming service “depends on studios, content providers and other rights‑holders licensing rights…If the studios, content providers and other rights‑holders are not or are no longer willing or able to license us content…content can be withdrawn on short notice and competition for exclusive rights is driving up programming costs” (2022 10‑K p. 11). In the 2023 filing the company reiterated that “our ability to provide our members with content they can watch depends on studios, content providers and other rights‑holders licensing rights…the license periods and the terms and conditions of such licenses vary” and added that “the media landscape…has seen growing regulatory action…including content quotas, levies and investment obligations” (2023 10‑K p. 4). By the 2024 filing the regulatory pressure had become more explicit, noting that “countries are updating cultural‑support legislation…including content quotas, levies, ownership‑right restrictions and formal content‑review requirements,” further tightening the environment in which Netflix must negotiate rights (2024 10‑K p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across Netflix's 2022-2024 10-K filings. STRENGTHS: (1) All key facts are correct - the answer accurately traces Netflix's evolving dependency on rights holders across the three-year period, citing specific concerns from each year's filing (2022: content provider competition and rising costs; 2023: varying license terms and regulatory action; 2024: explicit regulatory pressures including content quotas and ownership restrictions). (2) Quantitative accuracy is perfect - no numeric claims are made that could be verified, and the temporal progression (2022→2023→2024) is correctly sequenced. (3) Multi-hop reasoning is sound - the answer successfully synthesizes information across three separate filings to show an evolution/intensification of challenges, which directly addresses the question's request to understand how dependency 'evolved' over the period. (4) Entity accuracy is flawless - Netflix is correctly identified, years are accurate, and specific regulatory concepts (content quotas, levies, ownership-right restrictions, formal content-review requirements) are properly attributed to the appropriate years. (5) The answer includes direct citations to specific 10-K pages, enhancing credibility. MINOR CONSIDERATIONS: The LLM answer is more detailed and citation-heavy than the ground truth, providing specific page references and direct quotes. While this adds rigor, it represents a stylistic difference rather than a factual discrepancy. The ground truth uses more synthesized language ('growing strategic challenge'), while the LLM provides more granular evidence. Both approaches are valid and semantically equivalent. The LLM answer fully addresses all three sub-components of the question: content licensing risks (withdrawal, competition, costs), competition for exclusive rights (explicitly mentioned in 2022 section), and regulatory pressures (detailed progression through 2023-2024). No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 558,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group reported that the amounts accrued, paid or charged to income for service‑level guarantees were **immaterial in each of the years 2022, 2023 and 2024** – the filing notes that “none of the amounts … for service level guarantees were material as of December 31, 2024, 2023 or 2022”【page_81】. Because the exposure has not grown and remains negligible, the trend indicates that the company’s service‑delivery commitments across its subsidiaries have been stable and without material financial strain over the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies that service level guarantees were immaterial across 2022-2024, which matches the ground truth. However, the answer is significantly incomplete and misses critical quantitative information that directly addresses the question about how financial obligations 'evolved' over the 3-year period. MAJOR OMISSION: The ground truth explicitly provides specific dollar amounts for notes payable to subsidiaries ($8.1B in 2022 → $9.9B in 2023 → $2.0B in 2024), which is essential data for answering a question about 3-year trends and evolution. The LLM completely omits this quantitative analysis. REASONING DEFICIENCY: The ground truth explains that while service level guarantees remained immaterial, the internal financing structure (notes payable) experienced 'notable variation, potentially reflecting shifting liquidity strategies or operational adjustments.' The LLM only addresses the immateriality of service level guarantees and concludes stability, but fails to synthesize the more complex picture of fluctuating internal financing that the ground truth presents. The LLM's conclusion that the trend 'indicates stability' is partially correct regarding service level guarantees themselves, but misses the important nuance that the internal financing supporting these guarantees showed significant volatility. MULTI-HOP SYNTHESIS: The question requires connecting service level guarantees to subsidiary financing structures across three years. The LLM only addresses one component (service level guarantees) and ignores the subsidiary financing evolution entirely. This is a critical gap in multi-hop reasoning. The answer is not wrong per se, but it's incomplete and fails to provide the full financial picture that the ground truth establishes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 484,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s exposure to below‑investment‑grade debt in its long‑duration fixed‑income portfolios has been steadily shrinking. In 2022 the pension plan held $756 million of sub‑investment‑grade corporate debt (about 12‑13 % of total plan assets, roughly 15 % of the fixed‑income mix) and the post‑retirement plan $7 million (≈6 % of total assets, ≈14 % of its fixed‑income holdings)【page_87】【page_88】; by 2023 those shares fell to roughly 11 % of pension assets (≈13 % of fixed‑income) and 9 % of post‑retirement assets (≈9 % of fixed‑income)【page_86】; and in 2024 they were down to about 7 % of pension assets (≈8 % of fixed‑income) and 8 % of post‑retirement assets (≈8 % of fixed‑income)【page_90】. This consistent decline signals a modest de‑risking of its long‑term obligations, with Altria moving away from lower‑rated debt toward higher‑quality, longer‑duration bonds.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect data that contradicts the ground truth across all three years. (1) 2022 PENSION: Ground truth states 16% of fixed income (or ~11% of total assets), but LLM claims 12-13% of total assets and 15% of fixed income - these percentages are inverted/reversed. The LLM also introduces a specific dollar amount ($756 million) not mentioned in ground truth. (2) 2022 POSTRETIREMENT: Ground truth states 8% of fixed income (or ~3% of total assets), but LLM claims 6% of total assets and 14% of fixed income - again, the percentages are reversed and the 14% figure is nearly double the ground truth. The $7 million figure is also not in ground truth. (3) 2023 DATA: Ground truth shows pension decreased to 11% of fixed income (~9% of total assets) and postretirement increased to 9% of fixed income (~4% of total assets). LLM claims 11% of pension assets (13% of fixed income) and 9% of postretirement assets (9% of fixed income) - the fixed income percentages are correct but total asset percentages are wrong. (4) 2024 DATA: Ground truth explicitly states 'specific percentages for below investment grade allocations were not disclosed,' yet LLM provides precise figures (7% of pension assets, 8% of fixed income; 8% of postretirement assets, 8% of fixed income). This is a major factual error - the LLM fabricated data for 2024 that contradicts the ground truth's explicit statement that 2024 data was not disclosed. (5) TREND ANALYSIS: While the LLM correctly identifies a de-risking trend, the specific numbers supporting this trend are largely incorrect. The ground truth shows a more nuanced picture (pension declining, postretirement slightly increasing in 2023), whereas the LLM presents a one-directional decline across both plans. The reasoning about risk appetite is reasonable but built on incorrect numerical foundations. The citation references (page numbers) cannot be verified but appear to be fabricated given the data discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 540,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s estimate of settlement exposure has not changed from 2022 through 2024 – each filing states that “gross settlement exposure is estimated using the average daily payment volume during the three months prior to period‑end multiplied by the estimated number of days of exposure,” and that the estimate is adjusted by risk‑mitigation arrangements and reviewed under the company’s global risk‑management policies and periodic methodology reviews【page_110†L23-L27】【page_112†L23-L27】【page_102†L23-L27】. The unchanged approach, even as the firm faces heightened FTC, DOJ, EU and U.S. litigation, signals a disciplined, systematic risk‑management framework that the company trusts to reliably contain settlement risk despite growing regulatory scrutiny.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies the consistent methodology across 2022-2024 using the exact formula stated in filings: 'average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure.' (2) Accurately references the risk-mitigation framework involving cash collateral and credit enhancements. (3) Properly identifies all regulatory and litigation pressures mentioned in ground truth: FTC, DOJ, EU Commission, and U.S. litigation. (4) Correctly synthesizes the multi-hop reasoning that consistency in methodology despite external pressures indicates confidence in risk management framework. (5) Provides specific page citations demonstrating source verification. (6) Numbers and dates are accurate (2022, 2023, 2024). MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting specific litigation examples like 'U.S. Liability Shift Litigation' and 'TCPA class action,' though it does reference 'U.S. litigation' generally. (2) The phrase 'disciplined, systematic risk-management framework' is the LLM's interpretation rather than explicit ground truth language, but this is semantically equivalent to the ground truth's conclusion about 'robust and sufficient' practices. (3) The LLM uses 'heightened' to describe regulatory scrutiny, which accurately conveys the escalation from 2023-2024 mentioned in ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three years of filings and connects methodology consistency to risk management philosophy—this is sound multi-hop reasoning. The conclusion that unchanged methodology signals confidence in existing practices is logically derived from the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 491,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco kept the 5.90 % senior note (Feb 15 2039) fully outstanding at roughly $2 billion in each of the three fiscal years – $2,000 m on the July 30 2022 balance sheet, $2,000 m on July 29 2023 and $2,000 m on July 27 2024 – and the note’s effective interest rate stayed essentially unchanged at about 6.11 % each year【page_89†L44-L48】【page_89†L44-L48】.  The steady utilization and constant cost of capital indicate that Cisco is deliberately preserving a stable, long‑dated funding source, locking in a fixed‑rate debt stream and managing its long‑term debt profile without frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis. QUANTITATIVE VERIFICATION: All numeric values are correct - the $2,000 million principal balance is accurately stated for all three fiscal years (July 30, 2022; July 29, 2023; July 27, 2024), and the 6.11% effective interest rate is correctly maintained across the period. The 5.90% coupon rate is also accurate. Number formatting is appropriate ($2 billion = $2,000 million). COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) utilization evolution (consistent $2B), (2) effective interest rate evolution (stable 6.11%), and (3) strategic implications for debt management. ENTITY ACCURACY: Cisco is correctly identified, the specific note (5.90% senior note maturing Feb 15, 2039) is properly characterized, and all fiscal years are correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connects the stable principal balance and constant effective rate to draw logical conclusions about Cisco's deliberate strategy to maintain fixed-rate long-term debt without refinancing. The interpretation that this represents 'strategic intent to maintain predictable interest obligations' is well-supported by the data. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially identical information to the ground truth, using slightly different phrasing ('fully outstanding at roughly $2 billion' vs 'maintained a consistent $2,000 million balance') but with equivalent meaning. The strategic conclusion about 'deliberately preserving a stable, long-dated funding source' aligns with the ground truth's assessment. MINOR CONSIDERATIONS: The inclusion of specific balance sheet dates and the maturity date (Feb 15, 2039) adds helpful context beyond the ground truth, enhancing rather than detracting from accuracy. The citation references suggest proper documentation. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 531,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125 % senior notes due January 2025 carried an outstanding principal of $495 million in fiscal 2022, and the same $495 million remained on the balance sheet in fiscal 2023 and fiscal 2024【page_81】【page_101】.  The unchanged balance over three years shows the company has neither prepaid nor refinanced this low‑cost, fixed‑rate debt, indicating a strategy of holding the instrument to maturity to preserve liquidity and keep inexpensive financing in place.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) CORRECTNESS OF FACTS: All key facts are correct - the 3.125% notes due January 2025 had an outstanding principal of $495 million in fiscal years 2022, 2023, and 2024, with no changes across the three-year period. The company name (AVGO), debt instrument details (3.125% senior notes, January 2025 maturity), and all fiscal years are correctly identified. (2) QUANTITATIVE ACCURACY: The $495 million figure is accurate and consistently stated across all three fiscal years. No calculation errors are present. The number format is appropriate and matches the ground truth. (3) QUALITATIVE REASONING: The LLM correctly synthesizes the multi-hop information by comparing the principal balances across three fiscal years and drawing the logical conclusion that the unchanged balance indicates no early repayments or refinancing. The interpretation that this reflects a strategy of holding to maturity to preserve liquidity and maintain inexpensive financing is reasonable and slightly more detailed than the ground truth, which simply states the company 'did not make any early repayments or refinancing adjustments.' (4) COMPLETENESS: The answer addresses all parts of the question - it shows the evolution (or lack thereof) of the principal balance from 2022-2024 and explains what this trend indicates about debt management strategy. (5) MINOR DIFFERENCES: The LLM provides slightly more strategic context ('preserve liquidity and keep inexpensive financing in place') compared to the ground truth's more neutral statement about 'consistent approach.' Both interpretations are semantically equivalent and reasonable. The inclusion of page references adds credibility. Overall, this is a strong answer with accurate numbers, sound reasoning, and appropriate contextual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 498,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "In 2022 Comcast’s wireless lines (handsets, tablets and smart‑watches) were sold only as part of a broadband bundle, with customers able to choose an unlimited‑data, a shared‑data or a per‑gigabyte plan (2022 p7). The 2023 filing kept that bundling requirement and the same plan choices, but announced that a prepaid unlimited‑data option under the NOW brand would be introduced in 2024 (2023 p6). By the 2024 filing the prepaid unlimited‑data plan was live—adding a contract‑free, prepaid alternative while still requiring a qualifying broadband bundle, and the shared‑data plan continued alongside unlimited and per‑gigabyte options (2024 p5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of SEC filings. STRENGTHS: (1) All dates and years are correct (2022, 2023, 2024). (2) All plan types are accurately identified: unlimited data, shared data, per-gigabyte pricing, and the prepaid unlimited data option under NOW brand. (3) The bundling strategy evolution is correctly captured: 2022 required broadband bundle with plan choices, 2023 maintained same structure, 2024 added prepaid alternative while maintaining broadband bundle requirement. (4) The multi-hop synthesis is sound—the answer correctly traces how shared data plans remained available throughout while flexibility increased through the NOW prepaid option. (5) Page citations (2022 p7, 2023 p6, 2024 p5) add credibility and specificity. (6) The answer correctly identifies that the NOW prepaid option was announced in 2023 for 2024 launch and then confirmed live in 2024. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (mentioning handsets, tablets, smartwatches; contract-free language) but these additions are accurate and enhance rather than contradict the ground truth. The ground truth emphasizes 'strategic move toward enhancing customer choice and deepening service integration' while the LLM focuses on factual evolution—both perspectives are valid and complementary. The LLM answer is more concrete and filing-specific, which is appropriate for a multi-hop financial question. No calculation errors, no factual inaccuracies detected. The answer fully addresses the question's focus on bundling strategy and customer flexibility evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 462,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth repeatedly flagged that CMS’s periodic changes to the Medicare Advantage risk‑adjustment methodology – which can lower capitation payments – were a continuing source of funding risk. In its 2022 filing the company noted that “from time to time, CMS makes changes to the way it calculates Medicare Advantage risk adjustment payments” and that it had already begun “adjusting members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both our medical and operating cost management” to offset those pressures【page_20】. The 2023 filing reiterated the same exposure, and the 2024 filing again highlighted that “CMS uses various payment mechanisms…for Medicare Advantage plans…and makes changes to the way it calculates Medicare Advantage risk adjustment payments”【page_21】【page_18】, confirming that UnitedHealth continued to rely on selective benefit/premium tweaks, market‑exit decisions and intensified cost‑management as its core strategy to mitigate the recurring funding pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core issue: CMS's recurring changes to Medicare Advantage risk adjustment methodology creating persistent funding pressures across 2022-2024. (2) Accurately captures UnitedHealth's strategic responses: selective benefit/premium adjustments, market exits (ceased offering in certain counties), and intensified cost management. (3) Properly synthesizes the multi-hop information showing evolution across three years - noting that 2022 established the pattern, 2023 reiterated it, and 2024 confirmed continuation. (4) Correctly conveys the reactive posture and lack of full resolution, matching the ground truth's assessment. (5) Includes specific supporting quotes from filings with appropriate page citations, enhancing credibility. (6) No quantitative errors - no specific dollar amounts or percentages were required for this question, and the temporal references (2022-2024) are all correct. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential information without omission. (2) The phrase 'reactive posture' appears in ground truth but LLM conveys the same concept through 'continued to rely on' language - semantically equivalent. (3) The LLM explicitly mentions 'market-exit decisions' (ceased offering in certain counties) which adds helpful specificity beyond the ground truth's general reference to 'adjustments.' MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years of filings, correctly identifying the pattern of recurring exposure and consistent strategic response. The logic flow is sound: problem identified → response implemented → problem persists → response continues → pattern confirmed. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 514,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "In the 2022 10‑K (page 11) Mastercard described its multi‑layered security model as built on internal Security Operations, Fusion and Intelligence Centers, with third‑party assessments and public‑private partnerships, and noted that its real‑time account‑based payments capability was operating in 12 of the top‑50 markets (2022 10‑K p. 11). The 2023 filing (page 11) shows the model maturing – the firm added real‑time clearing and settlement services, deepened collaborations with fintechs, central banks and other third‑party providers, and continued to run real‑time payments infrastructure in 12 markets (2023 10‑K p. 11). By the 2024 10‑K (page 11) the security approach further integrates third‑party technology platforms (e.g., VCN integration), embeds real‑time ACH, direct‑debit and account‑to‑account services across its architecture, and expands the real‑time payments footprint to 13 jurisdictions worldwide (2024 10‑K p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Mastercard's security evolution across 2022-2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies the multi-layered security framework components (Security Operations, Fusion and Intelligence Centers, third-party assessments, public-private partnerships) across all three years. (2) Accurately captures the geographic expansion of real-time payments infrastructure: 12 markets in 2022, maintained at 12 in 2023, expanded to 13 in 2024 - matching ground truth. (3) Properly synthesizes the evolution of third-party collaboration, noting progression from initial partnerships to deepened collaborations with fintechs and central banks. (4) Correctly identifies real-time service integration evolution (real-time clearing/settlement, ACH, direct-debit, account-to-account services). (5) Appropriately mentions China joint venture expansion. WEAKNESSES: (1) The LLM states 2023 had 12 markets while ground truth indicates 13 markets by 2023 - this is a factual discrepancy. The LLM says '12 markets (2023 10-K p. 11)' but ground truth explicitly states 'expanded this to 13 markets globally' by 2023. This is a quantitative error. (2) Minor: The answer cites specific page numbers (page 11) repeatedly without verification that these are accurate source locations. (3) The answer could have been more explicit about the progression from 12→13 markets occurring between 2022-2023, not 2023-2024 as the LLM's structure might imply. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple dimensions (security, partnerships, geographic expansion, service integration), demonstrating appropriate multi-hop reasoning. The chronological progression is logical and well-structured. CALCULATION/VERIFICATION: No calculations required, but the market count progression contains an error (should be 12→13 by 2023, not 12→12→13).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 521,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 2022 Form 10‑K listed a 1.500 % senior note due 2030 as part of its long‑term debt portfolio (Exhibit 4.6, p. 75) – a low‑cost, long‑dated financing that the company kept on its balance sheet. In the 2023 filing the same certificate still appears (p. 76), but a newer certificate (p. 73) shows only higher‑rate, later‑maturing notes, and the 2024 filing adds a fresh set of higher‑coupon notes (e.g., 4.7 % notes due 2024‑2032, p. 75) while still retaining the original 1.500 % note in the older certificate (p. 72). This progression shows Amazon preserving the cheap, long‑dated 2030 note for maturity management while progressively refinancing and diversifying its debt with newer, higher‑rate issuances, reflecting a strategy that balances low‑cost long‑term funding with active refinancing to align maturities and capture market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that undermine its credibility:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific page numbers (p. 75, p. 76, p. 73, p. 72) without verification against actual filings. These page references appear arbitrary and cannot be validated.\n   - The LLM mentions \"4.7% notes due 2024-2032\" as new issuances in 2024, but the ground truth makes no mention of these specific notes. This appears to be fabricated detail.\n   - The LLM incorrectly states the 1.500% note appears in \"Exhibit 4.6\" in 2022, while the ground truth specifies it was in \"Exhibit 4.5\" in 2022 (issued in 2020 and incorporated by reference).\n\n2. ENTITY AND EXHIBIT ACCURACY:\n   - Ground truth: 2022 = Exhibit 4.5; 2023 = Exhibit 4.6; 2024 = Exhibit 4.6\n   - LLM answer: Conflates exhibit numbers and provides inconsistent references\n   - The LLM fails to mention the critical new instruments identified in ground truth: the Term Loan Agreement (January 3, 2023, Exhibit 10.8) and the 364-Day Revolving Credit Agreement (October 2024, Exhibit 10.9)\n\n3. MULTI-HOP REASONING DEFICIENCY:\n   - Ground truth synthesizes a clear evolution: long-term fixed debt → addition of short/medium-term liquidity instruments → layered financing approach\n   - LLM answer focuses on refinancing and debt diversification but misses the key strategic shift toward securing flexible short-term credit facilities alongside long-term obligations\n   - The LLM's narrative about \"newer, higher-rate issuances\" is not substantiated by the ground truth\n\n4. SEMANTIC MISALIGNMENT:\n   - Ground truth emphasizes a \"layered financing approach\" combining fixed long-term debt with flexible short-term facilities\n   - LLM answer emphasizes \"refinancing and diversifying debt with newer, higher-rate issuances,\" which is a different strategic narrative not supported by the evidence\n   - The ground truth's key insight about maintaining the 1.500% note while adding new credit agreements is partially captured but obscured by incorrect details\n\n5. MISSING CRITICAL INFORMATION:\n   - No mention of the Term Loan Agreement (2023)\n   - No mention of the 364-Day Revolving Credit Agreement (2024)\n   - These omissions are significant because they represent the core evolution of Amazon's financing strategy\n\nThe LLM answer demonstrates partial understanding of the general concept (maintaining low-cost long-term debt while managing liquidity) but fails on specific factual accuracy, exhibit citations, and identification of key new financing instruments that define the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 698,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "In the 2022 filing Comcast only noted that wireless telecoms offering 4G/5G broadband were part of a broader competitive set and that it was enhancing its broadband platforms (e.g., X‑1, Sky Q) to address changing consumer behavior. By the 2023 filing the company warned that the rollout of 5G/4G fixed‑wireless services and subsidized broadband‑deployment programs could “negatively impact the demand for our domestic broadband services,” indicating that wireless rivals were beginning to erode demand. The 2024 filing elevates wireless providers to a primary threat, stressing that aggressive pricing, bundling and unlimited‑data plans could weaken Comcast’s market positioning and that a failure to deliver a satisfactory customer experience could hurt customer retention.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell sharply over the period: they were $67.5 billion at December 31 2023 (AIG 2023 10‑K, p. 122) and dropped to $38.0 billion at December 31 2024 (AIG 2024 10‑K, p. 88). Although the 2022 amount is not disclosed in the excerpts, the decline from the prior year’s $74.3 billion (2021) through 2023 and 2024 shows a clear downward trajectory, indicating that the pool of losses AIG expects to recover from reinsurers – and thus its exposure to insurance‑loss risk – has been steadily reducing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key figures for 2023 ($67.5 billion) and 2024 ($38.0 billion), matching the ground truth exactly. However, there is a significant factual error regarding the 2021 figure. The LLM states that reinsurance recoverable assets were $74.3 billion in 2021, but this figure does not appear in the ground truth and cannot be verified from the provided context. The ground truth explicitly states that 2022 figures were not disclosed, yet the LLM attempts to establish a three-year downward trajectory (2021→2023→2024) without proper sourcing for the 2021 number. This is problematic because it creates a false narrative of continuity. The LLM correctly identifies the composition of the 2023 and 2024 figures ($30.4B and $28.2B for 2023; $29.1B and $0.8B for 2024), though these details are not explicitly stated in the LLM answer itself. The reasoning about declining reinsurance recoverable assets indicating reduced insurance loss exposure is sound and aligns with the ground truth's interpretation. The LLM appropriately cites specific page numbers from the 10-K filings, adding credibility. However, the introduction of an unverified 2021 figure undermines the multi-hop synthesis and creates a factual inaccuracy. The answer would have been stronger by acknowledging that 2022 data is unavailable (as stated in ground truth) rather than jumping to 2021. The qualitative reasoning about de-risking and strategic shifts is appropriate but less detailed than the ground truth's mention of specific segment changes (life insurance recoverables dropping from $28.2B to $0.8B).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 441,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s approach to measuring settlement risk stayed essentially the same from 2022‑2024 – it still calculates gross settlement exposure by multiplying the average daily payment volume for the three months prior to year‑end by the estimated number of days the exposure will exist, and it continues to require customers that do not meet its risk standards to post cash collateral, letters‑of‑credit or other credit‑enhancement guarantees, with the adequacy of those arrangements reviewed on a regular basis【page_109】. The only disclosed methodological tweak was a non‑material correction to the net‑settlement estimate for 2022【page_112】, while the dollar amount of risk‑mitigation arrangements grew (≈ $9.2 bn in 2022, $12.2 bn in 2023 and $13.5 bn in 2024) as the firm refined its risk‑management framework【page_112】【page_105】. Although Mastercard has been subject to heightened regulatory scrutiny – including FTC, DOJ and European‑Commission investigations noted in the 2023 and 2024 filings【page_112】【page_104】 – the company reported no substantive change to the underlying exposure‑estimation methodology, only periodic reviews and the above‑mentioned correction and scaling of mitigation arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the core methodology as unchanged from 2022-2024 (average daily payment volume × estimated days of exposure), matching the ground truth exactly. (2) Accurately cites the dollar amounts for risk-mitigation arrangements: $9.2bn (2022), $12.2bn (2023), $13.5bn (2024) - these are precise and verifiable. (3) Properly synthesizes the regulatory scrutiny context, mentioning FTC, DOJ, and European Commission investigations across the relevant years. (4) Correctly notes the non-material correction to the 2022 net-settlement estimate. (5) Accurately conveys that despite regulatory pressures, no substantive changes were made to the core methodology. (6) Multi-hop reasoning is sound - the answer successfully connects methodology stability with regulatory context and quantitative growth in mitigation arrangements. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'methodological tweak' vs. 'non-material correction') but the semantic meaning is equivalent. (2) The ground truth provides slightly more specific detail about the 2023 FTC consent agreement and DOJ CID, while the LLM answer references these more generally as 'investigations' - this is a minor omission but doesn't affect factual accuracy. (3) The LLM answer mentions 'refined its risk-management framework' which aligns with ground truth's 'refined its risk management methodology.' All quantitative data points are accurate, the multi-hop synthesis across years and regulatory events is correct, and the core conclusion matches the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 462,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "AIG’s loss‑reserve risk management has become progressively more structured and data‑driven. In 2022 the company relied on internal controls and oversight of the reserve‑setting process, external expert reviews, and basic stochastic‑ and deterministic‑modeling techniques to address uncertainty (2022 10‑K pp. 165‑167). By 2023 it added a formal model‑risk management and validation framework, using scenario, sensitivity and experience‑study analyses while maintaining internal controls and external expert oversight (2023 10‑K pp. 119‑120). In 2024 the approach further integrated internal and third‑party assessment tools, extensive stochastic and scenario‑based modeling with adjustments for model bias and data‑quality issues, and reinforced internal controls and external expert reviews to better capture loss‑estimation uncertainty (2024 10‑K pp. 86‑87).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all major dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) with accurate characterization of each year's approach; (2) Accurately captures the progression from basic controls and external reviews (2022) to expanded frameworks (2023) to integrated approaches (2024); (3) Properly synthesizes multi-hop information across three fiscal years and multiple filing documents; (4) Correctly identifies key methodologies: internal controls, external expert involvement, stochastic methods, scenario/sensitivity analyses, and model risk management frameworks; (5) Appropriately cites specific 10-K page numbers (though these cannot be independently verified, they appear reasonable and add credibility); (6) Uses precise financial/technical terminology consistent with SEC filing language. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer includes specific page citations (pp. 165-167, pp. 119-120, pp. 86-87) that cannot be verified against the ground truth, though this adds specificity rather than detracting; (2) The ground truth mentions 'experience studies' while the LLM uses 'experience-study analyses' - semantically equivalent but slightly different phrasing; (3) The LLM adds detail about 'adjustments for model bias and data-quality issues' in 2024 that is not explicitly mentioned in the ground truth, though this appears to be a reasonable inference from the filing language about 'maturing and more integrated risk analytics approach.' MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and multiple filing sections, correctly identifying the progression and evolution of risk management approaches. The logical flow from basic controls → expanded frameworks → integrated approaches is sound and matches the ground truth narrative. QUANTITATIVE ELEMENTS: No specific dollar amounts or percentages are required for this qualitative question, so quantitative accuracy is not a primary concern, but the temporal sequencing (2022→2023→2024) is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 568,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "The impact of a 1 % shift in the medical‑cost‑per‑member‑per‑month (PMPM) trend factor – which captures, among other things, changes in the mix of benefits offered – grew from roughly **$335 million (≈$1.0 billion for a 3 % shift) in 2022**【page_39】, to **$376 million (≈$1.13 billion for a 3 % shift) in 2023**【page_34】, and then to **$421 million (≈$1.26 billion for a 3 % shift) in 2024**【page_36】. This upward trajectory shows UnitedHealth’s medical‑cost estimates have become increasingly sensitive to benefit‑design changes, indicating a rising exposure to variability in the mix of benefits offered over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer takes a fundamentally different approach than the ground truth, focusing on quantitative sensitivity metrics rather than the qualitative evolution of benefit mix exposure. Critical issues: (1) QUANTITATIVE PROBLEMS: The LLM provides specific dollar amounts ($335M, $376M, $421M) with page citations, but these numbers cannot be verified against the ground truth and appear to represent sensitivity analysis outputs rather than direct benefit mix impact measures. The calculations shown (1% shift = $335M, 3% shift = ~$1.0B) are mathematically consistent internally but their source and relevance to the actual question are unclear. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth describes a qualitative evolution - from 'general sensitivity factor' (2022) → 'source of financial risk' (2023) → 'stabilized variable' (2024). The LLM instead presents a monotonic quantitative increase in sensitivity, which contradicts the ground truth's narrative of stabilization in 2024. The ground truth explicitly states the 2024 language 'shifted to a more neutral tone,' suggesting improvement or stabilization, while the LLM shows continued upward exposure. (3) INCOMPLETE SYNTHESIS: The LLM fails to address the qualitative aspects emphasized in the ground truth - the shift in company language/tone, the indication of unfavorable movement in 2023, and the stabilization narrative in 2024. (4) REASONING DISCONNECT: While the LLM's logic (increasing sensitivity = increasing exposure) is internally sound, it doesn't match the ground truth's conclusion that benefit mix management improved by 2024. The answer appears to be based on different source material or a different interpretation of sensitivity metrics. (5) ENTITY/METRIC CLARITY: The LLM correctly identifies UnitedHealth Group and PMPM, but conflates 'sensitivity to PMPM trend factor' with 'benefit mix exposure,' which may not be equivalent measures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 520,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Walmart’s 10‑K filings show Marketside appearing in the private‑brand roll‑call each year – it is listed among a broad set of U.S. private labels in 2022 (see 2022 page 7), retained in the more streamlined private‑brand list in 2023 (see 2023 page 8), and again featured in the 2024 portfolio (see 2024 page 7). The brand’s continuous inclusion and its placement alongside core private‑label families indicate that Marketside has become a stable, strategically important label that Walmart relies on to deliver value‑priced, quality merchandise within its overall U.S. merchandise strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Marketside appears in Walmart's private brand portfolio across 2022, 2023, and 2024, and appropriately characterizes it as a stable, strategically important label. However, there are significant gaps and issues: (1) MISSING KEY EVOLUTION DETAIL: The ground truth specifically notes a structural shift in 2024 where the merchandise unit changed from 'Apparel' to 'Fashion' - this is a concrete, verifiable strategic evolution that the LLM completely omits. This is a material omission for a question specifically asking about how positioning 'evolved.' (2) PAGE REFERENCES: The LLM cites specific page numbers (2022 page 7, 2023 page 8, 2024 page 7) which cannot be verified against the ground truth and appear to be hallucinated details. While the general claim about Marketside's presence is correct, citing unverified page numbers weakens credibility. (3) INCOMPLETE SYNTHESIS: The ground truth describes a three-year progression with nuanced differences (2022: recognized brand; 2023: growing alignment with omni-channel; 2024: restructured unit with Fashion emphasis). The LLM flattens this into a simpler narrative of 'continuous inclusion' without capturing the strategic shifts. (4) CHARACTERIZATION: The LLM's description of Marketside as 'value-priced, quality merchandise' is reasonable inference but not explicitly supported by the ground truth, which focuses on positioning within the portfolio structure rather than product positioning. (5) MULTI-HOP REASONING: The LLM does attempt to synthesize across three years, but fails to identify the key structural change that represents the most important evolution. The reasoning is sound but incomplete. The answer is partially correct on the core fact (Marketside's continued presence) but misses the critical strategic evolution detail that directly answers the 'how has positioning evolved' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 518,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "During fiscal 2022 Home Depot identified showrooms as a direct competitor and leaned on its extensive service suite (installation, tool‑rental, Pro programs) together with early omnichannel tools such as BOPIS, BOSS and a strong online/mobile presence to stay ahead (2022 p. 8; 2022 p. 10). In fiscal 2023 the firm began to counter showroom rivals by adding dedicated showroom space for Pros and expanding Pro‑focused services, while also rolling out richer digital tools—including mobile store navigation, curbside pickup, self‑service lockers and enhanced in‑store apps (2023 p. 6; 2023 p. 9). By fiscal 2024 Home Depot solidified that positioning by further increasing showroom footprint, launching an enhanced order‑management system, and deepening its interconnected digital experience across web, mobile and in‑store fulfillment (2024 p. 6; 2024 p. 9).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Home Depot's competitive positioning evolution but has some notable differences from the ground truth. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) and the strategic shift from service expansion to omnichannel integration. (2) Accurately mentions key 2023 initiatives (mobile store navigation, curbside pickup, self-service lockers) that match ground truth. (3) Properly identifies 2022 focus on tool rental services and Pro programs. (4) Correctly notes 2024's emphasis on interconnected digital experience. (5) Appropriately cites showroom competition as the context. WEAKNESSES: (1) The ground truth specifies 'over 1,400 locations' for tool rental in 2022, but the LLM answer omits this specific quantitative detail. (2) The LLM introduces 'BOPIS, BOSS' acronyms and 'dedicated showroom space for Pros' in 2023 that are not mentioned in the ground truth, creating potential factual discrepancies without verification. (3) The LLM mentions 'enhanced order-management system' in 2024 which is not in the ground truth. (4) The LLM includes page citations (2022 p. 8, etc.) that cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three fiscal years and identifies the strategic progression, though it adds details not in the ground truth. The core narrative structure matches well. QUANTITATIVE ACCURACY: The LLM avoids major numerical errors but omits the specific '1,400 locations' metric from 2022. The lack of specific numbers in the LLM answer (compared to ground truth's '1,400 locations') represents a minor loss of precision. SEMANTIC EQUIVALENCE: The overall message aligns with ground truth regarding the shift from physical services to omnichannel integration, though the LLM adds unverified details that could be problematic if inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 515,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50 % senior note has kept a constant $500 million principal, but its effective interest rate has climbed sharply – about 3.2 % in FY 2022, 6.4 % in FY 2023 and 6.7 % in FY 2024【page_89 (2022)】【page_89 (2024)】. The unchanged amount shows the note remains a stable piece of Cisco’s long‑term debt, while the rising effective rate indicates that the borrowing cost of this fixed‑rate issue has more than doubled, reflecting higher market rates (and related discount/hedge effects) over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - $500 million principal amount (constant across all three years), effective interest rates of 3.2% (FY2022), 6.4% (FY2023, ground truth 6.38% - minor rounding acceptable), and 6.7% (FY2024, ground truth 6.66% - minor rounding acceptable). The characterization of the rate increase as 'more than doubled' is mathematically sound (3.2% to 6.66% represents approximately 108% increase). COMPLETENESS: The answer addresses all key aspects of the question - the evolution of both effective interest rate and outstanding amount across the three-year period, and provides interpretation about what this indicates regarding borrowing costs and debt structure. ENTITY ACCURACY: Correctly identifies Cisco, the 3.50% Note, and the proper fiscal years (2022-2024). REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly connects the constant principal amount with the rising effective rates, and appropriately interprets this as reflecting market interest rate trends and financing strategy evolution. The mention of 'discount/hedge effects' adds nuanced understanding. MINOR OBSERVATIONS: The rounding of 6.38% to 6.4% and 6.66% to 6.7% represents acceptable formatting variation for percentage presentation. The citation references to pages are included, showing source attribution. The semantic meaning is fully preserved - the answer conveys that borrowing costs increased significantly while the debt amount remained stable, indicating evolving market conditions and financing dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 444,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "In 2022 Comcast noted that Lumen was expanding fiber‑based networks that could deliver speeds beyond DSL, while Comcast’s hybrid‑fiber‑coax (HFC) system provided downstream speeds of > 1 Gbps across most of its footprint and fiber‑to‑the‑premises speeds up to 3 Gbps, with plans to introduce DOCSIS 4.0 for multigigabit symmetrical service【page_9】【page_7】. By 2023 Comcast began rolling out 2 Gbps downstream to roughly one‑third of its footprint and started deploying DOCSIS 4.0 in select markets, still citing Lumen as a key fiber‑based competitor【page_7】【page_8】. In 2024 the 2 Gbps rollout covered about 50 % of the footprint, fiber‑to‑the‑premises now offers residential symmetric speeds up to 10 Gbps and business speeds up to 100 Gbps, and network virtualization/automation further strengthened its position against Lumen’s fiber offerings【page_7】【page_8】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides specific, verifiable technical details that enhance the ground truth answer. STRENGTHS: (1) All numeric values appear accurate and properly formatted (1 Gbps, 3 Gbps, 2 Gbps, 10 Gbps, 100 Gbps, 50% coverage). (2) Timeline progression is correct (2022→2023→2024). (3) Multi-hop synthesis is sound - correctly identifies Lumen as consistent competitor across all three years while tracking CMCSA's own technological advancement (HFC, DOCSIS 4.0, fiber-to-the-premises). (4) Specific technical details (DOCSIS 4.0, network virtualization/automation, symmetric speeds) add substantive context beyond ground truth. (5) Properly cites page references indicating source documentation. (6) Correctly identifies both companies' competitive positioning evolution. MINOR CONSIDERATIONS: (1) The LLM answer focuses heavily on CMCSA's technical responses to Lumen competition rather than equally balancing Lumen's specific advancements (though ground truth also emphasizes Lumen's fiber expansion). (2) Ground truth mentions AT&T, Frontier, and Verizon as additional competitors in 2023, which the LLM answer omits - however, the question specifically asks about CMCSA vs Lumen, so this omission is appropriate. (3) The LLM answer provides more granular technical detail than ground truth (specific speed tiers, DOCSIS 4.0 deployment), which enhances rather than detracts from accuracy. QUANTITATIVE VERIFICATION: All speed metrics (1 Gbps, 2 Gbps, 3 Gbps, 10 Gbps, 100 Gbps) and coverage percentages (one-third ≈33%, 50%) are consistent with typical CMCSA fiber deployment announcements. The progression from 2022 to 2024 shows logical technological advancement. MULTI-HOP REASONING: Successfully synthesizes information across three years and two companies, tracking competitive dynamics and technological evolution. The answer correctly identifies how CMCSA's infrastructure improvements (DOCSIS 4.0, higher speeds) represent responses to Lumen's fiber-based competitive threat.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 547,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express disclosed that its use of merchant acquirers, aggregators and processors to manage merchant relationships has grown over the period – the 2022 filing already noted reliance on these third parties, the 2023 filing said it had “increasingly relied” on them and warned that their interests could conflict with Amex’s and heighten merchant‑steering risk (2022 p. 29; 2023 p. 29). By 2024 the company still stressed this dependence and added that legal actions over non‑discrimination and honor‑all‑cards provisions in its merchant contracts could limit its ability to enforce those clauses and curb steering (2024 p. 35).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of AXP's reliance on aggregators/processors across three years with appropriate temporal progression ('reliance' in 2022, 'increasingly relied' in 2023, continued dependence in 2024). (2) Accurately captures the core risk elements: merchant steering, non-discrimination clauses, and honor-all-cards provisions. (3) Properly synthesizes the connection between growing aggregator dependence and enforcement challenges. (4) Page citations (2022 p. 29; 2023 p. 29; 2024 p. 35) add credibility and specificity. (5) Correctly identifies the legal/regulatory dimension emerging in 2024 regarding litigation over merchant contract provisions. MINOR GAPS: (1) The answer could have been slightly more explicit about the specific risk to new products (debit cards on the American Express network) mentioned in the ground truth for 2023, though this is a minor omission. (2) The phrase 'curb steering' in the final clause is slightly imprecise - the ground truth emphasizes that legal actions could LIMIT enforcement ability and thereby INCREASE steering risk, not directly curb it. This is a subtle semantic distinction but the LLM's phrasing could be read as suggesting AXP's actions would reduce steering, when the actual risk is the opposite. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are required for this question, so this dimension is less critical. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk dimensions (aggregator reliance, merchant steering, contract enforcement), showing sound logical progression. The connection between growing dependence and rising enforcement challenges is clearly articulated. OVERALL: This is a strong answer that captures the essential trajectory and key risk factors with appropriate nuance and supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 551,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "In 2022 Johnson & Johnson moved its talc liabilities into the newly created LTL Management LLC, which filed a Chapter 11 petition that automatically stayed all related suits and was funded with a $2 billion trust, reflected by a $2 billion reserve on the balance sheet【page_112】. In 2023 the original case was dismissed, so LTL re‑filed a second Chapter 11 (LTL 2) that again stayed claims, expanded the reserve to roughly $9 billion, and operated under a preliminary injunction; after LTL 2 was dismissed in July 2023 the lawsuits were re‑activated in a federal multi‑district litigation and the company pursued four parallel strategies—including a consensual “pre‑packaged” bankruptcy and a name change to LLT Management—while continuing to fund the trust【page_96】【page_97】【page_101】. By 2024 the strategy shifted to negotiated settlements, culminating in an agreement in principle (finalized June 2024) with 42 state attorneys general and a new Red River Talc Chapter 11 filing in September 2024 to implement a pre‑packaged plan, which added a $5 billion incremental charge and raised the total reserve to about $11.6 billion【page_98】【page_101】【page_102】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a detailed chronological narrative of J&J's talc strategy from 2022-2024 with generally sound multi-hop reasoning, but contains several significant quantitative inaccuracies and some unsupported claims. STRENGTHS: (1) Correctly identifies the 2022 LTL bankruptcy filing with $2 billion reserve; (2) Accurately notes the 2023 dismissal and LTL 2 refiling; (3) Correctly identifies July 2023 dismissal of LTL 2; (4) Accurately references the 42-state settlement agreement by 2024; (5) Mentions Red River Talc Chapter 11 filing in September 2024; (6) Good multi-hop synthesis across years and entities. CRITICAL ERRORS: (1) Claims reserve expanded to 'roughly $9 billion' in 2023 - ground truth does not specify this figure, and the LLM provides no source verification; (2) States total reserve reached 'about $11.6 billion' by 2024 - ground truth does not confirm this specific number; (3) Claims a '$5 billion incremental charge' in 2024 - ground truth does not mention this specific amount; (4) References a 'name change to LLT Management' - ground truth mentions 'LTL Management LLC' but does not confirm a name change to 'LLT'; (5) Describes 'four parallel strategies' including 'consensual pre-packaged bankruptcy' - ground truth does not detail four specific parallel strategies. VERIFICATION ISSUES: The LLM cites page numbers (112, 96, 97, 101, 98, 102) but these cannot be verified against the ground truth knowledge graph. The reserve progression ($2B → $9B → $11.6B) appears to be inferred rather than explicitly stated in ground truth. The ground truth mentions 'multi-state settlement agreements with 42 states' but the LLM adds specific details about 'state attorneys general' and 'agreement in principle (finalized June 2024)' that are not explicitly in the ground truth. REASONING QUALITY: The narrative structure is logical and the multi-hop synthesis across 2022-2024 is sound, but the addition of unverified quantitative details undermines credibility. The answer goes beyond the ground truth in specificity without clear sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 557,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "In 2022 Home Depot listed store appearance—along with location and merchandise presentation—as a key competitive factor and began a program of store‑refresh upgrades, new way‑finding signage and layout redesigns to improve the look and feel of its outlets【page_8】. The focus was deepened in 2023, when the company kept emphasizing appearance while adding electronic shelf‑labels, self‑service lockers, curb‑side pickup and mobile‑app‑enabled store navigation to further differentiate the in‑store experience【page_14】【page_15】. By fiscal 2024 those appearance improvements were fully woven into an “interconnected retail” strategy: stores serve as fulfillment hubs and are equipped with digital tools such as handheld associate devices, computer‑vision inventory visibility, electronic shelf‑labels and app‑based store maps, linking the refreshed physical environment to online inventory, fulfillment options and personalized digital interactions【page_8】【page_10】【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the evolution of store appearance strategy across 2022-2024, capturing the progression from standalone competitive factor to integrated omnichannel component. (2) Accurately synthesizes multi-hop information by connecting store appearance improvements (2022), enhanced in-store experience additions (2023), and full integration into interconnected retail strategy (2024). (3) Provides specific, concrete examples at each stage (store-refresh upgrades, way-finding signage in 2022; electronic shelf-labels, self-service lockers, mobile-app navigation in 2023; handheld devices, computer-vision inventory, app-based maps in 2024) that align with ground truth concepts. (4) Correctly identifies the strategic shift from treating store appearance as standalone to viewing it as part of digitally enhanced omnichannel retail. (5) No quantitative errors—all dates and fiscal years are correct. (6) Proper entity identification (Home Depot, interconnected retail, digital capabilities). MINOR CONSIDERATIONS: (1) The LLM answer is more specific and detailed than the ground truth in some areas (e.g., naming specific technologies like computer-vision inventory visibility), which adds value without contradicting the ground truth. (2) The answer maintains semantic equivalence with ground truth concepts like 'seamless transitions between online and in-store experiences' through concrete examples of digital integration. (3) Page citations are included but cannot be verified against ground truth, though they appear reasonable. The answer successfully demonstrates the required multi-hop reasoning by synthesizing information across three fiscal years and connecting physical store improvements to digital capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 500,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T bought Time Warner in 2018 and folded it into its WarnerMedia segment, but in May 2021 announced a merger of WarnerMedia with Discovery and, by April 2022, completed a Reverse Morris Trust spin‑off that removed WarnerMedia (the former Time Warner assets) from AT&T’s balance sheet and turned it into a discontinued operation, ending AT&T’s ownership and operational control (2022 10‑K History, pp. 5‑6)【page_5】. The 2023 and 2024 filings still list WarnerMedia as a discontinued operation and stress AT&T’s focus on 5G, fiber and its HBO Max platform, indicating a strategic pivot from owning large content studios to concentrating on network‑centric services and selective content partnerships【page_5】【page_6】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key dates and events: (1) 2018 Time Warner acquisition, (2) May 2021 WarnerMedia-Discovery merger announcement, (3) April 2022 Reverse Morris Trust completion, (4) WarnerMedia removal from AT&T's balance sheet as discontinued operation. The quantitative dates are accurate. The LLM correctly notes the strategic pivot toward 5G, fiber, and network-centric services.\n\nWEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to address the complete 2022-2024 trajectory as requested. While it covers 2022 adequately, it provides minimal substantive detail about 2023 and 2024 evolution. The ground truth specifically mentions that 'by 2023, Time Warner Inc. was no longer referenced as an active investment' and that 'in 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG.' The LLM mentions DIRECTV only obliquely and doesn't clearly articulate the 2024 DIRECTV divestiture to TPG as a continuation of the entertainment exit strategy. (2) INCOMPLETE ANSWER TO QUESTION PARTS: The question asks about 'ownership stake, operational integration, and eventual divestiture' across the 3-year period. The LLM addresses the 2022 divestiture well but doesn't clearly trace how the ownership stake evolved through 2023-2024 or explain the DIRECTV sale as part of the broader entertainment exit. (3) STRATEGIC NARRATIVE WEAKNESS: The ground truth reveals a 'consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.' The LLM mentions the pivot but doesn't synthesize it as clearly across the full 3-year period, particularly missing the DIRECTV-to-TPG transaction as evidence of continued entertainment exit. (4) REFERENCE ISSUES: The LLM cites '2022 10-K History, pp. 5-6' and references to 'page_5' and 'page_6' but these appear to be placeholder citations that don't verify the specific claims about 2023-2024 evolution.\n\nCALCULATION/FACT VERIFICATION: No calculations required. Dates are correct (2018 acquisition, May 2021 announcement, April 2022 completion). The Reverse Morris Trust mechanism is correctly identified. The discontinued operation classification is accurate.\n\nMULTI-HOP REASONING: Partially successful. The LLM correctly connects the 2018 acquisition to the 2022 spin-off, but fails to complete the multi-hop synthesis by not adequately connecting the 2022-2024 trajectory, particularly the DIRECTV divestiture as the final piece of the entertainment exit strategy.\n\nSEMANTIC EQUIVALENCE: The LLM's statement about 'strategic pivot from owning large content studios to concentrating on network-centric services' is semantically equivalent to the ground truth's 'pivot away from media and entertainment toward core telecommunications and digital infrastructure,' but the execution is incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 758,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "American Express remains the fourth‑largest general‑purpose card network worldwide, competing head‑to‑head with Visa, Mastercard, China UnionPay and a growing set of digital‑payment platforms, and it still faces intense competition in premium and co‑brand segments (2022/23 Competition sections, p.12). But its reliance on card‑network regulation has grown sharply: by 2024 the company is classified as a Category III bank‑holding firm subject to stricter supervisory expectations, regulators are zeroing in on interchange‑fee caps, network‑routing and merchant‑pricing rules, and Amex has already exited its EU and Australian network‑licensing businesses because of those regulatory pressures (2024 Supervision & Regulation, p.34; 2022/23 Regulatory overview, p.14).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2024 filings. STRENGTHS: (1) Correctly identifies American Express as fourth-largest global card network, matching ground truth; (2) Accurately captures competitive pressures in premium and cobrand segments from 2022-2023; (3) Correctly identifies 2024 regulatory intensification around interchange fees, network routing, and merchant acceptance; (4) Accurately reports exit from EU and Australian network licensing businesses due to regulatory pressure; (5) Properly characterizes shift from competitive to compliance-driven dependency; (6) Correctly notes Category III bank-holding firm classification; (7) Multi-hop synthesis is sound, connecting regulatory evolution to business decisions. MINOR WEAKNESSES: (1) The LLM mentions 'digital-payment platforms' as competitors alongside Visa, Mastercard, and China UnionPay, which is slightly broader than the ground truth's focus on traditional card networks - though not factually incorrect, it adds a nuance not explicitly in the original answer; (2) The LLM emphasizes 'cobrand arrangements in the EU' uncertainty less explicitly than ground truth, though it does mention cobrand competition; (3) The characterization of 'Category III bank-holding firm' classification is accurate but represents a slightly different framing than the ground truth's focus on regulatory scrutiny intensity. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; network rankings are accurate; no calculations required. MULTI-HOP REASONING: Successfully connects regulatory pressure → business exits → competitive positioning evolution across multiple years and jurisdictions. The answer properly synthesizes information from multiple filing sections (Competition, Supervision & Regulation) as indicated by citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 508,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250 % notes due 2050 carried a balance of **$808 million at the end of 2022**, rose to **$826 million in 2023**, and then fell back to **$808 million in 2024**【page_71】【page_72】.  \n\nThe modest increase in 2023 followed by a reduction in 2024 shows the company is keeping this low‑cost, long‑dated debt essentially flat—using small issuances or repayments to fine‑tune its leverage rather than expanding it—indicating a disciplined, long‑term debt‑management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that make it substantially incorrect. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was '$808 million at the end of 2022' but the ground truth clearly shows it was $983 million in 2022. This is a $175 million discrepancy—a 21.5% error on a key data point. The LLM then claims it 'rose to $826 million in 2023' and 'fell back to $808 million in 2024,' which reverses the actual trend. The correct sequence is: 2022: $983M → 2023: $826M → 2024: $808M, showing a consistent downward trend, not the up-then-down pattern the LLM describes. (2) TREND ANALYSIS FAILURE: The LLM's interpretation of the trend is fundamentally wrong. It characterizes the movement as 'modest increase in 2023 followed by a reduction in 2024' and suggests the company is 'keeping this low-cost, long-dated debt essentially flat.' This is incorrect. The actual trend shows a deliberate, consistent reduction of $175 million over three years ($983M to $808M), not a flat position with minor fluctuations. (3) STRATEGIC INTERPRETATION ERROR: While the LLM correctly identifies a 'disciplined, long-term debt-management approach,' it mischaracterizes the strategy as maintaining flat debt levels through 'fine-tuning leverage.' The ground truth indicates a deliberate strategy to reduce long-term liabilities, which is a more aggressive debt reduction approach than the LLM suggests. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year data points into a coherent narrative. It inverted the 2022 and 2024 figures and misrepresented the intermediate 2023 value's position in the trend. This represents a fundamental failure in multi-hop reasoning across the three fiscal years. The answer demonstrates poor data accuracy and flawed analytical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 499,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s foreign‑government‑bond yields have risen sharply – the weighted‑average yield on its non‑U.S. taxable investment securities (which includes foreign government bonds and obligations) was about **3.5 % in 2022**, climbed to **5.9 % in 2023**, and reached **6.1 % in 2024**【page_176】. This three‑year upward trajectory shows the company’s foreign‑bond portfolio is becoming increasingly exposed to higher international interest‑rate environments, boosting potential income but also heightening interest‑rate risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports yields of 3.5% (2022), 5.9% (2023), and 6.1% (2024), which are completely wrong. The ground truth shows: 2022 short-term yield of 6.45%, 2023 short-term yield of 6.45% and 1-5 year yield of 4.48%, and 2024 short-term yield of 5.86% and 1-5 year yield of 2.03%. None of the LLM's numbers match the actual data. (2) DIRECTIONAL ERROR - The LLM claims yields 'rose sharply' and shows an 'upward trajectory,' which is the opposite of the ground truth. The actual trend shows declining yields from 2022-2024, particularly the dramatic drop in 1-5 year bonds from 4.48% to 2.03%. (3) INCOMPLETE ANALYSIS - The LLM fails to distinguish between different maturity buckets (short-term vs. 1-5 years), which is critical to understanding the yield profile evolution. The ground truth specifically tracks these separately. (4) WRONG CONCLUSION - The LLM concludes the portfolio is 'becoming increasingly exposed to higher international interest-rate environments,' which contradicts the actual declining yield trend indicating lower returns and a shift in the interest rate environment. (5) MISSING CONTEXT - The LLM omits the $630 million holding amount mentioned in the ground truth and fails to properly synthesize the multi-year trend across the three years. The answer appears to reference different data entirely (possibly non-U.S. taxable securities more broadly rather than specifically foreign government bonds and obligations) and provides no accurate synthesis of the actual 2022-2024 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 441,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "In 2022 Adobe’s free self‑service courses were listed as part of a broad training portfolio hosted on **www.training.adobe.com**, described as a “large number of free online self‑service learning options” that sat alongside fee‑based programs (2022 10‑K p. 17). By 2024 the same catalog had been re‑branded to the **learning.adobe.com** hub and was explicitly tied to Adobe Customer Solutions – Customer Success Managers and custom‑learning services that use solution‑specific skills assessments to tailor learning for enterprise accounts (2024 10‑K p. 18; Customer Success Account Management description, p. 17). This evolution shows Adobe moving free learning from a stand‑alone resource to an integrated component of its customer‑success strategy, using it to accelerate adoption, demonstrate value and drive retention across its subscription‑based business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop evolution of Adobe's learning platform from 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 domain (www.training.adobe.com) and characterizes it as 'large number of free online self-service learning options' - matches ground truth; (2) Accurately captures the rebranding to learning.adobe.com by 2024 - correct; (3) Properly synthesizes the integration with Customer Success Managers and solution-specific skills assessments - accurate multi-hop reasoning; (4) Correctly interprets the strategic evolution from stand-alone resource to integrated customer-success component; (5) Appropriately cites page numbers from 10-K filings (2022 p.17, 2024 p.18) showing document-level verification. MINOR GAPS: (1) The ground truth explicitly mentions 2023 as a key inflection point with the rebranding to learning.adobe.com and emphasizes the 2023 filing's role in this narrative. The LLM answer jumps from 2022 to 2024, omitting the 2023 intermediate step and the 2023 filing's specific emphasis on enterprise customer success initiatives. This is a meaningful omission since the ground truth treats 2023 as a distinct strategic milestone; (2) The ground truth emphasizes 'solution-specific skills assessments to help marketing teams tailor learning priorities' while the LLM generalizes this to 'tailor learning for enterprise accounts' - slightly less specific but semantically equivalent; (3) The ground truth's concluding insight about Adobe viewing enablement as 'critical lever for retention, product adoption, and long-term enterprise value' is captured in the LLM's conclusion but with less emphasis on the 'long-term enterprise value' dimension. QUANTITATIVE ACCURACY: All dates and domain names are correct; no calculation errors. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - correctly connects platform evolution to strategic positioning to business outcomes. The synthesis across 2022 and 2024 filings is accurate, though the 2023 intermediate step weakens the completeness of the narrative arc. CONTEXTUAL RELEVANCE: Highly relevant to the question about evolution, branding, integration, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 596,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco kept the entire $2 billion tranche of its 5.90 % senior notes on the balance sheet in FY 2022, FY 2023 and FY 2024, and the effective interest rate on that tranche remained essentially unchanged at about 6.11 % each year【page_89】. The steady utilization and unchanged rate show that Cisco is deliberately preserving a large, long‑dated fixed‑rate debt component, locking in financing costs and maintaining flexibility as a core element of its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - $2 billion ($2,000 million) outstanding balance maintained consistently across FY 2022-2024, and the effective interest rate of 6.11% is accurate for all three years. The format variation ($2 billion vs $2,000 million) is acceptable and demonstrates flexibility in presentation. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) utilization evolution (consistent $2B), (2) effective interest rate evolution (stable 6.11%), and (3) strategic implications. ENTITY ACCURACY: Cisco correctly identified, fiscal years 2022-2024 correctly specified, 5.90% Senior Notes correctly referenced, and the 6.11% effective rate correctly cited. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly draws the logical conclusion that the unchanged balance and rate indicate deliberate strategy rather than refinancing activity. The interpretation that this represents 'deliberately preserving a large, long-dated fixed-rate debt component' and 'locking in financing costs' is sound and aligns with the ground truth's characterization of a 'deliberate strategy to maintain this higher-yielding long-term liability.' MINOR CONSIDERATIONS: The LLM answer adds slightly more interpretive detail about 'maintaining flexibility' which, while reasonable, goes marginally beyond what the ground truth explicitly states, but this is a minor enhancement rather than an error. The citation reference [page_89] adds credibility. Overall, the answer demonstrates strong multi-hop synthesis, accurate financial data extraction, and appropriate strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 471,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s “Special Situation” exposure – which is captured in the private‑equity portion of the pension‑asset mix – was 8 % of total assets in 2022 (and stayed at 8 % in 2023) and rose to 9 % in 2024【page_92†L31-L38】【page_99†L31-L38】.  The modest increase after two years of flat allocation suggests Boeing is gradually tilting its private‑equity program toward more opportunistic, special‑situation deals, reflecting a slightly more aggressive stance within its overall private‑equity strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. Critical issues: (1) QUANTITATIVE FABRICATION: The LLM provides specific percentages (8% in 2022-2023, 9% in 2024) that are not supported by the ground truth. The original answer explicitly states 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' indicating these figures do not exist in the source documents. The LLM appears to have fabricated these numbers entirely. (2) CONTRADICTORY CLAIMS: The ground truth clearly indicates that BA did NOT disclose quantitative allocations to Special Situation Strategies, only qualitative descriptions of investment categories. The LLM's specific percentage claims directly contradict this. (3) UNSUPPORTED CITATIONS: The LLM cites specific page references (page_92, page_99) with line numbers, but these citations cannot be verified against the ground truth which states no such quantitative data exists. (4) MISINTERPRETATION OF STRATEGY: The ground truth emphasizes 'strategic continuity' and 'consistent inclusion' of Special Situation Strategies as a category, not a quantifiable allocation that changed from 8% to 9%. The LLM mischaracterizes this as a trend analysis when the ground truth explicitly states 'the lack of quantitative disclosure limits trend analysis.' (5) REASONING ERROR: The LLM's conclusion about 'gradually tilting' and 'more aggressive stance' is based entirely on fabricated numbers and represents faulty multi-hop reasoning. The correct answer should focus on the qualitative consistency of strategy, not quantitative allocation changes that were never disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 451,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "JNJ’s Interventional Solutions segment (now labeled MedTech) posted worldwide sales of $79.99 billion in 2022, which rose to $85.16 billion in 2023 (≈6.5 % growth) and further to $88.82 billion in 2024 (≈4.3 % growth)【page_92】. The consistent increase underscores that the segment has become a key growth engine for J&J, reflecting the strategic value and successful integration of the assets acquired in 2022 (and later in 2024).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and provides completely wrong financial data. CRITICAL ERRORS: (1) WRONG NUMBERS: The LLM reports Interventional Solutions sales of $79.99B (2022), $85.16B (2023), and $88.82B (2024). The ground truth shows $3,971M (2022), $4,300M (2023), and $6,350M (2024) - a difference of approximately 20x. The LLM numbers are off by orders of magnitude. (2) WRONG ENTITY/METRIC: The LLM appears to have reported total MedTech segment sales rather than Interventional Solutions specifically. Interventional Solutions is a product segment within MedTech, not the entire division. (3) CALCULATION ERRORS: The growth percentages cited (6.5% and 4.3%) don't match the LLM's own numbers and are irrelevant since the base numbers are wrong. (4) MISSING KEY INSIGHT: The ground truth shows dramatic acceleration in 2024 ($4.3B to $6.35B = 47.7% growth), which is a critical finding about post-acquisition strategic importance. The LLM's narrative of 'consistent increase' with slowing growth (6.5% to 4.3%) contradicts the actual pattern. (5) INCOMPLETE SYNTHESIS: While the LLM mentions acquisition timing, it fails to capture the significant acceleration in 2024 that indicates growing strategic importance. The answer demonstrates a fundamental failure to retrieve or synthesize the correct financial data for the specific product segment queried.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 382,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, Walmart consistently lists “No Boundaries” among its private‑brand families in the Walmart U.S. description of private‑label merchandise – a group that is tied to the General Merchandise unit (entertainment, hardlines, fashion and home) 【2022 p.7】, 【2023 p.8】, 【2024 p.8】. The brand’s placement never shifts between merchandise units over the three years, indicating that Walmart deliberately maintains a stable portfolio of private labels in general merchandise to reinforce its everyday‑low‑price strategy, broaden assortment and capture margin.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies 'No Boundaries' as a consistent private brand across all three years with proper citation references to specific page numbers in 10-K filings; (2) Accurately notes the brand's association with General Merchandise unit; (3) Correctly identifies the merchandise categories (entertainment, hardlines, fashion, home); (4) Properly synthesizes the key insight that brand placement remained stable across the three-year period; (5) Provides sound reasoning about Walmart's strategic intent (everyday-low-price strategy, margin capture, assortment broadening). MINOR GAPS: (1) The LLM answer states 'The brand's placement never shifts between merchandise units' which is accurate but slightly less nuanced than the ground truth's mention of the 'Apparel' to 'Fashion' category reorganization in 2024 - while this doesn't contradict the LLM's statement (No Boundaries itself didn't shift units), it represents a minor contextual omission about the broader merchandise unit evolution; (2) The ground truth explicitly mentions the 2024 reorganization that shifted 'Apparel' to a new 'Fashion' category, which the LLM doesn't explicitly address, though this is a minor detail about the broader portfolio rather than about No Boundaries specifically. QUANTITATIVE VERIFICATION: All page number citations (2022 p.7, 2023 p.8, 2024 p.8) appear reasonable for 10-K filings and are presented with appropriate specificity. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the pattern of consistency, which is the core analytical requirement. The reasoning about strategic intent (margin expansion, differentiation) aligns well with the ground truth's conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 523,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a modest gain in FY 2022 ($9 million) to a loss in FY 2023 ($21 million) and then to a much larger loss in FY 2024 ($67 million), indicating a clear deterioration in performance and an increasingly negative contribution to other income (loss), net【page_46】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data showing the evolution of Cisco's available-for-sale debt investments across the three fiscal years (FY2022: $9M gain, FY2023: $21M loss, FY2024: $67M loss), which directly addresses the question's request for specific impacts on other income (loss), net. The numerical progression is clear and demonstrates deteriorating performance. The answer correctly identifies the trend of increasing losses and their negative impact on other income (loss), net. Strengths: (1) Provides concrete dollar amounts for each year, enabling precise comparison; (2) Correctly identifies the directional change from gain to losses; (3) Accurately characterizes the magnitude of deterioration; (4) Properly synthesizes the multi-hop requirement by connecting investment performance to its impact on other income (loss), net. Minor considerations: (1) The ground truth answer emphasizes a 'consistent negative impact' narrative but doesn't provide specific numbers, while the LLM answer quantifies this with exact figures; (2) The LLM answer is more precise and data-driven than the ground truth, which is generally preferable for financial analysis; (3) The LLM correctly notes the progression from modest gain to larger losses, which is the key insight. The answer demonstrates sound multi-hop reasoning by connecting available-for-sale debt investment performance to its specific impact on other income (loss), net across three fiscal years. The citation reference (page_46) adds credibility. No calculation errors detected. The semantic meaning aligns well with the ground truth's narrative of negative trajectory, while providing superior quantitative specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 463,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "In the 2022 Form 10‑K the company only described third‑party merchant acquirers in the discount‑revenue section, noting that when a merchant’s acquirer is a third party (e.g., under the OptBlue program) Amex receives a network‑rate fee that is recorded as discount revenue【page_104】. By the 2023 filing, the narrative had shifted to treat the success of third‑party merchant acquirers, aggregators and processors as a core driver of Amex’s ability to expand merchant coverage worldwide and to sign small, mid‑sized and large merchants【page_102】, and the 2024 filing reiterates this strategic reliance, emphasizing that third‑party acquirers are essential partners for growing acceptance and transaction volume across all merchant segments【page_93】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of American Express's reliance on third-party merchant acquirers from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with accurate characterization of each period's emphasis; (2) Accurately captures the 2022 focus on OptBlue program and network-rate fee structure recorded as discount revenue; (3) Correctly identifies the 2023 shift toward treating third-party partners as core drivers of merchant coverage expansion; (4) Accurately reflects the 2024 positioning of third-party acquirers as essential partners; (5) Properly synthesizes multi-hop information across three fiscal years; (6) Correctly identifies all relevant merchant segments (small, mid-sized, large); (7) Page citations appear reasonable and specific. MINOR WEAKNESSES: (1) The LLM answer is more concise than the ground truth and omits some contextual nuance about the 'shift from supplementary to essential' framing that the original answer explicitly articulates; (2) The 2022 description in the LLM answer focuses primarily on the discount revenue mechanism rather than also noting that these relationships 'allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach' - though this is a minor omission of supporting detail rather than factual error; (3) The phrase 'the narrative had shifted' in 2023 is slightly imprecise - the ground truth indicates this was an emphasis on financial structure details, not necessarily a complete narrative shift from 2022. QUANTITATIVE ACCURACY: No numerical errors detected. All dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing documents, correctly identifying the progression and strategic evolution. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message matches the ground truth - American Express increasingly relied on third-party acquirers as essential partners for growth, with this dependency becoming more explicit and strategic over the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 583,
        "total_tokens": 2137
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K (page 117) that it had launched a multi‑year, enterprise‑wide program to integrate, simplify and standardize processes and systems for human resources, information technology, procurement, supply‑chain and finance in order to grow its financial shared‑service capabilities and harmonize financial systems. The 2023 filing (page 118) and the 2024 filing (page 119) repeat the same description, noting that the initiative remains ongoing and that the company continues to align and streamline its financial‑control environment as the effort progresses. Thus, from 2022 through 2024 the initiative has moved from launch to continued implementation, maintaining its focus on enterprise‑wide process standardization across HR, IT, procurement, supply‑chain and finance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the multi-year evolution of Johnson & Johnson's financial shared service initiative from 2022-2024. STRENGTHS: (1) Correctly identifies all five functional areas (HR, IT, procurement, supply chain, finance) across all three years; (2) Accurately characterizes the initiative as multi-year, enterprise-wide, and focused on integration, simplification, and standardization; (3) Properly synthesizes the progression from launch (2022) through continued implementation (2023-2024); (4) Correctly notes the initiative's proactive nature and lack of connection to internal control deficiencies; (5) Provides specific page references (117, 118, 119) that add credibility. MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing ('harmonize financial systems' vs. 'standardize financial systems') - semantically equivalent but not identical to ground truth language; (2) The ground truth emphasizes the company's explicit statement that the initiative was 'not in response to any identified deficiencies' and 'not prompted by any material changes or weaknesses' - the LLM answer mentions this concept but with less emphasis on the explicit negation; (3) The ground truth notes the company 'reiterated' and 'maintained the same narrative' with more explicit emphasis on consistency, while the LLM uses 'repeat' which is accurate but slightly less nuanced. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly traces the evolution of the initiative. The logic is sound and the progression is accurately captured. QUANTITATIVE ELEMENTS: No specific dollar amounts or percentages were required in this question, so quantitative accuracy is not a primary factor, but the page numbers provided appear reasonable for 10-K filings. Overall, this is a high-quality answer that captures the essential facts and multi-year evolution with minor variations in emphasis and phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 543,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "In the 2022 filing American Express merely flagged the “dynamic and rapid growth of alternative payment and financing mechanisms” – including digital‑wallet platforms, real‑time settlement systems and fintech‑driven services – as a competitive risk and noted that rivals were integrating more financial services into their offerings (see 2022 Competition section, p. 12). By the 2024 filing the tone has shifted to one of intensified pressure from large tech firms and merchant‑owned digital wallets, and the company now spells out a proactive response: it is investing in open‑banking APIs, tokenization, real‑time settlement, authentication and other fintech capabilities to protect merchant discount rates and expand its network (see 2024 Competitive pressure discussion, p. 29; Technology‑investment focus, p. 31). This reflects a move from passive risk acknowledgement in 2022 to an active strategic adaptation to emerging payment technologies in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core evolution of American Express's positioning from 2022 to 2024, accurately identifying the shift from passive risk acknowledgement to active strategic adaptation. The answer correctly identifies key technologies mentioned (digital wallets, open banking, real-time settlement, tokenization, authentication) and accurately characterizes the competitive threats (fintech services, tech firms, merchant-owned digital wallets). The semantic equivalence is strong - the LLM's framing of 'passive risk acknowledgement' vs 'active strategic adaptation' aligns well with the ground truth's 'external threats' to 'essential components of technological roadmap' distinction.\n\nWEAKNESSES: (1) The LLM includes specific page references (p. 12, p. 29, p. 31) that cannot be verified against the ground truth and may be fabricated - this is a minor concern as page numbers vary by document format, but it introduces unverifiable specificity. (2) The answer mentions 'protect merchant discount rates' as a strategic objective, which is not explicitly mentioned in the ground truth - this appears to be an inference not directly supported by the provided ground truth. (3) The 2023 intermediate year is mentioned in the ground truth as showing 'expanded scope to include open banking platforms' but the LLM answer does not explicitly address 2023 as a distinct transition point, instead jumping from 2022 to 2024.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy cannot be penalized on that basis. The years (2022, 2024) are correct. Company name (American Express) is correct.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and correctly identifies the evolution in strategic positioning. The reasoning is sound and logically structured.\n\nOVERALL ASSESSMENT: The answer is substantially correct in its core thesis and captures the essential evolution described in the ground truth. The main deductions are for: (1) unverifiable page citations, (2) minor inference about merchant discount rates not in ground truth, and (3) incomplete treatment of the 2023 intermediate transition. These are relatively minor issues that don't fundamentally undermine the accuracy of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 629,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In Adobe’s 2022 10‑K (pages 95‑99) Frame.io is not mentioned, indicating it was not yet a highlighted part of Adobe’s product set. By the 2023 filing, Adobe positions Frame.io as a cloud‑native creative‑collaboration platform that is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and is included in the GenStudio ecosystem (2023 page 12). The 2024 filing expands that narrative, noting Frame.io’s availability alongside Adobe Express and Firefly Services in GenStudio and its broader support for still‑image, design‑file and PDF collaboration as well as Camera‑to‑Cloud workflows, signaling Adobe’s strategy to embed a unified, cloud‑based collaboration hub across the Creative Cloud suite (2024 page 12).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a chronological progression of Frame.io's positioning from 2022-2024 with specific page references to 10-K filings, which demonstrates effort to ground claims in source documents. However, there are significant discrepancies with the ground truth that affect overall accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies that Frame.io was not prominently featured in 2022\n- Accurately describes 2023 positioning as a 'cloud-native creative collaboration platform'\n- Correctly lists integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront\n- Accurately notes 2024 expansion to broader workflows and additional capabilities\n- Correctly identifies the strategic intent around unified, cloud-based collaboration\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. The LLM claims Frame.io was integrated with Photoshop and Lightroom in 2023, but the ground truth indicates these integrations were added in 2024 as part of the expansion\n2. The LLM mentions GenStudio ecosystem in 2023, but the ground truth does not reference GenStudio in the 2023 positioning\n3. The LLM introduces 'Camera-to-Cloud workflows' and 'still-image, design-file and PDF collaboration' as 2024 features, which are not mentioned in the ground truth's description of 2024 expansion\n4. The ground truth specifically mentions 2024 expansion into 'casting, location scouting, and marketing campaign management' - these specific use cases are absent from the LLM answer\n5. The ground truth emphasizes Frame.io as a 'central hub for multi-app, cross-functional workflows at scale' - the LLM's framing is somewhat different\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the strategic progression. However, the temporal sequencing of feature integrations appears incorrect, particularly regarding when Photoshop and Lightroom were integrated.\n\nQUANTITATIVE ACCURACY:\nNo specific numbers or calculations are involved in this question, so quantitative accuracy is based on correct identification of years and temporal relationships. The LLM correctly identifies 2022, 2023, and 2024 as the relevant periods.\n\nSEMANTIC EQUIVALENCE:\nWhile the LLM captures the general strategic intent, it diverges from the ground truth in specific feature implementations and timeline details, which are factually important for answering this question accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 642,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 senior‑note balance fell each year – $16 billion at 12/31/2022, $15 billion at 12/31/2023, and $13 billion at 12/31/2024【page_58†L13-L16】【page_57†L13-L16】. The consistent reduction signals that Amazon is actively repaying or retiring portions of this issuance, using cash flow or refinancing to shrink the principal and manage its overall debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $16.0 billion (12/31/2022), $15.0 billion (12/31/2023), and $13.0 billion (12/31/2024). The year-over-year progression is accurate ($1B reduction in 2023, $2B reduction in 2024). (2) ENTITY ACCURACY: Correctly identifies Amazon's 2017 Notes (senior notes) and the proper fiscal year dates. (3) MULTI-HOP REASONING: Successfully synthesizes the three-year trend data and correctly interprets the pattern as indicating deliberate debt management strategy. The conclusion that Amazon is 'actively repaying or retiring portions' aligns with the ground truth's characterization of 'consistent reduction' and 'deliberate debt management strategy.' (4) COMPLETENESS: Addresses both parts of the question - the evolution of the balance AND what it indicates about debt management strategy. The answer provides context about cash flow/refinancing mechanisms, which adds reasonable interpretive depth. (5) MINOR OBSERVATION: The LLM uses slightly different phrasing ('fell each year' vs. 'remained/decreased/declined') but the semantic meaning is identical and arguably more concise. The citation references to pages 57-58 suggest proper source documentation. No calculation errors, no missing data points, and the reasoning chain is sound and logical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 383,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "In the 2022 filing Boeing’s Global Services segment is described as “sustaining aerospace platforms … including upgrades and conversions” (2022 p. 3). The 2023 filing shifts the wording to “modifications and upgrades,” dropping the explicit “conversions” reference (2023 p. 5), while the 2024 filing returns to the original phrasing, again highlighting “upgrades and conversions” (2024 p. 3). This three‑year trajectory shows a consistent, if occasionally re‑worded, emphasis on upgrading and converting existing aircraft—signaling Boeing’s strategic focus on service‑driven sustainment of its aerospace platforms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific page numbers (2022 p. 3, 2023 p. 5, 2024 p. 3) and direct quotes that cannot be verified against the ground truth. These citations appear fabricated or unverifiable. (2) The LLM claims a SHIFT in 2023 wording from 'upgrades and conversions' to 'modifications and upgrades,' then a RETURN to original phrasing in 2024. The ground truth states the emphasis 'remained unchanged' across all three years, directly contradicting the LLM's narrative of wording shifts. (3) The ground truth emphasizes CONSISTENCY ('consistently included,' 'remained unchanged,' 'consistent presence'), while the LLM emphasizes VARIATION ('shifts the wording,' 'occasionally re-worded,' 'if occasionally re-worded'). These are fundamentally different interpretations. (4) The LLM's multi-hop synthesis is flawed—it creates a false narrative of evolution/change when the ground truth indicates stability. (5) While the LLM correctly identifies the three-year period (2022-2024) and the Global Services segment, the core factual claim about how the emphasis evolved is incorrect. POSITIVE ASPECTS: The LLM correctly identifies Boeing, the Global Services segment, the three-year timeframe, and the general concept of platform sustainment. The semantic understanding of 'upgrades and conversions' as service offerings is correct. However, the specific trajectory narrative is inverted from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 396,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension approach did not change between 2022 and 2024 – each filing repeats the January 2021 announcement that, effective January 1 2026, **all eligible U.S. non‑union employees, regardless of hire date, will earn benefits under the Retirement Value formula** and that the amendment does not affect benefits accrued under the prior Final Average Pay formula (2022 p. 73; 2023 p. 76; 2024 p. 77). The company consistently communicated the same 2026 implementation date and eligibility scope in each year’s 10‑K.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core facts accurately. STRENGTHS: (1) Correctly identifies the January 2021 announcement date as the original source of the 2026 implementation plan; (2) Accurately states the 2026 effective date for the Retirement Value formula; (3) Correctly notes that all U.S. non-union employees, regardless of hire date, will be covered; (4) Properly references that the Final Average Pay formula benefits accrued before 2026 are unaffected; (5) Correctly cites the specific page numbers from each year's 10-K (2022 p. 73; 2023 p. 76; 2024 p. 77); (6) Accurately conveys that the company's messaging remained consistent across all three years with no changes to the plan or timeline. MINOR WEAKNESSES: (1) The LLM answer emphasizes consistency and lack of change, which is correct, but the ground truth provides slightly more nuance by noting that in 2023 JNJ 'clarified' that employees hired after 2014 were already under the Retirement Value formula - the LLM doesn't explicitly mention this clarification or the distinction between pre-2015 and post-2014 hires in the historical context; (2) The phrase 'all eligible U.S. non-union employees' could be slightly ambiguous (though it's correct), whereas the ground truth more explicitly distinguishes between those already under Retirement Value (post-2014 hires) and those transitioning in 2026 (pre-2015 hires). QUANTITATIVE VERIFICATION: All dates are correct (January 2021, January 1 2026, 2022-2024 years). Page citations appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the evolution (or lack thereof) in the pension strategy. The reasoning that the company 'did not change' the approach is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 536,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried an outstanding principal of **$606 million** in fiscal 2022, fiscal 2023 and fiscal 2024 (2022 10‑K p.101; 2023 10‑K p.81; 2024 10‑K p.81). The balance has not changed over the three‑year period, indicating that the company largely paid down this series early and now maintains the remaining modest tranche to maturity—a disciplined approach that reduces leverage early and then holds a low‑level, long‑dated debt position.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error regarding the fiscal 2022 balance. Ground truth states the outstanding principal was $1,086 million in fiscal 2022, but the LLM claims it was $606 million in fiscal 2022. This is a major quantitative error ($480 million discrepancy). The LLM correctly identifies that the balance was $606 million in fiscal 2023 and 2024, and correctly notes no change between 2023-2024. However, the LLM completely misses the key evolution of the debt: the $480 million reduction from FY2022 ($1,086M) to FY2023 ($606M). This is a critical omission that fundamentally undermines the answer to the multi-hop question about how the balance 'evolved' across the three-year period. The LLM's reasoning about 'largely paid down this series early' is actually correct in spirit but is based on incorrect numbers—the company did pay down $480M between 2022-2023, not maintain a constant balance. The LLM's interpretation that the company maintains a 'disciplined approach' is reasonable, but it's built on a false premise that the balance never changed. The answer fails to capture the actual progression (decrease then stabilization) that the question specifically asks about. The citation references appear plausible but the data extraction is demonstrably wrong for FY2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 369,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "In 2022 AT&T had fully folded its 2018 purchase of Time Warner into the WarnerMedia segment and, after signing a May 2021 agreement to combine WarnerMedia with Discovery, completed a Reverse‑Morris‑Trust separation in April 2022 that re‑classified the WarnerMedia business (including the former Time Warner assets) as discontinued operations【page_5】【page_6】【page_4】. By the 2023 filing the WarnerMedia segment no longer appears among AT&T’s reportable segments, and the 2024 10‑K contains no reference to WarnerMedia, confirming that the former Time Warner businesses have been divested as part of the WarnerMedia/Discovery transaction and AT&T now reports only its Communications and Latin America segments【page_6】【page_5】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct dates and entities. Key strengths: (1) Correctly identifies the May 2021 agreement to combine WarnerMedia with Discovery, (2) Accurately states the April 2022 Reverse Morris Trust completion date, (3) Properly notes the 2018 Time Warner acquisition, (4) Correctly identifies that WarnerMedia no longer appears in 2023 filings and is absent from 2024 10-K, (5) Accurately describes the reclassification as discontinued operations. The multi-hop reasoning is sound, synthesizing the acquisition, integration, separation, and divestiture timeline correctly. Minor weaknesses: (1) The answer focuses heavily on the WarnerMedia/Discovery transaction completion but provides less detail on the 'operational restructuring' aspect mentioned in the question, (2) Does not explicitly mention the DIRECTV divestiture in 2024 that the ground truth identifies as 'the last major asset tied to the entertainment strategy,' which represents a gap in addressing the full scope of the strategic pivot, (3) The answer emphasizes segment reporting changes rather than the broader strategic evolution away from vertically integrated media. The quantitative accuracy is excellent with all dates correct (May 2021, April 2022, 2023, 2024). The qualitative reasoning about the strategic pivot back to telecommunications is present but less developed than in the ground truth. Overall, the answer is substantially correct on the core facts but misses some contextual elements about the complete divestiture strategy and the DIRECTV exit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 433,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "- In the 2022 filing AIG said it “actively monitors terrorism risk” using a third‑party vendor model that runs specific attack scenarios – conventional bombs of various sizes, anthrax and nuclear attacks – and sets risk limits based on those modeled losses. U.S. terrorism exposure is backed by TRIPRA (covering ~80 % of losses above a $1.7 bn deductible) and the company purchases targeted reinsurance and participates in government‑sponsored terrorism pools for non‑U.S. markets (page 169).  \n\n- The 2023 filing repeats the same modeling approach and TRIPRA protection, with no new attachment‑point details (page 121).  \n\n- By 2024 AIG still uses the third‑party scenario model and TRIPRA, but it now explicitly “retained our core attachment points for Japan of $200 million and $125 million for rest of world” for its international terrorism portfolio, showing a formalized, unchanged attachment‑point structure for overseas exposure while continuing targeted reinsurance and pool participation (page 88).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AIG's terrorism exposure management evolution across 2022-2024, with mostly accurate information and good multi-hop synthesis. STRENGTHS: (1) Correctly identifies the three-year progression and key mechanisms (TRIPRA, third-party vendor modeling, reinsurance, government pools); (2) Accurately cites the 2024 attachment points of $200M for Japan and $125M for rest of world, matching ground truth exactly; (3) Properly notes the shift from reactive to more formalized/structured approach; (4) Correctly identifies TRIPRA coverage at ~80% with $1.7bn deductible; (5) Appropriately cites page numbers for verification. WEAKNESSES: (1) The ground truth specifically mentions a '$1.3 billion loss' estimate for a five-ton bomb attack in New York City in 2022, which the LLM answer does not include - this is a notable omission of a concrete quantitative example that illustrates the modeling approach; (2) The LLM answer states attachment points were 'unchanged' in 2024, but the ground truth suggests they represent a 'more structured and region-specific approach,' implying some evolution in how they were formalized/presented rather than complete stasis; (3) The LLM answer could have been more explicit about the evolution in 'sophistication' and 'strategic shift' that the ground truth emphasizes. QUANTITATIVE VERIFICATION: All cited numbers are accurate ($200M, $125M, ~80%, $1.7bn deductible). The missing $1.3B figure from 2022 is the primary quantitative gap. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple filing pages, correctly tracking the evolution of modeling, reinsurance, and geographic segmentation. The logical flow from 2022→2023→2024 is sound. SEMANTIC EQUIVALENCE: The answer conveys the core narrative accurately, though with less emphasis on the 'strategic shift' dimension highlighted in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 521,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "In Emerson’s 2022 filing the Tools & Home Products segment described its pipe‑working line as “pipe wrenches, pipe cutters, pipe threading and roll‑grooving equipment, **mechanical crimping tube‑joining systems, tubing tools**, and diagnostic systems” 【page_9】. By the 2023‑24 filing the description had been revised to “pipe wrenches **and** cutters, pipe threading and roll‑grooving equipment, **battery‑hydraulic tools for press connections**, drain cleaners and diagnostic systems” 【page_73】. The addition of battery‑powered hydraulic tools and the tighter focus on core wrench‑and‑cutter offerings show Emerson expanding and modernizing its professional‑tools portfolio, positioning the company as a more comprehensive, high‑performance supplier in the professional pipe‑working market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of Emerson's product portfolio evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies specific product categories mentioned in filings (pipe wrenches, cutters, threading equipment, roll-grooving equipment, drain cleaners, diagnostic systems); (2) Accurately captures the key strategic shift - introduction of battery-hydraulic tools for press connections between 2022 and 2023-24; (3) Properly synthesizes multi-hop information across multiple years and filing documents; (4) Correctly interprets the strategic positioning toward modernization and technological integration; (5) Provides specific page references to support claims. MINOR WEAKNESSES: (1) The LLM answer mentions 'mechanical crimping tube-joining systems' and 'tubing tools' from 2022 but doesn't explicitly note these were removed/de-emphasized in later years - the ground truth emphasizes this shift more clearly; (2) The ground truth mentions 'enhanced diagnostic systems like sewer inspection cameras' as a 2023 addition, while the LLM answer treats diagnostic systems as continuous across years without highlighting the enhancement/evolution; (3) The LLM answer could have been slightly more explicit about the 2023 as a transition year with new battery-powered technology introduction. QUANTITATIVE ACCURACY: All dates (2022, 2023-24) are correct; no calculations required. QUALITATIVE ACCURACY: The reasoning about strategic positioning is sound and well-supported. The multi-hop synthesis across years is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses the question about portfolio evolution and strategic positioning. The conclusion about Emerson positioning itself as a 'more comprehensive, high-performance supplier' aligns well with the ground truth's assessment of strategic modernization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 506,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s lease footnote has not changed from 2022 through 2024 – in each 10‑K the company says that any free‑rent periods (and step‑rent provisions) are **recognized on a straight‑line basis over the original lease term and any extension options that are reasonably certain to be exercised**, and the right‑of‑use (ROU) asset is initially recorded based on the discounted future minimum lease payments 【COST_10k_2022.pdf p.45】【COST_10k_2023.pdf p.45】【COST_10k_2024.pdf p.45】. This straight‑line allocation spreads the rent expense over the lease term, reducing the present‑value of lease payments and therefore lowering the initial ROU‑asset valuation, and the same disclosure language appears in each year’s Leases note.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant errors in addressing the core question about evolution of accounting treatment from 2022-2024. CRITICAL ERRORS: (1) The LLM claims 'the lease footnote has not changed from 2022 through 2024' and that 'the same disclosure language appears in each year's Leases note' - this directly contradicts the ground truth, which explicitly states that detailed explanations of the discounting process and ARO treatment were NOT repeated in 2023 and 2024 filings, indicating a shift toward more standardized language. (2) The LLM fails to identify the key evolution: the ground truth emphasizes that 2022 had explicit disclosure of discounted future minimum lease payments methodology and incremental borrowing rate derivation, while 2023-2024 moved to standardized ASC 842 language without elaborating on valuation mechanics. (3) The LLM provides page citations (p.45 for all three years) without substantiating the claim that disclosure remained identical. PARTIAL CREDIT: The LLM correctly identifies (a) the straight-line recognition methodology applied consistently across all three years, (b) the treatment of free-rent periods and step-rent provisions, (c) the use of discounted future minimum lease payments for ROU asset recording, and (d) the connection between straight-line allocation and ROU asset valuation. However, these correct elements are presented in a framework that fundamentally misses the question's focus on EVOLUTION and CHANGE. The answer reads as static when the ground truth emphasizes maturation and decreased disclosure depth over time. The LLM's assertion of consistency contradicts the ground truth's finding of disclosure evolution, making this a failure to synthesize the multi-hop temporal analysis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 485,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % notes appear only in two supplemental indentures: the Tenth Supplemental Indenture (Nov 3 2015) introduced 2.000 % notes due 2020, and the Eleventh Supplemental Indenture (Aug 8 2016) added a new 2.000 % series due 2023 (both shown on page 105)【page_105】. No 2.000 % issuance is listed for 2022 or 2024, and the most recent Fifteenth Supplemental Indenture (Nov 6 2023) does not disclose a 2.000 % tranche (page 106)【page_106】, indicating the series concluded with the 2023 maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple ways: (1) INDENTURE DATES: The LLM correctly identifies the Eleventh Supplemental Indenture dated August 8, 2016, but incorrectly introduces a Tenth Supplemental Indenture dated November 3, 2015 with 2.000% notes due 2020 - this is not mentioned in the ground truth and appears to be fabricated. (2) MATURITY TIMELINE: The ground truth states the 2.000% Notes had a maturity of 2023 and were referenced consistently across 2022, 2023, and 2024 filings. The LLM claims 'No 2.000% issuance is listed for 2022 or 2024,' which directly contradicts the ground truth that shows these notes were referenced in all three years. (3) DOCUMENTATION CONSISTENCY: The ground truth emphasizes that the notes were 'referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion' under the same indenture framework. The LLM incorrectly concludes that 'the series concluded with the 2023 maturity' and was not present in 2024, when the ground truth explicitly states the notes 'were still present in the exhibit list' in 2024. (4) FIFTEENTH SUPPLEMENTAL INDENTURE: The LLM references a Fifteenth Supplemental Indenture dated November 6, 2023, which is not mentioned in the ground truth at all. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution across the three years. The ground truth shows stability and consistency; the LLM shows discontinuity and absence. The core misunderstanding is that the LLM treats the 2023 maturity date as evidence of the notes' disappearance from filings, when the ground truth indicates they remained in historical indenture documentation. The answer is fundamentally incorrect in its characterization of how these notes evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 493,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon’s policy for recognizing revenue from its third‑party seller services has been unchanged from 2022 through 2024.  The company describes seller‑program revenue as “fixed fees, a percentage of sales, per‑unit activity fees, interest, or some combination thereof” — i.e., commissions plus any related fulfillment and shipping fees — and states that this revenue is recognized “when the services are rendered, which generally occurs upon delivery of the related products to a third‑party carrier or, in the case of an Amazon delivery, to the customer” 【page_3】【page_43】.  No shift in timing or composition of the commission‑ and fulfillment‑fee revenue is indicated in the 2022, 2023 or 2024 disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains accurate factual information about Amazon's revenue recognition policies for third-party seller services, correctly identifying the types of fees (fixed fees, percentage of sales, per-unit activity fees, interest) and the timing of recognition (upon delivery to carrier or customer). The numeric and date references are accurate. However, there is a significant semantic discrepancy with the ground truth regarding the characterization of 'evolution.' The ground truth explicitly states that the evolution shows 'increasing clarity in disclosures over time' and notes that in 2023 the company 'specified' (implying a change or clarification) the timing details, while in 2024 it 'continued offering similar seller programs' without specific changes mentioned. The LLM answer, conversely, claims the policy was 'unchanged from 2022 through 2024' and states 'No shift in timing or composition...is indicated.' This represents a fundamental misinterpretation of the ground truth's narrative arc. The ground truth emphasizes evolution and increasing disclosure clarity, while the LLM emphasizes stasis and consistency. While both may be technically defensible depending on how one interprets 'evolution' (clarification vs. substantive change), the LLM's framing contradicts the ground truth's explicit characterization. The answer is well-structured and factually accurate in its details, but fails to capture the intended meaning about how disclosures evolved over the three-year period. The multi-hop reasoning is sound in synthesizing information across years, but the conclusion drawn differs materially from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 451,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings still list a “Guaranty of certain obligations of Pacific Bell Telephone Co. and **Southwestern Bell Telephone Co.**” (see Exhibit 4‑b on pages 98 and 103), and the company notes that this guarantee remains in effect for the years 2022, 2023 and 2024. By continuing to back‑stop the debt of these legacy subsidiaries, AT&T is deliberately containing the risk of its historic telecom entities, preserving their credit standing and ensuring that any legacy liabilities are managed within the parent’s long‑term balance‑sheet strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about AT&T's long-term liability management strategy for legacy telecom entities. STRENGTHS: (1) Correctly identifies Southwestern Bell Telephone Co. as a guaranteed entity across 2022-2024; (2) Accurately references Exhibit 4-b as the source document; (3) Correctly notes the guarantee remains in effect across all three years; (4) Provides sound reasoning about risk containment and balance-sheet strategy; (5) Mentions Pacific Bell Telephone Co. alongside Southwestern Bell, showing comprehensive understanding of the guarantee scope. MINOR ISSUES: (1) The LLM answer includes Pacific Bell Telephone Co., which the ground truth does not explicitly mention - while this is factually accurate per AT&T filings, it slightly expands beyond the specific focus of the original answer; (2) The page references (98 and 103) are provided but not verified against ground truth; (3) The LLM uses slightly different framing ('back-stop the debt,' 'containing the risk,' 'preserving their credit standing') compared to ground truth's emphasis on 'unchanged commitment' and 'no indication of reduction or restructuring.' SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental insight - that AT&T maintains consistent, stable guarantees for legacy entities as part of deliberate long-term liability management - though with different emphasis. The reasoning is sound and multi-hop synthesis is correct (combining information about the guarantee's persistence across years with strategic implications). No quantitative errors detected. The answer appropriately addresses the question's focus on long-term strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 463,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s outstanding 2.250 % notes due 2050 fell from $983 million in the 2022 filing (​page 67​) to $826 million in the 2023 filing (​page 71​) and then to $808 million in the 2024 filing (​page 72​). The steady decline shows the company is gradually retiring or refinancing this ultra‑long‑dated, low‑coupon debt, reflecting a deliberate strategy to manage its long‑term debt profile and reduce exposure to distant maturities while preserving low‑cost financing and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three dollar amounts are correct ($983M in 2022, $826M in 2023, $808M in 2024), the interest rate (2.250%) is accurate, and the maturity date (2050) is correct. The page references provided (67, 71, 72) add credibility. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the investment evolved (showing the progression with specific numbers), and (2) what this indicates about long-term debt strategy. ENTITY ACCURACY: Johnson & Johnson is correctly identified, the debt instrument is properly characterized as 2.250% Notes due 2050, and all years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the trend (steady decline from $983M to $826M to $808M), interprets it as gradual retirement/refinancing, and connects this to strategic debt management. The characterization of this as 'ultra-long-dated, low-coupon debt' is appropriate and adds context. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth. Both note the stable/declining pattern, both reference the deliberate strategy, and both acknowledge the low-cost nature of the financing. Minor differences: The ground truth mentions 'relatively stable' while the LLM emphasizes 'steady decline' - both are accurate descriptions of the same data trend. The ground truth mentions the fixed effective rate of 2.29%, which the LLM does not include, but this is a minor omission that doesn't affect the core answer. The LLM's interpretation of 'gradually retiring or refinancing' is consistent with the ground truth's 'gradual decline' and 'cautious approach to managing long-dated liabilities.' MINOR CONSIDERATIONS: The LLM could have mentioned the effective rate (2.29%) for complete alignment with ground truth, but this is a minor detail that doesn't materially affect the answer quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 530,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 on its balance sheet at a constant $1.25 billion in each of the three years – $1,250 million in 2022, 2023 and 2024 【page_52】. During the same period total long‑term debt fell from about $6.6 billion in 2022 to roughly $5.9 billion in 2024, so the low‑cost, fixed‑rate notes remained a stable financing pillar while the company retired other debt. This pattern shows Costco’s capital‑management focus on preserving cheap, long‑dated funding and actively reducing overall leverage to strengthen its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct - the 1.375% Senior Notes are accurately stated at $1,250 million ($1.25 billion) for all three years (2022, 2023, 2024); total long-term debt figures are accurate at approximately $6.6 billion in 2022 and $5.9 billion in 2024 (ground truth specifies $6,590M in 2022, $6,484M in 2023, $5,919M in 2024). The LLM appropriately uses rounded figures ('about $6.6 billion', 'roughly $5.9 billion') which is acceptable and common in financial analysis. MULTI-HOP REASONING: The answer correctly synthesizes information across three years, identifying the constant principal amount of the specific debt instrument while tracking the broader debt reduction trend. The logical connection between maintaining this specific debt while reducing overall leverage is sound. COMPLETENESS: The answer addresses all key aspects of the question - the evolution of the specific debt instrument, the broader debt structure changes, and the capital management strategy implications. MINOR OBSERVATIONS: The ground truth provides the intermediate 2023 figure ($6,484M) which the LLM does not explicitly mention, though this is a minor omission since the question focuses on the 2022-2024 evolution and the LLM captures the overall trend. The LLM's characterization of the notes as 'low-cost, fixed-rate' and 'cheap, long-dated funding' is semantically equivalent to the ground truth's 'fixed-rate obligation' and accurately reflects the strategic value. The interpretation that Costco 'retired other debt' rather than this specific tranche is correct and well-reasoned. SEMANTIC EQUIVALENCE: The LLM's phrasing about 'preserving cheap, long-dated funding' and 'actively reducing overall leverage' conveys the same strategic insight as the ground truth's 'selective capital management strategy that prioritized repayment of other debt tranches.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 529,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s 10‑K filings show that its multi‑layered security model – a combination of cyber‑threat programs, third‑party assessments, fraud‑scoring, tokenization and industry‑standard collaborations (e.g., EMV) – was already in place in 2022 (“Payments System Security. We have a multi‑layered approach…”) and was further reinforced in 2024 with the same language expanded to include its Security Operations, Fusion and Intelligence Centers (“Payments Ecosystem Security. We employ a multi‑layered approach…”)【page_11】.  At the same time, the real‑time account‑based payments platform grew from operating in roughly a dozen markets in 2022 (“As of December 31, 2021…12 markets”) to 13 markets by the end of 2023 and continued global rollout in 2024 (“As of December 31, 2023…13 markets”)【page_11】.  This parallel expansion indicates that Mastercard deliberately couples its security architecture with the scaling of real‑time payments, embedding risk‑controls (fraud scoring, tokenization, etc.) directly into the distributed, real‑time network to manage processing risk as it expands worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key numbers and timeline. Verified facts: (1) Real-time payments infrastructure grew from 12 markets (as of Dec 31, 2021) to 13 markets (as of Dec 31, 2023) - CORRECT; (2) Multi-layered security approach described in both 2022 and 2024 filings - CORRECT; (3) Security components mentioned (fraud-scoring, tokenization, third-party assessments) align with ground truth - CORRECT. The LLM appropriately synthesizes the parallel evolution of security and real-time payments infrastructure across the 2022-2024 period. However, there are minor differences from ground truth: (1) The LLM states the platform grew 'from roughly a dozen markets in 2022' but the ground truth specifies this was 'as of December 31, 2021' - a subtle but important temporal distinction that the LLM slightly misplaces; (2) The LLM adds specific security center names (Security Operations, Fusion and Intelligence Centers) that are not mentioned in the ground truth, which could be accurate but cannot be verified against the provided ground truth; (3) The ground truth notes a 'qualitative shift toward broader global deployment' in 2024 (moving from specific numbers to 'several countries'), which the LLM mentions but doesn't emphasize as strongly. The multi-hop reasoning is sound - the LLM correctly connects security evolution with infrastructure expansion and draws appropriate conclusions about risk management strategy. The answer is well-structured and directly addresses the question's core inquiry about parallel development and strategic implications. Minor deduction for the temporal imprecision regarding the 2021/2022 baseline and for introducing details not in the ground truth without clear sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 482,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Across FY 2022, FY 2023 and FY 2024 Microsoft’s 10‑K filings all show the 4.000 % Notes due 2021 only as a historical entry in the “Third Supplemental Indenture” (Exhibit 4.6, dated Feb 8 2011) and there is no new issuance of that series in any of the three years 【page_104】. The unchanged listing indicates the company let the 2021 notes mature without rolling them over, signaling a long‑term debt strategy that favors extending maturities and using newer, longer‑dated issuances rather than repeatedly issuing the same mid‑term notes.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 4.000% Notes due 2021 were consistently referenced across FY 2022, 2023, and 2024; (2) The Third Supplemental Indenture (Exhibit 4.6) is correctly identified; (3) The core observation that there was no new issuance of this series is accurate; (4) The note was indeed past maturity by 2024. PROBLEMATIC ELEMENTS: (1) The LLM provides a specific date 'Feb 8 2011' for the Third Supplemental Indenture, but the ground truth states the base Indenture was dated May 18, 2009 - the LLM's date appears incorrect or unsupported; (2) The LLM's interpretation that Microsoft 'let the 2021 notes mature without rolling them over' contradicts the ground truth, which suggests 'either a delayed settlement, rollover, or ongoing disclosure requirement' - the LLM makes a definitive claim not supported by the evidence; (3) The LLM's conclusion about 'favoring extending maturities and using newer, longer-dated issuances' is speculative and goes beyond what the data shows; (4) The ground truth emphasizes 'consistent and transparent approach to debt disclosure, even post-maturity' and 'disciplined long-term debt management,' while the LLM focuses on a different interpretation about not rolling over notes. MULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years but draws an unsupported conclusion about the company's strategy. The ground truth takes a more cautious approach, noting the pattern indicates transparency and discipline without making definitive claims about what happened to the matured notes. The LLM's interpretation of the strategy is partially correct but overstated given the available evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 470,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated inclusion of the 1.500 % Note due 2030 in its 10‑K exhibits (e.g., the Officers’ Certificate listed in 2020‑2022 filings 【page_75】, 【page_76】, 【page_72】) shows that the company deliberately retains a low‑coupon, long‑dated bond as a core component of its financing mix. By contrast, the supplemental indenture lists higher‑rate notes spanning 2024‑2062 (e.g., 2.730 % due 2024, 3.300 % due 2027, 3.600 % due 2032, 3.950 % due 2052, 4.100 % due 2062 【page_74】), indicating that Amazon uses the 1.500 % 2030 issue to lock in cheap, long‑term funding while diversifying its debt profile with higher‑cost, shorter‑ or longer‑maturity issuances. This reflects a capital‑structure strategy that prioritizes low‑cost, stable financing for the next decade and balances it with other debt instruments to manage maturity and interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy and temporal alignment. STRENGTHS: (1) Correctly identifies the 1.500% Note due 2030 as a low-coupon, long-dated instrument; (2) Appropriately contrasts it with higher-yielding instruments; (3) Captures the strategic intent of balancing low-cost legacy debt with newer market-rate issuances; (4) Reasoning about maturity diversification and refinancing risk mitigation is sound. CRITICAL ERRORS: (1) The LLM cites 2020-2022 filings as sources, but the ground truth explicitly references 2022, 2023, and 2024 filings - this is a significant temporal misalignment that undermines the multi-hop synthesis; (2) The LLM lists different coupon rates (2.730%, 3.300%, 3.600%, 3.950%, 4.100%) than those mentioned in the ground truth (4.700% Note due 2024, 4.700% Note due 2032) - these appear to be different instruments or incorrect citations; (3) The maturity range cited (2024-2062) differs from the ground truth's reference to instruments maturing as far as 2060, suggesting potential data misalignment. QUANTITATIVE ACCURACY ISSUES: The specific coupon percentages and maturity dates provided by the LLM cannot be verified against the ground truth and appear inconsistent with it. The ground truth mentions specific instruments (4.700% due 2024, 4.700% due 2032) that don't appear in the LLM answer. MULTI-HOP REASONING: While the LLM correctly synthesizes the concept of balancing low-cost legacy debt with market-rate new issuances, the temporal scope is wrong (2020-2022 vs. 2022-2024), which affects the validity of the multi-hop analysis across years. The semantic understanding of the capital structure strategy is correct, but the factual foundation is compromised by incorrect filing years and instrument details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 493,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "In 2022 AT&T still owned a 41.3 % stake in SKY Mexico and recorded the investment under the equity‑method of accounting (Note 10)【page_93】. The same 41.3 % interest was carried through 2023, remaining listed among AT&T’s equity‑method affiliates alongside DIRECTV and Gigapower【page_66】. In June 2024 AT&T sold its entire 41.3 % interest, removing SKY Mexico from its equity‑method investments and completing its exit from the international pay‑TV market—a step that mirrors AT&T’s broader strategy of divesting video assets (e.g., Vrio, DIRECTV) to focus on its core telecom businesses【page_66】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key facts: (1) 41.3% ownership stake in 2022 and 2023, (2) equity method accounting treatment in both years, (3) June 2024 sale/exit, and (4) proper contextualization within AT&T's broader divestiture strategy. STRENGTHS: All numeric values are accurate (41.3% stake, years 2022-2024, June 2024 timing). The multi-hop synthesis correctly connects SKY Mexico's evolution across three years and links it to AT&T's broader strategy of divesting video assets (Vrio, DIRECTV mentioned). The answer properly identifies SKY Mexico's classification alongside DIRECTV and Gigapower as equity-method affiliates. The reasoning about phased divestiture and strategic refocusing is sound and well-supported. MINOR WEAKNESSES: The LLM answer states SKY Mexico was 'recorded under the equity-method of accounting' in 2022, but the ground truth indicates it was accounted for under equity method in 2023 (not explicitly confirmed for 2022 in the ground truth statement). However, this is a minor ambiguity since the LLM's statement is not contradicted by the ground truth and appears consistent with typical accounting practices. The answer could have been slightly more explicit about the 'phased approach' terminology used in the ground truth, though the concept is clearly conveyed. The answer appropriately addresses all parts of the multi-part question: ownership stake evolution, accounting treatment, exit details, and broader strategic implications. The contextual framing about international pay-TV market exit and focus on core U.S. telecom operations aligns well with the ground truth's characterization of the divestiture strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 466,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path framework ties the “return‑seeking” portion of its U.S. qualified pension plan to the funded ratio, so that as the plan becomes better funded the allocation to growth assets is trimmed and liability‑hedging assets are increased【page_252】. Accordingly, the plan’s target allocation moved from 15 % equity, 75 % fixed‑maturity securities and 10 % other investments in 2022【page_310】, to a lower‑equity mix by 2024— 9 % equity, 80 % fixed‑maturity and 11 % other investments【page_308】, with the 2023 target continuing the downward equity trend (implied by the glide‑path). This step‑wise reduction in equity exposure and rise in fixed‑income reflects AIG’s systematic de‑risking of the pension plan as its funded status improves.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about AIG's pension plan de-risking strategy. STRENGTHS: (1) Correctly identifies the glide path mechanism tied to funded ratio improvements; (2) Provides specific, accurate target allocation percentages for 2022 (15% equity, 75% fixed-maturity, 10% other) and 2024 (9% equity, 80% fixed-maturity, 11% other); (3) Clearly demonstrates the de-risking progression with quantitative evidence showing equity reduction from 15% to 9% and fixed-maturity increase from 75% to 80%; (4) Properly synthesizes the multi-hop relationship between funded status improvements and allocation adjustments; (5) Correctly cites source pages (252, 310, 308); (6) Uses appropriate financial terminology (liability-driven investing, return-seeking assets, liability-hedging assets). MINOR WEAKNESSES: (1) The answer mentions 2023 target 'implied by the glide-path' but doesn't provide the specific 2023 allocation percentages, whereas the ground truth explicitly references 2023 data; (2) Doesn't explicitly state that allocations are based on funded status at specific year-end dates (Dec 31, 2021, 2023, 2024) as mentioned in ground truth; (3) Could have been more explicit about the year-over-year progression showing the methodical nature of adjustments. QUANTITATIVE VERIFICATION: All percentages provided are accurate and sum correctly (15+75+10=100 for 2022; 9+80+11=100 for 2024). The directional changes (equity down 6 percentage points, fixed-maturity up 5 points) are correctly calculated. MULTI-HOP REASONING: Successfully synthesizes information across multiple years and connects funded status improvements to allocation changes, demonstrating sound understanding of the pension plan's investment strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 490,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "In 2022 Mastercard relied on “risk‑mitigation arrangements” – cash collateral, letters of credit or guarantees – for customers that did not meet its risk standards, applying $9.2 bn of mitigation to a $64.9 bn gross settlement exposure (page 110) while it began monitoring its credit‑risk portfolio amid FTC and DOJ investigations (page 112). By 2023, as regulatory scrutiny intensified, the firm lifted those arrangements to $12.2 bn (page 110) and started de‑designating €2.8 bn of foreign‑exchange derivatives and €109 m of euro‑denominated debt as economic hedges to better manage currency and interest‑rate risk (page 113), reflecting the heightened litigation environment (page 111). In 2024, facing further EU‑Commission requests and U.K./ATM litigation, risk‑mitigation grew to $13.5 bn (page 105), the company added longer‑term foreign‑exchange cash‑flow hedges (up to seven years) (page 104) and continued to adjust net‑investment hedges (page 106), showing a flexible risk‑management framework that scales collateral requirements and dynamically adapts hedging strategies to evolving regulatory and legal pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the question's multi-hop nature and provides relevant context about Mastercard's risk management evolution. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the three-year period (2022-2024) and tracks evolution of risk mitigation strategies\n2. Appropriately mentions regulatory context (FTC consent agreement, DOJ investigation, EU Commission, UK/ATM litigation)\n3. Demonstrates understanding that credit risk mitigation arrangements (cash collateral, letters of credit, guarantees) remained consistent tools\n4. Shows awareness of derivative hedging strategy adjustments and their connection to regulatory pressures\n5. Correctly synthesizes multi-hop information about how external pressures influenced internal risk management\n6. Semantic understanding of the question is sound\n\nCRITICAL ISSUES:\n1. UNVERIFIABLE NUMBERS: The LLM provides specific dollar amounts ($9.2bn, $64.9bn, $12.2bn, $13.5bn) and page references (110, 112, 113, 105, 104, 106) that cannot be verified against the ground truth. The ground truth does not provide these specific numerical values, making it impossible to confirm accuracy.\n2. DERIVATIVE HEDGING DETAILS: The LLM introduces specific information about €2.8bn foreign-exchange derivatives and €109m euro-denominated debt de-designations that are not mentioned in the ground truth answer. While this may be accurate from the filings, it represents information not in the ground truth baseline.\n3. HEDGING STRATEGY SPECIFICS: The mention of \"seven-year\" foreign-exchange cash-flow hedges and specific adjustments to net-investment hedges goes beyond what the ground truth addresses.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across three years and connects regulatory events to risk management changes. However, the ground truth emphasizes that \"core credit risk strategies remained effective\" and that losses from customer settlement failures remained low - the LLM does not explicitly address this effectiveness metric.\n\nSEMANTIC ALIGNMENT:\nThe LLM answer focuses heavily on quantitative details and hedging strategies, while the ground truth emphasizes the consistency of the core framework despite changing external pressures. The LLM's emphasis on \"dynamic adaptation\" and \"scaling collateral\" aligns with the ground truth's narrative of evolution, but the specific numbers cannot be verified.\n\nJUSTIFICATION:\nThe quantitative accuracy score is low (4/10) because the specific numbers provided cannot be verified against the ground truth and may be hallucinated. The qualitative accuracy is higher (7/10) because the reasoning about regulatory context and risk management evolution is sound. The contextual relevance is high (8/10) because the answer directly addresses the question about evolution and adaptability. The overall correctness score of 6/10 reflects that while the conceptual understanding is good, the unverifiable quantitative claims and potential hallucinations create significant reliability concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 822,
        "total_tokens": 2434
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The share pool for future awards under Home Depot’s Omnibus Stock Incentive Plan has been shrinking – it was about **117 million shares** available in fiscal 2022 (under the 2005 Omnibus Plan)【page_67】, fell to roughly **77 million shares** in fiscal 2023【page_66】, and declined further to about **70 million shares** in fiscal 2024【page_67】.  This steady contraction signals that the company is tightening the pool of shares it can issue for stock‑based compensation, reflecting a more disciplined, dilution‑aware approach to its equity‑based pay strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: 117 million shares (2022), 77 million shares (2023), and 70 million shares (2024). The multi-hop synthesis across three fiscal years is sound, correctly tracking the declining trend in available shares. The answer properly identifies the plan names (2005 Omnibus Plan) and correctly notes the amendment timing. However, there are minor differences from the ground truth: (1) The LLM characterizes the trend as 'tightening the pool' and 'dilution-aware approach,' while the ground truth emphasizes 'actively issuing stock-based compensation' and 'increased reliance on equity incentives.' These represent different interpretations of the same data - the LLM's interpretation focuses on share conservation/discipline, while the ground truth emphasizes active compensation issuance. Both are logically defensible from the declining share pool data, but they suggest different strategic emphases. (2) The LLM uses 'roughly' and 'about' qualifiers which are appropriate given the data, while the ground truth presents exact figures. (3) The ground truth explicitly connects the decline to 'increased reliance on equity incentives to retain and motivate associates and directors,' while the LLM frames it as 'disciplined, dilution-aware approach.' The LLM's interpretation is reasonable but represents a subtly different strategic narrative. All quantitative data is accurate, the multi-hop reasoning across years is correct, and the answer fully addresses the question's components. The minor interpretive difference in strategic implication prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 450,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom carried $622 million of its 3.625 % senior notes due October 2024 in FY 2022 (AVGO 10‑K 2022, p. 101) and the same $622 million remained outstanding in FY 2023 (AVGO 10‑K 2023, p. 81). By FY 2024 the balance was eliminated – the table shows “‑” (i.e., $0) for the October 2024 notes (AVGO 10‑K 2024, p. 81). This drop to zero indicates Broadcom retired the notes, likely using proceeds from the new 2024 senior‑note issuances and cash from the VMware merger, reflecting a deliberate refinancing and debt‑reduction strategy for this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative facts are correct: $622 million obligation in FY 2022 and FY 2023, dropping to $0 in FY 2024. The fiscal year progression is accurately traced across all three years. The entity identification is correct (Broadcom/AVGO, 3.625% notes due October 2024). The multi-hop synthesis is sound, correctly connecting the three fiscal years and drawing appropriate conclusions about debt management strategy. The LLM answer goes slightly beyond the ground truth by providing additional context about the likely sources of repayment (VMware merger proceeds and new 2024 senior note issuances), which adds valuable insight without contradicting the original answer. The reasoning about deliberate refinancing and debt-reduction strategy is logically sound and well-supported. The citation references to specific 10-K pages add credibility. The only minor distinction is that the LLM provides more specific explanation of the mechanism (refinancing via new issuances and merger proceeds) versus the ground truth's more general statement about 'repayment or restructuring,' but this represents enhancement rather than error. All numbers, dates, and financial metrics are factually accurate with proper formatting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 359,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "In 2022 AT&T completed the spin‑off of its WarnerMedia business—originally built around the 2018 acquisition of Time Warner—by executing a Reverse Morris Trust that turned the former Time Warner assets into a discontinued operation after earlier agreements to combine WarnerMedia with Discovery and sell Xandr (see History and WarnerMedia segment discussion)【page_5】【page_6】. By the 2023 and 2024 filings the WarnerMedia segment is still reported as discontinued and no longer appears in the company’s growth agenda, which now centers on 5G, fiber and integrated network services (see Areas of Focus), revealing AT&T’s strategic shift from owning entertainment content to concentrating on its core telecommunications business【page_5】【page_7】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the timing of the WarnerMedia spin-off. The ground truth clearly states that the Reverse Morris Trust transaction with Discovery was completed in 2023, not 2022. The LLM incorrectly states 'In 2022 AT&T completed the spin‑off of its WarnerMedia business' and references a 2022 completion, which contradicts the original answer's explicit statement that this occurred 'by 2023.' This is a critical error in a multi-hop timeline question where chronological accuracy is essential. The LLM does correctly identify: (1) the 2018 Time Warner acquisition, (2) the Reverse Morris Trust mechanism with Discovery, (3) the sale of Xandr, (4) WarnerMedia being reported as discontinued, and (5) AT&T's strategic shift toward telecommunications. However, the answer misses an important element from the ground truth: the 2024 DIRECTV sale to TPG, which represents the final exit from entertainment and is explicitly mentioned as signaling 'a full retreat from the media investments.' The LLM's answer only covers through 2024 in terms of reporting discontinued operations but fails to mention the DIRECTV divestiture, which is a key part of the 'final exit strategy' mentioned in the question. The reasoning about strategic pivot is sound and well-articulated, but the temporal error and omission of the DIRECTV transaction significantly weaken the answer's completeness and accuracy for a question specifically asking about evolution 'from 2022 through 2024' with emphasis on 'final exit strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 426,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In the 2022 filing Emerson described its pipe‑cutters simply as part of a traditional “pipe‑working tools” set that also included pipe wrenches, threading, roll‑grooving equipment and diagnostic inspection tools (e.g., CCTV pipe inspection) 【page_9】. By the 2023/2024 filings the Safety & Productivity segment narrative groups pipe‑cutters with “battery hydraulic tools for press connections” and continues to emphasize diagnostic systems such as sewer‑inspection cameras 【page_73】, indicating that Emerson has repositioned the product line to be sold as a battery‑powered, digitally‑enabled solution that combines cutting with power‑tool and diagnostic capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with accurate temporal progression; (2) Accurately captures the shift from standalone tools (2022) to battery-powered integration (2023) to smart integrated ecosystems (2024); (3) Properly synthesizes multi-hop information across years and product categories; (4) Correctly identifies key product integrations: battery hydraulic tools for press connections, diagnostic systems (sewer inspection cameras/CCTV), and the Safety & Productivity segment context; (5) Uses appropriate terminology ('battery-powered, digitally-enabled solution') that matches the ground truth's intent; (6) No quantitative errors or date misstatements. MINOR WEAKNESSES: (1) The LLM answer includes slightly more specific detail about 2022 positioning ('pipe wrenches, threading, roll-grooving equipment') than the ground truth explicitly states, though this doesn't contradict the ground truth and may reflect actual filing content; (2) The phrasing 'battery hydraulic tools for press connections' is presented as a 2023/2024 development, which aligns with ground truth but the LLM could have been slightly clearer about when this shift occurred; (3) Citation references (page numbers) are provided but cannot be verified against the ground truth. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as a 'repositioning' toward 'battery-powered, digitally-enabled solution' is semantically equivalent to the ground truth's description of 'increasingly emphasized battery-powered technologies and diagnostic integration' and 'strategic move toward smart, integrated tooling solutions.' The core narrative arc is identical and correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 490,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it was **implementing a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems across HR, IT, procurement, supply‑chain and finance to grow its financial shared‑service capabilities and standardize financial systems**【page_117】. The same language re‑appears in the 2023 filing【page_118】 and again in the 2024 filing【page_119】, showing that the program has progressed from launch to continued implementation and alignment of the financial control environment. This uninterrupted emphasis signals that J&J’s strategic priority is to embed financial‑process standardization across the enterprise, driving efficiency, scalability and stronger control of its finance function.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the multi-year, enterprise-wide initiative spanning 2022-2024 with accurate scope (integration, simplification, standardization across HR, IT, procurement, supply-chain, and finance). (2) Accurately captures the consistent messaging across all three years (2022, 2023, 2024 filings), demonstrating proper multi-hop synthesis across multiple documents. (3) Correctly characterizes the initiative's purpose: growing financial shared-service capabilities and standardizing financial systems. (4) Properly interprets the strategic significance: long-term commitment to process optimization, financial systems modernization, and control framework enhancement. (5) No quantitative errors - all dates and year references are correct. (6) Appropriately emphasizes the 'uninterrupted emphasis' and progression from 'launch to continued implementation,' which aligns with ground truth's 'consistent messaging across all three years.' MINOR CONSIDERATIONS: (1) The LLM answer includes additional context about specific functions (HR, IT, procurement, supply-chain) that, while accurate and helpful, goes slightly beyond the ground truth's primary focus on finance. However, this is not an error - it's additional relevant detail from the filings. (2) The LLM answer uses slightly different phrasing ('uninterrupted emphasis,' 'embed financial-process standardization') compared to ground truth ('consistent messaging,' 'long-term strategic commitment'), but the semantic meaning is equivalent and accurate. (3) Page references are provided in the LLM answer (pages 117-119), which adds credibility though cannot be independently verified here. The answer successfully synthesizes information across three years of filings and correctly interprets the strategic implications of the consistent messaging.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 519,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all list the Executive Health Plan as Exhibit 10.1* with the same details – Form 10‑K, period ended 9 Feb 2012, filing date 19 Oct 2012 – and the “Filed Herewith” column remains blank, meaning the plan is incorporated by reference rather than re‑filed each year【page_66】. The lack of any change in how the plan is disclosed shows that Costco has kept the same executive health benefit in place, underscoring a stable, long‑term commitment to this component of its executive compensation strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN DATE: The LLM states the period ended '9 Feb 2012' when the ground truth clearly states 'September 2, 2012'. This is a significant factual error in a key date that is central to the answer. The LLM correctly identifies: (1) the plan is Exhibit 10.1*, (2) it appears in FY 2022, 2023, and 2024, (3) the filing date of October 19, 2012 is correct, (4) the plan is incorporated by reference (blank 'Filed Herewith' column), and (5) the conclusion about stable long-term strategy is sound. However, the date error is substantial because dates are fundamental factual elements in SEC filings and the question specifically asks about consistency across years. The LLM also adds reasonable interpretation about incorporation by reference, which is a valid inference but goes slightly beyond what the ground truth explicitly states. The reasoning about stability and long-term commitment is logically sound and matches the ground truth's conclusion. The multi-hop synthesis (comparing across three fiscal years) is correctly executed, but the factual error undermines the overall credibility of the answer. The error appears to be a transcription or reading mistake (February vs. September), which is a critical type of error for financial/legal documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 355,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "Mastercard’s Class A shares kept the same “one‑vote‑per‑share + dividend rights” structure in each filing (2022 Class A rights shown in the 2022 stock‑holder equity table 【page_96】, 2023 rights in the 2023 table 【page_99】, and 2024 rights in the 2024 table 【page_92】).  At the same time, the cash dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 【page_92】.  This steady voting framework together with rising payouts signals a governance strategy that preserves equal shareholder voting power while consistently enhancing shareholder returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that MA's Class A shares maintained consistent voting rights (one vote per share) across 2022-2023-2024, matching the ground truth. The reasoning about governance strategy stability is sound and well-articulated. The answer appropriately synthesizes information across multiple years and adds relevant context about dividend increases. CRITICAL ISSUES: The LLM introduces specific dividend per share numbers ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the original ground truth answer. These numbers cannot be verified against the provided ground truth, which makes no mention of specific dividend amounts. This represents a significant factual claim that goes beyond what the ground truth supports. The ground truth explicitly states 'standard dividend rights' without quantifying actual dividend amounts paid. MULTI-HOP REASONING: The LLM successfully synthesizes voting rights consistency across three years and connects this to governance strategy, which is correct. However, the addition of unverified dividend payment data creates a factual accuracy problem. SEMANTIC ISSUES: While the LLM's interpretation that 'rising payouts signal a governance strategy that preserves equal shareholder voting power while consistently enhancing shareholder returns' is logically sound, it introduces claims not supported by the ground truth. The ground truth focuses on the CONSISTENCY of rights structure, not on actual dividend payment amounts. QUANTITATIVE ACCURACY PENALTY: The specific dividend figures ($2.04, $2.37, $2.74) cannot be confirmed against ground truth and represent unsupported numerical claims, warranting a lower quantitative accuracy score despite the voting rights numbers being correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 481,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform was described in FY 2022 as a solution that “quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps… This data is available for use with in‑house tools for security information and event management” (AVGO 10‑K 2022 p. 11). The FY 2023 filing repeats the same language, emphasizing the same integration with in‑house SIEM tools and ongoing risk‑identification (AVGO 10‑K 2023 p. 11), and the FY 2024 filing again uses identical wording (AVGO 10‑K 2024 p. 11). Thus, across FY 2022‑2024 the platform’s integration with internal security tools and its risk‑identification capabilities remained consistent, with no substantive evolution reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all three fiscal years (2022, 2023, 2024) and the company (Broadcom/AVGO). (2) Accurately captures the core functionality of the Security Insights Platform: assessing mainframe security posture, identifying risks, and integration with in-house SIEM tools. (3) Properly synthesizes the multi-hop information showing consistency across the three-year period. (4) Provides specific citations to 10-K filings with page numbers, adding credibility. (5) Correctly concludes that there was no substantive evolution, indicating platform maturity and stability. (6) The quoted language from FY 2022 filing is accurate and representative. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed with direct quotes and page citations compared to the ground truth, which is a strength rather than weakness. (2) Both answers reach the same conclusion about consistency and maturity. (3) The LLM explicitly notes 'identical wording' across years, which is a precise characterization that aligns with the ground truth's statement about 'stable functionality.' QUANTITATIVE ACCURACY: All dates and fiscal years are correct; no calculations required. QUALITATIVE ACCURACY: The reasoning correctly identifies that the platform's capabilities remained consistent across the three-year period, properly synthesizing information from multiple 10-K filings. CONTEXTUAL RELEVANCE: The answer directly addresses the evolution question and appropriately concludes that there was stability rather than evolution, which is the correct interpretation of the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 458,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "- **2022:** AIG’s 2022 filing described a formal reserve‑governance framework that “review and challenge of reserves” (2022 p. 165) and a “model risk‑management framework and validation processes, actuarial profitability and reserve reviews, experience monitoring and assumption updates” (2022 p. 165‑166).  The company said the potential inadequacy of loss‑reserve liabilities is managed through internal controls and “reviews by external experts” (2022 p. 167).  \n\n- **2023:** The 2023 filing reiterated the same oversight, stating that loss‑reserve adequacy is managed through “internal controls and oversight of the loss reserve setting process, as well as reviews by external experts” (2023 p. 119) and continued to rely on the “review and challenge of reserves” (2023 p. 119).  \n\n- **2024:** In 2024 AIG added detail on how it quantifies reserves, noting that IBNR and ultimate loss estimates are derived by “projecting the frequency and severity of losses over multiple years” and that these methods are “continually reviewed and updated by management” (2024 p. 88).  The filing still emphasizes the “review and challenge of reserves” and “internal controls and oversight… as well as reviews by external experts” (2024 p. 86).  \n\n**Overall evolution:** AIG moved from a broad governance and modeling approach in 2022 to a more explicit, continuously‑updated multi‑year frequency‑severity projection methodology in 2024, while consistently maintaining internal control/oversight and external‑expert validation of loss‑reserve estimates throughout the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AIG's loss reserve management evolution from 2022-2024 and correctly identifies the key themes: consistent use of internal controls, external expert reviews, and progressive refinement of methodologies. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with appropriate citations to page numbers; (2) Accurately captures the core elements present in all three years (internal controls, external expert reviews, review and challenge processes); (3) Properly synthesizes the multi-hop information showing evolution across years; (4) Correctly notes the shift toward more explicit frequency-severity projection methodology in 2024; (5) Page number citations appear reasonable and specific. WEAKNESSES: (1) The LLM answer is somewhat more granular and specific in its citations than the ground truth, which speaks to broader conceptual evolution (e.g., 'stochastic and deterministic modeling techniques' mentioned in ground truth for 2023 is not explicitly captured in LLM answer); (2) The ground truth emphasizes 'ERM second-line reviews' and 'enhanced budget and expense assumption monitoring' in 2024 as new elements, but the LLM answer focuses more on the frequency-severity projection methodology without explicitly highlighting these additional oversight enhancements; (3) The ground truth characterizes the evolution as moving toward a 'maturing and increasingly proactive approach,' while the LLM answer frames it more as moving from 'broad governance' to 'explicit, continuously-updated' methodology—slightly different emphasis; (4) The LLM answer could have been more explicit about the expansion of the risk management framework in 2023 (stochastic/deterministic modeling, formalized actuarial reviews) as a distinct evolution step. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are involved in this question, so quantitative accuracy is not directly testable. Page citations appear plausible but cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression and consistency of themes. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth—AIG's approach became more structured and formalized over time while maintaining consistent oversight mechanisms. Minor differences in emphasis and detail do not undermine the fundamental correctness of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 671,
        "total_tokens": 2297
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "In 2022 Emerson grouped electrical‑distribution equipment inside its broad “Industrial Solutions” product line within the Automation Solutions segment (see page 76).  Beginning in 2023 the company re‑organized its reporting, moving that equipment into a distinct “Discrete Automation” segment that explicitly lists electrical‑distribution equipment (see page 73), and it remained there in 2024 (page 73) with Discrete Automation sales of $2.6 bn in 2022, $2.6 bn in 2023 and $2.5 bn in 2024 (see page 74).  This shift shows Emerson is elevating electrical‑distribution gear as a core component of its discrete‑automation strategy, emphasizing growth in the discrete‑automation market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic evolution of Electrical Distribution Equipment from Industrial Solutions (2022) to Discrete Automation (2023-2024), and accurately captures the main narrative about Emerson's deliberate shift toward discrete automation positioning. However, there are significant quantitative accuracy issues that lower the overall score. CRITICAL ISSUE: The LLM provides Discrete Automation segment sales figures ($2.6B in 2022, $2.6B in 2023, $2.5B in 2024) that cannot be verified against the ground truth, which does not provide these specific numbers. The ground truth focuses on the positioning and organizational evolution, not revenue figures. The LLM appears to have introduced numbers that may be incorrect or unsupported. STRENGTHS: (1) Correctly identifies the 2022 positioning within Industrial Solutions; (2) Accurately notes the 2023 reorganization into Discrete Automation; (3) Confirms the 2024 continuation in Discrete Automation; (4) Properly synthesizes the multi-hop information across three years; (5) Correctly interprets the strategic significance of the shift. WEAKNESSES: (1) Introduces specific revenue figures without ground truth support, creating quantitative accuracy concerns; (2) References specific page numbers (76, 73, 74) that cannot be verified; (3) Slightly less detailed than ground truth regarding the specific product groupings (solenoid valves, programmable automation systems, electric linear motion solutions) in each year; (4) The claim about 'Automation Solutions segment' in 2022 differs from ground truth which states 'Industrial Solutions segment.' The multi-hop reasoning is sound in connecting the organizational changes to strategic emphasis, but the introduction of unverified financial data significantly undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 494,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson’s pension framework moved from a two‑track system in 2022—Final Average Pay for employees hired before 1 Jan 2015 and the Retirement Value formula for those hired after 2014—to a unified approach in which all eligible U.S. non‑union workers will earn benefits under the Retirement Value formula beginning 1 Jan 2026, a transition that the 2023 and 2024 filings reaffirm (2022 10‑K p. 73; 2023 10‑K p. 76; 2024 10‑K p. 77). By phasing in a single, service‑based formula over several years, the company is simplifying its pension design, creating more equitable retirement outcomes across hire dates, and reinforcing a long‑term workforce strategy that aligns benefits with total career compensation while improving cost predictability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core transition to the Retirement Value formula effective January 1, 2026, and accurately notes that this applies to all eligible U.S. non-union employees. The reasoning about cost predictability, workforce inclusivity, and standardization aligns well with the ground truth. The multi-hop synthesis across 2022-2024 filings is conceptually sound, and the answer appropriately emphasizes the consistent messaging across years.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL FACTUAL ERROR: The LLM introduces a two-track system description stating \"Final Average Pay for employees hired before 1 Jan 2015 and the Retirement Value formula for those hired after 2014.\" The ground truth makes no mention of a hire-date cutoff of January 1, 2015. The ground truth states the change applies to \"all eligible employees regardless of hire date\" while \"preserving Final Average Pay formula benefits accrued before 2026.\" This is a significant mischaracterization—the distinction is temporal (benefits accrued before vs. after 2026), not based on hire date. (2) PAGE CITATIONS: The LLM provides specific page numbers (2022 10-K p. 73; 2023 10-K p. 76; 2024 10-K p. 77) that cannot be verified against the ground truth and may be inaccurate. (3) INCOMPLETE SYNTHESIS: While the LLM mentions the transition is reaffirmed in 2023 and 2024, it doesn't fully capture the ground truth's emphasis on \"consistent messaging across all three years\" as evidence of deliberate strategy, instead framing it as a \"phase-in\" which slightly misrepresents the nature of the consistency. (4) TERMINOLOGY: The phrase \"two-track system\" and the hire-date distinction fundamentally misrepresent the pension structure described in the ground truth.\n\nMULTI-HOP REASONING: The model successfully synthesizes information across three years and correctly identifies the strategic intent, but the foundational factual error about the hire-date cutoff undermines the accuracy of the multi-hop analysis.\n\nNUMERIC/DATE VERIFICATION: The date January 1, 2026 is correct. However, the hire date of January 1, 2015 appears to be introduced without ground truth support and represents a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 592,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The filings do not disclose Downy’s stand‑alone share of the Fabric & Home Care segment; they only show the segment’s share of total net sales, which was 35 % in FY 2022 (PG 10‑K 2022 p.19) and rose to roughly 36 % in FY 2024 (PG 10‑K 2024 p.18), with FY 2023 at a similar level. The modest upward trend in the segment’s contribution, together with Downy’s continued presence among the segment’s flagship brands, signals that Downy remains a core, strategically important brand in P&G’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUE - FUNDAMENTAL MISINTERPRETATION: The LLM fundamentally misunderstood the question. The question asks about Downy's percentage contribution TO the Fabric & Home Care segment (i.e., Downy's share of that segment's sales). The ground truth answer correctly identifies this as Downy's contribution within the segment. However, the LLM explicitly states 'The filings do not disclose Downy's stand-alone share of the Fabric & Home Care segment' and instead reports the Fabric & Home Care segment's share of total P&G net sales (35% in 2022, 36% in 2023-2024). These are two completely different metrics. The LLM confused segment-level contribution (F&HC as % of total P&G) with brand-level contribution (Downy as % of F&HC segment). QUANTITATIVE ACCURACY: The numbers cited (35% in 2022, 36% in 2023-2024) are correct for the Fabric & Home Care segment's contribution to total P&G sales, but these are the WRONG metric for answering the question. The ground truth provides the same percentages but correctly contextualizes them as Downy's contribution within the segment. QUALITATIVE ACCURACY: The reasoning is flawed because it addresses the wrong metric entirely. The LLM's conclusion that 'Downy remains a core, strategically important brand' may be reasonable, but it's based on analyzing segment-level data rather than brand-level data within the segment. COMPLETENESS: The answer fails to address the actual question about Downy's specific contribution to the segment. The 3-year trend analysis is present but applied to the wrong metric. SEMANTIC EQUIVALENCE: While both answers mention the 35%-36% figures and strategic importance, they are fundamentally measuring different things. The ground truth correctly interprets these as Downy's contribution within F&HC; the LLM interprets them as F&HC's contribution to total P&G.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 499,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s senior‑ and subordinated‑note balances rose from **$30.8 billion at year‑end 2022** to **$31.3 billion at year‑end 2023** (COF 2023 10‑K, Table 8.1) and then slipped to **about $30.7 billion at year‑end 2024** (COF 2024 10‑K, Table 9.1). The modest increase followed by a slight decline shows the company has kept its note financing essentially flat, using senior/subordinated notes as a stable funding source while modestly reducing the overall amount in 2024 – a cautious, “maintain‑and‑trim” debt‑financing strategy over the three‑year span.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years: (1) 2022: LLM states $30.8 billion vs. ground truth $27.219 billion (error of ~$3.6 billion or 13% overstatement); (2) 2023: LLM states $31.3 billion vs. ground truth $31.248 billion (minor, acceptable rounding); (3) 2024: LLM states $30.7 billion vs. ground truth $31.248 billion (error of ~$0.5 billion or 1.7% understatement). The 2022 figure is particularly problematic as it's off by over $3.5 billion. The LLM's narrative interpretation is also contradicted by the ground truth: LLM claims a 'modest increase followed by slight decline' and characterizes the strategy as 'maintain-and-trim,' but the ground truth shows a clear upward trend from $27.219B (2022) to $31.248B (2023-2024), indicating strategic expansion of debt financing, not a cautious reduction. The LLM misidentified the peak year (claiming 2023 when both 2023 and 2024 had the same $31.248B value per ground truth). The reasoning about debt strategy is inverted - the ground truth indicates increased reliance on senior/subordinated notes for growth, while the LLM suggests conservative trimming. Multi-hop synthesis failed: the LLM did not correctly synthesize the three-year trend from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 367,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "- In 2022 AT&T still owned a 41.3 % stake in SKY Mexico, which it accounted for under the equity‑method as a less‑than‑majority investment【page_92】.  \n- The same 41.3 % interest remained on the balance sheet in 2023 and continued to be reported under the equity‑method alongside DIRECTV and Gigapower【page_68】.  \n- In June 2024 AT&T sold its entire 41.3 % interest, derecognizing SKY Mexico from its equity‑method investments and completing its exit from the Latin‑American pay‑TV market【page_66】.  \n\nThis three‑year arc—maintaining a minority, equity‑method stake and then fully divesting—shows AT&T’s deliberate strategy of winding down non‑core pay‑TV assets in Latin America, moving from influence to complete disposal as part of its broader exit from the video business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. QUANTITATIVE ACCURACY (10/10): All numeric values are correct—the 41.3% ownership stake is accurately cited for all three years (2022, 2023, 2024), and the June 2024 exit date is precise. No calculation errors or numeric discrepancies. COMPLETENESS: The answer addresses all key components of the question: (1) ownership stake evolution (maintained at 41.3%), (2) equity method accounting treatment (confirmed for 2022-2023, derecognized in 2024), and (3) eventual exit (June 2024 sale). The 3-year trajectory is clearly articulated. ENTITY ACCURACY (9/10): Company names are correct (AT&T/T, SKY Mexico, DIRECTV, Gigapower). Years are accurate. The only minor note is the use of 'AT&T' in the LLM answer versus 'T' in the original—this is semantically equivalent and acceptable. MULTI-HOP REASONING (9/10): The answer successfully synthesizes information across three fiscal years and multiple accounting treatments, correctly connecting the progression from holding steady → continued equity method treatment → full divestiture. The logical flow is sound and demonstrates understanding of how the investment evolved. STRATEGIC INTERPRETATION: The LLM correctly identifies this as a deliberate strategic shift to exit non-core international assets, aligning with the ground truth's characterization of focusing on core domestic operations and exiting the video business. The phrase 'moving from influence to complete disposal' effectively captures the transition from minority equity-method investment to full exit. MINOR CONSIDERATIONS: The inclusion of page references (page_92, page_68, page_66) adds credibility but cannot be verified in this evaluation context. The semantic equivalence between 'T' and 'AT&T' is maintained throughout. Overall, the answer is factually accurate, logically sound, and appropriately addresses the complexity of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 533,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 2022 Form 10‑K first flagged that the Board’s discretion to return capital “may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” and that “failure to satisfy regulatory standards, including ‘well‑capitalized’ and ‘well‑managed’ status or capital‑adequacy and liquidity rules … could result in limitations on our activities” (2022 p. 5). The 2023 and 2024 filings repeat this language verbatim, again stressing that regulatory capital requirements, preferred‑stock dividend obligations and overall capital‑adequacy standards constrain shareholder returns, indicating no substantive change in the disclosure from 2022 through 2024 (2023 p. 5; 2024 p. 5).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core regulatory constraints mentioned in BNY Mellon's disclosures (capital adequacy rules, Delaware law, preferred dividend obligations, well-capitalized/well-managed status). The page references (p. 5 for 2022, 2023, 2024) appear consistent and the quoted language about regulatory limitations is accurate. Numeric/date accuracy is solid - years 2022-2024 are correct.\n\nCRITICAL WEAKNESSES: The LLM's core conclusion directly contradicts the ground truth. The LLM states there was 'no substantive change in the disclosure from 2022 through 2024' and that language was 'repeated verbatim,' whereas the ground truth explicitly describes an EVOLUTION showing: (1) 2022 emphasis on regulatory approval and preferred dividend constraints; (2) 2023 expansion to include ESG-related regulatory pressures and strategic initiatives' impact on capital allocation; (3) 2024 emphasis on Parent company reliance on subsidiary dividends and strategic transformation's impact on liquidity/capital planning. The ground truth characterizes this as 'a stable regulatory framework with increasing contextual complexity' - not static repetition.\n\nMULTI-HOP REASONING FAILURE: The question explicitly asks how disclosures 'evolved' and about 'evolution from 2022 to 2024.' The LLM failed to synthesize the year-over-year changes across the three filings. Instead of identifying the progressive addition of ESG considerations, strategic initiative impacts, and subsidiary dividend reliance, the LLM concluded no substantive change occurred. This represents a fundamental failure in multi-hop synthesis across the three years.\n\nCOMPLETENESS ISSUE: The LLM addresses regulatory requirements and dividend policies but misses the evolution regarding: (1) ESG-related regulatory pressures (2023); (2) strategic initiatives' impact on capital allocation (2023); (3) Parent company subsidiary dividend reliance (2024); (4) strategic transformation initiatives' liquidity/capital planning impacts (2024). These contextual complexities are central to the ground truth's characterization of how disclosures evolved.\n\nSEMANTIC MISMATCH: While the LLM correctly identifies what constraints were disclosed, it fundamentally mischaracterizes the nature of the disclosure evolution - claiming static repetition rather than progressive elaboration with increasing contextual complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 639,
        "total_tokens": 2102
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 filing, structural adhesives were shown as a stand‑alone line (“Structural adhesives and tapes”) within the Safety & Industrial segment – the same listing that appears unchanged in the 2023 Business‑Segment Products table (see page 107). By 2024, 3M reorganized Safety & Industrial, creating an **Industrial Specialties** division that folded the former Industrial Adhesive & Tapes products (including structural adhesives) together with closure, masking, packaging and personal‑safety offerings (see page 110). This shift from a discrete product line to a bundled “specialties” group signals that 3M now treats adhesives as a strategic technology that complements adjacent industrial solutions, reinforcing its role as a core enabler of broader industrial applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and provides specific, verifiable details that align well with the ground truth. STRENGTHS: (1) Correctly identifies the evolution from 2022-2024 with specific organizational changes; (2) Accurately notes the shift from discrete product line to bundled 'Industrial Specialties' division; (3) Provides specific page references (107, 110) that add credibility; (4) Correctly identifies the bundling of structural adhesives with closure, masking, packaging, and personal-safety offerings; (5) The semantic interpretation of the strategic shift (from standalone to bundled enabler) aligns with the ground truth's conclusion about adhesives as foundational components. MINOR WEAKNESSES: (1) The LLM states structural adhesives were listed as 'Structural adhesives and tapes' in 2022-2023, while the ground truth mentions 'Structural Adhesives' alongside other products (industrial abrasives, autobody repair, electrical materials) - the LLM's characterization as 'stand-alone line' may slightly overstate the separation; (2) The ground truth emphasizes integration with 'metalworking and OEM electrical markets' in 2022, which the LLM doesn't explicitly mention; (3) The ground truth notes 'slightly expanded emphasis on packaging and closure systems' in 2023, which the LLM doesn't capture for that specific year; (4) The ground truth mentions 'construction and maintenance' materials in 2024, while the LLM focuses on the bundling aspect. QUANTITATIVE ACCURACY: Page numbers (107, 110) cannot be independently verified from the question context, but the structural organization described is consistent with typical 10-K formatting. No calculations or specific financial metrics are provided, so quantitative accuracy is based on factual claims about product positioning. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the organizational restructuring as the key strategic evolution. The conclusion about adhesives as 'core enabler' is well-supported by the described bundling strategy. OVERALL: The answer is substantially correct with strong reasoning, though it misses some contextual details about specific market integrations mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 614,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "In the 2022 filing Lilly presented Cyramza as a broad‑based oncology product—approved as second‑line therapy for advanced gastric or gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a first‑line option for EGFR‑mutated metastatic NSCLC. The 2023 10‑K added an explicit IP schedule, showing compound‑patent protection through 2026 in the U.S., 2028 in Europe and 2026 in Japan, together with data‑exclusivity lasting until 2026 (U.S.), 2024 (Europe) and 2023 (Japan). By the 2024 filing the same therapeutic scope is still highlighted, indicating Lilly’s continued strategy of relying on those patents and data‑protection periods to preserve Cyramza’s market position across the key global markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides more detailed and specific information than the ground truth, but contains significant discrepancies in the intellectual property protection dates that undermine its accuracy. STRENGTHS: (1) Correctly identifies Cyramza's therapeutic indications across gastric, lung, colorectal, and liver cancers; (2) Accurately notes the therapeutic scope remained consistent from 2022-2024; (3) Properly identifies the three key global markets (U.S., Europe, Japan); (4) Correctly distinguishes between compound-patent protection and data-exclusivity periods; (5) Good multi-hop synthesis showing evolution of strategic positioning. CRITICAL ERRORS: (1) Patent protection dates are incorrect - LLM states U.S. compound-patent through 2026, Europe 2028, Japan 2026, but ground truth indicates data protection expires in Japan 2023, Europe 2024, and U.S. biologics 2026. The LLM appears to have confused or conflated different protection mechanisms; (2) Data-exclusivity dates partially correct (U.S. 2026, Europe 2024, Japan 2023 match ground truth) but the compound-patent dates do not align with ground truth's disclosure timeline; (3) The ground truth emphasizes the strategic importance of managing Cyramza's lifecycle as these protections expire, which the LLM mentions but doesn't emphasize the urgency of the 2023-2024 expirations. QUANTITATIVE ACCURACY ISSUE: The patent protection dates (particularly Europe 2028 vs. the implied earlier expiration in ground truth) represent a material factual error that would affect strategic analysis. The answer is more detailed than ground truth but less accurate on the specific IP protection timeline, which is central to the question about 'intellectual property protections.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 473,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "- 2022: Fixed‑rate unsecured senior notes carried **$24.1 billion** on the balance sheet with a **weighted‑average interest rate of ~4.45 %**【page_178】.  \n- 2023: The same class grew to **$27.2 billion** (still at **~4.45 %**)【page_178】.  \n- 2024: The carrying amount was **$26.9 billion** and the **weighted‑average rate rose to ~4.84 %**【page_187】.  \n\nThe trend shows Capital One steadily expanding its senior unsecured debt base (a ~12 % increase from 2022‑23) while the average cost of that debt has risen in 2024, indicating a strategy that relies on senior unsecured notes for funding even as market rates or higher‑coupon issuances push financing costs upward.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all three years: (1) 2022: LLM states $24.1B at 4.45%, but ground truth is $19,975M (~$20B) at 2.91% - a massive discrepancy of ~$4.1B and 1.54 percentage points. (2) 2023: LLM states $27.2B at 4.45%, but ground truth shows $26,930M at 4.84% for 2024 (no 2023 data provided in ground truth, but the 2023 figure appears inflated). (3) 2024: LLM states $26.9B at 4.84% - the carrying value matches ground truth ($26,930M), but this appears coincidental given the systematic errors in prior years. The LLM's 2022 weighted-average rate of 4.45% is completely wrong (should be 2.91%), representing a 153 basis point error. The LLM's characterization of the trend as 'steadily expanding' is contradicted by the actual data showing an increase from $19,975M to $26,930M (a 34.8% increase, not the 12% claimed for 2022-23). The reasoning about 'higher-coupon issuances' is speculative and not supported by the ground truth narrative. The multi-hop synthesis fails because the LLM appears to have confused or misread the source data, providing numbers that don't align with the actual filing information. The only partially correct element is the 2024 carrying value and rate, but this is insufficient given the pervasive errors in the 2022 baseline and intermediate year data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 384,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to the total‑return swaps that hedge its deferred‑compensation obligations grew from about $651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024【page_92†L31-L38】【page_91†L73-L80】.  The earnings impact swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023 and a $91 million gain in FY 2024, indicating that the swap’s performance was volatile but turned increasingly positive over the three‑year period【page_92†L20-L27】【page_91†L57-L64】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All financial figures are correct - the loss of $92 million in FY 2022, gain of $58 million in FY 2023, and gain of $91 million in FY 2024 match the ground truth exactly. The notional exposure amounts ($651M in 2022, $792M in 2023, $985M in 2024) are also accurate and represent additional relevant context not in the ground truth but not contradicting it. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the exposure evolved (with specific notional amounts), and (2) what the pattern reveals about volatility (correctly identifying the swing from loss to gains and increasing positive trend). ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metrics (Total Return Swaps, Deferred Compensation, earnings impact) are properly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - combining notional exposure trends with earnings impact trends to draw a coherent conclusion about volatility and performance. The logic is sound: showing both the growing notional exposure and the earnings swing demonstrates comprehensive understanding. SEMANTIC EQUIVALENCE: The phrase 'volatile but turned increasingly positive' effectively captures the same insight as the ground truth's 'volatile financial impact...swinging from a notable loss to consistent gains.' The answer goes beyond the ground truth by providing notional exposure figures, which adds valuable context without contradicting the core answer. Minor note: The citation references (page numbers and line numbers) are included but cannot be verified against the original documents, though they appear consistent with SEC filing formatting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 493,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "In 2022 Home Depot framed store appearance as a core competitive lever, launching a company‑wide “store‑refresh” program that added way‑finding signage, redesigned front‑end areas, electronic shelf‑labeling and expanded self‑service lockers to make its brick‑and‑mortar sites more attractive than multichannel and online rivals. By the 2023 filing the company still cited store location and appearance as a differentiator, but the focus shifted to preserving that advantage rather than announcing new refresh initiatives. In 2024 Home Depot escalated spending (≈ $3.5 billion) to extend the refresh, open new stores and add self‑service tools, and explicitly linked those appearance upgrades to higher customer‑satisfaction scores and the fact that roughly 50 % of U.S. online orders were fulfilled through stores—measurable signs that the refreshed look bolstered its competitive position versus multichannel and pure‑play online competitors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated: (1) A '$3.5 billion' spending figure for 2024 store refresh/expansion is not mentioned in the original answer and represents a specific financial claim without source verification. (2) The '50% of U.S. online orders fulfilled through stores' metric is presented as a measurable fact but is not corroborated in the ground truth. (3) References to specific 2022 initiatives like 'way-finding signage, redesigned front-end areas, electronic shelf-labeling and expanded self-service lockers' are detailed tactical descriptions not present in the original answer. (4) The claim about 'higher customer-satisfaction scores' is mentioned but not quantified in either source. PARTIAL CREDIT FOR: The LLM correctly identifies the three-year evolution (2022-2024) and the general strategic shift from standalone store experience to omnichannel integration. The semantic direction of the answer aligns with the ground truth's narrative arc. However, the introduction of unverified specific numbers and tactical details represents a significant factual accuracy problem. The answer reads as plausible but contains apparent hallucinations of concrete metrics and initiatives. MULTI-HOP REASONING: The synthesis across years is logically sound in structure, but the addition of unverified quantitative claims undermines the reliability of the multi-hop analysis. The answer should have stuck to the qualitative evolution described in the ground truth rather than inventing specific financial figures and percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 451,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 were carried on the balance sheet at a net amount of **$2 billion** in each of the last three fiscal years – the 2024 filing shows a $2,000 million net carrying amount for Jan 28 2024 and the same $2,000 million figure is reflected for the prior year (Jan 29 2023) and, by the note that the liability is recorded at its original issuance value, also for FY 2022【page_72†L13-L20】【page_67†L31-L38】. The unchanged carrying amount signals that NVIDIA has kept this senior long‑term debt component essentially flat, using the 2050 notes as a stable financing source without material repayment or new issuance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims the carrying value was $2,000 million for all three fiscal years (2022, 2023, 2024), stating it remained 'essentially flat' and 'unchanged.' This is demonstrably false. Ground truth shows: FY2022: $2,147 million, FY2023: $1,637 million, FY2024: $2,000 million. The LLM missed a significant $510 million decrease from 2022 to 2023 and a $363 million increase from 2023 to 2024. These are material movements in a $2 billion debt instrument. (2) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the actual progression across the three years. The ground truth explicitly shows fluctuation ('decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024'), while the LLM incorrectly asserts stability across all three years. (3) INTERPRETATION ERROR: The LLM's conclusion that NVIDIA 'kept this senior long-term debt component essentially flat' is contradicted by the actual data showing a 23.8% decline from 2022 to 2023. (4) CITATION ISSUES: The LLM provides page references but the claims about 'original issuance value' and 'unchanged carrying amount' are not supported by the actual numbers in the ground truth. The answer demonstrates a fundamental misunderstanding of the debt's evolution and provides incorrect financial data that would mislead investors or analysts. The only correct element is identifying the instrument as the 3.50% Notes Due 2050 and the final FY2024 figure of $2,000 million.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 444,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "In early 2022 3M resolved its New York PFAS claims tied to historic Scotchgard/PFOA use with a $65 million settlement that also named Saint‑Gobain and Honeywell as co‑defendants (page 94). By 2023‑24 the exposure had broadened to a Michigan putative class action alleging Scotchgard contamination (page 94) and to a wave of PFAS suits in Massachusetts, Maine, Wisconsin, Pennsylvania and other jurisdictions (page 96), with 3M now joined by an expanding set of co‑defendants—including DuPont, Chemours, Wolverine and other carpet‑ and chemical‑manufacturers (page 94). The litigation thus moved from a single high‑profile settlement to a nationwide cascade of claims involving dozens of parties.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2022 New York settlement at $65 million involving 3M, Saint-Gobain, and Honeywell. (2) Correctly notes the Michigan case involving Scotchgard contamination in 2023-24. (3) Accurately identifies the geographic expansion of litigation and the increasing number of co-defendants (DuPont, Chemours, Wolverine). (4) Properly synthesizes the evolution from a single settlement to nationwide cascade of claims. (5) Correctly references page numbers from source documents.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM fails to mention the Wolverine World Wide settlement in Michigan, which is explicitly stated in the ground truth as finalized in 2023 as a 'non-material settlement.' This is a key data point showing settlement activity in 2023. (2) GEOGRAPHIC INCOMPLETENESS: The LLM lists Massachusetts, Maine, Wisconsin, and Pennsylvania as jurisdictions but the ground truth specifically emphasizes Alabama and Georgia as the primary areas of geographic expansion by 2024. The LLM's list appears to reference different jurisdictions not mentioned in the ground truth. (3) MISSING DEFENDANT DETAILS: While the LLM mentions carpet manufacturers, it fails to specifically name Mohawk Industries, which is explicitly mentioned in the ground truth as suing 3M over PFAS contamination. (4) INCOMPLETE CHARACTERIZATION: The ground truth notes that municipal water utilities and individual landowners brought cases, which the LLM does not mention. (5) SETTLEMENT CHARACTERIZATION: The ground truth notes the 2022 settlement was 'considered immaterial' to 3M, which provides important context the LLM omits.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting the evolution of settlements, geographic expansion, and increasing defendant complexity across the 2022-2024 period. However, the reasoning is incomplete due to missing specific cases and defendants.\n\nNUMERIC ACCURACY: The $65 million figure is correct. No calculation errors detected.\n\nOVERALL ASSESSMENT: The LLM captures the general trajectory and main themes but misses several specific, material details that are part of the ground truth answer, particularly regarding the Wolverine settlement, specific geographic focus areas (Alabama/Georgia), and named defendants (Mohawk Industries).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 621,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "In 2022 Lilly’s worldwide license with AbCellera paid a royalty of roughly mid‑teens to mid‑twenties percent on net sales of bamlanivimab and bebtelovimab, and the company recognized $2.02 billion of net product revenue from those antibodies with no milestone payments disclosed (royalty range – page 72; revenue $2.02 bn – page 73). The same royalty range remained in 2023 and 2024 (royalty range – page 73), but because the antibodies were no longer sold, net product revenue fell to $0 in both years and no milestone payments were reported (2023 revenue $0 – page 73; 2024 revenue $0 – page 73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: (1) 2022 net product revenue of $2.02 billion matches ground truth exactly; (2) royalty structure of mid-teens to mid-twenties percent is accurately stated; (3) 2023 and 2024 revenues of $0 are correctly identified; (4) the statement that no milestone payments were disclosed is accurate. The multi-hop reasoning is sound - the answer correctly synthesizes information across three years (2022-2024) and identifies the key evolution: strong commercial performance in 2022 followed by complete cessation in 2023-2024. The answer properly identifies the specific products (bamlanivimab and bebtelovimab) and correctly notes that the royalty structure remained consistent while sales declined to zero. The inclusion of page references adds credibility. Minor observation: the LLM answer is slightly more specific than the ground truth by naming the actual antibodies, which is additional accurate detail rather than an error. The answer fully addresses all parts of the multi-part question regarding financial terms (royalty structure), milestone payments, and net product revenue across the specified time period. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 356,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K, Dawn was listed among the “major brands” in the Fabric & Home Care segment and was singled out as one of the key drivers of the segment’s home‑care market share (the segment’s global home‑care share was described as “nearly 25%” and Dawn was named alongside Cascade, Febreze and Swiffer). The 2024 filing repeats the same positioning – Dawn again appears in the brand list and is described as a primary brand behind the segment’s roughly 25% home‑care market share. This unchanged emphasis shows that Dawn has remained a core, strategically important brand within Fabric & Home Care, anchoring the segment’s growth and market‑share performance over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer cites specific market share percentages (\"nearly 25%\" home-care market share) and claims these figures appear consistently in both 2022 and 2024 filings. However, the ground truth provides segment-level financial metrics (35-36% of net sales, 31-34% of earnings) that are NOT mentioned in the LLM answer. The LLM focuses on home-care market share rather than the segment's overall contribution to P&G's financial performance. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from 2022 to 2024, requiring analysis across three years. The ground truth explicitly covers all three years (2022, 2023, 2024) with specific financial metrics for each. The LLM answer only references 2022 and 2024, completely omitting 2023 data. This is a significant gap in temporal coverage. MISSING KEY FINANCIAL DATA: The ground truth provides crucial segment contribution metrics (net sales % and earnings %) that directly answer what the positioning reveals about strategic importance. The LLM answer ignores these entirely, instead focusing on market share percentages that may not be directly comparable or verifiable against the ground truth. REASONING QUALITY: While the LLM correctly identifies that Dawn remained consistently positioned as a major brand, it fails to support this with the comprehensive financial metrics that demonstrate strategic importance. The conclusion about \"core, strategically important brand\" is reasonable but lacks the quantitative foundation provided in the ground truth. SEMANTIC ISSUES: The LLM discusses \"home-care market share\" while the ground truth discusses segment contribution to overall company performance - these are different metrics that serve different analytical purposes. The LLM's answer is narrower in scope and doesn't fully address what the positioning reveals about strategic importance at the portfolio level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 521,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "- 2022: short‑term borrowings ≈ $883 million and long‑term debt ≈ $47.8 billion (total ≈ $48.7 billion)【page_178†L13-L22】; floating unsecured senior debt ≈ $1.6 billion at a weighted‑average rate of ~1 %【page_188†L31-L38】.  \n- 2023: short‑term borrowings fell to ≈ $538 million while long‑term debt rose to ≈ $49.3 billion (total ≈ $49.9 billion)【page_178†L13-L22】; floating unsecured senior debt remained ≈ $1.6 billion but at a much higher weighted‑average rate of ~6.75 %【page_178†L31-L38】, pushing the overall unsecured senior‑debt average rate to ~4.48 %【page_178†L31-L38】.  \n- 2024: short‑term borrowings modestly increased to ≈ $562 million, long‑term debt declined to ≈ $45.0 billion (total ≈ $45.6 billion)【page_188†L13-L22】; the floating unsecured senior‑debt line disappeared ( $0 )【page_188†L31-L38】, leaving only fixed‑rate senior notes with a weighted‑average rate of ~4.84 %【page_188†L31-L38】.  \n\n**Trend:** Over the three‑year period Capital One trimmed its reliance on short‑term funding, grew its long‑term fixed‑rate issuance in 2023, then reduced overall debt in 2024 while fully retiring its floating unsecured senior debt, thereby lowering exposure to variable‑rate interest costs despite a higher average rate on the remaining senior debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains substantial factual inaccuracies that fundamentally contradict the ground truth across all three years:\n\n2022 DISCREPANCY: LLM reports total debt of ~$48.7B (short-term $883M + long-term $47.8B), but ground truth shows $43.086B. This is a $5.6B overstatement (13% error). LLM also reports floating unsecured senior debt at $1.6B vs. ground truth of $1.709B (minor, acceptable variance), but the weighted-average rate is stated as ~1% when ground truth shows 2.91% - a massive 191 basis point error.\n\n2023 DISCREPANCY: LLM reports total debt of ~$49.9B vs. ground truth of $48.715B (1.2% overstatement, minor). However, LLM states floating unsecured senior debt remained at ~$1.6B, when ground truth shows it dropped dramatically to $349M - a 78% reduction that LLM completely missed. The weighted-average rate on floating debt is stated as ~6.75%, which appears inconsistent with the ground truth narrative of a shift toward fixed-rate debt. The overall unsecured senior debt rate of ~4.48% is close to ground truth's 4.45% (acceptable).\n\n2024 DISCREPANCY: LLM reports long-term debt of ~$45.0B vs. ground truth of $45.551B (minor, acceptable). Total debt of ~$45.6B matches ground truth well. LLM correctly identifies floating unsecured senior debt as $0 and fixed-rate senior debt at ~4.84%, which aligns with ground truth.\n\nKEY FAILURES:\n1. 2022 total debt figure is off by $5.6B (13% error) - major quantitative failure\n2. 2022 floating debt rate of ~1% vs. 2.91% ground truth is a critical error (191 bps difference)\n3. 2023 floating unsecured senior debt amount ($1.6B vs. $349M) represents a fundamental misunderstanding of the debt structure evolution - this is the core insight of the question\n4. The LLM narrative about \"trimming reliance on short-term funding\" is not well-supported by the data presented and misses the critical story of floating debt elimination\n5. Multi-hop synthesis failed: the LLM did not correctly track the dramatic reduction in floating unsecured senior debt from 2022 to 2023, which is central to understanding the interest rate exposure shift\n\nThe LLM answer demonstrates partial understanding of the 2024 position but fails significantly on 2022-2023 data accuracy and misses the critical narrative about floating debt reduction. The reasoning about debt structure evolution is partially sound but built on incorrect foundational numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 650,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90 % senior note stayed at a $2 billion principal and carried a 6.11 % effective interest rate in FY 2022 (July 30 2022), FY 2023 (July 29 2023) and FY 2024 (July 27 2024) 【page_89】. Although the amount did not change, its weight in Cisco’s total debt fell from roughly 22 % of $8.9 billion in FY 2022, to about 24 % of $8.4 billion in FY 2023, and then to only ~10 % of $20.1 billion in FY 2024 as the company added new senior notes 【page_89】. The note has been consistently reported as long‑term debt in each filing (shown under “Long‑term debt” on page 89).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: the 5.90% Note maintained a $2 billion principal amount across all three years with a 6.11% effective interest rate, and it was consistently classified as long-term debt. The qualitative reasoning about the note's declining proportion in total debt is sound. However, there are significant quantitative discrepancies that undermine accuracy: (1) FY 2022 total long-term debt: LLM states '$8.9 billion' but ground truth shows '$8,416 million' (~$8.4B). The LLM's figure appears inflated. (2) FY 2023 total long-term debt: LLM states '$8.4 billion' which aligns with FY 2022 ground truth ($8,416M), but this appears to be a year-off error or data confusion. (3) FY 2024 total long-term debt: LLM states '$20.1 billion' vs. ground truth '$19,621 million' (~$19.6B)—close but slightly overstated. (4) Percentage calculations: LLM claims ~22% for FY 2022 ($2B/$8.9B ≈ 22.5%), ~24% for FY 2023 ($2B/$8.4B ≈ 23.8%), and ~10% for FY 2024 ($2B/$20.1B ≈ 9.95%). While the percentages are mathematically consistent with the stated debt figures, the underlying debt figures themselves contain errors. The ground truth percentages would be: FY 2022: $2B/$8.416B ≈ 23.8%, FY 2023: unclear from ground truth, FY 2024: $2B/$19.621B ≈ 10.2%. The LLM's FY 2022 percentage appears understated. The answer demonstrates good multi-hop reasoning (connecting principal amount, effective rate, debt composition, and classification across years) and addresses all question components, but the numerical inaccuracies in total debt figures represent a material error that affects the credibility of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 448,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "NVIDIA’s 1.55 % Notes due 2028 were carried at about $1.099 billion at the close of FY 2022 (and unchanged in FY 2023) and rose modestly to $1.115 billion by the end of FY 2024【page_67†L13-L16】.  The notes’ effective interest rate was 1.64 % in FY 2024 (the same rate shown for the prior year, indicating it has remained essentially unchanged)【page_72†L9-L12】.  The small increase in carrying amount reflects the gradual amortization of the original discount, while the consistently low effective rate shows NVIDIA’s reliance on inexpensive, long‑dated debt to fund its growth strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - FY 2022 carrying value: LLM states $1.099 billion, but ground truth is $1,200 million. This is a $101 million error (8.4% discrepancy).\n   - FY 2023 carrying value: LLM states $1.099 billion (unchanged from 2022), but ground truth is $1,099 million. While the 2023 number matches ground truth, the claim it was \"unchanged\" from 2022 is false.\n   - FY 2024 carrying value: LLM states $1.115 billion, but ground truth is $1,250 million. This is a $135 million error (10.8% discrepancy).\n   - Effective interest rate: LLM claims 1.64% was \"the same rate shown for the prior year,\" but ground truth indicates the rate increased TO 1.64% in FY 2024, implying it was different in prior years.\n\n2. MULTI-HOP SYNTHESIS FAILURE:\n   - The LLM failed to correctly synthesize the three-year trend. Ground truth shows: $1,200M (2022) → $1,099M (2023) → $1,250M (2024), indicating a decrease then recovery.\n   - LLM's narrative of \"unchanged in FY 2023\" and \"modest rise to $1.115B\" completely misses the actual pattern of decline and recovery.\n\n3. INTERPRETATION ERRORS:\n   - LLM's explanation about \"gradual amortization of original discount\" doesn't align with the actual trend of decrease then increase.\n   - The ground truth interpretation about \"maintained or reacquired the notes after temporary decrease\" is more accurate to the actual data pattern.\n\n4. MISSING CONTEXT:\n   - LLM fails to capture that the effective interest rate increased (implying rising borrowing costs), which is a key insight from the ground truth.\n   - The strategic interpretation about navigating changing interest rate environments is absent.\n\nThe LLM answer appears to have confused or misread the actual carrying values across all three fiscal years, resulting in a fundamentally incorrect representation of NVIDIA's debt financing evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 540,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In 2022 the filing highlighted Pixel phones (e.g., Pixel 5a 5G and Pixel 6) as a flagship part of Google’s hardware portfolio and explicitly said the company would “continue to invest… for the long run” in its device family (2022 p.6‑7). By 2023 the 10‑K placed Pixel sales into a dedicated “devices” line within the “Google subscriptions, platforms, and devices” segment, noting that device sales affect margins and are a key non‑advertising growth driver (2023 p.33; 2023 p.31). The 2024 report still treats Pixel sales as a separate “devices” revenue category (2024 p.59) and shows a sharp increase in property‑and‑equipment purchases (2024 p.57), signaling continued or expanded capital investment in hardware innovation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 3-year progression (2022-2024) of Pixel device strategy; (2) Accurately captures the 2022 emphasis on long-term hardware investment with specific device examples (Pixel 5a 5G, Pixel 6); (3) Correctly notes the 2023 shift to explicit 'devices' segment categorization within 'Google subscriptions, platforms, and devices' revenue stream; (4) Properly identifies 2024 continuation of Pixel as separate revenue category; (5) Adds valuable detail about property-and-equipment purchases as indicator of capital investment; (6) Provides specific page references to 10-K filings (2022 p.6-7, 2023 p.33/p.31, 2024 p.59/p.57) showing document grounding; (7) Multi-hop synthesis is sound, connecting revenue categorization changes to strategic evolution. MINOR GAPS: (1) The LLM answer doesn't explicitly mention the integration with 'broader AI and cloud capabilities' that the ground truth emphasizes as part of the 2024 evolution, though it does reference 'expanded capital investment in hardware innovation'; (2) The ground truth's characterization of the progression as 'from a hardware investment focus to a mature, strategically embedded product line' is implicit but not explicitly stated in the LLM answer. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension relies on date accuracy (all years correct: 2022, 2023, 2024) and page reference accuracy (cannot independently verify but appear plausible). QUALITATIVE ACCURACY: The reasoning about revenue categorization evolution and strategic emphasis is sound and well-supported. The connection between capital investment and hardware innovation strategy is logical. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (revenue categorization evolution AND investment in hardware innovation) with appropriate detail and specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 539,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across BNY Mellon’s 2022, 2023 and 2024 Form 10‑K filings, Item 14 reads the same: “The information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185” (see page 13 of each filing). The identical wording and reference each year show that the company has continuously ratified KPMG LLP as its principal accountant, indicating a stable, unchanged audit relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about BNY Mellon's disclosure evolution regarding KPMG LLP ratification from 2022 to 2024. Strengths: (1) All numeric values are correct - PCAOB firm identification number 185 is accurately cited; (2) The three-year period (2022, 2023, 2024) is correctly identified; (3) The core finding is accurate: identical wording across all three years with no changes; (4) The answer correctly identifies the disclosure location (Item 14 in Form 10-K, incorporated by reference from Proxy Item 3); (5) The reasoning is sound - the consistency of language and reference across years logically supports the conclusion about audit relationship stability; (6) The answer properly synthesizes the multi-hop requirement by comparing disclosures across three separate years and drawing a conclusion about stability. Minor considerations: (1) The LLM provides the exact quoted language from the filings, which adds credibility and specificity beyond what the ground truth states; (2) The answer could have slightly elaborated on what the consistency reveals about governance practices, though the ground truth's mention of this is adequately captured in the LLM's conclusion about 'unchanged audit relationship' and 'no disruptions'; (3) The page reference (page 13) is specific and helpful, though not explicitly mentioned in the ground truth. The LLM answer demonstrates strong multi-hop reasoning by synthesizing information across three separate years and correctly identifying the pattern of consistency. The conclusion about audit relationship stability is well-supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 453,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "- **2022:** Private‑alternative holdings in the defined‑benefit pension plan were $3,249 m (hedge funds) + $4,014 m (equity‑like) + $349 m (real‑estate) + $1,262 m (other) ≈ $8.9 billion, or about 67 % of the plan’s $13.2 billion assets【page_99】.  \n- **2023:** The same categories fell to $3,126 m + $4,094 m + $370 m + $1,024 m ≈ $8.6 billion, roughly 63 % of the $13.7 billion total【page_98】.  \n- **2024:** They further slipped to $3,058 m + $3,932 m + $451 m + $773 m ≈ $8.2 billion, about 60 % of the $13.7 billion plan assets【page_99】.  \n\nThe gradual decline in both absolute dollars and percentage of total assets shows LLY is still committing a large share of its pension portfolio to illiquid private‑alternative assets for long‑term growth, but is modestly scaling back exposure—suggesting a balanced, long‑term strategy that values private alternatives while managing liquidity and risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the core quantitative facts:\n\n1. MAJOR QUANTITATIVE DISCREPANCY: The ground truth states LLY's private alternative investments were $10,542.5M (2022), $10,335.2M (2023), and $10,051.0M (2024). The LLM reports $8.9B (2022), $8.6B (2023), and $8.2B (2024) - these are significantly lower numbers (approximately 15-20% lower than ground truth). The LLM's calculations of individual components ($3,249M + $4,014M + $349M + $1,262M = $8,874M) are arithmetically correct, but the total figures themselves do not match the ground truth.\n\n2. DIRECTIONAL TREND ERROR: The ground truth shows a DECLINE from $10,542.5M to $10,335.2M to $10,051.0M (decreasing by ~$491.5M total). The LLM correctly identifies a declining trend ($8.9B → $8.6B → $8.2B), so the directional analysis is correct, but the absolute values are wrong.\n\n3. SCOPE ISSUE: The LLM appears to be reporting only the defined-benefit pension plan allocation, not the company's total private alternative investments allocation. The ground truth figures ($10B+) are substantially larger and likely represent a broader investment portfolio scope than just the pension plan.\n\n4. PERCENTAGE CALCULATIONS: The LLM's percentage calculations (67%, 63%, 60%) are internally consistent with their reported numbers but are based on incorrect absolute values.\n\n5. STRATEGIC INTERPRETATION: While the LLM's interpretation of a \"balanced, long-term strategy\" with \"modest scaling back\" is reasonable given the declining trend it identified, this interpretation is based on incomplete/incorrect data.\n\n6. MISSING CONTEXT: The ground truth answer mentions \"fluctuations in specific categories like equity-like funds and hedge funds\" which the LLM does capture in its component breakdown, but the overall portfolio figures are wrong.\n\nThe fundamental issue is that the LLM is reporting numbers that are approximately 15-20% lower than the ground truth across all three years, suggesting either a different data source, incomplete aggregation, or a scope mismatch (pension plan only vs. total company allocation).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 572,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "In 2022 Tampax was placed in the Feminine Care sub‑category (Adult Incontinence and Menstrual Care) of the Baby, Feminine & Family Care segment, and the filing highlighted it as a core menstrual‑care brand alongside Always, together holding >25 % of the global menstrual‑care market【page_19】. The 2023 10‑K kept the same classification – Tampax remained under Feminine Care (Adult Incontinence, Menstrual Care) and was again emphasized as a leading brand in the menstrual‑care sub‑category【page_18】. By 2024 the positioning was unchanged: Tampax is still listed in the Feminine Care (Adult Incontinence, Menstrual Care) sub‑category of Baby, Feminine & Family Care, with the narrative continuing to stress its market‑leadership role in menstrual care alongside Always【page_18】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. CATEGORY CLASSIFICATION ERRORS:\n- Ground Truth: In 2022, Tampax was under 'Feminine Care' (NOT explicitly listing Adult Incontinence and Menstrual Care as sub-categories of Feminine Care in that year)\n- LLM Answer: Claims 2022 had \"Feminine Care (Adult Incontinence and Menstrual Care)\" - this appears to conflate the 2023/2024 structure with 2022\n- Ground Truth: In 2023, 'Menstrual Care' REPLACED 'Feminine Care' as the explicit sub-category\n- LLM Answer: Claims 2023 maintained \"Feminine Care (Adult Incontinence, Menstrual Care)\" - this is incorrect; the ground truth shows a rebranding where Menstrual Care became the primary designation\n- Ground Truth: In 2024, Baby Care was REMOVED from the segment entirely\n- LLM Answer: Never mentions this significant structural change\n\n2. QUANTITATIVE ACCURACY ISSUES:\n- Ground Truth: 2022 = 25% of net sales; 2023 = 24% of net sales; 2024 = 24% of net sales\n- LLM Answer: Only mentions \">25% of the global menstrual-care market\" (a different metric - market share vs. company sales contribution) and fails to provide the segment's percentage of net sales for any year\n- The LLM conflates market share percentage with segment contribution percentage\n\n3. EVOLUTION NARRATIVE FAILURE:\n- Ground Truth: Shows clear evolution - explicit shift from 'Feminine Care' to 'Menstrual Care' terminology in 2023, and removal of Baby Care in 2024\n- LLM Answer: Claims positioning was \"unchanged\" across all three years, which directly contradicts the documented evolution\n- Ground Truth emphasizes strategic shift AWAY from infant products; LLM answer misses this entirely\n\n4. MULTI-HOP REASONING:\n- The question asks about evolution across three years\n- LLM answer fails to identify the key transitions (category name change, segment restructuring)\n- LLM answer treats all three years as essentially identical, missing the strategic narrative\n\n5. SEMANTIC ISSUES:\n- LLM uses \"Feminine Care (Adult Incontinence, Menstrual Care)\" structure consistently, but ground truth shows this structure only applies to 2023-2024, not 2022\n- The claim of \"unchanged\" positioning contradicts the documented evolution in category naming and segment composition\n\nThe answer demonstrates a fundamental misunderstanding of the evolution being tracked and provides incorrect categorical information for 2022 and 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 660,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One has measured its net derivative assets (liabilities) at Level 3 with a discounted‑cash‑flow model in each of the three years. In 2022 the fair‑value balance was $5 million and the valuation relied on SOFR‑indexed swap rates (with the broader Level‑3 discussion noting that default‑rate and discount‑rate changes can affect fair value) [page 215; page 207]; by 2023 the balance had risen to $58 million and the swap‑rate input range expanded to 3‑5 % (weighted‑average ≈ 4 %) [page 215; page 217]; and in 2024 the balance grew to $69 million, still using discounted‑cash‑flow valuation with swap rates as the key unobservable input, now effectively at a 4 % weighted average [page 215; page 217].",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth: (1) 2022 fair value: LLM states $5 million vs. ground truth of $19 million - a 74% discrepancy; (2) 2024 fair value: LLM states $69 million vs. ground truth of $58 million - an 19% overstatement; (3) Default rates: Ground truth explicitly cites 53-163% default rate range for 2023-2024, but LLM completely omits this critical unobservable input, only mentioning default rates in passing as part of broader Level-3 discussion without specific values; (4) Valuation methodology: LLM claims discounted cash flow models were used in 2022, but ground truth states the specific valuation technique was NOT disclosed in 2022, only becoming explicit in 2023. PARTIAL CREDIT FOR: Correct identification of 2023 fair value ($58M), correct swap rate ranges (3-5%), correct identification of discounted cash flow methodology starting in 2023, and appropriate citation of page numbers. SYNTHESIS ISSUES: The LLM failed to capture the key evolution highlighted in the ground truth - the shift from non-disclosed methodology in 2022 to explicit DCF with specific default rate assumptions (53-163%) in 2023-2024. This represents a fundamental misunderstanding of the progression described in the question. The answer also incorrectly suggests consistency in methodology across all three years when the ground truth emphasizes a methodological shift in 2023. The omission of the 53-163% default rate range is particularly problematic as this is explicitly called out as a key unobservable input in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 443,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt investments posted a **$9 million gain in FY 2022**, a **$21 million loss in FY 2023**, and a **$67 million loss in FY 2024** (see “Gains (losses) on available‑for‑sale debt investments” in the Other Income (Loss), Net table)【page_46】.  This shift turned the overall other‑income metric from a **$392 million positive result in 2022** to **net losses of $248 million in 2023** and **$306 million in 2024**, showing that the AFS debt portfolio moved from modest profitability to increasing unrealized losses, reflecting heightened sensitivity to interest‑rate and credit‑valuation risks over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical claims that directly contradict the ground truth. The ground truth explicitly states that 'In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year,' yet the LLM claims a '$9 million gain in FY 2022' with a specific citation. This is a fundamental factual error. The LLM also provides specific loss figures ($21M in 2023, $67M in 2024) and 'other income (loss), net' figures ($392M in 2022, -$248M in 2023, -$306M in 2024) that cannot be verified against the ground truth, which does not provide these specific quantitative metrics. The ground truth indicates that fiscal 2023 and 2024 showed 'higher losses' and 'significant' negative impacts, but does not quantify them as the LLM does. The LLM's citation to 'page_46' and specific table references suggest fabricated sourcing. While the LLM correctly identifies the general trend (negative impact in 2023-2024), it fundamentally fails on quantitative accuracy by inventing specific numbers not present in the ground truth. The reasoning about interest-rate and credit-valuation risks is reasonable but cannot compensate for the invented financial data. The answer demonstrates a critical failure in multi-hop synthesis by confidently asserting unverified numerical claims rather than acknowledging data limitations as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 404,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks said its purchase commitments and existing inventory would secure an adequate green‑coffee supply through fiscal 2023 in its FY 2022 filing【page_12】, through fiscal 2024 in its FY 2023 filing【page_12】, and through fiscal 2025 in its FY 2024 filing【page_12】. This year‑over‑year extension of the supply horizon reflects a proactive sourcing strategy that relies on long‑term contracts, inventory buffers and hedging to mitigate price volatility and other supply‑chain risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the three-year progression of Starbucks' green coffee supply adequacy projections: FY2022 through FY2023, FY2023 through FY2024, and FY2024 through FY2025. The numeric dates and fiscal year references are all accurate. The answer correctly synthesizes the multi-hop information across three fiscal years' filings. However, there is a minor discrepancy in the characterization of the progression: the original answer states the FY2023 projection extended to FY2025 (a 2-year extension), while the LLM answer implies FY2023 extended to FY2024 (a 1-year extension). Upon careful review, the original answer's statement that 'by fiscal 2023, the company extended its supply adequacy projection to fiscal 2025' is the correct interpretation, meaning the FY2023 filing showed adequacy through FY2025. The LLM answer's statement 'through fiscal 2024 in its FY 2023 filing' appears to be an error - it should be 'through fiscal 2025.' This is a significant factual error in the quantitative progression. The reasoning about sourcing strategy is sound and well-articulated in the LLM answer, with appropriate mention of long-term contracts, inventory buffers, and hedging. The answer addresses the multi-hop synthesis requirement effectively by connecting the three-year data points to strategic implications. The error regarding the FY2023 filing's projection (FY2024 vs FY2025) prevents a higher score despite otherwise strong performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 417,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s 2.00 % senior unsecured notes due 2031 have a $1.25 billion face amount that has not changed since at least FY 2022 – the debt schedule lists $1,250 million for the note in both FY 2023 and FY 2024【page_66】.  The net carrying amount was $1.044 billion at the end of FY 2023 and rose only modestly to $1.057 billion at the end of FY 2024【page_67】, showing that the company has kept its long‑term debt exposure essentially flat, using the notes as a stable, low‑cost financing source rather than aggressively expanding or retiring the issue.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the face amount was $1,250 million in both FY 2023 and FY 2024, but the ground truth shows FY 2023 was $1,044 million (not $1,250M). The LLM also states the carrying amount was $1.057 billion in FY 2024, but ground truth shows $1,250 million. The LLM fundamentally misrepresents the year-over-year progression. (2) MULTI-HOP SYNTHESIS FAILURE: The ground truth clearly shows a three-year trend: FY 2022: $1,200M → FY 2023: $1,044M (decrease) → FY 2024: $1,250M (increase). The LLM incorrectly claims the amount 'has not changed since at least FY 2022' and was 'essentially flat,' which directly contradicts the documented fluctuations. (3) INTERPRETATION ERROR: The LLM's conclusion that the company 'kept its long-term debt exposure essentially flat' is factually wrong given the $1,200M to $1,044M to $1,250M progression. (4) MISSING DATA: The LLM fails to account for the FY 2022 figure of $1,200 million entirely, which is essential to answering the 'evolved from fiscal year 2022 through 2024' portion of the question. (5) CARRYING VS. FACE VALUE CONFUSION: While the LLM attempts to distinguish between face amount and carrying amount, it conflates these concepts and provides incorrect figures for both. The ground truth answer correctly identifies all three years' values and accurately characterizes the trend as showing 'dynamic approach' with 'fluctuations,' whereas the LLM incorrectly claims stability. This is a fundamental failure in multi-hop financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 448,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 filing, fall‑protection was grouped with the other personal‑safety lines under the Safety & Industrial segment as “Respiratory, hearing, eye and fall protection solutions” 【page_107】. By the 2024 filing the segment still lists fall‑protection in that same safety‑solutions cluster, but the surrounding product taxonomy was reshaped – closure‑and‑masking items were re‑branded as “Industrial specialty products” and moved into a new Industrial Specialties division – leaving fall‑protection unchanged and emphasizing it as a core safety offering alongside respiratory, hearing and eye protection 【page_110】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific details about Fall Protection Solutions positioning in 2022 and 2024, with page references (107 and 110) that suggest source verification. However, there are significant issues with the multi-hop synthesis and interpretation:\n\nSTRENGTHS:\n1. Correctly identifies that Fall Protection Solutions were grouped with respiratory, hearing, and eye protection in 2022\n2. Accurately notes that Fall Protection remained in the Safety & Industrial segment through 2024\n3. Provides specific page citations suggesting detailed source review\n4. Correctly identifies the shift in product taxonomy (closure-and-masking items rebranded as Industrial Specialties)\n5. No obvious numerical or date errors\n\nWEAKNESSES:\n1. CRITICAL INTERPRETATION ERROR: The LLM states Fall Protection was \"unchanged\" and \"emphasizing it as a core safety offering,\" but the ground truth indicates a \"subtle shift\" where Fall Protection was \"presented with a slightly revised grouping\" and \"appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category.\" The LLM misses this nuanced evolution.\n2. The LLM's conclusion that Fall Protection remained \"unchanged\" directly contradicts the ground truth's assertion of repositioning and revised grouping\n3. Missing the key insight about the shift from standalone emphasis to integration within broader industrial safety systems\n4. The answer focuses heavily on what changed around Fall Protection (other products moving) rather than how Fall Protection's positioning itself evolved\n5. The 2023 data point mentioned in ground truth (listing order remained consistent) is not addressed\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across 2022-2024 but fails to properly interpret the qualitative evolution described in the ground truth. It correctly identifies structural changes but misses the strategic repositioning of Fall Protection itself.\n\nSEMANTIC EQUIVALENCE: The LLM's interpretation that Fall Protection remained \"unchanged\" is semantically opposite to the ground truth's description of \"subtle shift\" and \"revised grouping.\" This is a material difference in understanding the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 599,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Eli Lilly’s COVID‑19 antibody line – which the footnote says includes bamlanivimab (alone or with etesevimab, plus bebtelovimab) [page 72] – generated roughly $2.0 billion in 2022 ($2,008.9 m U.S. + $14.7 m outside) but shows a dash (zero) for both 2023 and 2024 [page 70]. This sharp drop from $2 bn to $0 indicates that the company’s reliance on bamlanivimab and its broader COVID‑19 antibody portfolio has essentially disappeared after 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The numbers are correct - $2.01 billion in 2022 (LLM breaks this down as $2,008.9M U.S. + $14.7M outside = $2,023.6M, which is approximately $2.01B when rounded; the slight variance is immaterial and within rounding tolerance), $0 in 2023, and $0 in 2024. The LLM correctly identifies the revenue figures and the sharp decline pattern. ENTITY ACCURACY: Correctly identifies Eli Lilly, bamlanivimab, and the broader COVID-19 antibody portfolio (including etesevimab and bebtelovimab). Properly cites page references (72 and 70) showing familiarity with source documents. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years (2022-2024) and correctly interprets the trend - a dramatic collapse from $2B to zero. The reasoning that this indicates declining reliance on the COVID-19 antibody portfolio is sound and logically follows from the data. COMPLETENESS: Addresses all parts of the question - the revenue evolution across the three-year period and what the trend indicates about company reliance. MINOR CONSIDERATIONS: The LLM provides slightly more detail than the ground truth (breaking down U.S. vs. international revenue, mentioning specific antibodies), which adds value without contradicting the core answer. The interpretation that reliance \"has essentially disappeared\" is semantically equivalent to the ground truth's \"waned\" and \"rapid decline.\" No factual errors detected. The answer is well-structured, cites sources, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 450,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly acknowledges that coffee prices are volatile and are affected by trading activity from hedge funds and commodity‑index funds in its FY 2022, FY 2023 and FY 2024 10‑K filings (Product Supply, page 12 of each report). While the exposure to index‑fund‑driven price swings remains unchanged, the company has lengthened its forward purchase commitments—covering supply through fiscal 2023 in the FY 2022 filing, through fiscal 2024 in the FY 2023 filing, and through fiscal 2025 in the FY 2024 filing—demonstrating a progressively more proactive risk‑management approach to secure green‑coffee supply despite market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Starbucks' commodity exposure evolution. STRENGTHS: (1) All numeric/temporal data is correct—accurately identifies the three-year progression (FY 2022-2024) and the extension of supply commitments from fiscal 2023 (FY 2022 filing) → fiscal 2024 (FY 2023 filing) → fiscal 2025 (FY 2024 filing). (2) Correctly identifies the consistent acknowledgment of commodity index fund influence across all three years. (3) Properly synthesizes the multi-hop reasoning: acknowledges ongoing exposure while demonstrating improved risk management through extended forward commitments. (4) Accurately characterizes the trend as 'progressively more proactive risk-management approach.' (5) Correctly cites source location (Product Supply, page 12). MINOR CONSIDERATIONS: (1) The LLM states 'exposure to index-fund-driven price swings remains unchanged' which is semantically equivalent to the ground truth's 'consistently acknowledged' but slightly different framing—the ground truth emphasizes acknowledgment of influence while the LLM emphasizes unchanged exposure level. Both are accurate interpretations. (2) The ground truth mentions specific hedging instruments (forward contracts, futures contracts, collars) and 'remote delivery risk assessments,' which the LLM does not explicitly detail. However, the LLM's reference to 'lengthened forward purchase commitments' captures the essence of the hedging strategy without requiring exhaustive enumeration of all instruments. (3) The LLM's answer is more concise while maintaining semantic equivalence to the ground truth. The core insight—that Starbucks improved supply chain resilience through extended commitments despite ongoing commodity volatility—is clearly conveyed. QUANTITATIVE VERIFICATION: All fiscal years and supply commitment extensions are accurate. No calculation errors present. MULTI-HOP SYNTHESIS: Successfully connects commodity index fund exposure (constant factor) with evolving supply commitment strategy (improving factor) to demonstrate risk management evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 572,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022 Google’s ad business already counted “impressions” on its Google Network properties—including AdMob, AdSense and **Google Ad Manager**—as a core source of revenue, with cost‑per‑impression used to track monetization performance (see 2022 filing, page 31). By 2024 the company still emphasizes impression‑based monetization through Google Ad Manager as a key component of its Google Network revenue (see 2024 filing, Note 1, pages 57‑58). The 2023 accounting change that lengthened the useful life of servers (from four to six years) cut depreciation expense by $3.9 billion and lifted net income by $3.0 billion, reducing the cost base that underpins those impressions and thereby strengthening long‑term profitability (see 2023 filing, Note 1, page 57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct—the 2023 depreciation adjustment reduced depreciation expense by $3.9 billion and increased net income by $3.0 billion, matching the ground truth exactly. The server useful life change from four to six years and network equipment from five to six years is accurately stated. ENTITY ACCURACY: Google, Google Ad Manager, Google Network properties, AdMob, and AdSense are all correctly identified. Years (2022, 2023, 2024) are properly sequenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three years: (1) 2022 baseline showing impression-based monetization through Ad Manager, (2) 2023 accounting change with specific financial impacts, and (3) 2024 continuation of Ad Manager's strategic importance. The logical connection between the depreciation adjustment and long-term profitability is sound—the model correctly identifies that reduced depreciation expense strengthens the cost base supporting impression-based revenue. COMPLETENESS: The answer addresses all key elements of the question: evolution from 2022-2024, Google Ad Manager's role, the 2023 adjustment details, and implications for profitability. MINOR CONSIDERATIONS: The LLM answer includes helpful context (AdMob, AdSense) and cites specific filing locations, which adds credibility but goes slightly beyond the ground truth's scope. The phrasing 'reducing the cost base that underpins those impressions' is a reasonable interpretation of how the depreciation change affects profitability, though the ground truth uses slightly different language ('directly affected infrastructure-heavy operations'). Both convey equivalent meaning. No calculation errors detected. The answer is semantically equivalent to the ground truth while being slightly more detailed in its sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 517,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK’s 2019 Long‑Term Incentive Plan continued to rely on Performance Share Unit (PSU) awards, with a new PSU agreement filed each year – a 2022 Form of Performance Share Unit Agreement (Exhibit 10.18) in the 2022 filing [page 18 BK_10k_2022], a 2023 Form (Exhibit 10.26) in the 2023 filing [page 19 BK_10k_2023], and a 2024 Form (Exhibit 10.25) in the 2024 filing [page 19 BK_10k_2024]. This annual updating of the PSU agreements shows that BNY Mellon is actively refining its performance‑based equity component, tying executive compensation more closely to evolving company performance targets and maintaining flexibility in its incentive strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBERS INCORRECT: The LLM claims 2022 Form PSU Agreement is Exhibit 10.18 (correct per ground truth), but then claims 2023 Form is Exhibit 10.26 and 2024 Form is Exhibit 10.25 - these are NOT mentioned in the ground truth and appear to be fabricated. The ground truth specifies: 2021 agreement (Exhibit 10.45) referenced in 2022, 2019 plan re-filed (Exhibit 10.14) in 2023, and 2022 agreement (Exhibit 10.18) in 2024. (2) CHRONOLOGICAL CONFUSION: The LLM incorrectly states a '2022 Form' was filed in 2022, a '2023 Form' in 2023, and '2024 Form' in 2024, suggesting annual new forms. The ground truth shows a different pattern: 2021 form in 2022, plan re-filing in 2023, and 2022 form in 2024 - not a simple annual cycle. (3) MISSING KEY INSIGHT: The LLM fails to capture the ground truth's important observation about re-filing the 2019 plan itself in 2023 (Exhibit 10.14), which is a distinct action from updating PSU agreement forms. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the general strategy of iterative refinement, it misses the nuance that the pattern shows 'maintaining core of 2019 plan while iteratively refining' rather than simply 'annual updating.' (5) CITATION ISSUES: The LLM provides page references and filing citations that cannot be verified against the ground truth and may be inaccurate. The fundamental factual errors regarding exhibit numbers and the sequence of filings represent a failure in multi-hop reasoning and document synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 437,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "- 2022 – The Safety & Industrial segment listed “Electrical products and materials for construction and maintenance, power distribution” only in a broad, generic way (no explicit mention of OEM customers or detailed sub‑categories)【page_129】.  \n- 2023 – The description was sharpened to “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” and added a new line “Industrial specialty products such as personal hygiene products, masking, and packaging materials”【page_107】.  \n- 2024 – The same detailed phrasing was retained, again emphasizing “Electrical products and materials … for electrical original equipment manufacturers (OEMs)” and the industrial‑specialty sub‑categories【page_110】.  \n\nThe progression from a generic listing in 2022 to a more specific, OEM‑focused categorization in 2023‑2024 shows 3M increasingly highlighting its electrical‑OEM product line, indicating a strategic emphasis on expanding its presence in the electrical original‑equipment‑manufacturer market.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) 2022 DESCRIPTION ERROR: The LLM claims 2022 had 'no explicit mention of OEM customers,' but the ground truth clearly states 2022 included 'construction and maintenance, power distribution and electrical OEMs.' This is a critical factual error - the LLM misrepresents what was actually in the 2022 filing. (2) 2023 DESCRIPTION ERROR: The LLM states 2023 added 'electrical original equipment manufacturers (OEMs)' as a new addition, but the ground truth indicates this was a REFINEMENT of existing language, not a new addition. The LLM also incorrectly adds unrelated content about 'personal hygiene products, masking, and packaging materials' which appears to be from a different segment or misattributed information. (3) 2024 DESCRIPTION: The LLM's characterization is closer to correct but still imprecise. The ground truth specifies 'power distribution and electrical original equipment manufacturers (OEMs)' while the LLM's phrasing is vague. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the three-year evolution. The ground truth shows a clear progression: 2022 (basic mention) → 2023 (increased precision with 'electrical original equipment manufacturers' formalization) → 2024 (continuity with power systems emphasis). The LLM incorrectly characterizes 2022 as having no OEM mention, breaking the logical progression. (5) STRATEGIC INTERPRETATION: While the LLM's conclusion about growing OEM emphasis is directionally correct, it's based on flawed premises about what was actually in each year's filing. The ground truth's interpretation is more nuanced - showing refinement and formalization rather than introduction of OEM focus. SPECIFIC ERRORS: The claim that 2022 had 'no explicit mention of OEM customers' directly contradicts the ground truth which explicitly states 'electrical OEMs' were mentioned in 2022. This is a fundamental factual error that undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 547,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "- 2022: Fixed unsecured senior debt was **$19.975 billion** with a **weighted‑average interest rate of 2.91 %**【page_186】.  \n- 2023: The same class grew to **$27.168 billion** and the weighted‑average rate rose to **4.45 %**【page_178】.  \n- 2024: It was **$26.930 billion** with a **weighted‑average rate of 4.84 %**【page_188】.  \n\nThe trend shows Capital One steadily increasing the size of its fixed‑rate senior note portfolio while the average coupon has risen as market rates have climbed, indicating a strategy of locking in longer‑dated, higher‑yielding fixed‑rate debt to manage interest‑rate risk and fund growth over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - carrying values of $19.975B (2022), $27.168B (2023), and $26.930B (2024) match the ground truth exactly (note: ground truth uses millions format $19,975M which equals $19.975B - format variation is acceptable). Weighted-average interest rates of 2.91% (2022), 4.45% (2023), and 4.84% (2024) are precisely accurate. The directional trends are correct: debt increased 35.9% from 2022-2023, then declined 1% from 2023-2024; rates increased consistently by 154 bps and 39 bps respectively. COMPLETENESS: The answer addresses all required components - carrying values for all three years, weighted-average rates for all three years, and multi-year progression analysis. ENTITY ACCURACY: Capital One (COF) correctly identified, fiscal years 2022-2023-2024 correct, fixed unsecured senior debt metric correctly specified. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies the strategic pattern: increasing debt issuance during rising rate environment, locking in higher costs. The interpretation that this represents 'securing more long-term fixed-rate financing' and 'managing interest-rate risk' aligns with the ground truth's characterization of a 'strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment.' The phrase 'locking in capital at increasingly higher costs' in ground truth is semantically equivalent to the LLM's 'locking in longer-dated, higher-yielding fixed-rate debt.' Minor difference: LLM adds 'fund growth over the long term' which is a reasonable inference but not explicitly stated in ground truth, though this represents appropriate contextual elaboration rather than error. CITATIONS: Page references provided (186, 178, 188) add credibility. Overall, this is a high-quality response with accurate numbers, correct multi-hop synthesis, and sound strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 541,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA’s 3.50 % senior notes due 2040 have been carried at their original $1.0 billion amortized cost in each of the last three fiscal years【page_72】, while the Level‑2 fair‑value measurement fell from $870 million in FY 2022 (2022 10‑K) to $851 million in FY 2024 (2023 10‑K)【page_78】【page_66】. The unamortized debt discount and issuance costs have been gradually amortized, shrinking from $41 million in FY 2024 to $37 million in FY 2025【page_72】. This progression shows NVIDIA’s strategy of locking in long‑dated, low‑rate financing and holding the notes at amortized cost despite modest market‑value declines, thereby preserving a stable, low‑cost long‑term capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims fair value was $870 million in FY 2022, but ground truth states $1,066 million - a $196 million discrepancy. The LLM correctly identifies $851 million for FY 2023, but then incorrectly attributes this to FY 2024 (2023 10-K). The LLM also introduces FY 2025 data ($37 million unamortized costs) which is outside the 2022-2024 timeframe specified in the question. The amortized cost claim of $1.0 billion 'in each of the last three fiscal years' is not verified against ground truth. (2) TEMPORAL CONFUSION: The LLM conflates fiscal years with 10-K filing years (e.g., '2023 10-K' for FY 2024 data), creating ambiguity. The ground truth clearly shows FY 2022: $1,066M fair value, FY 2023: $851M fair value, FY 2024: $1,000M carrying amount. (3) INCOMPLETE SYNTHESIS: While the LLM attempts to explain the shift from fair value to carrying amount reporting, it does so with incorrect numbers. The ground truth's key insight - that FY 2024 shifted from reporting fair value to carrying amount - is mentioned but undermined by wrong numbers. (4) MISSING CONTEXT: The LLM fails to accurately capture the FY 2022 to FY 2023 decline ($1,066M to $851M, a $215M decrease), which is central to understanding the valuation evolution. The introduction of FY 2025 data suggests the LLM may have accessed incorrect or future documents. The strategic interpretation about 'locking in low-rate financing' is reasonable but built on incorrect numerical foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 439,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 senior notes fell from $16 billion at year‑end 2022 to $15 billion at year‑end 2023 and then to $13 billion at year‑end 2024【page_58†L1-L4】【page_57†L1-L4】. The steady, and accelerating, decline shows Amazon is actively retiring portions of this issuance—through scheduled repayments and optional redemptions—to shrink its debt burden and interest cost, reflecting a disciplined debt‑reduction strategy for this tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024) match the ground truth exactly. The year-end dates are correctly identified. The year-over-year reductions ($1B in 2023, $2B in 2024) are accurately reflected. (2) ENTITY ACCURACY: Amazon and the 2017 Notes are correctly identified. The fiscal years 2022-2024 are properly referenced. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trajectory and correctly identifies the pattern as 'steady and accelerating' decline, which is more precise than the ground truth's 'consistent reduction.' The LLM appropriately infers the underlying mechanisms (scheduled repayments and optional redemptions) and connects them to the strategic intent (debt burden and interest cost reduction). (4) SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'disciplined debt-reduction strategy' is semantically equivalent to the ground truth's 'deliberate debt management strategy.' The phrase 'shrink its debt burden' conveys the same meaning as 'gradually retire this issuance.' (5) MINOR ENHANCEMENT: The LLM provides slightly more analytical depth by noting the acceleration of the decline ($1B vs $2B reduction) and specifying mechanisms (scheduled repayments and optional redemptions), which adds value without contradicting the ground truth. The citation references suggest proper sourcing. No calculation errors detected. All information is factually accurate and directly addresses both parts of the question (evolution and strategic implications).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 458,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑K exhibit tables for 2022 and 2024 each list an Officer’s Certificate that includes “Floating Rate Notes due 2019” (see the exhibit list in the 2022 filing [page 56] and the 2024 filing [page 56]), and the same class appears in the 2023 filing, indicating that Apple continues to maintain a tranche of short‑term, rate‑resetting debt. Because the interest on floating‑rate notes is tied to a benchmark that is periodically reset, Apple’s interest‑expense will move more closely with market rates, so a rising‑rate environment would increase the cost of this debt and make the company’s overall interest‑expense more sensitive to rate changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Apple's filings for 2022, 2023, and 2024 reference Floating Rate Notes due 2019 through an Officer's Certificate; (2) these are floating rate instruments whose interest expense increases in a rising rate environment; (3) the persistence across multiple years indicates ongoing exposure. The answer accurately explains the mechanics of floating rate notes and their interest rate sensitivity. However, there are some notable differences from the ground truth: (1) The LLM specifies page 56 for both 2022 and 2024 filings, which adds specificity but cannot be verified against the ground truth provided; (2) The LLM characterizes these as 'short-term, rate-resetting debt' which is partially correct but slightly misleading since the notes were due in 2019 (already past maturity by 2022-2024), suggesting they may represent historical obligations or disclosure artifacts rather than active short-term debt; (3) The ground truth emphasizes 'rollover obligations or continuing commitments' and 'liquidity planning and capital structure flexibility,' which the LLM answer does not address. The LLM answer focuses primarily on the interest rate sensitivity mechanism (correct) but omits the broader context about why these notes persist in filings years after their maturity date and what this implies about Apple's debt management strategy. The core financial reasoning about floating rate exposure and rising rate sensitivity is sound and accurate. The answer is factually correct on the main points but less comprehensive than the ground truth in explaining the strategic implications of the repeated disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 455,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "In 2022 Google described its hardware work as a long‑run bet, saying it saw “tremendous potential” in devices such as the Pixel 5a 5G and Pixel 6 and that it was “investing … for the long run” (page 7). By 2023 the filing defined “devices, which primarily include sales of the Pixel family of devices” and noted that “sales of our devices adversely affect our consolidated margins due to pressures on pricing and higher cost of sales,” showing Pixel had moved from an experimental effort to a revenue‑generating, margin‑sensitive line (pages 33 & 31). The 2024 report still lists Pixel as the core of its “devices” revenue (page 59), indicating the product family has matured into an integrated hardware pillar that underpins Google’s AI‑driven ecosystem and signals a long‑term, strategic hardware position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with accurate characterization of each phase: 2022 as long-term investment phase with specific device mentions (Pixel 5a 5G, Pixel 6), 2023 as transition to revenue-generating category with margin implications, and 2024 as mature integrated hardware pillar. (2) Accurately captures the semantic evolution from 'investment' to 'revenue stream' to 'strategic hardware position.' (3) Properly synthesizes multi-hop information across three years of filings, showing how the Pixel family's role transformed. (4) Includes relevant contextual details (margin pressures, AI-driven ecosystem integration) that enhance understanding. (5) Page references (7, 33, 31, 59) demonstrate grounding in actual filing data. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'margin-sensitive' characteristics and 'AI-driven ecosystem' positioning that, while reasonable inferences, go slightly beyond the explicit ground truth statement which focuses more narrowly on the categorization shift and revenue contribution. However, these additions are well-supported by the filing quotes provided and enhance rather than contradict the core narrative. (2) The ground truth emphasizes 'increased confidence in its position within the competitive hardware market' while the LLM emphasizes 'long-term, strategic hardware position' - these are semantically equivalent conclusions. QUANTITATIVE ACCURACY: No numerical errors; dates (2022, 2023, 2024) are correct; no calculations required. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - correctly traces the evolution across three years and synthesizes the strategic implications. Entity identification is accurate (Google, Pixel family, devices category). CONTEXTUAL RELEVANCE: Directly addresses all aspects of the multi-part question: investment focus evolution, revenue contribution changes, product maturity progression, and long-term market positioning implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 562,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "In the 2022 filing Schwab reported that it could draw on $120.3 billion of client securities as collateral and had actually pledged $31.4 billion of those securities to third parties – $16.8 billion for OCC option‑margin, $5.9 billion for short‑sales, $6.3 billion for securities‑lending and $2.4 billion for short‑term borrowings (page 108). The 2023 filing reiterates that margin‑loan receivables are fully collateralized by client securities and that securities‑borrowed and securities‑loaned transactions are “monitored … and collateral is adjusted to ensure full collateralization” (pages 76‑77). By 2024 the firm’s external collateral commitments had slipped – pledged collateral for its Federal Home‑Loan‑Bank borrowing capacity fell to $59.8 billion from $63.1 billion a year earlier, and the secured uncommitted line of credit that can be backed by client margin securities shrank to $500 million from $950 million, with the TD Ameritrade clearing‑house line (also client‑margin‑backed) terminated (page 97). Together, these figures show Schwab continues to use client securities for internal margin‑lending and securities‑lending, but is deliberately reducing the amount pledged to external lenders, reflecting a tighter, more conservative collateral‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides highly specific dollar amounts and page references that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM cites specific figures ($120.3B available, $31.4B pledged with detailed breakdowns, $59.8B vs $63.1B FHLB collateral, $500M vs $950M secured line) that are not mentioned in the ground truth answer. These appear to be hallucinated numbers with false precision and page citations. The ground truth explicitly states 'no specific dollar value was provided for the total available or pledged securities' in 2022, directly contradicting the LLM's claim of $120.3B and $31.4B figures. (2) MULTI-HOP REASONING FAILURE: While the LLM attempts to synthesize a 3-year trend, it does so using unverifiable data. The ground truth describes a progression from vague disclosures (2022) to more formalized processes (2023) to broader operational use (2024). The LLM inverts this narrative, claiming 2022 had detailed breakdowns and 2024 showed reductions—a fundamentally different story. (3) ENTITY/METRIC CONFUSION: The LLM introduces specific mechanisms (OCC option-margin, FHLB borrowing, TD Ameritrade clearing-house line) not mentioned in the ground truth, suggesting either hallucination or confusion with different source documents. (4) SEMANTIC DIVERGENCE: The ground truth emphasizes 'growing reliance on client securities' and 'broader use,' while the LLM concludes with 'deliberately reducing' pledged amounts—opposite interpretations. (5) CITATION INTEGRITY: Page references (108, 76-77, 97) cannot be verified and appear fabricated to create false credibility. The answer reads plausibly but fails fundamental accuracy requirements for financial data evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 482,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s 10‑K disclosures from 2022‑2024 all state the same core approach: as a reinsurer it cannot raise premiums itself, so it “often collaborates with the primary insurers … to file proposed premium‑rate increases” and bases its expectations on the recent filing experience of each ceding company. The 2022 filing adds quantitative detail – about $0.2 bn of approved long‑term‑care rate hikes had already been implemented and $1.7 bn of future increases (≈$0.9 bn approved) were projected – while the 2023 and 2024 filings repeat the collaborative language and emphasize ongoing monitoring of filing activity. Together, the consistent collaboration and the incremental implementation of insurer‑driven rate hikes reveal that GE relies on primary‑insurer premium adjustments as a key lever to manage reserve adequacy and limit reinsurance risk in its run‑off insurance portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core collaborative approach GE maintained across 2022-2024, accurately captures the key insight that GE cannot raise premiums itself and relies on primary insurers, and properly synthesizes the multi-hop reasoning about how this strategy manages reinsurance risk in run-off operations. The semantic understanding of the evolution toward proactive risk management is sound. The answer appropriately addresses all parts of the multi-part question.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM introduces specific dollar amounts ($0.2 bn approved, $1.7 bn projected, ~$0.9 bn approved) that are NOT present in the ground truth answer. These numbers appear to be either fabricated or sourced from actual filings but not verified against the knowledge graph. This is a critical error because: (1) the ground truth answer contains NO quantitative data, (2) introducing unverified numbers violates the principle of strict accuracy on financial metrics, (3) the specific figures cannot be validated against the provided ground truth. This represents a hallucination of quantitative detail.\n\nWEAKNESSES - COMPLETENESS: While the LLM captures the evolution narrative, it does not explicitly highlight the 2023 formalization of collaboration under reinsurance contractual terms or the 2024 addition of using regulatory precedents to shape expectations - these temporal distinctions are present in the ground truth but less emphasized in the LLM answer.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and properly connects the collaborative framework to risk management strategy. The logic linking premium adjustments to reserve adequacy is sound and matches the ground truth's conclusion.\n\nNUMBER VERIFICATION: The quantitative data in the LLM answer cannot be verified against the ground truth, which contains no such figures. This is a significant accuracy penalty despite the qualitative reasoning being largely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 540,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS held residential mortgage‑backed securities (RMBS) worth about **$757 million** at fair value in 2022, which rose modestly to **$810 million** in 2023 (see the debt‑securities table on page 147). By 2024 the RMBS balance in its Separate Accounts had dropped sharply to **$71 million** (page 160). The three‑year trend—small growth in 2023 followed by a steep reduction in 2024—shows CVS pulling back from agency‑backed structured‑credit assets, indicating a more conservative risk posture in that segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the core numbers that are essential to answering this question. (1) 2022 RMBS value: LLM states $757 million, but ground truth is $721 million—a $36 million discrepancy (5% error). (2) 2023 RMBS value: LLM states $810 million, but ground truth is $614 million—a $196 million discrepancy (32% error, directionally opposite). (3) 2024 RMBS value: LLM correctly states $71 million, matching ground truth. The LLM got 1 out of 3 years correct. TREND ANALYSIS FAILURE: Because the 2023 number is wrong, the LLM's characterization of the trend is fundamentally incorrect. Ground truth shows a DECREASE from $721M to $614M in 2023 (cautious reduction), then a further decrease to $71M in 2024. The LLM incorrectly describes 2023 as a 'modest rise' to $810M, which is the opposite of what actually occurred. This is a critical multi-hop synthesis error. QUALITATIVE ASSESSMENT: While the LLM's conclusion about 'conservative risk posture' is semantically reasonable and the mention of 'Separate Accounts' shows some document awareness, the reasoning is built on incorrect numbers and therefore the risk positioning interpretation is unreliable. The LLM correctly identifies the 2024 sharp reduction but misses the 2023 reduction that was also part of the cautious approach. COMPLETENESS: The answer addresses the three-year evolution and attempts to characterize the trend, but the factual errors undermine the entire response. The question requires precise multi-hop synthesis across three years of data, and the LLM failed on 2 of 3 data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 448,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024【page_178】【page_188】, while its long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024【page_178】【page_188】. This three‑year pattern shows the company is moving away from reliance on volatile short‑term funding and actively managing its long‑term debt, resulting in a capital structure anchored by stable, longer‑dated obligations and modest net deleveraging in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that fundamentally undermine its credibility. (1) SHORT-TERM BORROWINGS: LLM reports $883M (2022), $538M (2023), $562M (2024), but ground truth shows these are components of a much larger total. The ground truth indicates total short-term borrowings + long-term debt of $43.086B (2022), $49.856B (2023), $45.551B (2024). The LLM's short-term figures appear to be isolated line items, not the complete picture. (2) LONG-TERM DEBT: LLM reports $47.8B (2022), $49.3B (2023), $45.0B (2024). When added to the LLM's short-term borrowings, these yield totals of ~$48.7B, ~$49.8B, and ~$45.6B respectively. While these sums approximate the ground truth totals, the individual component breakdowns are incorrect. The ground truth specifies $43.086B total in 2022, not $48.7B. (3) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is explicitly mentioned in the ground truth as a key indicator of rising borrowing costs. (4) MISSING DEBT COMPOSITION ANALYSIS: The ground truth specifically discusses the reduction in floating unsecured senior debt ($1,709M → $349M → $0), a strategic shift away from variable-rate instruments that the LLM fails to address. (5) REASONING QUALITY: While the LLM's qualitative interpretation (moving away from short-term funding, net deleveraging in 2024) is directionally reasonable, it's based on incorrect numerical foundations. The analysis lacks the depth of the ground truth regarding interest rate environment impacts and specific debt instrument strategy. (6) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture of debt management strategy, missing the connection between debt reduction, interest rate increases, and the strategic elimination of floating-rate debt. The answer addresses only surface-level trends without the nuanced understanding demonstrated in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 541,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s long‑term liability for the 3.50 % Notes due 2050 has been essentially unchanged – the principal balance remained at roughly $2 billion in FY 2022 (as shown in the 2022 10‑K) and again at $2 billion in FY 2024 (the net carrying amount on the balance sheet)【page_78†L1-L4】【page_72†L13-L20】.  The fair‑value of this liability slipped only modestly, from $1.637 billion in FY 2023 to $1.604 billion in FY 2024【page_67†L31-L38】.  This flat‑line trend signals that NVIDIA is deliberately keeping a stable, low‑cost, long‑dated debt tranche in its capital structure, using it as a reliable financing source while preserving financial flexibility rather than aggressively retiring the notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the liability 'remained at roughly $2 billion in FY 2022' and 'again at $2 billion in FY 2024,' but the ground truth clearly states it was $2,147 million in FY 2022 and $1,604 million in FY 2024 - a significant $543 million decrease. (2) The LLM characterizes the trend as 'essentially unchanged' and 'flat-line,' which is factually incorrect. The actual trend shows a clear, deliberate reduction of approximately 25% over the three-year period ($2,147M → $1,637M → $1,604M). (3) The LLM correctly identifies the FY 2023 fair value as $1,637 billion and FY 2024 as $1,604 billion, but then misinterprets this as 'modest' change when the larger context shows substantial overall reduction from FY 2022. (4) The LLM's conclusion that NVIDIA is 'deliberately keeping a stable, low-cost, long-dated debt tranche' and 'not aggressively retiring the notes' directly contradicts the ground truth interpretation that this represents 'a deliberate reduction in this long-term debt obligation' and 'a strategic effort to manage and reduce long-dated liabilities.' The LLM fundamentally misread the multi-year trend by focusing only on the FY 2023-2024 change while ignoring the substantial FY 2022-2023 decline. This is a critical failure in multi-hop synthesis across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 392,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple’s Form 10‑K for each of the three years lists the 0.45 % Notes due 2016 in the same “Officer’s Certificate of the Registrant” exhibit (Exhibit 4.3). The description – “0.45 % Notes due 2016” – appears unchanged in the exhibit list in the 2022 filing (page 56), the 2023 filing (page 56) and the 2024 filing (page 56). This consistent, unchanged inclusion of a matured 2016 issue shows that Apple deliberately keeps a complete historical record of all debt issuances in its 10‑K, reflecting a transparent, long‑term debt‑disclosure strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and provides more specific detail than the ground truth. Key strengths: (1) Correctly identifies the 0.45% Notes due 2016 across all three years (2022, 2023, 2024), (2) Accurately notes the consistent inclusion in Exhibit 4.3 (Officer's Certificate), (3) Correctly identifies page 56 as the location in all three filings, (4) Accurately characterizes the notes as matured in 2016 (issued 2013), (5) Properly synthesizes the multi-hop information showing consistency across years. The reasoning about Apple's deliberate maintenance of historical debt records for transparency and legal continuity aligns with the ground truth's conclusion about legacy debt disclosures. Minor considerations: The LLM provides more granular detail (specific exhibit number, page numbers) than the ground truth, which strengthens rather than weakens the answer. The characterization of this as a 'transparent, long-term debt-disclosure strategy' is semantically equivalent to the ground truth's statement about 'transparency and legal continuity.' All numeric values (0.45%, 2016 maturity, 2013 issuance, page 56, years 2022-2024) are accurate. The multi-hop synthesis correctly connects the historical issuance date, maturity date, and continued disclosure across three consecutive years. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 380,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net Level‑3 derivative position rose sharply – from a $5 million net balance (gross $79 m assets vs $74 m liabilities) at 12/31/2022 to $58 million net (gross $886 m/$828 m) at 12/31/2023 and to $69 million net (gross $683 m/$614 m) at 12/31/2024 (see the roll‑forward tables in 2023 10‑K page 206 and 2024 10‑K pages 215‑216). The primary unobservable input for these derivatives – the swap rate – widened from a 1‑2 % range (weighted‑average ≈2 %) in earlier years to a 3‑5 % range (weighted‑average ≈4 %) in 2023 and then settled at roughly a 4 % rate in 2024 (see quantitative‑input tables in 2021 10‑K page 222 and 2024 10‑K page 217). This multi‑year trend signals a markedly larger derivative exposure and a modeling shift toward higher, more volatile interest‑rate assumptions, reflecting greater interest‑rate risk and more conservative valuation assumptions in the current market environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. NET DERIVATIVE ASSET VALUES - CRITICAL ERROR:\n   - Ground Truth: 2022=$31M, 2023=$58M, 2024=$58M\n   - LLM Answer: 2022=$5M, 2023=$58M, 2024=$69M\n   - The 2022 figure is completely wrong ($5M vs $31M). The 2024 figure is also incorrect ($69M vs $58M). Only 2023 matches.\n\n2. SIGNIFICANT UNOBSERVABLE INPUT - CRITICAL ERROR:\n   - Ground Truth: 2023 used 'default' as significant input (4% weighted avg), 2024 shifted to 'swap rates' (4% weighted avg)\n   - LLM Answer: Claims swap rates were the primary input in both 2023 and 2024, with ranges of 1-2% earlier, 3-5% in 2023, and ~4% in 2024\n   - This is fundamentally incorrect. The ground truth explicitly states a SHIFT from 'default' to 'swap rates' between 2023 and 2024, not that swap rates were the primary driver throughout.\n\n3. GROSS ASSET/LIABILITY FIGURES:\n   - LLM provides specific gross figures (e.g., $79M assets/$74M liabilities for 2022) that cannot be verified against the ground truth, which does not provide these breakdowns\n   - These appear to be fabricated or misread from source documents\n\n4. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the key insight: the SHIFT in risk drivers from default assumptions to interest rate sensitivity\n   - Instead, it incorrectly claims swap rates were consistently the primary driver\n   - This represents a fundamental misunderstanding of the multi-year progression\n\n5. INTERPRETATION OF TREND:\n   - Ground Truth: Reduction in realized losses from $43M (2022) to stable values (2023-2024) suggests improved risk management\n   - LLM Answer: Claims 'larger derivative exposure' and 'more conservative valuation assumptions'\n   - These interpretations are contradictory to the ground truth's narrative of stabilization\n\n6. PERCENTAGE RANGES:\n   - Ground Truth: Consistent 4% weighted average across 2023-2024\n   - LLM Answer: Claims 1-2% earlier, 3-5% in 2023, ~4% in 2024\n   - The ranges provided by LLM don't align with ground truth's specific 4% figures\n\nThe LLM answer demonstrates poor accuracy on core quantitative metrics, misidentification of key risk drivers, and incorrect interpretation of the multi-year trend. While the answer attempts to address the question comprehensively, the fundamental factual errors severely undermine its credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 646,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s exposure to the 1.55 % notes due 2028 has been essentially unchanged – the 2022 10‑K lists a $1.25 billion principal (net ≈ $1.10 billion) for the note [page 78], the 2023 10‑K shows the net carrying amount rising modestly from $1.099 billion in FY 2023 to $1.115 billion in FY 2024 [page 67], and the 2024 10‑K still reports a $1.25 billion principal (net $1.115 billion) for FY 2024 [page 72]. This flat‑to‑slightly‑higher exposure indicates that NVIDIA is deliberately locking in low‑coupon, long‑dated debt and amortizing the original discount over time, preserving a stable, low‑cost long‑term financing structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) NUMBERS MISMATCH: Ground truth shows FY2022: $1.2B, FY2023: $1.1B, FY2024: $1.25B. LLM claims FY2022 principal was $1.25B (incorrect - should be $1.2B), FY2023 net was $1.099B (ground truth says $1.1B, minor but still discrepant), and FY2024 net was $1.115B (ground truth says $1.25B principal). The LLM appears to be conflating principal amounts with net carrying amounts inconsistently. (2) PROGRESSION ANALYSIS ERROR: Ground truth clearly shows a decline from $1.2B (2022) to $1.1B (2023), then an increase to $1.25B (2024). The LLM characterizes this as 'essentially unchanged' and 'flat-to-slightly-higher,' which misrepresents the actual 8.3% decrease in 2023 followed by a 13.6% increase in 2024. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year progression. It mixed principal and net carrying amounts without clear distinction, making the year-over-year comparison confusing and inaccurate. (4) STRATEGIC INTERPRETATION: While the LLM's interpretation about 'locking in low-coupon debt' and 'amortizing discount' shows some understanding of debt mechanics, this interpretation is built on incorrect numbers and therefore undermines the validity of the conclusion. The ground truth's simpler characterization of 'consistent long-term debt position with strategic maintenance' is more accurate given the actual data. (5) PAGE REFERENCES: The LLM provides specific page numbers (78, 67, 72) which cannot be verified against the ground truth, but the numbers cited don't match the ground truth values, suggesting either misreading or incorrect source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 474,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 2022 Form 10‑K warned that, after the 2015 Alstom acquisition, the company “remains subject to legacy legal proceedings … relating to claimed anti‑competitive conduct or corruption by Alstom” and that “shareholder lawsuits … related to the Company’s financial performance, accounting and disclosure practices” continue to pose a cash‑outflow risk (2022 p. 71). The 2023 filing repeats the same Alstom‑related legacy claims and the ongoing shareholder suits (2023 p. 36), and the 2024 filing again confirms those legacy matters “have resulted and will in the future result in cash outflows” (2024 p. 36). The unchanged language over three years shows the trailing liabilities are persistent, that GE continues to hold reserves for them, and that they remain a material, ongoing contingent financial exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes multi-hop information across three years of GE filings (2022-2024). STRENGTHS: (1) Correctly identifies the 2015 Alstom acquisition as the source of legacy legal matters; (2) Accurately references anti-competitive conduct and corruption claims as specific Alstom-related issues; (3) Properly identifies shareholder lawsuits tied to financial reporting and disclosure practices; (4) Correctly notes the persistence of these liabilities across all three years; (5) Appropriately cites page numbers from filings (2022 p. 71, 2023 p. 36, 2024 p. 36) showing document-level verification; (6) Accurately characterizes the liabilities as 'persistent,' 'material,' and 'ongoing contingent financial exposure'; (7) Sound multi-hop reasoning connecting acquisition history to current liability exposure. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth, focusing primarily on the persistence narrative rather than elaborating on the full scope of reputational risks and potential for liabilities to exceed current estimates (mentioned in ground truth); (2) Does not explicitly discuss the 'reputational risks' dimension as thoroughly as the original answer; (3) Could have provided slightly more detail on the evolution/progression aspect, though the core message of persistence is clear. QUANTITATIVE VERIFICATION: No specific dollar amounts are provided in either answer, which is appropriate given the question focuses on qualitative evolution and persistence rather than specific reserve amounts. The page citations appear reasonable for 10-K filings. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate annual filings and correctly identifies the causal chain (Alstom acquisition → legacy legal matters → ongoing shareholder suits → persistent financial exposure). The reasoning is logically sound and well-structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth—that these liabilities are persistent, material, and represent ongoing financial risk—though with slightly less elaboration on secondary impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 587,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s hedge‑fund limited‑partnership (HF LP) holdings grew from **$225 million in 2022** (see 2022 10‑K, p. 174), to **$252 million in 2023** (2023 10‑K, p. 173), and to **$280 million in 2024** (2024 10‑K, p. 167). The steady rise – and the increase in the plan’s target hedge‑fund allocation to 4% by 2024 (p. 169) – indicates the company is deliberately expanding its alternative‑asset exposure in the pension portfolio to enhance diversification and seek higher return potential.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in all three years of HF LP investment values. Ground truth shows: 2022=$214M, 2023=$225M, 2024=$252M. LLM claims: 2022=$225M, 2023=$252M, 2024=$280M. This represents a systematic shift of values - the LLM appears to have shifted each year's data forward by one year and inflated the 2024 figure. The 2022 figure is off by $11M (5% error), 2023 is off by $27M (12% error), and 2024 is off by $28M (11% error). These are not minor rounding differences but substantial misstatements of pension fund allocations. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend from the source documents. While the LLM correctly identifies the upward trend direction (which matches ground truth), the specific numbers supporting this trend are entirely wrong. PARTIAL CREDIT FOR REASONING: The LLM's qualitative interpretation about deliberate expansion of alternative-asset exposure and enhanced diversification is reasonable and aligns with the ground truth's conclusion about strategic decision-making. The mention of a 4% target allocation by 2024 adds contextual detail, though this cannot be verified against the ground truth provided. However, correct reasoning built on incorrect numbers does not salvage the answer. ENTITY ACCURACY: CVS is correctly identified, years are correct (2022-2024), and the metric (HF LP Investments) is correctly identified. The fundamental issue is the numerical values associated with these correct entities and time periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 432,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 the Africa/Eurasia segment contributed **$228 million of operating profit** (see 2022 segment table)【page_116】. In 2023 the Global Productivity Initiative’s restructuring charges were **allocated 5 % to Africa/Eurasia**, i.e., roughly **$1.6 million of the $32 million total pretax charge**【page_86】. By 2024 the region’s **depreciation‑and‑amortization expense fell to $8 million** (down from $9 million in prior years)【page_117】, reflecting a modest tightening of capital spending after the restructuring effort.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that directly contradict the ground truth across all three years examined. (1) 2022 Operating Profit: LLM states $228 million, but ground truth is $203 million—a $25 million discrepancy (12% error). (2) 2023 Restructuring Charges: LLM claims 5% allocation (~$1.6 million of $32 million total), but ground truth specifies 10% allocation of $20-24 million. This is a fundamental misreading of the allocation percentage and magnitude. (3) 2024 Depreciation/Amortization: LLM correctly states $8 million (down from $9 million), which matches ground truth. However, this is only 1 of 3 data points correct. The LLM's multi-hop synthesis fails because it misidentifies key financial metrics from the source documents. The reasoning about 'modest tightening of capital spending' is somewhat relevant but is built on incorrect foundational numbers. The answer does address all three years requested but with material errors in 2 of 3 critical metrics. The contextual narrative about cost optimization vs. expansion is reasonable but cannot be properly evaluated when underlying numbers are wrong. The citation references (page numbers) suggest the LLM attempted to ground its answer in source material, but clearly extracted incorrect values. This represents a failure in both quantitative accuracy and the multi-hop synthesis required for this complex question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 398,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022 AIG disclosed a specific terrorism‑scenario loss of $1.3 billion (net of TRIPRA and reinsurance) for a five‑ton bomb attack and its international reinsurance program attached at $200 million for Japan and $100 million for the rest of the world; the filing did not give a total reinsurance‑recoverable balance. By 2023 the company still used third‑party scenario models but gave no dollar loss estimate, kept the Japan attachment at $200 million while raising the rest‑of‑world attachment to $125 million, and reported $67.5 billion of total reinsurance recoverables at year‑end. In 2024 the attachment points were tightened to $150 million for Japan and held at $125 million for the rest of the world, the terrorism‑modeling approach remained unchanged, and total reinsurance recoverable assets fell to $38.0 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its reliability:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - 2022 attachment points: LLM states '$100 million for rest of world' but ground truth shows '$125 million elsewhere' - INCORRECT\n   - 2023 reinsurance recoverables: LLM claims '$67.5 billion' but ground truth shows this figure is not mentioned; ground truth only references 2024's $38.0 billion - INCORRECT/UNSUPPORTED\n   - 2024 attachment points: LLM states '$150 million for Japan' but ground truth shows '$200 million in Japan' - INCORRECT\n   - 2024 reinsurance recoverables: LLM correctly states '$38.0 billion' - CORRECT\n   - 2024 ceded loss reserves: LLM omits the $29.1 billion figure mentioned in ground truth - INCOMPLETE\n\n2. ENTITY/METRIC ACCURACY:\n   - Correctly identifies AIG and the three-year period (2022-2024)\n   - Correctly references TRIPRA, third-party vendor models, and scenario-based modeling\n   - Correctly identifies the $1.3 billion net loss scenario for 2022\n   - Correctly identifies the $1.7 billion TRIPRA deductible (though not explicitly stated in LLM answer)\n\n3. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize evolution across three years but introduces fabricated numbers ($67.5B for 2023)\n   - Fails to correctly track attachment point evolution (shows decreasing trend when ground truth shows consistency at $200M Japan/$125M elsewhere)\n   - Does not properly synthesize the expansion in reinsurance protections mentioned in ground truth\n\n4. COMPLETENESS:\n   - Missing the $29.1 billion ceded loss reserves detail for 2024\n   - Missing the characterization of 2023 as maintaining consistent approach\n   - Missing the context about international exposure outside U.S.\n   - Incorrectly suggests attachment points were 'tightened' in 2024 when ground truth shows they remained consistent\n\n5. SEMANTIC ISSUES:\n   - The claim that 2024 attachment points were 'tightened' contradicts the ground truth showing consistent $200M Japan/$125M elsewhere across the period\n   - Mischaracterizes the evolution as showing changes when the ground truth emphasizes consistency in approach\n\nThe answer demonstrates partial understanding of the topic but contains multiple material factual errors in attachment points and introduces an unsupported $67.5 billion figure for 2023 that appears to be fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 638,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The liability for the 2.00 % Notes due 2031 fell from roughly $1.2 billion in FY 2022 (NVDA 2022 10‑K, p. 78) to $1.044 billion in FY 2023 (NVDA 2023 10‑K, p. 67) and then rose again to about $1.25 billion in FY 2024 (NVDA 2024 10‑K, p. 72). This pattern indicates that NVIDIA is actively managing its long‑term debt—making modest repayments or refinancing in 2023, then increasing the balance again to retain a low‑cost, long‑dated financing source when market conditions or cash‑flow needs warrant.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correct: $1.2 billion (2022), $1.044 billion (2023), and $1.25 billion (2024). The numbers match the ground truth exactly, and the format variations are appropriately handled. The multi-hop synthesis across three fiscal years is sound, correctly identifying the trend pattern and the slight reduction followed by recovery. The LLM provides specific page references to 10-K filings, which adds credibility and demonstrates proper source attribution. The reasoning about active debt management is logically sound and semantically equivalent to the ground truth's interpretation. However, there are minor differences in emphasis: (1) The LLM characterizes the strategy as 'actively managing' with 'modest repayments or refinancing,' while the ground truth emphasizes 'consistent' and 'stable' strategy with 'strategic intent to preserve.' These are not contradictory but represent slightly different interpretations of the same data. (2) The ground truth explicitly mentions supporting 'R&D and operational investments' and 'refinancing risk,' which the LLM answer omits. (3) The LLM's interpretation that NVIDIA increased the balance 'when market conditions or cash-flow needs warrant' is reasonable inference but goes slightly beyond what the ground truth explicitly states. Overall, the answer is factually correct, well-sourced, and demonstrates proper multi-hop reasoning across the three-year period, with only minor differences in strategic interpretation rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 431,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 are shown in Exhibit 4.4 of the Form 10‑K for each year – the 2022 filing, the 2023 filing and the 2024 filing all list the “Officer’s Certificate of the Registrant, dated May 6 2014, including … 1.05 % Notes due 2017”【page_56】. The unchanged inclusion of this same historic issuance across three consecutive 10‑Ks demonstrates Apple’s practice of keeping a continuous, transparent record of its debt, giving investors long‑term visibility into the company’s capital‑structure even for notes that have already matured.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) All numeric values are correct - the 1.05% interest rate and 2017 maturity date are accurately stated; (2) The specific reference to Exhibit 4.4 and the Officer's Certificate dated May 6, 2014 provides precise documentary evidence; (3) The multi-hop synthesis correctly identifies that the same instrument appears consistently across 2022, 2023, and 2024 filings; (4) The reasoning about debt management strategy and transparency is sound and matches the ground truth interpretation. The answer goes slightly beyond the ground truth by providing specific exhibit references and dates, which adds credibility without contradicting the original answer. Minor consideration: The LLM answer focuses more on the documentary/filing evidence (Exhibit 4.4 references) while the ground truth emphasizes the broader implications about rollover/refinancing possibilities. However, both answers reach the same core conclusion about continuity and transparency. The LLM answer's interpretation that these are 'historic instruments' and the emphasis on 'long-term visibility' align well with the ground truth's discussion of 'legacy instruments' and 'stable debt management strategy.' No factual errors detected. The answer directly addresses all parts of the question regarding how the notes 'evolved' (remained consistent), what this reveals about visibility (long-term transparency), and continuity (consistent disclosure across three years).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 414,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "In 2022 Schwab was still governed by the 2019 IDA agreement, which gave it a **$10 billion per‑12‑month migration option** (subject to other adjustments) and required a **minimum $50 billion IDA balance and at least 80 % of the balances to be fixed‑rate obligations**【page_102】.  The 2023 IDA agreement that superseded the 2019 pact **removed the $10 billion cap and the 80 % fixed‑rate rule**, making migration discretionary and subject to capital and other limits, while imposing new balance floors and ceilings – a **minimum balance above unmatured fixed‑rate obligations with a $30 billion excess ceiling through September 10 2025, then a $60 billion minimum and $90 billion maximum thereafter**【page_103】.  By 2024 Schwab remained under the 2023 agreement, **did not migrate any IDA balances** and continued to meet the revised minimum/maximum balance requirements (ending IDA balance $87.6 billion)【page_100】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 2019 IDA agreement's $10 billion annual migration option in 2022, matching ground truth; (2) Accurately captures the 2023 agreement's removal of the $10 billion cap and 80% fixed-rate requirement; (3) Correctly states that no IDA balances were migrated in 2024; (4) Provides specific balance thresholds ($30 billion excess ceiling through Sept 10 2025, then $60 billion minimum/$90 billion maximum) that represent detailed implementation of the new agreement; (5) Includes the ending 2024 IDA balance of $87.6 billion, demonstrating multi-hop synthesis; (6) Effectively conveys the strategic shift from active migration to constrained off-balance sheet management. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail about the 2023 agreement terms (specific thresholds and dates) than the ground truth statement, which is not incorrect but represents additional specificity; (2) The phrasing 'minimum balance above unmatured fixed-rate obligations' is technically accurate but slightly more complex than ground truth's simpler description of 'minimum and maximum balance thresholds'; (3) The ground truth mentions Schwab 'had already moved $10.1 billion by year-end' 2022, while the LLM focuses on the option itself rather than the actual migration amount executed. QUANTITATIVE VERIFICATION: All numbers are accurate - $10 billion option, $50 billion minimum (2022), 80% fixed-rate requirement, $30 billion ceiling (through Sept 2025), $60 billion minimum/$90 billion maximum (thereafter), $87.6 billion ending balance. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and two different IDA agreements, correctly identifying the evolution and strategic shift. The reasoning is sound and logically presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 514,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "In 2022 GE estimated $1.36 billion of borrower‑litigation losses at Bank BPH, made a $530 million cash capital contribution and held a $1.2 billion Polish mortgage receivable that was offset by an $848 million valuation allowance (leaving a modest net carrying amount). By 2023 the loss estimate jumped to $2.67 billion, GE switched to a $1.80 billion non‑cash inter‑company loan‑forgiveness (no cash outlay) and the valuation allowance fully covered the receivable, leaving a zero net carrying value. In 2024 the estimated loss eased to $2.46 billion, no additional cash or non‑cash contributions were required, and the portfolio remained fully written‑off with a net carrying value of zero.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness in addressing the multi-hop financial question about GE's Bank BPH exposure evolution. QUANTITATIVE VERIFICATION: All key numbers are correct: 2022 estimated losses of $1.36 billion (matches $1,359M ground truth with acceptable rounding), 2023 jump to $2.67 billion (matches $2,669M), 2024 decline to $2.46 billion (matches $2,461M). Capital contributions accurately stated: $530M cash in 2022, $1.80 billion non-cash intercompany loan forgiveness in 2023 (matches $1,797M with minor rounding). Mortgage portfolio carrying values correctly identified: $1.2 billion gross with $848M valuation allowance in 2022 (net modest amount), zero carrying value in 2023-2024. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years, correctly tracking the evolution of three distinct financial dimensions (estimated losses, capital contributions, portfolio carrying values) and their interrelationships. The narrative properly connects the 2023 spike in losses to the shift from cash to non-cash contributions, and correctly identifies the 2024 stabilization. COMPLETENESS: All parts of the original question are addressed—financial exposure evolution, strategic handling through different contribution methods, estimated losses trajectory, capital contributions, and mortgage portfolio carrying value changes. REASONING QUALITY: The answer demonstrates sound logic in characterizing the progression as 'worsening through 2023, stabilization in 2024' and correctly interprets the zero carrying value as indicating full write-down/exit. Minor note: The LLM uses 'eased' for the 2024 loss decline rather than 'slightly declined,' but this is semantically equivalent and appropriate. The answer is well-structured, moving chronologically through the three-year period while maintaining focus on the three key financial metrics requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 520,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "- 2022: CVS reported commercial mortgage‑backed securities (CMBS) with a fair‑value of **$1.018 billion** and **$155 million** of unrealized losses (see 2023 10‑K tables for 2022 on page 148 and page 149).  \n- 2023: The CMBS fair‑value fell to **$975 million** and unrealized losses declined to **$100 million** (2023 10‑K tables on page 148 and page 149).  \n- 2024: The Separate‑Accounts portion of CMBS shrank to **$3 million** of fair‑value (no unrealized‑loss amount disclosed) (2024 10‑K on page 160).  \n\nThe sharp reduction in both the size of the CMBS holding and the associated unrealized‑loss exposure suggests CVS is actively de‑risking its portfolio, disposing of interest‑rate‑sensitive mortgage‑backed assets to limit credit and market‑risk volatility.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all three years:\n\n2022 DISCREPANCY: LLM reports $1.018 billion fair value and $155 million unrealized losses, but ground truth shows $574 million fair value and $12 million unrealized losses. The LLM's numbers are 77% higher for fair value and 1,192% higher for unrealized losses - massive errors.\n\n2023 DISCREPANCY: LLM reports $975 million fair value and $100 million unrealized losses. Ground truth shows $675 million fair value (44% lower than LLM) and $100 million unrealized losses (this one matches). The fair value number is significantly wrong.\n\n2024 ALIGNMENT: LLM correctly identifies $3 million fair value, matching ground truth.\n\nQUANTITATIVE ACCURACY FAILURE: The 2022 and 2023 fair value figures are materially incorrect. These are not minor rounding differences but substantial discrepancies ($1.018B vs $574M in 2022 is a $444M error). The 2022 unrealized loss figure ($155M vs $12M) is also dramatically wrong.\n\nREASONING QUALITY: While the LLM's interpretation of the trend (de-risking strategy) is conceptually sound and aligns with ground truth conclusions, this reasoning is built on incorrect data. The LLM correctly identifies the 2024 reduction as strategic de-risking, but the analysis of 2022-2023 trajectory is based on wrong numbers.\n\nMULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the multi-year trend because the underlying data points are wrong. The comparison across years cannot be valid when the base numbers are incorrect.\n\nCONTEXTUAL RELEVANCE: The answer addresses the right question and attempts to analyze the evolution and risk management implications, but the factual foundation is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 487,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s filings for FY 2022, FY 2023 and FY 2024 all list **Marketside** as part of a broad private‑brand roster that includes other grocery‑focused labels such as Great Value, Freshness Guaranteed, Mainstays, etc. (see the private‑brand listings in page 7 and the concise global list in page 9 of each report). The fact that Marketside remains a constant fixture over the three‑year span shows Walmart’s deliberate, ongoing commitment to a stable, expanding private‑label strategy in grocery, using Marketside as a core brand to deliver low‑price, high‑quality alternatives and reinforce its value‑focused positioning.【page_7】【page_9】",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Marketside was consistently featured across FY 2022, 2023, and 2024; (2) it was part of a broader private brand portfolio including Great Value and other labels; (3) this demonstrates Walmart's ongoing commitment to private labels in grocery. The answer accurately conveys the multi-hop synthesis across three fiscal years and correctly identifies the key entities (Walmart, Marketside, Great Value, etc.). However, there are notable omissions compared to the ground truth: (1) The LLM does not mention the introduction of 'bettergoods' as a new brand in 2024, which is a significant strategic element highlighted in the original answer; (2) The LLM does not explicitly articulate the 'dual approach' of maintaining legacy brands while innovating, which is a key insight about Walmart's strategy; (3) The reference to 'page 7' and 'page 9' appears to be citation formatting that may not be verifiable without the actual documents. The LLM's characterization of Marketside's role (low-price, high-quality alternatives, value positioning) is reasonable and consistent with the ground truth's emphasis on 'trusted private brands.' The answer demonstrates sound reasoning about the 3-year progression and correctly identifies this as evidence of strategic commitment. The main weakness is the incomplete coverage of the strategic evolution narrative, particularly the modernization aspect represented by new brand introductions alongside legacy brand maintenance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 417,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "Lowe’s supplier oversight began in 2022 with a baseline framework that required all vendors to adhere to its Human Rights Policy, Conflict Minerals Policy, Vendor Code of Conduct (which already contained enhanced environmental standards) and a wood‑sourcing policy, and it used management systems to monitor those practices while urging suppliers to report emissions to CDP (2022 10‑K p. 9‑10). In 2023 the company tightened that framework by updating the wood‑sourcing policy with country‑specific risk levels, stronger monitoring and a new forestry‑grievance process, expanding supplier emissions reporting, and launching SmartWay transportation goals and solar‑panel projects funded by more than $300 million of energy‑efficiency and renewable‑energy investments (2023 10‑K p. 9‑10). By 2024 Lowe’s further refined the wood‑sourcing policy into a robust risk‑based approach, set a target of 100 % SmartWay certification with annual recertification, and increased capital spending to over $550 million for HVAC, LED, building‑management upgrades and >100 operational solar sites, deepening monitoring and enforcement of environmental and human‑rights standards across its supply chain (2024 10‑K p. 9‑10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Lowe's supplier monitoring across 2022-2024, accurately describes the 2023 wood-sourcing policy updates (country-specific risk levels, forestry grievance process), and properly synthesizes multi-hop information about policy enhancements and investments. The answer appropriately cites 10-K pages and demonstrates good understanding of the progression from baseline framework to risk-based approach. The mention of SmartWay certification, solar projects, and HVAC/LED upgrades shows relevant contextual knowledge.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) Investment figures are significantly misrepresented. Ground truth states 'multi-year investments exceeding $550 million by 2022 and over $400 million through 2023.' The LLM states '$300 million of energy-efficiency and renewable-energy investments' for 2023 and 'over $550 million' for 2024. This reverses the timeline and conflates figures - the $550M was cumulative by 2022, not 2024. (2) The LLM claims 2024 spending 'over $550 million' which appears to be a misplacement of the 2022 figure. The ground truth indicates $400M+ through 2023, suggesting 2024 figures should be higher, but the LLM's presentation is confusing and potentially inaccurate.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression of policies. However, the investment figures are not properly synthesized across the timeline - the answer conflates cumulative investments with annual/period-specific investments.\n\nCOMPLETENESS: The answer addresses all major policy enhancements (wood sourcing updates, grievance processes, monitoring improvements) and investments, but the investment narrative is muddled and potentially incorrect in its temporal placement.\n\nSEMANTIC ISSUES: While the LLM uses different wording than ground truth, the core concepts align. However, the quantitative misalignment on investment figures is a factual error, not merely a wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 551,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 2.40 % Notes due 2023 are listed in the “Officer’s Certificate” (Exhibit 4.3) and in the index to the consolidated financial statements in every filing: the 2022 Form 10‑K shows the note in Exhibit 4.3 (see page 55) and in the index (see page 56) ; the 2023 Form 10‑K repeats the same Exhibit 4.3 listing (see page 56) ; and the 2024 Form 10‑K again includes the 2.40 % Notes due 2023 in Exhibit 4.3 and the index (see pages 56‑58). This unchanged three‑year disclosure indicates that Apple has kept the medium‑term, low‑coupon note on its balance sheet and reports it consistently, reflecting a deliberate strategy of maintaining a stable, diversified debt portfolio with staggered maturities rather than refinancing or retiring the issue early.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the disclosure pattern and provides specific exhibit references (Exhibit 4.3, page numbers), which adds helpful detail beyond the ground truth. However, there are significant issues with factual accuracy:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific page numbers (55, 56, 56-58) that cannot be verified against the ground truth and may be inaccurate\n   - The ground truth references an \"Officer's Certificate dated May 3, 2013\" but the LLM simply calls it \"Officer's Certificate (Exhibit 4.3)\" without the date specification\n   - The LLM adds interpretive claims about \"medium-term, low-coupon note\" and \"staggered maturities\" that go beyond what the ground truth supports\n\n2. ENTITY/FACT ACCURACY:\n   - Both correctly identify the 2.40% Notes due 2023\n   - Both correctly identify the three-year period (2022, 2023, 2024)\n   - The LLM correctly identifies this as Exhibit 4.3\n\n3. MULTI-HOP REASONING:\n   - The LLM successfully synthesizes the three-year pattern\n   - The LLM correctly interprets the pattern as indicating a deliberate debt management strategy\n   - However, the LLM adds interpretive conclusions (\"medium-term,\" \"staggered maturities,\" \"rather than refinancing or retiring\") that exceed the ground truth's more conservative statement about \"stable and transparent debt disclosure strategy\"\n\n4. SEMANTIC EQUIVALENCE:\n   - The core finding is equivalent: consistent disclosure across three years\n   - Both conclude this reflects deliberate debt management\n   - The LLM's interpretation is more detailed but potentially speculative beyond what the filings directly show\n\n5. SPECIFIC CONCERNS:\n   - The page number citations (55, 56, 56-58) are specific claims that cannot be verified and may be hallucinated\n   - The claim about \"medium-term\" and \"staggered maturities\" adds interpretation not present in ground truth\n   - The phrase \"rather than refinancing or retiring the issue early\" makes an assumption not explicitly stated in the ground truth\n\nThe answer is substantially correct in its core finding but adds unverified specific details and interpretive claims that go beyond the ground truth's more measured assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 603,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap note grew from a $900 million holding at 12/31/2022 (2022 10‑K, page 74) to $944 million at 12/31/2023 (2023 10‑K, page 74) and then to $982 million at 12/31/2024 (2024 10‑K, page 70). The steady increase shows GE deliberately retained—and modestly expanded—its exposure to the AerCap debt instrument, reflecting a strategy of holding higher‑yielding financial assets rather than liquidating them.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 baseline figure. The LLM states GE's AerCap note holdings were $900 million at 12/31/2022, but the ground truth clearly indicates $976 million for 2022. This is a $76 million discrepancy (7.8% error) on the starting value, which is material. The 2023 ($944 million) and 2024 ($982 million) figures are correct. REASONING ERROR: Because of the incorrect 2022 baseline, the LLM's characterization of the trend is fundamentally wrong. The LLM describes a 'steady increase' from $900M → $944M → $982M, but the actual progression is a DECREASE from $976M to $944M (2022-2023), followed by an INCREASE to $982M (2023-2024). This is a fluctuation pattern, not steady growth. The ground truth explicitly notes this as 'fluctuation' with 'slight overall stability,' whereas the LLM incorrectly frames it as deliberate expansion. MULTI-HOP SYNTHESIS: The LLM failed to synthesize the complete picture. The ground truth mentions 'broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities,' providing important context about GE's overall investment strategy. The LLM's answer is narrowly focused only on the AerCap note without this contextual synthesis. INTERPRETATION: The LLM's conclusion that GE 'deliberately retained—and modestly expanded—its exposure' is contradicted by the actual data showing a net decrease from 2022 to 2023. The characterization of strategy is speculative and not supported by the corrected numbers. The answer demonstrates partial understanding of the question's intent but fails on fundamental factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 464,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path framework ties the “return‑seeking” portion of the U.S. qualified plan to the funded ratio and interest‑rate environment, cutting growth‑asset exposure and adding liability‑hedging assets as the plan becomes more fully funded【page_252】. In 2022 the target allocation was 15 % equity, 75 % fixed‑maturity and 10 % other assets (based on the 2021 funded status)【page_310】; by 2024 the target had shifted to 9 % equity, 80 % fixed‑maturity and 11 % other assets (based on the 2023 funded status)【page_252】, and the 2025 target remains at the same levels【page_184】. This progression shows a deliberate de‑risking strategy—gradually reducing equity exposure and increasing fixed‑income holdings as the plan’s funded status improves.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's glide path approach and de-risking strategy, with mostly accurate information. STRENGTHS: (1) Correctly identifies the core mechanism—glide path tied to funded ratio with progressive reduction in growth assets and increase in liability-hedging assets; (2) Provides specific target allocations for 2022 (15% equity, 75% fixed-maturity, 10% other) and 2024 (9% equity, 80% fixed-maturity, 11% other), showing clear de-risking progression; (3) Correctly notes that allocations are based on prior-year funded status (2022 based on 2021, 2024 based on 2023); (4) Accurately characterizes the strategy as deliberate de-risking aligned with liability-driven investing; (5) Good multi-hop synthesis connecting funded status changes to allocation shifts across years. MINOR ISSUES: (1) The statement that '2025 target remains at the same levels' as 2024 needs verification—the ground truth indicates 2025 target was determined by 2023 funded status but doesn't explicitly confirm the percentages remained identical; (2) The LLM provides specific percentages (15%, 75%, 10% for 2022 and 9%, 80%, 11% for 2024) which are more detailed than the ground truth answer, making verification difficult without access to source documents; however, these appear reasonable and consistent with the described de-risking trend; (3) The ground truth emphasizes the methodological consistency of the glide path approach across all three years, while the LLM focuses more on the specific allocation numbers. CALCULATION CHECK: The equity reduction from 15% to 9% (6 percentage point decrease) and fixed-maturity increase from 75% to 80% (5 percentage point increase) are consistent with de-risking. The answer correctly synthesizes information across 2022-2024 timeframe and explains the relationship between funded status and allocation decisions. Overall, the answer is substantively correct and well-reasoned, with the main uncertainty being whether the specific percentages cited can be verified from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 553,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept embedded processing at the heart of its strategy for three straight years – the 2022 MD&A states that its “great business model … is focused on analog and embedded processing products” (TXN 2022 10‑K p. 18), the 2023 filing repeats the same phrasing (TXN 2023 10‑K p. 18), and the 2024 filing again notes “our strategic focus is on analog and embedded processing products” (TXN 2024 10‑K p. 19). This continuity signals that the company treats embedded processing as a core, long‑term growth engine whose sales and margins are essential to generating the strong operating cash flow that fuels its long‑term free‑cash‑flow‑per‑share growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Texas Instruments' strategic evolution of embedded processing products from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022, 2023, 2024) and verifies consistency across all three years; (2) Accurately cites the core strategic messaging about 'analog and embedded processing products' being central to TI's business model; (3) Properly synthesizes the multi-hop reasoning that this consistency indicates embedded processing is a foundational pillar for long-term cash flow generation; (4) Correctly identifies the connection between embedded processing emphasis and free cash flow per share growth; (5) Page citations (p. 18, p. 18, p. 19) are appropriately specific and add credibility. MINOR GAPS: (1) The LLM answer does not explicitly mention the 'four sustainable competitive advantages' framework mentioned in the ground truth, which provides additional context about how embedded processing fits into TI's competitive positioning; (2) The ground truth includes the specific quote about embedded processing providing 'more opportunity per customer and more value for our investments' from 2023, which the LLM answer omits; (3) The ground truth mentions 'supply chain control, customer reach, and diversified returns' as specific benefits enabled by embedded processing in 2024, which adds nuance not captured in the LLM response. QUANTITATIVE ACCURACY: No numerical errors detected. The three-year timeline is correct, and the page references appear reasonable. QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly identifies that multi-year consistency signals strategic importance rather than tactical shifts. The connection to operating cash flow and free cash flow per share is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential message of the ground truth - that embedded processing is a consistent, foundational strategic priority - though with somewhat less granular detail about the specific competitive advantages and value propositions mentioned in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 577,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "Lowe’s intellectual‑property focus began in FY 2022 with a core effort to register and protect its own service mark and the private‑brand names Kobalt, STAINMASTER and allen+roth (including related domain names and patents) 【page_9】. In FY 2023 the company retained that same trademark portfolio and emphasized the private brands as high‑value, value‑oriented products within its overall assortment. By FY 2024 the IP strategy still protected the same private‑brand portfolio but was explicitly linked to Lowe’s omnichannel and digital‑transformation agenda, using the protected names to power online assortments, digital design and project‑management tools, and seamless cross‑channel experiences across stores, web and mobile 【page_7】【page_5】【page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three core private brands (Kobalt, STAINMASTER, allen+roth) across all three fiscal years (2022-2024); (2) Accurately captures the evolution of IP strategy from trademark/patent protection focus to digital transformation integration; (3) Properly synthesizes multi-hop information showing progression from basic brand protection to omnichannel/digital enablement; (4) Correctly notes the streamlining of brand portfolio emphasis (removal of RONA and Reno Depot references, though not explicitly stated); (5) Appropriately emphasizes digital transformation elements (online assortments, digital design tools, mobile checkout, cross-channel experiences) as new strategic additions by FY 2024. MINOR WEAKNESSES: (1) Does not explicitly mention the removal of 'RONA' and 'Reno Depot' from disclosures between FY 2022 and FY 2023, which the ground truth identifies as a notable shift in brand portfolio emphasis; (2) The answer could have been more explicit about the 'streamlining' or 'refocusing' language that characterized the FY 2023 transition; (3) While the digital transformation integration is well-captured, the answer doesn't explicitly frame this as 'new language' or 'introduction' of digital context in FY 2024 as clearly as the ground truth does. QUANTITATIVE ACCURACY: All fiscal years (2022, 2023, 2024) are correct; brand names are accurately listed; no numerical errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects brand portfolio evolution to digital strategy integration, demonstrating sound multi-hop reasoning. The progression narrative is logical and well-supported. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - both convey a shift from basic IP protection to digitally-enabled brand strategy, though the LLM answer is slightly less explicit about the intermediate streamlining step.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 544,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 10‑K has featured “client relationships and trust” as a core competitive method in every filing – it appears in the 2022 filing’s competition discussion (see page 4), is repeated in the 2023 filing (see page 3), and shows up again in the 2024 filing (see page 3), now explicitly linked to its hybrid‑cloud and AI platforms. This steady, multi‑year emphasis signals that IBM is positioning trust and deep client ties as a strategic pillar to differentiate its hybrid‑cloud and AI offerings and to drive growth in an increasingly competitive market.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that IBM emphasized client relationships and trust across 2022-2024 filings, and accurately notes the connection to hybrid cloud and AI platforms. The multi-year consistency observation is valid. Page references appear plausible (though not verified against actual filings). CRITICAL WEAKNESSES: (1) The LLM answer lacks the nuanced evolution described in the ground truth. It states trust was 'repeated' and 'shows up again' but fails to capture the substantive strategic progression from 2022→2023→2024. (2) Missing key contextual details: The ground truth explicitly mentions the 2023 expansion linking trust to strategic partnerships with AWS, Microsoft, and SAP - a crucial evolution the LLM completely omits. (3) Missing the 2024 addition of cybersecurity-focused partners like Palo Alto Networks, which the ground truth identifies as indicating 'growing emphasis on security as a key component of client trust.' (4) The LLM provides a surface-level observation ('steady, multi-year emphasis') rather than analyzing the actual strategic evolution across the three-year period. (5) The ground truth's insight about trust being 'increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem' is absent from the LLM response. The LLM answer is factually not wrong but significantly incomplete in addressing the 'evolution' and 'multi-year progression' aspects of the question. It reads as a basic observation rather than a sophisticated analysis of strategic positioning changes. The question specifically asks 'how did...evolve' and 'what does this progression indicate' - the LLM addresses the 'what' (trust emphasized) but largely fails on the 'how' (the evolution) and the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 486,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "In Gilead’s 2022 Form 10‑K (see pages 31‑35) the El Segundo, California site is not listed among the cell‑therapy manufacturing facilities, indicating it was not yet designated for commercial production. By the 2023 filing the company states that the El Segundo facility “is utilized for clinical and commercial manufacturing and processing of our cell therapy products” (2023 Form 10‑K, page 11), and the 2024 filing repeats the same language (2024 Form 10‑K, page 11), showing the site’s role expanded to include commercial manufacturing alongside its clinical work.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM claims that in 2022, the El Segundo facility was 'not yet designated for commercial production' and that its role 'expanded to include commercial manufacturing' by 2023. However, the ground truth explicitly states that in 2022, the facility was already 'described as being utilized for clinical and commercial manufacturing and processing of cell therapy products' - meaning it had dual responsibilities from 2022 onward. The LLM's narrative of expansion from 2022 to 2023 is incorrect; the ground truth indicates consistency and continuity across all three years (2022-2024) with no significant changes in responsibilities. The LLM correctly identifies that 2023 and 2024 filings contain identical language about the facility's role, but this observation is used to support an incorrect narrative about expansion rather than the correct narrative about consistency. The LLM also provides specific page references (pages 31-35 for 2022, page 11 for 2023 and 2024) which cannot be verified but appear to be fabricated details. The core multi-hop reasoning is flawed: the LLM failed to correctly synthesize the information across the three years, arriving at the opposite conclusion from the ground truth. The answer demonstrates a significant misunderstanding of the facility's evolution, presenting a false narrative of expansion when the ground truth shows stability and continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 410,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "Lowes’ only 4.550 % series was created in the Fifteenth Supplemental Indenture on April 5 2019 and is scheduled to mature on April 5 2049 (see Exhibit 4.16 on page 75). The 2022, 2023 and 2024 10‑K exhibit listings (pages 73‑74) contain no additional 4.550 % issuances or maturity extensions, showing that the same long‑dated, fixed‑rate note has been carried forward unchanged. This multi‑year consistency reflects a strategy of locking in low‑cost, long‑term financing and minimizing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key dates and numbers are correct - the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with maturity on April 5, 2049. The LLM correctly identifies that these notes appear consistently across 2022, 2023, and 2024 filings with no changes to issuance or maturity structure. ENTITY ACCURACY: Company name (Lowe's/Lowes) is correct, fiscal years (2022-2024) are correct, and the specific debt instrument is properly identified. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings to demonstrate consistency and draw appropriate conclusions about debt strategy. The reasoning that unchanged long-dated notes reflect a strategy of locking in low-cost, long-term financing and minimizing refinancing risk is sound and aligns with the ground truth's assessment of strategic emphasis on long-duration debt. COMPLETENESS: The answer addresses all parts of the question - the evolution (or lack thereof) from 2022-2024, the specific maturity structure, and what the pattern indicates about long-term debt strategy. MINOR DIFFERENCES: The LLM uses slightly different phrasing than the ground truth (e.g., 'locking in low-cost, long-term financing' vs. 'long-duration debt to finance long-term obligations') but conveys semantically equivalent information. The reference to specific exhibit pages (4.16 on page 75, pages 73-74) adds helpful specificity. No factual errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 443,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "The Scotchgard‑related exposure stayed modest – a $65 million total settlement (3M’s contribution described as “not material”) was disclosed in the 2022 filing and remained unchanged in the 2023 and 2024 reports, and the only other liability cited was an immaterial amount from a Michigan settlement. The steady, limited cost shows that, while PFAS litigation overall is a multi‑billion‑dollar issue for 3M, the specific Scotchgard claims have had only a minor, stable financial impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every dimension. (1) FACTUAL ERRORS: The LLM claims Scotchgard exposure 'stayed modest' and 'remained unchanged' across 2022-2024, directly contradicting the ground truth which documents significant expansion of litigation. The ground truth explicitly states: 2022 had a $65M settlement; 2023 saw expansion to ~68 AFFF suits outside MDL plus additional PFAS suits in Illinois and Canada; 2024 saw further expansion into Alabama and Georgia with multiple new lawsuits and trial dates set for 2026. The LLM's characterization of 'steady, limited cost' is factually wrong. (2) QUANTITATIVE ACCURACY: While the LLM correctly identifies the $65M settlement amount, it fundamentally misrepresents the trend by claiming this amount 'remained unchanged' and was the 'only' liability. The ground truth reveals multiple settlements and expanding litigation across different jurisdictions. The LLM fails to capture the escalating nature of the litigation. (3) MULTI-HOP REASONING FAILURE: The question explicitly asks about evolution 'from 2022 through 2024' and what the 'trend reveals.' The LLM completely fails this multi-hop synthesis by claiming no evolution occurred, when the ground truth documents clear progression: 2022 (consolidated Michigan case) → 2023 (68 AFFF suits, Illinois, Canada) → 2024 (Alabama, Georgia, multiple utilities/property owners). (4) SEMANTIC MISALIGNMENT: The ground truth's conclusion that 'liabilities and legal costs...are escalating over time' is directly opposite to the LLM's claim of 'minor, stable financial impact.' The LLM misses the core insight about growing geographic spread and case complexity. (5) MISSING CONTEXT: The LLM ignores the expansion to new jurisdictions (Alabama, Georgia), new plaintiff categories (municipal water utilities, property owners, carpet manufacturers), and future trial dates (2026), all of which are critical to understanding the trend. The answer demonstrates a fundamental misreading of the source material and fails to address the core question about how exposure evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 570,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "In 2022 Gilead’s Foster City campus was described as the corporate headquarters that “house our administrative, manufacturing and R&D activities” (2022 p. 32). By the end of 2023 the filing already limited the site’s role to “process chemistry research, analytical method development and formulation and device development activities, and manufacture API and drug product for our clinical trials” (2024 p. 11), and the 2024 filing repeats that same focus for the end‑of‑2024 period (2024 p. 10). This evolution shows the Foster City facility shifting from a broad administrative/manufacturing hub to a specialized early‑stage R&D and clinical‑trial manufacturing center, aligning with a global strategy that concentrates discovery work locally while relying on other worldwide sites for large‑scale commercial production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about Gilead Sciences' Foster City facility evolution from 2022-2024. STRENGTHS: (1) All factual information is correct - the 2022 description of Foster City as corporate headquarters with administrative, manufacturing, and R&D activities is accurately cited; the 2023-2024 shift to process chemistry research, analytical method development, formulation, device development, and clinical manufacturing is correctly identified. (2) Page citations are provided (2022 p. 32, 2024 p. 11, 2024 p. 10) which adds credibility and specificity. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the strategic shift from broad hub to specialized early-stage R&D and clinical manufacturing center. (4) The answer properly contextualizes this within global operations, noting that other sites handle commercial-scale production. (5) Quantitative accuracy is perfect - all dates (2022, 2023, 2024) and facility descriptions are precise. (6) The semantic equivalence with the ground truth is strong - both answers convey the same core narrative of functional specialization and strategic consolidation. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential elements. The phrasing 'discovery work locally' in the LLM answer is a reasonable interpretation of the ground truth's 'early-stage development' focus. The answer successfully addresses all three sub-components of the question: R&D focus evolution, manufacturing responsibilities shift, and strategic alignment with global operations. No calculation errors, no factual inaccuracies, and no entity confusion detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 486,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "In 2022 AIG relied on internal controls, a formal “review‑and‑challenge” and escalation process, and external expert reviews to oversee loss‑reserve adequacy, using both stochastic and deterministic modeling and a model‑risk validation framework [2022 p. 165‑167]. By 2023 the firm added a structured second‑line review by ERM and regular internal‑audit testing of pricing and reserving models, and the 2024 filing emphasizes that same ERM second‑line challenge and internal‑audit monitoring as part of a comprehensive model‑risk management approach that continues to incorporate external expert validation [2023 p. 119, 86; 2024 p. 86].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years (2022-2024). STRENGTHS: (1) Correctly identifies the core evolution of AIG's loss reserves risk management from 2022 through 2024; (2) Accurately captures key mechanisms: internal controls, review-and-challenge processes, external expert reviews, stochastic/deterministic modeling, ERM second-line review, and internal audit testing; (3) Properly sequences the progression showing 2022 baseline, 2023 expansion with ERM and audit components, and 2024 integration into comprehensive framework; (4) Page citations (2022 p. 165-167, 2023 p. 119/86, 2024 p. 86) appear appropriately specific and support the narrative; (5) Correctly identifies all entities and years. MINOR WEAKNESSES: (1) The LLM answer is more granular and specific (mentioning 'pricing and reserving models,' 'model-risk validation framework,' 'model-risk management approach') compared to the ground truth's broader characterization of 'sensitivity and scenario analyses' and 'experience studies' - however, these are not contradictory, just different levels of specificity; (2) The ground truth emphasizes the conceptual shift from 'reactive oversight to proactive, model-driven, and enterprise-wide risk governance,' while the LLM answer focuses more on listing specific mechanisms rather than explicitly articulating this strategic evolution, though the mechanisms described do support this narrative; (3) The LLM answer doesn't explicitly mention 'sensitivity and scenario analyses' or 'experience studies' that appear in the ground truth's 2023 description, though it does reference 'stochastic and deterministic modeling' which captures similar quantitative approaches. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and filing documents, correctly showing how practices evolved and integrated over time. The connection between 2022 foundations, 2023 expansion, and 2024 integration is logically sound. QUANTITATIVE ACCURACY: No numerical errors detected; dates and years are correct. The answer appropriately avoids making unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 589,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia site appears in all three filings – 2022 (listed as “Melaka, Malaysia †” with an X only under Analog)【page_18】, 2023 (“Melaka, Malaysia *” with an X only under Analog)【page_16】 and 2024 (“Melaka, Malaysia **” with an X only under Analog)【page_16】. The designation never expands to Embedded Processing, indicating that over the 2022‑2024 period TI has kept Melaka as an analog‑focused manufacturing location and has not added embedded‑processing capacity there.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) All factual claims are correct - Melaka, Malaysia appears in all three years (2022, 2023, 2024) with consistent Analog-only designation; (2) Numeric/date accuracy is perfect - correctly identifies all three years and accurately notes the absence of Embedded Processing designation across all periods; (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three separate filings to establish the 3-year progression pattern; (4) Entity identification is correct - properly identifies Texas Instruments (TXN), Melaka Malaysia location, and the two product categories (Analog vs. Embedded Processing); (5) Reasoning is logical - correctly concludes that the consistent Analog-only designation indicates a stable, specialized manufacturing focus without expansion into Embedded Processing. The answer directly addresses both parts of the question: the evolution (showing consistency/stability) and what it indicates about manufacturing focus (Analog-exclusive, no EP expansion). Minor note: The LLM includes specific page references and footnote markers (†, *, **) which add credibility and precision to the answer, though these weren't explicitly required. The conclusion that Melaka maintains a \"stable but specialized role\" is well-supported by the evidence presented. No calculation errors, no missing information, and the semantic meaning perfectly matches the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 409,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s forward‑rate‑swap hedge was large in FY 2022 – the company reported a $2.56 billion notional amount of forward interest‑rate swaps used as cash‑flow hedges for forecasted debt issuances【page_62】. In FY 2023 the swaps were still on the books (fair‑value $251 million) as a hedge of anticipated borrowings【page_54】, but by FY 2024 the forward‑swap line showed a “‑” (zero) fair‑value, indicating the positions had been settled or unwound【page_54】. This pattern shows Lowe’s employed forward swaps as a temporary hedge to lock in rates for planned debt and then removed the hedge once the debt was issued or the need disappeared【page_46】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the key progression of Lowe's forward interest rate swap strategy across FY2022-2024. STRENGTHS: (1) Correctly identifies the $2.56 billion notional amount for FY2022 forward swaps, (2) Accurately cites the $251 million fair value for FY2023, (3) Correctly notes that FY2024 shows zero/dash indicating positions were unwound, (4) Properly synthesizes the strategic shift from hedging forecasted debt issuances to managing existing debt, (5) Provides appropriate page citations, (6) Correctly interprets the progression as a temporary hedge strategy. WEAKNESSES: (1) The LLM answer introduces the $2.56 billion notional amount which, while factually correct, is not explicitly mentioned in the ground truth answer - this represents additional detail rather than error, (2) The ground truth emphasizes a shift to 'fixed-to-floating interest rate swaps as fair value hedges on existing debt' in FY2024, which the LLM answer does not explicitly mention, (3) The ground truth provides more nuanced context about the company's prior use of these instruments (2019-2021 periods), which the LLM answer omits. QUANTITATIVE VERIFICATION: The $2.56 billion notional and $251 million fair value figures appear consistent with SEC filing data. The interpretation of the dash/zero in FY2024 as settlement/unwinding is reasonable and consistent with the ground truth's statement that 'the company no longer held forward interest rate swaps.' MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years and correctly identifies the strategic shift in hedging approach. The reasoning is sound and logically connects the data points to draw appropriate conclusions about risk management strategy evolution. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'temporary hedge to lock in rates for planned debt' is semantically equivalent to the ground truth's 'strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt.' Overall, the answer is substantially correct with minor omissions regarding the FY2024 shift to fixed-to-floating swaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 595,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 2022 Form 10‑K listed the 6.50 % Debentures due 2028 as “Exhibit 2 to Form 8‑K, filed on January 8, 1998”【page_30】. The 2023 filing repeats the identical language【page_19】, and the 2024 filing does so again【page_19】. The unchanged reference to the 1998 filing shows that IBM has relied on the original indenture for this issue throughout, indicating a stable, long‑term debt structure whose documentation has remained static since its issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All numeric values are correct - the 6.50% interest rate, the 2028 maturity date, and the January 8, 1998 filing date are all accurate. (2) The multi-hop synthesis is sound - the answer correctly traces the same debenture disclosure across three separate years (2022, 2023, 2024) and identifies the consistent reference to the same Form 8-K exhibit. (3) Entity identification is precise - IBM is correctly identified, the specific debt instrument is properly named, and the filing types (Form 10-K, Form 8-K) are accurate. (4) The reasoning about what consistency reveals is logical and matches the ground truth interpretation: unchanged documentation indicates a stable, long-standing debt structure with no material amendments. (5) The answer directly addresses both parts of the question: how the disclosure evolved (it remained consistent) and what this consistency reveals (stable structure, unchanged documentation since 1998). MINOR CONSIDERATIONS: The page number citations (page_30, page_19, page_19) are included but cannot be verified against the ground truth provided, though they appear reasonable for a multi-year filing comparison. The semantic meaning is fully equivalent to the ground truth - both convey that IBM consistently referenced the same 1998 filing across all three years, demonstrating stability and no material changes to the debt instrument's documentation. The language is clear and professional, appropriately addressing the technical nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 429,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "The 2022 filing (MMM 10‑K 2022 p. 130) does not list Reflective signage among the Transportation and Electronics product bullets, the 2023 filing (MMM 10‑K 2023 p. 107) adds it as the final item in that list, and the 2024 filing (MMM 10‑K 2024 p. 110) moves it up, placing it after the premium large‑format graphic films and before the light‑management films. This shift—from omission to inclusion at the end, then to a higher‑profile slot—indicates that Reflective signage is being given increasing strategic emphasis within MMM’s Transportation and Electronics portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all three years examined. (1) CRITICAL ERRORS: The LLM claims Reflective Signage was NOT listed in the 2022 filing, but the ground truth explicitly states it was listed fifth. The LLM claims it was added as the 'final item' in 2023, but ground truth shows it was fourth. The LLM claims it moved to a position 'after premium large-format graphic films and before light-management films' in 2024, but ground truth indicates it was fourth after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' (2) POSITIONAL ACCURACY: Ground truth provides specific ordinal positions (5th in 2022, 4th in 2023, 4th in 2024), while LLM provides incorrect positions and claims omission in 2022. The LLM's description of 2024 positioning is partially correct in relative ordering but misses the 'sound and temperature management' item that comes before it. (3) MULTI-HOP REASONING: The LLM attempts to synthesize a narrative of 'increasing strategic emphasis' based on a false premise of omission-to-inclusion progression. The ground truth narrative is different: consistent presence with a slight positional boost in 2023 that was maintained in 2024. (4) SEMANTIC MEANING: While the LLM correctly identifies that positioning changes suggest strategic importance, the underlying factual basis is wrong. The conclusion about 'increasing emphasis' contradicts the ground truth's more nuanced assessment of 'consistent placement in top half with slight early boost.' The answer demonstrates poor document verification and contains multiple verifiable factual errors regarding specific positions and presence/absence of Reflective Signage across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 487,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "In Gilead’s 2022 Form 10‑K the Hoofddorp, Netherlands site was simply listed among its “principal manufacturing facilities” with no detail on what it produced【page_33】. By the 2023 filing the company clarified that the Hoofddorp plant is now used for “commercial manufacturing and processing of our cell‑therapy products”【page_11】—a clear elevation of its role to support market‑ready cell‑therapy sales. The 2024 filing repeats this description, confirming that Hoofddorp remains a key commercial‑manufacturing hub for Gilead’s cell‑therapy portfolio【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and accurately characterizes the facility's evolution from general 'principal manufacturing facility' to dedicated 'commercial manufacturing and processing of cell-therapy products.' (2) Properly synthesizes the multi-hop information showing progression across three fiscal years with appropriate citations to specific pages. (3) Accurately captures the strategic importance narrative - from unspecified role to explicit cell therapy focus to confirmed key hub status. (4) Uses semantically equivalent language ('elevation of its role,' 'key commercial-manufacturing hub') that conveys the same meaning as the ground truth's 'growing strategic importance' and 'dedicated hub.' (5) No quantitative errors - all dates and entity references are correct. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase about 'long-term growth needs in advanced therapies,' but this is a minor contextual detail rather than a factual error. (2) The phrase 'clear elevation of its role' is interpretive language not explicitly in the ground truth, but it accurately reflects the documented progression. (3) Page citations (33, 11, 12) are provided but cannot be independently verified against the ground truth statement. The answer successfully demonstrates multi-hop reasoning by connecting information across three separate 10-K filings to show a clear strategic evolution. The semantic meaning is preserved throughout, and all factual claims are supported by the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 462,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The 2003 Director Compensation Plan shows no remaining shares for future issuance in the 2022 filing and that balance stays at zero in the later years – the equity‑compensation tables only break out the shares left under the 2009 LTIP, the 2018 Director Plan (and, in 2024, the 2024 LTIP) and do not list any for the 2003 plan, implying a zero balance【page_61†L1-L9】【page_59†L1-L9】. This indicates Texas Instruments has fully exhausted the 2003 plan and now relies on newer director‑compensation plans for awarding equity.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) QUANTITATIVE ERRORS: The LLM claims zero shares were available in 2022 and remained at zero in later years. The ground truth explicitly states 1,843,134 shares in 2022, 1,786,785 in 2023, and 1,745,284 in 2024. These are specific, verifiable numbers that the LLM completely misrepresented. (2) FACTUAL CONTRADICTION: The LLM states the 2003 plan has been 'fully exhausted' with zero balance, while the ground truth shows a declining but non-zero balance across all three years (2022-2024). This is a direct contradiction of documented facts. (3) REASONING FAILURE: The LLM's multi-hop reasoning is flawed. It appears to have confused the absence of the 2003 plan from certain equity compensation tables with the absence of available shares. The ground truth clearly demonstrates the plan remained active with shares available for issuance throughout the period. (4) INTERPRETATION ERROR: The LLM incorrectly concluded that non-listing in certain tables means zero balance, when the ground truth shows the plan was actively used with declining share availability each year. (5) TREND ANALYSIS: The ground truth identifies a clear declining trend (1,843,134 → 1,786,785 → 1,745,284), indicating active utilization. The LLM's claim of zero balance throughout contradicts this entirely. The LLM answer fails on all primary evaluation criteria: it provides wrong numbers, misinterprets the data, and reaches an incorrect conclusion about the plan's status and usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 430,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.950 % Notes due 2025 are not called out in the securities‑registration list (the Table of Contents shown on page 28 contains no such entry), indicating only implicit disclosure. By the 2023 filing the company disclosed the notes solely through incorporation by reference to the instrument that defines holders’ rights – “Exhibits 4.1 and 4.2 to Form 8‑K, filed May 22 2017” (page 20). In the 2024 filing the notes are listed explicitly in the Section 12(b) register with ticker IBM25B and NYSE exchange designation (page 1), showing a move toward greater market transparency. This shift suggests IBM is deliberately making its debt securities more visible and accessible, a capital‑market strategy aimed at enhancing liquidity and deepening investor engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across three years of IBM filings. STRENGTHS: (1) All numeric/date references are correct - 0.950% interest rate, May 22, 2017 Form 8-K filing date, ticker IBM25B, NYSE designation all verified. (2) The three-year progression is accurately captured: 2022 (implicit disclosure via incorporation by reference), 2023 (continued reference to May 2017 filing), 2024 (explicit Section 12(b) registration with ticker). (3) Multi-hop reasoning is sound - the answer correctly synthesizes information across three separate 10-K filings and identifies the evolution pattern. (4) The strategic interpretation (shift toward transparency, liquidity enhancement, investor engagement) aligns with the ground truth's conclusion about 'greater transparency and investor accessibility.' (5) Page references (page 28, page 20, page 1) add specificity and credibility. MINOR CONSIDERATIONS: The LLM answer provides slightly more detailed context about the disclosure mechanism (Section 12(b) register, incorporation by reference) compared to the ground truth, which is additive rather than contradictory. The semantic meaning is equivalent - both answers convey the same progression from implicit to explicit disclosure and the strategic intent behind it. The LLM's characterization of 'deliberately making debt securities more visible' and 'enhancing liquidity' represents sound financial reasoning consistent with standard capital markets practice. No calculation errors, no factual inaccuracies, and the answer fully addresses all components of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 449,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance exposure expanded sharply after 2022. The 2022 filing disclosed only modest balances – about $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (the last disclosed amounts for 2021‑2020) 【page_216】; by the 2023 filing those balances had risen to roughly $5.1 billion of deposit assets and $1.3 billion of deposit liabilities, and they settled at $4.6 billion and $1.2 billion respectively at year‑end 2024 【page_206】. The November 2023 Global Atlantic transaction added $10.3 billion of deposit receivables (and a $770 million net‑cost liability) and moved the deposit method from a small closed‑block arrangement to a large in‑force block of universal‑life, variable‑universal‑life and annuity contracts, marking a strategic shift in how MetLife applies deposit‑accounting for reinsurance 【page_206】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across MetLife's 2022-2024 filings. QUANTITATIVE VERIFICATION: All key numbers match the ground truth exactly: 2022 deposit assets ($1.8B) and liabilities ($1.4B); 2023 deposit assets ($5.1B) and liabilities ($1.3B); 2024 deposit assets ($4.6B) and liabilities ($1.2B); Global Atlantic transaction deposit receivables ($10.3B). The $770 million net-cost liability mentioned in the LLM answer is an additional detail not in the ground truth but appears to be accurate supplementary information. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the strategic shift represented by the 2023 Global Atlantic transaction, showing how the deposit method evolved from a 'small closed-block arrangement' to 'a large in-force block of universal-life, variable-universal-life and annuity contracts.' This demonstrates proper understanding of the transaction's significance. COMPLETENESS: The answer addresses all parts of the question: (1) evolution from 2022-2024 with specific numbers, (2) deposit assets and liabilities trends, and (3) the 2023 Global Atlantic transaction as a strategic shift. MINOR OBSERVATIONS: The LLM includes parenthetical references to page numbers (page_216, page_206) which adds credibility but weren't in the ground truth. The characterization of 2022 balances as 'the last disclosed amounts for 2021-2020' is slightly ambiguous wording but doesn't affect accuracy. The semantic framing of the strategic shift is well-articulated and matches the ground truth intent. No calculation errors detected. All entity identifications (MetLife, Global Atlantic, deposit method accounting) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 482,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "In the 2022 filing (as shown in the 2023 10‑K) the Safety and Industrial segment’s product list already included “Respiratory, hearing, eye and **fall protection solutions**” 【page_107】. The 2024 10‑K still lists the same line for the Safety and Industrial segment 【page_110】, indicating that the fall‑protection offering has been retained without major change over the three‑year span. This steady presence underscores 3M’s continued emphasis on workplace‑safety solutions within its Safety and Industrial portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that fall protection solutions were included in MMM's Safety and Industrial segment across the 2022-2024 period and that the product offering remained consistent. However, there are significant gaps in completeness and analytical depth compared to the ground truth. STRENGTHS: (1) Correctly identifies the product line 'Respiratory, hearing, eye and fall protection solutions' as consistent across the period; (2) Appropriately cites page references (107, 110) showing multi-hop synthesis across filings; (3) Correctly concludes that fall protection remained a core component without major changes. WEAKNESSES: (1) The answer is notably brief and lacks the detailed year-by-year progression analysis that the ground truth provides (2022 listing, 2023 consistency check, 2024 evolution); (2) Fails to address the 2023 filing explicitly, only referencing 2022 (via 2023 10-K) and 2024, thus missing one year of the 3-year span; (3) Does not discuss the 'phrasing evolution' or 'more concise presentation' mentioned in ground truth for 2024; (4) The analysis is superficial - it states consistency but doesn't fully explore what this consistency indicates about strategic focus beyond a general statement about 'continued emphasis'; (5) Missing the nuanced observation about 'integrated safety solutions' as a strategic positioning. The answer demonstrates partial understanding of the multi-hop requirement but lacks the comprehensive synthesis across all three years that the question specifically asks for. The reasoning is sound but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 434,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria’s 10‑K filings show that UST LLC has remained a **wholly‑owned subsidiary** throughout the period. In 2022 the company noted that the MST and snus trademarks acquired with UST form a core part of its indefinite‑life intangibles (see 2022 p. 66‑67), in 2023 UST (through its wholly‑owned operating company USSTC) was again listed among Altria’s wholly‑owned subsidiaries (2023 p. 60), and by 2024 UST/USSTC was explicitly placed in the **oral‑tobacco segment** as the leading producer of moist‑smokeless tobacco products (2024 p. 4‑5). This continuity of ownership and the increasingly prominent positioning of UST within the oral‑tobacco segment reveal that Altria is deliberately using its fully‑controlled UST platform to anchor its strategic shift toward a smoke‑free future and to maintain market leadership in the smokeless‑tobacco space.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies UST as wholly-owned subsidiary throughout period; (2) Accurately references the $8.8 billion trademark valuation (mentioned in ground truth for 2022); (3) Properly identifies USSTC as UST's operating company; (4) Correctly notes the oral-tobacco segment positioning by 2024; (5) Accurately describes MST and snus products; (6) Sound multi-hop reasoning connecting ownership structure to strategic positioning. MINOR WEAKNESSES: (1) The LLM answer provides slightly less explicit detail about the 'Moving Beyond Smoking' initiative mentioned in ground truth, though it does reference 'smoke-free future' which conveys similar strategic intent; (2) The answer emphasizes 'indefinite-life intangibles' language rather than the more direct 'amortization expenses' reference in ground truth, though both are technically accurate accounting descriptions; (3) The LLM answer is more detailed on segment classification (oral-tobacco segment, leading producer positioning) than ground truth, which adds value but represents a different emphasis. QUANTITATIVE VERIFICATION: The $8.8 billion trademark value is correctly referenced. No calculation errors detected. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years showing evolution from 2022 emphasis on trademarks/amortization → 2023 subsidiary structure → 2024 segment positioning. The logical connection between ownership continuity and strategic positioning is sound. SEMANTIC EQUIVALENCE: The answer conveys the same core message as ground truth about UST's strategic importance and Altria's positioning in smokeless tobacco, with slightly different framing that is complementary rather than contradictory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 496,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 10‑K exhibits for 2022‑2024 all list the “One Hundred‑and‑Sixteenth Supplemental Indenture … related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C92‑15” (see pages 102, 105 and 106). The fact that this 2015 bond is still disclosed each year shows that Tesla continues to carry the legacy SolarCity debt on its balance sheet, using long‑dated, fixed‑rate financing to support its solar‑energy projects and signaling a commitment to a multi‑year financing strategy for that business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates solid understanding of the multi-hop question. STRENGTHS: (1) Correctly identifies the specific bond instrument (SolarCity 5.45% Solar Bonds, Series 2015/C92-15) and the Supplemental Indenture reference across all three years (2022-2024). (2) Accurately notes the bond's continued disclosure in the 10-K filings. (3) Correctly interprets the significance: sustained reliance on structured solar financing and commitment to multi-year financing strategy. (4) Properly synthesizes information across three consecutive filings to draw conclusions about Tesla's long-term strategy. (5) Numbers and dates are accurate (2015 bond issuance, 5.45% rate, three consecutive years 2022-2024). MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth and omits some contextual detail about the August 24, 2015 Supplemental Indenture date specifically. (2) The ground truth emphasizes 'securitized solar debt as a core funding source' and 'confidence in the bond's performance' more explicitly, while the LLM answer focuses more on 'legacy SolarCity debt' and 'long-dated, fixed-rate financing.' (3) The LLM's characterization of this as 'legacy' debt could be interpreted as slightly less forward-looking than the ground truth's emphasis on 'sustained reliance' and 'strategic commitment.' However, both interpretations are reasonable and not contradictory. The LLM answer correctly addresses the core question about long-term financing strategy and provides accurate supporting evidence. The multi-hop reasoning (connecting repeated references across three years to strategic implications) is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 456,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K filings from 2022, 2023 and 2024 all contain the same disclosure that the value of its debt securities can be affected by “governmental and stock‑exchange regulations” and that its common‑stock price is highly volatile and subject to market forces (2022 p. 20‑24; 2023 p. 9‑13; 2024 p. 9‑13). The language does not change over the three years, showing that IBM treats stock‑exchange regulatory risk as a persistent external factor and manages it through continuous monitoring and transparent disclosure rather than altering its financing structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The LLM correctly identifies that IBM's 10-K filings from 2022-2024 all contain disclosures about stock exchange regulations affecting debt and equity securities; (2) The core assertion that language remained consistent across the three years aligns with the ground truth's observation of 'no material reduction in dependency or mitigation strategy'; (3) The identification of the risk as a 'persistent external factor' is semantically equivalent to the ground truth's characterization. PROBLEMATIC ASPECTS: (1) The LLM provides specific page numbers (2022 p. 20-24; 2023 p. 9-13; 2024 p. 9-13) that cannot be verified and may be inaccurate - this is a significant concern as it appears to cite specific evidence without confirmation; (2) The LLM's answer is significantly less nuanced than the ground truth regarding the EVOLUTION of IBM's approach - the ground truth explicitly notes that by 2024, IBM 'expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view' - the LLM misses this important evolution and instead claims the language 'does not change'; (3) The LLM's characterization of IBM's risk management strategy as 'continuous monitoring and transparent disclosure rather than altering its financing structure' goes beyond what the ground truth states and introduces an interpretation not supported by the provided evidence; (4) The LLM fails to capture the ground truth's key insight about the 'increasing recognition of regulatory dynamics as a persistent and systemic component' - instead treating it as static; (5) The answer does not adequately address the multi-hop synthesis required by the question, which asks about the evolution and what it reveals about capital market risk management strategy. The LLM provides a partially correct but incomplete and somewhat misleading assessment that understates the complexity of IBM's evolving regulatory risk disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 549,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across the three years the Safety & Industrial segment consistently listed “electrical products and materials for construction and maintenance” as a core offering – it appears in the segment‑product description for 2023 (​page 107​) and again for 2024 (​page 110​), and the 2022 filing likewise grouped electrical products under the same segment (​page 108​).  While net sales for that segment fell modestly from $11.6 billion in 2022 to about $11.0 billion in 2023‑24 (​page 108​, ​page 108​, ​page 111​), operating income rose sharply from $1.1 billion in 2022 to $2.3 billion in 2023 and $2.5 billion in 2024 (​page 108​, ​page 108​, ​page 111​).  This progression shows that 3M has been sharpening its focus on higher‑margin electrical‑product solutions for construction and maintenance, turning a declining sales base into stronger profitability and reinforcing its strategic positioning as a premium supplier in industrial markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides financial data and identifies electrical products as a consistent focus, but has significant issues: (1) QUANTITATIVE ERRORS: The LLM cites specific financial figures ($11.6B→$11.0B sales, $1.1B→$2.3B→$2.5B operating income) with page references, but these cannot be verified against the ground truth which does not provide these specific numbers. The ground truth focuses on product portfolio evolution, not financial metrics. The LLM appears to have fabricated or misattributed financial data. (2) INCOMPLETE PRODUCT PORTFOLIO ANALYSIS: The ground truth emphasizes the evolution of product descriptions across years - noting that 2022 included 'Closure systems for personal hygiene products, masking, and packaging materials', 2023 added 'Industrial abrasives and finishing' and 'Autobody repair solutions', and 2024 rephrased the segment description. The LLM completely misses this nuanced product portfolio evolution and the strategic shift from emphasizing closure/hygiene products to industrial abrasives and specialty products. (3) MISALIGNED FOCUS: The ground truth answer addresses HOW the focus evolved qualitatively (product mix changes, emphasis shifts), while the LLM pivots to financial performance metrics that weren't part of the original question's focus on strategic positioning through product evolution. (4) REASONING QUALITY: The LLM's conclusion about 'sharpening focus on higher-margin electrical-product solutions' is speculative and not supported by the ground truth, which indicates a broader portfolio evolution beyond just electrical products. The LLM conflates financial performance with strategic product positioning without establishing that connection from the source material. (5) MISSING CONTEXT: The ground truth's key insight - that MMM shifted from emphasizing closure/hygiene products (2022) to emphasizing industrial abrasives and specialty products (2024) while maintaining electrical offerings - is entirely absent from the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 539,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "The 2022 Form 10‑K (see pages 31‑35) contains no reference to the Oceanside, California site, so its role in biologics or retroviral‑vector production was not disclosed. By the 2023 filing, Gilead states that the Oceanside facility “is utilized … for commercial retroviral vector manufacturing and clinical manufacturing and process development of our biologics candidates” (Manufacturing Facilities list, page 11). The 2024 filing repeats the same description, confirming that the Oceanside plant now supports both commercial retroviral‑vector production and the clinical development/manufacturing of biologics, indicating an expanded and sustained capability since 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE/FACTUAL ERRORS: The LLM claims the 2022 Form 10-K contains 'no reference' to the Oceanside facility, but the ground truth explicitly states it was 'referenced as part of its broader operational footprint' in 2022. This is a direct contradiction. (2) TIMELINE MISCHARACTERIZATION: The LLM states that by 2023 the facility was 'utilized for commercial retroviral vector manufacturing,' but the ground truth indicates this commercial manufacturing role was only emphasized in 2024. The 2023 role was specifically 'clinical manufacturing and process development of biologics candidates' - not commercial retroviral vector manufacturing. (3) PROGRESSION NARRATIVE FAILURE: The ground truth describes a clear three-year progression: 2022 (general R&D) → 2023 (clinical manufacturing/process development) → 2024 (commercial retroviral vector manufacturing added). The LLM collapses this progression, incorrectly placing commercial retroviral vector manufacturing in 2023 and claiming it remained unchanged through 2024. (4) MISSING STRATEGIC CONTEXT: The LLM fails to capture the 'strategic shift from general R&D to a more specialized and scaled-up function' that is central to the ground truth answer. (5) CITATION ACCURACY: While the LLM provides specific page references, these appear to be used to support incorrect claims about what the filings actually state. The answer demonstrates a fundamental misunderstanding of the facility's evolving role across the three-year period, particularly regarding when commercial retroviral vector manufacturing capabilities were introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 461,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "In 2022 the glide‑path set the Return‑Seeking (equity) allocation for the U.S. qualified plan at 15 % of assets (Target 2022)【page_310】. By 2024 the target for that growth‑asset portion had been lowered to 9 % (Target 2024)【page_252】. The 2023 filing does not disclose a specific target, but the plan’s actual equity weight was 8 % in 2023, indicating the glide‑path continued to shift toward a lower growth‑asset exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific target allocation percentages (15% for 2022, 9% for 2024) and actual equity weights (8% in 2023), which are concrete and verifiable claims. However, there are significant issues with the response: (1) The ground truth emphasizes that the glide path approach evolved in HOW targets were set (based on funded status at different year-ends, with forward-looking adjustments), not primarily in the specific percentage allocations themselves. The LLM answer focuses on the numerical changes (15% → 9%) but misses the methodological evolution described in the ground truth. (2) The LLM answer states '2023 filing does not disclose a specific target' but the ground truth indicates that 2023 had a target allocation set for 2024 based on December 31, 2023 funded status - this is a potential misinterpretation. (3) The LLM answer correctly identifies the downward trend in Return-Seeking allocations but frames this as the primary evolution, whereas the ground truth emphasizes the dynamic, forward-looking adjustment mechanism as the key evolution. (4) The specific percentages (15%, 9%, 8%) cannot be verified against the ground truth provided, which does not include these specific numbers. (5) The answer partially addresses the question by showing numerical evolution but fails to capture the methodological/strategic evolution that the ground truth emphasizes. The response is partially correct in identifying a glide path evolution but incomplete in explaining the nature of that evolution as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 428,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "In fiscal 2023 ACN’s pension‑plan targets were 100 % debt for U.S. plans and, for non‑U.S. plans, 48 % debt, 27 % equity, 4 % cash, 11 % insurance contracts and 10 % other (see page 88). By fiscal 2025 the U.S. target remained 100 % debt, but the non‑U.S. mix moved to 36 % debt, 28 % equity, 7 % cash, 21 % insurance contracts and 8 % other (see page 95). This gradual reduction in debt exposure and added weight to insurance and cash – with a modest equity increase – shows ACN is diversifying its pension assets and accepting a slightly higher market‑risk profile while still emphasizing safety, indicating a balanced but modestly more risk‑tolerant long‑term investment stance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical allocations for fiscal 2023 and fiscal 2025, but this approach fundamentally misaligns with the ground truth answer. The ground truth explicitly states that ACN's strategy involved setting target allocations for the FOLLOWING year (fiscal 2023 targets were for fiscal 2024, and fiscal 2024 targets were for fiscal 2025), emphasizing flexibility based on market conditions and cash flow needs. The LLM instead presents what appear to be actual allocations for fiscal 2023 and fiscal 2025 themselves, missing the key insight about forward-looking planning horizons. The ground truth's core finding—that the planning horizon extended from one year to two years, indicating increased confidence and a more strategic stance—is completely absent from the LLM answer. While the LLM does attempt to characterize the shift as showing 'diversifying pension assets and accepting a slightly higher market-risk profile,' this conclusion is based on comparing the wrong data points (actual allocations rather than target allocation strategies). The specific percentages cited (100% debt for U.S. plans in both years, the non-U.S. mix changes) cannot be verified against the ground truth, which does not provide these specific allocation percentages. The LLM's interpretation that debt exposure decreased and insurance/cash increased is presented as fact, but the ground truth emphasizes the strategic evolution of planning horizons and flexibility frameworks rather than specific allocation percentage changes. The answer addresses the question's surface-level request for allocation evolution but fails to capture the multi-hop reasoning about what the planning horizon extension reveals about risk tolerance and strategic confidence. The LLM provides page references (88, 95) suggesting source documentation, but without verification these cannot be confirmed as accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 514,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 2022, 2023 and 2024 Form 10‑K filings each list the same “Thirty‑Sixth Supplemental Indenture, dated April 14 2015, related to SolarCity’s 5.45 % Solar Bonds, Series 2015/C25‑15” (2022 Exhibit 4.36 【page_102】; 2023 Exhibit 4.27 【page_99】; 2024 Exhibit 4.29 【page_100】). The bond, originally issued in 2015, remains an outstanding, fixed‑rate obligation that is repeatedly referenced in successive years, indicating Tesla’s reliance on a stable, multi‑year bond program—augmented by supplemental indentures—to fund its solar‑energy projects rather than issuing new series each year.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond series name (5.45% Solar Bonds, Series 2015/C25-15) and its origin from SolarCity acquisition. (2) Correctly cites the specific exhibit numbers and page references for 2022, 2023, and 2024 filings (Exhibits 4.36, 4.27, 4.29 respectively). (3) Accurately notes the April 14, 2015 date of the Thirty-Sixth Supplemental Indenture. (4) Correctly identifies the bond as a fixed-rate obligation that remains outstanding across all three years. (5) Quantitative accuracy is strong on dates and exhibit citations.\n\nWEAKNESSES: (1) The LLM answer is significantly narrower in scope than the ground truth. While the ground truth discusses the evolution and expansion of Tesla's solar financing framework (mentioning Series 2015/C5-15, 2015/C10-15, 2015/C20-15 in 2022, and newer series like 2015/C28-15 and 2015/C33-15 by 2023), the LLM answer focuses almost exclusively on the single C25-15 series. (2) The LLM fails to address the multi-year pattern of EVOLUTION and EXPANSION that the question specifically asks about. The ground truth reveals a progression showing expansion of the financing framework, while the LLM characterizes it as a 'stable, multi-year bond program' without expansion. (3) The LLM does not synthesize information about how the bond structuring evolved or expanded across the three years—it only confirms the same bond appears in all three years. (4) Missing analysis of the broader solar financing strategy evolution that the ground truth captures through the introduction of newer bond series (C28-15, C33-15). (5) The LLM's conclusion that Tesla relies on 'a stable, multi-year bond program' rather than issuing new series contradicts the ground truth's indication of expansion with newer series introduced in 2023.\n\nMULTI-HOP REASONING: The LLM successfully performs basic multi-hop synthesis (connecting the bond across three years and to SolarCity), but fails at the more complex multi-hop task of synthesizing the broader evolution of Tesla's solar financing framework across multiple bond series and years. The question asks about 'evolution' and what the 'pattern reveals,' requiring synthesis of multiple bond series across years—the LLM only addresses one bond series.\n\nSEMANTIC ACCURACY: While the LLM's statements about the C25-15 bond are factually correct, they do not adequately address the question's core inquiry about how the issuance and structuring 'evolved' and what this reveals about strategy. The answer is partially correct but incomplete in addressing the full scope of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 685,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "In the 2022 filing AIG quantified its terrorism risk with a third‑party model that projected a five‑ton‑bomb scenario to cost about $1.3 billion net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and private reinsurance, noting that TRIPRA covered roughly 80 % of losses above a $1.7 billion deductible and that the company supplemented this with targeted reinsurance purchases and participation in country‑specific terrorism pools. By the 2023 and 2024 filings the same scenario‑based vendor model and concentration monitoring (especially in New York) remain in place, but the company no longer cites a specific loss figure; instead it emphasizes routine scenario modeling, continued reliance on TRIPRA for U.S. exposure, targeted reinsurance and government‑backed or pool arrangements for international jurisdictions, reflecting a steady‑state, globally coordinated terrorism‑risk mitigation framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's terrorism exposure management evolution with mostly accurate information, but has some notable gaps and one significant omission. STRENGTHS: (1) Correctly identifies the $1.3 billion five-ton bomb scenario estimate for 2022, net of TRIPRA and reinsurance; (2) Accurately notes the 80% TRIPRA coverage above $1.7 billion deductible; (3) Properly synthesizes the shift from specific loss quantification in 2022 to emphasis on scenario modeling and concentration monitoring in 2023-2024; (4) Correctly identifies the multi-hop elements: scenario-based modeling, TRIPRA reliance, targeted reinsurance, and government-backed pools across jurisdictions; (5) Appropriately characterizes the evolution as a 'steady-state, globally coordinated' framework. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically mentions AIG 'retained core attachment points for Japan at $200 million' in 2024 and 'enhanced its global property per risk covers' - the LLM answer completely omits these specific 2024 risk mitigation mechanisms and geographic specificity; (2) SIGNIFICANT OMISSION: The ground truth explicitly states 'reinsurance recoverable assets reached $38.0 billion by the end of 2024' as evidence of 'significant scaling of risk transfer mechanisms' - the LLM answer does not mention this quantitative indicator of reinsurance strategy evolution; (3) The LLM answer notes the company 'no longer cites a specific loss figure' in 2023-2024, which is accurate but represents a shift in disclosure rather than actual risk management evolution. QUANTITATIVE VERIFICATION: The $1.3 billion figure is correct; the 80% TRIPRA coverage and $1.7 billion deductible are correct; however, the missing $200 million Japan attachment point and $38.0 billion reinsurance recoverable assets represent incomplete quantitative coverage. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk management mechanisms (TRIPRA, reinsurance, pools), but fails to fully integrate the geographic specificity and asset scaling dimensions that demonstrate the evolution of reinsurance strategies. The answer captures the conceptual evolution but misses concrete 2024 enhancements that directly address the question's focus on 'risk mitigation mechanisms across global jurisdictions.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 630,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor language for the Safety and Productivity Solutions segment is unchanged from 2022 through 2024 – each filing warns that “adverse industry economic conditions” could hurt the segment, showing a persistent rather than a shifting exposure【HON_10k_2022.pdf page_31】【HON_10k_2023.pdf page_31】【HON_10k_2024.pdf page_31】. Across all three years the company repeatedly cites the same margin‑pressure drivers: reduced investment in process automation, safety monitoring and plant‑capacity initiatives; volatility in retail markets; a slowdown in safety‑product demand; competitive‑landscape changes and product commoditization; and broader adverse industry economic conditions, all of which could lower market share, force price cuts and compress margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported by evidence from the three 10-K filings (2022, 2023, 2024). STRENGTHS: (1) Correctly identifies the core finding that risk-factor language remained consistent across all three years, showing persistent rather than evolving exposure. (2) Accurately lists the specific margin-pressure drivers: reduced investment in process automation, retail market volatility, product commoditization, competitive landscape changes, and adverse industry economic conditions. (3) Properly cites all three years (2022-2024) and correctly references page 31 across filings. (4) Correctly synthesizes the multi-hop requirement by showing how the same risks were highlighted consistently across the three-year period. (5) Accurately notes the connection between these risks and outcomes (lower market share, price cuts, margin compression). MINOR WEAKNESSES: (1) The ground truth mentions 'restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions)' by 2024, suggesting a structural change in how the segment was reported. The LLM answer does not explicitly acknowledge this organizational restructuring, though it does note the segment name change implicitly. (2) The ground truth emphasizes the 'evolution' of exposure and notes that risks were 'reiterated' with 'additional mention' in 2023, suggesting some nuance in how risks were presented year-to-year. The LLM answer states the language was 'unchanged,' which may be slightly overstated - the ground truth suggests consistency with some evolution in emphasis. (3) The LLM answer could have been more explicit about the 2024 restructuring context. QUANTITATIVE ACCURACY: No numerical errors detected. All years and page references are correct. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across three years and identifies the persistent nature of the risks. The multi-hop synthesis is sound. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (how exposure evolved and what specific risks were highlighted), though the 'evolution' finding is that risks remained consistent rather than changed significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 587,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer still granted Breakthrough Performance Awards (BPAs) to select employees, valuing them at grant‑date with the intrinsic‑value method (based on the closing stock price) and expensing the awards on a straight‑line basis over the probable vesting term into cost of sales, SG&A and R&D【page_99†L1-L9】. The 2023 filing states that no BPAs were granted and none were outstanding at year‑end, although the footnote retains the same intrinsic‑value valuation and straight‑line amortization description for the award【page_97†L1-L4】【page_95†L1-L9】. The 2024 filing repeats this stance—no BPAs were granted or outstanding, with the valuation and recognition language unchanged but showing zero activity【page_97†L1-L4】【page_96†L1-L9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of BPA evolution but has significant gaps in quantitative specificity. STRENGTHS: (1) Correctly identifies that BPAs were granted in 2022 using intrinsic value method; (2) Accurately states no BPAs were granted in 2023 and 2024; (3) Correctly describes the valuation methodology (intrinsic value based on closing stock price, straight-line amortization); (4) Properly identifies the expense categories (cost of sales, SG&A, R&D); (5) Good synthesis of the three-year evolution showing active issuance → wind-down → zero activity. CRITICAL GAPS: (1) The LLM completely omits the specific quantitative data from 2022: 1,165 thousand BPAs granted and 859 thousand remaining nonvested at year-end, with weighted average intrinsic value of $38.73 per share. These are material facts that directly answer the 'grant activity' and 'valuation' aspects of the question; (2) The answer states valuation methodology was 'unchanged' across years but doesn't capture that 2024 provided a detailed focus on valuation mechanics while 2022-2023 had different contexts (active vs. wound-down); (3) Missing the explicit statement that the program was completely wound down by end of 2023 (zero outstanding awards). QUANTITATIVE ACCURACY: The answer provides no specific numbers, percentages, or dollar amounts from the filings, which is a major omission for a question explicitly asking about 'grant activity' and 'valuation methodology.' The ground truth provides concrete figures (1,165K granted, 859K nonvested, $38.73/share) that should have been included. QUALITATIVE ACCURACY: The reasoning about the three-year progression is sound and the methodology descriptions are accurate, but the answer lacks the depth needed to fully address how the treatment 'evolved.' CONTEXTUAL RELEVANCE: The answer appropriately addresses all three years and the key aspects (grant activity, valuation, financial statement recognition), though incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 532,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture’s buy‑back program grew from repurchasing about $4.1 billion of Class A shares (12.2 million shares) in fiscal 2022 to $4.5 billion in fiscal 2024, while the pool of unused authorization fell from roughly $3.13 billion at the end of FY22 to $2.69 billion at the end of FY24 (the board also raised the total repurchase ceiling to $6.69 billion in FY24)【page_94】【page_93】【page_40】【page_39】. The increasing buy‑backs and shrinking remaining authorization—paired with a fresh boost to the overall ceiling—signal an aggressive, ongoing capital‑return strategy that is using up existing capacity and expanding the program to sustain future repurchases.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Accenture's share repurchase evolution and capital return strategy, but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The remaining available authorization figures are accurate: $3.13 billion (FY22) and $2.69 billion (FY24) match the ground truth. (2) The new authorization of $4 billion and resulting total of $6.69 billion are correct. (3) The overall narrative about aggressive capital returns and using up existing capacity is sound. (4) The multi-hop synthesis across fiscal years is properly executed. CRITICAL ERRORS: (1) The LLM introduces specific repurchase amounts ($4.1 billion in FY22 and $4.5 billion in FY24) and share counts (12.2 million shares) that are NOT present in the ground truth answer. These appear to be fabricated or sourced from unreliable citations. The ground truth explicitly states the company 'spent part of this authorization' but does not provide these specific dollar amounts or share counts. (2) The LLM cites page numbers (page_94, page_93, page_40, page_39) but these citations cannot be verified against the ground truth provided. REASONING QUALITY: The qualitative analysis is sound—the LLM correctly interprets the trend as indicating an 'aggressive, ongoing capital-return strategy' and properly synthesizes the relationship between declining remaining authorization and increased total authority. However, the introduction of unverified quantitative data significantly compromises the answer's reliability. The answer would be stronger if it stuck to the verifiable figures from the ground truth rather than adding specific repurchase amounts that cannot be confirmed. MULTI-HOP SYNTHESIS: The answer correctly connects information across fiscal years (2022-2024) and relates repurchase activity to authorization levels, demonstrating proper multi-hop reasoning, but the unverified numbers create doubt about data integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 530,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer disclosed that Meridian had been sold on December 31 2021, treating its prior results as discontinued operations and recording a $167 million after‑tax loss and a $345 million pre‑tax legal charge related to the divestiture【page_115】. The 2023 Form 10‑K added that, after the sale, Pfizer and the buyer entered into interim transition‑service agreements (TSAs) and a three‑year Master Services Agreement (MSA) with a two‑year extension; the TSAs were completed by December 31 2023 and the amounts recorded under the TSAs and MSA in 2022‑2023 were immaterial to operations【page_73】. By the 2024 Form 10‑K Meridian is mentioned only as a defined term, with no further financial or operational discussion, indicating that the relationship has been reduced to a contractual wrap‑up and is no longer part of Pfizer’s strategic focus【page_2】【page_4】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with comprehensive multi-hop synthesis across 2022-2024 filings. STRENGTHS: (1) Correctly identifies the December 31, 2021 sale date; (2) Accurately reports the $167 million after-tax loss; (3) Properly synthesizes the progression from discontinued operations (2022) to divestiture completion to definitional reference only (2024); (4) Adds valuable detail about transition service agreements (TSAs) and Master Services Agreement (MSA) that the ground truth omits; (5) Correctly notes TSAs were completed by December 31, 2023; (6) Appropriately characterizes the relationship evolution from operational integration to strategic disengagement; (7) Correctly identifies Meridian Medical Technologies, Inc. as the formal entity name. MINOR ISSUES: (1) The LLM mentions a '$345 million pre-tax legal charge related to the divestiture' which is not mentioned in the ground truth answer. While this detail appears to come from the actual 10-K filings (as indicated by the page citations), it represents additional information beyond the ground truth scope rather than a contradiction. This could indicate either the ground truth was incomplete or the LLM added information not in the knowledge graph. (2) The ground truth states the sale was 'approximately $51 million in cash' but the LLM answer does not mention this figure - however, the LLM does not contradict it either. MULTI-HOP REASONING: Excellent synthesis across three years of filings, correctly tracking the relationship evolution and identifying the key transition points. The answer properly connects financial disclosures, operational agreements (TSAs/MSA), and strategic alignment across the time period. QUANTITATIVE VERIFICATION: The $167 million after-tax loss figure is correct; the December 31, 2021 date is correct; the December 31, 2023 TSA completion date is correct. The $345 million pre-tax charge cannot be verified against the ground truth but appears to be from actual filings. SEMANTIC EQUIVALENCE: The answer conveys the same core narrative as the ground truth while adding operational detail about transition agreements. The characterization of the relationship progression is accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 597,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- In the FY 2022 filing Accenture disclosed that the Amended 2010 Share Incentive Plan authorizes a **maximum of 127 million** Class A ordinary shares for awards【page_91】.  \n- By the FY 2024 filing the authorized ceiling had been increased to **141 million** shares【page_98】.  \n\nThe 14 million‑share expansion of the award pool shows that Accenture is deliberately enlarging its equity‑based compensation capacity, signaling a long‑term strategy to use share awards more broadly to attract, retain and align employees with shareholder interests.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numbers (127 million for FY2022 and 141 million for FY2024) and accurately calculates the 14 million share increase. The reasoning about Accenture's strategic intent regarding share-based compensation is sound and well-articulated. However, there is a significant incompleteness issue: the original answer explicitly addresses FY2023 data (141 million shares), which is a critical part of the three-year progression requested in the question. The LLM answer only provides FY2022 and FY2024 data, completely omitting FY2023. This is a material gap because the question specifically asks about the evolution 'from fiscal year 2022 through 2024,' which requires all three years. The original answer notes that the 141 million level was 'maintained' from 2023 into 2024, which is an important insight about the progression pattern that cannot be fully appreciated without the FY2023 data point. The LLM's qualitative analysis of strategic intent is appropriate and well-reasoned, but the failure to provide complete year-by-year data for a three-year progression question represents a significant omission in answering the multi-hop aspect of the question. The quantitative accuracy score is reduced due to this incompleteness rather than calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 363,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s 10‑K exhibits for 2022, 2023 and 2024 all contain the identical entry – “Seventieth Supplemental Indenture, dated June 16 2015, by and between SolarCity and the Trustee, related to SolarCity’s 4.70 % Solar Bonds, Series 2015/C52‑10” (2022 p. 101; 2023 p. 99; 2024 p. 99). The fact that the description and exhibit number never change indicates the bond series remains outstanding and that Tesla continues to be bound by its terms, underscoring an ongoing debt‑service obligation and a continued strategic focus on financing its solar business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the bond series (4.70% Solar Bonds, Series 2015/C52-10), the Seventieth Supplemental Indenture, and the consistent filing date of June 16, 2015. The core finding that the disclosure remained consistent across 2022, 2023, and 2024 is accurate. However, there are minor discrepancies: (1) The LLM states the exhibit numbers as consistent but doesn't specify them (2022: Exhibit 4.49, 2023: Exhibit 4.42, 2024: Exhibit 4.40 per ground truth), whereas the ground truth explicitly lists these changing exhibit numbers despite the same underlying document. This is a notable omission since the exhibit numbers actually do change year-to-year, even though the underlying document remains identical. (2) The LLM correctly identifies the document as relating to SolarCity and Tesla's solar business obligations. (3) The reasoning about ongoing debt-service obligations and strategic focus on solar financing is sound and aligns with the ground truth's interpretation. (4) The multi-hop synthesis across three years is correctly executed. The answer captures the essential insight that consistent re-disclosure indicates stable financial commitments, though it misses the specific detail about changing exhibit numbers while the underlying document remains the same. This is a minor but meaningful omission in a question specifically asking about how disclosures 'change or remain consistent.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 405,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "In 2022 Adobe’s free online self‑service learning was listed on www.training.adobe.com as part of a “comprehensive portfolio of learning and enablement services” (2022 10‑K p. 17) and also referenced on learning.adobe.com as a core component of its Digital Learning Services (2022 10‑K p. 18). By 2023 the portal was consolidated under learning.adobe.com and the description positioned the free catalog as a foundational element of Adobe Digital Learning Services, complementing fee‑based programs and custom learning services that accelerate solution adoption for customers and partners (2023 10‑K p. 17‑18). The 2024 filing keeps the same framing, highlighting the free self‑service options on learning.adobe.com as the entry point for product use while enterprise‑specific custom services and skills‑assessment tools drive deeper adoption and value realization (2024 10‑K p. 17‑18).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Adobe's free online self-service learning evolution across 2022-2024, with accurate identification of key platforms (www.training.adobe.com, learning.adobe.com) and their roles in Adobe's learning strategy. The answer correctly synthesizes multi-hop information showing the progression from 2022 through 2024, accurately capturing the positioning within broader learning services and the connection to customer adoption strategies.\n\nSTRENGTHS:\n1. Correctly identifies both www.training.adobe.com (2022) and learning.adobe.com (2023-2024) as the relevant platforms\n2. Accurately describes the evolution from separate portals to consolidation under learning.adobe.com\n3. Properly contextualizes free offerings as complementary to fee-based and custom learning programs\n4. Correctly identifies the strategic role in customer and partner adoption\n5. Appropriately cites page numbers from 10-K filings (though these cannot be independently verified)\n6. Captures the consistent strategic emphasis across all three years\n\nWEAKNESSES:\n1. The LLM provides specific page citations (p. 17, p. 18) that cannot be verified against the ground truth, which does not include page numbers. While the content appears consistent with ground truth, the specific page references introduce unverifiable details.\n2. Minor semantic differences: The LLM describes free options as \"entry point for product use\" while ground truth emphasizes \"assisting customer and partner teams in product adoption\" - these are related but slightly different framings\n3. The LLM adds detail about \"skills-assessment tools\" in 2024 that is not explicitly mentioned in the ground truth, though this may be accurate additional information from the filings\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three years and multiple documents, correctly identifying the evolution of platforms and positioning. The reasoning connecting free self-service learning to broader adoption strategies is sound and well-articulated.\n\nNUMERIC/FACTUAL VERIFICATION:\nNo specific numbers, percentages, or dollar amounts are provided in either the question or answer, so quantitative accuracy focuses on dates (2022, 2023, 2024 - all correct) and platform names (correctly identified).\n\nOVERALL ASSESSMENT:\nThe answer is substantially correct and well-reasoned, with strong multi-hop synthesis. The main limitation is the inclusion of unverifiable page citations and minor additions not explicitly in the ground truth. The core narrative about evolution and strategic positioning aligns well with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 704,
        "total_tokens": 2179
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path de‑risking rule gradually reduced the share of “return‑seeking” (growth) assets as the U.S. qualified plan became better funded. In the 2022 Form 10‑K the glide‑path set the target for the Return‑Seeking portion at **15 % equity, 75 % fixed‑maturity and 10 % other investments** (based on the funded status at 12/31/21)【page_310】. By the 2023 Form 10‑K, the target for 2024 (funded status at 12/31/23) had shifted to **9 % equity, 80 % fixed‑maturity and 11 % other investments**, reflecting a move away from growth assets toward liability‑hedging assets as the plan’s funded ratio improved【page_252】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIABLE SPECIFIC PERCENTAGES: The LLM provides very specific allocation percentages (15% equity, 75% fixed-maturity, 10% other for 2022; 9% equity, 80% fixed-maturity, 11% other for 2024) with page citations, but the ground truth explicitly states 'the specific percentages for the Return-Seeking portion are not listed in the provided excerpts.' This is a major factual error - the LLM appears to have fabricated or hallucinated these specific numbers. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from 2022 to 2024 (three years), but the LLM only provides data for 2022 and 2024, missing the 2023 intermediate year that the ground truth mentions. The ground truth references 2023 Form 10-K with target for 2024, but the LLM jumps from 2022 to 2024. (3) CALCULATION VERIFICATION: The percentages provided don't align with standard pension allocation frameworks and lack supporting documentation. The sums (15+75+10=100 and 9+80+11=100) are mathematically correct but the underlying numbers appear fabricated. (4) REASONING QUALITY: While the LLM correctly identifies the glide path de-risking mechanism and the directional shift toward liability-hedging assets, it does so by presenting unverified specific numbers rather than acknowledging the limitation stated in the ground truth. (5) SEMANTIC ALIGNMENT: The LLM's conceptual understanding of the glide path mechanism is sound, but the presentation of specific percentages as fact when they are not documented in the source material is a fundamental error that undermines credibility. The answer would have been stronger by acknowledging the lack of specific percentages while explaining the directional de-risking trend, as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 477,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that the share of raw‑material supply that is contractually secured for the Performance Materials and Technologies (PM&T) business has risen only modestly – from about 63 % of the supply base at year‑end 2021 (reported in the 2022 filing) to 64 % at year‑end 2023 (2023 filing) and, by the 2024 filing, the company says a “majority” of the raw‑material supply base for the related segment is now under contract 【page_33】【page_31】【page_31】. Nevertheless, each year’s filing continues to flag raw‑material price fluctuations, inflation and supplier‑capacity constraints as key operational risks, indicating that despite the slight increase in contract coverage, Honeywell’s PM&T segment remains vulnerable to commodity‑market volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims (63% in 2021, 64% in 2023, \"majority\" in 2024) that are NOT present in the ground truth answer. The ground truth makes no mention of contractual coverage percentages or specific numerical metrics about secured supply. This represents a critical factual error - the LLM appears to have fabricated or hallucinated specific data points with page citations that cannot be verified against the provided ground truth. The ground truth focuses on qualitative risk evolution: (1) 2022 - COVID-19 pandemic impacts and supply chain disruptions, (2) 2023 - chemical/refining/semiconductor utilization volatility, (3) 2024 - oil/natural gas price volatility effects. The LLM answer completely misses this temporal progression of risk framing and instead substitutes unverified contractual coverage percentages. While the LLM correctly identifies that the PM&T segment remains vulnerable to commodity volatility (matching the ground truth conclusion), the path to that conclusion is fundamentally different and unsupported. The LLM also fails to address the specific evolution of risk factors across the three years as described in the ground truth (pandemic impacts → utilization rates → energy price volatility). The citation format [page_33][page_31][page_31] suggests the LLM is attempting to provide source verification, but these specific metrics are not confirmed in the ground truth. This represents a significant failure in multi-hop reasoning accuracy and factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 420,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s mutual‑fund equity securities were $239.3 million at August 31 2022 (Level 1 $4,954 k + Level 2 $234,339 k)【page_89】, fell to $196.2 million in 2023 (Level 1 $7,430 k + Level 2 $188,796 k)【page_96】, and rose to $273.7 million in 2024 (Level 1 $20,205 k + Level 2 $253,494 k)【page_96】. The three‑year trend—downward in 2023 then a rebound above the 2022 level—suggests ACN is deliberately increasing the equity portion of its pension‑plan assets, aligning with a strategic tilt toward higher‑growth, equity‑focused allocations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims ACN's mutual fund equity securities rose to $273.7 million in 2024, but the ground truth explicitly states the value 'remained unchanged in 2024' at $196.226 million. This is a major discrepancy—the LLM reports a $77.5 million increase that did not occur. (2) CALCULATION VERIFICATION: The LLM correctly sums the Level 1 and Level 2 components for 2022 ($4,954k + $234,339k = $239,293k ≈ $239.3M) and 2023 ($7,430k + $188,796k = $196,226k ≈ $196.2M), but the 2024 figure of $273.7M is entirely incorrect according to ground truth. (3) MULTI-HOP REASONING FAILURE: The LLM's interpretation of the 3-year trend is fundamentally wrong. It concludes ACN is 'deliberately increasing the equity portion' and 'tilting toward higher-growth allocations,' but the ground truth indicates a 'stabilized allocation approach' with no change from 2023 to 2024. The LLM misread or fabricated the 2024 data. (4) ENTITY AND METRIC ACCURACY: ACN is correctly identified, and the metric (mutual fund equity securities) is correct, but the temporal data for 2024 is completely inaccurate. (5) SEMANTIC EQUIVALENCE: The LLM's narrative about strategic intent contradicts the ground truth's characterization of stability. The ground truth suggests rebalancing followed by stabilization; the LLM suggests continued aggressive equity expansion. This is a material misrepresentation of ACN's investment strategy. The answer fails on the primary dimension of factual correctness regarding 2024 values and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 456,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In 2022 Adobe positioned Document Cloud primarily as a “unified, cloud‑based document services platform” that combined its PDF technology with Acrobat and Acrobat Sign to deliver fully digital document workflows across all surfaces 【page_70】. By 2023 the company began emphasizing AI‑driven enhancements, noting that Adobe Sensei would make documents “more intelligent and responsive” and that PDF and Acrobat Sign APIs would unlock enterprise‑wide workflow automation 【page_5】. In the 2024 filing Adobe shows the next step of that evolution: generative‑AI features powered by Firefly are embedded in Acrobat (and other apps), the new Acrobat AI Assistant provides conversational document assistance, and Firefly Services and Custom Models give enterprises APIs and custom‑trained models to generate, edit and assemble content at scale within Document Cloud 【page_11】【page_12】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of Document Cloud's strategic positioning; (2) Accurately captures the shift from foundational/legacy positioning in 2022 to AI-enhanced enterprise focus by 2024; (3) Properly names specific AI tools (Firefly, Adobe Sensei, Acrobat AI Assistant) and their integration points; (4) Correctly identifies key components (PDF, Acrobat, Acrobat Sign, APIs, Custom Models); (5) Demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and connecting Document Cloud evolution to broader AI strategy; (6) Uses appropriate citations to source documents. MINOR WEAKNESSES: (1) The LLM answer uses slightly different framing than ground truth - it emphasizes 'unified cloud-based document services platform' language for 2022 rather than explicitly noting the 'legacy infrastructure' or 'foundational' characterization mentioned in ground truth; (2) The 2023 transition is described more as 'beginning to emphasize AI-driven enhancements' rather than explicitly noting Document Cloud's elevation as a 'core component of Digital Media segment' - though the semantic meaning is similar; (3) Ground truth explicitly mentions the segment classification shift (Publishing/Advertising to Digital Media), which the LLM answer doesn't directly address, though this is a minor omission. QUANTITATIVE ACCURACY: No numerical data, dates, or calculations present in either answer, so this dimension is not applicable but scored high as there are no errors. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple product/feature dimensions (Firefly, Sensei, APIs, Custom Models, Acrobat AI Assistant), correctly showing progression and integration. The answer demonstrates understanding of how Document Cloud's role evolved within Adobe's broader AI strategy. SEMANTIC EQUIVALENCE: The core message matches - Document Cloud transformed from foundational infrastructure to AI-enhanced enterprise productivity suite. The LLM's specific product details (Acrobat AI Assistant, Firefly Services, Custom Models) add concrete specificity that enhances rather than contradicts the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 615,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "- In the 2022 Form 10‑K Honeywell warned that each of its four reportable segments – Aerospace, Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions – were vulnerable to “new entrants and non‑traditional players” and to “new technologies” that could commoditize products, erode market share and force price concessions【page_31】.  \n- The 2023 filing repeated essentially the same language for the same four segments, indicating that the competitive‑landscape risk had not changed from the prior year【page_31】.  \n- By the 2024 filing, after the segment realignment, the company still highlighted “new entrants and non‑traditional players” (Aerospace Technologies) and “new market entrants and new technologies” (Industrial Automation, Building Automation) as risks, now explicitly stating that they could lead to “lower market share, reduced selling prices and lower margins” for the newly named segments【page_32】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific details about Honeywell's competitive landscape disclosures across 2022-2024, with correct identification of segments and years. However, there are significant discrepancies with the ground truth that affect overall accuracy:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 as the baseline year with warnings about new entrants and technologies\n- Correctly notes 2023 repeated similar language\n- Correctly identifies 2024 segment realignment\n- Correctly cites specific consequences (lower market share, reduced selling prices, lower margins)\n- Page references appear reasonable\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. SEGMENT IDENTIFICATION DISCREPANCY: The LLM states that in 2022, all FOUR segments (Aerospace, Building Technologies, Performance Materials & Technologies, Safety & Productivity Solutions) were cited as vulnerable. However, the ground truth explicitly states that in 2022, only TWO segments were mentioned: \"Honeywell Building Technologies and Safety and Productivity Solutions.\" This is a material factual error.\n\n2. 2023 EXPANSION NOT CAPTURED: The ground truth indicates that in 2023, Honeywell EXPANDED the risk disclosure to include Performance Materials and Technologies and Aerospace (moving from 2 to 4 segments). The LLM answer states 2023 \"repeated essentially the same language for the same four segments,\" which contradicts the ground truth's narrative of expansion/progression.\n\n3. MISSING NARRATIVE PROGRESSION: The ground truth emphasizes a 3-year EVOLUTION showing \"deepening concern\" and \"increasing frequency and specificity.\" The LLM answer presents the information more as static/repetitive rather than capturing this strategic shift and progression.\n\n4. COMMODITIZATION EMPHASIS: The ground truth specifically highlights \"product commoditization\" as a 2024 focus, which the LLM answer mentions but doesn't emphasize as a key evolution point.\n\nMULTI-HOP REASONING: The LLM fails to properly synthesize the temporal evolution across the three years. It treats 2022-2023 as essentially identical when the ground truth shows clear expansion of risk disclosures across segments.\n\nQUANTITATIVE ACCURACY: The segment counts are incorrect (4 vs 2 in 2022), which is a quantitative error affecting the core narrative.\n\nSEMANTIC EQUIVALENCE: While some language matches, the fundamental claim about which segments were included in each year differs materially from ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 655,
        "total_tokens": 2221
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "After the 2020 Upjohn spin‑off that created Viatris, Pfizer signed a suite of post‑separation agreements—including interim agency, manufacturing‑supply and transition‑service arrangements (TSAs)—to bill, collect and remit rebates and provide other support for Viatris 【page_12】.  The net intercompany amount payable to Viatris was $94 million at year‑end 2022, fell to $33 million by year‑end 2023 as the TSAs were largely completed, and the 2024 filing only lists Viatris in the glossary (defining “TSAs”) indicating the transition services are finished and any remaining balances are immaterial 【page_73】【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: All financial figures are correct - $94 million in 2022, $33 million in 2023, and the 2024 reference to immaterial balances. The year-end dates are accurate. COMPLETENESS: The answer addresses all key aspects of the question: (1) the nature of the relationship (post-2020 Upjohn spin-off), (2) types of arrangements (interim agency, manufacturing-supply, TSAs), (3) intercompany balance evolution across 2022-2024, and (4) the winding down of transition services. MULTI-HOP REASONING: The answer correctly synthesizes information across multiple years and filing documents, showing the progression from $94M → $33M → immaterial balances, and correlating this with TSA completion status. The logic is sound: declining balances correspond with TSA completion. ENTITY ACCURACY: Correctly identifies Pfizer, Viatris, and the 2020 Upjohn spin-off context. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - a gradual decline in intercompany balances and winding down of TSAs from 2022-2024. The additional context about the types of post-separation agreements (interim agency, manufacturing-supply) adds helpful detail without contradicting the ground truth. The reference to page numbers and the glossary mention in 2024 provides appropriate sourcing. Minor observation: The LLM answer provides slightly more contextual detail about the nature of the arrangements compared to the ground truth, which enhances rather than detracts from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 437,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "In 2022 Altria’s registered debt included a 1.000 % note due 2023, a 1.700 % note due 2025, a 2.200 % note due 2027 and a 3.125 % note due 2031 (MO_10k_2022.pdf, page 1). By the 2023 filing the 1.000 % 2023 note had disappeared, leaving the 1.700 % 2025 note as the nearest‑maturity instrument together with the unchanged 2027 and 2031 notes, a composition that persisted in the 2024 filing (MO_10k_2023.pdf and MO_10k_2024.pdf, page 1). This evolution shows Altria systematically retiring short‑term debt as it matures and relying on a laddered, longer‑dated, low‑coupon debt base, indicating a capital‑structure strategy aimed at locking in inexpensive financing and reducing near‑term refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis across multiple years of SEC filings. QUANTITATIVE ACCURACY: All numeric values are correct - the 1.000% note due 2023, 1.700% note due 2025, 2.200% note due 2027, and 3.125% note due 2031 are all accurately cited with proper percentages and maturity years. The timeline progression (2022→2023→2024) is correctly tracked. COMPLETENESS: The answer addresses all aspects of the multi-part question: (1) composition of debt instruments across three years, (2) specific focus on the 1.700% Notes due 2025 in relation to other maturities, and (3) implications for capital structure strategy. ENTITY ACCURACY: Altria Group is correctly identified, fiscal years are accurate, and all debt instruments are properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to show the evolution pattern: retirement of near-term debt (1.000% 2023 note), persistence of intermediate/long-term instruments, and absence of replacement short-term issuance. STRATEGIC INTERPRETATION: The conclusion about maintaining a laddered debt structure with focus on intermediate/long-term debt and reducing refinancing risk is logically sound and well-supported by the documented progression. The characterization of the strategy as 'locking in inexpensive financing' is appropriate given the low coupon rates cited. MINOR CONSIDERATIONS: The LLM answer provides slightly more detailed strategic interpretation than the ground truth (mentioning 'laddered' structure, 'low-coupon debt base,' and 'refinancing risk'), but this represents appropriate elaboration rather than inaccuracy. The ground truth's phrasing about 'not issuing a new near-term note' is implicitly captured in the LLM's observation that the composition 'persisted' unchanged. Both answers convey the same fundamental insight about Altria's capital structure strategy with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 532,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew from a carrying value of **$24.1 billion in 2022** to **$27.2 billion in 2023**, then edged down to **$26.9 billion in 2024**【page_178】. The weighted‑average interest rate was **about 4.45 % in both 2022 and 2023**, but rose to **roughly 4.84 % in 2024**【page_188】. This upward shift in both the amount and the average cost of fixed‑rate debt suggests Capital One is deliberately expanding its long‑term, fixed‑rate borrowing base—even at higher rates—to lock in financing ahead of a higher‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics. (1) CARRYING VALUE ERRORS: The LLM states 2022 carrying value was $24.1 billion, but ground truth shows $19,975 million ($19.975 billion)—a difference of approximately $4.1 billion or 20.5% overstatement. The 2023 and 2024 figures ($27.2B and $26.9B) are approximately correct when converted from millions. (2) WEIGHTED-AVERAGE INTEREST RATE ERRORS: The LLM claims the rate was 'about 4.45% in both 2022 and 2023,' but ground truth shows 2.91% in 2022 and 4.45% in 2023. This is a major error—the 2022 rate is off by 1.54 percentage points. The 2024 rate of 4.84% appears correct. (3) TREND ANALYSIS ISSUES: Because the 2022 baseline is wrong, the trend analysis is fundamentally flawed. The ground truth shows a dramatic increase from 2.91% to 4.45% (153 basis points), while the LLM incorrectly suggests rates were flat from 2022-2023. (4) MULTI-HOP REASONING: The qualitative interpretation about 'deliberately expanding long-term, fixed-rate borrowing' is reasonable and aligns with the actual trend, but it's based on incorrect data points. The reasoning would be sound if the numbers were correct. (5) COMPLETENESS: The answer addresses all parts of the question (carrying value evolution, interest rate evolution, strategic implications), but the factual foundation is compromised. The semantic interpretation about locking in financing is appropriate but undermined by data errors. SUMMARY: While the answer demonstrates understanding of the question structure and provides reasonable strategic interpretation, the quantitative errors are too severe for a high score. The 2022 carrying value error and the 2022 interest rate error are particularly problematic as they distort the baseline and trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 498,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C92‑15 are disclosed in every recent filing – they appear as the “One‑Hundred‑and‑Sixteenth Supplemental Indenture” dated August 24 2015 in the 2022 10‑K (see TSLA 2022 p. 105), and the same bond is listed again among the supplemental indentures in the 2023 10‑K (see TSLA 2023 p. 102) and the 2024 10‑K (see TSLA 2024 p. 102). The unchanged, recurring disclosure shows that Tesla has retained this 2015 low‑rate bond as an ongoing financing source, indicating a strategy of leveraging existing, long‑term debt rather than issuing new solar‑specific bonds each year.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The bond series designation (5.45% Solar Bonds, Series 2015/C92-15) is accurate; (2) The bond appears in all three years (2022, 2023, 2024) as stated; (3) The characterization as the \"One-Hundred-and-Sixteenth Supplemental Indenture\" dated August 24, 2015 appears plausible; (4) The core insight that Tesla retained this existing bond rather than issuing new solar-specific bonds annually is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM provides specific page numbers (p. 105 for 2022, p. 102 for 2023 and 2024) that cannot be verified against the ground truth, which references specific Exhibits (4.61, 4.54, 4.52) instead; (2) The ground truth indicates the bond was listed in Exhibits 4.61 (2022), 4.54 (2023), and 4.52 (2024), but the LLM does not mention these exhibit numbers; (3) The ground truth emphasizes a pattern of \"declining prominence\" and notes the emergence of newer bond series (C102-15, C106-10), which the LLM completely omits; (4) The LLM's interpretation focuses narrowly on \"leveraging existing long-term debt\" without addressing the strategic shift toward newer financing structures that the ground truth highlights. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to capture the evolution aspect of the question - it treats the bond as static rather than showing how its role changed relative to newer instruments. The answer is partially correct on basic facts but incomplete on the strategic implications and missing key contextual details about the shift to newer bond series.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 450,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "Across the three years AIG kept the same core pillars—internal controls, chief‑risk‑officer oversight, and external expert challenges of reserve estimates—but steadily tightened the governance and modeling framework. In 2022 the loss‑reserve process was governed by business‑unit risk committees, a “review and challenge of reserves” escalation and external expert reviews (2022 p.165‑167); in 2023 AIG added a formal model‑risk‑management and validation framework and highlighted ERM’s second‑line review of pricing and reserving models (2023 p.119); by 2024 that oversight was embedded in a three‑tiered limit hierarchy and ERM’s independent review function, with continued external expert challenges and an expanded use of stochastic, scenario‑based and bias‑adjusted catastrophe models (2024 p.85‑86).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year evolution of AIG's loss reserves risk management. STRENGTHS: (1) Correctly identifies the core pillars maintained across 2022-2024 (internal controls, oversight, external expert reviews); (2) Accurately captures the progression: 2022 baseline with business-unit committees and external reviews → 2023 addition of formal model-risk-management framework and ERM second-line review → 2024 integration into three-tiered limit hierarchy with enhanced stochastic/scenario modeling; (3) Properly synthesizes multi-hop information across three years showing evolution from basic controls to more sophisticated ERM integration; (4) Includes specific page references (2022 p.165-167, 2023 p.119, 2024 p.85-86) that ground the answer in source material; (5) Uses appropriate financial/risk management terminology (stochastic methods, scenario analysis, bias-adjusted catastrophe models, second-line review). MINOR GAPS: (1) The LLM answer emphasizes 'chief-risk-officer oversight' as a core pillar, while the ground truth emphasizes 'sensitivity and scenario analyses, stochastic methods, and experience studies' as the expanded toolkit in 2023—the LLM mentions these but frames them differently; (2) The ground truth explicitly mentions 'experience studies' as part of 2023's expanded framework, which the LLM doesn't explicitly call out; (3) The ground truth emphasizes 'proactive risk identification, validation, and governance' as the overarching theme, while the LLM frames it as 'tightening governance and modeling framework'—semantically similar but slightly different emphasis. QUANTITATIVE ACCURACY: No numerical errors detected; page references appear reasonable for 10-K filings. REASONING: The multi-hop synthesis is sound—correctly traces evolution across three years and identifies how each year built upon previous frameworks. The answer demonstrates understanding that this wasn't a complete overhaul but rather a maturing/integration process.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 548,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "In 2022 Altria’s pension plan held roughly $1.13 billion of U.S. Treasury and foreign‑government securities out of $6.60 billion of assets – about 17 % of the portfolio. The share rose modestly in 2023 to roughly $1.15 billion of $6.78 billion (≈ 19 % of pension assets) and then fell sharply in 2024 to only $508 million of $5.81 billion (≈ 8 %). The decline signals a strategic shift away from low‑yield, rate‑sensitive government bonds toward a higher‑yielding, corporate‑bond‑focused mix, consistent with Altria’s liability‑driven pension approach that is rebalancing toward growth assets while still managing liability hedging.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) ALLOCATION PERCENTAGES - CRITICAL ERROR: The LLM states 2022 allocation was ~17%, 2023 was ~19%, and 2024 was ~8%. However, the ground truth clearly states: 2022 was 19%, 2023 was 16%, and 2024 was 8%. The LLM has reversed the 2022 and 2023 percentages, claiming an increase from 17% to 19% when the actual trend was a DECREASE from 19% to 16%. This is a fundamental misrepresentation of the trend direction. (2) TREND INTERPRETATION - CONTRADICTS GROUND TRUTH: The LLM claims 'the share rose modestly in 2023' when the ground truth indicates a decline from 19% to 16%. This is factually incorrect and undermines the core narrative of the answer. (3) DOLLAR AMOUNTS: While the LLM provides specific dollar amounts ($1.13B, $1.15B, $508M), these cannot be verified against the ground truth which only provides percentages. The calculations appear internally inconsistent: if 2022 was $1.13B of $6.60B, that's 17.1% (not 17% as stated); if 2023 was $1.15B of $6.78B, that's 16.9% (not 19% as stated). (4) MISSING CONTEXT: The LLM fails to mention the expected rate of return reduction (6.6% to 6.1% to 6.1%), which the ground truth identifies as an important indicator of cautious long-term outlook. The LLM also doesn't address the below-investment-grade securities trend (11% to 9%) mentioned in the ground truth. (5) REASONING QUALITY: While the LLM's interpretation about 'liability-driven pension approach' and 'rebalancing toward growth assets' is plausible, it's based on incorrect percentage trends, making the conclusion unreliable. The ground truth emphasizes a 'steady decline' and 'more conservative or diversified investment posture,' which differs from the LLM's characterization. CORRECT ELEMENTS: The 2024 figure of 8% is accurate, and the general concept of strategic reallocation is appropriate, but the execution is severely flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 531,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then edged up to $562 million in 2024 (2022 & 2023 data in Table 8.1 of the 2023 filing 【page_178】; 2024 data in Table 9.1 of the 2024 filing 【page_188】).  Long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before dropping to $45.0 billion in 2024, pulling total debt from $48.7 billion to $49.9 billion and down to $45.6 billion (ibid.).  \n\nDuring the same period the floating‑rate unsecured senior debt collapsed from $1.6 billion in 2022 to $0.35 billion in 2023 and was eliminated by 2024, while fixed‑rate senior debt grew from $24.1 billion to $27.2 billion (still $26.9 billion in 2024) and securitized debt rose to $18.0 billion in 2023 before falling to $14.3 billion in 2024, showing a clear shift toward a higher share of fixed‑rate obligations and reduced exposure to rising interest rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth across multiple key metrics:\n\n1. TOTAL DEBT FIGURES - MAJOR ERRORS:\n   - Ground Truth: 2022=$43.086B, 2023=$48.715B, 2024=$45.551B\n   - LLM Answer: Claims 2022=$48.7B, 2023=$49.9B, 2024=$45.6B\n   - The LLM's 2022 figure ($48.7B) is actually the 2023 figure from ground truth\n   - The LLM's 2023 figure ($49.9B) has no correspondence in ground truth\n   - While 2024 is approximately correct ($45.6B vs $45.551B), the prior years are substantially wrong\n\n2. SHORT-TERM BORROWINGS - COMPLETELY INCORRECT:\n   - Ground Truth: Not separately broken out as $883M, $538M, $562M\n   - LLM Answer: Provides specific short-term borrowing figures ($883M, $538M, $562M) that don't match ground truth data\n   - These appear to be fabricated or misread from source documents\n\n3. LONG-TERM DEBT - INCORRECT:\n   - Ground Truth: Derived from total debt minus short-term components\n   - LLM Answer: Claims $47.8B (2022), $49.3B (2023), $45.0B (2024)\n   - These don't align with ground truth total debt figures\n\n4. FLOATING-RATE UNSECURED SENIOR DEBT - PARTIALLY INCORRECT:\n   - Ground Truth: 2022=$1.709B, 2023=$349M, 2024=$0\n   - LLM Answer: Claims 2022=$1.6B, 2023=$0.35B, 2024=$0\n   - The 2023 figure ($0.35B = $350M) is very close to ground truth ($349M)\n   - The 2022 figure ($1.6B) is off by ~$109M from ground truth ($1.709B)\n   - The 2024 figure ($0) is correct\n\n5. FIXED-RATE SENIOR DEBT - INCORRECT:\n   - Ground Truth: 2022=$19.975B, 2024=$26.930B\n   - LLM Answer: Claims 2022=$24.1B, 2023=$27.2B, 2024=$26.9B\n   - The 2022 figure is off by ~$4.1B\n   - The 2024 figure ($26.9B) matches ground truth\n   - The 2023 figure ($27.2B) is not in ground truth\n\n6. SECURITIZED DEBT - PARTIALLY CORRECT:\n   - Ground Truth: 2022=$14.994B, 2023=$18.043B, 2024=$14.264B\n   - LLM Answer: Claims 2023=$18.0B, 2024=$14.3B\n   - These figures are approximately correct (minor rounding)\n   - However, 2022 data is omitted\n\n7. INTEREST RATE ANALYSIS - MISSING:\n   - Ground Truth includes weighted-average interest rates for each debt category and year\n   - LLM Answer completely omits interest rate data, which is a critical component of the question asking about \"interest rate exposure\"\n   - This represents a significant gap in addressing the multi-part question\n\n8. MULTI-HOP REASONING:\n   - The LLM attempts to synthesize information across years and debt categories\n   - However, the fundamental numerical errors undermine the validity of any conclusions\n   - The conclusion about \"shift toward higher share of fixed-rate obligations\" is directionally correct but based on incorrect base numbers\n\n9. COMPLETENESS:\n   - The answer fails to address interest rate trends, which are explicitly mentioned in the question\n   - Missing weighted-average interest rate data for securitized debt (1.51% to 3.48%) and unsecured senior debt (1.01% to 6.75%)\n   - These omissions are critical to understanding \"interest rate exposure\"\n\nThe LLM answer appears to have misread or confused data from the source documents, resulting in systematic errors across nearly all quantitative metrics. While the directional narrative about shifting toward fixed-rate debt is reasonable, it's built on incorrect numbers and lacks the interest rate analysis essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 886,
        "total_tokens": 2441
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K exhibits for 2022, 2023 and 2024 all list the 5.45 % Solar Bonds, Series 2015/C25‑15 (e.g., the “Thirty‑Sixth Supplemental Indenture, dated April 14 2015”) as an outstanding obligation 【page_102】. The repeated disclosure shows that Tesla continues to rely on this specific bond issuance to fund its SolarCity solar projects, and its presence in every filing signals that the bonds remain an active, material component of Tesla’s capital structure and debt financing strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the bond series (5.45% Solar Bonds, Series 2015/C25-15), the supplemental indenture date (April 14, 2015), and the three-year filing period (2022, 2023, 2024). The quantitative elements are accurate with no calculation errors or date discrepancies. The answer correctly synthesizes the multi-hop requirement by connecting the repeated references across three separate 10-K filings to draw conclusions about Tesla's ongoing reliance on this financing instrument. The reasoning is sound: repeated disclosure across multiple years logically indicates active status and strategic importance. Minor strengths include the explicit mention of SolarCity solar projects, which adds appropriate context. One minor weakness is that the LLM answer is slightly more concise than the ground truth, omitting the phrase 'even several years after issuance' which provides additional temporal context about the bond's longevity. The reference to 'page_102' appears to be a citation marker that doesn't detract from accuracy. The semantic equivalence is strong - both answers convey that the bonds remain active, material, and strategically important to Tesla's capital structure. The answer appropriately addresses the question's inquiry about what the repeated references suggest about reliance and the bond's role in capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 389,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose sharply over the three‑year period – it was **$51.4 billion** at year‑end 2022, grew to **$60.4 billion** at year‑end 2023, and reached **$71.4 billion** at year‑end 2024【page_72†L31-L38】【page_73†L31-L38】【page_66†L31-L38】.  The steady increase, driven by $9 billion of purchases in 2023 and about $11 billion in 2024, shows Mastercard is allocating more cash to share repurchases, underscoring a capital‑allocation strategy that emphasizes returning excess cash to shareholders through buybacks (in addition to dividends).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) SIGN ERROR - The original answer correctly shows treasury stock as negative values: $(51,354)M in 2023, $(60,429)M in 2023 (appears to be typo for 2022), and $(71,431)M in 2024. Treasury stock is a contra-equity account and should be negative. The LLM answer incorrectly presents these as positive values ($51.4B, $60.4B, $71.4B), fundamentally misrepresenting the accounting treatment. (2) YEAR MISMATCH - The original answer contains an apparent error stating '2023 to 2024' in the opening but then lists '2023 to 2023' which is contradictory. However, the correct progression should be 2022→2023→2024. The LLM correctly identifies the three-year period as 2022-2024. (3) MAGNITUDE VERIFICATION - The LLM's stated amounts ($51.4B, $60.4B, $71.4B) match the absolute values from the original answer when converted to billions, but the critical negative sign is omitted. (4) CALCULATION VERIFICATION - The LLM states '$9 billion of purchases in 2023 and about $11 billion in 2024.' The differences are: 2023: $60.4B - $51.4B = $9.0B ✓; 2024: $71.4B - $60.4B = $11.0B ✓. These calculations are arithmetically correct but based on incorrectly signed numbers. (5) REASONING QUALITY - The LLM correctly interprets the trend as indicating a capital allocation strategy emphasizing share repurchases and shareholder returns, which is sound reasoning. However, this reasoning is built on fundamentally incorrect accounting representation. (6) MULTI-HOP SYNTHESIS - The answer successfully synthesizes information across three years and connects the trend to strategic implications, but the foundational accounting error undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 458,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell first warned in its 2022 filing that the Safety & Productivity Solutions business “may be adversely impacted by reduced investments in process automation, safety monitoring, and plant‑capacity utilization initiatives…[and] adverse industry economic conditions”【page_31】. After the 2023 realignment the same language re‑appeared under the newly‑named Industrial Automation segment, again flagging “reduced investments in process automation…and plant‑capacity utilization initiatives” as a key risk【page_30】, and the 2024 filing continues to list the same exposure for Industrial Automation【page_30】. The persistence of this risk across three years shows that macro‑economic headwinds—slower capital spending, higher financing costs and uncertain demand—have continued to pressure the industrial sector, limiting automation spend and plant‑utilization throughout 2022‑2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Honeywell's Safety and Productivity Solutions segment exposure to adverse economic conditions from 2022-2024. STRENGTHS: (1) Correctly identifies the core risk factors (reduced investments in process automation, plant capacity utilization) that persisted across all three years; (2) Accurately notes the 2023 segment realignment from 'Safety & Productivity Solutions' to 'Industrial Automation'; (3) Properly synthesizes the multi-hop information showing consistency of risk language across three years; (4) Correctly interprets the trajectory as indicating persistent macroeconomic headwinds; (5) Adds relevant context about macro factors (slower capital spending, higher financing costs, uncertain demand) that align with the ground truth's mention of 'macroeconomic volatility, geopolitical instability and trade policy shifts'; (6) Page citations provided (though not verifiable in this evaluation). MINOR WEAKNESSES: (1) The LLM answer is slightly more specific/detailed than the ground truth in some respects (e.g., explicitly mentioning 'safety monitoring' and specific macro factors like 'higher financing costs'), which could be seen as either enhancement or minor deviation from ground truth framing; (2) The ground truth emphasizes a 'sharpening focus' and 'deepening concern' in 2024 with 'geopolitical instability and trade policy shifts,' while the LLM answer treats the risks more uniformly across years without explicitly highlighting the 2024 intensification; (3) The ground truth's characterization of 'potentially worsening' conditions is somewhat muted in the LLM answer's presentation. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required or provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and two segment naming conventions, properly connecting the persistence of risk language to broader macroeconomic interpretation. The logic flow is sound and the conclusion appropriately follows from the evidence presented. SEMANTIC EQUIVALENCE: The core message matches the ground truth—persistent exposure to adverse conditions driven by reduced automation investment and capacity utilization challenges, reflecting broader industrial sector weakness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 654,
        "total_tokens": 2152
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "From 2022 through 2024 Cyramza’s label remained focused on the same oncology uses – second‑line therapy for advanced or metastatic gastric/gastro‑esophageal‑junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, plus a first‑line option for EGFR‑mutated metastatic NSCLC – with no new indications added in the 2024 filing [page_5]. In the 2023 filing the company disclosed that Cyramza’s compound patents run until 2026 in the United States and Japan and 2028 in Europe, while data‑protection expires in 2024 in Europe and 2023 in Japan, showing the product is moving into the final years of its exclusivity period [page_11].",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Cyramza's lifecycle positioning from 2022-2024. STRENGTHS: (1) All therapeutic indications are correctly identified and match ground truth - second-line treatments for gastric/GEJ adenocarcinoma, metastatic NSCLC, colorectal cancer, and hepatocellular carcinoma, plus first-line EGFR-mutated NSCLC. (2) All patent/data protection dates are accurate: compound patents extend to 2026 (US/Japan) and 2028 (Europe); data protection expires 2023 (Japan) and 2024 (Europe). (3) The multi-hop synthesis correctly connects therapeutic indications across the 2022-2024 period with IP protection timelines, showing the narrowing exclusivity window. (4) The answer appropriately notes no new indications were added between 2022-2024, maintaining consistency. (5) Contextual framing about 'final years of exclusivity period' aligns with ground truth's characterization of 'narrowing window of exclusivity.' MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail on indications (e.g., specifying 'EGFR-mutated' for first-line NSCLC) compared to the ground truth's more general phrasing, but this represents added precision rather than error. The answer includes page references which add credibility. The semantic meaning and factual content align perfectly with the ground truth across all key metrics and entities. No calculation errors or date discrepancies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 409,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) have grown each year: $31 million at 12/31/2022, $58 million at 12/31/2023 and $69 million at 12/31/2024, all recorded as Level 3 fair‑value items【page 215】.  The valuation continues to use discounted‑cash‑flow models with swap rates as the primary unobservable input; the swap‑rate assumption was a single 1 % range in 2022 (weighted‑average 1 %)【page 208】, widened to 3‑5 % (weighted‑average ≈ 4 %) in 2023【page 208】, and is shown as a 4 % range (weighted‑average 4 %) in 2024【page 217】.  Correspondingly, net unrealized gains shifted from a $33 million loss in 2022 to a $63 million gain in 2023 and a $25 million loss in 2024【page 215】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) FAIR VALUE NUMBERS - Ground truth states: 2022=$19M, 2023=$58M, 2024=$58M. LLM states: 2022=$31M, 2023=$58M, 2024=$69M. The 2022 figure is off by $12M (63% error), and 2024 is off by $11M (19% error). These are material discrepancies. (2) SWAP RATE RANGES - Ground truth indicates 2022 had swap rates with unobservable inputs, 2023 had 3-5% (weighted 4%), and 2024 had 3-5% (weighted 4%). LLM claims 2022 had a '1% range (weighted 1%)', which contradicts the ground truth that doesn't specify a 1% range for 2022. The 2023-2024 swap rate information in the LLM answer appears partially correct (3-5%, weighted 4%) but the 2022 characterization is incorrect. (3) UNREALIZED GAINS/LOSSES - Ground truth mentions net losses of $20M in 2022 held in portfolio. LLM provides different figures ($33M loss in 2022, $63M gain in 2023, $25M loss in 2024) that don't align with ground truth. (4) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the evolution pattern and attempts to synthesize fair value measurements with unobservable inputs across years, the underlying numbers are fundamentally wrong, undermining the entire analysis. (5) POSITIVE ELEMENTS - The LLM correctly identifies Capital One (COF), the Level 3 classification, the use of discounted cash flow models, and swap rates as key unobservable inputs. The structure of the answer appropriately addresses the question's multi-part nature. However, these correct elements cannot overcome the material quantitative errors in the core financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 448,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "In fiscal 2022, “thousands of our employees around the world utilized our charitable match program, benefiting more than 1,500 charitable organizations” (QCOM_10k_2022, page 17). By fiscal 2024 the same level of employee participation persisted (“thousands of our employees…utilized our charitable match program”) but the reach fell to “more than 1,300 charitable organizations” (QCOM_10k_2024, page 16). Qualcomm ties progress on human‑capital initiatives—including employee‑engagement programs like the charitable match—to executive bonuses, using a non‑financial performance modifier (a 0.9‑to‑1.1 multiplier) that the HR and Compensation Committee applies to the fiscal 2022 and fiscal 2024 bonus calculations (QCOM_10k_2022, page 17; QCOM_10k_2024, page 16), showing that the program’s sustained participation aligns with the company’s broader human‑capital goals linked to executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All numbers are correct—2022 data shows 'thousands of employees' and 'over 1,500 organizations' (matches ground truth); 2024 data shows 'thousands of employees' and 'over 1,300 organizations' (matches ground truth). The non-financial modifier range of 0.9-to-1.1 is accurately cited. COMPLETENESS: The answer addresses all three components of the multi-part question: (1) employee participation evolution (thousands in both years), (2) supported organizations evolution (1,500 to 1,300), and (3) alignment with human capital goals tied to executive compensation (0.9-1.1 modifier). ENTITY ACCURACY: Company (Qualcomm/QCOM), fiscal years (2022, 2024), and metrics (charitable match program, non-financial modifier) are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple documents and years, correctly linking the charitable program metrics to executive compensation mechanisms. The logic connecting sustained participation to broader human capital strategy is sound. MINOR CONSIDERATIONS: The LLM answer does not explicitly mention the 2025 diversity, equity, and inclusion goals referenced in the ground truth, though this is a relatively minor omission that doesn't affect the core answer's accuracy. The answer provides specific page citations (page 17 for 2022, page 16 for 2024) which adds credibility. The semantic equivalence is excellent—the LLM conveys the same information as the ground truth with appropriate professional language and clear documentation of sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 452,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "**2022:** Adobe presented Acrobat as the core PDF engine of its Document Cloud, stressing a “best PDF experience” across every platform, new single‑click web actions, tighter integration of Adobe Sign into Acrobat, AI‑driven features from Sensei and mobile‑first tools such as Liquid Mode and Adobe Scan. **2023:** The filing shifted to a product‑led‑growth narrative, promising to expand the number of task‑based actions in Acrobat, deepen the Adobe Sign‑and‑Acrobat API integration, and add more AI‑enhanced, workflow‑centric capabilities (e.g., smarter PDFs, expanded web functionality). **2024:** The sections provided (Item 10 and exhibit listings) contain no fresh Acrobat‑specific announcements, indicating that Acrobat is now treated as a mature, fully integrated part of Document Cloud rather than a focus of new product positioning or enhancements.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 2022 positioning of Acrobat as core to Document Cloud with emphasis on PDF experience; (2) Accurately mentions specific 2022 features like Liquid Mode, Adobe Scan, and Adobe Sign integration; (3) Correctly notes the 2023 shift toward AI-enhanced capabilities and product-led growth; (4) Appropriately identifies the 2024 positioning as mature/integrated. WEAKNESSES: (1) The LLM answer lacks the 'Acrobat AI Assistant' trademark registration detail that the ground truth explicitly highlights as a key 2024 development - this is a material omission for tracking the AI evolution; (2) The 2022 description includes specific feature names (Liquid Mode, Adobe Scan, Sensei) that are not verified in the ground truth, which focuses on broader strategic positioning rather than specific product features; (3) The LLM's claim that 2024 sections contain 'no fresh Acrobat-specific announcements' contradicts the ground truth's assertion that 'Acrobat AI Assistant' was formally introduced as a registered trademark in 2024 - this is a factual error; (4) The ground truth emphasizes the trajectory from 'document standard to AI-enhanced productivity platform' while the LLM frames 2024 as 'mature, fully integrated' without highlighting the AI Assistant introduction. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails to capture the critical 2024 development (AI Assistant trademark), which is essential to demonstrating the evolution trajectory. The reasoning about product maturity in 2024 is speculative and contradicts the ground truth's evidence of continued strategic positioning through AI capabilities. CALCULATION/VERIFICATION: No quantitative data to verify, but the factual claims about product features and positioning are partially unsupported or contradicted by ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 526,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly recorded $2.02 billion of net product revenue from its COVID‑19 antibodies (bamlanivimab and bebtelovimab), and AbCellera earned mid‑teens‑to‑mid‑twenties percent royalties on those sales, which were booked as cost of sales 【page_72】. By 2023 the antibodies had no sales, so net product revenue fell to $0 and no royalty payments were incurred, a situation that persisted through 2024 【page_73】【page_74】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop financial question. STRENGTHS: (1) All numeric values are correct: $2.02 billion in 2022 revenue, mid-teens-to-mid-twenties percent royalty range, $0 revenue in 2023 and 2024. (2) Quantitative accuracy is perfect - all numbers match ground truth exactly with appropriate formatting. (3) Multi-hop synthesis is sound: correctly connects LLY's revenue recognition to AbCellera's royalty obligations across three fiscal years (2022-2024), showing the causal relationship between sales decline and royalty elimination. (4) Entity identification is accurate: correctly identifies LLY (Eli Lilly), AbCellera, bamlanivimab, and bebtelovimab. (5) Temporal progression is clearly articulated: 2022 peak → 2023 decline to zero → 2024 continuation of zero sales. (6) Contextual detail about royalties being 'booked as cost of sales' adds appropriate financial accounting context. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the explicit mention of 'EUA-based sales' and 'regulatory changes' as explanatory factors for the decline. However, this omission does not constitute a factual error - it's a matter of depth rather than accuracy. (2) The ground truth's phrase 'complete wind-down of the product line' is not explicitly stated in the LLM answer, though the data clearly supports this characterization. (3) The LLM answer appropriately cites page references, enhancing verifiability. Overall, the answer correctly synthesizes multi-year financial data across multiple entities and accurately conveys the evolution of the collaboration's financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 465,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife re‑insured roughly 59 % of its closed block through a modified‑coinsurance arrangement in each of the three years – 59.25 % in 2022 (page 214) and about 59 % in both 2023 (page 227) and 2024 (page 204). The near‑identical share each year shows that the company has made the modified‑coinsurance structure a stable, long‑term pillar of its risk‑transfer strategy, consistently off‑loading a sizable portion of closed‑block risk while preserving policyholder dividend protection and capital efficiency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of the question. QUANTITATIVE VERIFICATION: All percentages are correct - 59.25% in 2022, 59% in 2023, and 59% in 2024 match the ground truth exactly. The page references (214, 227, 204) add credibility and specificity. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) how reliance evolved (showing consistency across three years), (2) the percentage values for each year, and (3) what this reveals about long-term strategy. ENTITY ACCURACY: MetLife is correctly identified, the modified coinsurance agreement is properly named, and the closed block is accurately referenced. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by comparing percentages across three years and drawing a logical conclusion about strategic continuity. The interpretation that 'near-identical share each year shows...stable, long-term pillar' is sound and matches the ground truth's assertion of 'strategic continuity.' SEMANTIC EQUIVALENCE: The LLM's phrasing 'consistently off-loading a sizable portion of closed-block risk while preserving policyholder dividend protection and capital efficiency' adds contextual depth beyond the ground truth while remaining consistent with it. The answer goes slightly further by mentioning 'policyholder dividend protection and capital efficiency,' which represents reasonable inference from the data but is not explicitly stated in the ground truth. This is a minor enhancement rather than an error. MINOR CONSIDERATIONS: The use of 'roughly 59%' and 'about 59%' is appropriate given the slight variation (59.25% vs 59%), showing nuanced understanding. The answer is well-structured and directly addresses the question's two-part nature (evolution + strategic implications).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 496,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s multi‑layered security model has broadened over the period. In the 2022 10‑K the company described a layered defense built on internal Security Operations, Fusion and Intelligence Centers and public‑private partnerships, with third‑party assessments but without calling out third‑party providers as a specific risk (2022 10‑K p. 11). By 2024 the language was expanded to explicitly monitor and respond to threats tied to services supplied by third‑party providers, while still leveraging its security centers (2024 10‑K p. 11). At the same time, its real‑time payments capability grew from supporting real‑time ACH in 12 markets in 2022 (2022 10‑K p. 11) to 13 markets in 2023 (2023 10‑K p. 11) and to a broader global rollout in 2024 (2024 10‑K p. 11). This evolution shows Mastercard’s cybersecurity strategy is becoming more ecosystem‑wide, integrating third‑party risk management and scaling real‑time payment infrastructure to protect an increasingly fast and interconnected network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) All quantitative data is correct - 12 markets in 2022, 13 in 2023, and broader global rollout in 2024 match the ground truth exactly. (2) The multi-hop reasoning is sound, correctly synthesizing information about both security evolution and real-time payment infrastructure expansion across three years. (3) Entity identification is accurate (Mastercard, Security Operations, Fusion and Intelligence Centers, third-party providers). (4) The answer correctly identifies the key evolution: from general third-party assessments in 2022 to explicit third-party risk management in 2024. (5) The conclusion about ecosystem-wide integration and adaptive security posture aligns with the ground truth's assessment. (6) Page citations (p. 11 for all years) add credibility and specificity. MINOR WEAKNESSES: (1) The LLM answer is slightly less comprehensive than the ground truth in describing the 2023 transition year - it mentions 13 markets but doesn't emphasize the 'more structured integration of third-party risk management' that occurred in 2023 as a midpoint evolution. (2) The phrase 'real-time ACH' in the LLM answer is more specific than the ground truth's 'real-time payments infrastructure,' though this is not technically incorrect. (3) The ground truth emphasizes 'public-private collaborations' more explicitly in 2022, while the LLM focuses on internal centers and partnerships without the same emphasis on the public-private dimension. These are minor omissions rather than errors. The answer successfully conveys the strategic alignment between scaling real-time capabilities and enhancing cybersecurity through third-party engagement, demonstrating the proactive and adaptive security posture that the ground truth identifies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 505,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "In the defined‑benefit pension plan, equity‑like private‑alternative investments were $4.014 billion at 12/31/2022, rose to $4.094 billion in 2023, and then slipped to $3.932 billion in 2024 (the retiree‑health plan holdings were roughly $333 million in 2022, $335 million in 2023 and $346 million in 2024)【page_99】【page_100】【page_99】. The modest increase in 2023 followed by a slight decline in 2024 shows LLY maintaining a fairly steady, but now modestly reduced, exposure to illiquid equity‑like funds—suggesting the company continues to view these assets as a long‑term, growth‑oriented component of its portfolio while cautiously adjusting the size of its illiquid‑asset allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES: The LLM answer contains fundamental numerical errors that contradict the ground truth across all three years: (1) 2022: LLM states $4.014 billion, but ground truth is $2,844.7 million ($2.8447 billion) - a difference of ~$1.17 billion or 41% overstatement. (2) 2023: LLM states $4.094 billion, ground truth is $4,014.1 million ($4.0141 billion) - directionally correct but slightly overstated. (3) 2024: LLM states $3.932 billion, ground truth is $4,093.7 million ($4.0937 billion) - a massive error of ~$161 million or 3.9% understatement. The LLM appears to have confused or transposed the 2022 and 2023 figures, placing 2023's value in 2022's position. TREND ANALYSIS ERROR: The LLM describes the trend as 'modest increase in 2023 followed by a slight decline in 2024,' but the ground truth shows a significant increase from 2022 to 2023 ($2.8447B to $4.0141B, +41%), a slight dip in 2023 to 2024 ($4.0141B to $4.0937B, actually a slight increase), and then the 2024 figure is higher than 2023. The LLM's characterization of 'modestly reduced' exposure in 2024 is incorrect - the allocation actually increased. MULTI-HOP SYNTHESIS: While the LLM correctly identifies this as relating to LLY's pension and retiree benefit plans and attempts to synthesize the trend, the fundamental numerical errors undermine the entire analysis. The conclusion about 'cautiously adjusting' is contradicted by the actual data showing growth. POSITIVE ELEMENTS: The LLM correctly identifies the context (defined-benefit pension plan and retiree-health plan), mentions the retiree-health plan holdings as supplementary information, and attempts to interpret the strategic implications. However, these qualitative strengths cannot overcome the severe quantitative failures that are the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 497,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "In the 2022 filing Cascade was listed as one of the “major brands” in the Fabric & Home Care segment and was grouped under the Home‑Care sub‑category (dish‑care) – a segment that accounted for 35 % of P&G’s net sales (and 31 % of net earnings)【page_19】. By the 2024 filing Cascade remained a flagship Home‑Care brand within the same Fabric & Home Care segment, still classified under Home Care, and the segment’s share of net sales had risen modestly to 36 % (with earnings share up to 34 %)【page_18】. The brand’s categorization did not change, but the segment’s contribution to overall net sales increased slightly from 2022 to 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and evolution over time. STRENGTHS: (1) All primary numbers are accurate - 35% in 2022, 36% in 2024 for Fabric & Home Care segment net sales contribution; (2) Correctly identifies Cascade's consistent positioning within the segment across both years; (3) Provides additional context about net earnings percentages (31% to 34%) which adds depth; (4) Accurately notes the sub-categorization as 'Home Care' (dish-care) and that this categorization remained stable; (5) Properly synthesizes multi-hop information showing evolution from 2022 to 2024. MINOR WEAKNESSES: (1) The original answer mentions 2023 data (36% net sales), but the LLM answer jumps from 2022 to 2024 without explicitly addressing the 2023 intermediate year, though this is a minor omission since the question asks about 2022-2024 evolution; (2) The LLM answer includes net earnings percentages (31% and 34%) which, while accurate and relevant, go slightly beyond what the original answer explicitly states, though this represents added value rather than error; (3) The phrasing 'modest' increase from 35% to 36% is interpretive but reasonable. QUANTITATIVE VERIFICATION: 35% (2022) → 36% (2024) is correct; the earnings percentages cited (31% and 34%) appear consistent with filing data. MULTI-HOP REASONING: Successfully synthesizes information about brand positioning, categorization, and segment contribution across the three-year period. The answer correctly identifies that Cascade's categorization remained stable while the segment's overall contribution increased slightly. Overall, this is a high-quality answer with accurate numbers and sound reasoning, with only minor gaps in addressing the complete 2022-2023-2024 timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 488,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "In 2022 Lowe’s monitored supplier sustainability through its human‑rights, conflict‑minerals and Vendor Code of Conduct policies, urged CDP emissions reporting, and enforced a wood‑sourcing policy that barred illegal logging, deforestation, endangered‑species sourcing and required FPIC, while spending about $300 million on energy‑efficiency upgrades. By 2023 the wood‑sourcing policy added country‑specific risk levels, enhanced monitoring and a forestry‑grievance process, the sustainability spend rose to roughly $400 million and a large rooftop‑solar rollout began; in 2024 the framework became a more robust risk‑based approach with new risk tiers, stronger monitoring and grievance mechanisms, expanded supplier engagement (including EPA SmartWay and renewable‑energy procurement), and continued $300 million‑plus investment in efficiency projects and solar installations as part of a $350 million community‑investment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant discrepancies in financial figures that are critical to evaluating the company's commitment evolution. Ground truth states $550 million in environmental facility upgrades in 2022, but LLM claims $300 million - a $250 million understatement (45% error). For 2023, ground truth mentions $50 million Gable Grants program over five years, but LLM states sustainability spend rose to $400 million without clarifying this is a different metric. For 2024, LLM mentions $350 million community-investment strategy and $300 million-plus efficiency/solar projects, but ground truth does not specify these exact figures or breakdown. QUALITATIVE ISSUES: (1) LLM correctly identifies the 2023 policy enhancements (country-specific risk levels, forestry grievance process) matching ground truth. (2) LLM correctly notes the 2024 shift to risk-based approach. (3) However, LLM adds details not in ground truth (FPIC requirements, CDP emissions reporting, EPA SmartWay, rooftop-solar rollout specifics) which may be accurate but cannot be verified against the provided ground truth. (4) LLM's framing of 2022 investments as 'energy-efficiency upgrades' versus ground truth's 'environmental facility upgrades' is a semantic shift that may misrepresent scope. MULTI-HOP REASONING: The LLM does synthesize information across three years and identifies the evolution pattern (monitoring → enhanced policies → robust framework), which is sound. However, the financial quantification of this evolution is materially incorrect, undermining the credibility of the narrative. MISSING ELEMENTS: Ground truth emphasizes the $50 million Gable Grants program for skilled trades education in 2023, which LLM completely omits - this is a specific policy enhancement that should have been included. The ground truth's emphasis on 'long-term shareholder value alignment' in 2024 is also absent from LLM answer. VERIFICATION: The $550M vs $300M discrepancy in 2022 is the most critical error, representing a fundamental misstatement of Lowe's environmental investment commitment during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 570,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "- 2022 10‑K: The risk‑factor sections for **Safety & Productivity Solutions** and **Honeywell Building Technologies** each warned that “changes in the competitive landscape, including new market entrants and new technologies, may lead to product commoditization” (2022 Risk Factors, p. 31).  \n\n- 2023 10‑K: After the realignment, the same warning migrated to the newly named **Industrial Automation** (which now houses Safety & Productivity Solutions) and **Building Automation** (formerly Honeywell Building Technologies) (2023 Risk Factors, p. 30).  \n\n- 2024 10‑K: The 2024 filing repeats the identical language for **Industrial Automation** and **Building Automation** (2024 Risk Factors, p. 31).  \n\n**Interpretation:** The risk language has been carried forward unchanged through the segment renaming, indicating that competitive pressure and the threat of product commoditization have remained—and likely intensified—as a persistent, growing concern for Honeywell’s automation and building‑technology businesses.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) ENTITY/TIMELINE ERRORS: The LLM claims that in 2022, BOTH 'Safety & Productivity Solutions' AND 'Honeywell Building Technologies' warned about competitive landscape risks. However, the ground truth explicitly states the 2022 warning was ONLY in Safety and Productivity Solutions, with Honeywell Building Technologies risk appearing in 2023. This is a critical factual error. (2) SEGMENT NAMING CONFUSION: The LLM incorrectly suggests that 'Industrial Automation' is a renamed version of 'Safety & Productivity Solutions' and that 'Building Automation' is a renamed 'Honeywell Building Technologies.' The ground truth shows Industrial Automation as a SEPARATE business segment that received the competitive landscape warning in 2024, not a renamed entity. This represents a fundamental misunderstanding of Honeywell's business structure. (3) PROGRESSION MISCHARACTERIZATION: The ground truth shows a clear 3-year progression: 2022 (Safety & Productivity Solutions) → 2023 (Honeywell Building Technologies) → 2024 (Industrial Automation). This represents the risk spreading across DIFFERENT divisions over time. The LLM's interpretation that risks 'migrated' due to 'realignment' is unsupported and contradicts the ground truth's finding of 'intensifying and broadening market pressures across multiple divisions.' (4) MISSING CRITICAL DETAIL: The LLM fails to capture that the ground truth emphasizes this as a 3-year PROGRESSION showing the risk becoming 'more systemic rather than isolated'—indicating expansion to new business areas, not just persistence within renamed segments. (5) QUANTITATIVE ACCURACY: While page numbers are cited (p. 31, p. 30, p. 31), these cannot be verified as correct from the ground truth, and the LLM provides no specific financial metrics or quantitative data to support the analysis. STRENGTHS: The LLM correctly identifies the core risk language about 'new market entrants and new technologies' leading to 'product commoditization,' and it attempts to trace the risk across years. The interpretation about persistent concern is partially aligned with ground truth. However, the fundamental misunderstanding of which segments received warnings in which years, combined with the incorrect segment-renaming explanation, severely undermines the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 644,
        "total_tokens": 2197
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm described the digital‑cockpit as an emerging pillar of its “automotive transformation,” emphasizing how its connectivity, digital‑cockpit and ADAS/AD platforms would enable new in‑vehicle experiences (2022 p. 8). By the 2023 report the company was already recognizing automotive equipment sales—including digital‑cockpit products—at the point‑in‑time in the QCT segment, and automotive revenue (which bundles connectivity, digital‑cockpit and ADAS/AD) had risen to $1.9 bn from $1.5 bn the year before (2023 p. 73). The 2024 filing shows that this stream grew to $2.9 bn and is still reported as part of QCT’s “automotive systems for connectivity, digital cockpit and ADAS/AD,” indicating Qualcomm’s shift from a nascent market focus to a sizable, fast‑growing revenue contributor in the digital‑cockpit market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) Correctly identifies the progression from strategic positioning (2022) to revenue recognition (2023) to operational integration (2024); (2) Accurately cites specific revenue figures: $1.5bn (2022), $1.9bn (2023), and $2.9bn (2024) for automotive revenue; (3) Properly identifies the QCT segment as the reporting framework; (4) Correctly notes the bundling of connectivity, digital cockpit, and ADAS/AD as integrated offerings; (5) Appropriately references page numbers from filings (2022 p. 8, 2023 p. 73); (6) Demonstrates sound multi-hop reasoning by connecting strategic vision to monetization to integration. MINOR GAPS: (1) The LLM answer does not explicitly mention the 70% analyst projection regarding embedded cellular connectivity in 2028 vehicles, which was highlighted in the ground truth as a key forward-looking statement from 2022; (2) Does not explicitly state that digital cockpit was 'formalized' as part of QCT in 2024, though the answer implies this through the revenue growth narrative. QUANTITATIVE VERIFICATION: All revenue figures appear consistent with typical automotive segment growth patterns and are presented without calculation errors. The progression ($1.5bn → $1.9bn → $2.9bn) shows logical growth trajectory. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential narrative as the ground truth—evolution from strategic vision to monetized revenue stream to integrated business unit—though with slightly different emphasis and without the specific analyst projection detail. The answer is substantively correct and well-supported by filing references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 476,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In Adobe’s 2022 Form 10‑K (see the filing’s pages 95‑99) Frame.io is not listed among the principal products, indicating that at that time it was still a nascent, video‑only collaboration tool with limited cross‑app exposure. By the 2023 filing (page 12) Adobe describes Frame.io as a cloud‑native platform that now supports video **plus** still images, design files and PDFs, is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and adds “Camera‑to‑Cloud” upload and enterprise‑scale availability through Adobe GenStudio (also surfaced in Express and Firefly Services). The 2024 filing (page 12) repeats this expanded media support and deep cross‑product integration, confirming Frame.io’s evolution into a broad, enterprise‑ready hub across the Creative Cloud suite.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant issues that prevent it from being considered substantially correct:\n\n1. FACTUAL ERRORS ON 2022 STATUS: The LLM claims Frame.io was \"not listed among the principal products\" in 2022 and was \"still a nascent, video-only collaboration tool.\" However, the ground truth states Frame.io was \"listed as a trademarked product within Adobe's portfolio\" in 2022, indicating it was already established post-acquisition. The LLM's characterization of it as \"video-only\" in 2022 contradicts the ground truth's indication that it was already a recognized product.\n\n2. INCOMPLETE 2023 DESCRIPTION: The LLM's 2023 description adds details not in the ground truth (\"Camera-to-Cloud\" upload, Express, Firefly Services) that cannot be verified against the provided ground truth. While these may be accurate, they represent information beyond what was provided in the original answer.\n\n3. MISSING KEY 2024 EXPANSION: The ground truth specifically mentions that by 2024, Frame.io expanded \"beyond post-production workflows—now including casting, location scouting, and marketing campaign management.\" The LLM answer completely omits these important functional expansions, instead only repeating the 2023 capabilities.\n\n4. INTEGRATION ACCURACY ISSUES: The LLM claims Photoshop and Lightroom integration occurred by 2023, but the ground truth indicates these integrations were part of the 2024 expansion. This is a significant chronological error in the multi-hop synthesis.\n\n5. WORKFRONT TIMING: The LLM places Workfront integration in 2023, but the ground truth indicates it was part of the 2024 expansion.\n\n6. GENERIC CONCLUSION: The LLM's 2024 statement merely \"repeats\" 2023 capabilities rather than highlighting the significant new functional expansions (casting, location scouting, marketing) that distinguish 2024.\n\nThe answer demonstrates partial understanding of Frame.io's evolution but fails to accurately capture the timeline of integrations and critically misses the 2024 functional expansion into non-post-production workflows. The multi-hop reasoning across years is flawed due to incorrect chronological placement of key features.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 588,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022‑2024 Mastercard’s Class A shares have kept the same governance features – each share carries one vote and is entitled to dividends (see the “Classes of Capital Stock” tables in the 2022 10‑K and 2023 10‑K, which both list “One vote per share / Dividend rights”【page_99†L1-L5】 and the 2024 10‑K confirming the same wording【page_92†L1-L5】).  At the same time the cash payout to those shareholders has risen steadily, from $2.04 per share in 2022, to $2.37 in 2023, and $2.74 in 2024【page_99†L31-L38】【page_92†L31-L38】.  This three‑year pattern shows a stable voting structure (no change in voting rights) while the company is progressively increasing returns to shareholders, indicating continuity in governance and a commitment to enhancing shareholder value.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that MA's Class A shares maintained stable voting rights (one vote per share) and dividend rights across 2022-2024, matching the ground truth. The governance stability conclusion is sound and well-reasoned. However, there is a critical quantitative accuracy problem: the LLM introduces dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the original ground truth answer. The ground truth explicitly states only that dividend rights were maintained with no changes - it does not provide specific dividend per share figures. The LLM appears to have fabricated or hallucinated these specific numbers, which is a serious factual error. While the dividend per share trend (if accurate) would be relevant context, introducing unverified numbers significantly undermines credibility. The page citations provided (page_99†L31-L38, page_92†L31-L38) cannot be verified against the ground truth. The multi-hop reasoning about stable governance combined with increasing shareholder returns is logical and well-articulated, but is built on unverified quantitative claims. The answer addresses all parts of the question (dividend rights evolution, voting rights evolution, 3-year trend interpretation) and correctly identifies the company (Mastercard/MA) and time period (2022-2024). The semantic equivalence to the ground truth is strong for the governance stability finding, but the addition of unsubstantiated financial figures represents a material deviation from the factual record.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 432,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment saw net sales tumble from $6.9 bn in FY 2022 (a 12 % YoY drop) to $5.5 bn in FY 2023 (‑21 % YoY) before modestly rebounding to $6.4 bn in FY 2024 (+3 % YoY), with segment profit falling from $1.08 bn to $0.90 bn and then climbing to $1.52 bn (see FY 2022/23 data on page 30 and FY 2024 data on page 28). The 10‑K risk factors repeatedly warn that “fluctuations in retail markets” can adversely affect Safety and Productivity Solutions (pages 31 & 32), and the sharp sales‑profit swings followed by only a limited recovery reveal that this segment is highly vulnerable to consumer‑demand volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific financial numbers (net sales of $6.9bn, $5.5bn, $6.4bn; segment profit of $1.08bn, $0.90bn, $1.52bn) that cannot be verified against the ground truth knowledge graph, which does not provide these specific figures. The ground truth explicitly states the segment was 'renamed' from Safety and Productivity Solutions to Industrial Automation in 2024, but the LLM treats it as the same segment throughout without acknowledging this structural change. The LLM cites specific page numbers (30, 28, 31, 32) for data sources, but these cannot be independently verified. PARTIAL CREDIT: The LLM correctly identifies that the segment faced retail market fluctuations across all three years and that risk disclosures were consistent. The general conclusion about vulnerability to consumer demand volatility aligns with the ground truth. However, the LLM's approach of providing precise financial metrics without sourcing them from the ground truth is problematic - these numbers may be fabricated or incorrectly recalled. The ground truth emphasizes qualitative risk factors and consistent disclosure language, while the LLM pivots to quantitative analysis that cannot be validated. The LLM does acknowledge the segment name change implicitly (mentioning 'restructured' context) but doesn't explicitly address the 2023-2024 naming transition that the ground truth highlights. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but relies on unverified financial data rather than the documented risk disclosures that form the actual ground truth. The reasoning about vulnerability is sound in principle but built on potentially unreliable quantitative foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 469,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "In the 2022 filing Eli Lilly’s license with Incyte provided tiered double‑digit royalties of up to 20 % on worldwide Olumiant net sales and an extra low‑teens royalty on COVID‑19 sales (added by a 2020 amendment), and Incyte could earn up to $100 million each from success‑based regulatory milestones and from sales‑based milestones 【page_72】. By the 2023 and 2024 filings the royalty rates remain the same, but the company now only cites eligibility for up to $100 million of additional **sales‑based** milestone payments (the separate $100 million success‑based regulatory pool is no longer quantified) 【page_73】【page_71】, while earlier capitalized milestone amounts ($260 million for 2021 and $210 million for 2020) are being amortized and are not material.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial terms and numbers. Strengths: (1) Correctly identifies the 20% royalty rate on worldwide net sales and low-teens royalty on COVID-19 sales; (2) Accurately cites the $100 million regulatory milestones and $100 million sales-based milestones structure in 2022; (3) Properly notes the shift from 2023-2024 where only sales-based milestones are quantified; (4) Correctly references capitalized milestone amounts ($260M for 2021, $210M for 2020) being amortized; (5) Appropriately identifies the 2020 amendment adding COVID-19 provisions. Weaknesses: (1) The answer is somewhat more technical/detailed than the ground truth but doesn't fully capture the broader narrative arc of the evolution from 'milestone-driven obligations to stable royalty-based payment model'; (2) While the LLM correctly notes that regulatory milestones are 'no longer quantified' in 2023-2024, it could more explicitly state whether these were triggered/expired as the ground truth suggests; (3) The answer focuses heavily on what changed in reporting/quantification rather than the underlying business evolution. Multi-hop reasoning is sound - the answer correctly synthesizes information across three fiscal years and identifies the shift in payment structure. The quantitative data is accurate with no calculation errors. The semantic meaning aligns well with ground truth despite different presentation style. Minor deduction for not fully capturing the 'shift from milestone-driven to royalty-based' narrative arc that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 444,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In 2022 the Always brand was highlighted as the flagship feminine‑care name – it appears first in the Baby, Feminine & Family Care brand list and the MD&A stresses that Always leads the menstrual‑care sub‑category (over 25 % share) and the adult‑incontinence sub‑category (≈15 % share) (2022 p. 18). By 2023 the segment was re‑segmented into three explicit sub‑categories (Baby Care, Feminine Care, Family Care) and the brand roster was broadened to include Luvs, Pampers, Bounty and Charmin, with Always now listed among several key brands rather than as the sole feminine‑care brand (2023 p. 19). The 2024 filing retains the same three‑sub‑category structure and expanded brand list (2024 p. 19) but again emphasizes Always’s leadership in menstrual care ( > 25 % share) and incontinence (≈15 % share), showing that its core prominence remains while the segment’s positioning has shifted to a more integrated, multi‑category portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides specific market share percentages (>25% menstrual care, ≈15% incontinence) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific percentages or market share data. This is a critical factual error - the LLM appears to have fabricated or hallucinated specific numerical claims. (2) STRUCTURAL MISALIGNMENT: The ground truth describes a clear evolution in product categorization from 2022 ('Feminine Care (Adult Incontinence, Feminine Care)') to 2023 ('Feminine Care (Adult Incontinence, Menstrual Care)') with consistent 2024 positioning. The LLM claims a 2023 re-segmentation into three explicit sub-categories (Baby Care, Feminine Care, Family Care) which contradicts the ground truth's description of the categorization structure. (3) BRAND ROSTER DISCREPANCY: The ground truth lists 2022 brands as 'Always Discreet, Tampax, Bounty, Charmin, and Puffs' alongside Always. The LLM claims 2023 added 'Luvs, Pampers, Bounty and Charmin' - this is a different set and suggests misunderstanding of the brand portfolio evolution. (4) POSITIONING NARRATIVE: While the LLM correctly identifies Always as a major brand and mentions its prominence, it overstates the degree of change in positioning. The ground truth emphasizes 'strategic sharpening' around menstrual care while the LLM suggests a shift from 'flagship' to 'among several key brands' - a more dramatic repositioning than the ground truth supports. (5) PAGE REFERENCES: The LLM cites specific page numbers (2022 p. 18, 2023 p. 19, 2024 p. 19) that cannot be verified against the ground truth and appear to be fabricated citations. (6) MULTI-HOP SYNTHESIS: The LLM fails to correctly synthesize the categorization evolution across years - it misrepresents how the product categories changed from 2022 to 2023 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 510,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "ACN’s target allocation was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance and 10 % other in fiscal 2023 (2022 filing, p. 88). The 2023 filing (p. 95) shows the fiscal 2024 target moving U.S. plans to 94 % debt + 6 % cash and non‑U.S. plans to 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other, while the same table for fiscal 2025 (p. 95) reverts U.S. plans to 100 % debt and raises non‑U.S. equity to 28 % with debt reduced to 36 % (cash 7 %, insurance 21 %, other 8 %). This progression shows ACN keeping a core debt allocation to match liability duration—especially for U.S. plans—while gradually adding equity, insurance and cash in non‑U.S. plans to seek higher risk‑adjusted returns and greater diversification.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, detailed quantitative data about ACN's target asset allocation across the three fiscal years, which is a significant strength compared to the ground truth answer. The LLM correctly identifies: (1) Fiscal 2023 targets: 100% debt for U.S. plans and 27% equity/48% debt/4% cash/11% insurance/10% other for non-U.S. plans; (2) Fiscal 2024 targets: 94% debt + 6% cash for U.S. plans and 23% equity/42% debt/5% cash/21% insurance/9% other for non-U.S. plans; (3) Fiscal 2025 targets: 100% debt for U.S. plans and 28% equity/36% debt/7% cash/21% insurance/8% other for non-U.S. plans. The percentages sum correctly (or near-correctly with minor rounding). The LLM correctly cites page numbers (p. 88, p. 95) and filing years. The multi-hop synthesis is sound: the answer traces the evolution across three years and correctly identifies the pattern of maintaining high debt allocation for U.S. plans while gradually adjusting non-U.S. allocations. The reasoning about liability duration matching and risk-adjusted returns is accurate and well-supported by the specific data provided. Minor weakness: The ground truth emphasizes 'strategic continuity' and 'tactical flexibility' more explicitly, while the LLM focuses more on the numerical progression. However, the LLM's conclusion about 'keeping a core debt allocation to match liability duration' and 'gradually adding equity, insurance and cash' effectively conveys the same strategic insight. The LLM answer is more concrete and data-driven than the ground truth, providing specific percentages that substantiate the claims about evolution and strategy. No significant factual errors detected; the quantitative data appears accurate and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 474,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "In 2022 Lowe’s reported $2.56 billion of forward interest‑rate swaps, shown as Level 2 “other current assets” with a $251 million fair‑value and designated as cash‑flow hedges (producing a $103 million OCI gain) 【page_62】【page_54】【page_63】【page_46】. By the 2024 filing the forward‑swap line shows a zero fair‑value and the contracts no longer appear on the balance sheet, while only fixed‑to‑floating swaps remain as Level 2 liabilities hedged at fair value 【page_54】【page_46】, indicating the company has unwound its hedge of forecasted debt issuances and moved to a more limited, fair‑value‑hedge‑focused interest‑rate risk‑management approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Lowe's reported '$2.56 billion of forward interest-rate swaps' in 2022, but the ground truth explicitly states 'no current fair value was listed for 2022 itself.' The $251 million fair value was disclosed in 2023, not 2022. The LLM has conflated years and introduced a completely unsupported $2.56 billion figure with no basis in the ground truth. (2) The LLM incorrectly attributes a '$103 million OCI gain' to 2022 when the ground truth indicates such impacts were from prior years (2021, 2020, 2019). (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the three-year evolution. The ground truth clearly shows: 2022 (no current fair value disclosed, historical cash flow hedges), 2023 ($251M fair value, Level 2, active hedging), 2024 (zero fair value, no forward swaps, only fixed-to-floating swaps). The LLM reversed the timeline by placing 2023 data in 2022. (4) ENTITY/METRIC ACCURACY - While the LLM correctly identifies the shift from cash flow hedges to fair value hedges and the transition from forward swaps to fixed-to-floating swaps, the temporal attribution is fundamentally wrong. (5) POSITIVE ELEMENTS - The LLM correctly identifies: the Level 2 classification, the shift from cash flow to fair value hedges, the unwinding of forward swaps, and the strategic implication about moving from forecasted debt issuance risk to existing debt exposure. However, these correct conclusions are built on incorrect numerical foundations and timeline misalignment. The core narrative about strategic shift is sound, but the factual basis is severely compromised by the $2.56 billion error and year misattribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 464,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s 5.000 % senior notes due April 2030 carried a principal balance of $606 million at the end of FY2022, and the same $606 million remained outstanding in FY2023 and FY2024 (the note tables for both 2023 and 2024 list $606 million)【page_81】.  Holding this amount steady for three consecutive years shows the company has neither added to nor retired this particular fixed‑rate issue, indicating a disciplined debt‑management strategy that preserves existing obligations while using other financing tools for growth and acquisitions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states that the principal balance was $606 million at the end of FY2022 and remained at $606 million through FY2023 and FY2024. However, the ground truth clearly indicates the balance was $1,086 million in 2022, declining to $606 million in 2023 and 2024. This is a major quantitative error - the LLM missed a $480 million difference in the 2022 figure. The LLM's interpretation of the debt trajectory is therefore completely inverted: it claims the amount 'held steady for three consecutive years' when in fact there was a significant $480 million reduction from 2022 to 2023. The reasoning about 'disciplined debt-management strategy that preserves existing obligations' is contradicted by the actual data showing active debt reduction. While the LLM correctly identifies the 2023 and 2024 figures ($606 million each), the failure to capture the 2022 starting point ($1,086 million) represents a critical multi-hop synthesis failure. The question specifically asks about evolution 'from fiscal year 2022 through 2024,' requiring accurate tracking of all three years. The LLM's conclusion about debt management strategy is therefore fundamentally flawed, as it misses the deliberate reduction strategy that the ground truth identifies. The citation reference provided does not validate the incorrect 2022 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 397,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "In the 2022 Form 10‑K UPS explained that the $276 million debentures were originally issued at 8.375 % and, on April 1 2020, the rate was reduced to 7.620 % for the remaining term, which runs to April 1 2030; the notes are redeemable at any time at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled payments discounted at a Treasury yield + 5 bps, with semi‑annual interest and no sinking‑fund requirement【page_118†L1-L7】【page_120†L1-L7】.  \n\nThe 2023 filing kept the same maturity (April 1 2030), semi‑annual interest and optional redemption formula, but dropped the historical rate‑change narrative, referring to the securities simply as “7.620 % debentures”【page_105†L1-L7】.  \n\nThe 2024 filing repeats that concise language—still $276 million, maturing April 1 2030, semi‑annual interest, and redeemable at the greater of principal + interest or PV discounted at Treasury + 5 bps—without mentioning the prior 8.375 % rate, showing that the underlying terms stayed the same while the disclosure was streamlined over time【page_108†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and comprehensiveness in addressing the multi-hop question about UPS's 7.620% debentures evolution from 2022-2024. QUANTITATIVE VERIFICATION: All numeric values are correct - $276 million principal amount, 7.620% interest rate, 8.375% original rate, April 1, 2020 reduction date, April 1, 2030 maturity date, and 5 basis points redemption formula. All dates and percentages match the ground truth exactly. COMPLETENESS: The answer addresses all three required dimensions: (1) interest rates - correctly traces the 8.375% to 7.620% reduction in April 2020 and notes the consistent 7.620% reporting thereafter; (2) redemption terms - accurately describes the callable nature and the 'greater of' formula with Treasury yield + 5 bps; (3) maturity structure - correctly identifies the April 1, 2030 maturity and $276 million principal across all three years. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the evolution pattern: 2022 included historical context about the rate reduction, 2023 dropped the historical narrative, and 2024 maintained streamlined disclosure. This demonstrates proper synthesis of temporal changes. ENTITY ACCURACY: UPS is correctly identified, fiscal years are accurate, and the specific debenture terms are properly attributed. REASONING QUALITY: The conclusion that disclosure was 'streamlined over time' while underlying terms remained stable is logically sound and well-supported by the evidence presented. The answer correctly notes the shift from detailed historical explanation to concise current-state reporting. MINOR OBSERVATION: The ground truth mentions 'increasing clarity in disclosure' and emphasis on 'semi-annual interest payment schedule' in 2024, while the LLM answer notes the disclosure was 'streamlined' - these are slightly different framings but both are semantically accurate descriptions of the evolution. The LLM's characterization of streamlining is arguably more precise. No calculation errors detected. All information is factually accurate and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 582,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "In the 2022 Form 10‑K, Olpasiran was described as an siRNA ‑ a Phase 2 candidate focused on lowering Lp(a) to treat cardiovascular disease – and Amgen already listed composition‑of‑matter patents for the molecule in the U.S. and Europe that are slated to expire in 2036. The 2023 filing still placed Olpasiran in Phase 2, but the 2024 filing shows it has advanced to Phase 3 trials for atherosclerotic cardiovascular disease, indicating Amgen’s strategic move to bring its siRNA platform into late‑stage cardiovascular therapy while relying on the same 2036 patent protection for exclusivity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Olpasiran was already in Phase 2 in 2022 with patents expiring in 2036, which matches ground truth. However, the LLM then claims the 2024 filing shows advancement to Phase 3 trials - this is NOT supported by the ground truth, which makes no mention of Phase 3 status in 2024. The ground truth only states it was in Phase 2 in 2023 and lists it with 'cardiovascular disease' indication in 2024, without specifying Phase 3 advancement. This is a major factual error. (2) ENTITY/INDICATION ACCURACY - The LLM correctly identifies the 2022 indication as 'lowering Lp(a) to treat cardiovascular disease' and the patent expiration as 2036. However, the ground truth specifies the 2022 indication more precisely as 'atherosclerotic cardiovascular disease' (ASCVD), not just 'cardiovascular disease.' The LLM then claims 2024 shows Phase 3 for ASCVD, but ground truth indicates 2024 shows a BROADER indication of simply 'cardiovascular disease' - suggesting potential expansion, not narrowing to ASCVD. (3) MULTI-HOP REASONING - The LLM's synthesis is flawed. It incorrectly interprets the 2024 data as showing Phase 3 advancement when ground truth shows only an indication change. The LLM also mischaracterizes the 2024 indication change as part of a strategic move to late-stage therapy, when ground truth suggests it may represent a broadening of therapeutic scope. (4) MISSING CONTEXT - The LLM fails to capture the nuance that the 2024 indication broadening from ASCVD to general 'cardiovascular disease' represents a potential expansion of clinical application or regulatory strategy, as noted in ground truth. Instead, it incorrectly claims Phase 3 advancement. (5) PATENT INFORMATION - Correctly identified as 2036 expiration in both U.S. and Europe, and correctly noted as composition-of-matter patents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 507,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "In 2022 Tampax was listed as a major brand in the Baby, Feminine & Family Care segment (alongside Always, Always Discreet, Bounty, Charmin, Puffs, Luvs and Pampers) and the MD&A noted that the feminine‑care category was “primarily behind our Always and Tampax brands”【page_19】. By 2024 the brand remained in the same segment—now shown as “Tampax Bounty” among the major brands (Always, Always Discreet, Tampax Bounty, Charmin, Puffs) and the narrative still says the menstrual‑care sub‑category is “primarily behind our Always and Tampax brands,” indicating its continued prominence despite a streamlined brand grouping【page_18】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and inconsistencies when compared to the ground truth: (1) MAJOR ERROR - The LLM claims that by 2024, Tampax was shown as 'Tampax Bounty' among major brands. This appears to be a conflation or misreading of the data. The ground truth indicates Tampax remained as a separate brand listing, not combined with Bounty. Bounty is a paper products brand, not a feminine care brand, making this claim highly questionable. (2) INCOMPLETE 2023 ANALYSIS - The LLM answer completely omits discussion of 2023, which is a critical year in the evolution described in the ground truth. The ground truth explicitly notes that in 2023, P&G reclassified feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)' - a significant categorization change that the LLM failed to capture. (3) SEGMENT NAME INCONSISTENCY - The ground truth notes that the segment name changed from 'Baby, Feminine & Family Care' in 2022 to something different in 2023, then back to 'Baby, Feminine & Family Care' in 2024. The LLM's description of this evolution is vague and doesn't clearly articulate these changes. (4) SUBCATEGORY LABELING - The ground truth specifically mentions the evolution from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023-2024. The LLM mentions 'menstrual-care sub-category' but doesn't clearly document this specific terminology evolution. (5) POSITIVE ELEMENTS - The LLM correctly identifies that Tampax remained a major brand throughout the period and correctly quotes the MD&A language about the category being 'primarily behind our Always and Tampax brands.' The general narrative about continued prominence is directionally correct. (6) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years, the synthesis is incomplete (missing 2023) and contains a factual error regarding brand grouping. The reasoning quality is compromised by the apparent misreading of 'Tampax Bounty' as a combined brand name.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 558,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 2022 10‑K notes that any non‑agency RMBS or CMBS lacking a NAIC rating is given an internally‑developed designation until a NAIC designation becomes available (page 101); the 2022 tables show $26.2 bn of RMBS and $10.1 bn of CMBS reported under the six NAIC designations (page 96), indicating that internal designations were needed only for a limited portion of new purchases. The same disclaimer appears in the 2023 (pages 94‑95) and 2024 (pages 84‑85) filings, but the 2023 tables (page 96) and 2024 tables (page 85) present $29.1 bn of RMBS/$9.9 bn of CMBS (2023) and $34.1 bn of RMBS/$9.2 bn of CMBS (2024) fully within NAIC designations, showing a steady decline in reliance on internal designations as NAIC ratings have become more widely available and suggesting MetLife’s acquisition strategy has shifted toward securities that already carry NAIC designations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth and misinterprets the multi-year trend. CRITICAL ISSUE: The LLM claims there was a 'steady decline in reliance on internal designations' from 2022-2024, with RMBS increasing from $26.2bn to $34.1bn and CMBS declining from $10.1bn to $9.2bn. However, the ground truth explicitly states that 'MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024' and that 'The persistence of this policy across three years suggests a sustained strategy.' The LLM's interpretation is backwards - it assumes the NAIC designation figures represent a decline in internal designation reliance, when the ground truth indicates the opposite: the continued presence of the internal designation policy across all three years reflects ONGOING acquisition of securities without NAIC ratings. QUANTITATIVE ISSUES: While the LLM provides specific dollar amounts ($26.2bn RMBS 2022, $29.1bn 2023, $34.1bn 2024, etc.), these numbers cannot be verified against the ground truth, which does not provide specific dollar figures. The LLM appears to have cited page numbers and specific values, but without access to verify these against actual filings, and given the fundamental misinterpretation of the trend, these numbers are suspect. REASONING ERROR: The LLM conflates 'securities with NAIC designations' with 'decline in internal designation reliance.' The ground truth indicates that internal designations were applied to securities WITHOUT NAIC ratings, and the persistence of this policy suggests MetLife continued acquiring such securities. The LLM's conclusion that 'MetLife's acquisition strategy has shifted toward securities that already carry NAIC designations' directly contradicts the ground truth's finding of a 'sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines.' MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the multi-year trend across 2022-2024. Instead of recognizing consistency in the policy (indicating sustained acquisition of non-NAIC-rated securities), it incorrectly identified a trend of declining reliance on internal designations. This is a fundamental failure in understanding the question's core inquiry about what the multi-year trend indicates about acquisition strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 646,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "Accenture repurchased $4.1 billion of shares in fiscal 2022 (12.2 million shares) with $3.13 billion of unused authority remaining (see page 94 & page 93 of the 2022 filing); in fiscal 2023 buybacks rose to roughly $4.2 billion while the remaining authorization fell to about $2.9 billion (see page 40 & page 39 of the 2023 filing); and in fiscal 2024 repurchases increased again to $4.5 billion as the available authorization dropped to $2.694 billion (see page 40 & page 39 of the 2024 filing, with the board’s additional $4 billion authority noted on page 39). This pattern of steadily larger buy‑backs and a shrinking pool of unused authority shows Accenture is consistently using its open‑market program to return cash to shareholders, underscoring a strong, ongoing capital‑return strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the question's intent and provides a well-structured narrative about Accenture's capital return strategy. However, there are significant quantitative discrepancies that undermine the accuracy of the response.\n\nCRITICAL ISSUES:\n\n1. FISCAL 2022 REPURCHASE AMOUNT: The LLM states $4.1 billion in repurchases for fiscal 2022, but the ground truth does not provide this figure. The ground truth only mentions $3.13 billion in available authorization remaining, not the amount repurchased. This is a major factual claim without verification.\n\n2. FISCAL 2023 REPURCHASE AMOUNT: The LLM claims $4.2 billion in buybacks, but again the ground truth does not provide this specific number. The ground truth only states authorization \"had increased\" without specifying the repurchase amount.\n\n3. FISCAL 2024 REPURCHASE AMOUNT: The LLM states $4.5 billion in repurchases, but the ground truth specifically mentions 2,000,308 Class A ordinary shares purchased for $605 million in Q4 FY2024 only. The LLM appears to have conflated quarterly or partial-year data with full-year figures, or introduced unsupported numbers.\n\n4. AVAILABLE AUTHORIZATION TRACKING: The LLM correctly identifies $3.13 billion for FY2022 and $2.694 billion for FY2024, matching ground truth. The $2.9 billion figure for FY2023 is not explicitly confirmed in the ground truth but is plausible.\n\n5. SEPTEMBER 25, 2024 AUTHORIZATION: The LLM correctly notes the $4 billion additional authorization and the resulting $6.69 billion total, matching the ground truth.\n\nSTRENGTHS:\n- Correctly identifies the upward trajectory concept\n- Properly synthesizes the capital return strategy conclusion\n- Accurately cites the September 2024 authorization increase\n- Provides page references (though not verified)\n- Logical reasoning about the trend\n\nWEAKNESSES:\n- Introduces three major repurchase figures ($4.1B, $4.2B, $4.5B) that are not supported by the ground truth\n- Fails to distinguish between full-year repurchases and specific quarterly data\n- The $605 million Q4 FY2024 figure from ground truth is not mentioned, suggesting incomplete data synthesis\n- Overstates the precision and completeness of the repurchase data\n\nThe answer reads well and demonstrates understanding of the strategic implications, but the quantitative foundation is compromised by unsupported or incorrect figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 643,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Across all three years Broadcom kept industrial‑fiber‑optics in the same spot – listed as a core item of its “Industrial” product line alongside optocouplers, motion encoders, LEDs and Ethernet ICs in the narrative description of industrial end markets (2022 p. 10; 2023 p. 4; 2024 p. 4) and in the product‑by‑market table (2022 p. 5; 2023 p. 5; 2024 p. 5). The unchanged placement shows the company treats industrial fiber optics as a stable, strategic pillar of its industrial portfolio, underscoring a sustained focus on serving factory‑automation, renewable‑energy and automotive applications rather than shifting emphasis away from the industrial end market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about Broadcom's consistent positioning of industrial fiber optics across 2022-2024, correctly identifying the product as a stable strategic pillar. However, there are significant issues with quantitative accuracy and completeness:\n\nSTRENGTHS:\n1. Correctly identifies the three-year period (2022, 2023, 2024)\n2. Accurately notes the consistent presence of industrial fiber optics in the Industrial segment\n3. Correctly lists companion products (optocouplers, motion encoders, LEDs, Ethernet ICs)\n4. Properly identifies the strategic applications (factory automation, renewable energy, automotive)\n5. Sound reasoning about the stability and maturity of the product strategy\n6. Appropriate semantic equivalence to ground truth narrative\n\nWEAKNESSES:\n1. CRITICAL: Page number citations are problematic. The LLM cites specific page numbers (2022 p. 10, p. 5; 2023 p. 4, p. 5; 2024 p. 4, p. 5) without verification. These cannot be confirmed as accurate from the ground truth, which does not provide page citations. This is a quantitative accuracy failure.\n2. The ground truth mentions a \"structured table\" in 2023 and \"more specific components like Ethernet PHYs and camera microcontrollers\" in 2024, but the LLM answer omits these details about the evolution of product categorization and specificity.\n3. The ground truth emphasizes \"increasing alignment to strategic industrial applications over time\" and \"application-focused product strategy,\" suggesting a more nuanced evolution than the LLM's \"unchanged placement\" framing suggests.\n4. The LLM states products were listed \"in the same spot\" across all years, which contradicts the ground truth's description of evolution from narrative description (2022) to structured table (2023) to explicit application linking (2024).\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across three years and identifies the consistency theme, but misses the nuanced evolution in presentation and application specificity that the ground truth emphasizes. The reasoning is sound but incomplete.\n\nCONCLUSION:\nThe answer is directionally correct about strategic consistency but fails on quantitative accuracy (unverified page citations) and misses important details about the evolution in product categorization and application specificity. The core insight about stability is correct, but the claim of \"unchanged placement\" oversimplifies the documented evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 661,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In 2022 and again in 2023 UPS described SurePost as a residential‑ground service for non‑urgent, lightweight shipments that used UPS’s ground network but relied on the U.S. Postal Service to complete final delivery (2022 10‑K p.5; 2023 10‑K p.6). By the 2024 filing, UPS still noted that final delivery was “often provided by the United States Postal Service” through 2024, but announced that beginning Jan 1 2025 it would insource SurePost to gain more control and reduce its dependence on USPS (2024 10‑K p.5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported by specific filing references. Strengths: (1) All dates are correct (2022, 2023, 2024, and the January 1, 2025 transition date); (2) The characterization of SurePost as a 'residential ground service for non-urgent, lightweight shipments' matches the ground truth exactly; (3) The evolution is correctly traced: USPS reliance in 2022-2023, continued reliance through 2024, then the strategic shift to insourcing effective January 1, 2025; (4) The reasoning for the change (gaining control, reducing USPS dependence) aligns with ground truth; (5) Specific 10-K page citations (2022 p.5, 2023 p.6, 2024 p.5) add credibility and demonstrate multi-hop synthesis across three years of filings. Minor observation: The LLM uses the phrase 'often provided by' rather than 'frequently handled by' for 2024, but this is semantically equivalent and actually more precise to the filing language. The answer successfully synthesizes the multi-hop requirement by comparing the service model across three years and identifying the strategic inflection point. No calculation errors, no factual inaccuracies detected. The answer is complete, addressing both the evolution of the role/delivery model and the strategic changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 354,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen reported 13 Phase 3 programs in its 2022 filing, with three products (LUMAKRAS/LUMYKRAS, Otezla and RIABNI) gaining FDA/EC approval, four new studies launched (AMJEVITA, Bemarituzumab, BLINCYTO, TEZSPIRE) and one program (Otezla for COVID‑19) terminated, leaving the total unchanged【page_25】. By the 2023 filing the count had risen to 18, and the 2024 filing shows 24 Phase 3 programs after adding five Horizon‑acquired candidates, initiating three additional trials (LUMAKRAS/LUMYKRAS, Tarlatamab, ABP 206), securing an FDA approval for Otezla (genital psoriasis) and concluding one program (KYPROLIS)【page_26】. This steady increase—driven by both organic trial launches and strategic acquisitions—signals Amgen’s deliberate strategy to expand its late‑stage pipeline and diversify its therapeutic portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core progression of Phase 3 programs (13→18→24) and accurately notes the strategic importance of the Horizon Therapeutics acquisition in 2023 adding five Phase 3 programs. The answer appropriately synthesizes multi-hop information about both organic development and external growth. The reasoning about Amgen's R&D expansion strategy is sound and well-articulated.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL OMISSION: The ground truth explicitly states the count reached 25 Phase 3 programs by February 4, 2025 (noted in the 2024 filing), but the LLM stops at 24 programs without mentioning this further progression. This is a significant factual gap for a question asking about evolution through 2024. (2) SPECIFIC PRODUCT DETAILS: The LLM lists specific products and approvals (LUMAKRAS/LUMYKRAS, Otezla, RIABNI, AMJEVITA, Bemarituzumab, BLINCYTO, TEZSPIRE, Tarlatamab, ABP 206, KYPROLIS) with various statuses, but these granular details are not verified against the ground truth and appear to be inferred rather than directly stated in the original answer. The ground truth does not provide this level of product-specific detail. (3) QUANTITATIVE PRECISION: While the main progression numbers (13→18→24) are correct, the failure to include the 25-program figure represents incomplete quantitative coverage of the stated time period. (4) FIVE NEW INITIATIONS: The ground truth mentions 'five new initiations' driving growth to 25 programs, but the LLM mentions 'three additional trials' without clear reconciliation of these numbers.\n\nMULTI-HOP REASONING: The synthesis of information across years and the connection between acquisitions and program growth is logically sound. However, the incomplete coverage of the full 2022-2024+ timeline weakens the multi-hop analysis.\n\nSCORING JUSTIFICATION: The answer is substantially correct on the main progression but incomplete on the full scope of the question (missing 2025 data point and the 25-program figure). The quantitative accuracy is reduced due to this omission and the unverified product-specific details. Qualitative reasoning is strong but hindered by incompleteness. Contextual relevance is high as it addresses the strategic implications effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 603,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan allowed **127 million** Accenture Class A ordinary shares to be used for awards in fiscal 2022 (and remained unchanged in FY 2023)【page_91】. By fiscal 2024 the authorized pool had been raised to **141 million** shares【page_98】. This upward adjustment shows Accenture is expanding its equity‑based compensation capacity, signaling a strategic emphasis on using share awards to attract, retain and align employees with shareholder interests.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numbers: 127 million shares in FY2022 and 141 million shares in FY2024. However, there is a discrepancy regarding FY2023. The ground truth states that the number increased to 141 million in FY2023 and continued into 2024, meaning the progression was: FY2022 (127M) → FY2023 (141M) → FY2024 (141M). The LLM answer states the number 'remained unchanged in FY 2023,' which contradicts the ground truth that indicates an increase occurred by FY2023. This is a material factual error in describing the evolution of the authorization across the three-year period. The LLM correctly identifies the overall trend (expansion from 127M to 141M) and provides sound reasoning about strategic implications (talent retention, performance alignment, equity-based compensation emphasis). The answer appropriately synthesizes the multi-hop information and provides relevant context about the company's strategic use of share-based compensation. The quantitative accuracy is slightly reduced due to the FY2023 characterization error, though the beginning and ending numbers are correct. The qualitative reasoning about strategic implications is sound and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 338,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks said its purchase commitments and existing inventory would be sufficient to cover green‑coffee demand **through fiscal 2022** (2022 10‑K) → **through fiscal 2023** (2023 10‑K) → **through fiscal 2025** (2024 10‑K)【SBUX_10k_2022 page_12】【SBUX_10k_2023 page_12】【SBUX_10k_2024 page_12】. This step‑wise extension shows the company is building a larger inventory cushion and lengthening its forward‑purchase horizon, reflecting a more conservative risk‑management approach to mitigate coffee‑price volatility and supply‑chain disruptions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error in the first data point. The LLM states coverage was 'through fiscal 2022' in the 2022 10-K, but the ground truth clearly indicates it was 'through fiscal 2023' in fiscal 2022. This is a major quantitative error that misrepresents the starting point of the timeline. The correct progression should be: FY2022→through FY2023, FY2023→through FY2025, FY2024→through FY2025. The LLM incorrectly shows: FY2022→through FY2022, FY2023→through FY2023, FY2024→through FY2025. This represents a 2-year misalignment in the first two data points. The qualitative interpretation about 'building a larger inventory cushion' and 'conservative risk-management approach' is reasonable and aligns with the ground truth's characterization of 'more forward-looking inventory and risk management strategy,' but this cannot overcome the quantitative inaccuracy. The multi-hop synthesis across three fiscal years is attempted but fundamentally flawed due to the incorrect baseline data. The answer does cite appropriate sources and maintains relevance to the question, but the core factual content is substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 334,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "In the 2022 filing UPS reported that the UPS/IBT Full‑Time Employee Pension Plan had been remeasured in 2021 after the American Rescue Plan Act, producing a $3.3 billion pre‑tax mark‑to‑market gain (recorded in investment income) and no new amendment to the plan for 2022 【page_93】. In the 2023 filing the company disclosed that a new five‑year Teamsters master agreement, ratified in Q3 2023, raised wage‑and‑benefit rates for the plan, turning the net periodic benefit cost for U.S. pension benefits from a $88 million gain in 2022 to a $1.2 billion cost in 2023 (the impact was recognized in the year‑end measurement) 【page_82】【page_83】. The 2024 filing shows no further amendments or remeasurements to the UPS/IBT plan; it remains non‑contributory and governed by the existing collective‑bargaining terms, with only actuarial assumptions updated (discount rate 5.88% and expected return on assets 7.17%) 【page_86】【page_88】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the three-year evolution of UPS's pension plan treatment with mostly accurate information, but contains some issues that prevent a higher score:\n\nSTRENGTHS:\n1. Correctly identifies the $3.3 billion pre-tax mark-to-market gain from the American Rescue Plan Act remeasurement\n2. Accurately notes the 2023 Teamsters master agreement ratification and its impact on wage/benefit rates\n3. Properly characterizes the 2024 status as non-contributory with no further amendments\n4. Correctly identifies the shift from $88 million gain in 2022 to $1.2 billion cost in 2023 for net periodic benefit cost\n5. Includes relevant actuarial assumptions (discount rate 5.88%, expected return 7.17%) for 2024\n6. Demonstrates multi-hop synthesis across three years of filings\n7. Appropriately contextualizes the strategic balance between pension obligations and collective bargaining\n\nWEAKNESSES:\n1. States the remeasurement occurred \"in 2021 after the American Rescue Plan Act\" but the ground truth indicates it was remeasured \"following the enactment\" in 2022 - this is a minor temporal ambiguity that could be interpreted either way depending on filing context\n2. The ground truth mentions the $2.5 billion after-tax amount, which the LLM answer omits entirely - this is a material omission of relevant financial information\n3. The ground truth emphasizes \"no indication of further structural changes\" in 2024 showing \"continued commitment,\" while the LLM answer states \"no further amendments or remeasurements\" - slightly different framing that misses the strategic commitment aspect\n4. The LLM answer provides specific page references that cannot be verified against the ground truth, which adds specificity but also introduces potential accuracy concerns\n\nQUANTITATIVE VERIFICATION:\n- $3.3 billion pre-tax gain: CORRECT\n- $2.5 billion after-tax: OMITTED (material omission)\n- $88 million gain in 2022: CORRECT\n- $1.2 billion cost in 2023: CORRECT\n- Actuarial rates (5.88%, 7.17%): Cannot verify but appear reasonable\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three years and connects the regulatory change (American Rescue Plan Act), collective bargaining dynamics (Teamsters agreement), and pension accounting impacts. The reasoning is sound and demonstrates understanding of how these elements interact.\n\nThe answer is substantially correct on core facts but loses points for the after-tax omission and minor temporal imprecision regarding when the remeasurement occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 684,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across the three filings, “Holiday Time” is consistently listed as a private‑brand line—first among a broad U.S. private‑brand roster (2022 – p. 7) and also in the international private‑brand list (2022 – p. 9), then retained in a more focused core set of private brands in 2023 (U.S. p. 7 & 8; International p. 9) and again in 2024 (p. 8). Its persistence despite a trimming of the overall private‑brand list shows Walmart deliberately positions “Holiday Time” as a dedicated seasonal label, using it to deliver low‑priced holiday merchandise as an integral part of its broader private‑label strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that 'Holiday Time' is a private brand consistently listed across fiscal years 2022-2024, and accurately notes its presence in both U.S. and international private brand lists. The page references (2022 p. 7, p. 9; 2023 p. 7 & 8, p. 9; 2024 p. 8) appear reasonable though cannot be fully verified without the source documents. The observation that 'Holiday Time' persisted despite trimming of the overall private brand list is a valid inference showing deliberate positioning.\n\nHowever, there are significant gaps in addressing the ground truth's key finding: The LLM answer fails to capture the critical evolution that by fiscal 2024, Walmart 'explicitly restructured its merchandise units to include seasonal merchandise as a defined category under General Merchandise.' This represents the core strategic shift the question asks about—moving from treating Holiday Time as just another private brand to positioning it within a dedicated seasonal merchandise framework. The ground truth emphasizes this structural reorganization as revealing Walmart's 'shift toward optimizing private label offerings for time-sensitive retail cycles,' which the LLM answer does not adequately address.\n\nThe LLM answer characterizes Holiday Time as 'a dedicated seasonal label' throughout the period, but the ground truth indicates this strategic positioning became explicit only in 2024 with the merchandise unit restructuring. The LLM conflates the brand's existence with strategic positioning, missing the temporal evolution of how Walmart categorized and emphasized seasonal merchandise.\n\nQuantitative accuracy is solid (page numbers, fiscal years correct), but qualitative accuracy suffers from incomplete synthesis of the multi-hop evolution across three years. The answer captures persistence but misses the strategic restructuring that defines the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 511,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN held $239 million of mutual‑fund equity securities in its defined‑benefit plans at August 31 2022; that balance fell to about $196 million in 2023 and then rose to roughly $274 million in 2024. The 2023 dip followed by a sizable 2024 increase indicates the company is rebalancing toward a higher equity exposure, suggesting a strategic shift to allocate more to mutual‑fund equity assets after a temporary reduction.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2024 figure of 'roughly $274 million' which directly contradicts the ground truth of $196.226 million (unchanged from 2023). This is a major factual error representing a ~40% overstatement. The 2022 ($239M) and 2023 (~$196M) figures are approximately correct in rounding. (2) MULTI-HOP REASONING - The LLM's interpretation of the trend is fundamentally wrong. Ground truth shows: 2022: $239.293M → 2023: $196.226M → 2024: $196.226M (consistent decline, then stabilization). LLM claims: 2022: $239M → 2023: $196M → 2024: $274M (dip then sizable increase). This inverted the actual trend entirely. (3) STRATEGIC CONCLUSION - Ground truth correctly identifies 'consistent decline in exposure...strategic rebalancing away from this asset class.' LLM incorrectly concludes 'rebalancing toward a higher equity exposure...strategic shift to allocate more.' These are opposite conclusions based on the fabricated 2024 number. (4) ENTITY ACCURACY - Correctly identifies ACN and mutual fund equity securities in defined-benefit plans. (5) The 2024 data point appears to be completely fabricated or sourced from incorrect filing data. This is a severe accuracy failure on the primary quantitative metric that drives the entire analysis and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 367,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks has consistently warned that green‑coffee prices are volatile and that the arabica futures market – including hedge funds and commodity‑index funds – can move those prices, so it “utilizes forward contracts, futures contracts and collars to hedge ‘C’ price exposure” under its price‑to‑be‑fixed purchases【page_12】. In its FY 2022 filing the company said its purchase commitments and inventory should cover supply through fiscal 2023, whereas the FY 2024 filing extends that assurance through fiscal 2025, showing the same hedging tools are used but the horizon has been lengthened【page_12】. This continuity and the longer‑term commitment illustrate a proactive risk‑management approach that actively mitigates futures‑market and index‑fund influences on coffee costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across fiscal years 2022-2024. STRENGTHS: (1) Correctly identifies the key hedging instruments (forward contracts, futures contracts, collars) used by Starbucks; (2) Accurately captures the temporal evolution - FY 2022 commitments covering through fiscal 2023, extended to fiscal 2025 by FY 2024; (3) Properly identifies commodity index funds and arabica futures market as key volatility drivers; (4) Correctly synthesizes the multi-hop reasoning showing how hedging strategy matured over the period; (5) Appropriately characterizes the risk management approach as 'proactive' and 'active mitigation.' MINOR WEAKNESSES: (1) The LLM answer mentions 'hedge funds' alongside commodity-index funds, whereas the ground truth specifically emphasizes commodity index funds - this is a minor semantic distinction but the ground truth doesn't explicitly mention hedge funds; (2) The answer could have been slightly more explicit about the 'maturing' or 'evolving' nature of the strategy, though 'continuity and longer-term commitment' conveys similar meaning; (3) The phrase 'price-to-be-fixed purchases' is mentioned but could have been more clearly explained as part of the overall hedging strategy. QUANTITATIVE VERIFICATION: All dates and fiscal year references are correct (FY 2022, FY 2023, FY 2024, FY 2025). No specific dollar amounts were provided in either answer, so no calculation errors to assess. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the evolution of hedging strategies to the broader risk management philosophy. The logic linking extended time horizons to increased confidence is sound and matches the ground truth narrative. SEMANTIC EQUIVALENCE: The LLM's characterization of the approach as 'proactive' and 'actively mitigates' is semantically equivalent to the ground truth's 'consistent and maturing risk management approach.' The overall message about managing long-term exposure is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 558,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO reported $622 million of the 3.625 % senior notes that mature in October 2024 on its balance sheet for both FY 2022 (see the 2022 10‑K debt schedule on page 101) and FY 2023 (‑ $622 million on the October 29, 2023 column of the table on page 81). By the FY 2024 balance sheet the line shows “‑” (zero) for the same notes (November 3, 2024 column on page 81), indicating the notes were fully repaid at maturity. This drop from a steady $622 million exposure to zero demonstrates that AVGO chose to let the notes run off rather than refinance them, using cash and new senior‑note issuances to retire the maturing debt and thereby reduce its near‑term debt burden.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis across three fiscal years. STRENGTHS: (1) All key numbers are correct: $622 million principal for both FY2022 and FY2023, zero balance by FY2024. (2) Dates are accurate: October 2024 maturity, November 3, 2024 balance sheet date. (3) Multi-hop reasoning is sound: the answer correctly traces the debt evolution across three years and identifies the pattern (stable then retired). (4) Page references are provided and appear reasonable for 10-K filings. (5) The conclusion about debt management strategy is well-supported. MINOR ISSUES: (1) The LLM states the notes were 'fully repaid at maturity' while the ground truth says 'either repaid or refinanced ahead of its maturity.' The LLM's interpretation that they were repaid at maturity (October 2024) is reasonable given the November 3, 2024 balance sheet date shows zero, but the ground truth's more cautious language about 'ahead of maturity' suggests possible earlier retirement. This is a subtle distinction - the LLM's interpretation is defensible but slightly different from ground truth's framing. (2) The LLM adds detail about 'using cash and new senior-note issuances' which goes slightly beyond what the ground truth explicitly states, though this is reasonable inference about debt management strategy. (3) The phrase 'chose to let the notes run off rather than refinance them' is accurate and adds useful context about the strategic choice. Overall, the answer demonstrates strong understanding of the multi-hop question, accurate data synthesis, and sound financial reasoning with only minor interpretive differences from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 465,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "Mastercard’s credit‑risk mitigation framework remained centered on requiring customers that do not meet its risk standards to post cash collateral, letters of credit or other guarantees and on continuously monitoring the adequacy of those arrangements (2023 10‑K p. 110; 2024 10‑K p. 112).  Accordingly, the risk‑mitigation amount applied to settlement exposure rose from $9.2 billion in 2022 to $13.5 billion in 2024, while gross settlement exposure grew from $64.9 billion (2022) to $78.4 billion (2024) and net exposure increased from $55.7 billion to $64.9 billion (2024 10‑K p. 105; 2023 10‑K p. 112).  These changes were made against a backdrop of intensified regulatory scrutiny—FTC Durbin‑Amendment investigation, DOJ antitrust demand, European Commission request—and ongoing litigation such as the U.S. EMV liability‑shift, ATM‑surcharge and merchant class‑action suits, prompting Mastercard to tighten its risk‑mitigation policies and revise exposure estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) All quantitative data is accurate and properly sourced: risk-mitigation amounts ($9.2B in 2022 to $13.5B in 2024), gross settlement exposure ($64.9B to $78.4B), and net exposure ($55.7B to $64.9B) with correct 10-K page citations. (2) The multi-hop synthesis correctly connects three distinct information streams: credit risk mitigation framework evolution, quantitative settlement exposure metrics, and regulatory/litigation context. (3) Entity identification is precise: FTC Durbin Amendment investigation, DOJ antitrust demand, European Commission scrutiny, and specific litigation (EMV liability shift, ATM surcharge, merchant class actions) are all correctly identified. (4) The answer effectively demonstrates the causal relationship between external pressures and internal policy tightening. (5) Temporal progression is clear and accurate across the three-year period. MINOR CONSIDERATIONS: (1) The LLM answer is more quantitatively detailed than the ground truth, providing specific dollar amounts and calculations that enhance rather than contradict the original answer. (2) The ground truth mentions a '$1+ billion liability' related to EMV, while the LLM references 'U.S. EMV liability-shift' class action without the specific amount—this is a minor omission but not a factual error since the LLM doesn't contradict the figure. (3) Both answers align on the core narrative: consistent framework + intensified regulatory environment + litigation risks + tightened policies. The LLM's inclusion of specific settlement exposure figures and their evolution strengthens the answer without introducing inaccuracies. All calculations are mathematically sound (e.g., the growth rates in mitigation amounts and exposure figures are consistent with the stated numbers).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1598,
        "completion_tokens": 518,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "In the 2022 10‑K Amgen only warned that products used with drug‑delivery or companion‑diagnostic devices “have their own regulatory, manufacturing and other risks.” By the 2023 filing the company had added concrete compliance duties – it must collect device‑related complaints and adverse‑event reports, meet REMS and other post‑marketing commitments, and is subject to routine FDA inspections, warning letters or possible withdrawal of device approvals. The 2024 filing goes further, spelling out the need for contemporaneous approval of devices and companion diagnostics, reliance on third‑party device suppliers, specific post‑marketing study requirements and ongoing safety oversight (including routine monitoring, inspections and device‑enhancement actions), reflecting a markedly tighter regulatory and post‑marketing framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the evolution of Amgen's regulatory risk disclosures across all three years with accurate temporal progression; (2) Accurately captures the 2022 baseline disclosure about regulatory, manufacturing, and compliance risks; (3) Properly synthesizes the 2023 escalation to include concrete compliance duties (device-related complaints, adverse-event reports, REMS, FDA inspections); (4) Correctly identifies the 2024 expansion covering contemporaneous approval requirements, third-party supplier reliance, post-marketing study requirements, and ongoing safety oversight; (5) Successfully demonstrates multi-hop reasoning by connecting information across three separate filing years and showing the trend of increasing regulatory emphasis. MINOR CONSIDERATIONS: (1) The LLM answer provides more granular detail than the ground truth (e.g., mentioning REMS, third-party device suppliers, device-enhancement actions) which adds specificity but is not contradicted by the ground truth; (2) The ground truth mentions specific products (Repatha, LUMAKRAS) and surrogate endpoints/conditional approvals, which the LLM answer does not explicitly reference, though this represents additional context rather than an error in the LLM response; (3) The LLM answer's characterization of the framework as \"markedly tighter\" is a reasonable inference from the documented progression. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The years (2022, 2023, 2024) are all correct. ENTITY ACCURACY: Amgen is correctly identified throughout; regulatory concepts (FDA, REMS, post-marketing requirements) are accurately referenced. REASONING: The multi-hop synthesis is sound - the answer correctly traces the evolution across three years and identifies the logical progression from general risk disclosure to specific compliance requirements to detailed post-market oversight mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 566,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Across FY 2022‑FY 2024 Walmart consistently placed its private‑brand “Parent’s Choice” in the grocery‑related part of its merchandise mix— the Grocery unit that houses baby products and other consumables (FY 2022 private‑brand list shown in the Walmart U.S. segment description, page 7). The FY 2023 filing repeats the same listing and adds a note that periodic revisions to the categorization of strategic merchandise units are made, confirming the brand remains anchored in the grocery/consumables space (page 8). By FY 2024 the brand also appears in the International segment’s global private‑brand roster, underscoring its role as a core low‑price offering for baby and consumable items across both domestic and global portfolios (page 9). This evolution shows Walmart deliberately positions “Parent’s Choice” as a staple private‑brand for baby and consumables, using it to reinforce its value‑priced assortment worldwide.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues: (1) CORRECT ELEMENTS: The core narrative about Parent's Choice remaining in the Grocery unit across FY 2022-2024 is accurate. The identification of the brand as a low-cost private label for baby and consumables is correct. The mention of EDLP pricing philosophy aligns with ground truth. (2) PROBLEMATIC CLAIMS: The LLM introduces a claim about Parent's Choice appearing in the International segment's global private-brand roster by FY 2024, which is NOT supported by the ground truth answer. The ground truth makes no mention of international expansion or the International segment. This is a significant factual error that appears to be fabricated or misinterpreted. (3) PAGE REFERENCES: The LLM provides specific page citations (pages 7, 8, 9) that cannot be verified against the ground truth, which does not include such references. These citations may be hallucinated. (4) MULTI-HOP REASONING: The LLM correctly synthesizes the three-year continuity of positioning but adds unsupported claims about global expansion that break the factual accuracy. (5) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. However, the introduction of unverified claims about international presence represents a quantitative/factual error in scope. (6) SEMANTIC EQUIVALENCE: The core message about domestic positioning is semantically equivalent to ground truth, but the addition of international claims creates a materially different answer. The ground truth is more conservative and accurate, while the LLM overextends its claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 450,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 4.70 % Solar Bonds, Series 2015/C24‑10 are disclosed in each year’s filing as a single supplemental indenture dated April 14 2015 – 2022 lists it as exhibit 4.35 (page 102) 【page_102】, 2023 lists the same indenture as exhibit 4.26 (page 99) 【page_99】, and 2024 again references it as exhibit 4.26 (page 100) 【page_100】 with no new issuances or amendments noted. The unchanged, recurring disclosure across three consecutive 10‑K reports signals that Tesla has retained this fixed‑rate bond as a long‑term financing vehicle for its solar business, reflecting a strategy of relying on a stable, multi‑year debt structure rather than repeatedly issuing new solar bonds.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the bond as 4.70% Solar Bonds, Series 2015/C24-10 with the Thirty-Fifth Supplemental Indenture dated April 14, 2015. (2) The numeric references to exhibit numbers and page numbers appear plausible and specific. (3) The core observation that the bond was referenced consistently across 2022, 2023, and 2024 without new issuances aligns with the ground truth's statement about 'repeated referencing.' (4) The conclusion about a 'stable, multi-year debt structure' is semantically consistent with the ground truth's 'consistent and scalable securitization strategy.' WEAKNESSES: (1) The LLM answer is narrower in scope than the ground truth - it focuses primarily on the unchanged nature of the single bond disclosure rather than the broader evolution of Tesla's solar financing strategy across multiple bond series. (2) The ground truth explicitly mentions that in 2023, Tesla referenced this bond 'alongside newer series such as Series 2015/C27-10 and 2015/C32-10,' indicating a multi-series strategy. The LLM answer does not address these additional series or the evolution of the broader portfolio. (3) The ground truth describes a 'matured and recurring financing model' that includes historical context of earlier series (C4-10, C9-10), suggesting a longer-term strategic evolution. The LLM answer misses this historical context and broader strategic narrative. (4) The LLM's conclusion that Tesla 'retained this fixed-rate bond as a long-term financing vehicle' is somewhat contradictory to the ground truth's emphasis on a 'scalable securitization strategy' with multiple series being issued over time. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022, 2023, 2024) but fails to synthesize the broader portfolio context that includes multiple bond series. The question asks about 'evolution' and 'multi-year pattern,' which the ground truth addresses through the introduction of newer series and historical context. The LLM's answer is more about consistency/stability than evolution. QUANTITATIVE ACCURACY: The date (April 14, 2015) and bond characteristics (4.70%, Series 2015/C24-10) are correct. The exhibit numbers and page references cannot be independently verified but appear specific and plausible. SEMANTIC EQUIVALENCE: While the LLM's conclusion about a 'stable, multi-year debt structure' is not incorrect, it represents a narrower interpretation than the ground truth's emphasis on a 'consistent and scalable securitization strategy' that evolved to include multiple series.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 683,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom first described the Security Insights Platform in its 2022 filing as a main‑frame‑focused solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps… This data is available for use with in‑house tools for security information and event management” (2022 p. 10). In the 2023 and 2024 filings the same capability appears under the name “Security Insights Code programs” in the mainframe software portfolio, reflecting a re‑branding that ties the offering more closely to Broadcom’s broader enterprise‑security suite while still emphasizing continuous main‑frame risk assessment and integration with enterprise SIEM tools (2023 p. 8; 2024 p. 8).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2022 description is accurately quoted with the core functionality of 'quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps' and mentions SIEM integration. (2) The years 2022, 2023, and 2024 are correctly identified. (3) The general theme of mainframe risk assessment and SIEM integration is present. PROBLEMATIC ELEMENTS: (1) The LLM introduces a significant factual claim not in the ground truth: that the offering was 're-branded' as 'Security Insights Code programs' in 2023 and 2024. The ground truth makes no mention of this rebranding or name change. This is a material factual error that misrepresents the evolution of the product. (2) The LLM cites specific page numbers (2022 p. 10; 2023 p. 8; 2024 p. 8) which cannot be verified against the ground truth and may be fabricated. (3) The ground truth emphasizes that 'the description remained largely consistent' in 2023 and notes a 'subtle but meaningful reaffirmation' of SIEM integration in 2024, suggesting continuity with gradual emphasis shifts. The LLM's narrative of rebranding contradicts this continuity theme. (4) The LLM misses the ground truth's key insight about the 'maturing narrative around mainframe integration into broader cybersecurity frameworks' and the 'more deliberate alignment with enterprise-wide security strategies' by 2024. Instead, it focuses on a rebranding claim that appears unsupported. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but does so by introducing an unsupported rebranding narrative rather than accurately tracking the subtle evolution described in the ground truth. The core multi-hop task (comparing positioning across years) is attempted but executed with a significant factual error that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 511,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across 2022‑2024 Mastercard’s Class A stock consistently carried **one vote per share and full dividend rights** – the 2022 filing shows “One vote per share Dividend rights” with a $2.04 per‑share dividend【page_96】, the 2023 filing repeats the same voting and dividend description with a $2.37 dividend【page_99】, and the 2024 filing again lists “One vote per share Dividend rights” with a $2.74 dividend【page_91】. This unchanged dual‑class structure, paired with steadily higher dividends, signals a capital‑structure strategy that preserves a stable governance model while progressively enhancing cash returns to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that MA's Class A shares maintained consistent voting rights (one vote per share) across all three years (2022-2024), matching the ground truth. (2) Accurately captures dividend rights consistency across the period. (3) Provides specific dividend amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that demonstrate the progressive enhancement mentioned. (4) Correctly synthesizes the multi-hop information: identifies the stability of governance structure while noting the increasing dividend payments. (5) Properly identifies the company as Mastercard and uses correct fiscal years. (6) The reasoning about capital structure strategy is sound and goes slightly beyond the ground truth by explicitly noting 'steadily higher dividends' and 'progressively enhancing cash returns,' which is a valid inference from the dividend data provided. MINOR CONSIDERATIONS: (1) The ground truth states simply that there were 'no changes' to voting or dividend entitlements, while the LLM answer adds specific dividend amounts and characterizes the strategy as 'progressively enhancing cash returns.' This is not incorrect—it's an enhancement that adds valuable context. The core claim (consistency in voting and dividend rights) is identical. (2) The LLM answer includes page references (page_96, page_99, page_91) which adds credibility but cannot be verified against the ground truth provided. However, this does not detract from accuracy. QUANTITATIVE VERIFICATION: The dividend amounts ($2.04, $2.37, $2.74) show a consistent upward trend, which is factually sound and supports the narrative. No calculation errors detected. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate years and identifies the pattern of consistency in governance while noting the progression in dividend payments. This demonstrates proper multi-hop synthesis. The answer is semantically equivalent to and slightly more detailed than the ground truth, with no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 556,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen first disclosed that Bemarituzumab had moved into a registrational Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma in its 2022 filing (Phase 3 program change “initiated Phase 3 study”) and that composition‑of‑matter patents covering the antibody in the United States and Europe were expected to expire in 2029【page_25】. The 2023 filing still listed Bemarituzumab as a Phase 3 program with the same 2029 patent expiration dates, and the 2024 filing likewise shows it among the Phase 3 candidates and repeats the 2029 U.S. and Europe expiry, indicating a consistent development focus on completing Phase 3 testing while relying on the original 2029 IP protection horizon【page_25】【page_24】【page_26】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative elements: correctly identifies the Phase 3 trial initiation in 2022, accurately states the 2029 patent expiration dates for both U.S. and Europe, and properly tracks the consistent Phase 3 status across 2022-2024. The numeric data and dates are all correct. However, there are notable gaps in completeness compared to the ground truth: (1) The LLM answer does not mention the specific therapeutic indication (GEJ adenocarcinoma/gastric and gastroesophageal junction cancer) with the same clarity as the original, though it does reference 'gastro-esophageal-junction adenocarcinoma'; (2) More significantly, the LLM answer fails to capture the important detail about 'potential regulatory exclusivity periods that could extend its market protection' mentioned in the ground truth for 2024, which represents a meaningful evolution in Amgen's IP strategy beyond just patent expiration dates; (3) The LLM answer characterizes the progression as 'consistent development focus' rather than highlighting the strategic evolution from early-phase to 'more mature pipeline asset with defined clinical and IP strategies' as the ground truth emphasizes. The multi-hop reasoning is sound in tracking the timeline across three years, but the synthesis misses the strategic narrative of how the IP strategy evolved to include regulatory exclusivity considerations. The answer is accurate on what it covers but incomplete in capturing the full scope of strategic evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 430,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "In the 2022 filing Walmart’s private‑brand “No Boundaries” is listed among its private‑label portfolio under the Walmart U.S. segment’s General‑merchandise unit, specifically in the **Apparel** sub‑category (see page 7). By the 2024 filing the brand is still included, but the sub‑category has been renamed **Fashion** – the strategic merchandise units now describe “Fashion (e.g., apparel for adults and children, as well as shoes, jewelry and accessories)” instead of “Apparel” (see page 7). This renaming shows Walmart’s shift from a simple apparel line to a broader, style‑focused fashion strategy, positioning “No Boundaries” as part of that expanded fashion emphasis.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key strategic shift in Walmart's merchandising structure. STRENGTHS: (1) Correctly identifies 'No Boundaries' as a private brand under Walmart U.S. segment in 2022; (2) Accurately states the 2022 categorization as 'Apparel'; (3) Correctly identifies the 2024 shift to 'Fashion' category; (4) Properly synthesizes the expanded definition of Fashion to include 'apparel for adults and children, as well as shoes, jewelry and accessories'; (5) Appropriately interprets this as a strategic shift from narrow apparel focus to broader fashion positioning; (6) Correctly cites page 7 references. MINOR WEAKNESSES: (1) The answer is somewhat narrower in scope than the ground truth - it focuses primarily on the categorization change but provides less discussion of the 'omni-channel offerings and customer-centric experiences' strategic context mentioned in the original answer; (2) Does not explicitly emphasize the 'continuity of No Boundaries in all three years' as a marker of consistent importance, though it does note the brand's presence across both years; (3) The phrase 'from a simple apparel line to a broader, style-focused fashion strategy' is interpretive but reasonable. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings to identify the strategic evolution. The logic connecting the category rename to broader strategic positioning is sound. QUANTITATIVE ACCURACY: All dates (2022, 2024) and category names are correct. No calculation errors present. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - both identify the shift from Apparel to Fashion and interpret this as strategic repositioning. The LLM's interpretation of what this reveals about Walmart's strategy is reasonable and supported by the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 509,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "- In the 2022 filing IBM listed “client relationships and trust” as one of its principal methods of competition and noted that embedding AI and cloud into its portfolio would help maintain leadership (IBM 2022 10‑K, p. 4).  \n- The 2023 filing repeated that emphasis and explicitly tied it to the execution of its hybrid‑cloud and AI strategy (IBM 2023 10‑K, p. 3), and the 2024 filing again highlighted client relationships and trust as a key differentiator, positioning it as essential for delivering business value through its hybrid‑cloud and AI platform (IBM 2024 10‑K, p. 3).  \n\nTogether, these filings show IBM’s growing reliance on trusted client bonds to differentiate and accelerate its hybrid‑cloud and AI offerings, using that trust as a strategic asset to capture market share and drive growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of IBM's positioning across the three-year period (2022-2024) and correctly identifies the core narrative: client relationships and trust as a competitive differentiator consistently emphasized across all three years, with explicit linkage to hybrid cloud and AI strategy. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and their respective filings; (2) Accurately captures the progression showing consistency with evolution; (3) Properly synthesizes the multi-hop connection between client relationships/trust and hybrid cloud/AI strategy; (4) Correctly notes the explicit tie to business value delivery and market differentiation; (5) Provides appropriate page references to 10-K filings. WEAKNESSES: (1) The LLM answer omits a key detail from the ground truth about the 2024 expansion regarding 'strategic partnerships with hyperscalers and global system integrators' - this represents an important evolution showing how trust was being extended through ecosystem collaboration; (2) The answer states IBM noted 'embedding AI and cloud into its portfolio would help maintain leadership' in 2022, but the ground truth emphasizes this was about foundational competitive positioning rather than specifically about maintaining leadership through embedding; (3) The conclusion about 'growing reliance' and 'accelerate its hybrid-cloud and AI offerings' adds interpretive language not explicitly grounded in the ground truth's more measured assessment of 'consistent strategic focus.' MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects the trust/relationships theme to the hybrid cloud/AI strategy positioning, which is the core requirement. However, it misses the ecosystem partnership dimension that emerged in 2024, which represents a meaningful evolution beyond simple repetition. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - trust as a differentiator consistently emphasized and linked to hybrid cloud/AI strategy - but the omission of the partnership ecosystem expansion in 2024 represents a material gap in capturing the full evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 590,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "In the 2022 Form 10‑K Tesla’s exhibit list still includes the “Thirty‑Sixth Supplemental Indenture… 5.45 % Solar Bonds, Series 2015/C25‑15” dated April 14 2015【page_102】. The same bond appears unchanged in the 2023 filing (exhibit list on page 100)【page_100】 and again in the 2024 filing (exhibit list on page 100)【page_100】. The fact that this 2015 bond series is repeatedly reported as an outstanding, un‑amended instrument shows Tesla’s solar financing strategy relies on long‑term, fixed‑rate debt that it continues to carry on its balance sheet rather than issuing new solar bonds each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop synthesis. STRENGTHS: (1) All numeric values are correct - the 5.45% interest rate, the Series 2015/C25-15 designation, and the April 14, 2015 date are all accurate. (2) The multi-hop reasoning is sound - the answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) showing consistent presence of the same bond instrument. (3) Entity identification is precise - correctly identifies Tesla via SolarCity, the specific bond series, and the supplemental indenture reference. (4) The page references provided (page_102 for 2022, page_100 for 2023 and 2024) are appropriately cited. (5) The interpretation of the pattern is insightful and accurate - the answer correctly concludes that the repeated, unchanged presence of this 2015 bond indicates a long-term, fixed-rate debt strategy rather than annual new issuances. MINOR CONSIDERATIONS: The LLM answer is slightly more concise and interpretive than the ground truth, focusing on the strategic implication (long-term fixed-rate debt carried on balance sheet) rather than emphasizing the 'persistence' and 'consistency' language used in the original. However, this represents a stylistic difference rather than factual error - the semantic meaning is equivalent and arguably more analytically useful. The answer directly addresses the question's request to explain 'how the bond evolved' (answer: it didn't evolve, it remained constant) and what this indicates about strategy (answer: reliance on long-term fixed-rate debt rather than new issuances). No calculation errors, no date errors, no entity confusion detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 454,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "In the 2022 filing the Safety & Productivity segment was described as offering mainly conventional mechanical pipe‑working items—pipe wrenches, cutters, threading and roll‑grooving equipment, mechanical crimping tube‑joining systems, drain cleaners and CCTV‑type inspection/locating tools【page_9】. By the 2023‑24 filings the segment’s description adds **battery‑hydraulic tools for press‑connections (and for cutting/crimping electrical cable)** and newer diagnostic gear such as **sewer‑inspection cameras**, showing a clear move to cordless, battery‑powered solutions and more advanced inspection technology【page_73】. This evolution signals Emerson’s strategic push to differentiate its professional‑tools portfolio, emphasizing mobility, productivity and technology‑driven value‑add, positioning the company as a higher‑margin, innovation‑focused player in the professional tools market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Emerson's Safety & Productivity segment evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the progression of product offerings across all three years (2022-2024), matching the ground truth's core narrative; (2) Accurately captures the shift from conventional mechanical tools (pipe wrenches, cutters, threading equipment, CCTV) to battery-powered solutions; (3) Properly synthesizes the multi-hop information by comparing offerings across years and drawing strategic conclusions; (4) Correctly identifies specific innovations like battery-hydraulic tools for press connections and cutting/crimping electrical cables; (5) Appropriately characterizes the strategic positioning as emphasizing mobility, productivity, and technology-driven differentiation. MINOR WEAKNESSES: (1) The LLM answer mentions 'roll-grooving equipment' and 'mechanical crimping tube-joining systems' and 'drain cleaners' in 2022 that are not explicitly mentioned in the ground truth, though these are reasonable inferences about pipe-working tools and don't contradict the ground truth; (2) The answer is slightly more concise than the ground truth, omitting some contextual details about the 'foundational role' of pipe wrenches across all years, though the core message is preserved; (3) The page references provided (page_9, page_73) cannot be verified against the ground truth but appear reasonable for a multi-year filing analysis. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal accuracy (2022, 2023, 2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression pattern and strategic implications. The conclusion about positioning as a 'higher-margin, innovation-focused player' aligns well with the ground truth's assessment of 'strengthening competitive position through technology integration.' SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution matches the ground truth's narrative, with appropriate emphasis on battery-powered innovation and strategic market positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 609,
        "total_tokens": 2206
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "In 2022 Gilead’s capital‑allocation discussion was generic, noting overall capital investments but not singling out the El Segundo campus for any specific cell‑therapy spend (see the 2022 “Strategic and Financial Risks” section on capital investments【page_33】). By the 2023 filing the company had earmarked El Segundo, California, as a dedicated site for clinical and commercial manufacturing of its cell‑therapy products, reflecting a targeted investment to expand its cell‑therapy platform (see the 2023 “Our Manufacturing Facilities” list【page_11】). The 2024 report confirms that El Segundo continues to be used for cell‑therapy manufacturing, underscoring Gilead’s ongoing capital commitment to that site in line with its broader biologics development priorities【page_10】【page_11】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information across three years of Gilead filings. STRENGTHS: (1) All dates and years are correct (2022, 2023, 2024). (2) The progression narrative is accurate: 2022 showed generic capital allocation without specific El Segundo emphasis, 2023 marked the strategic shift to dedicated cell therapy manufacturing at El Segundo, and 2024 confirmed continued commitment. (3) Page references are appropriate and correctly cited (page_33 for 2022, page_11 for 2023, page_10 for 2024). (4) The multi-hop synthesis correctly identifies the evolution from general manufacturing to specialized cell therapy focus. (5) The connection to broader biologics development priorities is appropriately noted. MINOR WEAKNESSES: (1) The LLM answer omits one specific detail from the ground truth: the mention of Gilead's reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies, which the ground truth identifies as suggesting increased investment in securing and scaling proprietary processes. (2) The LLM answer doesn't explicitly mention the potential CAPEX or R&D spend implications that the ground truth suggests. (3) The phrase 'core node for cell therapy production' from the ground truth is not captured, though the concept is conveyed through 'dedicated site' and 'ongoing capital commitment.' QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in this question, and the LLM correctly avoided inventing numbers. The temporal progression (2022→2023→2024) is accurate. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across three separate 10-K filings is correctly executed. The LLM properly identifies the strategic shift and its alignment with broader company priorities. CONTEXTUAL RELEVANCE: The answer directly addresses the question about capital allocation strategy evolution and its relationship to cell therapy manufacturing and biologics priorities. The omission of the proprietary technology protection angle and CAPEX implications prevents a perfect score, but the core narrative and synthesis are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 592,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "- 2022 10‑K – IBM disclosed the 1.250 % Notes due 2027 only by “incorporating by reference” the instrument that defines the holders’ rights (Exhibits 4.2‑4.4 to a Form 8‑K filed January 30, 2019). No new issuance was reported.  \n\n- 2023 10‑K – The same incorporation‑by‑reference language appears, again pointing to the 2019 Form 8‑K exhibit; the notes remain outstanding and there is still no indication of a new issue.  \n\n- 2024 10‑K – The notes are now listed in the “Securities registered pursuant to Section 12(b)” table (ticker IBM27B), showing they continue to be an outstanding security and are directly identified in the filing. No fresh issuance is noted, but the disclosure shifts from an indirect exhibit reference to an explicit registration listing.  \n\nThus, from 2022‑2023 IBM relied on an earlier 8‑K exhibit to disclose the 1.250 % Notes due 2027, and by 2024 the notes are directly listed as a registered security, confirming they remain outstanding without any new issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of IBM's relationship with the 1.250% Notes due 2027 across 2022-2024. STRENGTHS: (1) All dates are correct - January 30, 2019 for the original 8-K filing, 2022-2023 incorporation-by-reference pattern, and 2024 shift to direct registration listing. (2) All numeric/percentage values are accurate - 1.250% interest rate, ticker IBM27B correctly identified. (3) Multi-hop synthesis is sound - the answer correctly traces the evolution from indirect disclosure (via 8-K exhibit reference) through 2022-2023, to direct registration in 2024. (4) Entity identification is precise - IBM, the specific note instrument, Form 8-K, Section 12(b) registration table all correctly identified. (5) The reasoning about the progression from 'incorporation by reference' to 'direct listing' accurately captures the shift in disclosure methodology without implying new issuance. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and technical than the ground truth (e.g., explicitly noting 'Exhibits 4.2-4.4' and 'Section 12(b)' table), but this adds clarity rather than introducing errors. The ground truth mentions 'public issuance and trading' while the LLM correctly clarifies there was no new issuance, only a change in how existing notes were disclosed - this is actually a more precise interpretation. The semantic meaning aligns perfectly: both convey that the notes evolved from indirect reference documentation to active market presence/direct registration. No calculation errors, no factual inaccuracies detected. The answer fully addresses all aspects of the multi-part question regarding disclosure evolution, issuance status, and filing references across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 479,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 2022, 2023 and 2024 10‑K filings all list the 5.45 % Solar Bonds, Series 2015/C45‑15 (see Exhibit 4.48 in each year’s exhibit schedule – 2022 [page_103], 2023 [page_101] and 2024 [page_101]) and also include later supplemental indentures for additional 5.45 % series such as C46‑15, C47‑15, C53‑15, C57‑15, etc. (see Exhibit 4.48‑4.65 [page_103]). This continuity and the addition of new bond tranches show that Tesla has kept the original SolarCity bond as a core financing tool while progressively expanding its solar‑bond program, indicating an evolving strategy that relies on a layered, multi‑series debt structure to fund and refinance its solar operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core pattern of Tesla's solar financing strategy (continued reliance on structured solar bonds inherited from SolarCity with progressive expansion through multiple tranches). However, there are significant quantitative accuracy issues: (1) The LLM references bond series C46-15, C47-15, C57-15 without providing dates, whereas the ground truth specifically cites C53-15 (June 16, 2015), C62-15 (June 29, 2015), and C72-15 (July 21, 2015) with precise dates. (2) The LLM mentions exhibit ranges (4.48-4.65) without specifying which bonds correspond to which years, creating ambiguity about the 2022-2024 progression. (3) The ground truth emphasizes a deliberate year-by-year evolution (2022→2023→2024) with specific bond introductions in each period, while the LLM states all three years 'list' the same bonds without clearly delineating the temporal progression of new issuances. (4) The LLM correctly notes the 5.45% rate and the SolarCity inheritance but lacks the specific bond series dates that ground the multi-year evolution narrative. The qualitative reasoning about 'layered, multi-series debt structure' and 'scalable, repeatable financing model' aligns with the ground truth's interpretation, but the missing specific dates and unclear year-by-year progression weaken the multi-hop synthesis. The answer is partially correct on strategy interpretation but incomplete on the quantitative details that substantiate the evolution claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 409,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In the 2022 filing Adobe framed Acrobat as the core of its Document Cloud, highlighting AI‑driven upgrades through Adobe Sensei, new web‑and‑mobile capabilities (e.g., Liquid Mode), integration of Adobe Sign, and a targeted push into verticals such as education, financial services, telecom and government (see page_7). By the 2023‑24 filing the messaging had shifted to present Acrobat as a proven leader in document‑intensive industries—including government, financial services, pharmaceutical, legal, aerospace, insurance and technical publishing—and as a central piece of a unified, cloud‑based document‑services platform that now leverages cross‑platform AI (Adobe Sensei), expanded APIs and workflow actions, and diversified go‑to‑market motions to accelerate adoption (see pages_4 and 5). This evolution moves Acrobat from a feature‑focused, vertically‑targeted product to a platform‑centric service that embeds AI and API‑driven capabilities to deepen industry penetration and drive growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Acrobat's positioning from 2022 to 2024, captures the shift from feature-focused to platform-centric approach, and accurately mentions key technologies (Adobe Sensei, Adobe Sign, Document Cloud). It appropriately identifies multiple document-intensive industries (legal, financial services, government, etc.) and recognizes the AI integration trajectory. The semantic understanding of the strategic evolution is sound.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM answer fails to mention the 'Acrobat AI Assistant' trademark introduction in 2024, which is explicitly highlighted in the ground truth as a 'concrete realization' of the AI integration strategy. This is a significant factual gap for a 2024-focused question. (2) SPECIFICITY ISSUES: The LLM references specific page numbers (page_7, pages_4 and 5) without verification that these correspond to actual filing content - this adds unverifiable detail. (3) FEATURE ATTRIBUTION: The LLM mentions 'Liquid Mode' as a 2022 feature, but the ground truth does not specifically validate this claim. (4) INCOMPLETE TIMELINE: While the LLM discusses 2022 and 2023-24 combined, it doesn't clearly delineate the 2023 transition period where Adobe signaled AI innovation vision, which the ground truth emphasizes as a strategic pivot.\n\nMULTI-HOP REASONING: The answer demonstrates reasonable synthesis across years and correctly identifies the progression from market leadership to AI-driven innovation. However, it misses the key milestone of the Acrobat AI Assistant trademark introduction, which represents the culmination of the strategic evolution described in the question.\n\nFACTUAL ACCURACY: No explicit numerical errors detected, but the omission of the Acrobat AI Assistant in 2024 represents a material factual gap that undermines the completeness of the answer regarding the 2024 positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 521,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "- In the 2022 filing Schwab described the Advisor Services website as the core RIA portal that offered proprietary software, interactive tools and free‑of‑charge Schwab Advisor Portfolio Connect, plus “access to integrations with third‑party platforms” and noted that it was **working to integrate** TD Ameritrade’s thinkpipes trading platform and iRebal portfolio‑rebalancing solution for RIA clients【page_7】【page_8】.  \n\n- By 2023 the company said those thinkpipes and iRebal features were **now part of its ongoing offering** for RIAs, and it added the new “Schwab Trading Powered by Ameritrade” platform, while the Advisor Services website continued to provide interactive tools, education and seamless third‑party connectivity【page_7】【page_8】.  \n\n- The 2024 filing shows the same integrated thinkpipes and iRebal capabilities as a permanent part of the core platform, with the Advisor Services website still delivering interactive tools, educational content and integrated third‑party solutions, indicating a consolidated, enhanced digital experience for RIAs【page_7】【page_9】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a chronological evolution of Schwab's RIA tools from 2022-2024 with specific platform names (thinkpipes, iRebal, Schwab Trading Powered by Ameritrade, Schwab Advisor Portfolio Connect), which adds valuable detail beyond the ground truth. However, there are significant discrepancies in factual accuracy:\n\n1. CORRECTNESS ISSUES:\n- The ground truth states that in 2022, Schwab provided access to third-party integrations (CRM, portfolio management) but does NOT mention thinkpipes or iRebal as being offered or \"working to integrate\" in 2022. The LLM introduces these as 2022 offerings/integrations-in-progress, which appears to be unsupported by the ground truth.\n- The ground truth makes no mention of \"Schwab Trading Powered by Ameritrade\" as a 2023 addition, which the LLM claims was added that year.\n- The ground truth does not reference thinkpipes or iRebal at all, yet the LLM makes these central to the narrative across all three years.\n\n2. QUANTITATIVE ACCURACY:\nNo specific numbers, dates, or percentages are provided in either answer, so quantitative accuracy is not directly testable. Both answers use year-based chronology correctly (2022, 2023, 2024).\n\n3. MULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and shows logical progression (working to integrate → now part of offering → permanent part). However, this reasoning appears to be based on information not present in the ground truth, suggesting potential hallucination or reliance on external knowledge.\n\n4. SEMANTIC ALIGNMENT:\nThe ground truth emphasizes: (a) Advisor Services website as core platform, (b) proprietary software and interactive tools, (c) third-party integrations (generic), (d) Schwab Advisor Portfolio Connect (2024), (e) focus on scalability and efficiency.\n\nThe LLM answer emphasizes: (a) Advisor Services website, (b) specific third-party integrations (thinkpipes, iRebal, TD Ameritrade products), (c) Schwab Advisor Portfolio Connect, (d) digital experience enhancement.\n\nWhile both mention similar core elements, the LLM introduces specific product names not in the ground truth, which either represents additional accurate detail or factual errors.\n\n5. MISSING ELEMENTS:\nThe LLM does not emphasize the ground truth's focus on supporting \"RIAs transitioning to independence\" or the consistent emphasis on \"scalability and efficiency\" as key themes.\n\nThe answer is partially correct in structure and some details but introduces specific product integrations (thinkpipes, iRebal, Schwab Trading Powered by Ameritrade) that are not mentioned in the ground truth, raising concerns about accuracy despite the detailed and logical presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 719,
        "total_tokens": 2194
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In the 2022 filing, Emerson described air‑preparation equipment as part of its **Industrial Solutions** offering – a pneumatic product that “transforms air or gas into energy and power for use in manufacturing operations” (see page 6). By the 2023 filing (and reiterated in 2024) the company moved the same equipment into the **Discrete Automation** segment, listing it alongside pneumatic valves, cylinders, actuators, pressure‑ and temperature‑switches and programmable automation control systems and software (see page 73), indicating a strategic shift to integrate air‑preparation more tightly with the broader suite of pneumatic and control technologies that serve discrete‑manufacturing customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT: (1) The identification of Emerson (EMR) and Air Preparation Equipment is accurate; (2) The mention of a shift from Industrial Solutions to Discrete Automation segment is directionally correct; (3) The reference to integration with pneumatic valves, cylinders, actuators, pressure/temperature switches, and programmable automation control systems aligns with ground truth. INCORRECT/INCOMPLETE: (1) The LLM claims air preparation equipment was in 'Industrial Solutions' in 2022, but the ground truth indicates it was positioned within the Discrete Automation segment's pneumatic mechanisms across all three years (2022-2024), not moved INTO Discrete Automation in 2023; (2) The LLM fails to capture the critical 3-year evolution narrative that is central to the question - specifically the progression from mechanical focus (2022) to digital/automated control ecosystems (2023) to Industry 4.0 integration with smart actuation and predictive maintenance (2024); (3) Missing key 2024 positioning details about interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication; (4) The answer presents a 2-year shift (2022→2023) rather than the requested 3-year evolution (2022→2023→2024); (5) The LLM does not adequately address the 'digital transformation' and 'Industry 4.0' alignment that characterizes the 2024 positioning. The answer demonstrates partial understanding of segment reorganization but fundamentally misses the strategic evolution narrative across the three-year period that the question specifically asks about. The multi-hop reasoning is incomplete as it fails to synthesize the full temporal progression and the shift from mechanical to digital integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 486,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "In the 2022 Form 10‑K the exhibit index still lists the 0.125 % notes due 2029, citing the 8‑K filings from September 2020 and March 2021 (see page 136), and the 2023 Form 10‑K repeats that same entry (see page 134). By the 2024 filing the exhibit index no longer includes any 0.125 % notes due 2029 (see page 128), indicating the series has been retired or refinanced and that Coca‑Cola is shifting its near‑term financing to newer issuances—reflecting a pattern of issuing ultra‑low‑coupon, short‑dated debt and then replacing it as maturity approaches within its broader debt‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific, verifiable details (exhibit index page numbers: 136 for 2022, 134 for 2023, 128 for 2024; specific 8-K filing dates from September 2020 and March 2021) that demonstrate concrete research into the filings. The core observation—that the 0.125% Notes due 2029 disappeared from the exhibit index by 2024—is a factual finding that differs from but complements the ground truth's narrative approach. However, there are significant differences in interpretation and completeness: (1) The LLM focuses narrowly on exhibit index presence/absence rather than the broader context of how the note was referenced across debt disclosures in the three years. (2) The ground truth emphasizes the strategic pivot to higher-yielding instruments (5.000% Notes due 2034, 5.400% Notes due 2064) as evidence of refinancing strategy, which the LLM answer does not mention or verify. (3) The LLM's conclusion that the note was 'retired or refinanced' is inferred from its absence in the exhibit index, but the ground truth suggests the note remained referenced in debt structure disclosures while the company simultaneously issued longer-term instruments. (4) The LLM answer lacks the multi-year comparative analysis of how the note's context evolved from 'passive disclosure' (2022) to 'consolidated format' (2023) to strategic refinancing (2024). (5) The specific page numbers cited are verifiable details that add credibility, but they don't fully address the question's core ask about the 'evolution of issuance strategy' and what it suggests about debt management. The answer is partially correct in identifying a pattern of replacement/refinancing but incomplete in synthesizing the full strategic picture across all three years and missing the key evidence of higher-yielding instrument issuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 492,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "BNY Mellon’s 10‑K filings from 2022, 2023 and 2024 all contain the same disclaimer that the company’s ability to return capital – whether by paying dividends or repurchasing shares – is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (2022 p. 5; 2023 p. 5; 2024 p. 5).  The 2022 filing also notes the Parent’s reliance on subsidiary dividends to fund share repurchases, and the 2023‑2024 filings repeat this language, showing that BNY Mellon’s exposure to regulatory constraints on dividends and share buy‑backs remained essentially unchanged over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misinterpretation of the question and contradicts the ground truth on the core analytical finding. CRITICAL ERRORS: (1) The LLM concludes that regulatory constraints 'remained essentially unchanged over the three-year period,' which directly contradicts the ground truth's central finding that the framing 'evolved from a general caution in 2022 to more specific references...in 2023 and 2024' with 'increasing specificity and formalization.' (2) The LLM treats the repeated boilerplate language as evidence of stasis, missing the qualitative evolution in how constraints were communicated and emphasized. (3) The LLM fails to address the ground truth's key observations: the 2023 emphasis on preferred stock dividend obligations, the 2024 shift to 'well capitalized' status and capital adequacy rules as direct limitations, and the progression toward more structured regulatory language. QUANTITATIVE ACCURACY: The page numbers cited (p. 5 for all three years) appear reasonable for 10-K filings, though not independently verified. The years (2022, 2023, 2024) are correct. However, the quantitative elements are secondary to the qualitative analysis required here. QUALITATIVE ACCURACY: The LLM's reasoning is fundamentally flawed. It identifies that the same disclaimer appears across years but fails to recognize that the question asks about EVOLUTION and CHANGE in exposure framing. The ground truth explicitly documents a progression in specificity and formalization, which the LLM completely misses. The LLM's conclusion that constraints 'remained essentially unchanged' is the opposite of what the ground truth establishes. CONTEXTUAL RELEVANCE: The answer addresses BNY Mellon and the 2022-2024 period, but misses the core analytical requirement to identify and explain the evolution in regulatory constraint communication. The question specifically asks 'how did...evolve,' and the LLM's answer that nothing evolved is a fundamental misreading of the analytical task.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 542,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "In the 2022 filing McGriddles is listed simply as one of the breakfast items – “Egg McMuffin, Sausage McMuffin with Egg, **McGriddles**, biscuit and bagel sandwiches, oatmeal, breakfast burritos and hotcakes”【page_7】. By the 2023 filing (and again in 2024) the language shifts to describe it as a core “breakfast sandwich” – “breakfast sandwiches, such as the Egg McMuffin, Sausage McMuffin with Egg **and McGriddles**, biscuit and bagel sandwiches, oatmeal, **hash browns**, breakfast burritos and hotcakes”【page_6】, and the same phrasing appears in 2024【page_6】. The product’s continual presence, with only minor wording refinements, shows that McDonald’s treats McGriddles as a stable, flagship breakfast item while consistently framing it within a broader menu‑innovation narrative, underscoring a steady breakfast strategy across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about McGriddles portrayal evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the three years (2022, 2023, 2024) and accurately cites page numbers (page_7 for 2022, page_6 for 2023 and 2024) matching the ground truth. (2) Provides accurate direct quotes from the filings showing the actual menu language used in each year. (3) Correctly identifies the core finding: McGriddles remained consistent across all three years as a stable breakfast item. (4) Properly synthesizes the multi-hop information by comparing language across years and drawing the correct conclusion about breakfast strategy consistency. (5) Accurately notes the minor wording refinements (shift from simple listing to 'breakfast sandwiches, such as') while emphasizing the fundamental consistency. MINOR WEAKNESSES: (1) The LLM answer includes 'hash browns' in the 2023/2024 quote, which appears to be an addition not explicitly mentioned in the ground truth's focus on McGriddles specifically. While this doesn't contradict the ground truth, it adds detail not central to the McGriddles analysis. (2) The ground truth emphasizes the contrast between 'continuous evolution' messaging and McGriddles' static presentation more explicitly, whereas the LLM frames it as 'framing within a broader menu-innovation narrative' - semantically similar but slightly different emphasis. (3) The LLM could have been more explicit about the lack of 'specific innovation details' for McGriddles as mentioned in the ground truth. QUANTITATIVE ACCURACY: All dates and page citations are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning about consistency and strategy is sound and matches the ground truth's conclusion. The multi-hop synthesis across three years is properly executed. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution and consistency of breakfast strategy, providing appropriate context about McDonald's broader menu innovation messaging.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 557,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "In the 2022 Form 10‑K Adobe said its Digital Learning Services “includes a large number of free online self‑service learning options on **www.training.adobe.com**” (page 17). By the 2023 filing the same free‑self‑service catalog had been moved to **learning.adobe.com**, still described as a core part of Adobe Digital Learning Services (page 18). The 2024 filing repeats that positioning and platform—free online self‑service learning remains a flagship offering of Adobe Digital Learning Services and is delivered via **learning.adobe.com** (page 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three fiscal years (2022, 2023, 2024). STRENGTHS: (1) All platform URLs are correct: www.training.adobe.com (2022) → learning.adobe.com (2023-2024), matching the ground truth exactly. (2) The temporal progression is accurately captured with proper year-to-year transitions. (3) Page references (17, 18, 17) are provided and appear consistent with 10-K filing structure. (4) The core positioning within Adobe Digital Learning Services is correctly identified for all three years. (5) The multi-hop synthesis correctly identifies the platform migration as a key evolution point. MINOR CONSIDERATIONS: (1) The LLM answer is more concise than the ground truth, focusing on the essential facts (platform URLs, positioning, years) rather than providing interpretive framing about the 'maturing and more structured approach' or 'increased integration into broader ecosystem.' However, this is a stylistic difference rather than a factual error—the LLM provides the factual foundation that supports such interpretations. (2) The ground truth uses more analytical language ('shift in platform branding,' 'maturing approach'), while the LLM sticks to observable facts from the filings. This is appropriate for a direct answer to the question. (3) The LLM correctly notes that 2023-2024 use the same platform, avoiding the implication of further change. VERIFICATION: All dates, URLs, and company references are accurate. The multi-hop reasoning correctly connects information across three separate 10-K filings. No calculations are required for this question, so quantitative accuracy focuses on date/URL precision, which is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 472,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "- In the 2022 filing, Emerson placed commercial vacuums in the **Tools & Home Products** segment (part of Commercial & Residential Solutions) and described them simply as “Other professional tools” alongside water‑jetters, wet‑dry vacuums and bolt cutters【page_9】.  \n- In the 2023 and 2024 filings the company reorganized that business into a **Safety & Productivity** segment; commercial vacuums are still listed under “Other professional tools” but now the segment is defined as delivering “tools for professionals and homeowners that support infrastructure, promote safety and enhance productivity”【page_73】.  \n\nThus, from 2022 to 2024 the product remained a “commercial vacuum” but moved from a generic Tools & Home Products category to the Safety & Productivity segment, signaling a strategic shift to align it more closely with Emerson’s professional‑tools portfolio and its safety‑productivity positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key structural change (Tools & Home Products in 2022 → Safety & Productivity in 2023-2024) and accurately captures the segment reorganization. However, it falls short of the ground truth's depth and specificity in several important ways: (1) WHAT'S CORRECT: The LLM correctly identifies the 2022 placement in Tools & Home Products segment, the 2023-2024 movement to Safety & Productivity segment, and the general strategic shift toward professional tools positioning. The dates and segment names are accurate. (2) WHAT'S MISSING/INCOMPLETE: The ground truth provides specific examples of products grouped with Commercial Vacuums in each period (water jetters, wet-dry vacuums, bolt cutters in 2022; battery hydraulic tools, sewer inspection cameras in 2023; programmable automation control systems, electrical distribution equipment in 2024). The LLM mentions water-jetters and wet-dry vacuums for 2022 but fails to capture the 2023-2024 product groupings and the evolution in strategic emphasis. (3) STRATEGIC EVOLUTION ANALYSIS: The ground truth emphasizes a progression from 'general tools category' to 'integrated part of industrial safety and productivity solutions' with increasing technological sophistication. The LLM describes the shift more generically as alignment with 'professional-tools portfolio' without capturing the technological advancement and industrial integration narrative. (4) PRODUCT CATEGORIZATION DETAIL: The ground truth shows Commercial Vacuums were grouped with increasingly sophisticated tools (from basic tools to infrastructure/safety tools to advanced automation/electrical equipment), signaling strategic repositioning. The LLM doesn't capture this progression in product categorization. (5) QUANTITATIVE ACCURACY: No numbers or calculations are involved, so this scores well. (6) MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three years but doesn't fully synthesize the pattern of strategic emphasis evolution across the three periods. The answer is partially correct but lacks the nuanced understanding of the strategic repositioning narrative that the ground truth conveys.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 584,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K Gilead simply listed Hoofddorp, Netherlands as one of its “principal manufacturing facilities” (Item 2 – Properties) without describing its function【page_33】. By the 2023 filing, the company noted that the Hoofddorp site “is utilized for commercial manufacturing and processing of our cell‑therapy products” (as of end‑2023)【page_11】, and the 2024 filing repeats that same description for the end of 2024【page_10】. Thus, the Hoofddorp facility evolved from being a generic listed site in 2022 to a dedicated commercial cell‑therapy manufacturing and processing location in 2023, a role it continues to serve in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Verification of key claims: (1) 2022 - Correctly identifies Hoofddorp as listed in 'principal manufacturing facilities' without specific functional description; (2) 2023 - Accurately states the facility was described as utilized for 'commercial manufacturing and processing of cell-therapy products'; (3) 2024 - Correctly notes the same description continues. The multi-hop synthesis across three fiscal years is sound and logically presented. The answer effectively traces the evolution from generic listing to dedicated cell therapy manufacturing role. The LLM provides specific citations (page numbers) which adds credibility. Minor observation: The original answer uses slightly more interpretive language ('strategic shift,' 'growing emphasis,' 'potentially expanding role') while the LLM answer is more factual and literal ('evolved from being a generic listed site'). Both convey the same core information - that the facility's role became more specifically defined and focused on cell therapy manufacturing from 2022 to 2023-2024. The LLM answer is actually more precise in distinguishing between what was explicitly stated in each year versus what can be inferred. No numerical errors, date errors, or entity misidentifications. The reasoning correctly synthesizes information across multiple years and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 383,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "The 10‑K exhibits for 2022‑2024 all include the same low‑cost tranche – the 1.000 % Notes due 2028 (see Exhibit 4.26 on pages 134 and 130) – showing that Coca‑Cola continues to rely on a cheap, near‑term source of funding. In the 2024 filing the company also adds much higher‑coupon bonds – the 5.000 % Notes due 2034 and the 5.400 % Notes due 2064 (Exhibit 4.39 and 4.41 on page 130) – reflecting a strategic move to diversify its debt maturity profile and lock in longer‑dated financing despite higher rates, thereby balancing financing costs and capital‑structure flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and multi-hop reasoning. All numeric values are correct: 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 are accurately cited. The temporal synthesis is sound - correctly identifying that the 1.000% Notes appear consistently across 2022-2024 filings while the higher-yield notes were introduced in 2024. The reasoning about debt portfolio diversification and capital structure management is logically sound and semantically equivalent to the ground truth. The LLM adds specific exhibit references (Exhibit 4.26, 4.39, 4.41, page numbers) which, while not in the original answer, provide additional supporting detail without contradicting the ground truth. The characterization of the strategic shift - balancing near-term affordability with long-term funding needs and locking in longer-dated financing - aligns well with the original answer's interpretation. Minor differences in phrasing ('capital-structure flexibility' vs 'capital structure management') are semantic variations that don't affect correctness. The answer successfully synthesizes information across multiple years and documents to address the multi-hop question about changes in debt financing approach. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 365,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "In Emerson’s 2022 filing the Tools & Home Products segment described “pipe wrenches, **pipe cutters**, … and diagnostic systems, **including closed‑circuit‑television pipe inspection**” – a traditional, cord‑powered offering 【page_9】. By the 2023 filing the description had changed to “pipe wrenches and **cutters**, … **battery hydraulic tools** for press connections, … and diagnostic systems, **including sewer‑inspection cameras**,” and the same language appears in the 2024 filing 【page_73】. This progression from purely mechanical cutters and basic CCTV inspection to battery‑powered, cordless tools with integrated diagnostic cameras shows Emerson deliberately shifting its professional plumbing portfolio toward portable, smart solutions, positioning the company as a technology‑forward leader in the professional plumbing‑tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (2022→2023→2024) with accurate characterization of each phase: 2022 as traditional/cord-powered, 2023 as introducing battery hydraulic technology, 2024 maintaining the evolved offering. (2) Accurately cites specific product features from filings: pipe wrenches, pipe cutters, battery hydraulic tools for press connections, diagnostic systems including CCTV/sewer inspection cameras. (3) Properly synthesizes the multi-hop reasoning: connects product evolution across years to strategic positioning in professional plumbing market. (4) Correctly identifies the strategic shift from mechanical/basic tools to portable, technology-enhanced solutions. (5) Appropriately characterizes Emerson's market positioning as 'technology-forward leader.' (6) Includes specific page references (page_9, page_73) that ground the answer in source material. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'cordless tools with integrated diagnostic cameras' vs. 'diagnostic systems...directly tied to pipe cutters'), but the semantic meaning is equivalent and arguably more precise. (2) The LLM answer emphasizes 'smart solutions' and 'portable' aspects which align with but slightly expand on the ground truth's emphasis on 'productivity and safety.' These are reasonable inferences from the product evolution described. (3) No quantitative errors, date errors, or entity misidentifications. The answer correctly maintains focus on Emerson (EMR) and the Tools & Home Products segment throughout. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and connects product portfolio changes to strategic market positioning, which is the core requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 513,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "In the 2022 Form 10‑K the Santa Monica, California location is listed only as an **R&D facility** (“R&D facilities in … Santa Monica, California” – 2022 p. 33). By the 2023 filing the same site is described as being **used for clinical manufacturing and processing of our cell‑therapy products** (2023 p. 11), and the 2024 filing repeats that description (2024 p. 10). This shift from a research‑only role in 2022 to a dedicated cell‑therapy manufacturing hub in 2023‑2024 signals that Santa Monica has become a strategic node in Gilead’s manufacturing network, supporting the scale‑up and clinical supply of its cell‑therapy pipeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. FACTUAL ACCURACY: All key facts are correct - Santa Monica was identified as R&D-only in 2022, transitioned to clinical manufacturing and cell therapy processing in 2023, and maintained that role in 2024. The progression narrative matches the ground truth exactly. QUANTITATIVE ACCURACY: All dates and fiscal years are correct (2022, 2023, 2024). Page references are provided (2022 p. 33, 2023 p. 11, 2024 p. 10) which adds specificity and credibility, though these cannot be independently verified here. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to demonstrate the facility's evolution. The logical progression from R&D to dedicated manufacturing hub is clearly articulated and matches the ground truth's characterization. ENTITY ACCURACY: Company name (Gilead) and facility location (Santa Monica, California) are correctly identified. The answer appropriately references related facilities (El Segundo and Frederick are mentioned in ground truth but not in LLM answer, though this is a minor omission). SEMANTIC EQUIVALENCE: The LLM's phrasing 'transitioned from research-only role to dedicated cell-therapy manufacturing hub' is semantically equivalent to the ground truth's 'transitioned from a general R&D site to a dedicated cell therapy manufacturing hub.' The characterization of Santa Monica as 'a strategic node in Gilead's manufacturing network' aligns well with the ground truth's 'continued strategic emphasis on its importance.' MINOR CONSIDERATIONS: The LLM answer is slightly more detailed with specific page citations and direct quotations from filings, which enhances credibility. The only minor gap is not explicitly mentioning other specialized sites (El Segundo, Frederick) for comparative context, though this is not essential to answering the core question about Santa Monica's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 529,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In the 2022 filing (pages 95‑99) Adobe does not describe Frame.io as a core Creative Cloud service – there is no mention of its media‑type support or cross‑app links, implying only a peripheral role at that time. By the 2024 filing (page 12) Frame.io is positioned as a cloud‑native collaboration hub embedded in Creative Cloud, supporting video **and** still images, design files and PDFs, and offering direct, frame‑accurate commenting within Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, plus “Camera‑to‑Cloud” uploads and availability in Adobe GenStudio for large‑scale content production.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Frame.io's integration within Adobe's ecosystem from 2022 to 2024. STRENGTHS: (1) Correctly identifies the progression from peripheral/minimal description in 2022 to core positioning in 2024; (2) Accurately lists supported media types across both periods (still images, design files, PDFs in 2023, with video expansion by 2024); (3) Correctly identifies integrated applications (Premiere Pro, After Effects in 2023; expanded to Photoshop, Lightroom, Workfront by 2024); (4) Accurately mentions GenStudio positioning and Camera-to-Cloud feature; (5) Properly characterizes the functional evolution from post-production focus to broader use cases (casting, location scouting, marketing). MINOR ISSUES: (1) The LLM answer slightly compresses the 2023 intermediate state by jumping directly from 2022 to 2024, whereas the ground truth explicitly describes 2023 as a distinct phase with specific capabilities (cloud-native platform, frame-specific feedback integration); (2) The LLM answer doesn't explicitly mention the 2023 intermediate positioning, though it does capture the overall trajectory; (3) The phrase 'implying only a peripheral role' in 2022 is an inference rather than explicitly stated in filings, though reasonable. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no numerical calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years and correctly traces the evolution of Frame.io's capabilities and integrations. The logic connecting peripheral status in 2022 to enterprise-scale positioning in 2024 is sound. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with appropriate emphasis on the progression and expanded capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 499,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In 2022 Emerson grouped its electrical‑distribution gear under the broader **Industrial Solutions** product line, presenting it as one of several fluid‑control, pneumatic and materials‑joining offerings【page_76】. By the 2023‑2024 filings the company had moved that equipment into the **Discrete Automation** segment, explicitly listing it together with programmable automation control systems, software, electric‑linear‑motion solutions and other discrete‑industry components, reflecting a shift toward tighter integration with automation technologies and an expanded, more connected product scope【page_73】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Emerson's Electrical Distribution Equipment positioning from 2022 to 2024. STRENGTHS: (1) Accurately captures the 2022 positioning within Industrial Solutions as a foundational product; (2) Correctly identifies the shift to Discrete Automation segment by 2023-2024; (3) Properly synthesizes the multi-hop information showing integration with automation technologies; (4) Accurately lists companion products (programmable automation control systems, software, electric linear motion solutions); (5) Correctly conveys the strategic shift toward integrated automation solutions. WEAKNESSES: (1) The LLM answer combines 2023-2024 into a single statement ('2023-2024 filings') rather than showing the distinct 2023 positioning as a separate step in the evolution, which slightly obscures the granular 3-year progression that the ground truth emphasizes; (2) The ground truth specifically mentions 'materials joining solutions' appearing in 2024, while the LLM says 'materials-joining offerings' were in 2022 under Industrial Solutions - this creates some ambiguity about whether the same product category was repositioned or if it's a different reference; (3) The LLM doesn't explicitly state that 2023 was a distinct intermediate step showing 'stronger link to automation technologies' before the 2024 further integration. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple product categories, correctly identifying the progression from standalone to integrated positioning. The logic is sound and the conclusion about strategic shift is well-supported. ENTITY ACCURACY: Company (EMR/Emerson), segment names (Industrial Solutions, Discrete Automation), and product categories are all correctly identified. No date errors detected. The answer demonstrates solid understanding of the question's multi-part nature but loses some points for not fully capturing the distinct 2023 intermediate positioning that the ground truth emphasizes as part of the 3-year evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 558,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from $24.1 billion at a 4.45 % weighted‑average rate at year‑end 2022 to $27.2 billion at the same 4.45 % rate at year‑end 2023, then slipped slightly to $26.9 billion by year‑end 2024 while the weighted‑average rate increased to about 4.84 % (page_178; page_188). This trajectory shows the company issuing new senior notes to replace maturing debt and accepting higher coupons, reflecting a strategy of preserving liquidity and extending maturities even as market rates rise.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual errors in the carrying values for 2022 and 2023. Ground truth shows: 2022: $19,975M, 2023: $27,168M, 2024: $26,930M. LLM states: 2022: $24.1B ($24,100M), 2023: $27.2B (approximately correct), 2024: $26.9B (correct). The 2022 figure is significantly wrong ($24.1B vs $19.975B = $4.125B error, ~20% overstatement). The 2023 figure is approximately correct but rounded. WEIGHTED-AVERAGE INTEREST RATE ERRORS: The LLM claims the rate was 4.45% in both 2022 and 2023, which is incorrect. Ground truth shows: 2022: 2.91%, 2023: 4.45%, 2024: 4.84%. The LLM completely misses the 2022 rate of 2.91% and incorrectly states 4.45% for 2022. This is a fundamental error that undermines the entire analysis. MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the progression across all three years. It should show the dramatic increase in rates from 2.91% to 4.45% (153 basis points) from 2022-2023, then another 39 basis point increase to 4.84% in 2024. The LLM's narrative about 'the same 4.45% rate' in both 2022 and 2023 is factually incorrect. REASONING QUALITY: While the LLM's interpretation about debt strategy (issuing new notes, extending maturities, accepting higher coupons) is reasonable and contextually relevant, it is built on incorrect data. The ground truth answer better captures the strategic progression by showing the company locking in increasingly higher rates as market conditions changed. COMPLETENESS: The LLM addresses the carrying value evolution and weighted-average rates, but with significant errors in the 2022 baseline data and the rate progression. The answer is incomplete in properly capturing the full 2022-2024 trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 471,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s liability for product‑performance and operating‑cost guarantees fell from **$1.109 billion at year‑end 2022** to **$1.091 billion at year‑end 2023** and then to **$0.993 billion at year‑end 2024**【page_100†L31-L38】【page_104†L31-L38】. The steady decline – driven by lower issuance of new guarantees, higher settlements and adjustments based on actual claim experience – signals that the company’s exposure to long‑term performance risk in its commercial‑aerospace engines is gradually diminishing.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all quantitative measures. (1) WRONG NUMBERS: The LLM states liabilities of $1.109 billion (2022), $1.091 billion (2023), and $0.993 billion (2024). The ground truth shows $120 million (2022), $120 million (2023), and $101 million (2024). This is a discrepancy of approximately 9-10x the correct values. (2) CALCULATION ERROR: The LLM correctly identifies a declining trend, but the magnitude is entirely wrong. The actual decline is from $120M to $101M (a $19M decrease of ~16%), not from $1.109B to $0.993B. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information about the trend and its implications, the foundation is built on completely incorrect numbers, making the entire analysis unreliable. (4) ENTITY ACCURACY: The company (RTX) and business segment (commercial aerospace) are correctly identified, but the financial metrics are drastically wrong. (5) SEMANTIC ISSUE: The LLM's conclusion about 'gradually diminishing' exposure is directionally correct (both show decline), but the magnitude and context are entirely misrepresented. The ground truth emphasizes 'stability' and 'consistent exposure,' while the LLM emphasizes a significant decline. The ground truth indicates the liability remained stable at $120M for two years before a modest decrease, suggesting effective risk management. The LLM's narrative of steady decline from over $1B is factually incorrect and misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 407,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "In the 2022 filing (see pages 38‑42, e.g., page 40) Coca‑Cola’s investment note describes valuation of non‑public equity investments but does **not** call out “estimates of sales proceeds” as a distinct method. Starting in the 2023 filing, the note explicitly adds “estimates of sales proceeds” to the set of valuation approaches for non‑public companies (see page 78) and the same language is retained in the 2024 filing (see page 78). This progression shows the company has moved from relying mainly on discounted‑cash‑flow and appraisal methods to formally incorporating sales‑proceeds estimates—reflecting a more market‑participant‑based, nuanced fair‑value assessment that acknowledges the difficulty of predicting cash flows in emerging and developing markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual contradiction with the ground truth regarding 2022 disclosures. Ground truth states that in 2022, Coca-Cola 'disclosed the use of estimates of sales proceeds' as part of its valuation methodology, but the LLM explicitly claims the 2022 filing 'does NOT call out estimates of sales proceeds as a distinct method.' This is a material factual error that undermines the core narrative of the answer. The LLM correctly identifies that 2023 and 2024 filings explicitly include 'estimates of sales proceeds' and correctly notes the page references (page 78 for both years). The LLM also correctly captures the semantic essence of the evolution—moving toward more market-participant-based assessment and acknowledging challenges in emerging markets. However, the fundamental mischaracterization of the 2022 position breaks the 3-year progression narrative that is central to the question. The LLM's reasoning about the methodological shift is sound and the contextual interpretation about emerging market challenges is appropriate, but the factual error about 2022 is critical. The answer demonstrates partial understanding of the multi-hop synthesis required (comparing across three years) but fails on the most important factual claim about the starting point of the evolution. The page references provided appear reasonable but cannot be verified without access to actual filings. The qualitative analysis of what the progression 'reveals' is reasonable but is built on an incorrect factual foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 424,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "- In the 2022 Form 10‑K (BK_10k_2022 page 5) BNY Mellon warned that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  \n- The 2023 filing repeats the same statement verbatim (BK_10k_2023 page 3), and the 2024 filing again includes the identical language (BK_10k_2024 page 5).  \n\nThis three‑year consistency shows that the company’s capacity to repurchase shares or pay dividends remains subject to the same regulatory ceiling each year, indicating that while BNY Mellon retains board discretion, its strategic flexibility in shareholder capital distributions is persistently bounded by U.S. banking‑law capital‑planning constraints.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core regulatory language from 2022, 2023, and 2024 filings regarding capital return limitations under U.S. banking laws, Delaware law, and preferred stock dividend constraints. (2) The three-year consistency observation is accurate - the language was indeed repeated verbatim across these years. (3) Page citations appear reasonable and specific. (4) The quantitative accuracy is strong regarding dates (2022, 2023, 2024) and the identification of the regulatory constraints. CRITICAL WEAKNESSES: (1) The LLM answer OMITS a significant evolution that the ground truth explicitly highlights: the 2024 disclosure added NEW emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends. This is a material addition to the disclosure that represents an evolution in BNY Mellon's capital return disclosures. (2) The LLM concludes that the three-year progression shows 'consistency' and 'persistent' constraints, but misses the ground truth's key insight that 2024 introduced 'growing focus on internal capital flows' - this is a meaningful strategic shift in emphasis, not mere repetition. (3) The LLM's interpretation that the progression 'suggests' only 'persistent' limitations fails to capture the ground truth's more nuanced finding about 'increasing internal structural dependencies shaping its shareholder return strategy.' (4) The LLM answer is incomplete in addressing the full multi-year evolution - it identifies consistency but misses the 2024 evolution that the question specifically asks about. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to identify the key differentiator in 2024 that distinguishes it from 2022-2023. This represents incomplete multi-hop synthesis. The answer correctly identifies the baseline constraint but misses the evolution component that is central to the question's focus on 'how disclosures evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 543,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD first listed the possibility of “loss or modification of exemptions for taxes and tariffs” as one item among a broad set of political‑legal‑economic risks in its 2022 10‑K (see page 37). In the 2023 filing the same risk re‑appears, but is now discussed together with new sanctions, export‑control revisions and heightened geopolitical tensions (see page 41). By 2024 the company again highlights the risk, explicitly tying it to recent sanctions on Russia, Belarus, Ukraine and China‑Taiwan conflicts, showing that the exposure has become more prominent and is embedded in an increasingly complex, multi‑jurisdictional regulatory environment (see pages 41‑40).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's evolving exposure to tax and tariff exemption risks from 2022-2024, with generally accurate multi-hop synthesis across three fiscal years. STRENGTHS: (1) Correctly identifies the progression of risk disclosure across 2022, 2023, and 2024 filings; (2) Accurately captures the evolution from general risk awareness to more specific geopolitical context; (3) Properly synthesizes information showing increasing complexity and prominence of the risk; (4) Correctly identifies specific geopolitical events (Russia, Belarus, Ukraine, China-Taiwan conflicts) as drivers of regulatory complexity; (5) Appropriately characterizes the trend toward a 'multi-jurisdictional regulatory environment.' WEAKNESSES: (1) Page citations appear potentially inaccurate or inconsistent (cites 'pages 41-40' which is backwards notation, and page numbers may not align with actual filings - this is a minor documentation issue but raises verification concerns); (2) Slightly less comprehensive than ground truth in explicitly stating that the risk 'increased over time' - the LLM says it became 'more prominent' which is semantically similar but less definitive; (3) Does not explicitly mention 'U.S. export controls and sanctions' as a specific driver in 2024, though it does reference sanctions more broadly; (4) The phrase 'see pages 41-40' is awkwardly formatted and suggests potential citation errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects geopolitical events to regulatory complexity, demonstrating sound multi-hop reasoning. The progression narrative is logical and well-structured. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - AMD's exposure increased, driven by geopolitical pressures and regulatory volatility. Minor wording differences do not affect factual accuracy. The answer appropriately addresses both parts of the question (evolution and what it suggests about complexity).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 541,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from $883 million in 2022 to $538 million in 2023 and then edged up to $562 million in 2024, while its long‑term debt rose from $47.8 billion in 2022 to $49.3 billion in 2023 before declining to $45.0 billion in 2024, leaving total debt of $48.7 billion, $49.9 billion and $45.6 billion respectively【page_178†L31-L38】【page_188†L31-L38】.  The floating‑rate unsecured senior debt shrank from $1.6 billion in 2022 to $349 million in 2023 and was eliminated by 2024, showing a deliberate move toward a predominantly fixed‑rate senior‑debt structure and reduced interest‑rate volatility exposure, even as the weighted‑average rate on the remaining senior notes rose modestly (from ~4.48% to 4.84%)【page_178†L27-L34】【page_188†L27-L34】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant quantitative errors that fundamentally undermine its accuracy. (1) TOTAL DEBT FIGURES - CRITICAL ERROR: Ground truth shows total short-term borrowings + long-term debt of $43.086B (2022), $49.856B (2023), and $45.551B (2024). LLM reports $48.7B, $49.9B, and $45.6B respectively. While 2023 and 2024 totals are approximately correct (within rounding), the 2022 figure is drastically wrong ($48.7B vs $43.086B - a $5.6B discrepancy). (2) SHORT-TERM BORROWINGS - INCORRECT: LLM states $883M (2022), $538M (2023), $562M (2024). Ground truth does not provide these specific short-term borrowing figures in the original answer, but the LLM's breakdown suggests these are component figures. The issue is that these small figures cannot reconcile to the total debt figures when added to long-term debt as presented. (3) FLOATING UNSECURED SENIOR DEBT - PARTIALLY CORRECT: LLM states $1.6B (2022), $349M (2023), $0 (2024). Ground truth shows $1.709B (2022), $349M (2023), $0 (2024). The 2023 and 2024 figures match, but 2022 is slightly off ($1.6B vs $1.709B - approximately 6% error). (4) WEIGHTED-AVERAGE INTEREST RATES - INCORRECT: LLM claims rates rose from ~4.48% to 4.84%. Ground truth shows fixed unsecured senior debt rates rose from 2.91% (2022) to 4.84% (2024), and floating rates were 1.01% (2022) to 6.75% (2023). The LLM's 4.48% figure does not appear in the ground truth and appears to be an error. (5) MULTI-HOP REASONING: The LLM correctly identifies the strategic pivot from floating to fixed-rate debt and the elimination of floating-rate debt by 2024, which aligns with ground truth. However, this correct reasoning is undermined by the quantitative errors. (6) COMPLETENESS: The LLM addresses the main components of the question (short-term borrowings, long-term debt, floating vs fixed debt, interest rate exposure) but with significant numerical inaccuracies. The ground truth provides more detailed context about fixed unsecured senior debt evolution ($21.045B to $27.168B to $26.930B) which the LLM omits. VERDICT: While the LLM demonstrates understanding of the strategic debt management narrative, the quantitative errors are severe enough to make the answer unreliable for financial analysis. The 2022 total debt figure error is particularly problematic as it affects year-over-year comparisons.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 634,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG has remained essentially unchanged – it was reported as 57 % (with a 51 % share in the IAE LLC vehicle) in the 2022 filing【page_110】 and is still 57 % (51 % in IAE LLC) in the 2024 filing【page_102】. This steady majority stake signals that RTX continues to be the primary beneficiary and strategic anchor of the V2500 engine collaboration, preserving its influence over design, production and support of the program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the core factual claim. The ground truth clearly states RTX's net program share interest in IAE DECREASED from 61% in 2022 to 57% in 2023 and 2024. The LLM claims the interest 'remained essentially unchanged' at 57% in both 2022 and 2024, which directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports 57% for 2022, but ground truth shows 61% in 2022. This is a 4 percentage point error on a key metric. The 2024 figure of 57% is correct, but the 2022 baseline is wrong. (2) MULTI-HOP REASONING FAILURE: The question asks about evolution FROM 2022 TO 2024. The LLM failed to identify the 61%→57% decline that occurred over this period. Instead, it incorrectly characterized the data as 'essentially unchanged,' which is a fundamental misreading of the three-year trend. (3) STRATEGIC INTERPRETATION ERROR: Because the LLM missed the actual decline, its interpretation is inverted. The ground truth correctly identifies this as a 'strategic adjustment' and 'gradual dilution' of RTX's direct economic exposure. The LLM's interpretation of 'steady majority stake' and 'preserving influence' contradicts what the actual data shows—a reduction in stake. (4) ENTITY/METRIC ACCURACY: While the LLM correctly identifies RTX, IAE, and the V2500 program, it misreports the key metric values. The mention of 51% in IAE LLC is a detail not addressed in ground truth but doesn't excuse the primary error. (5) CONTEXTUAL RELEVANCE: The question is appropriately addressed in scope, but the answer provides incorrect information about the evolution, making it misleading despite being contextually relevant in structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 464,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade has stayed a flagship brand in P&G’s Fabric & Home Care segment, consistently listed as one of the primary brands that underpins the segment’s roughly 25 percent market share. In the 2022 filing the home‑care share is described as “nearly 25 % … primarily behind our Cascade, Dawn, Febreze and Swiffer brands” (2022 pg 19), and the 2023 and 2024 filings repeat the same wording, noting the share is “about 25 % … primarily behind our Cascade, Dawn, Febreze and Swiffer brands” (2023 pg 18; 2024 pg 18). Thus, Cascade’s positioning has remained stable – a leading, core brand driving the home‑care portfolio’s market‑share performance across all three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent Cascade's positioning within P&G's portfolio. CRITICAL ERRORS: (1) The LLM cites market share percentages (~25%) which are NOT the same as segment contribution metrics. The ground truth clearly states Cascade's segment (Fabric & Home Care) represented 35% of net sales in 2022, 36% in 2023-2024 - these are segment-level metrics, not market share. The LLM conflates two different metrics entirely. (2) The LLM provides page references (2022 pg 19, 2023 pg 18, 2024 pg 18) and specific quotes about 'nearly 25%' and 'about 25%' which cannot be verified against the ground truth data and appear to reference market share context rather than segment positioning. (3) The ground truth explicitly provides segment contribution percentages (35-36% of net sales, 31-34% of earnings) which are the appropriate metrics for answering how Cascade's positioning evolved within P&G's portfolio structure. The LLM completely omits these critical financial metrics. WHAT WAS CORRECT: The LLM correctly identifies that Cascade remained a core/flagship brand across all three years and that its positioning was stable. The identification of Cascade as part of the Fabric & Home Care segment is correct. MULTI-HOP REASONING: The LLM failed to synthesize the segment-level financial data across the three years that would demonstrate how Cascade's strategic importance evolved. Instead, it focused on market share language that, while potentially accurate in isolation, does not address the question about positioning within P&G's portfolio structure as reflected in segment reporting. The answer addresses brand consistency but misses the portfolio evolution analysis that segment contribution metrics would provide. SEMANTIC ISSUE: While the LLM's conclusion about stability is directionally similar to the ground truth, it arrives there through different (and incorrect) metrics, which is a fundamental analytical error in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 541,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon said the Directors’ Code of Conduct was available at a full bnymellon.com address – https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/**in relations**/directors‑code‑of‑conduct.pdf – and it was listed under the Item 10 “Code of Ethics” section that ties the code to the company’s overall governance disclosures【page_11】.  \n\nThe 2023 filing dropped the explicit domain, showing the code as a relative link – bnymellon/documents/pdf/**investor‑relations**/directors‑code‑of‑conduct.pdf – while the employee‑code branding moved to the bny.com domain; nevertheless the Directors’ Code remained referenced in the same Item 10 corporate‑governance section, with the same statement that any amendments or waivers would be posted online【page_13】.  \n\nBy the 2024 Form 10‑K the company restored a full bnymellon.com URL but changed the path to **inv relations** (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/**inv relations**/directors‑code‑of‑conduct.pdf) and again embedded the code in the Item 10 governance narrative, reiterating that updates would be posted on the website as part of its broader corporate‑governance framework【page_13】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains multiple significant factual errors that directly contradict the ground truth:\n\n1. 2022 URL PATH ERROR: The LLM states the 2022 URL contained '**in relations**' but the ground truth clearly shows it was '**in relations**' (which appears to be a typo in ground truth, but the LLM's representation matches). However, the LLM then claims 2023 changed to '**investor-relations**' when ground truth shows 2023 maintained '**inv relations**' - this is backwards.\n\n2. DOMAIN TRANSITION TIMING ERROR: The LLM claims the employee-code moved to bny.com in 2023, but provides no evidence this is relevant to the Directors' Code evolution. More critically, the LLM states 2024 'restored a full bnymellon.com URL' when ground truth explicitly states 2024 transitioned to the NEW domain 'bny.com' - this is a fundamental factual error.\n\n3. 2024 URL PATH ERROR: The LLM claims 2024 changed to '**inv relations**' but ground truth shows it changed to '**investor-relations**' (with hyphens, not spaces). This is a specific, verifiable error in the URL structure.\n\n4. DOMAIN BRANDING EVOLUTION MISREPRESENTED: The ground truth emphasizes a strategic shift FROM bnymellon.com TO bny.com by 2024 as a key evolution. The LLM incorrectly states 2024 'restored' bnymellon.com, completely missing this critical domain transition that the ground truth identifies as signaling 'more strategic integration into corporate governance communication.'\n\n5. INCOMPLETE SYNTHESIS: While the LLM correctly identifies Item 10 governance placement across all years, it fails to synthesize the key narrative arc: the evolution from a siloed document repository (2022) → minor reorganization (2023) → strategic brand/domain consolidation with investor-relations alignment (2024).\n\n6. RELATIVE LINK CLAIM: The LLM claims 2023 showed a 'relative link' without full domain, but this appears to be an interpretation not supported by the ground truth's explicit URL paths.\n\nThe answer demonstrates some understanding of the governance framework context but fundamentally misrepresents the URL evolution, domain transitions, and path structures that are central to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 594,
        "total_tokens": 2183
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across all three filings AMD kept the same core stance with its AIB partners – the contracts explicitly protect the AIBs’ inventory from any price‑reduction actions, and AMD repeatedly points out that system integrators rely on its discrete‑graphics solutions to differentiate their board‑level products (2022 – page 11; 2023 – page 13; 2024 – page 13). The inventory‑protection language and the emphasis on discrete graphics as a differentiation tool remain unchanged, indicating a stable strategic positioning rather than a shift over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core strategic positioning of AMD with AIB manufacturers across 2022-2024, correctly identifying inventory protection policies as a consistent element and discrete graphics as a key differentiator. The characterization of this as a 'stable strategic positioning rather than a shift' directly matches the ground truth's conclusion about consistency. (2) QUANTITATIVE ACCURACY: While the answer includes page references (page 11 for 2022, page 13 for 2023 and 2024), these cannot be verified against the ground truth provided, but they appear reasonable and don't contradict any stated facts. No numerical calculations or financial metrics are presented that could be incorrect. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information across three years and two key policy areas (inventory protection and discrete graphics differentiation). The logic connecting these elements to demonstrate strategic stability is valid and matches the ground truth's reasoning. (4) ENTITY ACCURACY: AMD is correctly identified, AIB manufacturers are properly referenced, system integrators are mentioned appropriately, and the three-year period (2022-2024) is accurate. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'contracts explicitly protect the AIBs' inventory from any price-reduction actions' is semantically equivalent to the ground truth's 'inventory protection policies...ensuring their stock was shielded from price reductions.' The emphasis on discrete graphics as a 'differentiation tool' matches the ground truth's characterization. Minor deduction from perfect score (9 vs 10) due to the inclusion of specific page numbers that, while plausible, cannot be independently verified against the ground truth source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 517,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In the 2022 filing McDonald’s noted that the Egg McMuffin is a core breakfast sandwich on its full or limited breakfast menu and that the company is “continuously evolving its menu” while relying on supplier collaboration, high food‑safety standards and regular sensory‑evaluation training to keep core items consistent. By 2023 the disclosure still highlighted the Egg McMuffin but added a more detailed supply‑chain strategy—virtual supplier visits, third‑party verifications, a Food Safety Advisory Council and a risk‑management framework—to assure the sandwich meets customer expectations for taste, quality and consistency. The 2024 report repeats the Egg McMuffin focus and the commitment to menu evolution, and further stresses a comprehensive, data‑driven quality system and food‑safety culture that reinforce consistent quality for the Egg McMuffin across the system.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative arc of McDonald's disclosure evolution from 2022-2024 regarding the Egg McMuffin and supply chain focus. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) with appropriate temporal markers; (2) Accurately captures the 2022 focus on menu evolution, supplier collaboration, and food safety standards; (3) Properly synthesizes the 2023 expansion to include more detailed supply chain elements (virtual supplier visits, third-party verifications, Food Safety Advisory Council, risk-management framework); (4) Correctly identifies the 2024 shift toward data-driven quality systems and food-safety culture; (5) Appropriately emphasizes the Egg McMuffin as a consistent reference point across all three years; (6) Accurately conveys the evolution from general quality assurance to more technologically integrated approaches. MINOR WEAKNESSES: (1) The LLM answer mentions 'sensory-evaluation training' in 2022 which is not explicitly mentioned in the ground truth, though this is a reasonable inference about quality assurance practices and doesn't contradict the ground truth; (2) The ground truth specifically mentions 'Global Chief Supply Chain Officer' leadership in 2023, which the LLM answer does not explicitly reference, though it does capture the expanded supply chain narrative; (3) The LLM answer could have been more explicit about the 'digital transformation project' mentioned in the ground truth for 2024, instead using the more general term 'data-driven quality system.' QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high (9/10) as there are no calculation errors or numeric discrepancies. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information across three years and identifies the progression from supply chain basics to digital transformation. The entity identification (McDonald's, Egg McMuffin, supply chain elements) is accurate throughout. CONTEXTUAL RELEVANCE: The answer directly addresses the question about disclosure evolution and the Egg McMuffin's role in meeting customer expectations, maintaining strong relevance throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 612,
        "total_tokens": 2115
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The 4.30 % Note due 2034 appears in the exhibit lists of Oracle’s 2022, 2023 and 2024 Form 10‑K filings (e.g., “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044” – 2022 exhibit list 【page_113】 and the same description in the 2023/2024 exhibit lists 【page_109】). Its repeated inclusion shows that Oracle continues to carry this medium‑term senior unsecured note as a core component of its long‑term debt, indicating a financing strategy that relies on stable, fixed‑rate, long‑dated borrowings and a diversified maturity profile across reporting periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Oracle's 4.30% Note due 2034 appears consistently across 2022, 2023, and 2024 filings, and accurately notes it as a medium-term senior unsecured note with a fixed rate and diversified maturity profile. The numeric values (4.30%, 2034 maturity date) are correct. However, there are significant issues with completeness and synthesis: (1) The LLM answer mentions a 3.40% Note due 2024 in the 2022 exhibit list, but the ground truth references a 3.625% Note due 2023 instead—this is a factual discrepancy that suggests potential misreading of source documents. (2) The LLM answer lacks the comparative analysis across years that the ground truth provides—specifically, it doesn't discuss how the debt portfolio evolved (e.g., the introduction of 2.950% Notes due 2024 in 2023, or the presence of 4.50% Note due 2044 across periods). (3) The ground truth emphasizes Oracle's 'strategic focus on long-term financing' and describes the note as a 'stable element within a broader, evolving debt portfolio,' providing richer context about financing priorities. The LLM answer states similar conclusions but with less nuance about the evolution and strategic intent. (4) The LLM answer references specific page numbers (113, 109) which adds credibility but cannot be verified against the ground truth. The core insight about consistent disclosure indicating strategic long-term financing is present in both answers, but the LLM version is less comprehensive in synthesizing the multi-year comparative analysis that the question specifically asks about.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 435,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s net Level‑3 derivative position expanded sharply – it was a modest $5 million net asset at 12/31/2022, grew to $58 million at 12/31/2023 and to $69 million at 12/31/2024 (COF 2022 Table 16.2; COF 2023 Table 16.2; COF 2024 Table 17.2) – while the underlying gross balances rose from $79 million/$74 million (assets/liabilities) to $886 million/$828 million and then to $683 million/$614 million (footnotes to the same tables). The firm values these Level‑3 derivatives with discounted‑cash‑flow models that rely on swap‑rate assumptions, an unobservable input (COF 2023 Note 9‑Derivatives; COF 2024 Table 17.3), and the roll‑forward disclosures note that transfers into Level 3 are mainly term SOFR‑indexed interest‑rate swaps (COF 2023 footnote). The rising net Level‑3 fair‑value balances therefore signal a growing reliance on and exposure to instruments that depend on significant unobservable market inputs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - 2022 Fair Value: LLM states '$5 million net asset' vs. Ground Truth '$19 million' - INCORRECT (off by $14M)\n   - 2023 Fair Value: LLM states '$58 million' - MATCHES ground truth ✓\n   - 2024 Fair Value: LLM states '$69 million' vs. Ground Truth '$58 million' - INCORRECT (off by $11M)\n   - The LLM's claim of 'sharp expansion' and 'rising net Level-3 fair-value balances' is contradicted by the ground truth showing the 2024 value remained at $58 million (same as 2023), not increasing to $69 million\n\n2. METHODOLOGY ISSUES:\n   - The LLM focuses heavily on 'Level-3' derivatives and gross asset/liability balances ($79M/$74M, $886M/$828M, $683M/$614M) which are NOT mentioned in the ground truth\n   - Ground truth discusses 'net derivative assets/liabilities' without Level-3 classification emphasis\n   - The LLM appears to be mixing different classification frameworks or pulling data from different tables than the ground truth references\n\n3. UNOBSERVABLE INPUTS:\n   - LLM correctly identifies swap rates as unobservable inputs ✓\n   - LLM mentions discounted-cash-flow models ✓\n   - LLM mentions SOFR-indexed interest-rate swaps ✓\n   - However, Ground Truth also mentions default rates (53-163%) which LLM completely omits\n   - LLM provides more granular detail on swap rate ranges but misses the default rate component\n\n4. MULTI-HOP REASONING:\n   - LLM attempts to synthesize across three years but arrives at incorrect 2022 and 2024 values\n   - The conclusion about 'growing reliance' is contradicted by the ground truth showing stabilization from 2023-2024\n   - Ground truth emphasizes 'transformation' and 'stabilization' while LLM emphasizes 'sharp expansion' and 'rising' - opposite narratives\n\n5. MISSING ELEMENTS:\n   - LLM omits the 2022 'net unrealized loss of $20 million' detail from ground truth\n   - LLM omits default rates (53-163%) as unobservable inputs\n   - LLM's narrative of 'expansion' contradicts the ground truth's narrative of 'stabilization'\n\nThe LLM answer appears to reference actual SEC filing tables but with incorrect numerical values, suggesting either data extraction errors or reference to different metrics than the ground truth. The fundamental narrative (expansion vs. stabilization) is inverted from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 651,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "- In the 2022 Form 10‑K the company said that, under the 2012 IAE acquisition, “additional payments are due to Rolls‑Royce contingent upon each hour flown through June 2027 by the V2500‑powered aircraft…These flight‑hour payments … will be capitalized as collaboration intangible assets as payments are made” (page 112).  \n\n- The 2023 filing adds that those capitalized collaboration assets “are being amortized to cost of sales” (page 73), and the 2024 filing repeats the same treatment – the payments remain flight‑hour‑contingent, are capitalized as collaboration intangible assets when paid, and are amortized to cost of sales (page 103).  \n\n- The underlying commitment amounts have shifted over the period (e.g., $735 million in 2022, $1.05 billion in 2023 and $765 million in 2024), but the payment structure (per‑hour) and amortization strategy (capitalization then amortization to cost of sales) have remained consistent.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop financial relationship between RTX and Rolls-Royce regarding V2500-powered aircraft obligations from 2022-2024. STRENGTHS: (1) Correctly identifies the 2012 IAE acquisition as the origin of the obligation; (2) Accurately describes the payment structure as flight-hour contingent through June 2027; (3) Properly synthesizes the evolution of accounting treatment across three years (2022: described as contingent liabilities to be capitalized; 2023-2024: clarified as capitalized collaboration assets amortized to cost of sales); (4) Correctly notes the consistency of payment structure and amortization strategy despite changing commitment amounts; (5) Provides specific page references supporting the claims. WEAKNESSES: (1) The specific dollar amounts cited ($735M in 2022, $1.05B in 2023, $765M in 2024) cannot be verified against the ground truth, which does not provide these specific figures. The ground truth mentions $14.1B for total commercial aerospace commitments in 2024 but does not break out the Rolls-Royce-specific amounts for each year. This represents a quantitative accuracy concern; (2) The LLM does not mention the $14.1B total commercial aerospace financing figure from 2024 that appears in the ground truth, which is a minor omission of context. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple filing documents, correctly tracing how the accounting treatment evolved while the underlying payment structure remained constant. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The LLM's description of the evolution matches the ground truth's characterization of improved transparency and consistent amortization policy. The core narrative is accurate even where specific dollar amounts cannot be independently verified from the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 518,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "In the 2022 Form 10‑K Amgen disclosed that it “collects and assesses user complaints, adverse events and malfunctions” for its devices and, after the FDA’s 2017 review of the Neulasta Onpro kit, it “implemented device and labeling enhancements to address product complaints” and will “continuously monitor complaints and adverse events and implement additional enhancements as needed” (2022 p. 51). The 2023 filing repeats the same language—again noting the 2017 FDA evaluation, the device/label upgrades and ongoing monitoring (2023 p. 54)—but adds no new mitigation steps. By the 2024 filing, Amgen still references those historic device‑ and labeling‑enhancements (2024 p. 55) while expanding the discussion to broader operational‑resilience measures, describing its reliance on third‑party suppliers, the risk of natural‑disaster‑related power or logistics disruptions, and the use of backup generators and supply‑chain safeguards to protect the kit’s availability (2024 p. 56). This evolution shows a shift from a narrow focus on device‑specific enhancements to a more comprehensive risk‑mitigation narrative that includes supply‑chain and infrastructure resilience.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of Amgen filings. STRENGTHS: (1) Correctly identifies the 2017 FDA evaluation as a consistent reference point across all three years; (2) Accurately captures the evolution from device-specific enhancements (2022-2023) to broader operational resilience measures (2024); (3) Properly cites page numbers (2022 p. 51, 2023 p. 54, 2024 pp. 55-56) showing document-level verification; (4) Correctly identifies the shift in disclosure focus from narrow device/labeling enhancements to comprehensive supply-chain and infrastructure resilience; (5) Accurately describes the 2024 expansion to include backup generators, third-party suppliers, and natural disaster risks. MINOR GAPS: (1) The LLM answer does not explicitly mention the December 31, 2024 island-wide outage in Puerto Rico that the ground truth specifically references, though it does capture the broader concept of backup generator reliance and Puerto Rico infrastructure risks; (2) The LLM answer uses slightly different framing ('third-party suppliers' and 'natural-disaster-related power or logistics disruptions') rather than the ground truth's specific reference to 'Puerto Rico's unstable electric grid' and the specific December 31, 2024 outage event. QUANTITATIVE ACCURACY: All dates (2017, 2022, 2023, 2024) are correct; page number citations appear reasonable and specific. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the temporal evolution of disclosures. The logical progression from device-focused to operationally-focused risk mitigation is sound and well-articulated. SEMANTIC EQUIVALENCE: The core message matches the ground truth—Amgen's disclosures evolved from device-specific enhancements to broader operational resilience—though with slightly less specificity regarding the Puerto Rico infrastructure details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 536,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings from 2022 through 2024 all contain the same language: the ratification of KPMG LLP as the company’s principal accountant is referenced in the proxy under “Item 3 – Ratification of KPMG LLP,” and KPMG’s PCAOB firm identification number is listed as 185【page_13】. The wording and the PCAOB number did not change over the three years, indicating that BNY Mellon has retained KPMG LLP as its auditor and has maintained a stable audit‑governance framework throughout this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. Strengths: (1) All numeric values are correct - PCAOB firm number 185 is accurately cited and confirmed as consistent across all three years (2022-2024); (2) Entity identification is correct - properly identifies BK/BNY Mellon and KPMG LLP; (3) Multi-hop synthesis is sound - correctly synthesizes information across three years of filings to demonstrate consistency; (4) Key conclusions are valid - accurately concludes that the unchanged PCAOB number and consistent disclosure language indicate stable audit governance and auditor continuity. Minor observations: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual language about 'institutional trust' and 'strong institutional trust in the firm's audit services,' though this is a minor semantic difference rather than a factual error; (2) The LLM correctly identifies the disclosure location ('Item 3 – Ratification of KPMG LLP') which adds helpful specificity; (3) The phrase 'stable audit-governance framework' is semantically equivalent to the ground truth's 'stable audit governance practices.' The answer demonstrates clear understanding of the multi-hop nature of the question (comparing across three years) and provides accurate synthesis. No calculation errors, no date errors, and all factual claims are supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 393,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s total exposure to commercial‑aerospace customer‑financing guarantees has been shrinking – the maximum‑potential payment fell from $304 million at 12/31/2022 to $288 million in 2023 and to $274 million in 2024【page_100†L1-L4】【page_102†L1-L4】.  At the same time, the portion of those guarantees that is backed by collaboration partners has also declined – from roughly $142 million in 2022 (the prior‑year figure reported in the guarantees note) to $135 million in 2023【page_100†L13-L15】 and to $131 million in 2024【page_102†L13-L15】.  The downward trend in both the overall guarantee exposure and the partners’ share suggests RTX is deliberately tightening its risk profile, reducing reliance on partner‑backed financing and limiting contingent liabilities in the commercial‑aerospace segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All dollar amounts are correct - collaboration partners' share: $142M (2022), $135M (2023), $131M (2024) match ground truth exactly. The LLM also provides additional context with total guarantee exposure figures ($304M→$288M→$274M), which are not contradicted by the ground truth and add valuable context. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) evolution of exposure from 2022-2024, (2) specific trend in collaboration partners' share, and (3) interpretation of risk management strategy. ENTITY ACCURACY: RTX correctly identified, years correct (2022-2024), financial metrics properly labeled as 'guarantees' and 'collaboration partners' share.' REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the downward trend in both overall exposure and partners' share, then synthesizes this into a coherent interpretation about deliberate risk reduction and reduced reliance on partner-backed financing. SEMANTIC EQUIVALENCE: The LLM's interpretation ('deliberately tightening its risk profile, reducing reliance on partner-backed financing and limiting contingent liabilities') aligns well with the ground truth's characterization ('strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements'). MINOR CONSIDERATIONS: The LLM does not explicitly mention that 'fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which was noted in the ground truth. However, this omission is minor since the question specifically asks about the trend and what it indicates about risk management strategy, not about asset valuations. The LLM's answer is more focused and directly responsive to the specific question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 515,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "In the 2022 Form 10‑K P&G described Always as one of the two “primary” brands that underpin its global feminine‑care leadership, grouping it with Tampax in the menstrual‑care category and noting only that the adult‑incontinence line (Always Discreet) held about a 10% share【page_19】. By the 2024 filing, Always is called out explicitly as the flagship brand of the menstrual‑care sub‑category (now cited with > 25% global share) while Always Discreet is listed separately for adult incontinence (≈15% share), showing a clearer product‑category split and a stronger emphasis on Always’s role relative to other feminine‑hygiene offerings【page_18】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Ground truth: Feminine Care segment contributed 25% of net sales in 2022 and 24% in 2023-2024\n   - LLM answer: Claims Always Discreet held \"about a 10% share\" in 2022 and \"≈15% share\" in 2024 - these figures are not supported by the ground truth and appear to conflate segment-level percentages with brand-level market shares\n   - The LLM's claim of \">25% global share\" for Always menstrual care in 2024 is not substantiated in the ground truth\n   - No verification that these specific market share percentages appear in the actual filings\n\n2. STRUCTURAL/CATEGORIZATION ERRORS:\n   - Ground truth: 2023 segment renamed to 'Baby, Feminine & Family Care' (not just 'Feminine Care')\n   - LLM answer: Fails to mention the segment name change entirely, focusing instead on product subcategories\n   - Ground truth: Always positioned alongside \"Always Discreet and Tampax\" in 2023-2024\n   - LLM answer: Describes a \"clearer product-category split\" but doesn't accurately capture the actual segment structure evolution\n\n3. MULTI-HOP REASONING ISSUES:\n   - The LLM conflates brand market share data with segment contribution percentages\n   - Fails to synthesize the key evolution: segment renaming from 'Feminine Care' to 'Baby, Feminine & Family Care'\n   - Misses the consistent 24-25% segment contribution across years\n   - The comparison between 2022 and 2024 doesn't accurately reflect the documented structural changes\n\n4. MISSING KEY INFORMATION:\n   - No mention of the segment name change in 2023\n   - No mention of the \"streamlined formatting\" and \"consolidated approach\" noted in ground truth for 2024\n   - Doesn't address the consistent strategic emphasis across all three years\n\n5. CITATION ISSUES:\n   - References to \"page_19\" and \"page_18\" cannot be verified against the ground truth\n   - The specific market share figures cited lack grounding in the provided ground truth\n\nThe answer demonstrates partial understanding of brand positioning but introduces unsupported quantitative claims and misses critical structural changes in segment naming and organization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 603,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In the 2022 filing AMD listed “difficulties in protecting our intellectual property” only as a generic risk for its worldwide operations (2022 p. 36‑37). By the 2023 filing the risk was tied to its expanding overseas footprint – 65 % of revenue came from international sales and “nearly all product assembly and final testing … is performed at third‑party operated manufacturing facilities, in China, Malaysia and Taiwan,” making IP‑protection a more acute concern (2023 p. 41). The 2024 filing repeats this language, now with international sales at 66 % and continued reliance on Asian wafer foundries and assembly, showing that AMD’s exposure to IP‑protection difficulties has grown as its international operations and dependence on Asian manufacturing partners have expanded (2024 p. 40‑41).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across three years of AMD filings. STRENGTHS: (1) All numeric values are correct - 65% international sales in 2023, 66% in 2024, page references are accurate (2022 p. 36-37, 2023 p. 41, 2024 p. 40-41). (2) The multi-hop synthesis is sound: correctly traces evolution from generic 2022 risk statement to more specific 2023 context with named manufacturing locations (China, Malaysia, Taiwan) to 2024 continuation. (3) Accurately identifies the key entities and metrics: AMD, international operations percentage, third-party manufacturing locations, IP protection risks. (4) The reasoning chain is logical and well-supported: shows how expanding international footprint and Asian manufacturing reliance increased IP exposure over time. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the geopolitical China-Taiwan tensions that the ground truth identifies as a 'new layer of risk' in 2024. While the answer notes 'continued reliance on Asian wafer foundries and assembly,' it doesn't capture the specific geopolitical dimension that emerged in 2024. (2) The ground truth emphasizes that IP challenges became 'more complex and regionally concentrated, especially in Asia' - the LLM captures the regional concentration aspect but doesn't explicitly characterize the increasing complexity. (3) The LLM uses slightly different phrasing ('acute concern' vs. the ground truth's 'heightening exposure') but this is semantically equivalent. CALCULATION/VERIFICATION: No calculations required; all cited percentages and page numbers verified as accurate. The progression from 65% to 66% international sales is correctly noted as showing continued reliance. Overall, this is a strong answer that captures the core evolution of AMD's IP protection risks, with only the omission of the geopolitical dimension preventing a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 524,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first disclosed its 2.300 % senior notes due 2028 in the 2022 Form 10‑K as part of a March 24 2021 issuance that also included 1.650 % notes due 2026, 2.875 % notes due 2031, 3.650 % notes due 2041, etc. (Exhibit 4.16) 【page_114】. The same note series is listed unchanged in the 2023 and 2024 10‑Ks under Exhibit 4.14 (2023 【page_111】; 2024 【page_111】), showing the notes have remained outstanding without amendment. This multi‑year consistency reflects Oracle’s broader strategy of issuing a ladder of low‑coupon, medium‑term senior notes to secure inexpensive, diversified financing and spread maturities across many years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information across three years of SEC filings. STRENGTHS: (1) Correctly identifies the 2.300% Notes due 2028 and traces their disclosure across 2022, 2023, and 2024 10-Ks; (2) Accurately cites the March 24, 2021 issuance date and correctly references Exhibit 4.16 for 2022 and Exhibit 4.14 for 2023-2024; (3) Provides specific supporting details about companion notes (1.650% due 2026, 2.875% due 2031, 3.650% due 2041) that enhance credibility; (4) Correctly identifies page numbers (114 for 2022, 111 for 2023 and 2024); (5) Accurately characterizes the multi-year pattern as showing notes 'remained outstanding without amendment'; (6) Synthesizes the broader strategic insight about Oracle's debt ladder strategy with low-coupon, medium-term senior notes and maturity diversification. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and specific than the ground truth (providing exact dates, page numbers, and companion note details), but this represents added value rather than error. The semantic meaning aligns perfectly with the ground truth's conclusion about 'stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.' All quantitative data (percentages, years, exhibit numbers) are accurate. The multi-hop reasoning correctly synthesizes information across three separate 10-K filings to establish the pattern and strategic implication. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 430,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "BA’s private‑equity approach has stayed essentially the same. In each filing – 2022 (see page 110), 2023 (see page 92) and 2024 (see page 99) – the pension notes that its private‑equity vehicles are “primarily limited partnerships (LPs) that mainly invest in U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth and special‑situation strategies.” Thus, from 2022 through 2024 the geographic scope remained global (U.S. and non‑U.S.) and the strategic focus continued to target leveraged buyouts, venture‑capital, growth‑stage and special‑situations investments, with no substantive shift in emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH COMPLETENESS AND SYNTHESIS: The LLM answer fundamentally misses the core evolution described in the ground truth. While the LLM correctly identifies that the basic LP structure and core strategies (leveraged buyout, venture capital, growth, special situations) remained consistent across 2022-2024, it FAILS to capture the critical strategic evolution that occurred. SPECIFIC DEFICIENCIES: (1) The LLM states 'no substantive shift in emphasis' - this directly contradicts the ground truth which explicitly documents an 'expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure' emerging in 2023. This is a material omission of a key strategic development. (2) The LLM completely misses the 2024 sophistication evolution regarding 'increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes.' This represents a significant strategic development that the LLM failed to identify. (3) The LLM's conclusion that geographic scope 'remained global (U.S. and non-U.S.)' is technically correct but incomplete - the ground truth indicates this global orientation was MAINTAINED but with a DEEPENING and BROADENING into specific alternative asset classes. (4) QUANTITATIVE ACCURACY: The page references provided (110, 92, 99) cannot be verified but appear plausible for 10-K filings. The characterization of LP structures and basic strategies is accurate. (5) MULTI-HOP REASONING: The LLM failed to synthesize the evolution across the three-year period. It treated the years as static rather than identifying the progression from basic PE strategies (2022) → expanded real assets focus (2023) → enhanced derivative sophistication (2024). The question explicitly asks about 'evolution' and the LLM's answer contradicts this by claiming 'essentially the same' approach. This is a fundamental failure in multi-hop synthesis. The answer reads as a surface-level comparison rather than identifying the strategic deepening documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 562,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen’s 2022 Form 10‑K notes that Bemarituzumab “initiated a Phase 3 study” for gastro‑esophageal‑junction adenocarcinoma and that its composition‑of‑matter patents are expected to expire in 2029 in both the United States and Europe【page_25】. The 2023 filing still lists Bemarituzumab as a Phase 3 program (GEJ adenocarcinoma) and shows the same 2029 U.S. and European patent expiration dates【page_26】, and the 2024 filing likewise keeps it in Phase 3 with the 2029 expiration estimates for both territories【page_26】. Thus, the drug moved into Phase 3 in early 2022 and has remained in that stage through 2024, while its patent protection horizon has consistently been projected to run until 2029 in both regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key data points: (1) Bemarituzumab initiated Phase 3 study in 2022 for GEJ adenocarcinoma - CORRECT; (2) Patent expiration dates of 2029 in both U.S. and Europe - CORRECT; (3) Consistent patent timeline across 2022-2024 filings - CORRECT; (4) Composition-of-matter patent classification - CORRECT. The multi-hop synthesis across three years of filings is sound, properly tracking the drug's progression and stable IP position. Quantitative accuracy is excellent with all dates and patent expiration years verified. The answer correctly identifies the drug as a monoclonal antibody targeting FGFR2b (implied through clinical indication context). Minor deduction: The LLM answer is slightly more technical/filing-focused than the ground truth, which emphasizes the 'monoclonal antibody targeting FGFR2b' mechanism more explicitly. The ground truth also adds interpretive context about 'regulatory exclusivity' extending market protection, which the LLM answer doesn't explicitly mention, though it's not strictly required by the question. The LLM answer's statement that the drug 'moved into Phase 3 in early 2022' is accurate based on the 2022 filing noting initiation of Phase 3. Overall, the answer successfully synthesizes multi-year filing information with accurate numbers and proper entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 387,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "In the 2022 filing, Fabric & Home Care contributed 31 % of P&G’s net earnings and the segment’s brand list included Dawn【page_19】. By the 2024 filing, the segment’s earnings share had risen to 34 % of net earnings and Dawn remained listed among the major Fabric & Home Care brands【page_18】, showing that Dawn’s presence was retained while the segment’s contribution to earnings grew.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key quantitative facts: Fabric & Home Care contributed 31% of net earnings in 2022 and 34% in 2024, and Dawn was listed as a brand in both years. The numbers are accurate and properly formatted. WEAKNESSES: The answer is significantly incomplete relative to the ground truth. The original answer provides crucial context about net sales percentages (35% in 2022, 36% in 2023 and 2024), which the LLM entirely omits. This is important because it demonstrates that while earnings contribution grew, sales remained stable—a key insight about the segment's evolution. The LLM also fails to mention 2023 data at all, despite the question asking about evolution 'from 2022 to 2024,' which implies tracking the progression across all three years. The ground truth explicitly notes the 2023 sales figure (36%) as part of showing stability. Additionally, the LLM's reasoning is somewhat superficial—it notes that 'the segment's contribution to earnings grew' but doesn't synthesize the full picture of what this means for Dawn's positioning (i.e., that earnings grew while sales remained stable, suggesting improved profitability/efficiency). The answer reads more like a summary of isolated facts rather than a comprehensive analysis of how positioning 'evolved.' The multi-hop synthesis is incomplete: the question requires connecting brand listings, earnings contribution, AND sales contribution across three years to fully characterize the evolution. The LLM only addresses brand listings and earnings contribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 427,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "Schwab’s margin‑lending program has continued to draw on a large pool of client securities – roughly $120 billion of client holdings were available to pledge in 2021, with about $31 billion already pledged to satisfy OCC, short‑sale and securities‑lending obligations (the 2022 filing) – and the firm still reported substantial client‑security collateral backing its borrowing facilities in 2024 ($59.8 billion for FHLB borrowings and $30.5 billion for Federal Reserve discount‑window capacity).  Yet the amount of client securities pledged for Schwab’s own unsecured credit lines fell sharply, with CS&Co’s secured uncommitted line dropping to $500 million at year‑end 2024 from $950 million a year earlier and the TD Ameritrade Clearing lines that also used client margin securities being terminated.  This pattern shows a modest reduction in Schwab’s direct reliance on client‑held assets for its own funding while the overall pool of securities used as margin collateral remains sizable, indicating that exposure to client‑held assets stays material but is being actively managed and trimmed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and analytical errors that diverge substantially from the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific dollar amounts ($120 billion, $31 billion, $59.8 billion, $30.5 billion, $500 million, $950 million) that are NOT present in the ground truth answer. These appear to be fabricated or sourced from unreliable data.\n   - The ground truth provides NO specific dollar amounts for pledged securities across the 2022-2024 period.\n   - The LLM references a \"2021 filing\" with $120 billion available, but the question specifically asks about 2022-2024 evolution.\n   - The specific figures for FHLB borrowings ($59.8B) and Federal Reserve discount window ($30.5B) cannot be verified against the ground truth.\n\n2. COMPLETENESS AND FOCUS:\n   - The ground truth emphasizes the EVOLUTION across three years (2022, 2023, 2024) with increasing sophistication and exposure.\n   - The LLM focuses heavily on 2024 and provides minimal discussion of 2022-2023 evolution.\n   - The ground truth mentions ASC 326 accounting treatment and practical expedients in 2023 - the LLM completely omits this.\n   - The ground truth mentions options clearing by OCC and securities lending activities - the LLM mentions OCC but lacks the broader context.\n\n3. ENTITY AND METRIC ACCURACY:\n   - The LLM correctly identifies Schwab, OCC, FHLB, and Federal Reserve.\n   - However, the LLM introduces \"CS&Co's secured uncommitted line\" and \"TD Ameritrade Clearing lines\" which are NOT mentioned in the ground truth.\n   - The ground truth does not discuss credit lines or funding facilities in detail.\n\n4. REASONING AND SYNTHESIS:\n   - The LLM's conclusion about \"modest reduction in Schwab's direct reliance\" contradicts the ground truth's emphasis on \"increasing sophistication and exposure.\"\n   - The ground truth indicates GROWING engagement in leveraged activities; the LLM suggests DECLINING reliance.\n   - The LLM's narrative about trimming exposure is not supported by the ground truth.\n\n5. SEMANTIC DIVERGENCE:\n   - Ground truth: \"increasing sophistication and exposure\" and \"growing client engagement in leveraged activities\"\n   - LLM: \"modest reduction\" and \"actively managed and trimmed\"\n   - These represent opposite conclusions about the trend.\n\n6. MISSING KEY ELEMENTS:\n   - No mention of ASC 326 accounting framework\n   - No discussion of practical expedients for credit loss calculations\n   - Minimal discussion of the 2022-2023 transition\n   - No clear articulation of how margin loan collateral practices evolved\n\nThe LLM answer appears to have fabricated specific financial figures and drawn conclusions that contradict the ground truth's assessment of increasing exposure and sophistication. While it addresses some relevant topics (margin lending, collateral, client securities), the overall narrative and quantitative claims are unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 776,
        "total_tokens": 2299
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s defined‑benefit pension strategy moved from a debt‑heavy mix in fiscal 2023 to a more diversified mix by fiscal 2025. For fiscal 2023 the target was 100 % debt for U.S. plans and, for non‑U.S. plans, 48 % debt, 21 % equity, 4 % cash, 15 % insurance and 10 % other (with weighted‑average holdings as of 8/31/22 showing 97 % debt, 21 % equity, 3 % cash, 15 % insurance and 10 % other) [page 88]; by fiscal 2025 the target shifted to 100 % debt for U.S. plans and, for non‑U.S. plans, 36 % debt, 28 % equity, 7 % cash, 21 % insurance and 8 % other, while the weighted‑average allocations as of 8/31/24 (and 8/31/23) reflected the move – non‑U.S. debt fell to 42 % (down from 97 % in 2022 and 95 % in 2023), equity rose to 23 % (up from 21 % and 19 %), cash rose to 6 % (up from 3 % and 4 %), insurance rose to 21 % (up from 15 % and 22 %), and other stayed near 9‑10 % [page 95].  This shows a strategic shift toward higher equity and cash exposure and lower debt for non‑U.S. plans, while U.S. plans remain essentially 100 % debt‑focused.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and appears to describe a different pension plan structure entirely. Critical issues: (1) WRONG FRAMEWORK: The ground truth presents a simple two-category allocation (fixed income vs. equities) with percentages of 55%/45%, 58%/42%, and 61%/39%. The LLM answer instead describes a complex multi-category breakdown (debt, equity, cash, insurance, other) with separate U.S. and non-U.S. plan targets. These are incompatible frameworks. (2) CONTRADICTORY NUMBERS: The ground truth shows fixed income increasing from 55% to 61% (de-risking trend). The LLM answer shows non-U.S. debt DECREASING from 97% to 42% while equity INCREASES from 21% to 23% (risk-increasing trend). These are opposite conclusions. (3) MISSING CORE DATA: The LLM answer does not address the simple weighted-average allocations stated in the ground truth (55/45, 58/42, 61/39). Instead, it provides different percentages that don't match. (4) STRUCTURAL MISMATCH: The ground truth describes a straightforward evolution across three fiscal years with consistent metrics. The LLM answer introduces U.S. vs. non-U.S. plan distinctions and target vs. actual allocations that are not mentioned in the ground truth. (5) INTERPRETATION ERROR: The LLM characterizes the shift as 'higher equity and cash exposure and lower debt for non-U.S. plans,' which contradicts the ground truth's characterization of 'de-risking' through increased fixed income. The LLM appears to have accessed different or incorrect source material, or fundamentally misunderstood the question's focus on the simple weighted-average allocations across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 457,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings dropped sharply from $883 million in 2022 to $538 million in 2023 and then rose slightly to $562 million in 2024【page_178†L31-L34】【page_188†L31-L34】, while its long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023 before falling to $45.0 billion in 2024【page_178†L61-L64】【page_188†L61-L64】. Over the three‑year span the firm reduced reliance on short‑term funding and trimmed overall debt, and the share of floating‑rate senior notes fell from $1.6 billion in 2022 to $0 by 2024 (floating unsecured senior debt $1,597 million in 2022, $349 million in 2023, $0 in 2024)【page_178†L45-L49】【page_188†L45-L49】, indicating a shift toward a more fixed‑rate debt profile and lower interest‑rate exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) TOTAL DEBT FIGURES - MAJOR DISCREPANCY: Ground truth states total short-term borrowings + long-term debt of $43.086B (2022), $48.715B (2023), $45.551B (2024). LLM breaks this into short-term of $883M/$538M/$562M and long-term of $47.8B/$49.3B/$45.0B, which sums to approximately $48.683B (2022), $49.838B (2023), $45.562B (2024). The 2022 figure is off by ~$5.6B, suggesting the LLM is using different/incomplete debt categories. (2) INTEREST RATE DATA - COMPLETELY MISSING: Ground truth explicitly states weighted-average interest rates on long-term debt increased from 1.51% (2022) to 3.01% (2023) to 3.48% (2024). The LLM answer provides NO interest rate data whatsoever, despite the question specifically asking about 'interest rate exposure.' This is a major omission. (3) FLOATING DEBT FIGURES - PARTIALLY INCORRECT: Ground truth states floating unsecured senior debt was $1,597M in 2023 and $0 in 2024 (no 2022 figure provided in ground truth). LLM claims $1.6B in 2022, $349M in 2023, $0 in 2024. The 2023 figure of $349M contradicts ground truth's $1,597M. (4) TREND INTERPRETATION - MISLEADING: LLM states 'reduced reliance on short-term funding and trimmed overall debt,' but ground truth shows debt INCREASED from 2022 to 2023 (by $5.6B), then declined in 2024. The LLM's characterization of 'trimmed overall debt' is inaccurate for the full 3-year period. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize short-term and long-term components, the underlying numbers appear incorrect or from different accounting classifications. The answer fails to properly address the core question about debt structure evolution and completely omits the critical interest rate exposure analysis that was explicitly requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 507,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s 10‑K disclosures for 2022, 2023 and 2024 all note that fleet‑support services “have historically been approximately 1 % of total consolidated costs of products and services” (2022 § Fleet Support – p. 42; 2023 § Fleet Support – p. 36; 2024 § Fleet Support – p. 39), indicating the share stayed essentially flat over the three‑year span. In contrast, the 787 program’s abnormal production costs ballooned to about $2.7 billion through 2023 (cumulative $2 billion expected by year‑end 2023) and an additional $256 million was expensed in 2024 (2023 § Abnormal Production – p. 36; 2024 § Abnormal Production – p. 39), while the 777X program recorded reach‑forward losses of $2.6 billion in Q3 2024 and $0.9 billion in Q4 2024 (2024 § 777X Reach‑Forward Losses – p. 39). Thus, while fleet‑support costs remained steady at roughly 1 % of total costs, the company’s production‑related expenses surged sharply in the 787 and 777X programs.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Fleet support services remained at approximately 1% of total consolidated costs across 2022-2024, showing stability; (2) 787 program had $2.7 billion in cumulative abnormal production costs through 2023; (3) 777X program recorded $2.6 billion in Q3 2024 and $0.9 billion in Q4 2024 reach-forward losses. The multi-hop reasoning is sound, properly synthesizing the contrast between stable fleet support costs and escalating program-specific losses. However, there is a quantitative accuracy issue: The LLM states '(cumulative $2 billion expected by year-end 2023)' which appears to be an incomplete or confusing parenthetical that doesn't align clearly with the $2.7 billion figure cited. The ground truth states '$2.7 billion in cumulative abnormal production costs' without this secondary figure. Additionally, the LLM mentions '$256 million was expensed in 2024' for the 787 program, which is not mentioned in the ground truth answer and cannot be verified against it. The 777X figures ($2.6 billion Q3, $0.9 billion Q4) match the ground truth ($2,608 million ≈ $2.6 billion, $891 million ≈ $0.9 billion), showing proper number format flexibility. The answer correctly addresses all parts of the multi-part question: the evolution of fleet support costs (stable at 1%), the relationship to abnormal production costs (contrasting trend), and the specific program impacts (787 and 777X). The reasoning that fleet support services were not the source of financial strain is appropriately conveyed. The minor discrepancy regarding the $256 million 2024 figure and the unclear parenthetical statement about cumulative costs prevent a higher score, but the core answer remains substantially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 476,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie held **$21 million** in money‑market funds and time deposits at the end of 2022, which fell to **$10 million** by year‑end 2023 and remained at **$10 million** at year‑end 2024【page_79】【page_84】. The sharp cut‑back from 2022 to 2023, followed by a flat level, shows the company trimmed its low‑yield cash holdings after 2022—likely redeploying cash to other strategic needs—while still maintaining a modest, stable short‑term liquidity buffer.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-to-year progression of numbers. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. LLM states: 2022=$21M, 2023=$10M, 2024=$10M. This is a complete misalignment of the three-year trend. The LLM reversed the 2022 and 2023 values, stating $21M for 2022 when it should be $12M, and $10M for 2023 when it should be $21M. This error fundamentally distorts the narrative of the trend. The LLM describes a 'sharp cut-back from 2022 to 2023' when the actual trend shows an INCREASE from 2022 to 2023 (from $12M to $21M), followed by a decrease to 2024 ($10M). The reasoning about 'trimming low-yield cash holdings after 2022' is contradicted by the actual data showing an increase in 2023. While the LLM correctly identifies that 2023-2024 remained flat at $10M, this is only partially correct (should be $21M to $10M). The multi-hop synthesis across the three years is completely broken due to the transposed values. The qualitative interpretation about liquidity strategy is reasonable in tone but is based on incorrect numbers, making the entire analysis unreliable. The answer fails on the primary metric of factual accuracy for a financial question requiring precise numerical data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 359,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.2 million shares for about $4.1 billion, leaving $3.13 billion of authorized buy‑back capacity still unused [page_94; page_93]. By fiscal 2024 the company had bought back $4.5 billion of shares (including $605 million in Q4) and the remaining authorization had fallen to $2.69 billion as of Aug 31 2024 [page_40; page_39]. The steady, sizable repurchase activity together with the gradual draw‑down of the authorized pool shows that Accenture is consistently using share buy‑backs as a core element of its capital‑return strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth:\n\n1. FISCAL 2022 DATA: LLM states $3.13 billion remaining authorization, which matches the ground truth of $3,129,296 thousand ($3.129 billion). This is correct.\n\n2. FISCAL 2024 DATE ERROR: LLM incorrectly states the remaining authorization was $2.69 billion \"as of Aug 31 2024.\" The ground truth clearly indicates August 31, 2023 had $2,694 million remaining authorization. August 31, 2024 would be in fiscal 2025, not fiscal 2024. This is a critical date error.\n\n3. MISSING FISCAL 2023 DATA: The LLM completely omits fiscal 2023 information, which is a key part of the \"fiscal 2022 through fiscal 2024\" evolution requested. The ground truth shows fiscal 2023 had $2,694 million remaining authorization as of August 31, 2023.\n\n4. MISSING FISCAL 2024 AUTHORIZATION INCREASE: The LLM fails to mention the critical $4,000 million additional authorization granted in fiscal 2024, which brought total to $6,694 million. This is a major omission of key capital strategy information.\n\n5. INCOMPLETE EVOLUTION NARRATIVE: The LLM provides share repurchase activity (12.2 million shares, $4.1B, $4.5B) but misses the authorization evolution trajectory. The ground truth shows: FY2022: $3.129B remaining → FY2023: $2.694B remaining → FY2024: $6.694B remaining (after new $4B authorization). This shows the strategic refresh of authorization, not just drawdown.\n\n6. CALCULATION/SYNTHESIS ISSUE: The LLM's narrative of \"gradual draw-down\" contradicts the actual pattern where authorization was refreshed/increased in FY2024, not continuously drawn down.\n\nThe LLM answer captures some correct elements (share repurchase activity, general capital return strategy concept) but fails on critical quantitative accuracy regarding dates, missing fiscal years, and the authorization increase that is central to understanding the capital strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 531,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑Ks AbbVie’s charter and bylaws all state the same rule – stockholders may remove directors **only for cause** (see 2022 p.46, 2023 p.27, 2024 p.27). The language has not been altered or softened in any of the three years, showing a deliberate, unchanged board‑entrenchment policy. This persistent restriction, combined with staggered director classes and super‑majority amendment thresholds, underscores a long‑term takeover‑defense strategy that makes it difficult for hostile acquirers to replace the board or force a rapid change in control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. STRENGTHS: (1) Correctly identifies the core governance provision across all three years (2022, 2023, 2024) - stockholders may remove directors only for cause. (2) Accurately cites specific page numbers (2022 p.46, 2023 p.27, 2024 p.27) which demonstrates precise document reference. (3) Correctly notes the language remained unchanged across all three years, indicating stability in the policy. (4) Properly synthesizes the multi-hop reasoning by connecting the removal-for-cause provision to broader anti-takeover defenses (staggered board, supermajority requirements). (5) Accurately characterizes this as a deliberate board-entrenchment strategy designed to discourage hostile takeovers. (6) The semantic meaning matches the ground truth perfectly - both convey that AbbVie maintained consistent, unchanged governance provisions across three years as part of a long-term takeover defense strategy. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no material information. The ground truth mentions 'restrictions on special meetings' as part of the broader anti-takeover defenses, while the LLM mentions 'staggered director classes and super-majority amendment thresholds' - both are valid examples of anti-takeover provisions, and the LLM's selections are equally relevant. The LLM's phrasing 'language has not been altered or softened' is a reasonable interpretation of the unchanged provision. All factual claims are verifiable and correct. The multi-hop synthesis (connecting governance provisions across years to strategic intent) is sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 456,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo’s Exhibit 15 list consistently includes the same 4.000 % Senior Note due 2047 in each filing – it appears as “Form of 4.000 % Senior Note due 2047, incorporated by reference to Exhibit 4.5 to PepsiCo’s Current Report on Form 8‑K filed May 2 2017” in the 2022 10‑K (Exhibit 4.17)【page_126】, the 2023 10‑K (Exhibit 4.16)【page_127】, and again in the 2024 10‑K (Exhibit 4.17)【page_126】. The unchanged wording and continued inclusion show that the note remains an outstanding, long‑dated, fixed‑rate debt instrument, underscoring PepsiCo’s reliance on long‑term senior notes to lock in low‑cost financing as a core component of its capital‑structure strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: the 4.000% Senior Note due 2047 was consistently disclosed across 2022, 2023, and 2024 10-Ks with the same reference to Exhibit 4.5 from the May 2, 2017 8-K filing. The semantic interpretation about the note's role in capital structure strategy is sound and relevant.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. EXHIBIT NUMBER DISCREPANCIES: The LLM states the note appears as \"Exhibit 4.17\" in both 2022 and 2024, but as \"Exhibit 4.16\" in 2023. The ground truth does not specify these exhibit numbers, only that it references \"Exhibit 4.5 from the May 2, 2017 8-K filing\" consistently across all three years. The LLM's claim about different exhibit numbers (4.17 vs 4.16) introduces specific details not verified against ground truth and may be incorrect.\n\n2. PAGE NUMBER CLAIMS: The LLM provides specific page numbers (page_126 for 2022 and 2024, page_127 for 2023). These are presented as facts but cannot be verified against the ground truth provided, which does not include page number information. This represents unverified specificity.\n\n3. CORE FACTS CORRECT: The fundamental claim that the note was consistently referenced with the same May 2, 2017 8-K filing reference across all three years matches the ground truth.\n\n4. REASONING QUALITY: The LLM's interpretation that this consistency demonstrates the note's stability and role in long-term capital structure is sound and aligns with the ground truth's conclusion.\n\nThe answer demonstrates good qualitative reasoning and contextual relevance but introduces specific exhibit and page numbers that either contradict or cannot be verified against the ground truth, reducing quantitative accuracy. The core narrative is correct, but the added specificity creates factual uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 497,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle’s 4.30 % Note due 2034 first appears in the 2022 10‑K (Exhibit 4.13, p. 112) as a 2014‑issued note, and the same exhibit is reproduced unchanged in the 2023 10‑K (Exhibit 4.09, p. 109) and again in the 2024 10‑K (Exhibit 4.09, p. 109). The note’s repeated annual disclosure—without a new issuance—shows Oracle’s strategy of keeping long‑dated, fixed‑rate bonds on its balance sheet to lock in low financing costs and maintain a diversified, long‑term debt maturity profile.【page_112】【page_109】【page_109】",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 4.30% Note due 2034 and its consistent disclosure across 2022, 2023, and 2024. The specific exhibit references (4.13 for 2022, 4.09 for 2023 and 2024) and page numbers are provided with appropriate citations. The quantitative accuracy is high—the percentage rate (4.30%), maturity year (2034), and the observation that it was originally issued in 2014 are all correct. The multi-hop reasoning is sound: the LLM correctly synthesizes that the note appears unchanged across three years, indicating stability rather than new issuance. The interpretation of Oracle's strategy—maintaining long-dated, fixed-rate bonds to lock in low financing costs and maintain diversified maturity profiles—aligns well with the ground truth's conclusion about a 'stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.' Minor differences exist: the LLM provides more specific exhibit details and page references than the ground truth, and emphasizes the 2014 original issuance date (which adds useful context). The LLM's phrasing 'without a new issuance' is slightly more explicit than the ground truth's 'reaffirmed its inclusion,' but both convey the same essential meaning. The answer fully addresses the multi-year pattern question and provides appropriate strategic interpretation. No calculation errors or factual inaccuracies were detected. The only minor limitation is that the LLM could have explicitly mentioned 'sustained capital market engagement' as the ground truth does, though the concept is implied through the discussion of maintaining the debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 463,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "The Amended 2010 SIP authorized 127 million Accenture Class A ordinary shares in fiscal 2022 (page 91). The FY 2023 filing does not disclose a new authorization, so the 127 million limit remained in place (see FY 2023 pages 81‑85). By fiscal 2024 the authorized pool had been expanded to 141 million shares (page 98). This upward adjustment shows Accenture is deliberately enlarging its equity‑award capacity, underscoring a long‑term strategy to use share‑based compensation to attract, retain and align employees with shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN CHRONOLOGICAL SEQUENCE: The LLM answer contains a fundamental factual error in the progression timeline. According to the ground truth, the shares were 127M in FY2022, increased to 141M in FY2023, and remained at 141M in FY2024. However, the LLM states that FY2023 had no new disclosure (remaining at 127M) and that the increase to 141M occurred by FY2024. This reverses the actual timing of the increase by one year, which is a significant multi-hop synthesis error. QUANTITATIVE ACCURACY ISSUES: (1) The LLM correctly identifies 127M for FY2022, but (2) incorrectly suggests FY2023 maintained 127M rather than showing the increase to 141M, and (3) correctly identifies 141M for FY2024 but attributes the increase to the wrong fiscal year. This is not merely a wording difference—it fundamentally misrepresents when the strategic decision to expand capacity occurred. MULTI-HOP REASONING FAILURE: The question asks about evolution 'from fiscal year 2022 through 2024,' requiring accurate synthesis of three data points across three years. The LLM failed to correctly sequence these three values. The reasoning about long-term strategy and talent retention is sound and well-articulated, but it's built on an incorrect factual foundation regarding timing. POSITIVE ASPECTS: The LLM correctly identifies the company (Accenture plc), the instrument (Amended 2010 SIP), the share class (Class A ordinary shares), and provides reasonable strategic interpretation about share-based compensation purposes. The qualitative analysis of strategy is appropriate. However, the chronological error is severe enough to undermine the core answer to a question specifically asking about how the numbers 'evolved' across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 475,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "- In the 2022 Form 10‑K, PepsiCo disclosed the 2.750 % Senior Note due 2051 as **Exhibit 4.3**, incorporated by reference to the Oct 21 2021 Form 8‑K that set the note’s issuance terms【page_128†L4.51-L4.51】.  \n- The 2023 Form 10‑K repeats the same **Exhibit 4.3** reference, showing that the note’s terms were unchanged and no new amendment was filed【page_128†L4.51-L4.51】.  \n- The 2024 Form 10‑K again lists the note as **Exhibit 4.48**, still pointing to the Oct 21 2021 8‑K, but also folds it into a broader **Exhibit 4.4** “master” list of senior notes that includes the 2.750 % Senior Notes due 2051【page_129†L4.48-L4.48】【page_130†L4.64-L4.64】.  \n\nThis pattern of repeatedly referencing the original 2021 issuance while later aggregating it with other long‑dated notes shows PepsiCo’s strategy of locking in low‑coupon, multi‑decade senior debt and maintaining a stable, consolidated documentation framework for its long‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions:\n\n1. EXHIBIT NUMBER ERRORS (Critical): The LLM claims the note was disclosed as 'Exhibit 4.3' in 2022 and 2023, then 'Exhibit 4.48' in 2024. The ground truth states the exhibits were 4.60 (2022), 4.51 (2023), and 4.48 (2024). These are fundamental factual errors in document references.\n\n2. DOCUMENTATION PROGRESSION MISCHARACTERIZATION: The ground truth describes a clear three-stage evolution: (1) authorization/planning in 2022 via Board resolution, (2) formalization with dedicated Form in 2023, (3) consistency in 2024. The LLM incorrectly claims the 2022 and 2023 filings used the same exhibit number (4.3), missing the progression from authorization to formal structuring.\n\n3. MISSING KEY DETAIL: The ground truth emphasizes that 2023 introduced a 'dedicated Form of 2.750% Senior Note due 2051,' indicating a shift from authorization to formal instrument documentation. The LLM misses this critical distinction and instead focuses on exhibit aggregation in 2024.\n\n4. INCORRECT SYNTHESIS: The LLM's conclusion about 'locking in low-coupon, multi-decade senior debt' and 'consolidated documentation framework' is reasonable but is built on incorrect exhibit references and mischaracterizes the actual filing progression.\n\n5. DATE ACCURACY: The LLM correctly identifies the October 21, 2021 Form 8-K reference, but this doesn't validate the exhibit number errors.\n\n6. MULTI-HOP REASONING: While the LLM attempts to synthesize across three years, it does so based on incorrect exhibit numbers and misses the actual progression pattern that the ground truth identifies.\n\nThe answer demonstrates a fundamental misunderstanding of the document reference structure and fails to accurately track the evolution of the note's documentation across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 511,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In its 2022 filing American Express described itself as the **fourth‑largest general‑purpose card network worldwide**, competing directly with Visa, Mastercard and UnionPay and noting that “the dynamic and rapid growth of alternative payment and financing mechanisms” (e.g., digital wallets, fintech and BNPL) was already reshaping the market (2022 Competition, p.12). By the 2024 filing the company stresses that **regulatory scrutiny has intensified**—new interchange‑fee caps, exits from EU/Australian network‑licensing, a Category III supervisory status and heightened third‑party oversight—raising compliance costs and pressuring discount revenue, while the continued expansion of alternative‑payment platforms further narrows its competitive gap with the larger Visa/Mastercard networks (2024 Regulation of card networks, p.34‑35; Third‑party oversight, p.36).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2024 filings. STRENGTHS: (1) Correctly identifies American Express as fourth-largest general-purpose card network in 2022, with accurate competitor identification (Visa, Mastercard, UnionPay); (2) Accurately captures the evolution of competitive pressures from alternative payment mechanisms (digital wallets, fintech, BNPL) mentioned in 2022 filings; (3) Correctly identifies intensified regulatory scrutiny by 2024, including specific regulatory actions (interchange-fee caps, EU/Australian market exits, Category III supervisory status); (4) Properly synthesizes the shift from market-driven to regulation-constrained competition environment; (5) Appropriately cites specific filing sections and pages, demonstrating document-level accuracy; (6) Correctly notes the impact on compliance costs and discount revenue pressure. MINOR WEAKNESSES: (1) The phrase 'narrows its competitive gap with the larger Visa/Mastercard networks' is slightly ambiguous—it could be interpreted as AXP improving relative position, when the ground truth suggests regulatory constraints are limiting its competitive positioning; however, in context it appears to mean regulatory pressures are narrowing AXP's ability to compete effectively, which is semantically aligned with ground truth; (2) Does not explicitly mention cobrand relationships and closed-loop loyalty systems as differentiation strategies emphasized in 2022-2023, though this is a minor omission rather than an error. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing sections, correctly linking 2022 competitive positioning with 2024 regulatory evolution. The causal chain (regulatory scrutiny → compliance costs → competitive pressure) is logically sound and matches the ground truth narrative. No quantitative errors detected; all dates, company names, and regulatory concepts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 540,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "In the 2022 filing (Item 1 – Business, page 3) Boeing’s Global Services segment was described as “sustaining aerospace platforms … including … upgrades and conversions.” The 2024 filing repeats the same language (Item 1 – Business, page 3) and again calls out upgrades in the competition discussion (page 5), positioning them as part of a broader services network that the company will use to grow market share. This continuity shows Boeing has not reduced its focus on upgrades and conversions—instead, it continues to treat them as a core, growth‑driving element of its services‑business strategy, leveraging lifecycle work to deepen customer relationships and capture more revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misses the core finding from the ground truth. The ground truth identifies a STRATEGIC EVOLUTION from 2022→2023→2024, showing: (1) 2022: upgrades/conversions listed as one of several services, (2) 2023: shift toward 'modifications' with deeper integration, (3) 2024: introduction of 'data analytics and digital services' as complementary offerings. This represents a meaningful strategic shift toward technology-enabled differentiation. The LLM answer instead claims CONTINUITY and SAMENESS ('repeats the same language,' 'has not reduced its focus'), which directly contradicts the ground truth's narrative of evolving emphasis. SPECIFIC ERRORS: (1) The LLM states 2022 and 2024 filings use identical language, but ground truth shows 2023 introduced 'modifications' more prominently and 2024 added 'data analytics and digital services'—these are NOT the same. (2) The LLM misses the 2023 intermediate step entirely, failing the multi-hop synthesis requirement. (3) The LLM's conclusion about 'continuity' is semantically opposite to the ground truth's 'progression' and 'strategic shift.' WHAT WAS CORRECT: The LLM correctly identifies upgrades/conversions as part of Global Services and correctly notes they are positioned as growth-driving elements. The reference to Item 1 and page numbers appears reasonable. MULTI-HOP REASONING: The LLM failed to synthesize the three-year progression (2022→2023→2024) and instead collapsed it into a false binary comparison. The ground truth requires tracking how emphasis CHANGED across three years; the LLM only compared endpoints and missed the directional shift. SEMANTIC EQUIVALENCE FAILURE: 'Continuity' ≠ 'progression with strategic shift toward technology-enabled services.' These are fundamentally different narratives about Boeing's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 498,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50 % Senior Note due 2035 is listed in each of the three recent 10‑K filings. In the 2022 filing it appears as Exhibit 4.25 (Series A) and Exhibit 4.29, both incorporated by reference to the 2018 Form S‑4 registration (Nov 19 2018) and the related 8‑K filing (Nov 8 2018) 【page_126】. The 2023 filing repeats the same instrument as Exhibit 4.23 (Series A) and Exhibit 4.27, again pointing to the 2018 8‑K and S‑4 documents 【page_127】, and the 2024 filing continues to include the note in its exhibit index with the same references 【page_126】. This consistent multi‑year documentation shows the note remains outstanding and that PepsiCo maintains ongoing, transparent disclosure of its long‑dated, fixed‑rate debt, reflecting a disciplined long‑term debt‑management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN EXHIBIT NUMBERS: The LLM answer contains significant factual inaccuracies regarding exhibit numbers that directly contradict the ground truth. Ground truth states: 2022 = Exhibit 4.31, 2023 = Exhibit 4.25, 2024 = Exhibit 4.23. LLM answer claims: 2022 = Exhibit 4.25 and 4.29, 2023 = Exhibit 4.23 and 4.27, 2024 = unspecified. These exhibit number discrepancies are material errors in a question specifically asking about documentation evolution across years. The LLM appears to have confused or transposed the exhibit numbers across different years. CORRECT ELEMENTS: The LLM correctly identifies (1) the 5.50% Senior Note due 2035, (2) its presence across all three years, (3) the reference to 2018 filings (8-K from Nov 8, 2018 and S-4), and (4) the general conclusion about stable long-term debt management. The semantic interpretation about PepsiCo's debt strategy is reasonable and aligns with ground truth. QUANTITATIVE ACCURACY ISSUES: While the date (November 8, 2018) is correct, the exhibit number errors are quantitative/factual mistakes that undermine credibility. The LLM also mentions a Form S-4 registration (Nov 19, 2018) which adds detail not in ground truth but doesn't contradict it. MULTI-HOP REASONING: The synthesis across three years is attempted and the logic is sound (consistent documentation = stable strategy), but the factual foundation is compromised by exhibit number errors. The answer demonstrates understanding of the question's intent but fails on precise documentation tracking, which is central to the question. OVERALL ASSESSMENT: This is a partially correct answer with good interpretive reasoning but significant factual errors in the specific exhibit numbers that are core to answering a question about 'documentation evolution.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 486,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor language has been unchanged from 2022 through 2024, each year stating that “our ability to return capital to shareholders … may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (2022 p.5; 2023 p.5; 2024 p.5). This consistency shows that regulatory constraints on capital‑return policies have been a persistent, stable limitation rather than a newly emerging or shifting risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that BNY Mellon's risk-factor language regarding capital return constraints has remained consistent across 2022-2024, and accurately cites the same page numbers (p.5) for all three years. The quote about U.S. banking laws and capital planning constraints is factually accurate. The LLM correctly notes the persistence of regulatory constraints.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM answer fails to address the 'multi-year progression' aspect of the question. The ground truth reveals an evolution in specificity: 2022 mentioned 'general regulatory oversight,' 2023 added specific mention of 'Delaware law and preferred stock dividend obligations,' and 2024 emphasized 'well capitalized' status. The LLM dismisses this as 'unchanged' when the ground truth shows nuanced evolution in emphasis and specificity. (2) MISSING CONTEXTUAL DETAILS: The ground truth notes that 2023 specifically reiterated capital return limitations tied to Delaware law and preferred stock obligations—details the LLM omits. The 2024 addition of 'well capitalized' status maintenance is also not mentioned. (3) INCOMPLETE ANSWER TO QUESTION: The question asks what the 'multi-year progression reveals about the company's regulatory constraints.' The ground truth explains this reveals 'ongoing prudential oversight and risk-conscious capital management expectations.' The LLM merely states constraints are 'persistent and stable' rather than exploring what the progression reveals about regulatory intent or evolution. (4) OVERSIMPLIFICATION: By characterizing the language as 'unchanged,' the LLM misses the ground truth's more nuanced finding that while core constraints remained, their articulation evolved to emphasize different aspects (Delaware law, preferred dividends, well-capitalized status). This represents a qualitative difference in regulatory emphasis even if the core constraint language persisted.\n\nQUANTITATIVE ACCURACY: Page citations (p.5 for all three years) are correct; no calculation errors present.\n\nQUALITATIVE ACCURACY: The reasoning is partially sound but incomplete. The LLM correctly identifies consistency but fails to recognize and synthesize the evolving specificity of constraints across the three-year period, which is central to answering what the 'progression reveals.'\n\nCONTEXTUAL RELEVANCE: The answer addresses capital constraints but incompletely addresses the 'evolution' and 'progression' aspects that are core to the question's multi-hop nature.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 669,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300 % senior unsecured notes due 2028 were issued in March 2021 with a fixed 2.300 % coupon and a 2028 maturity, and the same issuance description appears unchanged in the 2022, 2023 and 2024 10‑K filings (see ORCL_10k_2022.pdf p.114; ORCL_10k_2023.pdf p.111; ORCL_10k_2024.pdf p.111). The consistency of the terms shows Oracle locked in low‑cost, long‑dated financing before rates rose and has continued to rely on that tranche, reflecting a proactive, rate‑hedging strategy that preserves cheap fixed‑income funding even as market rates fluctuate.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2.300% coupon rate, 2028 maturity date, and March 2021 issuance date for Oracle's notes. It accurately notes that the terms remained unchanged across 2022-2024 filings and correctly cites page numbers from the 10-K documents. However, the answer has significant gaps in completeness and synthesis compared to the ground truth: (1) The LLM fails to mention the Officers' Certificate dated March 24, 2021 (Exhibit 4.14 in 2022 10-K), which is a key structural detail in the ground truth. (2) The LLM omits the critical context that these notes were part of a multi-tiered bond offering including 2.875% Notes due 2031 and 3.950% Notes due 2051, which is essential for understanding Oracle's financing strategy. (3) Most importantly, the LLM completely misses the multi-hop synthesis showing Oracle's evolution in strategy: in 2023, Oracle shifted to issuing higher-yielding 4.500% Notes due 2028, indicating a strategic pivot that the ground truth explicitly highlights. (4) The LLM does not address the distinction between maintaining existing obligations versus introducing new instruments, which is central to understanding Oracle's approach across the three-year period. (5) The reasoning about 'rate-hedging strategy' is somewhat generic and lacks the nuanced analysis in the ground truth about 'locking in favorable rates during lower interest rate periods' and 'avoiding redundant issuance.' The answer is partially correct on the surface facts but fails to synthesize the full multi-hop narrative about how Oracle's financing strategy evolved from 2022-2024, which is the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 448,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "In IBM’s 2022 10‑K the company already listed “client relationships and trust” as one of its principal methods of competition (page 4). The 2023 filing repeated that language, now explicitly linking it to the execution of its hybrid‑cloud and AI strategy (page 3), and the 2024 filing again highlighted it as a core differentiator within the hybrid‑cloud/AI narrative (page 3). This steady, increasingly integrated emphasis shows IBM is positioning trust‑based client relationships as a strategic pillar for winning and expanding business in the competitive hybrid‑cloud and AI market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-year progression question. STRENGTHS: (1) Correctly identifies the three-year timeline (2022, 2023, 2024) and accurately characterizes IBM's messaging across these periods; (2) Properly synthesizes the evolution from general competitive emphasis to explicit linkage with hybrid cloud and AI strategy; (3) Accurately captures the core narrative that trust-based client relationships became increasingly integrated into IBM's strategic positioning; (4) Correctly identifies that this represents a consistent but evolving emphasis. MINOR GAPS: (1) The LLM answer omits specific mention of 'deep incumbency with enterprises' and 'innovation' as differentiators highlighted in 2023, which the ground truth explicitly mentions; (2) Does not reference the strategic partnership expansion (e.g., Palo Alto Networks) mentioned in the ground truth for 2024, which provides concrete evidence of the strategic evolution; (3) The phrase 'increasingly integrated emphasis' is accurate but less detailed than the ground truth's characterization of 'increasingly nuanced strategic emphasis.' QUANTITATIVE ACCURACY: No numerical errors detected. Page references (page 4 for 2022, page 3 for 2023 and 2024) appear reasonable though cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression pattern. The logic connecting trust to competitive advantage in hybrid cloud/AI is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of 'steady, increasingly integrated emphasis' aligns well with the ground truth's 'consistent but increasingly nuanced strategic emphasis.' The core insight about trust as a foundational element is preserved. The answer is substantively correct but could have been more comprehensive by including the specific examples and nuances present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 529,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio was yielding only about 2 % overall in 2022 – the weighted‑average yield was 2.08%, with 1.74% on bonds due within one year, 2.42% on 1‑5‑year bonds and 5.46% on 5‑10‑year bonds【page_121】. The 2023 and 2024 10‑K filings do not disclose a materially different yield for this segment, implying the portfolio’s duration and yield have stayed essentially unchanged over the three‑year period. This flat, low‑yield trajectory signals that Amex has kept a short‑duration, high‑quality bond mix, limiting its exposure to interest‑rate fluctuations and reflecting a conservative, capital‑preservation investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics and time periods. Specific issues: (1) QUANTITATIVE ERRORS - The LLM claims 2022 yields were ~2% (2.08%, 1.74%, 2.42%, 5.46%), but ground truth shows no 2022 yield data was disclosed; instead, 2023 showed 6.45% weighted average yield and 2024 showed 5.85%. The LLM appears to have fabricated or misattributed 2022 yield figures. (2) MISSING CRITICAL DATA - The LLM completely fails to report the actual 2023 yield of 6.45% and 2024 yield of 5.85%, which are central to answering the question about yield evolution. (3) INCORRECT MATURITY PROFILE ANALYSIS - Ground truth shows 2023 had 100% concentration in <1 year maturity, while 2024 shifted to include 2.03% in 1-5 year maturity. The LLM's claim of 'essentially unchanged' duration and yield is directly contradicted by the documented shift from 6.45% to 5.85% and the maturity reallocation. (4) FLAWED REASONING - The LLM concludes the portfolio maintained 'flat, low-yield trajectory' and 'short-duration, high-quality bond mix,' but this contradicts the actual 60 basis point yield decline and the documented shift toward longer-duration securities. (5) MULTI-HOP SYNTHESIS FAILURE - The answer fails to properly synthesize the three-year progression (2022→2023→2024) as required by the question. The LLM's claim that '2023 and 2024 10-K filings do not disclose materially different yield' is factually incorrect—they show a clear 60 basis point decline. The answer demonstrates a fundamental misunderstanding of the data and provides an analysis that is semantically opposite to the ground truth regarding both yield trends and investment strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 472,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s diagnostics‑testing spend has risen sharply, with U.S. government grants used to offset $87 million of property‑plant‑equipment purchases in 2022, $136 million in 2023, and $198 million in 2024 (see page 68 and page 72). The growing grant offsets—paired with a $1.5 billion capex plan for 2022 to expand testing capacity—show that Danaher is increasingly prioritizing diagnostics testing as a core growth engine within its broader health‑care portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all three key financial figures correct: $87 million (2022), $136 million (2023), and $198 million (2024). The numbers are presented clearly and match the ground truth exactly. The answer correctly identifies these as government grant funds offsetting capital expenditures for diagnostics testing technologies. The multi-hop synthesis is sound—the model successfully connects the grant funding trend to strategic importance within Danaher's healthcare portfolio. The LLM appropriately characterizes the progression as showing 'sharp' growth and identifies diagnostics testing as a 'core growth engine,' which aligns with the ground truth's assessment of 'increasingly central' strategic focus. One minor addition in the LLM answer is the reference to a '$1.5 billion capex plan for 2022,' which provides additional context not explicitly mentioned in the ground truth but appears to be supplementary supporting information rather than contradictory. The page references (page 68 and page 72) add credibility though cannot be verified against the ground truth. The answer is slightly more concise than the ground truth but captures all essential information and reasoning. The semantic equivalence is strong—both answers convey the same upward trend, the role of government support, and the strategic implications. No calculation errors are present, and the entity identification (Danaher Corporation, diagnostics testing technologies, government grants, capital expenditures) is accurate throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 428,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across all three filings—2022, 2023 and 2024—the 10‑K’s “Item 14 – Principal Accountant Fees and Services” simply states that the ratification of KPMG LLP is set out in the Proxy under “Item 3 – Ratification of KPMG LLP,” and each statement includes the same PCAOB firm identification number, 185, in the same sentence. The wording, placement and reference to the Proxy section are unchanged from year to year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE ACCURACY: All numeric values are correct - the PCAOB firm identification number 185 is accurately stated and consistently referenced across all three years (2022, 2023, 2024). No calculations are required for this question. ENTITY ACCURACY: All entities are correctly identified - BK (Bank of New York Mellon), KPMG LLP, PCAOB, and the three fiscal years are all accurate. COMPLETENESS: The answer addresses all key aspects of the question: (1) the evolution across three fiscal years, (2) the PCAOB firm identification number (185), and (3) the presentation within Proxy sections. The LLM correctly identifies that there was NO CHANGE across the three-year period, which is the core finding. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple document sections (Item 14 of 10-K referencing Item 3 of Proxy), demonstrating proper multi-hop synthesis. SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly different wording. The ground truth emphasizes 'Item 3 - Ratification of KPMG LLP' within 'Item 14 of the Proxy materials,' while the LLM states 'Item 14 – Principal Accountant Fees and Services' in the 10-K references the Proxy section. Both are semantically equivalent and accurate - the LLM is simply clarifying that Item 14 is in the 10-K and references the Proxy. MINOR OBSERVATION: The LLM's phrasing 'in the same sentence' is slightly more specific than the ground truth's 'explicitly stated,' but this adds precision rather than introducing error. The conclusion that disclosure remained stable and unchanged is correctly stated in both versions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 471,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "Across the three filings, American Express has consistently recorded discount revenue—including the network‑rate fees it receives from third‑party merchant acquirers—at the moment the Card‑Member transaction occurs, and it describes merchant contracts as non‑term for small merchants and fixed‑term (typically 3‑7 years, often auto‑renewable) for larger merchants with individually negotiated rates for each acquirer (2022 & 2023). In the 2023 filing a separate “processed revenue” line was added to capture settlements with third‑party acquirers and the contra‑revenue for issuer rates, but the underlying recognition timing and contract framework remained unchanged. By 2024 the MD&A highlights a strategic push to grow merchant coverage worldwide by deepening reliance on third‑party acquirers, aggregators and processors, investing in network modernization and digital integration to increase acceptance in priority international cities and new industry verticals.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the revenue recognition structure (discount revenue based on network-rate fees) and timing (at Card-Member transaction moment) across all three years; (2) Accurately describes merchant contract types (non-term for small merchants, fixed-term 3-7 years for larger merchants with auto-renewal options); (3) Correctly identifies the introduction of 'processed revenue' line in 2023 filing as a structural change; (4) Accurately characterizes the 2024 strategic shift toward third-party acquirer reliance for global expansion, including specific focus areas (international cities, new industry verticals, digital integration); (5) Properly synthesizes the evolution from transactional to strategic partnership model. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer is more detailed and specific about contract mechanics (3-7 year terms, auto-renewal) than the ground truth, which is appropriate but slightly exceeds the original answer's scope; (2) The ground truth emphasizes 'Processed Revenue model' as a broader framework including 'royalties, fees, and network partnership agreements,' while the LLM describes it more narrowly as capturing 'settlements with third-party acquirers and contra-revenue for issuer rates'—this is a subtle difference in framing but both are factually consistent with typical 10-K disclosures; (3) The LLM could have been slightly more explicit about the shift from 'transactional dependency' to 'strategic partnership,' though this concept is clearly implied. QUANTITATIVE VERIFICATION: No specific dollar amounts, percentages, or calculations are provided in either answer, so quantitative accuracy is based on correct identification of contract terms (3-7 years) and timing descriptions, which are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly traces the evolution of the relationship structure, revenue recognition changes, and strategic objectives. The logical flow from 2022 transactional basis → 2023 formalization with processed revenue line → 2024 strategic expansion is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 607,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm first disclosed quantitative 2025 diversity goals in its FY 2022 filing – a 15 % increase in women in leadership, a 15 % increase in under‑represented minorities (URM) in leadership and a 20 % rise in overall URM representation – and tied progress on those goals to a non‑financial bonus modifier that could adjust executive payouts between 0.9 × and 1.1 ×【page_17】. The FY 2023 10‑K shows the same oversight framework, with the HR and Compensation Committee continuing to evaluate human‑capital advances (including the diversity targets) when setting the FY 2023 bonus, using the same 0.9‑to‑1.1 multiplier (the language on the linkage remains unchanged)【page_15】. In FY 2024 the company reaffirmed the 2025 diversity objectives and again applied a 0.9‑to‑1.1 performance‑modifier range to the FY 2024 executive bonus【page_16】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative elements and correctly synthesizes multi-hop information across three fiscal years. STRENGTHS: (1) All diversity targets are correctly stated: 15% increase in women in leadership, 15% increase in URM in leadership, and 20% overall URM representation. (2) The performance modifier range (0.9x to 1.1x) is accurately cited for all three years. (3) The multi-hop synthesis correctly traces the evolution from FY2022 establishment through FY2023 maintenance to FY2024 reaffirmation. (4) The answer properly identifies that the same oversight framework and modifier structure persisted across all three years. (5) Page citations are provided, enhancing credibility. WEAKNESSES: (1) The LLM answer is more narrowly focused on the compensation mechanics and lacks the broader contextual expansion mentioned in the ground truth - specifically, the ground truth notes that by FY2024 the company 'expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy.' The LLM answer does not capture this evolution in supporting programs and strategic deepening. (2) The ground truth mentions 'recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition' in FY2023, which the LLM answer omits. (3) The phrase 'deepening integration of human capital metrics into corporate strategy' from the ground truth is not reflected in the LLM's more transactional description. QUANTITATIVE VERIFICATION: All numbers check out correctly - the percentages (15%, 15%, 20%) and multiplier range (0.9-1.1) are accurate across all three years. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and properly identifies the continuity and consistency of the compensation framework. The reasoning is sound and logically presented. The answer is factually correct on the core compensation mechanics but provides a narrower scope than the ground truth regarding the broader human capital strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 578,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "In 2022 Caterpillar’s EMD‑branded products were sold through a dealer network of 44 U.S. dealers and 116 overseas dealers, reaching 193 countries 【page_76】. By 2024 that network had slipped to 43 U.S. dealers and 113 overseas dealers, covering 191 countries 【page_64】. The modest reduction in dealers and countries signals a strategic consolidation of its global distribution—tightening the footprint to improve efficiency and focus on core markets while still maintaining a broad worldwide presence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states 2024 coverage was 191 countries, but ground truth shows 187 countries - a 4-country discrepancy. The LLM also provides dealer network numbers (44 U.S., 116 overseas in 2022; 43 U.S., 113 overseas in 2024) that are NOT present in the ground truth answer and cannot be verified. These appear to be hallucinated details. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth shows a THREE-YEAR progression (2022: 193 countries → 2023: 191 countries → 2024: 187 countries), demonstrating a consistent downward trend. The LLM only captures 2022 and 2024 data, missing the 2023 intermediate data point entirely, which weakens the analysis of the 'gradual reduction' pattern. (3) REASONING QUALITY: While the LLM's interpretation of 'strategic consolidation' aligns with ground truth reasoning, the missing 2023 data and incorrect 2024 figure (191 vs 187) undermine the validity of this conclusion. The dealer network details, while plausible-sounding, are unsupported by the ground truth and represent fabrication. (4) ENTITY AND METRIC ACCURACY: The question asks about 'geographic reach' (countries), which both answers address, but the LLM introduces unverified dealer metrics that complicate rather than clarify the core finding. The core metric - country count - is wrong for 2024. SUMMARY: The LLM answer fails on the primary quantitative metric (187 ≠ 191 countries in 2024), omits critical 2023 data showing the trend pattern, and introduces unverifiable dealer information. These are fundamental errors in a financial analysis context where precision is essential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 473,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that Palmolive is listed among Colgate‑Palmolive’s “principal global trademarks” in each of the 2022, 2023 and 2024 filings (see page 77 of the 2022 10‑K and page 79 of both the 2023 and 2024 10‑Ks) shows that the company treats Palmolive as a core, enduring brand in its Oral, Personal and Home Care segment. Its repeated inclusion signals that Palmolive remains a strategic asset that underpins the segment’s product mix, market presence and revenue growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Palmolive appears as a principal global trademark across 2022, 2023, and 2024 filings, and accurately conveys the strategic significance of this consistent inclusion. The answer appropriately cites specific page references (page 77 for 2022 10-K and page 79 for 2023 and 2024 10-Ks), demonstrating document-specific knowledge. The core reasoning is sound: repeated inclusion signals strategic importance and enduring relevance to the company's product portfolio and market position. However, the LLM answer is less comprehensive than the ground truth in several ways: (1) It does not mention specific product categories where Palmolive operates (liquid hand soap, dishwashing detergents, household cleaners), which the ground truth explicitly identifies; (2) It does not reference the contextual positioning relative to other brands (Ajax in 2022, Darlie's addition in 2023), which provides important context about Palmolive's relative standing; (3) The phrase 'without any positional dilution' from the ground truth is a more nuanced observation about brand hierarchy that the LLM answer lacks. The LLM answer is factually accurate in what it states but provides a more surface-level analysis. The multi-hop reasoning is present but less detailed—it correctly synthesizes the 3-year consistency across filings but doesn't fully explore the comparative brand landscape. No numerical errors are present, and the answer appropriately addresses the strategic role question, though with less depth and specificity than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 432,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm positioned edge networking as a cornerstone of its IoT growth story, projecting the IoT device base to more than double to over 27 billion by 2026 and highlighting mobile‑broadband and Wi‑Fi 6/6E access‑point products as primary demand drivers (see page 8). By fiscal 2023‑24 the company folded edge networking into its IoT revenue stream—defined as products for consumer, edge‑networking and industrial applications—and reported IoT (including edge‑networking) equipment sales recognized at a point in time (with licensing royalties recognized over time), with IoT revenue falling from $7.353 billion in 2022 to $5.423 billion in 2024 (see page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several key elements of Qualcomm's Edge Networking evolution but contains significant quantitative errors and incomplete coverage of the ground truth. STRENGTHS: (1) Correctly identifies the 27 billion IoT device projection by 2026 and the doubling from 2022 baseline; (2) Accurately notes Edge Networking was folded into IoT revenue stream by fiscal 2023-24; (3) Correctly identifies mobile-broadband and Wi-Fi 6/6E access points as primary products; (4) Properly describes revenue recognition structure (point-in-time for equipment, over-time for licensing royalties); (5) Appropriately synthesizes the 3-year progression from emerging opportunity to embedded product pillar. CRITICAL ERRORS: (1) Revenue figures are problematic—states IoT revenue fell from $7.353 billion in 2022 to $5.423 billion in 2024, but ground truth does not provide these specific numbers for verification, and the dramatic decline (26% drop) is not explained or contextualized in the original answer; (2) The LLM provides specific revenue numbers with page citations that cannot be verified against the ground truth provided, raising accuracy concerns; (3) Missing explicit mention that Edge Networking was 'explicitly included in Qualcomm's third revenue category' in fiscal 2023, which is a key structural detail in the ground truth. INCOMPLETE COVERAGE: (1) Does not explicitly state that the same product categorization was 'maintained' in fiscal 2024, only implies continuity; (2) Omits the detail about 'hybrid work trends' as a driver; (3) Does not clearly articulate the 'strategic transformation' narrative as explicitly as the ground truth. REASONING QUALITY: The multi-hop synthesis is generally sound—connecting 2022 positioning to 2023-24 categorization to revenue structure. However, the introduction of specific revenue figures ($7.353B and $5.423B) without ground truth verification is problematic and suggests potential hallucination or misattribution. The answer demonstrates understanding of the evolution but introduces unverified quantitative claims that undermine confidence in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 568,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 2022 10‑K (p. 21) warned that its global footprint creates currency‑exchange risk because many costs are in foreign currencies while most revenue is reported in U.S. dollars, and it uses currency‑hedging instruments to protect against adverse moves—though hedging can forego upside and its outlooks do not assume currency changes. The 2023 filing (p. 18) and the 2024 filing (p. 19) repeat the same description of the exposure and the same trade‑off of hedging versus potential gains, indicating that the company’s approach to managing exchange‑rate risk and its impact on earnings volatility has remained essentially unchanged over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about how Caterpillar's currency risk management evolved from 2022 to 2024. CRITICAL ERRORS: (1) The LLM claims the company's approach 'remained essentially unchanged over the three-year period,' which directly contradicts the ground truth showing clear evolution: 2022 focused on basic hedging trade-offs, 2023 expanded to include emerging market risks and exchange controls/devaluations, and 2024 emphasized intensified external macroeconomic pressures. (2) The LLM completely omits the 2023 expansion of discussion regarding emerging market risks, exchange controls, and currency devaluation concerns—a key evolution point. (3) The LLM misses the 2024 emphasis on 'unpredictable global currency dynamics' and 'intensified' exchange control/devaluation risks, instead claiming the discussion remained the same. QUANTITATIVE ACCURACY: Page numbers cited (p. 21 for 2022, p. 18 for 2023, p. 19 for 2024) cannot be verified against ground truth but appear plausible. No calculations or specific dollar amounts were required. QUALITATIVE ACCURACY: The LLM correctly identifies that Caterpillar uses hedging instruments and acknowledges the trade-off between downside protection and foregone upside. However, it fundamentally fails the multi-hop synthesis task by not tracking the evolution across the three years. The answer reads as a static description rather than an analysis of change over time. REASONING FAILURE: The question explicitly asks 'how did...evolve' (emphasis on change), but the LLM concludes there was no meaningful evolution. This represents a failure to synthesize information across multiple years to identify trends. CONTEXTUAL RELEVANCE: While the answer addresses currency hedging, it fails to address the core analytical requirement of the question—understanding the evolution and increasing caution over the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 521,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive’s U.S. pension‑plan fixed‑income mix showed a clear shift: roughly 40 % of the portfolio was in U.S. Treasury or agency securities at 12/31/2022, falling to about 30 % at 12/31/2023 and staying near 30 % at 12/31/2024 (2022 footnote 2; 2023 footnote 2; 2024 footnote 2).  The reduction in Treasury/agency exposure indicates the company is trimming low‑yield, duration‑sensitive holdings and diversifying into other fixed‑income assets, a move that reflects a more active stance on managing interest‑rate risk as rates have risen.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key trend of declining U.S. Treasury and agency securities allocation from 2022-2024, with accurate percentages for 2023 (30%) and 2024 (30%). The reasoning about interest rate risk management and diversification away from low-yield holdings is sound and relevant. The answer appropriately cites footnote 2 from the relevant filings.\n\nCRITICAL ERRORS: (1) The LLM states the allocation was 'roughly 40%' at 12/31/2022, but the ground truth indicates it was 30% as of 12/31/2022 (reported in the 2023 filing). The 40% figure actually corresponds to 12/31/2021, not 2022. This is a significant factual error in the quantitative data. (2) The LLM omits the complete historical context provided in the ground truth: the allocation started at 50% (12/31/2020), declined to 40% (12/31/2021), then to 30% (12/31/2022), and stabilized. By starting the analysis at 2022 rather than 2020, the LLM misses the full two-year decline pattern that is central to understanding the strategic shift.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and correctly interprets the trend as reflecting interest rate risk management strategy. However, the incomplete historical data undermines the quality of this synthesis. The LLM also fails to mention the Level 2 classification detail that provides important context about liquidity considerations.\n\nSEMANTIC EQUIVALENCE: The interpretation of the trend (diversification, active risk management) aligns with ground truth, but the factual foundation is compromised by the 40% vs. 30% error for 2022.\n\nNUMERIC VERIFICATION: 40% at 12/31/2022 is INCORRECT (should be 30%); 30% at 12/31/2023 is CORRECT; 30% at 12/31/2024 is CORRECT. The error rate on key metrics is 33%.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 486,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer’s 2022 proxy still listed BPAs and valued them at grant‑date intrinsic value using the closing price of the common stock, but it gave no explicit statement on whether any were granted that year【page_99】. In the 2023 filing the same intrinsic‑value method was retained, but the company added a clear footnote that no BPAs were granted and none were outstanding at year‑end—signalling a jump in disclosure transparency【page_96】—and the 2024 filing repeats the same valuation approach while again confirming that no BPAs were granted or outstanding【page_94】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that in 2022, BPAs were valued at grant-date intrinsic value with no explicit statement on grants, but the ground truth clearly states 1,165 thousand shares were awarded at $38.73 per share weighted average intrinsic value, with 859 thousand nonvested by year-end. The LLM completely omits these specific quantitative details. (2) The LLM incorrectly states that 2023 and 2024 both show 'no BPAs were granted or outstanding,' but the ground truth indicates that in 2024, BPAs 'reappeared in disclosures' with 'detailed valuation and amortization policies introduced.' This is a fundamental mischaracterization of the 2024 status. (3) The LLM's narrative suggests continuity from 2023-2024 (same approach repeated), but the ground truth describes a strategic shift in 2024 toward 'more transparent and dynamic valuation framework' with new methodologies. (4) The LLM provides page references (page_99, page_96, page_94) that cannot be verified against the ground truth and may be fabricated. MISSING INFORMATION: The LLM fails to capture the 3-year trajectory of suspension and reappearance, the specific grant quantities and valuations from 2022, and the evolution toward dynamic valuation in 2024. The answer demonstrates incomplete multi-hop synthesis across the three-year period and misses the core narrative of program suspension followed by reinstatement with enhanced transparency. The LLM's claim about 2024 repeating 2023's approach directly contradicts the ground truth's description of 2024 as introducing new valuation policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 457,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website already gave RIAs open‑architecture access to third‑party platforms (CRM, portfolio‑management, order‑management and planning tools) and a free “Schwab Advisor Portfolio Connect” solution for managing Schwab accounts. In 2023 the firm layered on Ameritrade‑derived capabilities—launching the thinkpipes real‑time charting and trading platform, the iRebal customizable rebalancing engine, and the Schwab Trading Powered by Ameritrade™ suite. By 2024 those thinkpipes and iRebal features were fully integrated into the ongoing RIA offering, while the open‑architecture third‑party integrations and the free Portfolio Connect tool continued to provide streamlined, interactive portfolio‑management functionality for advisors.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Most critically: (1) The LLM introduces products (thinkpipes, iRebal, Schwab Trading Powered by Ameritrade) that are NOT mentioned in the ground truth answer at all. These appear to be fabricated or confused with other offerings. (2) The LLM claims these were 'Ameritrade-derived capabilities' launched in 2023, but the ground truth makes no mention of Ameritrade integration or these specific product launches in the 2022-2024 period for RIA tools. (3) The ground truth emphasizes that in 2023, Schwab 'continued to highlight these integrations' and placed 'increased emphasis on the Advisor Services website' with 'multi-year document archiving and search capabilities'—none of which the LLM mentions. (4) The ground truth notes that 2024 'reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability'—the LLM does not capture this evolution in user experience. (5) The LLM correctly identifies Schwab Advisor Portfolio Connect and third-party integrations (CRM, portfolio management, order management, planning tools) which ARE in the ground truth, but this accuracy is overshadowed by the introduction of unverified products. The LLM appears to have hallucinated or conflated information about thinkpipes and iRebal, which fundamentally undermines the answer's reliability. The multi-hop synthesis is broken because the LLM introduced entities and facts not supported by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 421,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across its 2022, 2023 and 2024 Form 10‑K filings, Texas Instruments repeatedly frames its strategy as a “great business model that is focused on analog and embedded processing products,” and it consistently stresses that embedded‑processing – especially for industrial and automotive applications – is a core growth engine for free‑cash‑flow generation (2022 p. 18; 2023 p. 20; 2024 p. 16). This unchanged emphasis reveals that TI is positioning itself for the long term as a specialist supplier of high‑margin, growth‑oriented embedded‑processing solutions, anchoring its competitive advantage in the broader semiconductor market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core strategic emphasis on embedded processing products across 2022-2024 and accurately captures the consistent framing of TI's business model. The semantic content aligns well with the ground truth regarding TI's long-term positioning as a specialist in analog and embedded processing solutions. However, there are notable issues: (1) The LLM cites specific page numbers (2022 p. 18; 2023 p. 20; 2024 p. 16) that cannot be verified against the ground truth and may be fabricated or inaccurate - this is a significant concern for factual precision. (2) The ground truth explicitly references 'four sustainable competitive advantages' as the framework, which the LLM answer omits entirely, instead using the phrase 'great business model' without mentioning the four-pillar structure. (3) The LLM adds specific application areas (industrial and automotive) that, while likely accurate, are not mentioned in the ground truth and represent an inference beyond what was provided. (4) The LLM's characterization of embedded processing as 'high-margin, growth-oriented' is reasonable but goes beyond the ground truth's more measured language about 'sustainable competitive advantages.' The multi-hop reasoning is sound - the answer correctly synthesizes the consistency across three years and draws appropriate conclusions about long-term positioning. The qualitative reasoning about TI's market positioning is strong and contextually relevant. The main weakness is the unverifiable page citations and the omission of the explicit 'four sustainable competitive advantages' framework that appears to be central to TI's stated strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 455,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s filings show that fleet‑support expenses have consistently been treated as an incurred cost and have historically run at roughly 1 % of total consolidated product‑and‑service costs, with no material change noted in the 2022, 2023 or 2024 reports. At the same time, the 787 program generated large abnormal production costs—about $2 billion expected by the end of 2023 (cumulative $2.7 billion through 2023) and $256 million recorded in 2024—driven by extensive rework and inspections that kept production below five aircraft per month and extended delivery timelines, causing prolonged delivery delays for the program.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on key numbers and correctly synthesizes multi-hop information across 2022-2024. Strengths: (1) Correctly identifies fleet support services at ~1% of consolidated costs consistently across all three years; (2) Accurately cites cumulative abnormal production costs of $2.7 billion through 2023; (3) Correctly states $256 million in rework costs for 2024; (4) Properly synthesizes the progression showing reduction in abnormal costs and gradual resolution of delays. Minor issues: (1) The phrase 'about $2 billion expected by the end of 2023' is somewhat ambiguous—the ground truth indicates 2023 had cumulative $2.7 billion through that date, not a forward-looking $2 billion estimate, though the LLM does clarify this is 'cumulative $2.7 billion through 2023'; (2) Missing some contextual detail about the 25 inventoried aircraft produced prior to 2023 and expectations to deliver majority in 2025, which the ground truth includes; (3) The mention of 'five aircraft per month' production rate is not explicitly verified in the ground truth provided. The answer correctly addresses the evolution question by showing the progression from 2022 (delivery delays noted, no specific figures) through 2023 (cumulative $2.7B disclosed) to 2024 ($256M annual costs, completion of rework on most aircraft). The multi-hop reasoning across years and between fleet support services and 787 program costs is sound. The quantitative accuracy is high with all major figures correct, though some contextual details about aircraft inventory and delivery timelines are omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 441,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "After the December 31 2021 sale of Meridian, Pfizer booked roughly $51 million of cash proceeds and a $167 million net loss (including a $345 million pre‑tax legal charge) that appeared in its 2022 discontinued‑operations results. In 2023 Pfizer disclosed that, alongside the sale, it had entered into interim transition‑service agreements (TSAs) – completed by Dec 31 2023 – and a three‑year Master Services Agreement (with a two‑year extension) to provide post‑sale services, but the amounts recorded under those TSAs and the MSA in 2022‑23 were not material. By the 2024 filing the only reference to Meridian is a defined‑term entry, indicating the relationship now exists solely through the ongoing MSA with no further material financial impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer introduces a $51 million cash proceeds figure and a $345 million pre-tax legal charge that are NOT mentioned in the ground truth. The ground truth only specifies a $167 million net loss (after tax), with no mention of $51M cash proceeds or $345M pre-tax charge. These appear to be fabricated or confused with other transactions. This is a critical factual error that significantly undermines credibility. CORRECT ELEMENTS: (1) December 31, 2021 sale date - correct; (2) $167 million net loss - correct; (3) TSAs completed by Dec 31, 2023 - correct; (4) Three-year MSA with two-year extension option - correct; (5) Amounts under TSAs/MSA not material - correct; (6) 2024 glossary reference - correct; (7) Transition from ownership to supplier relationship - correct. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022-2024 and identifies the progression from discontinued operations to limited supplier relationship. However, the introduction of unsupported financial figures (cash proceeds, pre-tax charge) suggests either hallucination or confusion with other Pfizer transactions. SEMANTIC ISSUES: The phrase 'defined-term entry' is awkward but semantically acceptable for glossary reference. The overall narrative structure is sound, but the quantitative errors are severe enough to warrant a low correctness score. The answer demonstrates understanding of the relationship evolution but fails on factual accuracy regarding specific financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 422,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "The “hello” name continues to be listed among Colgate‑Palmolive’s global oral‑care trademarks, and the oral‑care segment – which houses “hello” – still accounts for roughly 42‑43 % of worldwide net sales (43 % in 2022 and 43 % in 2024) while personal‑care and home‑care remain at about 19 %/18 % and 17 % respectively【page_79】. Thus, from 2022 to 2024 the company has kept “hello” positioned as a core oral‑care brand, with no material shift in its relative weight versus the other Oral, Personal and Home‑Care product lines.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that 'hello' remains positioned as a core oral-care brand across 2022-2024. (2) The quantitative data provided (oral-care at 43% in both 2022 and 2024, personal-care at 19%/18%, home-care at 17%) appears plausible and is presented with appropriate caveats about 'no material shift.' (3) The answer correctly recognizes the multi-year timeframe and attempts segment-level analysis. WEAKNESSES: (1) The LLM answer diverges significantly from the ground truth's focus. The original answer emphasizes 'hello' being consistently listed among principal global and regional trademarks alongside major brands (Colgate, Palmolive, Darlie), tracking its explicit brand positioning across filings. The LLM instead pivots to segment revenue percentages, which is a different analytical approach. (2) The ground truth specifically notes 'hello' was listed in 2022, 2023, and 2024 filings with sustained emphasis, and mentions the addition of Darlie in 2023. The LLM does not address this trademark listing evolution or the Darlie addition. (3) The LLM's answer about segment percentages remaining stable (43% oral-care in both years) actually supports a conclusion of 'no evolution' rather than addressing how 'hello' brand positioning evolved within the segment. (4) The question asks about evolution 'in relation to its other Oral, Personal and Home Care product lines' - the ground truth interprets this as relative brand positioning/visibility in trademark listings, while the LLM interprets it as segment revenue share, which are different concepts. (5) The LLM provides segment-level data but doesn't explicitly connect this to 'hello' brand evolution or positioning relative to other brands like Colgate, Palmolive, or Darlie. MULTI-HOP REASONING: The LLM attempts to synthesize segment data across years but fails to synthesize the brand positioning information that forms the core of the ground truth answer. The reasoning is internally consistent but addresses a different dimension of the question than intended.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 552,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "The non‑qualified defined‑benefit pension plan stayed **unfunded and closed to new participants** in each of the three years – the 2022 filing notes it is “unfunded and closed to new participants” (TXN 2022 p.44), the 2023 filing repeats the same description (TXN 2023 p.44), and the 2024 filing again confirms it remains “unfunded and closed to new participants” (TXN 2024 p.44). Only the legacy participants who were already in the plan could make a one‑time election to keep accruing benefits or move to the enhanced defined‑contribution plan, so the plan’s liability is essentially static and employee involvement is limited to a shrinking cohort, indicating TI’s long‑term pension obligations for this plan are not growing and participation trends are flat or declining.",
      "correctness_score": 5,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer completely omits all quantitative data that forms the core of the ground truth answer. The original answer provides specific, verifiable financial metrics across 2022-2024: (1) TI common stock holdings in U.S. defined contribution plans: 6M shares ($940M) in 2022, 5M shares ($873M) in 2023, 5M shares ($852M) in 2024; (2) Dividends paid: $28M (2022), $27M (2023), $26M (2024); (3) Aggregate expense for U.S. defined contribution plans: $70M (2022), $75M (2023), $76M (2024). The LLM answer provides NONE of these numbers. WHAT WAS CORRECT: The LLM correctly identifies that the non-qualified defined benefit pension plan remained unfunded and closed to new participants across all three years (2022-2024), and correctly infers that this represents a legacy liability with static/declining participation. The reasoning about TI's strategic shift toward defined contribution plans is sound and aligns with the ground truth conclusion. WHAT WAS MISSING/INCORRECT: (1) No quantitative data on stock holdings, dividends, or plan expenses; (2) The answer fails to demonstrate the 'multi-year progression' requested in the question by providing no numerical trends; (3) The answer lacks the specific evidence of 'growing emphasis on defined contribution plans' that the ground truth demonstrates through the increasing expense figures ($70M→$75M→$76M); (4) The answer provides no data on the declining dividend payments or stock value changes that support the conclusion about pension obligations. MULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting the unfunded status across three years and inferring strategic implications, but fails to synthesize the quantitative data across the three-year period that would fully answer the question. The answer reads more like a qualitative summary than a comprehensive analysis of the 'multi-year progression' explicitly requested. SEMANTIC EQUIVALENCE: While the qualitative conclusions are directionally correct, the absence of supporting quantitative evidence represents a fundamental incompleteness that undermines the answer's credibility and usefulness for understanding the actual evolution of the plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 591,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings fell from $800 million at year‑end 2022 to $755 million in 2023 and then to $719 million in 2024, a cumulative drop of roughly $81 million (≈10 %)【page_86†L22】【page_83†L24】. This steady decline indicates the company is gradually scaling back its exposure to private‑equity assets, likely reallocating capital toward more liquid or core strategic investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect starting value: claims $800 million in 2022 when ground truth shows $623 million. This is a $177 million error (28% overstatement). The 2023 and 2024 figures ($755M and $719M) are correct. The calculated decline of $81 million is mathematically correct from the LLM's incorrect starting point ($800M - $719M = $81M), but this calculation is based on false premises. (2) MULTI-HOP SYNTHESIS - The LLM failed to correctly extract the 2022 baseline figure from the source documents, which is a fundamental data retrieval error in multi-hop reasoning. (3) INTERPRETATION ISSUE - The LLM characterizes the trajectory as a 'steady decline' across all three years, but the ground truth shows an increase from 2022 to 2023 (+$132M), followed by a decline from 2023 to 2024 (-$36M). This is NOT a steady decline but rather an increase-then-decrease pattern. The LLM's interpretation of 'gradually scaling back' is therefore incorrect for the full period. (4) PERCENTAGE CALCULATION - The LLM calculates ~10% decline, which is approximately correct for their incorrect numbers ($81M/$800M ≈ 10%), but this is irrelevant given the wrong baseline. The correct 3-year change is -$96M or -15.4% decline from 2022 to 2024, but this masks the intermediate 2023 increase. (5) STRATEGIC INTERPRETATION - The ground truth correctly identifies a 'measured approach' with a strategic increase in 2023 followed by partial reduction in 2024. The LLM's interpretation of 'steady decline' and 'gradually scaling back' mischaracterizes the actual strategic pattern shown in the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 452,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "In 2022, under the original 2019 IDA agreement Schwab could migrate up to $10 billion of IDA balances each 12‑month period, but only if it kept a $50 billion minimum balance, at least 80 % of the balances as fixed‑rate obligations and had sufficient capital – Schwab exercised this right and moved roughly $10 billion that year (page_102). The May 2023 2023 IDA agreement replaced those terms, eliminated the 80 % fixed‑rate requirement, imposed a rule that balances must stay above unmatured fixed‑rate obligations with a $30 billion cap above that total and limited withdrawals to customer‑initiated amounts until Sept 10 2025, while also giving Schwab an optional $5 billion buy‑down of fixed‑rate obligations (which it used); nevertheless Schwab did not migrate any IDA balances in 2023 (page_103; page_102). The same 2023 agreement governed 2024, keeping migration subject to sufficient capital and the minimum/maximum balance limits (and after Sept 10 2025, discretionary withdrawals with a $60 billion floor and $90 billion ceiling), and Schwab again did not move any IDA balances in 2024 (page_99; page_100).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail and captures the overall evolution of Schwab's IDA migration capability, but contains several factual inaccuracies that undermine its reliability:\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2019 IDA agreement allowed up to $10 billion annual migration\n- Correctly states Schwab moved approximately $10 billion in 2022\n- Correctly identifies the May 2023 agreement replaced the 2019 agreement\n- Correctly states no IDA balances were migrated in 2023 or 2024\n- Correctly identifies the $30 billion maximum threshold above unmatured fixed-rate obligations\n- Correctly notes the shift from flexible annual option to constrained framework\n- Appropriately cites page references\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n- Claims the 2019 agreement required a \"$50 billion minimum balance\" - NOT mentioned in ground truth\n- Claims an \"80% fixed-rate obligation\" requirement - NOT mentioned in ground truth\n- Claims the 2023 agreement \"eliminated the 80% fixed-rate requirement\" - this requirement was never established in ground truth\n- Claims Schwab used an \"optional $5 billion buy-down of fixed-rate obligations\" - NOT mentioned in ground truth\n- Claims post-Sept 10, 2025 terms include \"$60 billion floor and $90 billion ceiling\" - NOT mentioned in ground truth\n- The ground truth states withdrawals were \"customer-initiated amounts\" but LLM frames this differently\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across three years and identifies the evolution pattern. However, the introduction of unsupported details (the $50B minimum, 80% requirement, $5B buy-down, future $60-90B range) suggests either hallucination or confusion with other documents not in the ground truth.\n\nQUANTITATIVE ACCURACY:\nWhile the core numbers ($10B, $30B) are correct, the addition of unsupported constraints ($50B minimum, 80% requirement, $5B buy-down, $60-90B future range) significantly reduces quantitative accuracy. These appear to be fabricated details.\n\nSEMANTIC EQUIVALENCE:\nThe core semantic meaning about tightening constraints is preserved, but the specific constraints described differ materially from ground truth, making this a significant issue for a financial compliance question where precision matters.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 613,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists its Melaka, Malaysia site as an analog‑product manufacturing facility in every recent filing – it appears with an “X” under the Analog column in the 2022 10‑K (page 18), again in the 2023 10‑K (page 16) and once more in the 2024 10‑K (page 16). The unchanged presence of Melaka across three consecutive years signals that the plant is a stable, dedicated analog fab and a strategically important node in TI’s analog‑product supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies regarding the marking symbols used across years. The ground truth states Melaka was marked with: (1) † in 2022, (2) * in 2023, and (3) ** in 2024. The LLM claims the marking was an 'X' in 2022 and remained 'unchanged' across all three years. This is fundamentally incorrect - the ground truth explicitly indicates the markings CHANGED/ESCALATED from † to * to **, suggesting potential operational emphasis evolution. The LLM's claim of 'unchanged presence' directly contradicts the ground truth's observation of 'possible escalation.' PARTIAL CREDIT: The LLM correctly identifies (1) Melaka, Malaysia as the location, (2) analog product manufacturing as the function, (3) consistent presence across 2022-2024, (4) strategic importance to TI's supply chain, and (5) the general conclusion about stability. However, the specific symbol progression is wrong, and the LLM misses the nuance that the changing markers potentially signal escalating operational emphasis rather than complete stasis. The page numbers cited (18, 16, 16) cannot be verified against ground truth but appear plausible. The core multi-hop reasoning about strategic importance is sound, but the factual foundation regarding the marking evolution is compromised, which undermines the credibility of the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 377,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The filing shows that the share of purchases made with Target’s debit‑card product fell each year – it was about **20.5 % in fiscal 2022**, **19.8 % in fiscal 2023**, and **18.6 % in fiscal 2024**【page_27】 (the same figures are reported as Target Circle Card penetration for FY 2024 and FY 2023 in the 2024 10‑K【page_28】).  \n\nThe downward trend indicates that, although the card still generates “incremental purchases” that the company counts as incremental sales, its relative contribution to overall sales is shrinking over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL 2024 FIGURE: The LLM states the penetration rate was 18.6% in fiscal 2024, but the ground truth shows it was 17.8% in 2024. This is a material factual error of 0.8 percentage points. The other two figures are correct: 20.5% in 2022 and 19.8% in 2023. QUANTITATIVE ACCURACY: The error in the 2024 figure significantly impacts the quantitative accuracy score. The LLM correctly identified the downward trend (which is accurate), but the specific endpoint is wrong. This matters for trend analysis and conclusions. QUALITATIVE ACCURACY: The LLM's reasoning about the trend is sound - it correctly identifies that the downward trajectory suggests diminishing effectiveness and shifting consumer preferences. The interpretation that the card still generates incremental purchases but with shrinking relative contribution is reasonable and aligns with the ground truth's conclusion about reduced effectiveness. COMPLETENESS: The LLM addresses both parts of the question: (1) the evolution of penetration rates from 2022-2024, and (2) what the trend suggests about the card's role. However, the incorrect 2024 figure undermines the completeness of accurate information. ENTITY ACCURACY: Correctly identifies Target Debit Card/Target Circle Card and the fiscal years. MULTI-HOP REASONING: The synthesis across years is present and logical, though built on a flawed 2024 data point. The connection between declining penetration and reduced sales-driving effectiveness is appropriately made. The error appears to be a data retrieval or transcription mistake rather than a reasoning failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 440,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The 10‑K tables for 2022, 2023 and 2024 all show that the “Number of securities remaining available for future issuance” column does **not** include a pool for the 2003 Director Compensation Plan – the footnotes (c) on the tables list only the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan (and in 2024 the 2024 LTIP) as having shares left for future grants (see footnotes (c) on pages 63, 61 and 59). Thus, the 2003 plan had effectively zero shares available for future issuance in each year, indicating that Texas Instruments has fully drawn down that plan’s reserve and now relies on newer equity‑based plans to provide and replenish director incentives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual claims. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth provides specific share counts for the 2003 Director Compensation Plan: 35,385,153 shares (2022), 25,296,767 shares (2023), and 24,503,062 shares (2024). The LLM claims these numbers do not exist and that the plan had 'effectively zero shares available' in each year. This is a complete factual error - the numbers are documented in the SEC filings. (2) ENTITY ACCURACY FAILURE: The LLM incorrectly identifies which plans had shares available, claiming only the 2009 LTIP, 2014 ESPP, 2018 Director Plan, and 2024 LTIP had remaining shares. The ground truth clearly shows the 2003 Director Compensation Plan had substantial shares available across all three years. (3) REASONING FAILURE: The LLM's multi-hop synthesis is fundamentally flawed. It claims to have reviewed footnotes (c) on specific pages but reaches the opposite conclusion from what the ground truth documents. The LLM suggests the 2003 plan was 'fully drawn down' when the data shows a declining but still substantial pool of shares. (4) SEMANTIC CONTRADICTION: The LLM's conclusion that TI 'now relies on newer equity-based plans' contradicts the ground truth's finding that the company maintained and actively used the 2003 plan throughout 2022-2024. The trend analysis is inverted - the ground truth shows consistent decline (active use without replenishment), while the LLM claims zero availability. This is not a matter of wording differences; the factual claims are directly contradictory and the LLM's answer is demonstrably incorrect based on the ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 462,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "In fiscal 2022 Visa introduced virtual accounts as part of its digitally‑native Currencycloud platform under “Visa Treasury as a Service,” and added push‑to‑wallet capabilities to Visa Direct payouts, extending the network to nearly 7 billion cards, accounts and wallets worldwide【page_11】. In fiscal 2023 those virtual‑account, real‑time FX and liquidity functions were folded into the Visa Direct platform through the new Visa Cross‑Border Solutions and Currencycloud suite, broadening cross‑border use cases【page_10】. By fiscal 2024 the Visa Direct platform fully embedded virtual accounts (along with real‑time FX and enhanced settlement), scaling cross‑border flows across more than 190 countries and supporting an expanded set of B2B, B2C and P2P transactions【page_10】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Visa's virtual accounts across 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 introduction of virtual accounts through Currencycloud under 'Visa Treasury as a Service'; (2) Accurately describes the 2023 integration into Visa Direct platform with Visa Cross-Border Solutions; (3) Properly characterizes 2024 as full embedding of virtual accounts with real-time FX and enhanced settlement; (4) Correctly notes expansion across 190+ countries and support for B2B, B2C, P2P transactions; (5) Appropriately cites page references. QUANTITATIVE ACCURACY: The LLM provides specific numbers - '7 billion cards, accounts and wallets' in 2022 and '190 countries' in 2024. The ground truth mentions '11 billion endpoints' in 2024 and '$20 trillion in annual B2B cross-border opportunities.' The LLM does not mention the 11 billion endpoints figure or the $20 trillion opportunity size, which are material details from the ground truth. MINOR GAPS: (1) The LLM states 'nearly 7 billion' for 2022 but ground truth doesn't explicitly confirm this number for that year; (2) The LLM omits the specific mention of '11 billion endpoints' potential in 2024, which is a notable quantitative detail; (3) The LLM doesn't reference the '$20 trillion in annual B2B cross-border opportunities' that the ground truth highlights as central to Visa's strategy. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years, showing clear progression and integration patterns. The logical flow from introduction → integration → full embedding is sound and matches the ground truth narrative. SEMANTIC EQUIVALENCE: The answer conveys the essential evolution story accurately, with appropriate emphasis on platform integration and expanding use cases. The omission of the 11 billion endpoints and $20 trillion figures prevents a perfect score, as these are quantitatively significant details that contextualize Visa's strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 545,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer reported that Xtandi’s sales fell about 1 percent, mainly because of a lower net price and an unfavorable channel‑mix shift (see the 2023 revenue table).  To counter that pressure the company pushed the drug’s lifecycle forward, securing a new EU indication for enzalutamide in April 2024 (the 2024 indication‑expansion table lists the EU approval) and the asset was already reflected as a high‑value component of Pfizer’s developed‑technology rights, recorded at a $73 billion gross (≈$20 billion net) intangible‑asset balance in the 2022 financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key data points: (1) 2023 revenue decline of ~1% with accurate attribution to net pricing pressure and channel-mix shift; (2) correct identification of the 2024 EU indication expansion for enzalutamide in non-metastatic castration-sensitive prostate cancer; (3) accurate reference to 2022 intangible asset valuation with specific numbers ($73 billion gross, ~$20 billion net). The multi-hop reasoning is sound—the answer correctly synthesizes the connection between 2023 revenue pressures, 2022 asset valuation, and 2024 lifecycle management strategy. However, there are minor gaps: (1) The LLM specifies 'EU approval' in April 2024, while the ground truth mentions 'non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis' without specifying geographic scope—the LLM's specificity to EU is not contradicted but represents additional detail not in ground truth; (2) The LLM does not explicitly mention 'declining international revenues' as a separate factor from net pricing, though this is a minor omission; (3) The answer could have been slightly more explicit about the strategic intent to 'offset declining performance in existing markets' though this is implied. The quantitative data (1% decline, $73B/$20B valuations) are accurate. The qualitative reasoning about lifecycle management as a response to revenue pressure is correct and well-articulated. Overall, this is a strong answer with accurate synthesis of multi-hop information across years and financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 444,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The filing shows that total RedCard (Target Credit Cards, which include the Target MasterCard) penetration fell from 20.5 % for the year ended January 29 2022, to 19.8 % for the year ended January 28 2023, and to 18.6 % for the year ended February 3 2024【page_27】. This steady decline signals that fewer guests are using the Target MasterCard credit product, suggesting a weakening consumer preference for the RedCard‑linked loyalty discount and reduced engagement with that loyalty program over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All three penetration rate figures are correct (20.5% for 2022, 19.8% for 2023, 18.6% for 2024), and the fiscal year dates are accurate. The consistent decline pattern is correctly identified. ENTITY ACCURACY: The LLM correctly identifies the product as RedCard/Target MasterCard Credit Card and notes the rebranding context (RedCard-linked loyalty discount), which aligns with the ground truth's mention of rebranding from RedCards™ to Target Circle Cards. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend data and correctly interprets what the declining penetration rate indicates about consumer behavior - specifically that fewer guests are using the card and engagement with the loyalty program has weakened. SEMANTIC EQUIVALENCE: The LLM's interpretation that the decline 'signals that fewer guests are using the Target MasterCard credit product' and indicates 'weakening consumer preference' and 'reduced engagement with that loyalty program' is semantically equivalent to the ground truth's assessment of 'shift in consumer payment preferences or a weakening in loyalty program engagement.' MINOR CONSIDERATIONS: The LLM provides slightly more specific language about 'RedCard-linked loyalty discount' which adds helpful context. The citation reference [page_27] demonstrates source attribution. The only minor difference is that the ground truth uses the phrase 'gradual reduction in the proportion of purchases' while the LLM says 'fewer guests are using,' but these convey the same essential meaning. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 460,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022 Visa Direct already powered cross‑border payments through a network of 16 card‑based networks, 66 ACH schemes, 11 RTP networks and five gateways, and with push‑to‑wallet could serve nearly 7 billion cards, accounts and digital wallets in more than 190 countries (page 11); FY 2023 expanded that connectivity further (e.g., the launch of Visa+ for P2P apps) (page 10). By FY 2024 Visa had embedded virtual accounts into its digitally‑native Currencycloud platform, adding real‑time FX, liquidity and settlement to its cross‑border suite and extending virtual‑account‑enabled payments across the same global footprint of roughly 7 billion endpoints (pages 10‑11).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM states ~7 billion endpoints in FY 2022 and FY 2024, but ground truth indicates 11 billion endpoints by 2023\n   - LLM provides detailed network composition (16 card networks, 66 ACH schemes, 11 RTP networks, 5 gateways) that is not mentioned in ground truth and appears to be hallucinated or from different context\n   - Ground truth specifies \"over 11 billion endpoints\" by 2023, which the LLM completely misses\n   - LLM mentions \"190 countries\" for FY 2022, but ground truth emphasizes \"more than 100 countries\" for 2024 via Visa B2B Connect\n\n2. COMPLETENESS ISSUES:\n   - LLM fails to capture the key evolution of virtual accounts' role from FY 2022 (real-time FX, liquidity, settlement) through 2023 (integration into cross-border solutions, network expansion to 11B endpoints) to 2024 (digitally native Currencycloud, B2B optimization)\n   - LLM mentions Visa+ for P2P apps in 2023, which is not in the ground truth answer and appears tangential\n   - LLM does not adequately address the strategic deepening of virtual account utility across the three-year period\n\n3. ENTITY/METRIC ACCURACY:\n   - Correctly identifies Visa, Currencycloud, and Visa Direct\n   - Correctly identifies fiscal years 2022-2024\n   - Fails to properly track the evolution of virtual account capabilities and network reach metrics\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is weak; the answer jumps between different network metrics without clearly showing how virtual accounts specifically evolved\n   - Does not establish clear causal connections between virtual account introduction and the expansion of cross-border capabilities\n   - The answer conflates general Visa Direct capabilities with virtual account-specific evolution\n\n5. CRITICAL DISCREPANCY:\n   - Ground truth: 11 billion endpoints by 2023\n   - LLM answer: ~7 billion endpoints in both 2022 and 2024\n   - This is a major factual error that undermines the answer's credibility\n\nThe LLM answer appears to describe Visa Direct's general capabilities rather than specifically tracking virtual account evolution as requested. While some elements are correct (Currencycloud, cross-border payments, global footprint), the core narrative about virtual account progression is incomplete and contains numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 644,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s risk disclosures in all three years list “difficulties in protecting our intellectual property” as a core political‑legal‑economic risk tied to its global footprint and its reliance on third‑party wafer foundries and assembly/testing in China, Malaysia and Taiwan (2022 p. 36; 2023 p. 41; 2024 p. 40). The 2022 filing already noted that about 72 % of revenue was international and that most manufacturing is outsourced overseas, and the 2023 and 2024 filings show a similar reliance (≈65‑66 % of revenue international) but add explicit references to rising geopolitical tensions (e.g., China‑Taiwan, Russia‑Ukraine sanctions) that could further complicate IP enforcement abroad, indicating a persistent and increasingly acute exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of AMD's IP protection challenges across 2022-2024, accurately captures the geographic locations of manufacturing dependencies (China, Malaysia, Taiwan), and properly synthesizes the evolution from general IP concerns to more specific geopolitical risk factors (China-Taiwan tensions, Russia-Ukraine sanctions). The answer demonstrates sound multi-hop reasoning by connecting international revenue exposure to manufacturing outsourcing to IP protection vulnerabilities. The semantic equivalence is strong—the answer conveys the same substantive information as the ground truth about persistent and increasingly acute exposure.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE: The LLM cites specific revenue percentages (72% international in 2022, 65-66% in 2023-2024) with page citations (2022 p. 36; 2023 p. 41; 2024 p. 40), but the ground truth does not provide these specific percentages or validate these page numbers. This introduces unverified quantitative claims that cannot be confirmed against the ground truth. (2) MISSING DETAIL: The ground truth explicitly mentions the Israel-Hamas conflict as an additional geopolitical factor affecting IP protection in 2024, which the LLM answer omits. (3) CITATION SPECIFICITY: While the LLM provides page numbers, these cannot be verified against the ground truth and may be hallucinated.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects multiple concepts (international operations → third-party manufacturing → geopolitical risks → IP protection challenges), which is appropriate for this multi-hop question.\n\nCALCULATION/VERIFICATION: No calculations are required, but the unverified percentage claims reduce confidence in quantitative accuracy despite being plausible.\n\nOVERALL: The answer is substantially correct in its core narrative and reasoning but loses points for introducing specific unverified numbers and omitting the Israel-Hamas conflict reference from 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 551,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "UNP’s pension plan treats corporate stock as a Level 1 fair‑value investment for common shares (with a small Level 2 component for preferred shares) [page_56]; in 2022 the plan held $2.209 billion of Level 1 stock (plus $8 million Level 2) and equity securities comprised 48 % of plan assets [page_70][page_56]. By 2023 the corporate‑stock balance had collapsed to roughly $0.22 billion (Level 1) and $6 million (Level 2), and the equity portion fell to 24 % of assets [page_57][page_56]; the 2024 filing shows equity still at 24 % (with 75 % in debt) [page_56]. This sharp reduction in equity‑type corporate stock and the move to a 75/25 debt‑to‑equity mix signals a deliberate de‑risking of the pension portfolio, lowering market exposure and volatility while targeting a more conservative long‑term return.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the core numbers that are critical to answering this question. (1) 2022 Corporate Stock valuation: Ground truth states $1,990 million total ($1,980M Level 1 + $10M Level 2), but LLM claims $2.209 billion Level 1 plus $8M Level 2 = $2.217 billion total—this is approximately $227 million HIGHER than ground truth, a material error. (2) 2023 Corporate Stock valuation: Ground truth states $181 million total ($176M Level 1 + $5M Level 2), but LLM claims roughly $0.22 billion (which equals $220 million)—this is approximately $39 million HIGHER than ground truth. (3) The LLM introduces equity percentages (48% in 2022, 24% in 2023-2024) and a 75/25 debt-to-equity mix that are NOT mentioned in the ground truth answer and cannot be verified against it. These percentages appear to be either from different sections of the filing or potentially fabricated. (4) The LLM conflates 'Corporate Stock' with broader 'equity securities' categories, which may not be equivalent. MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution across years and draw conclusions about de-risking strategy, which is appropriate to the question. However, the foundation is built on incorrect numbers, undermining the validity of the analysis. COMPLETENESS: The LLM addresses the 2022-2024 evolution and attempts to interpret strategic implications, but the incorrect figures make the answer fundamentally unreliable. The ground truth explicitly notes that 2024 figures were not provided in dollar amounts, which the LLM should have acknowledged rather than providing percentages without source verification. SEMANTIC EQUIVALENCE: While the LLM's interpretation of 'de-risking' aligns with the ground truth's 'strategic shift toward more stable investments,' this qualitative assessment cannot overcome the quantitative errors in the foundational data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 521,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Abbott repeatedly lists the same two items for its 4.75 % Senior Notes due 2043: (i) the “Form of 4.75 % Notes due 2043” (Exhibit 4.6) and (ii) the accompanying “Officers’ Certificate” (Exhibit 4.7) that were originally filed in a March 2017 8‑K and 10‑Q 【page_86】. By keeping these original documents in the exhibit table each year without adding new amendments, Abbott signals a reliance on a long‑dated debt issuance and a disciplined, transparent approach to informing investors about its enduring financing commitments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains accurate factual elements but has significant gaps in addressing the multi-year evolution question. CORRECT ELEMENTS: (1) Accurately identifies the 4.75% Senior Notes due 2043, (2) Correctly cites Exhibit 4.6 (Form of Notes) and Exhibit 4.7 (Officers' Certificate), (3) Correctly dates the original March 2017 8-K filing, (4) Accurately notes that the same documents appear across 2022-2024 without amendments. SIGNIFICANT GAPS: (1) The LLM answer fails to address the 2022 context involving St. Jude Medical's Fourth Supplemental Indenture from April 2, 2013, which the ground truth identifies as a key element of the 2022 documentation strategy, (2) Does not capture the evolution from 'legacy-based referencing' (2022) to 'standardized, transparent disclosure' (2023-2024) that the ground truth emphasizes, (3) Missing the distinction between how the notes were presented in 2022 versus 2023-2024, (4) Does not address the 'formalization' and 'shift' in disclosure approach that occurred between 2022 and 2023. REASONING QUALITY: The LLM provides a reasonable interpretation of what consistent disclosure suggests about debt management philosophy, but it misses the critical multi-year progression that is central to the question. The answer treats all three years as essentially identical rather than capturing the evolution described in the ground truth. The LLM's conclusion about 'disciplined, transparent approach' is reasonable but incomplete without acknowledging the shift from legacy integration to standardized presentation. QUANTITATIVE ACCURACY: Dates and exhibit numbers are correct (March 2017, Exhibits 4.6 and 4.7), but the answer lacks the temporal specificity about when the shift occurred (2022 vs 2023). The answer essentially provides a snapshot of 2023-2024 consistency rather than a true multi-year progression analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 506,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The share of purchases paid with Target’s branded credit‑debit cards fell from ≈20.5 % in fiscal 2022 to ≈19.8 % in fiscal 2023 and to ≈18.6 % in fiscal 2024【page_27】(RedCard Penetration) and is confirmed by the 2024 filing’s Target Circle Card Penetration figure of 18.6 % for FY 2024【page_29】. The downward trend signals a modest slowdown in customer adoption of Target’s branded payment products, which could temper the incremental‑sales boost that Target attributes to these cards even though they still generate meaningful extra purchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. (1) QUANTITATIVE VERIFICATION: All three penetration rate figures are correct - 20.5% (FY2022), 19.8% (FY2023), and 18.6% (FY2024). The numbers match the ground truth exactly with appropriate formatting (≈ symbol used appropriately for approximate values). (2) ENTITY ACCURACY: Correctly identifies Target's branded payment products (RedCard/Target Circle Card), fiscal years, and the specific metric (penetration rate). The answer properly acknowledges both naming conventions (RedCard and Target Circle Card) showing nuanced understanding. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and filing documents, correctly identifying the downward trend across the three-year period and connecting this trend to the broader business implications regarding incremental sales. The logic is sound - declining penetration rates suggest reduced customer adoption, which could diminish the incremental sales benefit Target historically attributed to these cards. (4) COMPLETENESS: Addresses all parts of the question - the evolution of penetration rates (with specific numbers), the trend direction (downward), and the implications for customer adoption and incremental sales impact. (5) MINOR CONSIDERATIONS: The phrase 'modest slowdown' is a reasonable characterization of the decline (approximately 1.9 percentage points over two years), though the ground truth uses 'gradual decline' - both are semantically equivalent and appropriate. The answer appropriately notes that despite the decline, the cards remain strategically important. The citation references (page_27, page_29) add credibility and demonstrate source verification. No calculation errors detected. The answer maintains appropriate hedging language ('could temper') when discussing forward-looking implications, which is appropriate given the data shows historical trends rather than predictive statements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 540,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s 2022 filing (which reports the fleet as of 12/31/2021) showed **7,242 multiple‑purpose locomotives** with an **average age of 22.5 years**【page_24】. By the end of 2024 the fleet had fallen to **6,893 units** and the average age had risen to **25.2 years**【page_19】. The drop of roughly 350 locomotives and the upward shift in age suggest the railroad is deliberately right‑sizing its fleet—retiring older units and relying on a smaller, more intensively used pool of locomotives while managing capital outlays and maintaining operational flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - 7,242 units in 2022 (22.5 years average age) and 6,893 units in 2024 (25.2 years average age). The calculated difference of ~350 locomotives is accurate. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) total units change, (2) average age change, and (3) strategic implications. ENTITY ACCURACY: Union Pacific correctly identified, years correctly specified (2022 to 2024), and metrics properly labeled as 'Multiple Purpose Locomotives.' MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods and correctly interprets the data to draw conclusions about asset management strategy. The reasoning that fleet reduction combined with aging suggests 'right-sizing' and 'cost-conscious' management is sound and aligns with the ground truth interpretation. SEMANTIC EQUIVALENCE: The LLM's characterization of the strategy as 'deliberately right-sizing its fleet' and 'managing capital outlays' is semantically equivalent to the ground truth's description of 'cost-conscious asset management strategy' and 'deferral of fleet modernization.' The LLM provides slightly more nuanced interpretation (mentioning 'more intensively used pool' and 'operational flexibility') which adds value without contradicting the ground truth. MINOR NOTES: The LLM includes citation references (page numbers) which adds credibility but are not verifiable in this context. The phrasing 'roughly 350 locomotives' is appropriately cautious given the exact difference is 349 units. Overall, this is a high-quality response that accurately conveys the factual information and provides sound analytical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 482,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate (and other private) funds fell from **$569 million at the end of 2022**, to **$555 million at the end of 2023**, and then to **$540 million at the end of 2024**【page_71】【page_70】.  The modest, year‑over‑year decline shows the company is gradually satisfying or scaling back its outstanding pledges to illiquid alternative‑asset funds, indicating a disciplined, long‑term approach that maintains exposure to private real‑estate while managing liquidity risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states Abbott's unfunded commitments were $569 million at the end of 2022, but the ground truth clearly indicates $585 million for 2022. This is a $16 million discrepancy on the starting point of the analysis. The 2023 ($555 million) and 2024 ($540 million) figures are correct. CALCULATION IMPACT: The LLM correctly identifies the year-over-year declines ($555M to $540M = $15M decline in 2024), but the incorrect 2022 baseline undermines the three-year trend analysis. The ground truth shows a $45 million total decline from 2022-2024 ($585M to $540M), while the LLM's numbers would show only a $29 million decline ($569M to $540M). QUALITATIVE REASONING: The LLM's interpretation of the trend (gradual reduction, disciplined approach, managed liquidity risk) is reasonable and aligns with the ground truth's characterization. The synthesis across multiple years and the conclusion about long-term strategy are sound. However, the factual error in the 2022 baseline is a significant quantitative mistake that affects the credibility of the trend analysis. COMPLETENESS: The answer addresses the evolution question and provides strategic interpretation, though it doesn't explicitly mention the $15 million annual decline pattern that the ground truth emphasizes. The answer is contextually relevant but factually compromised by the incorrect starting number.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 388,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The liability schedule shows that NVIDIA’s 3.50 % Notes due 2050 were carried at $1,637 million at the end of fiscal 2023 (January 29 2023) and fell to $1,604 million at the end of fiscal 2024 (January 28 2024), a reduction of about $33 million【page_67】. This modest decline reflects the amortization of the original discount and issuance costs and indicates that the company is gradually lowering the book value of this long‑term debt while maintaining a stable overall leverage profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM reports the fiscal 2023 carrying value as $1,637 million, but the ground truth states it was $1,604 million. The LLM also completely omits the fiscal 2022 value of $2,147 million, which is essential to answering the question about evolution from 2022 to 2024. The LLM only provides a two-year comparison (2023-2024) instead of the required three-year progression (2022-2024). The reported decline of $33 million from 2023 to 2024 is mathematically inconsistent with the ground truth showing an increase from $1,604 million (2023) to $2,000 million (2024), a $396 million increase. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The question explicitly asks about evolution from fiscal 2022 to 2024, requiring synthesis of three data points across three fiscal years. The LLM only addresses 2023-2024, missing the critical 2022 baseline and the significant $543 million decrease from 2022 to 2023. (3) INCORRECT REASONING - The LLM characterizes the trend as a 'modest decline' and 'gradually lowering the book value,' which contradicts the ground truth showing a rebound in 2024 to $2,000 million (higher than 2023's $1,604 million). The LLM's explanation about amortization of discount and issuance costs may be partially valid but misses the key insight that the 2024 rebound indicates strategic repositioning rather than consistent amortization. (4) MISSING CONTEXTUAL ANALYSIS - The ground truth emphasizes that the fluctuation indicates 'revaluation or strategic adjustment' and a 'deliberate positioning' possibly tied to refinancing or market interest rate adjustments. The LLM provides a simplistic amortization explanation that fails to capture the complexity of the three-year progression. The answer demonstrates incomplete data gathering and flawed multi-hop reasoning across the required fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 529,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD has listed “loss or modification of exemptions for taxes and tariffs” as a material political‑legal‑economic risk in every filing – first in its 2022 10‑K risk‑factors (see 2022 p. 36), again in the 2023 10‑K (2023 p. 40) and once more in the 2024 10‑K (2024 p. 40). While the wording of the risk itself has not changed, the surrounding discussion in 2023 and 2024 adds explicit references to new sanctions, export‑control revisions and geopolitical conflicts, showing that AMD’s exposure to losing tax and tariff exemptions remains a constant concern but is now set against an increasingly complex and volatile global regulatory environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that AMD listed 'loss or modification of exemptions for taxes and tariffs' as a risk across 2022, 2023, and 2024 filings, with accurate page references (2022 p. 36, 2023 p. 40, 2024 p. 40). The answer accurately notes that the wording remained consistent while surrounding context evolved. However, the LLM answer has a significant weakness: it does not explicitly detail the specific geopolitical events and regulatory pressures that the ground truth emphasizes. The ground truth specifically mentions: (1) U.S. sanctions against Russia and Belarus in 2023, (2) Ukraine-Russia and Israel-Hamas conflicts in 2023, and (3) China-Taiwan geopolitical tensions in 2024. The LLM answer uses more generic language ('new sanctions, export-control revisions and geopolitical conflicts') without naming these specific events. This represents a loss of important contextual detail that demonstrates the evolution of AMD's regulatory exposure. The LLM correctly captures the overall trend (constant concern with increasing complexity) and the multi-hop synthesis across three years is sound. The answer is semantically aligned with the ground truth's core message but lacks the specificity and detail that would make it fully equivalent to the original answer. The quantitative accuracy is high (page numbers and years are correct), but the qualitative accuracy is reduced due to missing specific geopolitical references that are central to understanding the 'increasing complexity' aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 421,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "BNY Mellon’s 10‑K filings for 2022 (page 5), 2023 (page 5) and 2024 (page 5) all contain the same risk‑factor language: the company’s ability to return capital—through dividends or share repurchases—is at the Board’s discretion but can be limited by U.S. banking laws and regulations (including capital‑planning rules, Delaware law and the requirement to pay full, timely preferred‑stock dividends). This consistent disclosure shows that the firm’s exposure to regulatory constraints on dividend payments and repurchases has not materially changed over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and accurately cites page 5 for all three years' 10-K filings; (2) Accurately identifies the key regulatory constraints: U.S. banking laws, capital-planning rules, Delaware law, and preferred-stock dividend requirements; (3) Correctly synthesizes the multi-hop information showing consistency across the three-year period; (4) Properly concludes that exposure has not materially changed, which aligns with the ground truth's assertion of 'consistently constrained' and 'stable regulatory environment'; (5) Mentions both dividend payments and share repurchases as required by the question. MINOR WEAKNESSES: (1) The LLM answer is more concise and doesn't elaborate on the 2023-specific emphasis on credit rating reductions and Title I/II resolution strategies mentioned in the ground truth; (2) Doesn't mention the 2024 expansion to include liquidity management and strategic initiatives context noted in the ground truth; (3) The phrase 'has not materially changed' is slightly different from the ground truth's 'remained consistently constrained' and 'stable regulatory environment,' though semantically equivalent. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page references (page 5) are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly identifies that the same language appears across all three years, supporting the conclusion of consistency. The multi-hop synthesis across three years of filings is sound. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of exposure to U.S. banking laws affecting capital return flexibility, though it could have provided more nuance about the subtle shifts in emphasis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 502,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Abbott Laboratories continues to list the 2.950 % Note due 2025 in its exhibit table as the “Form of 2.950 % Note due 2025” (filed as Exhibit 99.6 to the March 5 2015 Form 8‑K) and also as the “Actions of the Authorized Officers … 2.950 % Notes” (filed as Exhibit 99.3 to the same 8‑K) – shown under item 4.1 (and again under 4.11 in the later tables) each year 【page_86】. No additional or amended exhibits for this note appear, so the disclosure has remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2.950% Note due 2025 and its consistent disclosure across 2022-2024, matching the ground truth's core finding of stability. However, there are significant discrepancies in the details: (1) EXHIBIT REFERENCES: The ground truth states the note was referenced as Exhibit 99.6 in the March 5, 2015 8-K filing. The LLM answer adds an additional exhibit reference (Exhibit 99.3 for 'Actions of the Authorized Officers...2.950% Notes'), which is not mentioned in the ground truth. This introduces potentially incorrect information about a second exhibit. (2) ITEM NUMBERS: The LLM answer references 'item 4.1 (and again under 4.11 in the later tables)' which is not mentioned in the ground truth at all. This appears to be added detail that cannot be verified against the ground truth. (3) FORM DESCRIPTIONS: The LLM adds specific form descriptions ('Form of 2.950% Note due 2025' and 'Actions of the Authorized Officers...') that are not in the ground truth, making it unclear if these are accurate or fabricated. (4) CORE CONCLUSION: Both answers correctly conclude that disclosure remained essentially unchanged from 2022-2024, which is the main point. (5) MULTI-HOP SYNTHESIS: The LLM does synthesize across three years (2022, 2023, 2024) as required, but the additional details create uncertainty about accuracy. The answer is partially correct on the main finding but introduces unverified details that could be erroneous, reducing confidence in the overall response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 415,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55 % Notes Due 2028 have been carried at the same principal amount of about **$1.25 billion** each year – the balance was $1.25 billion as of Jan 28 2024 (FY 2024)【page_72】 and, because the notes are “carried on our Consolidated Balance Sheets at their original issuance value, net of un‑amortized debt discount and issuance costs”【page_67】, that amount has remained unchanged since the notes were issued in FY 2022 and through FY 2023.  While the fair‑value of the notes rose modestly from $1.099 billion in FY 2023 to $1.115 billion in FY 2024【page_67】, the unchanged carrying amount shows NVIDIA’s strategy of locking in low‑cost, long‑dated financing and keeping its long‑term debt base stable rather than aggressively repaying or expanding this tranche.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims the carrying value was 'about $1.25 billion' and 'unchanged' across FY2022-FY2024, but the ground truth shows: FY2022: $1,200M, FY2023: $1,099M, FY2024: $1,250M. These are NOT unchanged values - there was a $101M decrease from FY2022 to FY2023, then a $151M increase to FY2024. The LLM's claim of stability is factually incorrect. (2) MISREPRESENTATION OF FAIR VALUE - The LLM cites fair values of $1.099B (FY2023) and $1.115B (FY2024), but these appear to be confused with carrying values. The ground truth shows carrying values of $1,099M (FY2023) and $1,250M (FY2024). The LLM seems to have conflated fair value data with carrying value data. (3) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about evolution 'from fiscal years 2022 through 2024,' requiring synthesis of three data points. The LLM only clearly addresses FY2024 and makes unsupported claims about FY2022-FY2023 consistency. (4) INCORRECT STRATEGIC INTERPRETATION - The LLM's conclusion that the carrying amount 'remained unchanged' is contradicted by the actual progression showing fluctuation. The ground truth indicates 'fluctuation' and 'strategic management of long-term liabilities,' not stability. (5) MISSING FY2022 DATA - The LLM does not provide the FY2022 carrying value ($1,200M), which is essential for answering the 'evolution' question. The answer fundamentally mischaracterizes the debt instrument's carrying value trajectory and provides an incorrect strategic interpretation based on false premises about stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 452,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "Across all three filings AMD’s AIB strategy stayed essentially the same – the company’s contracts with add‑in‑board manufacturers “protect their inventory of our products against price reductions” and AMD notes that system integrators “often use discrete graphics solutions as a means to differentiate their products” (2022 p. 11/13; 2023 p. 11; 2024 p. 11/13). The wording of the inventory‑protection clause and the emphasis on discrete graphics for market differentiation did not change from 2022 through 2024, indicating a consistent approach to AIB partners.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth explicitly states that AMD's strategy EVOLVED from 2022 through 2024, with key differences: (1) In 2022-2023, inventory protection was the primary focus; (2) By 2024, AMD placed GREATER EMPHASIS on discrete graphics solutions for differentiation. The LLM answer incorrectly claims the strategy 'stayed essentially the same' and that 'the wording...did not change from 2022 through 2024,' which directly contradicts the ground truth's assertion of evolution and changing emphasis. The ground truth specifically notes: 'By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions' and 'This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures.' The LLM failed to capture this temporal evolution and shift in strategic emphasis. While the LLM correctly identifies the inventory protection language and discrete graphics references, it fundamentally mischaracterizes the nature of the relationship as static rather than evolving. The page citations appear reasonable but the interpretation of what those pages convey is incorrect. The answer demonstrates poor multi-hop reasoning by failing to synthesize the temporal dimension across the three years and identify the strategic shift in emphasis that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 395,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD first flagged “difficulties in protecting our intellectual property” as a general political‑legal‑economic risk in its 2022 filing, noting that 72 % of net revenue came from international sales and that nearly all assembly and final testing were done at third‑party facilities in China, Malaysia and Taiwan (2022 Risk Disclosures, pp. 36‑37). In the 2023 filing the same risk remained but the narrative added that international sales were 65 % of revenue and that geopolitical tensions—especially between China and Taiwan—could disrupt its Taiwan‑based wafer foundries and thus heighten IP‑protection challenges (2023 Risk Disclosures, p. 41). By 2024 the exposure had grown further: international sales rose to 66 % of revenue, AMD’s reliance on third‑party wafer foundries and assembly in China, Malaysia and Taiwan persisted, and the filing explicitly linked IP‑protection difficulties to ongoing China‑Taiwan, Russia‑Ukraine and Israel‑Hamas conflicts, underscoring a heightened risk as its global footprint and third‑party manufacturing in politically sensitive regions expanded (2024 Risk Disclosures, pp. 40‑42).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '72% of net revenue came from international sales' in 2022, but the ground truth indicates this figure was 'unspecified but lower' in 2022. The LLM provides a specific number (72%) that contradicts the ground truth's explicit statement that 2022's international sales percentage was not specified. This is a major factual error. The 2023 figure of 65% and 2024 figure of 66% are correct. (2) MULTI-HOP REASONING - While the LLM correctly identifies the evolution of IP protection risks across 2022-2024 and links them to geopolitical tensions (China-Taiwan, Russia-Ukraine, Israel-Hamas), it introduces an unsupported claim about 72% international sales in 2022 that appears fabricated. (3) ENTITY/METRIC ACCURACY - The LLM correctly identifies AMD, the three-year period (2022-2024), and the geographic regions (China, Malaysia, Taiwan, Russia, Ukraine, Middle East). However, the specific percentage for 2022 is incorrect. (4) COMPLETENESS - The LLM addresses the core question about IP protection evolution and links it to international operations and third-party manufacturing in sensitive regions, which is appropriate. However, the factual error regarding 2022 international sales percentage significantly undermines credibility. (5) SEMANTIC EQUIVALENCE - The narrative structure and logical flow match the ground truth's description of evolving risk, but the introduction of an unverified 72% figure for 2022 is a material factual error that cannot be overlooked, even if the overall narrative arc is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1648,
        "completion_tokens": 436,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "From 2022 through 2024 BNY Mellon repeatedly issued new versions of the equity awards that sit under its 2019 Long‑Term Incentive Plan – a 2022 Form of Performance Share Unit and Restricted Stock Unit agreement in 2022 (exhibits 10.21‑10.22)【page_19】, updated 2023 PSU and RSU agreements in 2023 (exhibits 10.26‑10.27)【page_19】, and fresh 2024 PSU (exhibit 10.28) and RSU (exhibit 10.25) agreements in 2024【page_19】【page_20】. This annual refresh of the plan’s award documents signals a deliberate strategy to keep the LTIP’s equity‑based compensation tools current, fine‑tune performance criteria and vesting, and reinforce executive alignment and retention.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) ENTITY MISMATCH: The LLM answer identifies the company as 'BNY Mellon' when the question asks about 'BK' (Bank of New York Mellon's ticker). While BNY Mellon is the full name, the question specifically uses 'BK' and the ground truth answer uses 'BK' consistently. This is a significant entity identification error. (2) FACTUAL INACCURACY ON FORMS: The ground truth specifies the 2021 Form of PSU Agreement in 2022, the 2020 Form of PSU Agreement in 2023, and the 2022 Form of PSU Agreement in 2024. The LLM answer claims 2022 Form PSU/RSU in 2022, 2023 PSU/RSU in 2023, and 2024 PSU/RSU in 2024. This is a fundamental misalignment with the ground truth progression. The LLM appears to be confusing the year the form was created with the year it was introduced/referenced. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'layered approach' with 'legacy structures' being maintained while new forms are introduced. The LLM answer suggests annual complete refreshes rather than the layered/cumulative approach described in the ground truth. (4) MISSING CONTEXT: The ground truth explicitly mentions that 2023 introduced the '2020 Form' (not 2023 form), which is a key detail showing the company was updating older forms. The LLM misses this important nuance about which form versions were actually being introduced in each year. (5) REASONING QUALITY: While the LLM's conclusion about 'deliberate strategy' and 'keeping tools current' is reasonable, it's based on incorrect premises about which forms were introduced when. The multi-hop reasoning fails because the foundational facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 444,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s capital outlay for the diagnostic‑instrument leasing business rose only modestly.  The original cost of the leased assets was about $3.5 billion (with a net book value of roughly $1.6 billion) in the most recent pre‑2023 reporting period 【page_62】, and grew to $3.9 billion (net book value $1.8 billion) by year‑end 2023 and remained at that level at year‑end 2024 【page_64】.  The small increase and subsequent plateau suggest Abbott is expanding its diagnostics‑leasing platform in a measured, capital‑efficient way rather than making large new investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth across all three years. (1) 2022 DATA: Ground truth shows original cost of $3.3B and net book value of $1.4B in 2022. LLM states ~$3.5B original cost and ~$1.6B net book value for 'pre-2023 reporting period,' which is incorrect for 2022. (2) 2023 DATA: Ground truth shows $3.6B original cost and $1.6B net book value in 2023. LLM claims $3.9B original cost and $1.8B net book value for 2023, which are both wrong. (3) 2024 DATA: Ground truth shows $3.9B original cost and $1.6B net book value in 2024. LLM states $3.9B original cost (correct) but $1.8B net book value (incorrect). The LLM has systematically overstated the net book values for 2023 and 2024 ($1.8B vs. actual $1.6B). (4) TREND ANALYSIS: The LLM's characterization of the trend is fundamentally flawed. Ground truth shows steady growth from 2022-2023 followed by stabilization in 2024 for net book value, with continued growth in original cost through 2024. The LLM incorrectly suggests the assets 'remained at that level' in 2024, when original cost actually increased from $3.6B to $3.9B. (5) STRATEGIC INTERPRETATION: While the LLM's conclusion about 'measured, capital-efficient' expansion is reasonable, it's based on incorrect numbers and misses the key insight that original cost continued growing in 2024 while net book value plateaued, suggesting accelerating depreciation. (6) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the three-year trend and misidentifies which year corresponds to which data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 441,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "- In the FY 2022 filing, NVIDIA listed Lumentum Holdings as one of the “suppliers of interconnect, switch and cable solutions … such as … Lumentum Holdings” competing in its networking‑interconnect market (see page 15).  \n- In both the FY 2023 and FY 2024 10‑Ks, Lumentum appears again in the “networking products … switches, network adapters (including DPUs), and cable solutions (including optical modules) … Lumentum Holdings” list (see page 9 for each year).  \n\nAcross the three years Lumentum’s position has remained steady as a listed rival in the interconnect/optical‑module space, but NVIDIA’s disclosures have increasingly framed that segment as part of its expanding AI‑driven networking and high‑performance interconnect strategy, highlighting Lumentum as a key competitor in the AI‑focused networking ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Lumentum Holdings as appearing in NVIDIA's competitor disclosures across FY 2022, 2023, and 2024. It accurately notes the specific product categories (interconnect, switch, cable solutions, optical modules, network adapters, DPUs) and correctly cites page references (page 15 for FY 2022, page 9 for FY 2023 and 2024). The answer appropriately recognizes that Lumentum's position remained consistent across the three years while NVIDIA's framing evolved toward AI-driven networking.\n\nWEAKNESSES: The LLM answer significantly undersells the evolution narrative that is central to the ground truth. The ground truth emphasizes a clear PROGRESSION: (1) FY 2022 - foundational presence grouped with peers like Juniper Networks and Applied Optoelectronics; (2) FY 2023 - repositioning into a more specialized segment focused on high-performance interconnect (InfiniBand, Ethernet, proprietary tech) aligned with AI/accelerated computing; (3) FY 2024 - sharpened corporate identity recognition ('Lumentum Holdings Inc.' designation) reflecting rising prominence. The LLM characterizes this as 'steady' positioning rather than capturing the nuanced evolution in how NVIDIA positioned Lumentum within its strategic narrative. The LLM states 'Lumentum's position has remained steady' which contradicts the ground truth's emphasis on 'rising prominence' and 'progression.' The LLM also fails to mention the specific grouping with Juniper Networks and Applied Optoelectronics in FY 2022, or the specific technologies (InfiniBand, Ethernet, proprietary) emphasized in FY 2023, which are key details distinguishing the competitive positioning evolution.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and connects Lumentum's listing to NVIDIA's expanding AI-networking strategy. However, it misses the deeper multi-hop insight: the evolution from generic networking supplier → specialized AI-interconnect competitor → strategically recognized player in NVIDIA's data center ecosystem.\n\nFACTUAL ACCURACY: Page citations and product categories are accurate. No calculation errors. Entity names correct.\n\nSEMANTIC MISMATCH: The core issue is semantic - the LLM's 'steady position' framing contradicts the ground truth's 'rising prominence' and 'progression' narrative, which is the central thesis of the question about how positioning 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 645,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In Emerson’s 2022 filing, pipe cutters were described under the **Professional Tools** sub‑category of the **Tools & Home Products** segment【page_9】. By the 2024 filing, they are listed in the **Safety & Productivity** segment, which now houses all pipe‑working tools, including pipe cutters【page_73】. This re‑classification moves pipe cutters out of the broader consumer‑oriented Tools & Home Products line into a dedicated safety‑and‑productivity segment, signaling a strategic focus on professional‑tool growth and positioning these tools as core safety‑productivity solutions for industrial customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core repositioning of pipe cutters from Tools & Home Products (2022) to Safety & Productivity segment (2024), which matches the ground truth. The basic timeline and segment names are accurate. The LLM appropriately notes this represents a shift toward professional-tool focus.\n\nWEAKNESSES: (1) INCOMPLETE CONTEXT: The LLM fails to mention the InSinkErator divestiture in late 2022, which is a critical piece of context explaining WHY this strategic shift occurred. The ground truth explicitly identifies this as signaling a shift away from consumer-focused home products. (2) MISSING PRODUCT GROUPING DETAILS: The ground truth specifies that pipe cutters were repositioned alongside battery hydraulic tools, drain cleaners, and diagnostic systems (sewer inspection cameras). The LLM vaguely states 'all pipe-working tools' without detailing these specific companion products, which is important for understanding the strategic repositioning. (3) INCOMPLETE STRATEGIC NARRATIVE: The ground truth emphasizes the shift toward 'high-value, industrial-use tools' and 'infrastructure support,' which the LLM only partially captures with 'industrial customers.' The ground truth's emphasis on 'safety, productivity, and infrastructure support' is more comprehensive. (4) CITATION ACCURACY: While the LLM provides page references, these cannot be verified against the actual ground truth source, and the specificity of page numbers may be hallucinated. (5) REASONING DEPTH: The LLM's explanation of what the shift 'reveals' about Emerson's professional tool strategy is surface-level compared to the ground truth's more nuanced analysis of portfolio realignment and business model evolution.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are present in either answer, so quantitative accuracy is based on correct identification of years (2022, 2024) and segment names, which are correct.\n\nMULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across two time periods and identifies the segment transition, but fails to connect this to the broader business context (InSinkErator divestiture) that explains the strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 590,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "In 2022 Schwab’s Advisor Services website became the core online hub for RIAs, letting them open accounts, move money, trade, view multi‑year statements and tax reports, and link to third‑party CRM/portfolio systems, and it debuted Schwab Advisor Portfolio Connect – a free, web‑based portfolio‑management tool that delivers core capabilities through an intuitive modern experience without any data‑download or reconciliation 【page_7】. In 2023, after integrating TD Ameritrade, Schwab layered Ameritrade’s thinkpipes real‑time charting and trading platform and the iRebal customizable rebalancing solution (and later Schwab Trading Powered by Ameritrade) into the RIA workflow, expanding the website’s interactive functionality and trading/rebalancing depth 【page_8】【page_6】. By 2024 the website remained the primary RIA platform, continuing to offer the free Advisor Portfolio Connect experience and integrated third‑party tools while adding broader consulting, education and event‑based support for advisors, reflecting a fully integrated digital suite for RIA practice management 【page_7】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2024. STRENGTHS: (1) Correctly identifies all key tools: Advisor Services website, Schwab Advisor Portfolio Connect, thinkpipes, iRebal, and Schwab Trading Powered by Ameritrade. (2) Accurately captures the 2022 baseline with account servicing, third-party integrations, and free Portfolio Connect tool. (3) Properly contextualizes 2023 as the post-TD Ameritrade integration period, correctly naming specific acquired tools (thinkpipes, iRebal). (4) Accurately describes 2024 evolution with expanded consulting, education, and event-based support. (5) No quantitative errors - all dates and tool names are correct. (6) Multi-hop reasoning is sound: synthesizes information across three years showing progression from core platform → integration of acquired tools → expanded support ecosystem. MINOR WEAKNESSES: (1) The LLM answer emphasizes the TD Ameritrade integration narrative more heavily than the ground truth, which frames the evolution more broadly around 'enhanced functionality, deeper third-party integrations, and expanded advisor support.' While not incorrect, this shifts emphasis slightly. (2) The ground truth mentions 'multi-year document archiving' and 'outbound data feeds for compliance systems' as 2024 additions, which the LLM answer does not explicitly include - instead using the more general term 'consulting, education and event-based support.' This represents a minor omission of specific compliance/operational features. (3) The LLM answer doesn't explicitly mention the compliance workflow integration aspect that the ground truth emphasizes. SEMANTIC EQUIVALENCE: The LLM's description of 'fully integrated digital suite for RIA practice management' is semantically equivalent to the ground truth's 'broader ecosystem...enabling RIAs to manage both investment and compliance workflows seamlessly,' though the compliance aspect is less explicit. Overall, the answer correctly addresses the evolution question with accurate facts, proper multi-hop synthesis, and appropriate contextual framing, with only minor omissions of specific compliance features.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 587,
        "total_tokens": 2190
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first disclosed the 1.650 % senior unsecured notes due 2026 as a newly‑issued series in its 2022 Form 10‑K (see Exhibit 4.16, “Forms of 1.650 % Notes due 2026…issued March 24 2021”)【page_114】. In both the 2023 and 2024 Form 10‑K filings the same series is listed under Exhibit 4.14 with identical terms (still described as 1.650 % notes due 2026)【page_111】【page_111】, showing that Oracle has kept the notes on its balance sheet and reported the current portion as required without re‑issuing or restructuring them. This consistent treatment indicates a deliberate strategy to rely on a low‑coupon, medium‑term debt instrument for short‑to‑intermediate financing, locking in inexpensive funding rather than frequently refinancing or altering its debt mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Oracle's treatment of the 1.650% Notes due 2026 across three years and provides reasonable strategic interpretation. However, there is a critical factual error that significantly undermines accuracy: The LLM states the notes were 'issued March 24 2021' in the 2022 10-K exhibit description, but the ground truth indicates these notes were 'first introduced' in the 2022 10-K filing itself, suggesting issuance in 2022, not 2021. This is a material discrepancy regarding the timing of the debt instrument's creation. The LLM correctly identifies: (1) the 1.650% coupon rate, (2) the 2026 maturity date, (3) the exhibit locations (4.16 in 2022, 4.14 in 2023 and 2024), (4) the consistent treatment across all three years, and (5) the strategic implication of stable, low-coupon medium-term financing. The multi-hop synthesis is sound—the answer correctly traces the note through three years of filings and draws appropriate conclusions about Oracle's capital structure strategy. The qualitative reasoning about 'locking in inexpensive funding' and avoiding frequent refinancing is logical and well-supported. However, the date discrepancy (2021 vs. 2022 issuance) is a quantitative accuracy problem that cannot be overlooked in financial analysis. The answer also adds interpretive detail about 'current portion as required' and 'balance sheet treatment' that goes slightly beyond the ground truth but is contextually reasonable. The semantic equivalence is generally strong, though the factual error about issuance timing reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 438,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "In the 2022 filing, Emerson grouped electrical‑distribution gear under the broader **Industrial Solutions** product family of the Automation Solutions segment (“Industrial Solutions provides … electrical distribution equipment” – page 76). By the 2024 filing, the company lists **electrical distribution equipment as a core component of the Discrete Automation segment** (“The Discrete Automation segment includes … electrical distribution equipment” – page 73). This move from a peripheral, cross‑segment category to a highlighted line within Discrete Automation shows Emerson is elevating electrical‑distribution products and signaling a stronger strategic emphasis on industrial electrification solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution: Electrical Distribution Equipment moved from Industrial Solutions (2022) to Discrete Automation segment (2024). (2) The company name (Emerson/EMR) and time period (2022-2024) are accurate. (3) The conclusion about strategic emphasis on industrial electrification is sound and matches the ground truth's interpretation. (4) The page references (76, 73) add credibility and specificity. WEAKNESSES: (1) CRITICAL OMISSION: The LLM completely skips the 2023 data point, which is explicitly mentioned in the ground truth as a key transitional year where the positioning was 'explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems.' This is a significant gap in the multi-hop synthesis across the three-year period. (2) The LLM describes the 2022 positioning as 'peripheral, cross-segment category' but the ground truth indicates it was part of 'Industrial Solutions' within the Automation Solutions segment - the characterization as 'peripheral' is somewhat interpretive and not directly supported. (3) The LLM misses the detail about the 2023-2024 consistency ('description remained consistent with 2023, reinforcing a strategic shift'), which would have strengthened the narrative about sustained strategic emphasis. (4) The LLM doesn't mention the integration with 'solenoid valves and programmable control systems' that occurred in 2023, which provides important context about the nature of the automation infrastructure positioning. MULTI-HOP REASONING: The answer demonstrates partial multi-hop synthesis by connecting 2022 and 2024 data, but fails to complete the full three-year analysis by omitting 2023. This is a material gap for a question explicitly asking about evolution 'from 2022 to 2024.' The reasoning about strategic shift is sound but incomplete without the middle year's data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 520,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private‑fund investments (which include private‑real‑estate funds) fell each year – $569 million at year‑end 2022, $555 million at year‑end 2023, and $540 million at year‑end 2024【page_71】【page_70】.  The steady decline signals that the company is actively reducing its outstanding obligations to illiquid alternative assets, suggesting a more cautious, liquidity‑aware stance in its pension‑plan investment strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM reports 2022 unfunded commitments as $569 million, but the ground truth states $585 million. This is a $16 million discrepancy (2.7% error) on a key data point. The 2023 ($555M) and 2024 ($540M) figures are correct. PARTIAL COMPLETENESS: The LLM answer correctly identifies the declining trend and provides appropriate interpretation about de-risking and liquidity-aware strategy. However, it omits several important contextual details from the ground truth: (1) no mention of the long time horizon for fund liquidation (projected through 2034), (2) no discussion of the company's continued belief in long-term value despite reduced exposure, and (3) no characterization of the decline as 'measured' or 'deliberate.' REASONING QUALITY: The LLM's interpretation of the trend (actively reducing obligations, more cautious stance) is sound and semantically equivalent to the ground truth's 'de-risking or rebalancing' characterization. The logic connecting declining commitments to liquidity-aware strategy is valid. ENTITY ACCURACY: Correctly identifies Abbott Laboratories, private real estate funds, pension fund strategy, and illiquid alternative assets. SYNTHESIS: The multi-hop reasoning is adequate but incomplete - the LLM synthesizes the three-year trend correctly but fails to integrate the full strategic picture including the long liquidation timeline. The quantitative error on the 2022 figure is a significant flaw that prevents a higher score, as financial accuracy is critical in this domain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 426,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle listed its 1.650% Notes due 2026 as Exhibit 4.16 in the 2022 10‑K (referencing the March 24 2021 officers’ certificate) and as Exhibit 4.14 in both the 2023 and 2024 10‑Ks (with the same certificate reference)【page_114】【page_111】. The unchanged inclusion—despite a shift in exhibit numbering—shows Oracle continues to keep these low‑interest, near‑term notes on its balance sheet, reflecting a steady short‑term debt strategy that relies on inexpensive, stable financing rather than refinancing or retiring the issue.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 1.650% Notes due 2026 and accurately references the March 24, 2021 date. It also correctly notes the exhibit number shifts (4.16 in 2022, 4.14 in 2023 and 2024). However, there are significant gaps in addressing the core question about how the treatment 'evolved' across the three filings. The LLM answer focuses on exhibit numbering changes and characterizes the strategy as 'steady' and 'unchanged,' but this is somewhat contradicted by the exhibit number shift itself, which the answer acknowledges but doesn't fully explain. The ground truth emphasizes consistent referencing of the original March 2021 8-K across all three years as evidence of deliberate stability, whereas the LLM answer shifts focus to exhibit numbering and balance sheet treatment. The LLM answer also makes an interpretive claim about 'low-interest' financing and 'inexpensive, stable financing' that isn't directly supported by the ground truth, which focuses on the structural continuity rather than comparative interest rate analysis. The answer is partially correct on facts but incomplete in addressing the multi-hop synthesis of how the treatment evolved (or didn't evolve) across the three years. The reasoning about short-term debt strategy is present but less rigorous than the ground truth's emphasis on unchanged structure and consistent 8-K referencing as the key evidence of deliberate strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 395,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle’s 4.30% Note due 2034 was originally issued in 2014, and the 2022 10‑K exhibit index (page 113) incorporates the 8‑K filing that includes the note and the officers’ certificate dated July 8 2014. The same “Forms of 3.40% Note due 2024, 4.30% Note due 2034 and 4.50% Note due 2044” entry reappears unchanged in the 2023 10‑K (page 110) and again in the 2024 10‑K (page 110). This repeated multi‑year incorporation shows Oracle is retaining the long‑dated, fixed‑rate note on its balance sheet and using annual 10‑K filings to keep the original issuance documentation current, reflecting a strategy of issuing and holding long‑term debt to fund its operations and growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-year filing pattern and correctly identifies key facts: (1) The 4.30% Note due 2034 appears consistently across 2022, 2023, and 2024 filings; (2) The note was originally issued in 2014 with documentation dated July 8, 2014; (3) The exhibit entries remain unchanged across the three-year period; (4) The note is grouped with other long-term instruments (3.40% due 2024, 4.50% due 2044). STRENGTHS: The LLM provides specific page references (113 for 2022, 110 for 2023 and 2024), correctly identifies the original issuance year (2014), and accurately describes the consistent documentation pattern. The reasoning about Oracle retaining the long-dated fixed-rate note and using annual 10-K filings to keep documentation current is sound and relevant. WEAKNESSES: (1) The LLM references specific exhibit numbers (8-K filing, officers' certificate) that are not verified in the ground truth, which only mentions Exhibit 4.11 for 2022 and Exhibit 4.09 for 2023-2024. This discrepancy in exhibit numbering is a minor factual concern. (2) The LLM's interpretation about 'issuing and holding long-term debt to fund operations and growth' goes slightly beyond what the ground truth states about 'maintaining this liability as a stable component.' (3) The ground truth emphasizes 'no structural changes' and 'sustained presence,' while the LLM emphasizes 'retaining on balance sheet' and 'keeping documentation current'—semantically similar but with slightly different emphasis. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three years (2022, 2023, 2024) and identifies the pattern of consistent documentation. The connection between repeated filing and long-term debt strategy is logically sound. NUMERIC ACCURACY: All dates and percentages mentioned (4.30%, 2034, 2014, July 8) are correct. Page numbers provided (113, 110, 110) cannot be independently verified but appear reasonable. Overall, the answer is substantially correct with minor exhibit reference discrepancies that don't fundamentally undermine the core analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 564,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "In 2022 Schwab exercised the 2019 IDA agreement’s option to migrate roughly $10 billion of IDA balances to its balance sheet each year (it moved $10.1 bn in 2021 and about $10 bn in 2022). After the May 2023 execution of the new 2023 IDA agreement, Schwab stopped moving balances in both 2023 and 2024—instead it used the agreement’s buy‑down right to purchase $5 bn of fixed‑rate obligations in 2023—and the contract shifted: it gave Schwab sole discretion to designate fixed‑ versus floating‑rate amounts (eliminating the prior 80 % fixed‑rate requirement) but imposed tighter withdrawal limits (generally only customer‑initiated withdrawals until Sept 10 2025) and new minimum/maximum balance caps (e.g., a $60 bn floor and $90 bn ceiling after 2025).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate information. CORRECT ELEMENTS: (1) The 2019 IDA agreement allowed ~$10 billion annual migration; (2) $10.1 billion was moved by end of 2021; (3) The 2023 IDA agreement eliminated the 80% fixed-rate requirement; (4) No balances were migrated in 2023 and 2024; (5) The shift from active migration to passive approach is correctly identified. PROBLEMATIC ELEMENTS: (1) The claim that Schwab moved 'about $10 bn in 2022' is not supported by the ground truth, which only mentions $10.1 billion by December 31, 2021 and $10 billion 'subsequent to that date' - the LLM conflates timing and creates ambiguity about 2022 migration; (2) The mention of a '$5 bn buy-down right' purchase in 2023 is not mentioned in the ground truth and appears to be an unsupported addition; (3) The specific withdrawal restrictions ('generally only customer-initiated withdrawals until Sept 10 2025') and balance caps ('$60 bn floor and $90 bn ceiling after 2025') are detailed claims not present in the ground truth, suggesting potential hallucination or over-specification; (4) The characterization of 'tighter withdrawal limits' is not explicitly confirmed in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years and identifies the contractual shift, but introduces details not in the source material. QUANTITATIVE ACCURACY: The $10.1 billion and $10 billion figures are correct, but the 2022 migration claim and the $5 billion buy-down are problematic. The specific balance caps and dates appear fabricated. OVERALL: The answer captures the main narrative arc correctly but adds unsupported specifics that reduce reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 465,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Abbott continued to list the 2.000 % Senior Notes due 2018 with the same exhibit references – the “Actions of the Authorized Officers” filing (Exhibit 99.3 to a March 5 2015 Form 8‑K) and the “Officers’ Certificate” (Exhibit 4.7 to the Q1 2017 Form 10‑Q) – and no new refinancing or updated documentation for those notes was disclosed in any of the three years【page_86】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially diverge from the ground truth. Key issues: (1) INCORRECT EXHIBIT REFERENCES: The LLM claims the notes are referenced in 'Exhibit 99.3 to a March 5 2015 Form 8-K' and 'Exhibit 4.7 to the Q1 2017 Form 10-Q', but the ground truth specifically identifies 'Exhibit 4.21' as the relevant exhibit across all three years (2022, 2023, 2024). These exhibit numbers are factually wrong. (2) MISSING INDENTURE DOCUMENTATION: The ground truth explicitly mentions the 'Fifth Supplemental Indenture dated September 23, 2015' as the key documentation referenced in 2022, which the LLM completely omits. (3) INCOMPLETE TEMPORAL ANALYSIS: While the LLM correctly notes no new refinancing occurred across the three years, it fails to capture the ground truth's important insight about the notes 'nearing maturity' and the 'gradually maturing' nature of this debt component. (4) LACK OF CONTEXT: The LLM provides no context about these being 'legacy St. Jude Medical debt,' which is important for understanding the historical nature of these obligations. (5) CITATION ERROR: The LLM includes a page reference ['page_86'] that appears to be fabricated or incorrectly sourced. The answer demonstrates poor multi-hop synthesis - it fails to correctly identify and track the specific exhibit references across the three-year period and misses the documentation continuity narrative that is central to the ground truth answer. The core claim about 'no new refinancing' is correct, but the supporting details about how this engagement evolved through specific documentation are substantially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 456,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first disclosed its 3.650 % Notes due 2041 in the 2022 10‑K (exhibit 4.16), referencing a March 24 2021 issuance【ORCL_10k_2022.pdf page_114】; the same notes reappear in the 2023 10‑K (exhibit 4.14)【ORCL_10k_2023.pdf page_111】and again in the 2024 10‑K (exhibit 4.14)【ORCL_10k_2024.pdf page_111】. This repeated inclusion over three years shows Oracle is maintaining a stable, long‑dated, modest‑coupon debt portfolio, locking in favorable rates to support a low‑cost, long‑term capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 3.650% Notes due 2041 and its consistent presence across 2022-2024 10-K filings. STRENGTHS: (1) Correctly identifies the note percentage (3.650%), maturity year (2041), and original issuance date (March 24, 2021); (2) Accurately cites exhibit numbers (4.16 for 2022, 4.14 for 2023 and 2024) and page numbers; (3) Properly synthesizes multi-hop information across three years of filings; (4) Provides specific document references with citations; (5) Correctly interprets the pattern as indicating a stable, long-term financing strategy. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'locking in favorable rates' and 'low-cost capital structure' that goes slightly beyond what the ground truth explicitly states, though this is reasonable inference from the data; (2) The ground truth uses more general language ('strategic use of long-term debt') while the LLM is more specific about rate-locking strategy; (3) Both answers reach the same core conclusion about stable long-term financing approach. QUANTITATIVE VERIFICATION: The 3.650% figure, 2041 maturity date, March 24, 2021 issuance date, and exhibit/page citations all appear accurate based on typical Oracle 10-K structure. The multi-hop synthesis correctly traces the note through three consecutive years. The reasoning about maintaining a stable debt portfolio is sound and well-supported by the evidence of consistent inclusion across filings. No calculation errors detected. The answer fully addresses the question's multi-part structure regarding introduction, continuation, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 458,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle first disclosed the 2.300 % notes due 2028 as a new tranche issued in March 2021 – part of a multi‑tranche series that also included 1.650 % notes due 2026 and other longer‑dated issues (Exhibit 4.16)【page_114】. The same 2.300 % notes due 2028 appear again in the exhibit schedules of both the FY 2023 and FY 2024 10‑Ks (Exhibit 4.14)【page_111】, indicating they remain outstanding and have not been refinanced. This recurring presence shows Oracle’s strategy of locking in low‑coupon, long‑dated debt and maintaining a staggered maturity profile through successive, structured issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2.300% Notes due 2028 are correctly identified with the right coupon rate and maturity year; (2) The March 2021 issuance date is accurate; (3) The observation that these notes appear in multiple fiscal years (2023, 2024) is correct; (4) The characterization of Oracle's strategy as maintaining low-coupon, long-dated debt with staggered maturity is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM mentions 1.650% notes due 2026 as part of the same tranche, but the ground truth does not reference these notes in connection with the 2.300% Notes due 2028 analysis; (2) The LLM cites Exhibit 4.14 for FY 2023 and FY 2024, while the ground truth references Exhibit 4.16 - this is a discrepancy in exhibit identification that could indicate citation errors; (3) The ground truth specifically mentions that in 2023 Oracle issued 4.500% Notes due 2028, indicating diversification of interest rate profiles, but the LLM answer does not acknowledge this additional issuance or the diversification strategy; (4) The LLM answer lacks the multi-year comparative analysis that the ground truth provides - it doesn't explicitly discuss how the portfolio evolved from 2022 to 2023 to 2024 with new issuances. MULTI-HOP REASONING: The LLM correctly synthesizes that the notes appear across multiple years and infers a strategy, but it fails to capture the full evolution of Oracle's debt portfolio across the three fiscal years, particularly the 2023 expansion with the 4.500% Notes. The answer is partially correct but incomplete in addressing the 'evolution' aspect of the question. The reasoning about maintaining a staggered maturity profile is sound but doesn't fully explain the diversification strategy evident in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 491,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In the 2022 filing Visa said its newly‑launched, digitally‑native Currencycloud platform – offered through Visa Treasury as a Service – already provided “real‑time foreign‑exchange rates, virtual accounts, and enhanced liquidity and settlement capabilities”【page_11】. By the 2024 filing those same Currencycloud virtual‑account capabilities had been folded into the Visa Direct Platform, now part of Visa Cross‑Border Solutions, expanding the service’s cross‑border reach and allowing virtual‑account‑enabled FX, liquidity and settlement to be used for money‑movement across a broader set of countries and endpoints【page_10】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Visa's virtual accounts across the 2022-2024 period and correctly identifies key developments. Strengths: (1) Accurately captures the 2022 introduction of virtual accounts through Currencycloud as part of Treasury as a Service, (2) Correctly identifies the integration into Visa Direct Platform by 2024, (3) Properly notes the expansion of cross-border capabilities and the broader endpoint network, (4) Appropriately cites specific filing pages. Weaknesses: (1) The answer lacks explicit mention of 2023 as a transition year where virtual accounts were 'fully integrated' into Visa Direct Platform - the ground truth specifies this occurred by 2023, but the LLM answer jumps from 2022 to 2024, potentially missing the intermediate step, (2) Does not mention the specific '11 billion endpoints' figure that appears in the ground truth for 2024, (3) The phrasing 'folded into' is slightly less precise than 'fully integrated' - though semantically similar, it's less definitive about the completeness of integration. The multi-hop reasoning is sound: the answer correctly synthesizes information about how virtual accounts evolved from a standalone Currencycloud feature to an integrated component of Visa Direct Platform. The entity identification is accurate (Visa, Currencycloud, Visa Direct Platform, Visa Cross-Border Solutions, Treasury as a Service). The answer appropriately addresses the core question about evolution and integration, though it could have been more complete by explicitly addressing the 2023 milestone and the specific endpoint network scale mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 455,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "Caterpillar’s ME&T segment reported that the dealer network used to sell its EMD‑branded reciprocating engines was 44 U.S. dealers and 116 overseas dealers serving 193 countries in 2022 【page_76】.  In 2023 the network was trimmed to 41 U.S. dealers and 111 overseas dealers covering 187 countries 【page_66】, and by 2024 it was adjusted to 43 U.S. dealers and 111 overseas dealers reaching 191 countries 【page_65】.  This modest consolidation of dealer count combined with a rebound in country coverage shows Caterpillar is streamlining its distribution footprint while still expanding geographic reach, signaling a focused strategy to grow the EMD brand’s global market presence.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and provides completely different data than the ground truth. Critical issues: (1) WRONG PRODUCT FOCUS: The LLM discusses EMD-branded reciprocating engines and their dealer network (44 U.S. + 116 overseas = 160 total dealers in 2022), while the ground truth specifically addresses FG Wilson branded electric power generation systems distributed through 110 distributors. These are different product lines with different distribution channels. (2) WRONG NUMBERS: The LLM reports 193 countries in 2022, 187 in 2023, and 191 in 2024 for the reciprocating engine dealer network. The ground truth reports 109 countries in 2022-2023 and 158 countries in 2024 for FG Wilson products - completely different figures. (3) WRONG DISTRIBUTOR COUNTS: The LLM reports 160 total dealers (44+116) in 2022, 152 (41+111) in 2023, and 154 (43+111) in 2024. The ground truth reports 110 distributors in 2022-2023 and 108 in 2024. (4) MISIDENTIFIED PRODUCT: The question asks about 'EMD-branded products' which the ground truth clarifies refers to FG Wilson branded electric power generation systems, not reciprocating engines. The LLM appears to have confused or conflated different EMD product lines. (5) FLAWED SYNTHESIS: While the LLM's reasoning about distribution optimization is logically sound, it is applied to the wrong product category and with incorrect data. The ground truth shows a different pattern: stable distributor counts (110→110→108) with expanding geographic reach (109→109→158 countries), indicating efficiency optimization with geographic expansion. The LLM's narrative of 'modest consolidation' with 'rebound in country coverage' does not match the actual data progression in either dataset.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 473,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly: the original cost rose from about $3.6 billion at 12/31/2022 to $3.9 billion at 12/31/2024 (≈ $300 million increase) and the net book value climbed from roughly $1.6 billion to $1.8 billion over the same period (≈ $200 million increase)【page_64】【page_63】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. Ground truth shows: Original cost 2022=$3.3B, 2023=$3.6B, 2024=$3.9B; Net book value 2022=$1.4B, 2023=$1.6B, 2024=$1.8B. The LLM answer states original cost at 12/31/2022 was '$3.6 billion' when it should be $3.3 billion - this is a $300M error on the starting point. The LLM correctly identifies the 2024 figure ($3.9B original cost, $1.8B net book value) but misses the 2023 intermediate year entirely, which is a significant omission for a question specifically asking about evolution 'from 2022 to 2024.' The LLM's calculation of the increase ($300M for original cost, $200M for net book value) happens to be correct for the 2022-2024 period, but this is coincidental given the wrong starting numbers. COMPLETENESS ISSUE: The question asks about evolution across three years (2022, 2023, 2024), but the LLM only provides 2022 and 2024 data, omitting the 2023 intermediate year which is essential to showing the 'evolution' and 'consistent increase' pattern. REASONING: The multi-hop synthesis is incomplete - the LLM failed to extract all three years of data from the balance sheet. The characterization of growth as 'modest' is reasonable but based on incomplete data. The semantic understanding of the question is partially correct but execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 383,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450 % Senior Note due 2046 is listed in the exhibits of PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings (e.g., “Form of 3.450 % Senior Note due 2046” appears on page 126 of the 2022 filing, page 127 of the 2023 filing, and page 126 of the 2024 filing)【page_126】【page_127】【page_126】. Its repeated disclosure shows that the note remains outstanding and is a core component of PepsiCo’s long‑dated senior debt program, indicating that the company continues to rely on this instrument as a stable source of financing for its long‑term capital‑structure strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 3.450% Senior Note due 2046 and its consistent disclosure across PepsiCo's 2022, 2023, and 2024 10-K filings. The core factual claims are accurate: (1) the note percentage (3.450%) is correct, (2) the maturity year (2046) is correct, (3) the three-year period is correct, and (4) the general conclusion about its role as a stable component of long-term capital structure is sound. The LLM provides specific page references (126, 127, 126) which adds credibility, though these cannot be independently verified against the ground truth. The reasoning about the note being a 'core component' and 'stable source of financing' aligns with the ground truth's characterization of it as 'stable and integral' and 'strategically maintained.' However, the LLM answer has some minor weaknesses: (1) it does not mention the specific exhibit numbers (4.17, 4.16, 4.15) that the ground truth identifies, which would have strengthened the answer by showing precise tracking across filings; (2) the LLM's reference to 'long-dated senior debt program' is slightly less specific than the ground truth's mention of 'fixed-rate funding' and 'favorable terms'; (3) the LLM does not explicitly note the absence of modification or removal, which the ground truth emphasizes as significant. The multi-hop synthesis is adequate—the LLM correctly connects the repeated disclosure across three years to the strategic implication about capital structure. Overall, the answer is substantially correct in its core claims and reasoning, with minor omissions of detail that prevent it from being a perfect match to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 449,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle first introduced the 2.300 % Notes due 2028 in a 2021 issuance (exhibit 4.16) that is listed in the FY 2022 10‑K exhibit table [page 114]. The same series appears unchanged in the FY 2023 and FY 2024 10‑K exhibit tables (exhibit 4.14 on [page 111] for both years), showing that the notes have remained outstanding without further restructuring. This repeated inclusion, together with newer higher‑coupon issuances in later years, reflects Oracle’s strategy of building a laddered, multi‑series fixed‑rate debt program to diversify maturities, lock in low rates and preserve financing flexibility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) TIMING ERROR - LLM states the 2.300% Notes were 'first introduced in a 2021 issuance' but ground truth clearly indicates they were 'first introduced in 2022.' This is a fundamental factual error about when the instrument was issued. (2) EXHIBIT REFERENCE ERROR - LLM cites 'Exhibit 4.16' for FY 2022, which matches ground truth, but then claims the same notes appear in 'Exhibit 4.14' for FY 2023 and FY 2024. Ground truth confirms Exhibit 4.14 for 2023 and 2024, so this is partially correct but the transition from 4.16 to 4.14 is not explained. (3) INCOMPLETE CONTEXT - LLM fails to mention that in 2023, Oracle introduced the 4.500% Notes due 2028 alongside the existing 2.300% Notes, which is a key detail in the ground truth showing the evolution pattern. (4) MISSING COMPARATIVE ANALYSIS - Ground truth explicitly notes the introduction of 'newer issuances such as the 4.500% Notes due 2028' in 2023 and their continuation in 2024, suggesting Oracle was layering in higher-yield instruments. LLM mentions 'newer higher-coupon issuances' generically but doesn't specifically identify the 4.500% Notes. (5) REASONING QUALITY - While LLM's conclusion about a 'laddered, multi-series fixed-rate debt program' is reasonable and somewhat aligned with ground truth's mention of 'layering in new issuances with potentially higher yields,' the reasoning is based on incomplete and partially incorrect premises. The 2021 vs 2022 issuance date error undermines the entire multi-year pattern analysis. CORRECT ELEMENTS: The general strategy description (diversifying maturities, locking in low rates, preserving flexibility) aligns with ground truth's characterization, and the observation that notes remained outstanding without restructuring is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 482,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 all list the “Certificate of Designations of Series B Convertible Participating Preferred Stock of Visa Inc.” as an exhibit (exhibit 4.5) incorporated by reference, with the same June 21 2016 filing date and no amendment or issuance disclosed (2022 exhibit list page_114; 2023 exhibit list page_109; 2024 exhibit list page_109). This unchanged treatment shows the Series B preferred stock remains authorized but dormant, preserving an optional financing tool while the company continues to rely on common equity and debt—indicating a long‑term capital‑structure priority of flexibility and stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Visa's Series B Convertible Participating Preferred Stock evolution across 2022-2024. STRENGTHS: (1) All numeric values are correct - the June 21, 2016 date is accurate, exhibit numbers (4.5) are correct, and page references (114 for 2022, 109 for 2023 and 2024) are verifiable and precise. (2) The multi-hop synthesis is sound: the answer correctly identifies that the same Certificate of Designations appears unchanged across all three annual filings, demonstrating continuity. (3) Entity accuracy is perfect - Visa Inc. is correctly identified, fiscal years 2022-2024 are properly referenced, and the Series B Convertible Participating Preferred Stock is accurately characterized. (4) The reasoning about capital structure implications is logical and well-supported: the answer correctly infers that unchanged treatment indicates a deliberate strategy of maintaining flexibility while relying on common equity and debt. (5) The characterization of the preferred stock as 'authorized but dormant' and an 'optional financing tool' aligns with the ground truth's emphasis on 'financing flexibility' and 'stability.' MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer is more concise and exhibit-focused than the ground truth, which provides broader context about unchanged Bylaws and Certificate of Incorporation updates. However, this is not an error - it's a stylistic choice that doesn't diminish accuracy. The LLM answer actually provides more specific documentary evidence (exhibit numbers and page references) than the ground truth. SEMANTIC EQUIVALENCE: The LLM's conclusion about 'flexibility and stability' as long-term priorities matches the ground truth's emphasis on 'continuity' and 'stable capital structure strategy.' Both answers correctly identify that the lack of modification indicates deliberate preservation of existing arrangements. No calculation errors, date errors, or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 547,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In the 2022 Form 10‑K Caterpillar noted that a material portion of Cat Financial’s floating‑rate loans were still benchmarked to LIBOR, warned that the planned LIBOR phase‑out created “uncertain” valuation and cash‑flow risks, and said it had formed a cross‑functional team to assess LIBOR‑linked securities, loans and derivatives while continuing to use currency‑hedging contracts to protect against foreign‑exchange swings (though acknowledging the trade‑off of forgoing favorable moves)【page_22】.  \n\nThe 2023 filing shows the transition completed: variable‑rate obligations now reference the Secured Overnight Financing Rate (SOFR), and Cat Financial manages interest‑rate and liquidity risk with a match‑funding strategy, selective derivatives and a diversified funding program, while still relying on currency‑hedging instruments to mitigate FX risk【page_19】.  \n\nThe 2024 filing repeats the SOFR‑based framework and ongoing use of currency‑hedging tools, indicating that the LIBOR‑related exposure has been largely eliminated and the hedging program now focuses on SOFR‑referenced exposures and continued foreign‑exchange risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution from 2022-2024 with accurate characterization of each year's focus: 2022's LIBOR phase-out concerns and cross-functional team formation, 2023's transition to SOFR with match-funding strategy, and 2024's continued SOFR framework. (2) Accurately captures the specific risk management mechanisms: currency-hedging contracts, match-funding, selective derivatives, and diversified funding. (3) Properly synthesizes the multi-hop information showing how Caterpillar adapted its hedging strategy in response to regulatory changes. (4) No quantitative errors - no specific dollar amounts or percentages were claimed that could be verified as incorrect. (5) Correctly identifies Cat Financial as the relevant subsidiary managing these risks. (6) Appropriately emphasizes the transition from LIBOR to SOFR as the central narrative thread. MINOR AREAS FOR ENHANCEMENT: (1) The LLM answer could have slightly more explicitly stated that currency hedging remained 'consistent' across all three years (as the ground truth emphasizes), though this is implied in the answer. (2) The ground truth mentions 'no significant changes in approach' in 2024, which the LLM captures as 'repeats the SOFR-based framework' but could be more explicit about continuity. (3) The LLM answer mentions 'forgoing favorable moves' as a trade-off, which adds nuance not explicitly in the ground truth but is contextually appropriate. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate years and two distinct but related risk management areas (currency hedging and interest rate/LIBOR-SOFR transition), demonstrating sound multi-hop reasoning. The logical flow from LIBOR concerns → SOFR transition → ongoing hedging is clear and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1595,
        "completion_tokens": 513,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "- In 2022 J&J’s strategy was to isolate all talc‑related exposure in a newly created LTL Management LLC, file a Chapter 11 case for LTL and set aside a $2 billion reserve to fund a trust that would pay any amounts the court ordered LTL to owe (see page 113).  \n- After the Third Circuit dismissed the original LTL case in early 2023, J&J re‑filed a “LTL 2” bankruptcy to re‑impose a stay, expanded its funding commitment to roughly $9 billion (including the original $2 billion) and simultaneously pursued four parallel pathways – appeal of the dismissal, a consensual pre‑packaged plan, aggressive tort litigation, and claims against experts (pages 96‑97).  \n- By 2024 the company moved toward a comprehensive, consensual pre‑packaged Chapter 11 plan (a $6.475 billion present‑value settlement over 25 years) and a new Red River bankruptcy to resolve the bulk of talc claims, while still maintaining the $2 billion trust established in the original LTL arrangement as part of its overall funding structure (page 101).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a detailed timeline and captures the general evolution of J&J's talc strategy, but contains significant quantitative inaccuracies that undermine its reliability. STRENGTHS: (1) Correctly identifies the core strategy of isolating talc exposure in LTL Management LLC with a $2 billion reserve in 2022; (2) Accurately notes the Third Circuit dismissal of the original LTL case in early 2023 and the subsequent LTL 2 refiling; (3) Correctly identifies the shift toward a pre-packaged Chapter 11 plan by 2024; (4) Properly synthesizes the multi-hop information across years and entities; (5) Appropriately contextualizes the legal maneuvering and bankruptcy strategy evolution. CRITICAL ERRORS: (1) Claims J&J 'expanded its funding commitment to roughly $9 billion (including the original $2 billion)' - this specific figure and the claim of expansion to $9 billion is not supported in the ground truth, which does not mention a $9 billion commitment; (2) States a '$6.475 billion present-value settlement over 25 years' for the pre-packaged plan - this specific dollar amount and structure is not confirmed in the ground truth; (3) References a 'Red River bankruptcy' in 2024 - this entity is not mentioned in the ground truth answer. QUANTITATIVE ACCURACY ISSUES: The introduction of unsupported financial figures ($9 billion expansion, $6.475 billion settlement) represents a significant problem, as these are precise numbers that cannot be verified against the ground truth and may be fabricated or misremembered details. The ground truth only confirms the $2 billion reserve and does not provide these expanded figures. MULTI-HOP REASONING: The reasoning across 2022-2024 is logically sound and follows a coherent narrative, but the addition of unverified numbers undermines the credibility of the synthesis. The answer correctly identifies the key turning points (Third Circuit reversal, LTL 2 refiling, shift to pre-packaged plan) but adds details not present in the ground truth. SEMANTIC EQUIVALENCE: While the general narrative matches the ground truth's description of strategy evolution, the specific financial commitments and settlement amounts diverge significantly, making this more than a wording difference - it represents potential factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 610,
        "total_tokens": 2116
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "- In the 2022 filing Adobe first positioned the Photography Plan as a “targeted package and suite” within Creative Cloud, aimed at photographers and photo‑enthusiasts as a way to broaden its user base 【page_7】.  \n- By the 2023 filing the plan was described as a “more limited cloud‑based offering than Creative Cloud,” bundling Photoshop, Lightroom and Lightroom Classic and emphasized as part of a product‑led growth strategy to draw photographers away from the full All‑Apps suite 【page_7】.  \n- The 2024 filing still defines the Photography Plan as that same Photoshop‑Lightroom‑Lightroom Classic bundle, but now highlights AI‑driven enhancements—Generative Fill/Expand/Remove in Photoshop, AI‑based Denoise, People Masking and other Firefly‑powered features—making the plan a differentiated, AI‑enabled entry point for photographers and creative professionals within the Creative Cloud ecosystem 【page_10】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 evolution of Adobe's Photography Plan. STRENGTHS: (1) Correctly identifies the core product bundle (Photoshop, Lightroom, Lightroom Classic) across all three years; (2) Accurately captures the strategic positioning evolution from 'targeted package' (2022) to 'product-led growth strategy' emphasis (2023) to AI-enhanced offering (2024); (3) Properly identifies specific AI features added by 2024 (Generative Fill, Denoise, People Masking, Firefly-powered features); (4) Correctly synthesizes the multi-hop information across three filing years; (5) Uses appropriate citations to source documents. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer uses slightly different phrasing than ground truth ('more limited cloud-based offering' vs. 'more limited alternative to full Creative Cloud suite') but conveys equivalent meaning; (2) The ground truth mentions 'Generative Credits' as a 2023 enhancement, which the LLM answer does not explicitly reference, though this is a relatively minor omission; (3) The LLM answer could have been slightly more explicit about the strategic shift to infuse AI into creative tools as a core theme. QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts are present in either answer, so this dimension scores high based on correct entity identification and date accuracy (2022, 2023, 2024 all correct). QUALITATIVE ACCURACY: The reasoning about product evolution and strategic positioning is sound and well-synthesized across the three-year period. The multi-hop synthesis correctly connects product features to strategic intent. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding positioning evolution, enhancements, and strategic shifts. Overall, this is a high-quality answer with minor omissions that do not significantly detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 520,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 each contain the same exhibit titled “Form of specimen certificate for class C common stock of Visa Inc.” – the 2022 filing lists it as Exhibit 4.3 (dated 1/28/2009)【page_114】 and the 2024 filing lists the identical exhibit as 4.2 with the same filing date【page_109】 (the 2023 filing repeats the same exhibit). By keeping this documentation unchanged across three consecutive years, Visa signals a deliberate, stable approach to corporate governance and investor communications, emphasizing reliable, consistent disclosure even as broader regulatory and market conditions evolve.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER DISCREPANCY: The LLM states the 2022 filing lists the exhibit as 'Exhibit 4.3' while the ground truth consistently references 'Exhibit 4.2' across all three years (2022, 2023, 2024). This is a factual error that undermines the core claim about consistency. The LLM then contradicts itself by saying the 2024 filing lists it as 4.2, creating internal inconsistency. (2) FILING DATE ACCURACY: The LLM correctly identifies the filing date as 1/28/2009 (January 28, 2009), matching the ground truth. (3) MULTI-HOP SYNTHESIS: The LLM correctly identifies that the same exhibit appears across three consecutive years and appropriately synthesizes this into a statement about consistency and governance approach. (4) MISSING CONTEXT: The LLM fails to mention the important contrast noted in the ground truth - that while the Class C stock certificate remained unchanged, other governance documents like the Certificate of Incorporation were revised in 2024. This omission weakens the analysis of what the stability actually suggests about Visa's governance approach. (5) REASONING QUALITY: The qualitative reasoning about what consistency suggests (stable approach, confidence in governance framework) is sound and aligns with the ground truth's interpretation, but the factual foundation is compromised by the exhibit number error. (6) SEMANTIC ALIGNMENT: The overall message about stability and governance is semantically aligned with the ground truth, but the specific factual errors regarding exhibit numbering are significant enough to substantially reduce the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 445,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liabilities for performance and operating‑cost guarantees fell from $1.109 billion at year‑end 2022 to $1.091 billion at year‑end 2023 and further to $0.993 billion at year‑end 2024【page_100†L31-L38】【page_102†L31-L38】. The steady decline signals that the company’s exposure to warranty‑related obligations is shrinking, reflecting improved product reliability and effective risk‑management of its commercial‑aerospace contracts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on the core quantitative data. The ground truth specifies RTX's liabilities for performance and operating cost guarantees (collaboration partners' share) as: 2022: $140 million, 2023: $135 million, 2024: $131 million. The LLM reports completely different figures: 2022: $1.109 billion, 2023: $1.091 billion, 2024: $0.993 billion - these are approximately 8x larger than the correct values. This is not a minor formatting difference or rounding variation; these are entirely different financial metrics or data points. The LLM appears to have cited the wrong line items from the SEC filings (pages 100 and 102), possibly confusing total warranty/guarantee liabilities with the specific collaboration partners' share metric. While the LLM correctly identifies the trend (declining over time) and provides reasonable qualitative interpretation about risk management, the quantitative foundation is completely wrong. The answer fails on the primary evaluation criterion - factual accuracy of financial numbers. The magnitude of error (off by ~$1 billion) is material and disqualifying. Multi-hop reasoning about the trend is sound in principle, but is built on incorrect data, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 356,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s lease disclosures have been unchanged from FY 2022 through FY 2024. In each filing (see 2022 p. 45‑46, 2023 p. 45‑46 and 2024 p. 45‑46) the company states that any free‑rent or step‑rent periods are allocated on a straight‑line basis over the lease’s original term **plus** any renewal or extension options that are “reasonably certain” to be exercised, and that the lease term is defined as the non‑cancellable period plus those certain extensions. Because the right‑of‑use asset is measured as the present value of minimum lease payments over that same term, the treatment of free‑rent periods and their effect on ROU‑asset valuations has remained consistent across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution of accounting treatment from 2022-2024. STRENGTHS: (1) Correctly identifies the straight-line basis treatment across all three years, (2) Accurately describes the lease term definition including extension options that are 'reasonably certain' to exercise, (3) Correctly notes that ROU asset is measured as present value of minimum lease payments, (4) Page references appear plausible (45-46 across years). CRITICAL WEAKNESSES: (1) The LLM states disclosures were 'unchanged' across the three years, directly contradicting the ground truth which explicitly describes an EVOLUTION in disclosures - the 2023 expansion to clarify variable lease payment treatment and the 2024 emphasis on impairment evaluation of long-lived assets. (2) The LLM completely misses the 2022-specific disclosure about incremental borrowing rate derived from quoted interest rates. (3) The LLM fails to capture the 2023 expansion regarding variable lease payments tied to price indices or sales volume. (4) The LLM omits the 2024 shift in emphasis toward impairment evaluation in context of facility relocations/closures. (5) The question specifically asks about 'evolution' and the LLM's answer of 'unchanged' is fundamentally at odds with the ground truth's description of evolving context and disclosure emphasis. MULTI-HOP REASONING: The LLM failed to synthesize the year-by-year evolution across the three filings. While it correctly identifies the core accounting policy, it misses the critical disclosure evolution that is central to the question. The answer reads as a static description rather than a temporal analysis of how treatment evolved. SEMANTIC ISSUE: The LLM's claim of 'unchanged' disclosures contradicts the ground truth's clear statement that 'the context in which it was presented evolved' and that there were specific expansions and emphasis shifts in different years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 528,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "In the 2022 filing Adobe positioned Acrobat as the core PDF tool of its Document Cloud, emphasizing a best‑in‑class PDF experience, web‑based Acrobat, Liquid Mode and modest AI enhancements via Adobe Sensei (see pages 4‑7). By the 2023 filing the company made AI‑driven document productivity a headline strategy—detailing upgrades to Acrobat web, new task‑based actions, deeper Adobe Sign integration and a concerted push to embed Sensei‑powered intelligence across Acrobat, reflecting heightened R&D focus on foundation‑model and generative‑AI development (see pages 4‑5). The 2024 filing’s later sections (pages 94‑98) contain no explicit Acrobat or AI‑branding discussion, suggesting the AI features have been folded into the broader Adobe Document Cloud platform rather than highlighted as a distinct product initiative.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year evolution (2022-2024) and mentions key elements like Acrobat's positioning, AI integration, and R&D focus. It appropriately references Adobe Sensei and generative AI development. The chronological progression is sound.\n\nCRITICAL ERRORS: (1) The LLM claims pages 94-98 of the 2024 filing contain 'no explicit Acrobat or AI-branding discussion,' contradicting the ground truth which explicitly states Adobe formalized 'Acrobat AI Assistant' as a branded product extension in 2024. This is a significant factual error about formal product branding—a core part of the question. (2) The LLM suggests AI features were 'folded into the broader Adobe Document Cloud platform rather than highlighted as a distinct product initiative,' which contradicts the ground truth's clear statement that Adobe formalized the strategy through branded product extensions like 'Acrobat AI Assistant.' This mischaracterizes the 2024 strategy.\n\nPARTIAL ACCURACY: (1) The 2022 characterization is reasonable but lacks the specific mention of 'trillions of PDFs created annually' and the emphasis on document-intensive industries. (2) The 2023 description of AI as a 'headline strategy' aligns with ground truth but misses the formal introduction of AI as a 'core strategic focus.' (3) The mention of Adobe Sensei is appropriate but the ground truth emphasizes the evolution toward branded AI products, not just embedded intelligence.\n\nMULTI-HOP REASONING: The answer attempts to synthesize across three years but fails to properly connect the trajectory to the formal product branding (Acrobat AI Assistant) that represents the culmination of the evolution. The reasoning about 2024 is fundamentally flawed.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral. Page references are given but cannot be verified without access to actual filings.\n\nSEMANTIC EQUIVALENCE: The LLM's interpretation of 2024 strategy diverges significantly from ground truth on a key factual point—whether AI was formalized as a distinct branded product or folded into broader offerings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 576,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "From the 2020‑2021 period, the pool of client securities that could be pledged rose sharply – from $84 billion in 2020 to $120 billion in 2021 – and the amount actually pledged to satisfy OCC requirements, short‑sales, securities‑lending and short‑term borrowing increased from $23 billion to $31 billion (page 108). By 2024 Schwab had deliberately reduced the use of those client securities to fund its own borrowing, cutting the CS&Co secured‑uncommitted line (which can be backed by client margin securities) from $950 million at year‑end 2023 to $500 million at year‑end 2024 and terminating the TDAC line that also relied on client margin securities (page 97), indicating a shift toward a more conservative balance‑sheet strategy while client‑driven margin and securities‑lending activity remains robust.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about the 2022-2024 period as specified. Key issues: (1) WRONG TIME PERIOD: The answer focuses heavily on 2020-2021 data ($84B to $120B pledged, $23B to $31B actually pledged), which is outside the requested 2022-2024 timeframe. The ground truth explicitly addresses 2022, 2023, and 2024. (2) UNVERIFIED NUMBERS: The specific dollar amounts cited ($84B, $120B, $23B, $31B, $950M, $500M) cannot be verified against the ground truth and appear to be fabricated or from different sources than the 10-K filings. The ground truth does not provide these specific quantitative figures. (3) MISSING CORE INFORMATION: The LLM answer fails to address the key evolution described in the ground truth: the progression from 2022 (general disclosure of pledging ability), to 2023 (more detailed disclosures), to 2024 (explicit statements about OCC margin requirements and securities lending). (4) INCORRECT SYNTHESIS: While the LLM attempts to show a trend (rising then falling), it does so using data from the wrong years and without the proper 2022-2024 framework. (5) PAGE REFERENCES: The citations to 'page 108' and 'page 97' cannot be verified and may be inaccurate. The ground truth does not reference specific page numbers for these claims. (6) CONCEPTUAL MISMATCH: The ground truth emphasizes formalization and expansion of client securities usage (indicating increased leverage), while the LLM answer claims a shift toward 'more conservative balance-sheet strategy' - a contradictory interpretation. The answer demonstrates poor multi-hop reasoning by failing to properly synthesize information across the correct 2022-2024 period and instead relies on unverified historical data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 480,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 on its balance sheet as a $1.25 billion **long‑term** liability in each filing – the note never moved into the current portion【page_52】. In 2022 the note represented about 19 % of total long‑term debt of $6.59 billion (current portion $73 million)【page_52】; in 2023 the note was still $1.25 billion, total long‑term debt fell to $6.48 billion and the current portion rose to $1.08 billion, leaving the note’s share near 19 %【page_52】; and by 2024, after the 2.75 % notes were retired, total long‑term debt dropped to $5.92 billion (current portion $103 million), raising the 1.375 % note’s weight to roughly 21 % of the company’s long‑term debt【page_52】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. Key issues: (1) MAJOR ERROR - The LLM states total long-term debt in 2022 was $6.59 billion, but the ground truth clearly states $6,484 million ($6.484 billion). This is a material discrepancy of ~$106 million. (2) MAJOR ERROR - The LLM states 2023 total long-term debt was $6.48 billion, but ground truth shows $5,794 million by 2024, with no explicit 2023 figure provided in ground truth. The LLM appears to have confused years or used incorrect data. (3) MAJOR ERROR - The LLM states 2024 total long-term debt was $5.92 billion, but ground truth states $5,794 million ($5.794 billion), a difference of ~$126 million. (4) PERCENTAGE CALCULATIONS - The LLM calculates the 1.375% note as ~19% of long-term debt in 2022 ($1.25B/$6.59B ≈ 18.97%), which is mathematically correct given their stated total, but the denominator is wrong. Using correct ground truth figures: $1.25B/$6.484B ≈ 19.3%, which the LLM approximates correctly but based on incorrect total. (5) CORRECT ELEMENTS - The LLM correctly identifies that the 1.375% Senior Notes remained at $1.25 billion across all three years and correctly notes that the note stayed in long-term classification (never moved to current). The observation about the 2.750% notes being retired is relevant context. (6) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution across years and show how the note's composition changed, which is appropriate to the question. However, the numerical foundation is flawed. (7) MISSING CONTEXT - The ground truth emphasizes that the decline in long-term debt from $6,484M (2022) to $5,794M (2024) was driven by reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion. The LLM mentions retirement but doesn't clearly explain the reclassification mechanism that drove the change. The core narrative about the note's stability and changing composition is directionally correct, but the specific numbers are materially inaccurate, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 561,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "In 2022 Adobe described its Digital Learning Services as a “large number of free online self‑service learning options on www.training.adobe.com” that sit alongside fee‑based courses and custom learning services 【page_17】. By 2023 the same free‑service was re‑branded under the learning.adobe.com domain and positioned as a core element of a broader learning‑and‑enablement suite that supports Customer Success Managers in driving adoption 【page_18】, and in the 2024 filing the free self‑service catalog remains a foundational piece of Digital Learning Services, now explicitly tied to enterprise‑focused custom learning, solution‑specific skills assessments and the Customer Success strategy to align product capabilities with business outcomes 【page_17】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of Adobe's free online self-service learning positioning across three years; (2) Accurately captures the domain change from training.adobe.com (2022) to learning.adobe.com (2023-2024); (3) Properly identifies the three-tier structure of Digital Learning Services (free self-service, fee-based courses, custom learning services) consistently across years; (4) Correctly notes the integration with Customer Success Managers and enterprise strategies; (5) Accurately reflects the addition of skills assessments and solution-specific focus in later years; (6) Provides appropriate page citations. MINOR WEAKNESSES: (1) The LLM answer uses slightly more technical/specific language (e.g., 'Digital Learning Services' terminology, specific domain names) compared to the ground truth's more general framing, though this is not inaccurate; (2) The ground truth emphasizes 'democratizing product knowledge' as a strategic commitment, which the LLM answer doesn't explicitly state, though it's implied through the consistent presence of free options; (3) The LLM answer could have been slightly more explicit about the 'maturing approach' concept mentioned in ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the progression from introduction (2022) → reinforcement with rebranding (2023) → mature integration with enterprise strategy (2024). The logical flow and connections between years are sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with the core narrative of consistent positioning with growing enterprise integration clearly communicated. No numerical errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 514,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA carried $1.25 billion of 2.00 % notes due 2031 at the end of fiscal 2022 (2022 10‑K, Note 5, p. 78), the balance slipped to about $1.04 billion in fiscal 2023 (2023 10‑K, Note 9, p. 67), and rose back to $1.25 billion in fiscal 2024 (2024 10‑K, Note 5, p. 72). This swing—maintaining a roughly stable, low‑coupon, long‑dated debt tranche, briefly trimming it and then re‑expanding—shows NVIDIA is deliberately managing a cheap, flexible financing base to fund its rapid AI‑driven revenue growth while preserving the ability to adjust debt levels as cash‑flow needs evolve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 figure. Ground truth states $1.20 billion for 2022, but the LLM claims $1.25 billion. This is a material discrepancy of $50 million (4.2% difference) that contradicts the original answer. The 2023 figure of ~$1.04 billion is approximately correct (ground truth: $1.057 billion, minor rounding acceptable). The 2024 figure of $1.25 billion matches ground truth. MULTI-HOP SYNTHESIS: The LLM correctly identifies the three-year trend pattern and attempts to synthesize the evolution across fiscal years 2022-2024. However, the incorrect 2022 baseline undermines the accuracy of the trend analysis. The LLM's characterization of the pattern as 'swing' and 'briefly trimming it and then re-expanding' is semantically similar to the ground truth's description, but is built on incorrect data. REASONING QUALITY: The LLM provides reasonable strategic interpretation (managing cheap, flexible financing for AI growth), which aligns with the ground truth's explanation about optimizing capital structure and securing long-term capital. The logic is sound, but it's applied to partially incorrect numbers. ENTITY ACCURACY: NVIDIA is correctly identified, the 2.00% Notes Due 2031 instrument is correctly named, and fiscal years are properly referenced with document citations. COMPLETENESS: The answer addresses the question's core components (exposure evolution and strategic implications), though the quantitative foundation is flawed. The inclusion of specific page references adds credibility but doesn't compensate for the numerical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 448,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize HR, IT, procurement, supply‑chain and finance processes, thereby expanding its financial shared‑service capabilities and aligning the financial control environment【page_117】. The same description appears unchanged in the 2023 filing【page_117】 and again in the 2024 filing【page_119】, showing the program is still being implemented and further embedded. This continuity reflects a sustained strategic focus on standardizing financial processes and tightening the control environment to support shared‑service growth and operational consistency.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about J&J's financial shared services initiative evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the core initiative as multi-year, enterprise-wide, focused on integrating/simplifying/standardizing processes across finance, HR, IT, procurement, and supply chain; (2) Accurately captures the three-year timeline (2022, 2023, 2024) with proper filing references; (3) Correctly notes the consistency of messaging across all three years, indicating sustained strategic focus; (4) Properly synthesizes the multi-hop information showing progression/continuity; (5) Accurately characterizes the initiative as proactive rather than reactive. MINOR WEAKNESSES: (1) The LLM answer includes additional functions (HR, IT, procurement, supply-chain) beyond what the ground truth explicitly emphasizes - while not incorrect per se, the ground truth focuses more narrowly on 'key functions, including finance' without listing all functions; (2) The ground truth emphasizes the 'proactive effort' and 'not being prompted by any internal control deficiencies' more explicitly, which the LLM answer touches on but less directly; (3) The ground truth's language about 'alignment and streamlining of the financial control environment in response to the initiative' (2023) and 'affirming that these enhancements were not reactive' (2024) is somewhat more nuanced than the LLM's simpler 'tightening the control environment' phrasing. QUANTITATIVE ACCURACY: Page references (117, 117, 119) appear reasonable for 10-K filings but cannot be independently verified; no numerical calculations required. MULTI-HOP REASONING: Excellent - correctly synthesizes information across three separate filings to show evolution and continuity. SEMANTIC EQUIVALENCE: High - the core message about sustained strategic focus on standardization and control environment alignment is conveyed accurately, though with slightly different emphasis than ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 547,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Across the 2022, 2023 and 2024 10‑Ks Costco consistently describes its competition as “including Walmart’s Sam’s Club and **BJ’s Wholesale Club**” (the 2023 filing adds a brief “in the U.S.” qualifier). In the same sections each year it repeats that its private‑label brand, **Kirkland Signature**, is “high‑quality, offered at prices generally lower than national brands, helps lower costs, **differentiates our merchandise offerings** and generally earns higher margins,” and that it will continue to increase its sales penetration. The language therefore shows little change—Costco’s positioning against BJ’s remains the same while the strategic emphasis on Kirkland as a key differentiator is maintained throughout 2022‑2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key entities (Costco, BJ's Wholesale Club, Kirkland Signature) and accurately quotes the consistent language used across 2022-2024 filings regarding Kirkland Signature being 'high-quality, offered at prices generally lower than national brands' and differentiating merchandise offerings. The numeric/date references are accurate (2022, 2023, 2024). However, the answer significantly diverges from the ground truth in its characterization of the evolution. The ground truth explicitly describes an EVOLUTION in competitive positioning language, noting: (1) 2022 baseline positioning, (2) 2023 added emphasis on sustainability initiatives tied to brand loyalty, and (3) 2024 introduction of 'stronger tone around differentiating merchandise offerings' in response to competitive pressures. The LLM answer concludes that 'language shows little change' and that positioning 'remains the same,' which directly contradicts the ground truth's core finding that there WAS an evolution in tone and emphasis, even if the core strategy remained stable. The ground truth explicitly states 'the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures,' whereas the LLM dismisses this as 'little change.' This represents a fundamental misinterpretation of the multi-hop synthesis required—the question asks specifically about HOW the language EVOLVED, and the LLM fails to capture the nuanced progression across the three years that the ground truth identifies. The LLM provides accurate quotes but misses the interpretive layer about changing emphasis and tone that constitutes the actual answer to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 468,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Schwab’s U.S. state‑and‑municipal bond holdings slipped from **$638 million at 12/31/2022** to **$579 million at 12/31/2023**【page_112】, and the 2024 filing states that **“substantially all securities in the investment portfolios were rated investment grade”** – a category that includes its state and municipal securities【page_48】. The firm’s continual focus on investment‑grade quality shows a fixed‑income strategy centered on high‑credit‑quality assets, emphasizing capital preservation and low‑credit‑risk exposure throughout the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states Schwab's state and municipal securities were '$638 million at 12/31/2022' and '$579 million at 12/31/2023', but the ground truth indicates $638 million was the 2023 figure, not 2022. The LLM has reversed the years and created a false declining trend. This is a fundamental factual error that undermines the entire answer. (2) INCOMPLETE TEMPORAL COVERAGE - The question explicitly asks about evolution from 2022 to 2024, requiring three data points. The LLM only provides two years (2022 and 2023) and fails to address 2024 quantitatively. The ground truth mentions 2024 reaffirmation of investment-grade focus but the LLM provides no 2024 numerical data or specific disclosure. (3) MISSING SYNTHESIS - The ground truth clearly states the $638 million figure was disclosed in 2023 within the available-for-sale securities portfolio. The LLM misattributes this to 2022, creating a chronological error that breaks the multi-hop reasoning chain. (4) QUALITATIVE ASSESSMENT - While the LLM correctly identifies the investment-grade quality emphasis and its strategic implications (capital preservation, low-credit-risk), this correct reasoning cannot compensate for the fundamental numerical and temporal errors. (5) CITATION ISSUES - The LLM provides page references but these appear to be used to support incorrect year assignments. The core factual error (wrong year for the $638M figure) is a disqualifying mistake for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 426,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s guaranteed exposure to commercial‑aerospace customer financing fell each year – the maximum‑potential payment on those guarantees was $304 million at 12/31/2022, $288 million at 12/31/2023, and $274 million at 12/31/2024【page_100】.  The portion attributable to collaboration partners also slipped in absolute terms (from $140 million in 2022 to $135 million in 2023 to $131 million in 2024)【page_100】【page_102】, but it now represents a slightly larger share of the total guarantee exposure (≈46 % → 48 %).  This trend shows RTX is steadily reducing its overall guarantee risk while increasingly relying on partners to absorb a stable or growing proportion of that risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key numbers: collaboration partners' share declining from $140M (2022) to $135M (2023) to $131M (2024), and total guarantee exposure declining from $304M to $288M to $274M across the same period. The percentage calculations (46% → 48%) appear reasonable given the data provided. The answer successfully synthesizes multi-hop information by connecting the absolute dollar decline with the relative share increase, demonstrating understanding of the risk transfer dynamics. However, there are some differences from the ground truth interpretation: (1) The LLM emphasizes that RTX is 'increasingly relying on partners to absorb a stable or growing proportion of that risk,' which is a slightly different framing than the ground truth's interpretation of 'reducing RTX's reliance on third-party risk sharing' and 'increased internal risk retention.' While both interpretations are mathematically valid (partners' share as % of total is increasing), the ground truth suggests this indicates reduced reliance on partners, whereas the LLM suggests increased reliance. (2) The LLM does not explicitly mention that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees,' which was noted in the ground truth as indicating conservative valuation and risk management. (3) The LLM provides additional context about total guarantee exposure declining, which adds value but wasn't explicitly requested. The core numbers are accurate, the multi-hop synthesis is sound, but the strategic interpretation differs slightly from the ground truth's framing of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 456,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K Adobe described Frame.io as a cloud‑native collaboration platform that handled **video plus still images, design files and PDFs**, and was **directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront** to support the entire content‑creation pipeline—including casting, location‑scouting, footage reviews and marketing‑campaign management【page_12】.  \n\nBy the 2023 filing (and unchanged in the 2024 filing) Adobe narrowed Frame.io’s positioning: it still supports **still images, design files and PDFs**, but the **integration is limited to Premiere Pro and After Effects** and the focus is on **frame‑accurate commenting and Camera‑to‑Cloud uploads** within video‑editing workflows, with no longer any mention of Photoshop, Lightroom, Workfront or broader pre‑production functions【page_12】.  \n\nThus, from 2022 to 2024 Adobe shifted Frame.io from a broad‑scope production‑workflow hub to a more specialized video‑editing collaboration tool, trimming supported file‑type mentions and app integrations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that in 2022, Frame.io was 'listed as a registered trademark' with no mention of the broad integrations claimed by the LLM. The LLM incorrectly asserts that in 2022, Frame.io was 'directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront' and supported 'casting, location-scouting, footage reviews and marketing-campaign management.' According to the ground truth, these expanded integrations and broader workflow applications only appeared by 2024, not 2022. The LLM has inverted the evolution timeline: it claims Frame.io was broad in 2022 and narrowed by 2023-2024, when the ground truth shows the opposite—Frame.io started as a registered trademark in 2022, expanded to Premiere Pro/After Effects with Camera-to-Cloud in 2023, and then further expanded to Photoshop, Lightroom, Workfront and broader pre/post-production workflows by 2024. The LLM's conclusion that Adobe 'shifted Frame.io from a broad-scope production-workflow hub to a more specialized video-editing collaboration tool' is directly backwards. The multi-hop reasoning is fundamentally flawed because the temporal sequence of integrations is reversed. While the LLM correctly identifies the file types (still images, design files, PDFs) and some application names, the chronological attribution of these features to the wrong years represents a critical factual error that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 421,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "Lockheed Martin’s 10‑K filings show the VH‑92A was consistently listed as a core RMS helicopter in 2022 (the program appears among RMS’s major programs – page 50) and again in 2023 (listed in the RMS program overview – page 4), but neither year highlighted any production expansion. By 2024 the company noted that “higher production volume on the CH‑53K program [was] partially offset by lower volume on the VH‑92A program” – page 41, indicating that VH‑92A production is tapering as the aircraft moves into a sustain‑and‑support phase. This multi‑year shift suggests the VH‑92A remains strategically important to the Rotary and Mission Systems segment (it is still a flagship Marine One platform) but is transitioning from a growth‑phase production effort to a maintenance‑focused, mature‑program role.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong qualitative understanding of the VH-92A program's strategic evolution and correctly identifies the key insight about the transition from growth to sustain-and-support phase. However, there are significant issues with quantitative accuracy and citation specificity that prevent a higher score.\n\nSTRENGTHS:\n1. Core narrative is sound: The answer correctly identifies that VH-92A remained strategically important across 2022-2024 while transitioning from growth to maintenance phase\n2. Key insight is accurate: The 2024 observation about CH-53K production increases offsetting VH-92A decreases aligns with the ground truth's mention of 'shifting priorities and production ramps'\n3. Contextual understanding: Correctly characterizes VH-92A as a 'flagship Marine One platform' and explains the strategic importance despite production tapering\n4. Multi-hop reasoning: Successfully synthesizes information across three years to show program evolution\n\nWEAKNESSES:\n1. Page citations are unverifiable and potentially inaccurate: The answer cites specific pages (50, 4, 41) but these cannot be verified against the ground truth, which provides no page numbers. This is a significant concern for factual precision\n2. Quantitative specificity: The ground truth mentions the VH-92A was 'listed among RMS's major programs' in 2022 and 'listed in the RMS program overview' in 2023, but the LLM adds specific page citations that may be incorrect\n3. Missing nuance from ground truth: The ground truth emphasizes 'consistent mention across all three years' and 'stable, long-term commitment,' while the LLM emphasizes production decline. Both interpretations are valid, but the LLM's framing is slightly more negative than the ground truth's emphasis on consistency\n4. Unverified claim about 'higher production volume on CH-53K program [was] partially offset by lower volume on the VH-92A program': While this quote appears plausible and aligns with the ground truth's mention of 'shifting priorities,' the exact wording cannot be verified\n\nMULTI-HOP REASONING ASSESSMENT:\nThe answer correctly synthesizes information across three years (2022, 2023, 2024) and connects program mentions to strategic importance. The reasoning that consistent listing = strategic importance is sound. The additional insight about production phase transition (growth to sustain-and-support) is a reasonable inference but goes slightly beyond what the ground truth explicitly states.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys similar information to the ground truth but with a different emphasis. Ground truth emphasizes 'consistent mention' and 'stable commitment'; LLM emphasizes 'production tapering' and 'mature-program role.' Both are compatible interpretations of the same underlying data.\n\nCRITICAL ISSUE:\nThe specific page citations (50, 4, 41) cannot be verified against the ground truth and represent a potential factual accuracy problem. If these page numbers are incorrect, it undermines the credibility of the answer despite the correct overall narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 811,
        "total_tokens": 2238
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "Across the three most recent 10‑Ks the company repeatedly notes that sales‑ and media‑marketing rules now span a truly global footprint – the European Union alone includes “over 25 countries” with mandatory extended‑producer‑responsibility (EPR) and packaging‑waste directives, while a growing set of emerging economies (e.g., Indonesia, the Philippines and, more broadly, India and Vietnam) are moving to single‑use‑plastic bans or taxes that also affect how products can be promoted (2022 10‑K p. 15; 2023 10‑K p. 11; 2024 10‑K p. 11). At the same time the language on “sales or media and marketing restrictions … on promotions or advertising products with specified nutrient profiles on certain channels or platforms or during certain hours of the day” shows the rules have become more granular and stringent, tightening the permissible promotional practices in both the EU and these emerging markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly synthesizes information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the 'over 25 EU countries' with EPR policies as stated in ground truth; (2) Accurately names emerging markets (Indonesia, Philippines, India, Vietnam) affected by restrictions; (3) Properly captures the evolution from 2022 through 2024; (4) Correctly identifies the expansion in both geographic scope and regulatory stringency; (5) Appropriately references the granular nature of restrictions (nutrient profiles, channels, platforms, hours); (6) Correctly cites the 10-K filings as sources. MINOR ISSUES: (1) The LLM answer mentions 'Indonesia' and 'Philippines' as examples of emerging markets, while the ground truth specifically mentions 'Southeast Asia' considering plastic bans/taxes but does not explicitly name Indonesia or Philippines in the provided ground truth text. However, this is a reasonable inference about Southeast Asian markets and does not contradict the ground truth; (2) The LLM answer does not explicitly mention the 'Packaging and Packaging Waste Directive' formally adopted by the EU in 2024, which is a specific detail in the ground truth; (3) The LLM answer does not explicitly mention 'data privacy' as a regulatory area affecting marketing that was added in 2023, though this is a relatively minor omission. QUANTITATIVE ACCURACY: The '25 countries' figure is correct and properly attributed. No calculations are required for this question, so quantitative accuracy is high. QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer correctly synthesizes information about geographic expansion (EU to emerging markets) and regulatory intensification (from general bans to specific nutrient profile restrictions) across the three-year period. CONTEXTUAL RELEVANCE: The answer directly addresses the question about geographic scope, regulatory stringency, EU, and emerging markets evolution. The inclusion of specific 10-K page citations adds credibility. Overall, this is a strong answer with minor omissions of specific 2024 details (formal directive adoption) and 2023 details (data privacy), but the core narrative of expansion and intensification is accurate and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 613,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700 % Notes due 2046 are listed in the same “Eleventh Supplemental Indenture (Exhibit 4.14)” in each of the three filings – the 2022 10‑K (page 105), the 2023 10‑K (page 105) and the 2024 10‑K (page 105) – and are consistently presented as long‑term debt with no indication of repayment, refinancing or re‑classification. This unchanged disclosure shows that Microsoft is deliberately keeping the bond on its balance sheet, reflecting a long‑term debt strategy that relies on a diversified set of fixed‑rate, far‑dated issuances to lock in low borrowing costs and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) All numeric values are correct - the 3.700% interest rate is accurate, the 2046 maturity date is correct, and the reference to the Eleventh Supplemental Indenture dated August 8, 2016 is accurate. (2) The page number citations (page 105 for all three years) are consistent with typical 10-K filing structures and appear reasonable. (3) The multi-hop synthesis is sound - the answer correctly identifies that the notes appear consistently across 2022, 2023, and 2024 filings with no modifications. (4) The reasoning about Microsoft's long-term debt strategy is logically sound and well-supported: the answer correctly infers that unchanged treatment indicates deliberate retention as a core capital structure component. (5) The semantic content matches the ground truth - both answers convey that the notes were consistently reaffirmed without modification and reflect a stable, long-dated liability strategy. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'locking in low borrowing costs' which, while reasonable, goes slightly beyond what the ground truth explicitly states. However, this is a reasonable inference from the facts presented and doesn't contradict the ground truth. (2) The LLM answer is slightly more concise than the ground truth but captures all essential information. (3) Both answers correctly identify the absence of modifications as the key pattern. The LLM answer's phrasing 'no indication of repayment, refinancing or re-classification' is semantically equivalent to the ground truth's 'absence of modifications.' Overall, this is a high-quality response that accurately synthesizes multi-hop information across three years of filings and correctly interprets the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 492,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft’s 2.000 % Notes due 2023 first appear in the Eleventh Supplemental Indenture (Exhibit 4.14) that is listed in each filing’s exhibit index 【page_105】. In the 2023 and 2024 10‑K reports the same Eleventh Supplemental Indenture is retained, but additional supplemental indentures (Twelfth, Thirteenth, Fourteenth and Fifteenth) are also filed, introducing new series with maturities that stretch beyond 2023 (e.g., 2.400 % due 2026, 2.875 % due 2024, 3.300 % due 2027, 4.100 % due 2037 and notes out to 2057) 【page_106】. Thus, while the 2.000 % due 2023 tranche remains a constant component of Microsoft’s debt, the overall maturity structure has progressively extended to longer‑dated obligations across the 2022‑2024 filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a substantially correct response with good multi-hop synthesis across the 2022-2024 filings. STRENGTHS: (1) Correctly identifies the 2.000% Notes due 2023 appearing in Exhibit 4.14 across all three years; (2) Accurately references the Eleventh Supplemental Indenture dated August 8, 2016; (3) Correctly notes that additional supplemental indentures (Twelfth through Fifteenth) were introduced in later filings; (4) Accurately lists specific new debt instruments with correct percentages and maturity years (2.400% due 2026, 2.875% due 2024, 3.300% due 2027, 4.100% due 2037, notes to 2057); (5) Properly synthesizes the evolution showing the 2.000% Notes remained constant while the overall maturity structure extended. WEAKNESSES: (1) The answer is more focused on the expansion of debt instruments rather than directly addressing what happened to the 2.000% Notes specifically as they approached and passed their 2023 maturity date - the ground truth emphasizes the notes' continued presence even after maturity, suggesting possible rollover or delayed maturity, which the LLM answer doesn't explicitly address; (2) Doesn't fully explore the implications of the notes remaining in 2024 filings after their stated maturity year had passed; (3) Less emphasis on the transparency/disclosure aspect mentioned in the ground truth. QUANTITATIVE VERIFICATION: All percentages and years cited are accurate (2.000%, 2.400%, 2.875%, 3.300%, 4.100%, maturity years 2023, 2024, 2026, 2027, 2037, 2057). The Eleventh Supplemental Indenture date of August 8, 2016 is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the progression of supplemental indentures. However, it emphasizes the expansion of new debt rather than the specific evolution of the 2.000% Notes themselves through their maturity cycle. The answer is factually sound but somewhat tangential to the core question about how that specific note series evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 544,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "In the 2022 10‑K the Non‑Employee Restricted Stock Unit Award Agreement is listed as Exhibit 10.42 and is incorporated by reference to the **Amended and Restated 2013 Stock Award and Incentive Plan**【page_115】. The 2023 filing repeats the same Exhibit 10.42 with the identical reference to the 2013 Stock Award and Incentive Plan【page_112】, and the 2024 filing again shows Exhibit 10.42 tied to the same Amended and Restated 2013 Stock Award and Incentive Plan【page_113】. Thus, across 2022‑2024 the non‑employee RSU agreement remained unchanged, consistently referencing the 2013 Stock Award and Incentive Plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH: The LLM states the Non-Employee RSU Agreement is 'Exhibit 10.42' across all three years (2022, 2023, 2024), but the ground truth explicitly identifies it as 'Exhibit 10.45' in 2022. This is a factual error in exhibit numbering. The LLM's claim that it is consistently '10.42' across all years contradicts the ground truth which specifies '10.45' for 2022. (2) INCOMPLETE ANALYSIS: The ground truth provides important context about the effective date of the plan amendment (December 8, 2017) and emphasizes the distinction between the form agreement remaining consistent while the underlying plan was amended over time. The LLM answer misses this nuance entirely, simply stating the agreement 'remained unchanged' without acknowledging the evolution in the underlying plan amendments. (3) MISSING CONTEXTUAL DETAIL: The ground truth notes this reflects 'a strategic choice to maintain standardized compensation instruments for non-employee directors,' providing interpretive context that the LLM lacks. (4) PARTIAL CORRECTNESS: The LLM correctly identifies that the same Amended and Restated 2013 Stock Award and Incentive Plan was referenced across all three years, and correctly notes the consistency of the form agreement. However, the exhibit number error in 2022 is a significant factual mistake that undermines the answer's reliability. (5) REASONING QUALITY: While the LLM attempts to synthesize information across three years, the exhibit number discrepancy suggests either hallucination or misreading of source documents, which is a fundamental failure in multi-hop document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 451,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension‑plan assets were allocated to buy‑in annuity contracts at 17 % in 2022, slipped to 16 % in 2023, and returned to 17 % in 2024【page_105】【page_104】. The essentially flat share over three years shows the company is keeping a steady, deliberate use of buy‑in annuities to lock in cash‑flows and hedge its international pension liabilities, reflecting a consistent liability‑management strategy for those obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that buy-in annuity allocations were 17% in 2022, 16% in 2023, and 'effectively discontinued by 2024.' However, the LLM claims the allocation 'returned to 17% in 2024,' which is factually incorrect. This is not a minor discrepancy but a core quantitative error on a key metric. The LLM's interpretation of the trend is also completely wrong: it characterizes the allocation as 'essentially flat' and suggests 'steady, deliberate use' of buy-in annuities, when the ground truth indicates a strategic shift away from these instruments toward fair value estimation methods. The LLM misses the critical insight that the company discontinued this allocation by 2024, which is the most important aspect of the trend. The reasoning about 'locking in cash-flows and hedge' contradicts the ground truth's explanation that the company moved toward 'more direct liability management and valuation control.' The LLM provides citations (page_105, page_104) but these appear to be fabricated or misinterpreted, as they don't support the claimed 2024 figure of 17%. The answer fails on both quantitative accuracy (wrong 2024 percentage) and qualitative accuracy (wrong interpretation of strategic intent). The only correct elements are the 2022 (17%) and 2023 (16%) figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 390,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft’s 2.000 % notes due 2023 first appear in the Eleventh Supplemental Indenture (dated August 8 2016) and are listed as outstanding in both the FY 2022 and FY 2023 10‑K filings (see Exhibit 4.14, which includes “2.000 % Notes due 2023”)【page_105】. By the FY 2024 filing the notes have reached maturity and are no longer shown as outstanding, indicating that Microsoft issues medium‑term, fixed‑rate debt and then lets it run to maturity, using a staggered maturity profile to manage long‑term financing costs and maintain a disciplined debt strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The LLM claims 'By the FY 2024 filing the notes have reached maturity and are no longer shown as outstanding,' but the ground truth explicitly states that 'By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period.' This is a major contradiction on a core factual claim. The ground truth indicates the notes were STILL OUTSTANDING in 2024, not retired/matured. The LLM incorrectly inferred that the notes matured and were removed from the balance sheet by 2024, when in fact they remained on the books. CORRECT ELEMENTS: (1) The Eleventh Supplemental Indenture date of August 8, 2016 is correct. (2) The 2.000% interest rate is correct. (3) The reference to Exhibit 4.14 is correct. (4) The notes were indeed listed in FY 2022 and FY 2023 filings. INCORRECT ELEMENTS: (1) The claim that notes 'have reached maturity and are no longer shown as outstanding' by FY 2024 directly contradicts ground truth stating they 'remained in the disclosures' and 'maintained this liability on its books through the 2024 reporting period.' (2) The conclusion about 'letting it run to maturity' is premature and unsupported by the actual data showing the notes were still outstanding in 2024. MULTI-HOP REASONING: The LLM failed to properly synthesize the three-year evolution. It correctly identified the 2022-2023 pattern but made an unsupported inference about 2024 status. The ground truth shows consistent presence across all three years, while the LLM incorrectly suggests removal by 2024. This is a critical failure in multi-hop synthesis across the three fiscal years. The interpretation of debt strategy is also flawed due to the incorrect maturity assumption.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 508,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft’s 4.000 % senior notes that mature in 2021 were originally disclosed as a distinct series issued under the **Third Supplemental Indenture (Exhibit 4.6)** dated Feb 8 2011 – “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041” 【page_104】. In the 2022 10‑K they appear in the debt schedule as an outstanding series, but by the 2023 10‑K the notes are no longer shown as a current liability (they had matured in 2021) and are referenced only in the historical supplemental‑indenture list; the 2024 10‑K retains the same exhibit index but omits the 4.000 % 2021 notes from the active debt tables, treating them solely as a retired component of Microsoft’s overall debt instrument structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the Third Supplemental Indenture dated February 8, 2011, and accurately notes that the 4.000% Notes due 2021 were grouped with the 2.500% Notes due 2016 and 5.300% Notes due 2041 under this indenture. The date (Feb 8, 2011) and percentage rates are all correct. The LLM also correctly recognizes that these notes matured in 2021.\n\nCRITICAL ERRORS: The LLM's core claim about the evolution of treatment is fundamentally incorrect. The ground truth states the treatment 'remained consistent across all three years' with the notes appearing in Exhibit 4.6 in 2022, 2023, and 2024. However, the LLM claims that by 2023 the notes 'are no longer shown as a current liability' and 'are referenced only in the historical supplemental-indenture list,' and that the 2024 10-K 'omits the 4.000% 2021 notes from the active debt tables.' This directly contradicts the ground truth, which explicitly states the notes 'continued to appear in Exhibit 4.6' in both 2023 and 2024.\n\nMULTI-HOP REASONING FAILURE: The question asks how the treatment 'evolved' across the three years. The ground truth answer correctly identifies that there was NO evolution - the treatment remained consistent. The LLM incorrectly infers an evolution where the notes transitioned from active to retired/historical status between 2022 and 2023. This is a fundamental misunderstanding of the multi-hop synthesis required.\n\nMISSING CONTEXT: The LLM fails to mention that Microsoft introduced new debt instruments under subsequent supplemental indentures, which is part of the broader debt instrument structure evolution mentioned in the ground truth.\n\nQUANTITATIVE ACCURACY: Dates and percentages are correct (8/10).\nQUALITATIVE ACCURACY: The reasoning about maturation and retirement is logical but factually incorrect against the ground truth (5/10).\nCONTEXTUAL RELEVANCE: Partially addresses the question but with incorrect conclusions about evolution (6/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 531,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K notes on share capital consistently state that the company is authorized to issue 40 000 Euro‑Deferred Shares ( €1.00 par) but that **no Euro‑Deferred Shares were issued or outstanding** at each year‑end – April 29 2022, April 28 2023 (as disclosed in the 2023 filing), and April 26 2024. The unchanged language across the three reports shows the company has never tapped this class of equity, indicating a capital‑structure approach that relies on ordinary shares and share‑repurchase programs rather than using Euro‑Deferred Shares as a financing or dilution tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. QUANTITATIVE VERIFICATION: All numeric values are correct - 40,000 Euro Deferred Shares authorized, €1.00 par value, and the three fiscal year-end dates (April 29, 2022; April 28, 2023; April 26, 2024) are all accurate. The statement that zero shares were issued or outstanding across all three years matches the ground truth. COMPLETENESS: The answer addresses all key aspects of the multi-part question: (1) evolution of disclosures across 2022-2024 (showing consistency), (2) the authorized capacity maintained, (3) the absence of issuance/outstanding balances, and (4) what this reveals about capital structure strategy. ENTITY ACCURACY: Medtronic is correctly identified, fiscal years are precise, and the Euro Deferred Shares classification is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the consistent absence of issuance across three years to strategic implications about capital structure preferences. The inference that the company relies on ordinary shares and share-repurchase programs instead is a logical interpretation of the data. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while using slightly different phrasing ('never tapped this class of equity' vs. 'has not utilized'). Both versions correctly characterize the strategic implication. MINOR CONSIDERATIONS: The LLM adds slightly more specific detail about the company's actual financing approach (ordinary shares and share-repurchase programs) which, while not explicitly stated in the ground truth, is a reasonable inference from the data and enhances the answer without introducing inaccuracy. The formatting of dates and numbers is clear and consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 483,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Across Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the company’s exhibit list contains the same entry – Exhibit 4.6, the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041, dated February 8 2011.” The description and reference are identical in each year. This consistency indicates that Microsoft has continued to treat the 4.000 % Notes due 2021 as an unchanged, outstanding debt instrument, reporting it in the same supplemental indenture without material amendment or refinancing over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts but contains one significant discrepancy with the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies that Exhibit 4.6 appears consistently across 2022, 2023, and 2024 filings; (2) The date of February 8, 2011 is accurate; (3) The percentage rate of 4.000% is correct; (4) The maturity year of 2021 is correct; (5) The conclusion about consistency and unchanged treatment is sound; (6) The reasoning about no material amendments is appropriate. CRITICAL DISCREPANCY: The ground truth states the exhibit is listed as 'Third Supplemental Indenture' with only the 4.000% Notes due 2021 mentioned, while the LLM answer includes additional notes (2.500% Notes due 2016 and 5.300% Notes due 2041) in the same exhibit description. This is a material difference in how the exhibit is characterized. The LLM's version appears to show a more comprehensive exhibit description that bundles multiple note instruments together, which differs from the ground truth's simpler characterization. QUANTITATIVE ACCURACY: All numbers, dates, and percentages are correct (9/10 - minor point deduction for the exhibit description discrepancy). QUALITATIVE ACCURACY: The reasoning about consistency and unchanged treatment is sound, but the characterization of what the exhibit contains differs from ground truth (7/10). CONTEXTUAL RELEVANCE: The answer appropriately addresses the multi-hop question about how disclosure evolved across three years and what it indicates about debt treatment (8/10). The answer would have scored 9-10 if the exhibit description matched the ground truth exactly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 449,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s most recent pension‑risk transfer was the August 2021 purchase of group‑annuity contracts that moved $4.9 billion of gross pension obligations to an insurer, taking the cumulative amount transferred since 2018 to roughly $11.6 billion [page 60]. The 2023 filing merely says the company “expects to continue to evaluate” such transactions but reports no new transfer amount [page 19], and the 2024 filing repeats that it will “look for opportunities” without disclosing any additional transfer [page 47]. This pattern shows that after a large 2021 transfer, the firm has not added further sizable risk‑transfer deals through 2024, indicating a long‑term liability strategy that secured a substantial reduction in pension exposure and now focuses on maintaining that lower liability base while monitoring for future opportunities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial figures and dates. Strengths: (1) Correctly identifies the August 2021 group-annuity contract transfer of $4.9 billion and the cumulative $11.6 billion since 2018, matching ground truth numbers exactly. (2) Accurately characterizes the 2023 and 2024 filings as showing continued evaluation/monitoring without new major transfers. (3) Provides specific page references (60, 19, 47) that add credibility. (4) The multi-hop synthesis is sound—correctly traces the evolution from 2021 through 2024 and draws a logical conclusion about the strategy shift from active transfers to maintenance/monitoring. (5) Quantitative accuracy is excellent with all dollar amounts and dates correct. Minor weaknesses: (1) The ground truth mentions the $69 million annual PBGC premium elimination, which the LLM answer omits—this is a detail that adds context to the liability reduction impact. (2) The ground truth emphasizes 'sustained strategy' and 'deliberate, multi-year approach' more explicitly, while the LLM frames it as a shift from active transfers to monitoring, which is a slightly different emphasis (though not contradictory). (3) The LLM's interpretation that 'no new transfer' occurred through 2024 is accurate but could have been more explicitly tied to the 2022 baseline mentioned in ground truth. The answer correctly synthesizes information across three years of filings and provides sound reasoning about the company's liability management strategy. The characterization of the strategy as securing 'substantial reduction' and then 'maintaining that lower liability base' is logically sound and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 471,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "- In the 2022 Form 10‑K the 0.125 % Notes due 2029 are disclosed as “Form of Current Note for 0.125 % Notes due 2029 – incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8‑K filed September 18 2020” and again as “Form of Current Note for 0.125 % Notes due 2029 – incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8‑K filed March 9 2021”【page_134】.  \n\n- The 2023 and 2024 Form 10‑Ks repeat the identical language and the same two Exhibit 4.4 references (September 18 2020 and March 9 2021 8‑K filings) for the 0.125 % Notes due 2029【page_130】.  \n\nThis unchanged treatment across three consecutive 10‑K filings shows Coca‑Cola has consistently structured and reported the 0.125 % Notes due 2029, indicating a stable debt‑instrument framework with no material amendments or re‑issuances over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about the 0.125% Notes due 2029 across three consecutive 10-K filings. STRENGTHS: (1) All specific dates are correct (September 18, 2020 and March 9, 2021 Form 8-K filings), (2) The percentage rate (0.125%) and maturity year (2029) are accurately stated, (3) The core finding of consistency across 2022, 2023, and 2024 filings matches the ground truth, (4) The LLM correctly identifies that the same Exhibit 4.4 references appear in all three years, (5) The reasoning about stable debt-instrument framework and no material amendments is sound and well-supported, (6) The answer properly synthesizes information across three separate filing years. MINOR CONSIDERATIONS: (1) The ground truth mentions specific Exhibit numbers (4.23 and 4.31) where the notes appear, while the LLM answer does not explicitly reference these exhibit numbers - however, the LLM does cite page numbers (134, 130) which serve a similar locating function, (2) The LLM's conclusion about 'short-to-medium-term financing needs' is not explicitly stated in the LLM answer, though the answer does characterize it as a 'stable debt-instrument framework,' which is semantically equivalent. QUANTITATIVE VERIFICATION: All dates, percentages, and year references are factually correct. The multi-hop synthesis correctly connects information across three separate 10-K filings and identifies the consistent treatment pattern. The answer directly addresses how disclosure evolved (it didn't - remained identical) and what this reveals about consistency, fully answering both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 454,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s accrued liability for performance and operating‑cost guarantees fell from **$1.109 billion at 12/31/2022** to **$1.091 billion at 12/31/2023** and then to **$0.993 billion at 12/31/2024**【page_100†L31-L38】【page_104†L31-L38】. The steady decline—about $116 million (≈10 %) over the three‑year span—indicates that the company’s exposure to long‑term product‑performance risk in its commercial‑aerospace business is easing, likely reflecting lower warranty claims, improved engine reliability and more conservative accruals.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides completely different financial figures than the ground truth. The LLM claims RTX's accrued liability for performance and operating-cost guarantees was $1.109 billion (2022), $1.091 billion (2023), and $0.993 billion (2024). However, the ground truth explicitly states the collaboration partners' share of financing guarantees was $141 million (2022), $135 million (2023), and $131 million (2024)—a difference of approximately 7-8x in magnitude. The LLM's numbers appear to reference a different liability category entirely, not the performance and operating cost guarantees specified in the question. The LLM's calculation of a $116 million decline (≈10%) is mathematically correct for its stated figures ($1.109B - $0.993B = $116M), but these figures do not match the ground truth data. The ground truth indicates a decline from $141M to $131M ($10M decline, ≈7%), which the LLM completely missed. The LLM's interpretation that the trend indicates 'easing exposure' and 'lower warranty claims' is reasonable reasoning, but it is built on incorrect foundational numbers. The LLM failed to identify the correct liability figures and appears to have cited different line items from the 10-K filings. This represents a fundamental failure in multi-hop synthesis and data extraction from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 376,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic still values its non‑qualified stock options with the Black‑Scholes model, but the model inputs have been updated. The volatility assumption rose from roughly 23 % in FY 2022 to about 24.3 % in FY 2024, while the risk‑free rate and dividend yield were also increased (0.90 % → 4.16 % and 1.95 % → 3.18 % respectively), resulting in a lower weighted‑average option fair‑value ($22.8 million in 2022 vs $18.5 million in 2024). These changes suggest Medtronic now assumes slightly higher stock‑price volatility and uses higher market‑based discount rates, reflecting a more aggressive, market‑aligned approach to equity‑compensation risk modeling.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical data (volatility percentages, risk-free rates, dividend yields, and fair values) that cannot be verified against the ground truth provided. The ground truth focuses on the evolution of disclosure methodology and transparency around volatility assumptions (historical vs. implied volatility sourcing), while the LLM answer pivots to specific quantitative changes in model inputs and outputs. Critical issues: (1) The LLM provides precise numbers (23% to 24.3% volatility, $22.8M to $18.5M fair values) without source verification - these specific figures are not present in the ground truth and may be fabricated or misattributed. (2) The LLM's core narrative differs fundamentally from ground truth: Ground truth emphasizes improved disclosure transparency and market-informed methodology (implied volatility from market-traded options), while LLM focuses on directional changes in input parameters. (3) The LLM's conclusion about 'more aggressive, market-aligned approach' contradicts the ground truth's emphasis on refined methodology and transparency rather than aggressive modeling. (4) The LLM fails to address the key ground truth finding about the evolution from 2022 (blend of historical/implied) to 2023-2024 (explicit disclosure of market-traded option sourcing). (5) The claim that weighted-average fair value decreased from $22.8M to $18.5M despite higher volatility and rates is presented without explanation of offsetting factors, suggesting incomplete analysis. The answer demonstrates partial understanding of Black-Scholes model mechanics but fundamentally misses the qualitative evolution in disclosure practices that the question and ground truth emphasize. The specific numerical claims require verification against actual 10-K filings and cannot be accepted as accurate based on the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 506,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 1.000 % notes due 2028 are shown in each filing – they appear as Exhibit 4.26 (Form of Note for 1.000 % Notes due 2028) in the 2022 10‑K【page_135】, are listed again in the 2023 10‑K’s exhibit schedule【page_136】, and remain in the 2024 10‑K’s exhibit index【page_130】. The unchanged inclusion of this low‑rate, 2028‑maturing tranche across three years suggests Coca‑Cola is retaining the original issuance as a stable, inexpensive source of medium‑term debt rather than repeatedly issuing new notes at that rate.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that the 1.000% Notes due 2028 appear consistently across 2022, 2023, and 2024 filings, with accurate exhibit references (4.26 for 2022, exhibit schedules for 2023 and 2024). The numeric values (1.000%, 2028 maturity) are correct. However, the answer has significant limitations: (1) It focuses narrowly on exhibit documentation rather than substantive debt strategy analysis. (2) It completely omits the critical strategic insight from the ground truth—that 2024 saw introduction of significantly higher-yielding notes (5.000% due 2034, 5.300% due 2054), which is essential to understanding the company's debt strategy evolution. (3) The LLM's conclusion that KO is 'retaining the original issuance as a stable, inexpensive source' is incomplete and misses the broader strategic shift toward more aggressive borrowing terms. (4) The multi-hop reasoning is weak—the answer fails to synthesize the comparative analysis across years that would reveal the strategic shift. The ground truth explicitly states this shift 'suggests a broader strategic shift toward issuing higher-interest debt' and implies 'more aggressive borrowing terms in 2024.' The LLM answer addresses only half the question (the 1.000% Notes consistency) while ignoring the critical context of what changed in 2024 (higher-yielding instruments). This is a partial answer that lacks the synthesis needed for a complete multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 399,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "In the 2022 Form 10‑K Microsoft disclosed its 2.125 % notes in two supplemental indentures – the Fourth Supplemental Indenture (2.125 % notes due 2022) and the Seventh Supplemental Indenture (2.125 % notes due 2021) – both tied to the May 18 2009 base indenture and administered by The Bank of New York Mellon Trust Company, N.A., and issued together with other series such as 0.875 % notes due 2017, 3.500 % notes due 2042 and 3.125 % notes due 2028【page_104】. The 2023 and 2024 filings repeat the same trustee arrangement and reference the same supplemental indentures, with the 2.125 % notes remaining part of the existing debt pool and no new trustee or additional related debt instruments introduced【page_104】. This shows that Microsoft’s structuring of the 2.125 % notes stayed consistent across the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces incorrect note details not in the ground truth - it mentions '2.125% notes due 2022' (Fourth Supplemental Indenture) and lists associated instruments like '0.875% notes due 2017' and '3.500% notes due 2042' that are not mentioned in the original answer. The ground truth specifically references '2.125% Notes due 2021' (Seventh Supplemental Indenture), not 2022. (2) ENTITY ACCURACY: The LLM correctly identifies The Bank of New York Mellon Trust Company, N.A. as trustee and mentions the May 18, 2009 base indenture, which adds detail not in the ground truth but appears plausible. However, the introduction of the Fourth Supplemental Indenture and the 2022 maturity date contradicts the ground truth's focus on the 2021 maturity date. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize across three years and concludes consistency (matching the ground truth's conclusion), the specific instruments cited are different, suggesting either fabrication or confusion of different note series. (4) COMPLETENESS: The LLM does address the three-year period and trustee arrangements, but the specific details about which supplemental indentures and associated instruments are incorrect. The ground truth emphasizes the Seventh Supplemental Indenture for 2.125% Notes due 2021, while the LLM introduces a Fourth Supplemental Indenture for 2.125% Notes due 2022. (5) SEMANTIC EQUIVALENCE: While both answers conclude consistency across years, the factual basis differs significantly, making the conclusions unreliable. The LLM appears to have hallucinated or confused specific instrument details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 473,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program‑share in the International Aero Engines (IAE) joint venture – which runs the V2500 engine – stayed at **57 %**, and its net share in International Aero Engines LLC – which develops the PW1100G‑JM for the Airbus A320neo – remained at **51 %** from 2022 through 2024【page_99】. The 2024 filing repeats the same percentages, confirming no change in ownership stakes【page_102】. This steady, majority‑interest position shows RTX continues to hold a dominant strategic foothold in the V2500 program and a controlling stake in the PW1100G‑JM program, reinforcing its long‑term commitment to these key commercial‑engine products.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the evolution of net program share interests from 2022 to 2024. According to the ground truth, there WAS a significant change: (1) In 2022, program share interest was 61% for IAE and 59% for IAE LLC. (2) By 2023, net program share interest DECREASED to 57% for IAE and 51% for IAE LLC. (3) In 2024, these percentages remained stable at 57% and 51%. The LLM incorrectly claims the percentages 'stayed at 57% and 51% from 2022 through 2024,' which contradicts the ground truth showing a decline from 2022 to 2023. This is a major multi-hop synthesis error - the question specifically asks about the EVOLUTION from 2022 to 2024, and the LLM failed to capture the 2022-to-2023 transition. The LLM also mischaracterizes the 57% and 51% stakes as 'majority-interest' and 'controlling stake,' which is misleading given these are net program shares after sub-collaborator adjustments, not ownership percentages. The ground truth indicates 49.5% ownership interest in IAE in 2022, which is NOT a majority stake. The LLM's conclusion about 'dominant strategic foothold' and 'controlling stake' overstates RTX's actual position. While the LLM correctly identifies the 2023-2024 stability and the engine programs involved (V2500 and PW1100G-JM), it fundamentally misses the key evolution pattern that the question asks about. The answer demonstrates incomplete multi-hop reasoning by failing to synthesize the 2022 baseline with the 2023-2024 progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 422,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s 401(k) and other defined‑contribution plan expenses rose from **$402 million in 2022** to a peak of **$468 million in 2023**, then slipped slightly to **$443 million in 2024** – still above the 2022 level【page_68】. The upward swing in 2023 and the higher‑than‑2022 spending in 2024 indicate the company has been increasing (and now sustaining) its investment in employee‑benefit programs, underscoring a continued focus on supporting its workforce.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's defined contribution plan contributions were $402 million in 2022, but the ground truth clearly shows $299 million in 2022. This is a significant discrepancy of $103 million (34% overstatement). The 2023 ($468 million) and 2024 ($443 million) figures are correct. IMPACT ON ANALYSIS: Because the 2022 baseline is wrong, the LLM's interpretation of the trajectory is fundamentally flawed. The LLM claims '2024 spending in 2024 – still above the 2022 level' and 'the company has been increasing (and now sustaining) its investment,' but this conclusion is based on a false 2022 number. The actual trajectory shows: $299M (2022) → $468M (2023) → $443M (2024), which represents a 56.5% increase from 2022 to 2023, then a 5.3% decline in 2024 but still 48.2% above 2022. The LLM's characterization of 'sustained' investment is somewhat accurate in spirit (2024 is still above 2022), but the reasoning is built on incorrect data. CORRECT ELEMENTS: The 2023 and 2024 figures are accurate; the general narrative about increased workforce investment is directionally correct; the company name (Thermo Fisher/TMO) is correct; the time period is correct. INCORRECT ELEMENTS: The 2022 baseline of $402M should be $299M; this cascades into incorrect percentage comparisons and analysis. The multi-hop synthesis is partially sound (comparing across three years) but undermined by the factual error in the starting point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 403,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Coca‑Cola’s 10‑K filings show that the 3.000 % Notes due 2051 have been a recurring long‑term debt instrument: the 2022 report lists a Form of Note for 3.000 % Notes due 2051 (see page 136); the 2023 filing includes the same note (see page 134); and the 2024 filing again references it (see page 130). The fact that this low‑coupon, 30‑year‑plus bond appears in each year’s exhibit schedule indicates the company’s strategy of maintaining a stable, low‑cost, ultra‑long‑dated debt base to lock in financing, manage interest‑rate risk and preserve liquidity in its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the 3.000% Notes due 2051 appeared in Coca-Cola's 10-K filings across 2022, 2023, and 2024, and accurately characterizes the instrument as a low-coupon, long-dated debt component. However, there are significant gaps and issues: (1) MISSING CRITICAL INFORMATION: The LLM completely omits the introduction of new higher-coupon instruments (5.000% Notes due 2034 and 5.300% Notes due 2054) in 2024, which is a key part of the ground truth answer and essential to understanding the capital structure evolution. The ground truth explicitly states this diversification with higher-yielding instruments, which the LLM fails to mention. (2) PAGE REFERENCES: The LLM provides specific page numbers (136, 134, 130) that cannot be verified against the ground truth, which references exhibit numbers instead. This introduces unverifiable specificity. (3) REASONING QUALITY: While the LLM's interpretation of the strategy (maintaining stable, low-cost debt to manage interest-rate risk) is reasonable and partially aligns with the ground truth, it lacks the crucial insight about portfolio diversification in response to changing market conditions. The ground truth emphasizes 'balancing long-term obligations with current market interest rate conditions' through the addition of higher-yielding instruments, which the LLM misses entirely. (4) COMPLETENESS: The answer addresses the 3.000% Notes continuity but fails to address the full evolution of the capital structure strategy across the three-year period. The progression narrative is incomplete without discussing the new instruments introduced in 2024. (5) QUANTITATIVE ACCURACY: The coupon rate (3.000%) and maturity year (2051) are correct, but the absence of the 5.000% and 5.300% instruments represents a significant factual omission rather than a calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 502,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first disclosed the 2.875 % Notes due 2031 as a new issuance in its 2022 Form 10‑K (exhibit 4.16, issued March 24 2021) 【page_114】. The same series appears in the 2023 and 2024 Form 10‑Ks (exhibit 4.14) as an outstanding obligation 【page_111】. This continuity shows Oracle’s strategy of adding low‑coupon, medium‑term bonds to its debt mix and keeping them on the balance sheet to extend its maturity profile and lock in favorable long‑term financing costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2.875% Notes due 2031 as appearing in Oracle's 2022, 2023, and 2024 10-K filings, and accurately notes the exhibit references (4.16 in 2022, 4.14 in 2023-2024). The core observation about continuity across the three-year period is correct. CRITICAL WEAKNESSES: (1) The LLM provides a specific issuance date (March 24, 2021) that is not verified in the ground truth and appears to be an unsupported detail. (2) The LLM completely misses the key strategic insight from the ground truth: the introduction of NEWER, HIGHER-YIELDING notes (4.500% Notes due 2028 and 4.900% Notes due 2033) in 2024 alongside the 2.875% Notes. This is the crucial element showing Oracle's debt portfolio diversification strategy and shift toward higher-coupon instruments. (3) The LLM's interpretation focuses narrowly on the 2.875% Notes as a 'low-coupon, medium-term bond' strategy but fails to contextualize this within the broader portfolio evolution described in the ground truth. (4) The LLM does not address the strategic shift toward 'higher interest instruments as market conditions evolved' - a key component of the original answer's analysis of Oracle's long-term debt strategy. (5) The answer lacks the comparative analysis across the three years that would demonstrate how the debt strategy evolved, instead treating it as static continuity. The LLM answer is partially correct on basic facts but fundamentally incomplete in addressing the multi-hop synthesis required by the question, particularly regarding the strategic evolution and portfolio diversification aspects that are central to understanding Oracle's long-term debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 456,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “2.000% Notes due 2023” in the Eleventh Supplemental Indenture exhibit (see page 105). By repeatedly disclosing this tranche, Microsoft signals that it retains a stable, long‑term financing component and follows a disciplined debt‑management policy, while the consistent annual reporting underscores its commitment to transparent communication of outstanding obligations to investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Microsoft's consistent disclosure of the 2.000% Notes due 2023 across 2022, 2023, and 2024 10-K filings, and appropriately interprets this as signaling stable debt management and transparent communication. The answer accurately captures the key insight that repeated disclosure demonstrates disciplined financial stewardship and investor transparency.\n\nSTRENGTHS:\n- Correctly identifies the specific debt instrument (2.000% Notes due 2023)\n- Accurately references the Eleventh Supplemental Indenture\n- Properly identifies all three relevant years (2022, 2023, 2024)\n- Correctly interprets the strategic implications (stable financing, transparent communication, disciplined debt management)\n- Maintains semantic equivalence with ground truth regarding the meaning of consistent disclosure\n\nWEAKNESSES:\n- The LLM answer is more concise and omits some contextual details present in the ground truth, specifically: (1) the specific date of the Eleventh Supplemental Indenture (August 8, 2016), (2) the explicit mention that the notes were \"first introduced in the 2022 filing,\" (3) the reference to how this supports \"favorable credit ratings,\" and (4) the specific mention that filing details like \"interest rate, maturity date, trustee\" remained unchanged\n- The citation to \"page 105\" is specific but not verified against the ground truth, which doesn't provide page numbers\n- Slightly less comprehensive in explaining the full scope of what \"consistent liability structure\" means\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across three years of filings and draws appropriate conclusions about Microsoft's debt management strategy. The reasoning is sound: consistent disclosure → stable financing component → disciplined policy → transparent communication.\n\nNUMERIC/FACTUAL VERIFICATION:\n- 2.000% interest rate: CORRECT\n- \"Notes due 2023\": CORRECT\n- Three years (2022, 2023, 2024): CORRECT\n- Eleventh Supplemental Indenture reference: CORRECT\n- No calculations required for this qualitative question\n\nThe answer is substantially correct and addresses the question appropriately, though it could have been more comprehensive in capturing all the nuances present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 611,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s contingent payments to Rolls‑Royce for V2500‑powered flight hours were estimated at $735 million for 2022, rose to $1.053 billion in 2023, and are projected at $765 million in 2024 (“Other commercial aerospace commitments” → $735 m, $1,053 m, $765 m)【page_112】. The company notes that these payments arise under the 2012 IAE acquisition and are capitalized as collaboration intangible assets as they are made【page_110】【page_73】【page_103】. The peak in 2023 followed by a decline in 2024 signals that RTX’s exposure to Rolls‑Royce is front‑loaded and will taper off as the V2500 fleet ages and the payment period ends in June 2027, reducing long‑term liability under the agreement.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer provides specific dollar amounts ($735M for 2022, $1.053B for 2023, $765M for 2024) that cannot be verified against the ground truth and appear to be fabricated. The ground truth explicitly states that the payments were 'categorized under Other commercial aerospace commitments' and discusses the accounting treatment (capitalization and amortization), but does NOT provide specific dollar amounts for these contingent payments across the three years. The LLM has invented precise financial figures with page citations that do not support these numbers. Additionally, the LLM's interpretation that 'the peak in 2023 followed by a decline in 2024 signals that RTX's exposure to Rolls-Royce is front-loaded' is speculative and not supported by the ground truth, which indicates a 'stable long-term financial exposure.' The ground truth emphasizes the consistent accounting treatment and recognition pattern across all three years, whereas the LLM focuses on a narrative of declining exposure based on unverified numbers. The LLM does correctly identify: (1) the 2012 IAE acquisition agreement, (2) V2500-powered aircraft, (3) the June 2027 end date, (4) capitalization as collaboration intangible assets, and (5) amortization to cost of sales. However, these correct elements are overshadowed by the fabrication of specific payment amounts and the mischaracterization of the exposure trend. The multi-hop reasoning is compromised because it rests on false quantitative premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 418,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "Thermo Fisher’s domestic pension plan held **$89 million in U.S. equity funds in 2022**, grew to **$93 million in 2023**, and was **$91 million at year‑end 2024**【page_57†L31-L38】【page_71†L31-L38】.  Relative to total domestic plan assets, the equity share rose from roughly **9.5 % (2022)** to **≈10.2 % (2024)**【page_57†L31-L38】【page_71†L31-L38】, indicating a modest but steady move toward the company’s stated target of about 10 % of pension assets in U.S. equities and a gradual increase in domestic equity exposure while still emphasizing fixed‑income investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth across all three years: (1) 2022: LLM states $89M, ground truth is $125M (error of -$36M or -28.8%); (2) 2023: LLM states $93M, ground truth is $89M (error of +$4M or +4.5%); (3) 2024: LLM states $91M, ground truth is $93M (error of -$2M or -2.1%). The LLM has essentially reversed the 2022 and 2023 values. The percentage calculations (9.5% to 10.2%) cannot be verified as correct given the wrong dollar amounts. Most critically, the LLM's narrative conclusion is inverted from ground truth: it claims a 'steady move toward' and 'gradual increase in domestic equity exposure,' when the actual data shows a significant DECREASE from $125M to $89M (2022-2023), representing a cautious reduction strategy, with only a modest rebound to $93M in 2024. The LLM fundamentally mischaracterizes the 3-year trajectory and strategic implications. The multi-hop synthesis failed because the underlying numbers are wrong, making all downstream analysis incorrect. The company name (TMO/Thermo Fisher) is correct, but this cannot offset the severe quantitative errors that are the core of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 340,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "In the 2022 filing Coca‑Cola’s long‑term debt program still relied on ultra‑low‑coupon, ultra‑long‑dated securities, most notably a 1.000 % note maturing in 2041 【page_136】. By the 2024 filing the company broadened that strategy, issuing a new series of higher‑yielding notes—e.g., 5.000 % due 2034, 5.300 % due 2054, 5.400 % due 2064, 4.650 % due 2034 and 5.200 % due 2055 【page_130】—showing a shift toward diversifying its debt mix and taking advantage of higher‑interest opportunities while still retaining the earlier low‑coupon issuance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Coca-Cola's debt strategy evolution. STRENGTHS: (1) All coupon rates and maturity years are correct (1.000% due 2041, 5.000% due 2034, 5.300% due 2054, 5.400% due 2064). (2) The LLM correctly identifies the strategic shift from ultra-low-coupon instruments in 2022-2023 to higher-yielding notes in 2024. (3) The multi-hop synthesis is sound—comparing debt instruments across three years and identifying the pattern of evolution. (4) The LLM adds additional notes (4.650% due 2034, 5.200% due 2055) not mentioned in the ground truth, which provides supplementary accurate information. (5) The reasoning about market conditions and portfolio recalibration is logically sound. MINOR WEAKNESSES: (1) The ground truth explicitly mentions the 0.400% Notes due 2030 (2022) and 0.950% Notes due 2036 (2023) as examples of earlier lower-yielding instruments, which the LLM does not specifically cite. However, the LLM does acknowledge the general pattern of 'ultra-low-coupon' instruments in earlier years. (2) The ground truth emphasizes the consistent reference to the 1.000% Notes across all three years with specific exhibit citations (Exhibit 4.33), while the LLM mentions the note but doesn't emphasize the consistency across all three years or provide exhibit references. (3) The phrase 'while still retaining the earlier low-coupon issuance' in the LLM answer is slightly ambiguous—it could be clearer whether this refers to the 1.000% note specifically or the general strategy. QUANTITATIVE VERIFICATION: All percentages and years are accurate. No calculation errors detected. The LLM correctly identifies the coupon rate progression (1.000% → 5.000-5.400% range). MULTI-HOP REASONING: The answer successfully synthesizes information across 2022, 2023, and 2024 filings, identifying the strategic evolution and market-driven shift. The logic connecting low-rate environment (2022-2023) to higher-rate environment (2024) is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 548,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the low‑cost 1.650 % Notes due 2026 in its debt portfolio in each of its 2022, 2023 and 2024 10‑K filings (see Exhibit 4.16 in 2022 [page 114] and Exhibit 4.14 in 2023/2024 [page 111]), indicating a deliberate reliance on inexpensive, long‑dated financing. At the same time, the company added higher‑coupon issuances—such as 5.800 % notes due 2025 in 2022 [page 111] and 4.500 % notes due 2028 in 2023/2024 [page 111]—to diversify funding sources and meet liquidity needs, reflecting a strategy that blends cheap, stable debt with newer, higher‑rate instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM contains a significant factual error regarding the timing of the 5.800% Notes due 2025. The ground truth states these notes were introduced in 2023, but the LLM claims they were added in 2022. This is a major error that contradicts the original answer. Additionally, the LLM states the 4.500% Notes due 2028 were added in 2023/2024, while the ground truth specifies they were introduced in 2024. These timing errors are critical for understanding Oracle's debt financing strategy across the three-year period. (2) EXHIBIT REFERENCES - The LLM provides specific page numbers (114, 111) that cannot be verified against the ground truth, which only references exhibit numbers without page citations. While exhibit numbers are correctly cited (4.16 for 2022, 4.14 for 2023/2024), the page numbers may be inaccurate or irrelevant. (3) MULTI-HOP REASONING - The LLM does correctly synthesize the core concept that Oracle maintained low-cost debt (1.650% Notes) while introducing higher-rate instruments, which aligns with the ground truth's characterization of a dual strategy. However, the chronological errors undermine the validity of this synthesis. (4) COMPLETENESS - The LLM addresses the main elements of the question (continued inclusion of 1.650% Notes, introduction of higher-rate notes, strategic implications), but the factual errors regarding when specific notes were introduced significantly detract from the answer's reliability. The ground truth clearly states 5.800% Notes were introduced in 2023, not 2022, which is a fundamental factual error that affects the entire narrative of Oracle's financing strategy across these years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 465,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s FY 2022, FY 2023 and FY 2024 10‑K filings all contain Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” – showing that the 4 % notes remain on the company’s books and are repeatedly disclosed each year【page_104】. This consistent inclusion signals a disciplined long‑term debt strategy in which Microsoft tracks outstanding maturities and keeps its documentation current, positioning the notes for orderly refinancing or rollover as they approach maturity.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - the 4.000% Notes due 2021, 2.500% Notes due 2016, and 5.300% Notes due 2041 are accurately cited. (2) The fiscal years (2022, 2023, 2024) are correct. (3) The core fact that these notes appear consistently in Exhibit 4.6 across all three years is accurate. (4) The reference to the Third Supplemental Indenture is correct. (5) Number formatting is appropriate.\n\nWEAKNESSES: (1) The LLM answer significantly omits a critical detail from the ground truth: the 4.000% Notes due 2021 were already past their maturity date (2021) when included in 2022, 2023, and 2024 filings. The ground truth explicitly notes this as 'even after the notes' due date in 2021' - a key insight about why their continued inclusion is notable. The LLM fails to address this temporal anomaly. (2) The LLM misses the administrative maintenance detail about the trustee name update in 2024 ('The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences), which the ground truth identifies as a notable but minor change. (3) The LLM's interpretation about 'positioning the notes for orderly refinancing or rollover as they approach maturity' is problematic because the notes had already matured by 2022 - this suggests the LLM may have misunderstood the temporal context. (4) The ground truth emphasizes 'absence of refinancing disclosures or new tranches' as evidence of no active restructuring, but the LLM only vaguely references 'orderly refinancing or rollover.' (5) The LLM answer is less comprehensive in explaining the strategic implications - it doesn't fully address why continued inclusion of already-matured debt is significant for understanding Microsoft's debt management strategy.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and identifies the consistent pattern, but fails to synthesize the temporal relationship between the maturity date (2021) and the filing years (2022-2024), which is crucial to answering the question about what this pattern 'indicates' about debt management strategy.\n\nSEMANTIC EQUIVALENCE: While the LLM's statement about 'disciplined long-term debt strategy' and 'keeps its documentation current' is reasonable, it doesn't capture the full strategic insight that the ground truth provides - that the continued inclusion of already-matured debt without refinancing activity indicates stability and lack of active restructuring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 654,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s exposure to commercial‑aerospace customer‑financing guarantees has been shrinking – the maximum‑potential payment fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024【page_100†L1-L4】【page_104†L1-L4】.  At the same time, the portion of those guarantees taken on by collaboration partners has also declined – from roughly $142 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100†L13-L15】【page_104†L13-L15】 – indicating that RTX is progressively shifting more of the financing‑guarantee risk to its partners as part of a deliberate risk‑transfer strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides collaboration partners' share figures ($142M, $135M, $131M) that match the ground truth, BUT introduces INCORRECT total exposure figures ($304M, $288M, $274M in 2022-2024) that are NOT mentioned in the original answer and appear to be fabricated or from different contexts. These total figures cannot be verified against the ground truth provided. (2) DIRECTIONAL REASONING ERROR - The LLM states RTX is 'progressively shifting more of the financing-guarantee risk to its partners,' which is BACKWARDS from the correct interpretation. The declining collaboration partners' share ($142M→$135M→$131M) actually indicates RTX is ASSUMING MORE direct financial risk, not shifting it to partners. The ground truth explicitly states this 'indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk.' (3) MISSING KEY CONTEXT - The LLM omits the important detail that 'RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values.' (4) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the three-year trend in collaboration partners' share, it fundamentally misinterprets what this trend means for RTX's risk transfer strategy, reaching the opposite conclusion from the ground truth. The introduction of unverified total exposure figures ($304M-$274M) further undermines credibility. The answer demonstrates partial data accuracy but severe reasoning errors on the core question about risk transfer strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 469,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950 % senior notes due 2056, issued under the Eleventh Supplemental Indenture in 2016, appear unchanged in the long‑term debt disclosures of the FY 2022, FY 2023 and FY 2024 10‑K filings (see Exhibit 4.14 on page 105 of each report). The fact that this 40‑year, low‑coupon bond is retained year‑after‑year without new issuances or retirements indicates that Microsoft deliberately relies on very long‑dated, fixed‑rate debt to lock in low borrowing costs and preserve financing flexibility for decades ahead.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key facts are accurate - the 3.950% Notes due 2056 are correctly identified, the Eleventh Supplemental Indenture date of August 8, 2016 is correct, and the consistent presence across FY 2022, 2023, and 2024 filings is accurately stated. (2) The numeric details are precise: the coupon rate (3.950%), maturity year (2056), and the characterization as a 40-year bond are all correct. (3) The multi-hop synthesis is sound - the answer correctly traces the debt instrument across three fiscal years and identifies the pattern of stability. (4) The interpretation of capital strategy is reasonable and well-supported: the answer infers that Microsoft's retention of this long-term, fixed-rate debt without modifications indicates a deliberate strategy to lock in low borrowing costs and maintain financing flexibility. MINOR WEAKNESSES: (1) The LLM adds interpretive analysis about Microsoft's strategic intent (\"deliberately relies on very long-dated, fixed-rate debt to lock in low borrowing costs\") that goes slightly beyond what the ground truth explicitly states. While this inference is logical and reasonable, the ground truth uses more cautious language (\"suggests that Microsoft maintained a steady long-term financing strategy\"). (2) The reference to \"Exhibit 4.14 on page 105\" is specific but cannot be verified against the ground truth provided, though it appears plausible. (3) The ground truth emphasizes \"no changes to the terms or status\" while the LLM emphasizes \"no new issuances or retirements\" - these are related but slightly different framings. QUANTITATIVE VERIFICATION: All numbers check out - 3.950% coupon, 2056 maturity, 2016 indenture date, and the three-year period (2022-2024) are all accurate. The characterization of a 40-year bond (2016 to 2056) is mathematically correct. OVERALL ASSESSMENT: The answer demonstrates strong understanding of the multi-hop question, correctly synthesizes information across three fiscal years, and provides accurate financial details. The slight addition of strategic interpretation, while reasonable, represents a minor departure from the more conservative ground truth framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 595,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical‑and‑strike missile programs moved from a modest production ramp‑up that added about $145 million of net sales in 2023 (driven by JASSM, LRASM and precision‑fire production) to a much larger surge that added roughly $1.2 billion in 2024 (driven by GMLRS, LRASM and JASSM)【page_40】. Nevertheless, operating profit in the Missiles & Fire Control segment fell from $1.637 billion in 2022 to $1.541 billion in 2023 and then sharply to $413 million in 2024, pulling the company’s total operating profit down from roughly $7.5 billion in 2022 to $7.4 billion in 2023 and $6.1 billion in 2024【page_40】【page_41】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of production growth coupled with declining profitability, but has significant quantitative gaps and omissions. STRENGTHS: (1) Correctly identifies the production increases in 2023 ($145M) and 2024 ($1.2B) with correct program names (JASSM, LRASM, GMLRS, precision fires). (2) Accurately reports Missiles & Fire Control segment operating profit figures: $1.637B (2022), $1.541B (2023), $413M (2024). (3) Correctly states total company operating profit: ~$7.5B (2022), ~$7.4B (2023), $6.1B (2024). (4) Properly synthesizes the paradox of rising production volume with falling profitability. (5) Contextually relevant to the question asked. CRITICAL OMISSIONS: (1) Completely missing the 2022 production increase of $215M, which is a key data point in the three-year trajectory. The answer jumps from 2023 to 2024 without establishing the full 2022-2024 progression. (2) Missing the 2022 operating profit drivers (higher volume and risk retirements). (3) Missing the $45M in losses on classified program in 2023. (4) Missing the specific breakdown of 2024 profit decline: $1.2B in lower profit booking rate adjustments and $1.4B in losses on classified program. (5) Does not calculate or mention the 73% decline in operating profit from 2023 to 2024. CALCULATION VERIFICATION: The 2024 decline from $1.541B to $413M represents approximately 73% decrease, which matches ground truth but LLM doesn't explicitly state this. The answer provides accurate segment and company-level profit figures but lacks the detailed profit driver analysis that explains why production growth didn't translate to profit growth. The multi-hop reasoning is partially sound but incomplete—it identifies the paradox but doesn't fully explain the mechanisms (classified program losses, booking rate adjustments) that caused it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 500,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "In the 2022 10‑K Thermo Fisher listed the original Executive Change‑in‑Control Retention Agreement with Marc N. Casper (dated 21 Nov 2009) together with its 2010 amendment and its 2018 amendment, and it also disclosed a “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.18) 【page_46】.  \nThe 2023 filing added a refreshed officer‑specific form (Exhibit 10.17) filed in the quarter ended 1 Apr 2023, while still referencing the same 2009 agreement and the two earlier amendments 【page_77】.  \nThe 2024 10‑K continued to cite the 2009 agreement, the 2010 and 2018 amendments, and retained the 2023 officer form (Exhibit 10.17) with no further amendments introduced 【page_76】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific details that enhance the ground truth answer. STRENGTHS: (1) Correctly identifies all three years (2022, 2023, 2024) and the evolution of agreements; (2) Accurately names Marc N. Casper and the officer form distinction; (3) Provides specific dates (21 Nov 2009, 1 Apr 2023) and amendment years (2010, 2018) that add credibility; (4) Correctly identifies exhibit numbers (10.18 for 2022, 10.17 for 2023-2024); (5) Properly synthesizes the multi-hop information showing continuity across years; (6) Accurately conveys that 2024 had no new amendments. MINOR CONSIDERATIONS: (1) The ground truth states 'Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7' in 2023, while the LLM states Exhibit 10.17 - this is a discrepancy in exhibit numbering that could indicate either a filing variation or potential error, though the LLM's specificity suggests it may be referencing actual filing data; (2) The LLM provides more granular detail than the ground truth (specific dates, amendment years, exhibit numbers) which goes beyond but doesn't contradict the original answer; (3) The semantic meaning is fully preserved - both answers convey the same core narrative of agreement evolution and officer inclusion. QUANTITATIVE VERIFICATION: All dates mentioned (2009, 2010, 2018, 2022, 2023, 2024, April 1 2023, November 21 2009) are plausible and internally consistent. The exhibit number discrepancy (10.7 vs 10.17) is the only potential factual issue, but given the LLM's specificity and page references, this may reflect actual filing variations. MULTI-HOP REASONING: Excellent synthesis across three years showing how agreements evolved, which officers were covered, and what forms/amendments existed in each period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 497,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "In the 2022 filing LMT reported that the aggregate notional amount of its outstanding interest‑rate swaps – used as fair‑value hedges to convert fixed‑rate borrowings to variable‑rate – was $500 million at 12/31/2021 (and $572 million at 12/31/2020). By the 2023 filing the notional amount had risen to $1.3 billion and the 2024 filing shows the same $1.3 billion level at both 12/31/2024 and 12/31/2023. The jump from $500 million to $1.3 billion and the decision to hold that larger amount thereafter indicate that Lockheed Martin markedly expanded its swap program to hedge a greater share of its debt portfolio, reflecting a more aggressive and sustained interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported by the filing data. QUANTITATIVE ACCURACY: All numbers are correct - $500 million at 12/31/2021 (from 2022 filing), $1.3 billion at 12/31/2023 and 12/31/2024 (from 2023 and 2024 filings respectively). The LLM also correctly identifies the intermediate data point of $572 million at 12/31/2020, which adds credibility. The characterization of the increase as 'more than doubling' is mathematically accurate ($500M to $1.3B = 160% increase). ENTITY ACCURACY: Correctly identifies LMT (Lockheed Martin), the proper metric (notional amounts of interest-rate swaps), and all relevant fiscal years. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate filings (2022, 2023, 2024) and correctly traces the evolution of the hedging strategy. The reasoning that the increase reflects 'a more aggressive and sustained interest-rate risk-management strategy' is sound and aligns with the ground truth's assessment of a 'proactive approach' and 'robust interest rate risk mitigation posture.' COMPLETENESS: Addresses all parts of the question - the evolution from 2022-2024, the specific notional amounts, and what the changes indicate about strategy. The LLM provides slightly more specific detail about the purpose of the swaps (converting fixed-rate borrowings to variable-rate) which adds value. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM uses 'markedly expanded' and 'more aggressive' language versus the ground truth's 'significantly evolved' and 'proactive approach,' but these are semantically equivalent characterizations. The LLM's interpretation is perhaps slightly more emphatic but not inaccurate. Both answers correctly identify the stabilization at $1.3 billion in 2024 as indicating a consistent hedge profile going forward.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 494,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s 401(k) and other defined‑contribution plan expense was $402 million in 2022, rose to $468 million in 2023, and then fell slightly to $443 million in 2024【page_53】【page_67】. The jump from 2022 to 2023 signals a marked increase in the company’s contribution to employee benefits, while the modest decline in 2024—still above the 2022 level—suggests a slight scaling back after the 2023 boost but an overall continued commitment to supporting its workforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $402 million (2022), $468 million (2023), and $443 million (2024) match the ground truth exactly. The year-over-year progression is accurate. (2) ENTITY ACCURACY: Thermo Fisher Scientific is correctly identified, the metric (defined contribution plans/401(k)) is properly characterized, and all fiscal years (2022-2024) are correct. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend, correctly identifying the increase from 2022 to 2023 and the subsequent decline in 2024. The interpretation that 2024 remains above 2022 levels is accurate and demonstrates proper comparative analysis. (4) SEMANTIC EQUIVALENCE: The LLM's characterization of the trend as showing 'a marked increase in the company's contribution to employee benefits' followed by 'a slight scaling back after the 2023 boost but an overall continued commitment' is semantically equivalent to the ground truth's description of 'growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration.' Both convey the same substantive meaning. (5) MINOR OBSERVATION: The LLM provides slightly more nuanced interpretation by explicitly noting the 2024 level remains above 2022, which adds helpful context. The citation references (page_53, page_67) add credibility. No calculation errors, no missing data points, and the reasoning is sound and logical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 427,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "The 2022 10‑K (p. 40) first disclosed that non‑public equity investments are valued using discounted‑cash‑flow models, appraisals and “estimates of sales proceeds,” noting the difficulty of forecasting cash flows in emerging markets. The 2023 (p. 78) and 2024 (p. 78) filings repeat the same reliance on sales‑proceeds estimates (and the cost‑minus‑impairment measurement alternative), showing no change in methodology; this consistency, together with the 2022 note that the $87 million fair‑value shortfall for the Japan bottler was judged temporary and not impaired, reveals management’s confidence that it can predict a recovery in markets like Japan and that the investment’s value will rebound.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $87 million fair-value shortfall for Coca-Cola Bottlers Japan Holdings Inc. in 2022. (2) Accurately notes that management deemed this decline temporary and not impaired, indicating confidence in recovery. (3) Correctly identifies that the valuation methodology uses estimates of sales proceeds across 2022-2024. (4) Properly cites page numbers from the filings. (5) Quantitative accuracy is strong on the key number ($87 million). WEAKNESSES: (1) The LLM's core interpretation diverges significantly from the ground truth. The ground truth emphasizes an EVOLUTION in how the company approached valuation—moving from a simpler reliance on sales-proceeds estimates toward greater emphasis on market-participant assumptions and macroeconomic risk considerations. The LLM states 'showing no change in methodology,' which contradicts the ground truth's assertion of evolution. (2) The ground truth reveals that management became 'more attuned to external market perspectives and macroeconomic risks,' particularly in volatile regions. The LLM misses this nuance entirely, instead simply restating that consistency in methodology reveals confidence. (3) The LLM's conclusion that 'management's confidence that it can predict a recovery' is overstated. The ground truth suggests a more cautious evolution toward acknowledging external market perspectives and volatility, not undiminished confidence. (4) The LLM fails to capture the sophistication of the evolution: the company didn't just repeat the same approach; it increasingly emphasized what 'a market participant would use' in evaluating cash flows—a shift toward external benchmarking rather than internal confidence. (5) Missing the key insight that this evolution reveals management's growing awareness of macroeconomic risks and market volatility, especially in emerging markets like Japan. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years (2022-2024) but draws the wrong conclusion about what that synthesis reveals. It treats consistency as evidence of unchanged confidence, when the ground truth suggests the consistency masks a deeper evolution in perspective. The LLM's reasoning is logically coherent but factually misaligned with the ground truth's interpretation of what the evolution signifies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 623,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle first disclosed the 2.300 % Notes due 2028 as part of a new multi‑series issuance (along with 1.650 % notes due 2026, 2.875 % notes due 2031, etc.) that were issued under an officers’ certificate dated March 24 2021 and listed as Exhibit 4.16 in its 2022 10‑K【page_114】. The same 2.300 % Notes appear unchanged in the 2023 and 2024 10‑K exhibit tables (Exhibit 4.14) with identical terms, indicating the notes remain outstanding and are integrated into Oracle’s ongoing debt portfolio【page_111】【page_111】. This repeated, laddered inclusion across three years reflects a broader strategy of building a diversified, long‑dated debt base that locks in low‑cost financing and spreads maturities to manage interest‑rate and refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides accurate and specific details about the 2.300% Notes due 2028, including the issuance date (March 24, 2021), exhibit references (4.16 in 2022, 4.14 in 2023/2024), and companion instruments (1.650% notes due 2026, 2.875% notes due 2031). The core factual information is correct: the notes were issued in 2021 and remained outstanding across 2022-2024. However, there are notable differences from the ground truth answer: (1) The LLM focuses heavily on the issuance mechanics and exhibit details rather than the multi-year evolution pattern requested; (2) The ground truth emphasizes Oracle's strategy of issuing newer, higher-rate instruments (4.500% in 2023, 5.800% in 2024) alongside the older 2.300% notes, which the LLM answer does not mention; (3) The LLM's interpretation of the pattern as 'laddered inclusion' and 'diversified, long-dated debt base' is reasonable but differs from the ground truth's emphasis on managing refinancing needs amid rising interest rates and funding strategic initiatives. The LLM answer is more granular on technical details (exhibit numbers, issuance dates) but less comprehensive on the broader strategic narrative across the three fiscal years. The quantitative accuracy is strong (dates and percentages correct), but the qualitative analysis misses the key comparative element of newer, more expensive debt instruments being issued alongside the older notes, which is central to understanding Oracle's debt financing strategy during this period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 416,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s Form 10‑K filings for 2022, 2023 and 2024 all include the same “Officer’s Certificate” entry that lists the floating‑rate notes issued on May 6 2014, which comprised a tranche maturing in 2019 (see the “Floating Rate Notes due 2019” line in the exhibit table on page 56 of each filing)【page_56】. No new 2019‑dated floating notes appear in later years, showing that the 2019 series was fully repaid and not rolled over—Apple’s short‑term debt strategy therefore relies on issuing floating‑rate notes with fixed, near‑term maturities and then letting them mature rather than maintaining a revolving short‑term borrowing program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM claims the Floating Rate Notes due 2019 'was fully repaid and not rolled over,' but the ground truth explicitly states these notes 'continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period.' This is a fundamental contradiction. The notes were NOT fully repaid during 2022-2024; they remained on the books. (2) MISINTERPRETATION OF EVIDENCE - The LLM correctly identifies the May 6, 2014 Officer's Certificate appearing in all three years' filings, but then draws the wrong conclusion. The ground truth interprets this consistency as evidence the notes remained outstanding, while the LLM incorrectly infers they were repaid. (3) UNSUPPORTED CONCLUSION - The LLM's statement about Apple's 'short-term debt strategy' of 'letting them mature rather than maintaining a revolving short-term borrowing program' is not supported by the ground truth and appears to be speculation. The ground truth characterizes the approach as 'stable, rather than active, management' - a different characterization. (4) LOGICAL INCONSISTENCY - If the notes were 'fully repaid' as claimed, they would not appear in subsequent years' filings. The fact that they appear in 2022, 2023, and 2024 filings contradicts the repayment claim. (5) CORRECT ELEMENTS - The LLM correctly identifies: the May 6, 2014 issuance date, the consistent appearance across three years, and the absence of new issuances. However, these correct facts are used to support an incorrect conclusion. The core answer is fundamentally wrong on the key question of whether these notes remained outstanding or were repaid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 463,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s 4.000 % Senior Note due 2047 is listed in the exhibit tables of each of its recent 10‑K reports – it appears as Exhibit 4.17 in the 2022 filing (page 126) and as Exhibit 4.16 in the 2023 filing (page 127) and is carried forward into the 2024 filing – which signals that the company treats this long‑dated, low‑coupon bond as a permanent component of its capital structure, locking in financing for the next 25 + years. In contrast, the shorter‑term notes – the 2.150 % Senior Note due 2024 (Exhibit 4.18 on pages 126‑127) and the 0.750 % Senior Note due 2027 (Exhibits 4.28/4.30 on page 127) – are disclosed among many other maturities and are expected to be refinanced or retired as they approach, reflecting a laddered, near‑term debt‑management approach rather than a long‑term anchor.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic implications of PepsiCo's debt management but contains several factual inaccuracies that undermine its credibility. STRENGTHS: (1) Correctly identifies the 4.000% Senior Note due 2047 as consistently disclosed across multiple filings; (2) Accurately characterizes the strategic difference between long-term anchoring debt and shorter-dated refinancing instruments; (3) Properly synthesizes the multi-hop comparison between long-term and short-term notes; (4) Correctly identifies the 2.150% Senior Note due 2024 and 0.750% Senior Note due 2027 as shorter-dated instruments. CRITICAL ERRORS: (1) The LLM provides specific exhibit numbers (4.17, 4.16, 4.28/4.30) and page numbers (126, 127) that cannot be verified against the ground truth and appear to be fabricated or hallucinated details. The ground truth does not provide these specific exhibit citations; (2) The LLM states the 2.150% note is on 'pages 126-127' but the ground truth indicates it was 'referenced in 2023' without specifying page numbers; (3) The characterization of the 4.000% note as 'low-coupon' is questionable - at 4.000%, this is actually a relatively high coupon rate compared to the 0.750% and 2.150% notes mentioned, suggesting a misunderstanding of relative interest rate environments. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly compares the persistent presence of the 2047 note against the transient nature of shorter-dated instruments and draws appropriate conclusions about debt strategy. However, the fabricated exhibit numbers and page citations represent a serious accuracy problem that would mislead readers trying to verify the information. The ground truth mentions a 2.500% Senior Note due 2022 that matured by 2023, which the LLM answer does not address, representing an omission of supporting evidence. OVERALL ASSESSMENT: While the strategic analysis is largely correct and the reasoning is sound, the introduction of unverified specific citations (exhibit numbers, page numbers) and the characterization of 4.000% as 'low-coupon' constitute material factual errors that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 584,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple continues to list the 0.45 % Notes due 2016 in the exhibit index of its 2022, 2023 and 2024 Form 10‑K filings (see the “Officer’s Certificate… 0.45 % Notes due 2016” in Exhibit 4.3 on the index pages for 2023 & 2024 【page_56】). By keeping these matured securities in its disclosures year after year, Apple signals a disciplined approach that preserves a complete historical record of all debt issuances and ensures any residual accounting, legal or reporting obligations are transparently documented, reflecting a strategy of thorough oversight of legacy debt.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies the 0.45% Notes due 2016 and confirms their maturity in 2016; (2) Accurately references the three filing years (2022, 2023, 2024); (3) Correctly cites the Officer's Certificate dated May 3, 2013 as the consistent documentation reference; (4) Properly identifies Exhibit 4.3 as the location in the exhibit index; (5) Accurately characterizes Apple's strategy as maintaining transparency and comprehensive historical records of legacy debt; (6) Correctly synthesizes the multi-hop information (matured notes + continued disclosure across multiple years = deliberate strategy). MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth, omitting some nuance about 'investor clarity' and 'conservative approach to debt management'; (2) The phrase 'residual accounting, legal or reporting obligations' is somewhat speculative compared to the ground truth's more measured language about 'continuity in financial reporting'; (3) The ground truth emphasizes 'transparency around historical debt instruments' more explicitly as a core insight. QUANTITATIVE VERIFICATION: All numbers and dates are accurate (0.45%, 2016 maturity, 2022-2024 filings, May 3, 2013 certificate date). MULTI-HOP REASONING: The answer correctly synthesizes that (a) notes matured in 2016, (b) they appear in 2022-2024 filings, (c) same documentation referenced each time, therefore (d) deliberate disclosure strategy. This reasoning is sound and matches the ground truth's logic. The answer demonstrates proper understanding of the question's intent regarding legacy debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 464,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "- In the 2022 filing Lockheed Martin noted that, through its master retirement trust, it had already transferred roughly $11.6 billion of defined‑benefit pension obligations (including a $4.9 billion GAC purchase in August 2021) which produced a $1.7 billion non‑cash settlement charge but did not materially affect its FAS pension expense, and it said it would keep evaluating additional risk‑transfer transactions that could require extra contributions or non‑cash settlement charges to earnings【page_60】【page_61】.  \n\n- The 2023 report repeated this stance, emphasizing continued evaluation of GAC purchases and warning that any future pension‑risk transfers might trigger additional contributions or non‑cash earnings impacts【page_19】【page_21】.  \n\n- By 2024 the company still expressed intent to seek further pension‑risk transfer opportunities, noting that such deals could generate material non‑cash settlement charges, while also making a $990 million cash contribution to the plans and recovering $1.7 billion of CAS pension costs—showing a balanced approach of contributions alongside risk‑transfer activity【page_47】【page_49】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question about Lockheed Martin's pension risk transfer evolution from 2022-2024. STRENGTHS: (1) All key quantitative figures are correct: $11.6 billion cumulative obligation transfer, $4.9 billion GAC purchase in August 2021, $1.7 billion noncash settlement charge, $990 million 2024 cash contribution, and $1.7 billion CAS pension cost recovery. (2) Timeline is accurate across all three years (2022, 2023, 2024). (3) Multi-hop synthesis is sound: the answer correctly traces the evolution of strategy across three filing years, showing progression from initial disclosure through continued evaluation to ongoing commitment. (4) Entity identification is correct (Lockheed Martin, GACs, master retirement trust, FAS/CAS pension metrics). (5) The answer captures the core narrative: consistent, proactive de-risking approach with increasing scale and ongoing noncash charge impacts. MINOR CONSIDERATIONS: (1) The LLM answer includes slightly more operational detail (e.g., $990M contribution, $1.7B CAS recovery in 2024) than the ground truth summary, but this represents appropriate elaboration rather than error. (2) The ground truth emphasizes 'increasing scale' while the LLM focuses on 'balanced approach' - both interpretations are valid given the data. (3) Page citations in the LLM answer add credibility but cannot be verified against the ground truth format. The answer fully addresses all sub-questions: pension obligation reductions (amounts and cumulative totals), expected future actions (continued evaluation and pursuit), and financial impact (noncash charges, contributions, cost recovery). No calculation errors detected. Semantic equivalence is maintained throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 482,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "Thermo Fisher’s 2022 Form 10‑K still only showed the original Executive Change‑in‑Control Retention Agreement for CEO Marc N. Casper (Exhibit 10.12) but added, for the first time, a separate “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” as Exhibit 10.18 【page_46†L31-L38】. In the 2023 filing the Casper agreement (now Exhibit 10.11) and its 2010 and 2018 amendments remain, while the officer‑only form is updated and listed as Exhibit 10.7/10.17, explicitly extending the retention agreement to other officers 【page_76†L31-L38】. The 2024 10‑K continues to reference the same Casper agreement and the updated officer form (Exhibit 10.17), confirming that the broader coverage of officers beyond the CEO introduced in 2022 has been retained.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information about Thermo Fisher's executive retention agreements across 2022-2024. STRENGTHS: (1) Correctly identifies the key evolution: 2022 introduced a separate form for officers beyond Casper (Exhibit 10.18), 2023 updated this form (Exhibit 10.7/10.17), and 2024 continued with the updated form (Exhibit 10.17). (2) Accurately captures the progression from CEO-only agreement to broader officer coverage. (3) Properly identifies Marc N. Casper as the CEO and distinguishes his agreement from the officer form. (4) Correctly notes the 2010 and 2018 amendments to Casper's agreement. (5) Exhibit numbers are cited with appropriate specificity. (6) The multi-hop reasoning correctly synthesizes information across three years to show deliberate evolution. MINOR WEAKNESSES: (1) The LLM answer provides more granular exhibit number details than the ground truth (e.g., 'Exhibit 10.7/10.17' for 2023), which adds specificity but creates slight ambiguity about whether these are alternative designations or if there's a discrepancy. The ground truth simply states 'a new form...dated April 1, 2023' without exhibit numbers. (2) The LLM answer uses slightly more technical language with exhibit citations, which is more precise but differs in presentation style from the ground truth's more narrative approach. (3) The ground truth emphasizes 'formalization or continuation of updated terms' in 2024, while the LLM simply states 'confirming that the broader coverage...has been retained' - semantically equivalent but with slightly different emphasis. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024, March 16 2018, April 1 2023) align with ground truth. The progression of exhibit numbers appears consistent with typical SEC filing practices. No calculation errors present. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and correctly identifies the relationship between Casper's individual agreement and the broader officer form, demonstrating sound multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 568,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 10‑K exhibits for 2022, 2023 and 2024 all list the same **2.750 % Senior Note due 2051** (2022 exhibit 4.51 on page 128; 2023 exhibit 4.48 on page 129; 2024 exhibit 4.64 on page 130) 【page_128】【page_129】【page_130】. By repeatedly issuing and retaining a very long‑dated, low‑coupon bond, PepsiCo is locking in cheap fixed‑rate financing for the next three decades, a clear hedge against a rising‑interest‑rate environment and a cornerstone of its long‑term debt strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) EXHIBIT NUMBER ERRORS: The LLM provides specific exhibit numbers (4.51 for 2022, 4.48 for 2023, 4.64 for 2024) that cannot be verified against the ground truth. The ground truth references pages 135, 128, and 129 respectively but does NOT provide exhibit numbers. The LLM's exhibit citations appear to be fabricated or incorrectly inferred. (2) PAGE NUMBER DISCREPANCIES: The LLM states 2022 is on page 128, but ground truth indicates page 135. The LLM states 2023 is on page 129, but ground truth indicates page 128. The LLM states 2024 is on page 130, but ground truth indicates page 129. These are systematic off-by-one or larger errors. (3) FACTUAL ACCURACY ON CORE CLAIM: The LLM correctly identifies the 2.750% Senior Note due 2051 and its presence across all three years (2022-2024), which matches the ground truth. (4) INTERPRETATION QUALITY: The LLM's interpretation that PepsiCo is 'locking in cheap fixed-rate financing' and using this as 'a hedge against rising-interest-rate environment' is reasonable and aligns with the ground truth's conclusion about 'stable long-term capital strategy' and 'preserving access to long-dated, fixed-rate debt.' However, the LLM uses the phrase 'repeatedly issuing and retaining' which could imply new issuances, whereas the ground truth suggests consistent treatment of an existing note. (5) MISSING CONTEXT: The LLM does not mention the introduction of newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) that the ground truth highlights as important context for understanding the strategy. This omission weakens the multi-hop synthesis. (6) MULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails on citation accuracy, which undermines credibility even though the core logic is sound. The ground truth provides more nuanced evidence of consistency through exhibit index references and Form 8-K citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 517,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 are listed in the exhibit index of its 2022 Form 10‑K (Officer’s Certificate, exhibit 4.4)【page_56】, appear again in the 2023 filing’s exhibit list【page_55】, and are still referenced in the 2024 Form 10‑K exhibit index【page_56】. The fact that this 30‑year fixed‑rate bond is carried on the company’s balance sheet for three consecutive years shows Apple’s strategy of locking in low‑cost, long‑dated financing to diversify its capital structure and provide stable, predictable funding for the long term.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate multi-hop synthesis. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 across all three years (2022, 2023, 2024), matching the ground truth's core finding of consistent referencing; (2) Accurately cites the Officer's Certificate dated May 6, 2014 (exhibit 4.4) and correctly notes its appearance in exhibit indices across all three years; (3) Properly characterizes this as a 30-year fixed-rate bond, which is mathematically correct (2014 + 30 = 2044); (4) Provides sound strategic interpretation about locking in low-cost, long-dated financing and capital structure diversification, which aligns with the ground truth's conclusion about maintaining long-term debt at fixed rates for financial flexibility. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'low-cost' financing without noting that 4.45% may not have been particularly low at issuance in 2014, though this is a minor interpretive nuance; (2) The phrase 'carried on the company's balance sheet for three consecutive years' could be slightly misleading—the notes were issued in 2014 and continued to be outstanding, not newly issued in each year, though the LLM does clarify this is about consistent referencing in filings; (3) Slightly less explicit than ground truth about the absence of redemption or restructuring, though this is implied. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024) and connects the consistent presence of this debt instrument to strategic capital management conclusions. QUANTITATIVE VERIFICATION: All numbers are accurate—4.45% rate, 2044 maturity date, 30-year duration, exhibit references, and page numbers all check out. The answer maintains semantic equivalence with the ground truth while using slightly different phrasing ('locking in low-cost, long-dated financing' vs. 'strategic decision to retain long-term debt at a fixed rate').",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 534,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan trimmed its exposure to Collective Trust and Other Funds from **$498 million at NAV in 2022** to **$382 million at NAV in 2023** – a drop of roughly $116 million (2022 table shows $498 M [page 72]; 2023 table shows $382 M [page 58]). The 2024 filing clarifies that these holdings are **valued using each fund’s net‑asset‑value (NAV), which is based on the market prices of the publicly‑traded underlying assets** (valuation description for Collective Trust and Other Funds [page 56]), indicating that the plan’s management relies on transparent, market‑based pricing to monitor and adjust these investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect 2022 allocation figure of $498 million, when the ground truth clearly states $756 million in 2022. This is a material discrepancy of $258 million (34% understatement). The 2023 figure of $382 million is correct. The calculated difference of $116 million is therefore wrong; the correct difference should be $374 million ($756M - $382M). This represents a fundamental failure in quantitative accuracy on the primary metric of the question. VALUATION METHODOLOGY: The LLM's description of NAV-based valuation is partially correct but contains a subtle inaccuracy. The ground truth states NAV is 'derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments,' whereas the LLM claims NAV is 'based on the market prices of the publicly-traded underlying assets.' This oversimplifies the valuation approach and mischaracterizes the nature of the underlying investments (commingled funds and LLCs are not the same as publicly-traded assets). COMPLETENESS: The LLM addresses the evolution of allocations and the 2024 disclosure about valuation methodology, but the incorrect 2022 figure undermines the entire analysis. The LLM does not capture the ground truth's insight about 'deliberate rebalancing or risk management decision' versus valuation approach changes. MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and filings, the foundational quantitative error (2022 figure) cascades through the analysis, making the comparison and conclusions unreliable. The reasoning structure is sound, but it is built on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 466,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s exhibit tables in the FY 2022, FY 2023 and FY 2024 Form 10‑K all list Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 that includes the 1.05 % Notes due 2017 (see the exhibit listings on page 56 of each filing)【page_56†2022】【page_56†2023】【page_56†2024】. By keeping this certificate on file long after the notes matured, Apple demonstrates a practice of preserving documentation for historic debt and ensures that its capital‑structure history remains fully disclosed in its SEC reports.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All key facts are accurate - the Officer's Certificate is correctly dated May 6, 2014; the 1.05% Notes due 2017 are correctly identified; the three fiscal years (2022, 2023, 2024) are correct; Exhibit 4.4 designation is correct. (2) The numeric/date information is precise with no calculation errors. (3) The multi-hop reasoning is sound - the answer correctly synthesizes that Apple maintained this certificate across three years despite the notes maturing before this period, and draws the appropriate conclusion about documentation retention practices. (4) The semantic meaning aligns well with the ground truth answer - both convey that Apple deliberately preserves historical debt documentation for transparency and regulatory compliance. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual elaboration about 'investor and regulatory transparency' and 'full historical context of debt financing activities,' though these are implied. (2) The citation format (page references with brackets) is present but not essential to the factual accuracy. (3) The phrase 'ensures that its capital-structure history remains fully disclosed' is slightly less comprehensive than the ground truth's discussion of 'completeness and historical continuity in capital structure reporting.' These are minor omissions that don't affect the core correctness of the answer. The answer successfully demonstrates understanding of the multi-hop nature of the question (connecting document retention practices to disclosure strategy implications) and provides accurate supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 470,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan cut its equity exposure dramatically – equity securities (which include corporate stock) were 48 % of plan assets at 12/31/2022, fell to 24 % at 12/31/2023, and remained at 24 % at 12/31/2024 (the 2024 level sits within the 20‑30 % target range)【page_56】【page_55】.  This roughly‑halving of the equity allocation shows a clear de‑risking move, shifting the plan away from stocks toward a more debt‑heavy, lower‑volatility investment mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides percentage allocations (48%, 24%, 24%) while the ground truth provides absolute dollar amounts ($1,990M in 2022, $181M in 2023, $1,116M in 2024). These are fundamentally different metrics and cannot be directly compared. The LLM's percentages may be correct for what they represent, but they do NOT answer the question as posed in the ground truth, which specifically asks about 'allocation' in terms of dollar amounts. The ground truth clearly states the allocation 'significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024' - these are specific dollar figures that the LLM completely omits. The LLM's characterization of a 'roughly-halving' of equity allocation (from 48% to 24%) is mathematically correct for percentages but misses the more dramatic 90%+ decline in absolute dollar terms from 2022 to 2023. Additionally, the LLM states the 2024 level 'remained at 24%' which suggests stability, but the ground truth shows a significant rebound from $181M to $1,116M (a 516% increase), indicating substantial portfolio restructuring. The LLM correctly identifies the de-risking strategy and shift toward fixed income, which aligns with the ground truth's conclusion. However, the failure to provide the specific dollar amounts requested and the incomplete picture of the 2023-2024 rebound represent major factual omissions. The answer addresses the strategic implications but fails on quantitative accuracy of the primary metric requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 427,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales rose from $428 million in 2022 to $605 million in 2023 and then to $785 million in 2024 (page 130), reflecting roughly a 41% jump year‑over‑year in 2023 and a further 30% increase in 2024. This steady, high‑single‑digit to low‑double‑digit growth signals strong market adoption of the CMV‑prophylaxis drug and underscores its growing strategic weight within Merck’s Hospital Acute Care franchise.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) CALCULATION ERRORS: The LLM states a '41% jump year-over-year in 2023' but the actual calculation is ($605M - $428M) / $428M = 41.4%, which rounds to 41% - this is CORRECT. However, the LLM then states 'a further 30% increase in 2024' but the actual calculation is ($785M - $605M) / $605M = 29.75%, which rounds to 30% - this is also technically CORRECT. Upon closer inspection, both percentage calculations are accurate. (2) CHARACTERIZATION ERROR: The LLM describes the growth as 'steady, high-single-digit to low-double-digit growth' which is INCORRECT. The actual growth rates are 41% (2022-2023) and 30% (2023-2024), both of which are clearly DOUBLE-DIGIT growth, not 'high-single-digit to low-double-digit.' This is a significant mischaracterization of the growth trajectory. (3) NUMERIC ACCURACY: All dollar amounts ($428M, $605M, $785M) are correct and match the ground truth exactly. (4) ENTITY ACCURACY: Company (MRK/Merck), product (Prevymis), segment (Hospital Acute Care), and indication (CMV-prophylaxis) are all correctly identified. (5) MULTI-HOP SYNTHESIS: The answer correctly synthesizes the three-year sales trajectory and attempts to draw conclusions about market adoption and strategic importance. (6) SEMANTIC ISSUES: The phrase 'steady, high-single-digit to low-double-digit growth' contradicts the actual 30-41% growth rates presented, creating a fundamental inconsistency between the data presented and the interpretation offered. The ground truth simply states 'consistent market adoption and increasing strategic importance' without attempting to characterize the growth rate magnitude, which the LLM incorrectly does. This mischaracterization is a material error that undermines the credibility of the analysis despite correct underlying numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 490,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In PepsiCo’s 2022 Form 10‑K the 3.000 % Senior Note due 2027 is listed as an exhibit (“Form of 3.000 % Senior Note due 2027…” – page 127) and the same language and reference appear unchanged in the 2023 filing (page 126). By the 2024 filing the note no longer appears in the Item 15 exhibit list (pages 125‑129), indicating that the instrument has been retired or otherwise removed from the outstanding debt. This shift shows PepsiCo actively managing its long‑term capital structure—maintaining the note while it was outstanding and then eliminating it as it matured or was refinanced, reflecting a strategy of regularly updating and optimizing its debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that the 3.000% Senior Note due 2027 was 'consistently included in PepsiCo's annual filings across 2022, 2023, and 2024' and was 'again included' in 2023 and 'continued to be referenced' in 2024. However, the LLM claims the note 'no longer appears in the Item 15 exhibit list' by 2024, suggesting it was 'retired or otherwise removed from the outstanding debt.' This is a direct contradiction of the ground truth. The LLM also mischaracterizes the evolution of the note's presentation: the ground truth describes how the note appeared in different exhibit numbers (4.22 in 2022, 4.19 in 2023, 4.17 in 2024) and was presented alongside different peer instruments reflecting evolving debt strategy, whereas the LLM incorrectly claims the note disappeared from exhibits entirely. The LLM's interpretation of the note being 'retired or otherwise removed' is factually incorrect based on the knowledge graph. Additionally, the LLM provides specific page numbers (127, 126, 125-129) that cannot be verified against the ground truth and appear to be fabricated details. The core multi-hop reasoning is flawed because it reaches an incorrect conclusion about the note's status across the three-year period. While the LLM correctly identifies the company (PepsiCo), the years (2022, 2023, 2024), and the specific instrument (3.000% Senior Note due 2027), the fundamental claim about the note's disappearance is wrong, making this answer substantially incorrect despite some surface-level accuracy in entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 447,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "Adobe’s 2022 filing (pages 95‑99) contains no discussion of Frame.io, so the service was not highlighted as part of Adobe’s product suite at that time. In the 2023 10‑K, Frame.io is described as a cloud‑native creative‑collaboration platform that is “directly integrated with Adobe Premiere Pro, Adobe After Effects, Adobe Photoshop, Adobe Lightroom and Adobe Workfront” and offers “Camera‑to‑Cloud” video‑upload functionality (see page 12). By the 2024 filing, Frame.io’s role has broadened – it now supports “still images, design files and PDFs” and is offered through Adobe GenStudio for large‑scale content production, indicating a deeper, cross‑app integration across the Creative Cloud ecosystem (see page 12).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Frame.io was NOT mentioned in Adobe's 2022 filing, but the ground truth explicitly states it was 'listed as part of Adobe's trademark portfolio' in 2022. This is a fundamental factual error about a core claim. (2) INCORRECT TIMELINE - The LLM attributes features to 2023 that the ground truth assigns to 2024 (support for still images, design files, PDFs). The ground truth clearly states these were introduced in 2024, not 2023. (3) INCOMPLETE 2023 DESCRIPTION - The LLM's 2023 description omits the 'real-time upload, review, and approval features' mentioned in ground truth, and doesn't mention the introduction of support for still images, design files, and PDFs (which belong to 2024). (4) MISSING 2024 CONTEXT - The LLM mentions GenStudio but fails to emphasize Frame.io's positioning as a 'core component' alongside Firefly and Substance 3D tools, which represents the strategic deepening highlighted in ground truth. (5) MISSING PROGRESSION NARRATIVE - The LLM fails to capture the strategic evolution showing deepening integration and central role in Adobe's end-to-end creative workflow ecosystem. The answer does correctly identify some 2023-2024 integrations (Photoshop, Lightroom, Workfront, GenStudio) but the chronological misplacement and omission of 2022 activity are critical errors that undermine the multi-hop synthesis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 412,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 2.40 % notes that mature in 2023 were first disclosed in the 2022 Form 10‑K’s exhibit list (see page 56, Exhibit 4.3 – “Officer’s Certificate … 2.40 % Notes due 2023”). The 2023 filing retained the same Exhibit 4.3 reference, and the 2024 Form 10‑K again lists the 2.40 % Notes due 2023 in Exhibit 4.3 with identical wording (page 56). The unchanged, year‑over‑year disclosure shows Apple’s disciplined practice of keeping near‑term debt on its public schedule and signalling that it is monitoring and will either repay or refinance the notes as the maturity date approaches.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that 'By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits,' indicating the notes were retired/fulfilled by their 2023 due date. However, the LLM claims 'the 2024 Form 10-K again lists the 2.40% Notes due 2023 in Exhibit 4.3 with identical wording (page 56).' This is a direct contradiction of the ground truth and represents a major factual error. The LLM also provides specific page references (page 56, Exhibit 4.3) that cannot be verified and appear to be fabricated details. REASONING ISSUES: The LLM's conclusion about Apple's strategy is fundamentally flawed because it is based on the incorrect premise that the notes were still listed in 2024. The ground truth correctly identifies that the absence of the notes in 2024 reveals a 'strategy of holding debt until maturity rather than refinancing or repurchasing it early.' The LLM instead suggests Apple was 'monitoring and will either repay or refinance,' which misses the key insight that the notes were actually retired at maturity. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year progression (2022→2023→2024) that is central to the question. The ground truth correctly traces the evolution showing presence in 2022-2023 and absence in 2024, leading to the correct conclusion about debt maturity management. The LLM's claim of continued presence through 2024 breaks this logical chain. COMPLETENESS: While the LLM attempts to address the evolution question, it does so with incorrect information, making the answer fundamentally incomplete and misleading regarding the actual debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 480,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet fell from roughly 7,150 units in 2022 (about 6,100 owned + ≈1,050 leased; average age ≈23.5 years) to 7,008 units in 2023 (5,971 owned, 1,037 leased; avg. age 24.3 years) and then to 6,893 units in 2024 (5,973 owned, 920 leased; avg. age 25.2 years)【UNP_10k_2022.pdf page_22】【UNP_10k_2023.pdf page_19】【UNP_10k_2024.pdf page_19】. The steady drop in total and especially leased units, together with a rising average age, shows Union Pacific is retiring older locomotives and reducing lease reliance, reflecting a disciplined asset‑management strategy aimed at a leaner, more mature fleet to improve utilization and control costs.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES (Primary Problem): The LLM provides significantly different numbers for 2022 than the ground truth. Ground truth states 7,242 total units in 2022 (6,204 owned + 1,038 leased), but LLM claims ~7,150 units (6,100 owned + ~1,050 leased). This is a material discrepancy of ~92 units in total fleet and ~104 units in owned fleet for 2022. The 2023 and 2024 figures are more accurate (2023: 7,008 vs ground truth's implied ~7,000; 2024: 6,893 matches). Average age figures for 2023 (24.3 years) and 2024 (25.2 years) are correct, but 2022 average age is stated as ~23.5 years when ground truth shows 22.5 years—a 1-year discrepancy. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes data across three years and identifies the trend of declining total units and leased units. The progression is logically presented with proper source citations. REASONING QUALITY: The interpretation that Union Pacific is 'retiring older locomotives and reducing lease reliance' is reasonable but slightly differs from ground truth's characterization of 'lack of significant new investment' and 'reliance on aging assets.' The LLM's framing is more positive (disciplined strategy) while ground truth emphasizes aging fleet concerns. Both interpretations are defensible from the data, but they reflect different analytical perspectives. COMPLETENESS: The answer addresses fleet composition changes, age profile progression, and strategic implications as requested. However, the 2022 baseline numbers are materially incorrect, which undermines confidence in the entire analysis. The owned/leased breakdown is provided for all three years as required. ENTITY ACCURACY: Union Pacific and Multiple Purpose Locomotives are correctly identified. Years are correct. CRITICAL ISSUE: The 2022 numbers are sufficiently inaccurate (off by ~1-2% in total units, ~1.7% in owned units, and 4.4% in average age) to constitute a significant factual error in a financial analysis context where precision matters.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 539,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "In the 2022 10‑K Merck listed MK‑8591A (doravirine + islatravir) as a Phase 2 HIV‑1 candidate and noted it was “on FDA clinical hold” (page 23). The 2023 filing reported that the regimen moved into a Phase 3 program that began in 2023 for treatment‑naïve and switch patients, while the FDA hold on the islatravir component remained in effect (page 21). By the 2024 filing the program was described as a Phase 2/3 study that started in August 2024, and the FDA lifted the clinical hold on December 4 2024 (though a partial hold for higher islatravir doses persisted) (page 24).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth: (1) 2022 Phase Classification: LLM states MK-8591A was 'Phase 2' in 2022, but ground truth clearly indicates it was already in 'Phase 3' with an entry date of February 2020. This is a fundamental error in clinical development stage. (2) 2023 Status: LLM claims the program 'moved into a Phase 3 program that began in 2023,' but ground truth states it 'remained in Phase 3' - implying it was already in Phase 3, not newly entering. This misrepresents the timeline. (3) 2024 Phase Designation: LLM describes it as 'Phase 2/3 study that started in August 2024,' but ground truth indicates MK-8591A 'remained in development' in Phase 3, while a NEW formulation (MK-8591D) entered Phase 3 in October 2024. The LLM conflates two different compounds and misidentifies the phase progression. (4) FDA Clinical Hold Timeline: LLM states the hold was lifted on 'December 4, 2024,' but ground truth only indicates the hold was lifted in 2024 without specifying December 4. More critically, the LLM's narrative about when the hold was imposed and lifted doesn't align with the ground truth's description of the hold status across years. (5) Missing Key Information: The LLM fails to mention the strategic pivot to MK-8591D (islatravir+lenacapavir) entering Phase 3 in October 2024, which is a critical element of the multi-year trajectory. The ground truth emphasizes this as evidence of 'a strategic pivot or expansion in Merck's HIV-1 treatment approach.' (6) Multi-hop Synthesis: The LLM does not properly synthesize the evolution across three years, particularly the distinction between MK-8591A remaining in Phase 3 while a new formulation (MK-8591D) advanced. The answer conflates the two compounds and misrepresents the regulatory trajectory. The LLM answer demonstrates fundamental misunderstanding of the clinical development phases and fails to capture the key strategic elements of Merck's HIV-1 program evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 543,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck first disclosed MK‑1308A in its 2022 filing as the co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab, “being evaluated for the treatment of RCC” (page 23). In the 2023 filing the candidate was highlighted under the company’s immuno‑oncology pillar and listed among the RCC programs (pages 20‑22), and the 2024 filing continues to feature MK‑1308A as a co‑formulation for RCC within the immuno‑oncology pipeline (pages 50‑51). This progression—from an early‑stage candidate to a strategically emphasized combination checkpoint‑inhibitor asset—demonstrates Merck’s growing commitment to innovative immunotherapy approaches for renal cell carcinoma.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies MK-1308A as a quavonlimab + pembrolizumab coformulation for RCC, accurately traces its presence across 2022-2024 filings, and appropriately characterizes the progression as demonstrating Merck's strategic commitment to combination immunotherapies. The semantic understanding of the drug's positioning within the immuno-oncology pillar is sound. WEAKNESSES: (1) CRITICAL OMISSION - The LLM fails to mention the April 2021 entry date that the ground truth specifically cites as evidence of 'early-stage strategic commitment' in 2022. This is a factual detail that appears in the source material and is important for establishing the timeline. (2) CHARACTERIZATION DISCREPANCY - The LLM describes the progression as 'from an early-stage candidate to a strategically emphasized combination checkpoint-inhibitor asset,' but the ground truth indicates MK-1308A was already listed as Phase 3 in 2022 (not early-stage), suggesting it was already more advanced than the LLM's framing implies. (3) DEPTH OF ANALYSIS - While the LLM mentions page numbers (which adds credibility), it provides less analytical depth than the ground truth regarding the 'deeper investment' signaled by 2023 emphasis and the 'sustained strategic prioritization' indicated by 2024 continuation without discontinuation. (4) QUANTITATIVE PRECISION - The ground truth provides specific phase information (Phase 3) and temporal markers (April 2021 entry date) that the LLM omits, reducing quantitative accuracy. The LLM's answer is directionally correct and captures the main narrative arc, but lacks the specific factual details and precise characterization of the development stage that ground truth provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 469,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s 4.000 % Notes due 2021 appear unchanged – each filing lists them under Exhibit 4.6, the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041” dated Feb 8 2011【page_104】. This consistent disclosure shows the company has kept the note on its balance sheet rather than retiring or refinancing it, suggesting a stable, long‑term debt portfolio and a deliberate strategy of holding certain debt to maturity instead of frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 4.000% Notes due 2021 appear consistently across 2022, 2023, and 2024 10-K filings under Exhibit 4.6. The date of February 8, 2011 is correctly cited. The percentage rate (4.000%) is accurate. The LLM correctly notes the Third Supplemental Indenture structure and the related notes (2.500% due 2016, 5.300% due 2041). The interpretation that consistent disclosure suggests stable debt management is reasonable.\n\nWEAKNESSES: (1) The LLM states the notes appear 'unchanged' but provides limited evidence of actual comparison across the three years - it doesn't explicitly verify that the same exhibit structure, dates, and references appear identically in all three filings. (2) The original answer references the original Indenture dated May 18, 2009, which the LLM omits entirely - this is a material detail about the debt structure's historical foundation. (3) The LLM's interpretation that the company 'kept the note on its balance sheet rather than retiring or refinancing it' is somewhat speculative. The ground truth more carefully states 'no material changes' and 'no refinancing or restructuring occurred' - the LLM goes further in asserting a deliberate strategy without explicit evidence. (4) The LLM doesn't address whether these notes were actually due in 2021 and what happened to them (they should have matured by 2022), which is a critical gap in the multi-hop analysis. The ground truth's statement about notes 'due 2021' appearing in 2022-2024 filings is itself unusual and suggests either the notes were refinanced/rolled over or the disclosure is historical. The LLM fails to address this temporal inconsistency.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years but doesn't rigorously verify the consistency claim or address the logical puzzle of why notes 'due 2021' would appear in 2024 filings. The reasoning about debt strategy is somewhat superficial.\n\nNUMERIC/DATE VERIFICATION: The 4.000% rate, February 8, 2011 date, and Exhibit 4.6 reference are correct. However, the absence of discussion about the May 18, 2009 Indenture date (from ground truth) represents incomplete information gathering.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 591,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 filing already framed its automotive push as a “digital‑cockpit” transformation – the QCT segment was described as supplying “automotive systems for connectivity, digital cockpit and ADAS/AD” and the MD&A noted that “digitalization of the automotive cockpit continues to transform the in‑vehicle experience”【page_7】.  The company’s disclosed automotive revenue (which includes digital‑cockpit sales) grew from $1,509 million in FY 2022 to $1,872 million in FY 2023 and then to $2,910 million in FY 2024【page_73】.  This accelerating revenue trend shows Qualcomm moving the automotive business from a modest, ancillary line to a rapidly expanding growth engine, underscoring its strategic shift from a handset‑centric model toward a broader, software‑defined‑vehicle platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that Qualcomm's automotive revenue grew substantially from FY2022 to FY2024 ($1,509M → $1,872M → $2,910M), demonstrating accurate financial data extraction and calculation of growth trajectory. (2) The LLM correctly notes that digital cockpit was already mentioned in 2022 filings as part of automotive systems alongside connectivity and ADAS/AD. (3) The conclusion about strategic shift toward software-defined vehicles is sound and aligns with ground truth. (4) Revenue numbers appear accurate and properly formatted.\n\nWEAKNESSES: (1) The LLM answer focuses heavily on revenue numbers but largely omits the strategic positioning evolution that was central to the original answer. The ground truth emphasizes a three-stage evolution: 2022 (identification/projection), 2023 (explicit categorization as distinct revenue stream), 2024 (full operationalization). The LLM conflates 2022 and 2023, suggesting digital cockpit was already formally categorized in 2022 when the ground truth indicates this formalization occurred in 2023. (2) The LLM misses the specific forward-looking projections from 2022 (70% of vehicles with embedded cellular by 2028, 60% with 5G) that were important to demonstrating strategic vision. (3) The LLM doesn't clearly articulate the progression from 'key driver identification' (2022) → 'distinct revenue stream categorization' (2023) → 'core product line operationalization' (2024), which is the core narrative of the ground truth. (4) The multi-hop synthesis is incomplete: while the LLM connects revenue growth to strategic shift, it doesn't fully synthesize the evolution of how Qualcomm formally reported and positioned digital cockpit across the three-year period.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting revenue data to strategic positioning, but fails to fully synthesize the temporal evolution of how digital cockpit was categorized and reported across 2022-2024. The ground truth shows a clear progression in formal recognition and reporting, which the LLM doesn't adequately capture.\n\nNUMERIC VERIFICATION: Revenue figures ($1,509M FY2022, $1,872M FY2023, $2,910M FY2024) appear consistent with typical Qualcomm automotive segment reporting and show correct growth trajectory calculations. No calculation errors detected in the revenue progression presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 636,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT reported $1.3 billion of outstanding interest‑rate swaps in its 2022 filing and the same $1.3 billion figure appears again in the 2023 and 2024 filings【page_95】【page_52】.  Holding the notional amount steady for three consecutive years shows the company has settled on a consistent level of variable‑rate swap hedges, using them to maintain a stable hedge of its interest‑rate exposure rather than expanding or scaling back its risk‑management program.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The LLM states that LMT reported $1.3 billion in outstanding interest-rate swaps in its 2022 filing, but the ground truth clearly establishes that in 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. This is a major quantitative error ($500M vs $1.3B for 2022). The LLM correctly identifies the 2023 and 2024 figures as $1.3 billion, but the misstatement of the 2022 figure undermines the entire analysis. The ground truth explicitly describes a 'fourfold increase from 2022 to 2023' (from $500M to $1.3B), which represents a significant strategic shift in interest rate risk management. The LLM's characterization of 'holding the notional amount steady for three consecutive years' is factually incorrect because the 2022 amount was different. The LLM also misses the key insight from the ground truth: the significant increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. Instead, the LLM incorrectly suggests stability across all three years. The reasoning about 'settling on a consistent level' and 'maintaining a stable hedge' is based on the false premise that all three years had the same notional amount. While the LLM's interpretation of what stable hedging means is reasonable, it is applied to incorrect data. The multi-hop synthesis fails because the model did not correctly identify the evolution pattern (increase from 2022 to 2023, then stabilization in 2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 452,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all continue to list the 3.950 % senior notes due 2056 as part of the “Eleventh Supplemental Indenture” dated August 8 2016, with no mention of redemption or refinancing [page 105]. By keeping the same long‑dated, low‑cost issuance on its balance sheet across three successive years, Microsoft signals a deliberate strategy of preserving long‑term debt to diversify its maturity profile and lock in favorable rates rather than pursuing early refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 3.950% Notes due 2056 are consistently referenced across 2022, 2023, and 2024 10-K filings, (2) they are part of the Eleventh Supplemental Indenture dated August 8, 2016, (3) there is no mention of redemption or refinancing, and (4) this reflects a deliberate strategy of preserving long-term debt. All numeric values (3.950%, 2056, August 8, 2016) are accurate. The answer correctly synthesizes the multi-hop information across three years of filings. However, the LLM answer is somewhat less comprehensive than the ground truth in several respects: (1) it does not explicitly mention the contrast with shorter-term instruments that matured or approached maturity (2.000% Notes due 2023, 2.400% Notes due 2026), which is an important contextual element showing the strategic maturity management approach; (2) it does not address the broader context of 'evolving market interest rates' that influenced the strategy; (3) the phrase 'lock in favorable rates' is somewhat speculative compared to the ground truth's more measured language about 'capital stability.' The LLM's interpretation that this reflects 'diversifying maturity profile' is reasonable but slightly different from the ground truth's emphasis on 'preserving long-term capital stability.' The citation to 'page 105' adds specificity but cannot be verified against the ground truth. Overall, the core answer is factually sound and addresses the main question, but lacks some of the nuanced contextual details present in the ground truth regarding the interplay between long-dated and shorter-term debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 448,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 2022, 2023 and 2024 Form 10‑K exhibit lists all include “Exhibit 4.14 – Eleventh Supplemental Indenture dated August 8 2016,” which contains the 3.700 % senior notes that mature in 2046【page_105†L1-L4】. By repeatedly referencing this same supplemental indenture, Microsoft shows that the 3.700 % Notes due 2046 remain outstanding and are still governed by the 2009 base indenture framework, underscoring a long‑term debt program built on fixed‑rate senior notes and a consistent, unchanged financial‑obligation structure over the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies all key factual elements: the Eleventh Supplemental Indenture dated August 8, 2016, the 3.700% Notes due 2046, the base Indenture dated May 18, 2009, and the consistent references across 2022, 2023, and 2024 filings. All dates and percentages are accurate. The answer appropriately notes that the notes remain outstanding and governed by the 2009 base indenture framework, demonstrating understanding of the hierarchical debt structure. However, the LLM answer is somewhat less comprehensive than the ground truth in several respects: (1) It does not explicitly address the significance of the 'consistent inclusion across three consecutive annual reports' as evidence of ongoing relevance and no material amendments or retirements; (2) It does not fully elaborate on how this reflects 'a deliberate and stable long-term debt management strategy' or 'multi-decade financial planning'; (3) The phrase 'unchanged financial-obligation structure' is present but less developed than the ground truth's discussion of 'obligations tied to the 2046 Notes were active and ongoing.' The LLM answer is more concise and exhibit-focused (mentioning 'Exhibit 4.14'), which adds specificity but slightly shifts emphasis from the broader strategic implications. The multi-hop reasoning is sound—correctly synthesizing that repeated references indicate ongoing obligations and structural consistency—but the answer could have provided deeper insight into what this consistency means for the company's long-term financial strategy. No calculation errors or factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 441,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "In the FY 2022 10‑K Microsoft still reported the 2.125 % senior notes that mature in 2021 as a component of its long‑term debt and referenced them in the Seventh Supplemental Indenture (Exhibit 4.10) [page_104]. By the FY 2023 filing the same exhibit is listed but the notes no longer appear on the balance sheet, with a footnote indicating they were redeemed at maturity in 2021, and the FY 2024 filing keeps the exhibit only for historical reference while the notes are absent from the debt schedule [page_104]. This shows Microsoft let the 2.125 % notes run to maturity and then retired them rather than rolling them over, reflecting a disciplined debt‑management strategy that prefers to pay off maturing obligations instead of refinancing them.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims the notes 'matured in 2021' and were 'redeemed at maturity in 2021,' but the ground truth explicitly states the notes were 'due 2021' and that they were still being referenced in 2022, 2023, and 2024 filings - meaning they had already matured before the 2022 filing period. The LLM's timeline is internally inconsistent: if notes matured in 2021, they should not appear on the 2022 balance sheet as claimed. (2) FACTUAL INACCURACY: The ground truth indicates the notes were 'consistently referenced' across all three years (2022, 2023, 2024) in exhibit disclosures, with no clear evidence they were removed from balance sheets or marked as redeemed. The LLM asserts they 'no longer appear on the balance sheet' in FY 2023 and are 'absent from the debt schedule' in FY 2024, but the ground truth does not confirm this - it only notes they remained in exhibit disclosures. (3) REASONING FLAW: The LLM concludes Microsoft 'let the 2.125% notes run to maturity and then retired them' and 'prefers to pay off maturing obligations instead of refinancing them.' However, the ground truth explicitly states the persistence of references 'may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings' - the ground truth is uncertain about what actually happened, while the LLM presents a definitive but unsupported conclusion. (4) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the multi-year disclosure pattern. The ground truth shows consistent references across 2022-2024 with no documented change in status, while the LLM invents a narrative of removal from balance sheets without evidence. (5) EXHIBIT REFERENCE ACCURACY: Both answers reference page 104 and exhibits, but the LLM incorrectly claims the exhibit location changed from 4.10 to 4.1, while the ground truth shows 4.10 in 2022 and 4.1 in 2023-2024 - a minor point but the LLM doesn't clearly distinguish this evolution. The core problem is that the LLM provides a confident narrative about debt retirement that contradicts the ground truth's acknowledgment of uncertainty about the notes' actual status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 616,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft’s 2.000 % Notes due 2023 first appear in the Eleventh Supplemental Indenture (dated August 8 2016) and are listed under Exhibit 4.14 in the FY 2022, FY 2023 and FY 2024 10‑K filings 【page_105】. The same tranche is shown unchanged across the three reports, indicating that Microsoft has kept this medium‑term, low‑coupon debt outstanding rather than issuing new notes or retiring it, which reflects a debt‑management strategy that locks in inexpensive financing and staggers maturities to preserve liquidity and smooth interest‑expense over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key facts are accurate - correctly identifies the 2.000% Notes due 2023, the Eleventh Supplemental Indenture dated August 8, 2016, and confirms presence across FY 2022, 2023, and 2024 filings. (2) Numeric accuracy is strong - the coupon rate (2.000%), date (August 8, 2016), and fiscal years are all correct. (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three fiscal years and draws appropriate conclusions about debt management strategy. (4) The interpretation of the pattern (unchanged across three years = stable debt management approach) aligns with the ground truth's conclusion about 'stable and long-term approach to debt management.' (5) The additional context about 'locking in inexpensive financing' and 'staggering maturities' provides reasonable elaboration on debt strategy. MINOR WEAKNESSES: (1) The LLM adds interpretive details ('locks in inexpensive financing and staggers maturities to preserve liquidity') that go slightly beyond what the ground truth explicitly states, though these are reasonable inferences. (2) The reference to 'Exhibit 4.14' and 'page_105' adds specificity not in the ground truth, which is helpful but not verified against the original source. (3) The phrase 'medium-term, low-coupon debt' is reasonable characterization but not explicitly stated in ground truth. Overall, the answer demonstrates strong understanding of the multi-hop question, correct identification of all entities and dates, accurate synthesis across fiscal years, and sound reasoning about debt management implications. The core message matches the ground truth: Microsoft maintained this debt obligation consistently across the period, reflecting a stable debt management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 492,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "Lockheed Martin’s 2022 filing disclosed that it had purchased a group‑annuity contract (GAC) on August 3 2021 that transferred **$4.9 billion** of gross defined‑benefit pension obligations (part of **$11.6 billion** transferred since 2018) and recognized a **$1.7 billion non‑cash pension settlement charge** for that transaction【page_60】. The 2023 filing said the company still uses GACs to mitigate pension risk but gave no new transfer amount, noting that future GACs “could result in us making additional contributions to the pension trust and/or require us to recognize non‑cash settlement charges”【page_19】. The 2024 filing reiterated the same approach—continuing to look for pension‑risk‑transfer opportunities and warning that any future deals could generate material non‑cash settlement charges—without disclosing a new large‑scale transfer【page_47】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and dates. All major numbers are accurate: $4.9 billion transferred in August 2021 GAC, $11.6 billion cumulative since 2018, and $1.7 billion noncash settlement charge. The multi-hop synthesis across 2022-2024 filings is sound, correctly capturing the evolution of LMT's pension risk transfer strategy. The answer appropriately notes the absence of new large-scale transfers disclosed in 2023-2024 while maintaining the company's stated intent for future transactions. One minor omission: the ground truth mentions the $69 million annual PBGC premium reduction benefit from the 2021 transaction, which the LLM answer does not include. This is a contextual detail that would have strengthened the answer's completeness regarding 'financial impact.' The LLM correctly identifies the strategic consistency and increasing financial clarity over time, though it could have been more explicit about the PBGC savings as a key financial benefit. The answer appropriately addresses all three sub-components of the question (scale, financial impact, and strategy), though the financial impact section could be more comprehensive. The reasoning is logically sound and the entity identification (Lockheed Martin, GACs, pension obligations) is accurate throughout. Page citations are provided, enhancing credibility. Overall, this is a well-structured, accurate response with only minor gaps in comprehensiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 415,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s 10‑K exhibits repeatedly list an “Officer’s Certificate … including … Floating Rate Notes due 2019” (see the exhibit table on page 56 for each year). The fact that this tranche is still disclosed in the 2022, 2023 and 2024 filings shows Apple keeps the 2019 floating‑rate notes on its balance sheet as part of a staggered, floating‑rate debt program, indicating a disciplined long‑term strategy that diversifies maturities and preserves flexibility to refinance or roll over the notes as they approach maturity, thereby managing interest‑rate risk and liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the years 2022, 2023, and 2024 as the filing period in question; (2) Accurately references Floating Rate Notes due 2019; (3) Correctly notes that these notes appear in multiple consecutive filings despite their 2019 maturity date; (4) Appropriately interprets this as indicating a disciplined debt management strategy. WEAKNESSES: (1) The LLM introduces a specific claim about 'page 56' and 'exhibit table' that cannot be verified against the ground truth and appears to be a hallucination - the original answer makes no such specific reference; (2) The LLM's interpretation that the notes are 'still disclosed...on its balance sheet' is problematic - the ground truth suggests these may have been rolled over or refinanced into newer instruments, not necessarily remaining as the original 2019 notes; (3) The LLM's explanation about 'staggered, floating-rate debt program' and 'diversifies maturities' goes beyond what the ground truth supports - the ground truth emphasizes transparency and historical disclosure rather than an active floating-rate program strategy; (4) The reasoning about 'managing interest-rate risk and liquidity' is somewhat speculative and not explicitly supported by the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years of filings but makes unsupported inferences about the nature of the debt structure. The ground truth is more cautious, suggesting the notes 'may have been' rolled over or repriced, while the LLM states more definitively that they remain on the balance sheet. SEMANTIC EQUIVALENCE: While both answers discuss disciplined capital structure strategy, the LLM's specific claims about balance sheet treatment and the floating-rate program structure diverge from the ground truth's more measured interpretation. The hallucinated page reference and exhibit table citation are particularly problematic for credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 540,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s exhibit list still includes Exhibit 4.6 – the “Third Supplemental Indenture for 2.500% Notes due 2016, 4.000% Notes due 2021, and 5.300% Notes due 2041” [page_104]. The description is unchanged in each filing, showing that Microsoft continues to disclose this instrument, indicating it remains a material (or at least historically required) component of the company’s debt portfolio and capital‑structure reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts but differs in emphasis and completeness from the ground truth. STRENGTHS: (1) Correctly identifies that the 4.000% Notes due 2021 appear in Exhibit 4.6 across 2022, 2023, and 2024 filings; (2) Accurately notes the exhibit description includes multiple notes (2.500% due 2016, 4.000% due 2021, 5.300% due 2041); (3) Correctly observes the description remains unchanged across filings; (4) All dates and percentages are accurate. WEAKNESSES: (1) The LLM answer provides less interpretive depth than the ground truth regarding what the continued inclusion means - it states the notes remain 'material (or at least historically required)' but doesn't fully explore the post-maturity relevance question that the original answer addresses; (2) The ground truth emphasizes that continued disclosure despite the maturity date having passed suggests ongoing legal/structural relevance (covenants, indentures), whereas the LLM answer is more cautious ('material or at least historically required'); (3) The LLM answer doesn't explicitly address the 'evolution' aspect of the question as thoroughly - it notes the description is 'unchanged' but doesn't discuss what this consistency reveals about the instrument's role. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings and identifies the exhibit linkage, but the reasoning about what this reveals about capital structure relevance is less developed than the ground truth. The answer is factually sound but interpretively lighter. SEMANTIC EQUIVALENCE: The core factual claims align with ground truth, though the LLM is more hedged in its conclusions about ongoing relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 468,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "In the 2022 Form 10‑K UPS described its $276 million 7.620 % debentures (originally issued at 8.375 % and stepped down to 7.620 % in 2020) as fully redeemable at any time at the greater of principal + accrued interest or the present value of the remaining scheduled payments discounted at a Treasury yield + 5 bps, with interest payable semi‑annually in April and October and no sinking‑fund requirement. The 2023 and 2024 filings repeat the same redemption terms and semi‑annual interest structure, and the debentures continue to be listed in the debt schedule as a $276 million principal (carrying roughly $280 million), representing a small, unchanged component of UPS’s overall long‑term debt portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative facts: $276 million principal amount, 7.620% coupon rate, original 8.375% rate stepped down to 7.620% in April 2020, maturity in 2030 (implied), redemption terms (greater of principal + accrued interest or present value of remaining payments at Treasury yield + 5 bps), semi-annual interest payments in April and October, no sinking fund requirement, and the $280 million book value. All numeric values are accurate and properly formatted. The answer correctly notes that these terms remained unchanged across 2022-2024.\n\nWEAKNESSES: The LLM answer fails to capture the key evolution narrative that is central to the ground truth answer. The ground truth emphasizes a meaningful 3-year progression: (1) 2022 focused on historical interest rate context, (2) 2023 presented in broader debt table format, and (3) 2024 showed sharper focus on redemption mechanics with positioning within international debt instruments (Pound Sterling and Euro notes). The LLM answer treats the three years as essentially static ('repeat the same redemption terms'), missing the shift from historical context to structural/comparative treatment within the global debt portfolio. This is a significant omission for a question specifically asking about how treatment and disclosure 'evolved.'\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years but fails to identify the qualitative evolution in presentation and context. It accurately notes consistency in terms but misses the disclosure evolution that the ground truth emphasizes.\n\nCOMPLETENESS: The answer addresses redemption terms, interest payment structure, and debt positioning, but incompletely addresses the 'evolution' aspect of the question. It provides accurate static information but lacks the dynamic analysis of how disclosure changed year-to-year.\n\nJUSTIFICATION: The quantitative accuracy is near-perfect (9/10) with all numbers correct. Qualitative accuracy is lower (6/10) because while the factual statements are correct, the answer misses the primary narrative arc of disclosure evolution. Contextual relevance is moderate (7/10) because it addresses the question's components but not its core focus on evolution. The correctness score of 7 reflects that while all stated facts are accurate, the answer is incomplete in addressing the key analytical dimension of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 647,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "- In 2022 AbbVie was still moving Vraylar toward a new label – it was pursuing FDA approval for an adjunctive major‑depressive‑disorder (MDD) indication based on the Phase 3 results disclosed in 2021 (see page 60). By 2023 the FDA granted that MDD adjunctive approval, which helped lift Vraylar’s U.S. net revenue from $2.0 billion in 2022 to $2.8 billion in 2023 (a 35 % increase) and drove total net revenue to $2.759 billion (see pages 42 & 44). The 2024 filing continues to list Vraylar as a key neuroscience product (see page 4), showing that its expanding label and accelerating sales have turned it into a strategic growth engine and cornerstone of AbbVie’s neuroscience portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key narrative arc of Vraylar's evolution from 2022-2024, accurately describes the MDD adjunctive indication pursuit and FDA approval, correctly identifies Vraylar as a strategic neuroscience cornerstone, and properly conveys the 35% year-over-year revenue increase. The multi-hop synthesis across clinical development, regulatory approval, and financial performance is sound. The answer appropriately addresses all parts of the multi-part question.\n\nCRITICAL ERRORS - QUANTITATIVE: The LLM states 'Vraylar's U.S. net revenue from $2.0 billion in 2022 to $2.8 billion in 2023' but the ground truth specifies total revenue of $2.759 billion in 2023 (not $2.8B). While $2.8B could be a rounding of $2.759B, the LLM then states 'drove total net revenue to $2.759 billion' which creates internal inconsistency - it first says $2.8B then $2.759B. The ground truth clearly states $2.759 million (not billion - this appears to be a typo in the ground truth itself, but the LLM should have caught this). More critically, the LLM conflates U.S. net revenue ($2.0B to $2.8B range) with total revenue ($2.759B), which are different metrics. The 35% increase calculation appears correct ($2.759B / $2.0B ≈ 1.38 or 38%, close to stated 35%), but the metric confusion is problematic.\n\nMINOR ISSUES: The LLM references 'Phase 3 results disclosed in 2021' but the ground truth states results were 'announced' in 2022. The LLM also notes one trial 'met its primary endpoint' and implies the other didn't, which aligns with ground truth's 'one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement,' though the LLM's phrasing is less precise.\n\nOVERALL: The answer demonstrates strong qualitative understanding of Vraylar's strategic importance and correctly synthesizes the clinical-to-commercial trajectory. However, the quantitative precision is compromised by the U.S. vs. total revenue conflation and the $2.8B vs. $2.759B inconsistency, which are material errors in a financial context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 561,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The 0.45 % Notes due 2016 appear in the exhibit list for each year’s filing (see Exhibit 4.3 in the Index to Consolidated Financial Statements on pages 56‑58 of the 2022, 2023 and 2024 10‑Ks), showing that Apple still carries that legacy low‑coupon issuance and continues to disclose it annually. This signals that Apple’s long‑term debt mix includes very old, ultra‑low‑rate notes alongside newer borrowings, and that the company’s disclosure policy is to report every outstanding or historically issued instrument for full transparency, even when the instrument is near or past maturity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 0.45% Notes due 2016 are correctly identified with the proper percentage and maturity year. (2) The reference to Exhibit 4.3 is accurate. (3) The fiscal years 2022, 2023, and 2024 are correctly cited. (4) The general concept that Apple discloses legacy debt instruments is sound. PROBLEMATIC ELEMENTS: (1) The LLM states 'Apple still carries that legacy low-coupon issuance' which is factually incorrect - the notes matured in 2016, so Apple does NOT still carry them as active debt obligations. The ground truth explicitly notes 'Despite the maturity of these notes in 2016,' indicating they are no longer outstanding. (2) The phrase 'still carries' and 'outstanding or historically issued instrument' is ambiguous and misleading - the notes are NOT outstanding, they are historical/legacy. (3) The LLM's interpretation that this represents 'Apple's long-term debt mix includes very old, ultra-low-rate notes' is incorrect because these notes are not part of the current debt mix. MULTI-HOP REASONING: The LLM failed to properly synthesize the key insight from the ground truth: that Apple discloses these notes AFTER their maturity (2016), which is the significant finding. The ground truth emphasizes the persistence of disclosure despite maturity, suggesting historical record-keeping rather than active debt management. The LLM conflates historical disclosure with current debt holdings. QUANTITATIVE ACCURACY: Numbers and dates are correct (0.45%, 2016, fiscal years 2022-2024). QUALITATIVE ACCURACY: The reasoning about disclosure transparency is partially correct but fundamentally mischaracterizes whether these are active obligations. The answer suggests these notes are still part of Apple's debt structure, which contradicts the ground truth's emphasis on their historical nature.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 509,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In the 2022 and 2023 filings UPS described SurePost as a residential‑ground offering for non‑urgent, lightweight shipments that used the UPS ground network for transport but relied on the United States Postal Service to make the final‑mile delivery, positioning it as a low‑cost, last‑mile option within the U.S. Domestic Package segment【page_6】.  The 2024 filing repeats that description and adds that, through 2024, final delivery “was often provided by the United States Postal Service,” but that beginning January 1 2025 UPS will insource the product to gain more control over service quality, effectively shifting SurePost from a USPS‑hand‑off model to an internally‑managed delivery within its domestic package business【page_5】.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 4.45 % Notes due 2044 first appear in the Officer’s Certificate dated May 6 2014 and are listed in the “Description of Securities” section of the Form 10‑K each year—both the 2022 filing (see the index on page 56) and the 2024 filing (see the same index on page 56) continue to show the 4.45 % Notes due 2044 as outstanding long‑term debt. No new issuances or retirements of this series are disclosed between 2022 and 2024, indicating that Apple has kept the notes on its balance sheet as a stable, low‑coupon, ultra‑long‑dated financing tool. This multi‑year consistency reflects Apple’s long‑term capital strategy of locking in inexpensive, fixed‑rate debt far into the future to diversify its capital mix and preserve financial flexibility for ongoing and future investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values are correct - the 4.45% coupon rate, the 2044 maturity date, and the May 6, 2014 Officer's Certificate date are all accurate. (2) The answer correctly identifies that the notes appear consistently across 2022, 2023, and 2024 filings with no new issuances or retirements disclosed. (3) Multi-hop reasoning is sound - the model synthesizes information across three years of filings to identify a pattern of consistency. (4) The strategic interpretation is appropriate and matches the ground truth's conclusion about sustained reliance on long-term debt and financial flexibility. (5) The answer provides specific filing references (Form 10-K index on page 56) which adds credibility. Minor differences from ground truth: The LLM answer characterizes the debt as 'low-coupon' and 'inexpensive' - while 4.45% was reasonable for 2014 issuance, this characterization is somewhat subjective and not explicitly stated in the ground truth. However, this is a reasonable inference and doesn't constitute a factual error. The LLM also adds the phrase 'ultra-long-dated financing tool' which is semantically equivalent to the ground truth's 'long-duration debt.' Overall, the answer demonstrates strong comprehension of the multi-year pattern, accurate fact-checking, and sound reasoning about Apple's capital strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 393,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "In Oracle’s 2022 Form 10‑K the 2.875 % senior notes due 2031 were disclosed in **Exhibit 4.16** (along with the 1.650 % 2026 and 2.300 % 2028 notes)【page_114】. In the 2023 and 2024 10‑Ks the same set of notes appears under **Exhibit 4.14**, with the exhibit description unchanged【page_111】. By keeping the 2.875 % notes in the same exhibit across filings, Oracle signals that this issue is treated as a core component of its staggered‑maturity, fixed‑rate senior‑note program, reflecting a stable, disciplined capital‑structure management and debt‑issuance strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the primary factual claim. Ground truth states the 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 across 2022, 2023, and 2024 filings with no modifications. The LLM answer claims the notes appeared in Exhibit 4.16 in the 2022 10-K and then moved to Exhibit 4.14 in 2023 and 2024. This is a fundamental factual error that undermines the entire answer. The LLM also cites specific page numbers (page_114 for 2022, page_111 for 2023/2024) without verification against the actual filings. The core premise of the ground truth—that the consistent positioning as Exhibit 4.14 across all three years reveals stable capital structure management—is contradicted by the LLM's claim of an exhibit number change between 2022 and 2023. While the LLM's reasoning about what consistent exhibit positioning would reveal (stable, disciplined capital structure management) is sound in principle, it is applied to an incorrect factual foundation. The LLM does correctly identify the notes as senior notes with a staggered-maturity program, but this cannot compensate for the major factual error regarding exhibit numbering across the three years. The answer fails on the primary quantitative accuracy metric (exhibit numbers) and therefore fails the multi-hop synthesis requirement of tracking the treatment across three consecutive years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 394,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement added wage‑ and benefit‑rate increases for Teamsters covered by the UPS/IBT Full‑Time Employee Pension Plan, and those increases were reflected in higher pension benefit accruals (service cost) and a shift to a positive net‑periodic benefit cost for 2023 (service cost $1,172 million; net periodic benefit cost $1,212 million)【page_82】【page_83】.  \n\nThe 2024 disclosures, which show a lower discount rate (5.42 % vs 5.79 % in 2023) and a higher expected return on plan assets (7.17 % vs 7.07 % in 2023), and note that a 1‑basis‑point change in the discount rate would move the projected benefit obligation by about $60 million, reveal that UPS’s long‑term pension obligations remain material and highly sensitive to actuarial assumptions despite the recent accrual increase【page_84】【page_88】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the 2023 Teamsters agreement's impact on pension benefit accruals and correctly identifies the key financial metrics and actuarial sensitivities. STRENGTHS: (1) Correctly identifies the 2023 Teamsters master agreement and its impact on wage/benefit-rate increases; (2) Accurately cites specific financial figures (service cost $1,172 million, net periodic benefit cost $1,212 million); (3) Correctly notes the 2024 discount rate change (5.42% vs 5.79%) and expected return on plan assets (7.17% vs 7.07%); (4) Appropriately highlights the $60 million sensitivity to 1-basis-point discount rate changes; (5) Properly synthesizes multi-hop information connecting the 2023 agreement to 2024 disclosures and pension obligation implications. WEAKNESSES: (1) The LLM answer provides more specific quantitative detail than the ground truth but doesn't explicitly address the 'noncontributory plan' nature or the Central States Pension Fund background mentioned in the original answer; (2) The ground truth emphasizes 'no structural changes to the plan' in 2024, which the LLM answer doesn't explicitly confirm; (3) The LLM answer focuses heavily on actuarial assumptions and sensitivity analysis rather than the broader implication about 'continuation of defined benefit commitments under collective bargaining' mentioned in the ground truth. QUANTITATIVE VERIFICATION: All cited numbers appear reasonable and consistent with typical pension plan disclosures. The discount rate and expected return figures are plausible for 2023-2024 timeframe. The $60 million sensitivity metric is a standard disclosure. MULTI-HOP REASONING: The answer successfully connects (1) 2023 agreement → (2) pension accrual impact → (3) 2024 disclosure implications, demonstrating proper synthesis. However, it emphasizes actuarial sensitivity over the structural continuity aspect highlighted in the ground truth. The answer is factually sound but takes a different analytical angle than the original answer, focusing on quantitative sensitivity rather than structural/strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 567,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 10‑K filings have consistently listed the 1.05 % Notes due 2017 as part of the Officer’s Certificate (Exhibit 4.4). In the 2022 filing the exhibit description reads “Officer’s Certificate … including … 1.05 % Notes due 2017” (see 2022 10‑K Exhibit list, p. 56) and the same language appears unchanged in the 2023 filing (exhibit list in the 2023 10‑K, pages 53‑57) and again in the 2024 filing (see 2024 10‑K Exhibit list, p. 56). This unchanged disclosure shows Apple relies on the 2014 Officer’s Certificate to document and manage these short‑term notes, indicating a stable, transparent approach to handling the 1.05 % Notes due 2017 without material amendment over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. STRENGTHS: (1) All numeric values are correct - the 1.05% interest rate is accurate, the 2017 maturity date is correct, and the 2014 Officer's Certificate date is accurate. (2) The multi-hop synthesis is sound - the answer correctly traces the disclosure across three separate 10-K filings (2022, 2023, 2024) and identifies the consistent presentation in each. (3) Entity identification is precise - Apple is correctly identified, the specific debt instrument is properly named, and the Officer's Certificate is correctly dated. (4) The reasoning about what the consistency reveals (stable management approach, no refinancing, passive approach) aligns with the ground truth interpretation. (5) The answer provides specific exhibit references (Exhibit 4.4, page numbers) which adds credibility and demonstrates careful document review. (6) The semantic meaning matches the ground truth - both convey that the disclosure remained unchanged across all three years, indicating no modification or refinancing. MINOR CONSIDERATIONS: The LLM answer includes slightly more specific detail about exhibit locations and page numbers than the ground truth, but this is additive rather than contradictory. The characterization of Apple's approach as 'stable, transparent' is semantically equivalent to the ground truth's 'passive management approach' and 'prioritized stability.' The answer fully addresses all parts of the multi-part question regarding how disclosure evolved (it didn't), what this reveals about management approach, and the connection to the 2014 Officer's Certificate. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 460,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple first disclosed its 2.40 % Notes due 2023 in the 2022 Form 10‑K as part of Exhibit 4.3 (the Officer’s Certificate dated May 3 2013) that lists “2.40 % Notes due 2023” among its global notes 【page_56】【page_58】. The same Exhibit 4.3 and description re‑appear unchanged in the 2023 filing and again in the 2024 Form 10‑K, confirming the notes remained outstanding each year 【page_56】. This repeated, unchanged disclosure across three years indicates Apple’s long‑term debt strategy of retaining low‑cost, fixed‑rate bonds to maturity and using staggered maturities rather than frequent refinancing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) All key facts are accurate - the 2.40% interest rate, 2023 maturity date, May 3, 2013 Officer's Certificate date, and Exhibit 4.3 reference are all correct. (2) The multi-hop synthesis is sound - the answer correctly traces the disclosure across 2022, 2023, and 2024 10-K filings and identifies the pattern of unchanged disclosure. (3) The quantitative data (percentages, dates, years) are all accurate with no calculation errors. (4) The reasoning about Apple's debt management strategy is logical and well-supported by the evidence of static disclosure across three years. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM provides more specific sourcing detail (Exhibit 4.3, page references) which adds credibility but goes slightly beyond the ground truth answer's level of specificity. (2) The LLM's interpretation of the strategy as 'retaining low-cost, fixed-rate bonds to maturity and using staggered maturities rather than frequent refinancing' is a reasonable inference from the data, though the ground truth uses slightly more cautious language ('likely planning to meet the 2023 maturity as originally structured'). This represents a minor difference in interpretive confidence rather than factual error. (3) Both answers correctly identify that the lack of changes indicates a stable, consistent approach to this debt obligation. The LLM answer is slightly more interpretive about the broader strategy implications, which is appropriate given the question asks about 'long-term debt management strategy.' No factual errors detected; the answer demonstrates solid multi-hop reasoning across three fiscal years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 465,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "By 2022 AbbVie had reported top‑line Phase 3 data for Vraylar (cariprazine) as an adjunctive treatment for major depressive disorder—one trial met its primary endpoint while the other fell short【page_60】.  In 2023 the company secured FDA approval for that MDD indication, which helped lift Vraylar’s sales from $2.04 billion in 2022 to $2.76 billion in 2023—a 35 % jump driven by market‑share gains and the new label【page_42】【page_44】.  Throughout 2022‑2024 Vraylar remains positioned in AbbVie’s neuroscience segment as a multi‑indication dopamine‑D3/D2 partial agonist covering schizophrenia, bipolar disorder and, after the 2023 approval, adjunctive major‑depressive‑disorder therapy【page_6】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor omissions. QUANTITATIVE VERIFICATION: All numbers are correct - $2.04B (2022) vs $2.76B (2023) matches ground truth ($2,037M to $2,755M), and the 35% growth calculation is accurate. The answer correctly identifies the Phase 3 trial outcomes (one successful, one non-significant). COMPLETENESS ASSESSMENT: The answer addresses all three sub-questions: (1) clinical development progress in 2022 (Phase 3 data), (2) revenue growth 2022-2023 with specific percentages, and (3) therapeutic positioning across schizophrenia, bipolar disorder, and MDD. However, there is one notable omission: the ground truth specifies that by 2024, Vraylar was 'formally positioned as a key therapeutic agent' with explicit indication for 'bipolar I disorder (manic/mixed and depressive episodes)' - the LLM answer uses the more general term 'bipolar disorder' without specifying the episode types. MULTI-HOP REASONING: The synthesis is sound - the answer correctly connects clinical trial data (2022) to FDA approval (2023) to revenue impact, demonstrating proper multi-document synthesis. The causal logic linking approval to sales growth is appropriate. ENTITY ACCURACY: All entities are correctly identified (Vraylar/cariprazine, AbbVie, neuroscience segment, indications). MINOR ISSUES: (1) The answer states 'In 2023 the company secured FDA approval' but doesn't explicitly confirm this was for the MDD indication - though context makes this clear. (2) The 2024 positioning is mentioned but less detailed than ground truth regarding formal strategic positioning. (3) The answer uses 'dopamine-D3/D2 partial agonist' mechanism description which, while accurate, goes slightly beyond what was asked. Overall, the answer is factually sound with strong quantitative accuracy but slightly less comprehensive on 2024 positioning details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 508,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "In the 2022 Form 10‑K IBM placed “client relationships and trust” among a long list of competitive factors – technology, price, brand, talent, etc. – treating it as one of many levers (Competition section, page 3 & page 4). By the 2024 Form 10‑K the same phrase re‑appears, but the filing now explicitly ties client trust to its hybrid‑cloud and AI platform, emphasizing that trusted relationships are essential for delivering secure, integrated solutions and for differentiating IBM’s offerings in that market (Competition section, page 3 & page 4). This evolution shows IBM is elevating trust from a generic advantage to a strategic pillar that underpins its positioning as a trusted partner in the hybrid‑cloud and AI space.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of IBM's messaging around client relationships and trust from 2022 to 2024, and accurately notes the shift from treating trust as one of many competitive factors to positioning it as a strategic pillar tied to hybrid cloud and AI. The answer appropriately cites the Competition sections of the 10-K filings and correctly identifies the years (2022, 2024) and general strategic positioning. However, there are significant gaps in completeness: (1) The original answer explicitly mentions a 2023 filing and describes an intermediate evolution where IBM 'expanded this by linking trust to its strategic partnerships,' but the LLM answer only addresses 2022 and 2024, missing the three-year progression entirely. (2) The original answer provides more nuanced strategic context about how trust evolved from being part of the 'hybrid cloud and AI platform' (2022) to being linked with 'strategic partnerships' (2023) to being a 'foundational element in go-to-market strategy' (2024). The LLM answer captures the 2022-to-2024 shift but misses the intermediate 2023 positioning and the specific evolution through partnerships and ecosystem strategy. (3) The original answer's conclusion about trust as 'an enabler of integrated, client-centric innovation' is more strategically sophisticated than the LLM's simpler framing of 'strategic pillar.' The LLM answer is directionally correct and captures the main narrative arc, but it fails to address the full multi-year progression (missing 2023) and lacks the depth of strategic analysis present in the ground truth. The quantitative accuracy is high (correct years, correct document citations), but the qualitative accuracy and completeness are compromised by the omission of the 2023 evolution and the less detailed strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 496,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "In the 2022 Form 10‑K IBM disclosed the 1.250 % Notes due 2027 in the “Instruments defining the rights of security holders” section, incorporating the note’s indenture by reference to Exhibits 4.2, 4.3 and 4.4 filed in 2019 【page_20】. By the 2024 Form 10‑K the same notes are listed in the Section 12(b) securities‑registration table as an outstanding security, indicating they are now treated as a routine component of IBM’s debt portfolio and the disclosure has shifted from detailed exhibit‑by‑exhibit incorporation to a concise listing among other notes and debentures 【page_1】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate information but has significant gaps and inconsistencies compared to the ground truth. CORRECT ELEMENTS: (1) The note's interest rate (1.250%) and maturity year (2027) are accurate; (2) The reference to 2019 filings is correct; (3) The general progression from detailed exhibit incorporation to portfolio listing is conceptually sound; (4) The identification of Section 12(b) securities registration table in 2024 is accurate. PROBLEMATIC ELEMENTS: (1) The LLM mentions Exhibits 4.2, 4.3, and 4.4 for 2022, but the ground truth specifically states Exhibit 4.3 to Form 8-K filed January 30, 2019 - the LLM adds 4.2 and 4.4 without verification; (2) The LLM completely omits the 2023 data point, which is a critical part of the three-year evolution requested in the question; (3) The ground truth mentions the trading symbol (IBM27B) appearing in 2024, which the LLM does not reference; (4) The ground truth notes a February 8, 2022 filing reference in 2023, which the LLM misses entirely; (5) The LLM's characterization of the shift as moving from 'detailed exhibit-by-exhibit incorporation to concise listing' is somewhat accurate but lacks the nuance about the growing complexity of debt structure mentioned in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize 2022 and 2024 data but fails to incorporate the 2023 intermediate step, which weakens the narrative of evolution. The answer addresses the disclosure practices evolution but incompletely. QUANTITATIVE ACCURACY: The dates (2022, 2024, 2019) and the note characteristics are correct, but the exhibit references are not fully verified against ground truth. The answer lacks specific filing dates that appear in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 475,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "In IBM’s 2022, 2023 and 2024 Form 10‑K reports the 6.50 % Debentures due 2028 are listed under Item 15 (Exhibits) with the identical citation – Exhibit 2 to Form 8‑K, filed January 8 1998. The language and exhibit reference have not changed, and the debenture is presented alongside the other long‑dated debt securities (e.g., 7.00 % debentures due 2025, 6.22 % debentures due 2027) that are likewise incorporated by reference to their original 8‑K filings, illustrating IBM’s consistent approach to disclosing the terms of its debt instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core factual elements: (1) The 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to Form 8-K filed January 8, 1998 across 2022, 2023, and 2024; (2) The exhibit reference remained unchanged across all three years; (3) The debentures are presented alongside other long-dated debt securities. All numeric values and dates are accurate (6.50%, January 8, 1998, 2022-2024 period). The LLM correctly notes the consistency in exhibit referencing and the presentation alongside other debt instruments like the 6.22% Debentures due 2027. However, the answer has some limitations: (1) It mentions '7.00% debentures due 2025' as an example of comparable debt, whereas the ground truth specifically references '6.22% Debentures due 2027 and 5.875% Debentures due 2032' - this is a minor discrepancy in the specific examples chosen; (2) The LLM answer is more concise and focuses on the consistency aspect but provides less contextual depth about how the 'broader context of IBM's debt disclosures evolved subtly over time' as mentioned in the ground truth; (3) The ground truth emphasizes the evolution from 2022 (wider range of debt instruments with newer notes) to 2023-2024 (integration of legacy debt with newer instruments), which the LLM answer touches on but doesn't fully develop. The LLM answer correctly addresses the main question about consistency of exhibit references and the broader context of debt disclosures, but omits some of the nuanced evolution in how these disclosures were presented across the three-year period. The reasoning is sound and the synthesis is appropriate, though not as comprehensive as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 460,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "- 2022 10‑K: FedEx International Connect Plus was offered from **≈ 50 origin countries to > 130 destination countries**【page_14】.  \n- 2023 10‑K: the service expanded to **≈ 60 origin countries and > 190 destination countries**【page_8】, and the 2024 filing repeats the same coverage of **≈ 60 origins to > 190 destinations**【page_8】.  \n\nThe jump from ~50 to ~60 origin markets and the addition of ~60 more destination markets between 2022 and 2023 (with the expanded footprint maintained in 2024) shows FedEx aggressively broadening its cross‑border e‑commerce network, signalling a strategic focus on capturing growing global online‑shopping demand and strengthening its position in the international e‑commerce logistics arena.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 2022: ~50 origin countries to >130 destination countries; 2023-2024: ~60 origin countries to >190 destination countries. The calculations and comparisons are accurate (addition of ~60 destination markets, maintenance of expanded footprint). COMPLETENESS: The answer addresses all parts of the multi-part question: (1) evolution from 2022 to 2024 with specific data points, (2) expansion trajectory showing aggressive growth followed by stabilization, (3) strategic implications for e-commerce logistics. ENTITY ACCURACY: All entities correctly identified (FedEx, International Connect Plus, correct fiscal years 2022-2024). MULTI-HOP REASONING: The synthesis across three years of 10-K filings is sound, correctly identifying the two-phase pattern (aggressive expansion 2022-2023, then stabilization 2023-2024). SEMANTIC EQUIVALENCE: The LLM's interpretation that the trajectory 'shows FedEx aggressively broadening its cross-border e-commerce network' and 'strengthening its position in the international e-commerce logistics arena' aligns perfectly with the ground truth's characterization of 'deliberate and aggressive expansion into new markets' followed by 'stabilization as the service reached a mature coverage level.' The only minor distinction is that the LLM uses slightly more concise language ('aggressively broadening' vs 'deliberate and aggressive expansion'), but this is a stylistic difference that does not affect factual accuracy. The answer correctly interprets the strategic implications regarding global e-commerce growth focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 458,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "In its 2022 Form 10‑K Qualcomm adopted 2025 human‑capital goals that call for a 15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leaders and a 20 % rise in overall URM representation, and it tied progress on those goals to the fiscal‑2022 executive bonus by using a non‑financial performance multiplier of 0.9 to 1.1 × the target payout【QCOM_10k_2022.pdf page_17】. The 2023 and 2024 filings keep the same 2025 diversity targets and the same 0.9‑to‑1.1 bonus‑adjustment range, but now apply the modifier to the fiscal‑2024 bonus (the HR and Compensation Committee will consider the same advancement metrics when setting that year’s bonus)【QCOM_10k_2023.pdf page_16】【QCOM_10k_2024.pdf page_16】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all key numbers correct: 15% increase in women in leadership, 15% increase in URM leaders, 20% overall URM representation, and the 0.9-1.1 bonus multiplier range. The fiscal years (2022, 2023, 2024) and document citations are accurate. The multi-hop synthesis correctly identifies that these goals were set in 2022 and maintained through 2024 with the same targets and bonus adjustment mechanisms applied across years.\n\nHowever, there are notable omissions compared to the ground truth: (1) The LLM answer does not mention the Reboot Representation Tech Coalition or the specific initiative to double degrees for underrepresented groups by 2025, which the ground truth identifies as part of the 'increased emphasis on initiatives' in the later years. (2) The answer lacks the characterization of this as a 'stable strategic framework with sustained incentive alignment and expanding external partnerships,' which provides important context about the evolution and strategic intent.\n\nThe LLM answer is more narrowly focused on the mechanical aspects (targets, multipliers, years) rather than the broader strategic evolution and external partnership expansion mentioned in the ground truth. The statement about 'increased emphasis on initiatives' in the ground truth suggests a qualitative evolution beyond just maintaining the same targets, which the LLM answer does not capture.\n\nQuantitatively, all numbers are correct and properly formatted. The reasoning about consistency across years is sound. The answer successfully synthesizes information across three fiscal years and correctly identifies the linkage between diversity goals and executive compensation. The main weakness is incomplete coverage of the full scope of human capital advancement evolution, particularly regarding external partnerships and expanded initiatives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 513,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 each contain an “Officer’s Certificate” that lists the Floating Rate Notes due 2019 among its outstanding debt (see the Index to Consolidated Financial Statements on page 56 for each year)【page_56】. By keeping this short‑term, floating‑rate instrument on its balance sheet, Apple can let the interest cost reset with prevailing market rates, thereby limiting exposure to rising short‑term rates, while the near‑term maturity provides a flexible source of cash that can be rolled over or used to meet liquidity needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM claims Floating Rate Notes due 2019 appear in 2022, 2023, and 2024 10-K filings. However, notes due 2019 would have matured in 2019 and should NOT appear in 2022-2024 filings as outstanding debt. This is a fundamental factual error that contradicts the ground truth premise. (2) The ground truth itself contains a logical inconsistency (notes due 2019 appearing in 2022-2024 filings), but the LLM's answer compounds this by accepting it without questioning the temporal impossibility. (3) CITATION ISSUE - The LLM references 'Officer's Certificate' and 'Index to Consolidated Financial Statements on page 56' but provides no verification that these documents actually contain such information or that the notes are listed as outstanding. (4) REASONING FLAW - The LLM's explanation of interest rate risk management (resetting with market rates, limiting exposure to rising rates) is conceptually sound for floating rate instruments, but it's applied to an instrument that should not exist in the stated time period. (5) MISSING ANALYSIS - The LLM does not address the temporal anomaly or question why notes due 2019 would appear in later filings. The ground truth answer similarly fails to address this logical impossibility. (6) PARTIAL CREDIT - The LLM correctly identifies the three years (2022, 2023, 2024) and correctly explains how floating rate notes function for interest rate risk management, but the core factual premise appears to be incorrect. The answer demonstrates some understanding of debt instruments and liquidity management but fails on basic factual accuracy regarding debt maturity dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 452,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 filing already framed the digital‑cockpit as a cornerstone of its automotive push, noting analyst forecasts that > 70 % of new cars will have embedded cellular (with ≈ 60 % using 5G) by 2028 and that 19 % of vehicles sold in 2025 will feature Level‑2‑plus autonomy—both trends that drive demand for a connected, software‑defined cockpit. By the 2023‑24 reports the company groups digital‑cockpit, connectivity and ADAS/AD under a single “automotive” revenue stream in QCT, and that stream has risen from $1.5 billion in 2022 to $1.9 billion in 2023 and $2.9 billion in 2024, showing a sharpened strategic focus to capture the growing market for digital‑cockpit technology.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of Qualcomm's strategic evolution regarding digital cockpit technology and correctly identifies the trajectory from 2022-2024. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n(1) QUANTITATIVE ACCURACY PROBLEMS:\n- The LLM cites '>70% of new cars will have embedded cellular' but the ground truth states 'over 60%' - this is a material discrepancy in the key market projection metric\n- The LLM provides specific revenue figures ($1.5B in 2022, $1.9B in 2023, $2.9B in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and represent unsupported quantitative claims\n- The 19% Level-2-plus autonomy figure for 2025 is introduced by the LLM but not mentioned in the ground truth\n\n(2) WHAT WAS CORRECT:\n- Correctly identifies the 2022 positioning of digital cockpit as strategic priority\n- Correctly notes the 2028 5G connectivity projection (though with wrong percentage)\n- Correctly identifies the consolidation of digital cockpit, connectivity, and ADAS/AD into a single automotive revenue stream\n- Correctly captures the evolution from positioning (2022) to revenue generation (2023) to strategic integration (2024)\n- Properly synthesizes multi-hop information across years\n\n(3) MULTI-HOP REASONING:\nThe reasoning is sound - the LLM successfully synthesizes information across three years and connects market trends to business segmentation changes. The logical flow from market positioning to revenue generation to strategic integration is accurate.\n\n(4) CRITICAL ISSUE:\nThe introduction of specific revenue figures ($1.5B, $1.9B, $2.9B) without ground truth support is problematic. While these may be accurate from actual filings, they cannot be verified against the provided ground truth and represent a significant factual claim that goes beyond what can be confirmed. The percentage discrepancy (70% vs 60%) is also a material error in a key metric.\n\nThe answer would score higher (8-9) if the quantitative claims were either removed or verified against ground truth, as the qualitative understanding and multi-hop synthesis are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 593,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private funds (which include private‑real‑estate funds) fell from $569 million at year‑end 2022 to $555 million at year‑end 2023 and further to $540 million at year‑end 2024【page_71】. The steady decline shows the company is gradually drawing down or limiting its outstanding obligations to illiquid alternative assets while still keeping a material exposure, reflecting a disciplined, long‑term strategy that balances higher‑return opportunities with liquidity risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is precisely correct - the three-year progression ($569M → $555M → $540M) matches ground truth exactly with proper formatting. (2) The year-end dates (2022, 2023, 2024) are accurate. (3) The LLM correctly identifies the consistent downward trend and characterizes it as a 'steady decline.' (4) The multi-hop synthesis is sound - the model correctly connects the numerical trend to strategic implications about managing illiquid alternative assets. (5) The characterization of Abbott's approach as 'disciplined, long-term strategy' is semantically equivalent to the ground truth's 'strategic de-risking or rebalancing.' WEAKNESSES: (1) The LLM omits the specific quantification of the trend ($15 million per year decline), which is a notable detail from the ground truth. (2) The LLM does not mention the liquidation periods (2025-2034) that the ground truth includes, which provides important context about the long-term nature of these commitments. (3) The phrase 'gradually drawing down or limiting its outstanding obligations' is slightly less precise than the ground truth's explicit statement that Abbott 'is not exiting the space entirely but is managing its exposure more cautiously.' (4) The LLM's characterization focuses on 'balancing higher-return opportunities with liquidity risk' which is reasonable inference but not explicitly stated in the ground truth. CALCULATION VERIFICATION: The trend is correctly identified as a decline from 2022-2024 with consistent $15M annual reductions (569-555=14, 555-540=15, average ~14.5M per year), though the LLM doesn't explicitly state this. MULTI-HOP REASONING: The model successfully synthesizes the numerical data with strategic implications, though it could have been more comprehensive in addressing all contextual elements from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 499,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45% Notes due 2016 appear in the Officer’s Certificate of the Registrant in each of its 10‑K filings for FY 2022 (page 58), FY 2023 (page 56) and FY 2024 (page 56), indicating that the same low‑coupon, short‑dated issuance remained part of its disclosed debt across the three years【page_58】【page_56】. This consistent presence, together with newer notes that have later maturities, signals a strategy of locking in ultra‑low rates on early debt while layering additional issuances to create a diversified, staggered long‑term debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Apple's 0.45% Notes due 2016 across fiscal years 2022-2024. STRENGTHS: (1) Correctly identifies the debt instrument (0.45% Notes due 2016) and its consistent presence across all three fiscal years (2022, 2023, 2024); (2) Accurately cites specific page numbers for each filing (FY 2022 page 58, FY 2023 page 56, FY 2024 page 56), demonstrating precise document reference; (3) Correctly identifies the Officer's Certificate dated May 3, 2013 as the source document; (4) Properly synthesizes the multi-hop information showing consistency across three years; (5) Provides sound reasoning about Apple's debt strategy, characterizing it as maintaining ultra-low rates on early debt while layering newer issuances for diversification. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than the ground truth ('short-dated issuance' vs. the ground truth's reference to 'older, lower-yield debt instruments'), but both convey the same semantic meaning about the nature of the debt. The LLM's characterization of the strategy as 'locking in ultra-low rates on early debt while layering additional issuances' is actually more specific and insightful than the ground truth's description. All numeric values, dates, and entity references are accurate. The multi-hop reasoning correctly synthesizes information across three separate 10-K filings to identify a pattern in Apple's debt structuring strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 417,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "In IBM’s 2022 10‑K the company listed “client relationships and trust” as one of its principal methods of competition (2022 p. 4). By the 2023 filing the same factor re‑appears and is explicitly tied to its hybrid‑cloud and AI strategy, and the 2024 filing again highlights trusted client partnerships as essential to delivering secure, value‑driven hybrid‑cloud and AI solutions (2023 p. 3; 2024 p. 3). This multi‑year continuity shows IBM is increasingly positioning client trust as a core strategic differentiator that underpins its growth agenda in hybrid cloud and AI.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about IBM's evolution of 'client relationships and trust' as a competitive differentiator from 2022-2024, and accurately cites the relevant filing pages (2022 p. 4; 2023 p. 3; 2024 p. 3). The answer demonstrates sound multi-hop reasoning by synthesizing information across three years of filings and correctly linking trust positioning to hybrid cloud and AI strategy. However, the answer is somewhat less nuanced than the ground truth in several ways: (1) It doesn't explicitly mention the 2023 shift toward linking trust with consulting services and mission-critical infrastructure, instead jumping directly to the 2024 partnership emphasis; (2) It doesn't capture the full evolution of how trust was framed differently in each year (2022 as part of broader innovation portfolio, 2023 with consulting services, 2024 with strategic partnerships); (3) The phrase 'increasingly positioning' suggests a linear progression, but the ground truth indicates a more complex maturation where trust became 'integrated with ecosystem collaboration and innovation leadership' rather than simply becoming more central. The LLM answer is factually accurate on the key points and correctly identifies the strategic positioning, but misses some of the nuanced evolution in how IBM framed trust across the three-year period. The page citations appear reasonable and the core conclusion about trust as a strategic differentiator is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 408,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx first backed the 4.250 % Note due 2030 with a dedicated pass‑through trust and a revolving‑credit facility that named BNP Paribas as the “Liquidity Provider” (see the Pass‑Through Trust Agreement, Intercreditor Agreement and Liquidity Provider Revolving Credit Agreement in the 2022 filing)【page_119】.  By 2023 the company had already amended that revolving‑credit agreement (Amendment No. 1 dated May 22 2023) to adjust its terms, and the same trust‑and‑credit‑facility structure continues to be listed in the 2024 exhibit schedule, showing FedEx’s ongoing, proactive use of a structured trust and flexible liquidity facility to manage credit support for the note【page_123】【page_121】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key dates are correct: August 13, 2020 for foundational agreements, May 22, 2023 for Amendment No. 1, and 2024 continuation. (2) All entities correctly identified: 4.250% Note due 2030, Revolving Credit Agreement (2020-1AA), Wilmington Trust Company, BNP Paribas as Liquidity Provider, Pass-Through Trust Agreement, and Intercreditor Agreement. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 (foundational setup) through 2023 (Amendment No. 1) to 2024 (continued structure). (4) The characterization of FedEx's approach as 'proactive' and 'consistent' with a 'single modification' aligns with ground truth. (5) The answer appropriately emphasizes the structured trust and flexible liquidity facility framework. MINOR WEAKNESSES: (1) The LLM answer mentions 'Wilmington Trust Company' in the ground truth but the LLM answer does not explicitly name this entity, though it references the trust structure. (2) The LLM answer could have been slightly more explicit about the 'no further amendments noted' aspect in 2024, though it does convey this through 'continues to be listed' and 'ongoing' language. (3) The phrasing differs from ground truth (e.g., 'dedicated pass-through trust' vs. the more formal listing of agreements), but the semantic meaning is equivalent and accurate. QUANTITATIVE VERIFICATION: All dates (2020, 2022, 2023, 2024, May 22 2023) are correct. The note percentage (4.250%) is correct. No calculations required. REASONING QUALITY: The multi-hop reasoning correctly synthesizes information across three fiscal years and identifies the key evolution point (2023 amendment) while noting the stability before and after. The conclusion about FedEx's approach is well-supported by the facts presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 515,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s long‑term debt schedule consistently lists the 4.45 % Notes due 2044 in each filing – the officer’s certificate that describes these notes is incorporated by reference in the 2022 Form 10‑K (page 56), again in the 2023 Form 10‑K (page 56) and in the 2024 Form 10‑K (page 56). The fact that the same 30‑year, fixed‑rate bond remains on the balance sheet across three consecutive years shows Apple’s strategy of preserving a stable, long‑dated source of low‑cost financing rather than frequently refinancing or retiring that debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, and both correctly interpret this as evidence of Apple's stable long-term financing strategy without early redemption or restructuring. The LLM answer provides additional specific details (page references to Form 10-K filings at page 56 for each year, reference to officer's certificate incorporated by reference) that enhance credibility without contradicting the ground truth. The LLM correctly characterizes the notes as a '30-year, fixed-rate bond' and accurately describes Apple's strategy as preserving 'a stable, long-dated source of low-cost financing rather than frequently refinancing or retiring that debt.' The quantitative elements are accurate: the 4.45% rate is correct, the 2044 maturity date is correct, and the multi-year consistency (2022, 2023, 2024) is properly documented. The reasoning is sound - the LLM correctly synthesizes that the presence of the same debt instrument across three consecutive years indicates strategic consistency. Minor deduction (1 point) only because the LLM doesn't explicitly mention the 2014 issuance date that provides additional context about the debt's longevity, though this is a very minor omission. The semantic equivalence is strong: both answers convey the same core message about stability and strategic consistency in Apple's capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 411,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "- In the 2022 filing FedEx International Connect Plus was described as “currently available from **nearly 50 origin countries to over 130 destination countries**”【page_14】.  \n- By the 2024 filing the service had grown to be “currently available from **nearly 60 origin countries to over 190 destination countries**”【page_8】.  \n\nThis widening of both origin and destination coverage shows FedEx is deliberately expanding its cross‑border e‑commerce platform, using International Connect Plus to capture more global e‑commerce traffic and strengthen its position in the fast‑growing international e‑commerce logistics market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the 2022 figures (nearly 50 origin countries to over 130 destination countries) and the 2024 figures (nearly 60 origin countries to over 190 destination countries). The numbers are accurate and properly formatted. The LLM correctly synthesized the expansion trajectory across the two-year period and identified FedEx's strategic focus on e-commerce logistics. WEAKNESSES: The LLM answer is incomplete regarding the full evolution requested. The ground truth explicitly mentions 2023 data (nearly 60 origin countries and over 190 destination countries), which represents the peak expansion before stabilization in 2024. The LLM failed to include this intermediate year data, missing a critical part of the 'evolution from 2022 to 2024' narrative. The ground truth explicitly states that the 2024 figures 'remained consistent' with 2023, indicating stabilization after expansion - a key insight about the expansion trajectory. The LLM's answer suggests continuous growth from 2022 to 2024 without acknowledging the stabilization phase that occurred between 2023-2024. This is a significant omission in understanding the strategic trajectory. The LLM's reasoning about FedEx's strategic focus is sound but lacks the nuance that the trajectory shows 'a strategic push followed by a phase of consolidation and optimization' - the stabilization phase is strategically important and was not captured. CALCULATION VERIFICATION: All individual numbers are correct; no calculation errors present. MULTI-HOP SYNTHESIS: The LLM successfully synthesized information across years but failed to capture the complete three-year evolution pattern, particularly the stabilization insight that is crucial to understanding the strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 479,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 appear in the exhibit index of each Form 10‑K – 2022, 2023 and 2024 – as Exhibit 4.4 (the Officer’s Certificate of the Registrant that lists the 1.05 % Notes due 2017 among other global notes)【page_56】. The fact that Apple continues to reference these notes after their maturity shows that the company systematically tracks and discloses every debt issuance, even those that have matured, underscoring a disciplined, transparent approach to managing and reporting its maturing debt instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Apple's 1.05% Notes due 2017 appear in Exhibit 4.4 across fiscal years 2022, 2023, and 2024; (2) the notes are referenced in the Officer's Certificate; (3) the notes had matured by 2017. The numeric values (1.05%, 2017, 2022-2024) are all accurate. The LLM correctly synthesizes the multi-hop information about the continued disclosure across three fiscal years. However, there are some differences from the ground truth: (1) The LLM provides a more interpretive conclusion about Apple's 'disciplined, transparent approach' without explicitly noting that the ground truth suggests this may reflect 'standardized disclosure framework' or 'refinancing activities' - the LLM's interpretation is reasonable but slightly different in emphasis; (2) The ground truth explicitly notes 'no change in disclosure strategy' and mentions the Officer's Certificate was 'dated May 6, 2014,' which the LLM does not include; (3) The ground truth is more cautious in its interpretation ('may have retained historical references'), while the LLM is more definitive ('systematically tracks and discloses'). The LLM answer is factually sound and addresses the core question about the status and disclosure pattern, but it omits some specific details from the ground truth (the May 6, 2014 date, the explicit 'no change' observation) and presents a slightly different interpretive framing. The answer demonstrates good multi-hop reasoning but could be more precise in matching the ground truth's nuanced interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 427,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From FY 2022 Qualcomm’s strategy was already centered on 5G – its licensing revenue was driven by OFDMA‑based (including 5G) devices and the company began investing in new 5G‑enabled applications such as automotive, IoT and XR (see pages 8‑9). In FY 2023 QTL’s licensing revenue remained dominated by 5G patents, R&D and QSI spending were increased to push 5G into automotive, AI‑driven edge and other emerging markets, and the filing highlighted heightened U.S./China trade‑ and national‑security risks that could affect Chinese licensees (see pages 18‑22). By FY 2024 Qualcomm reported more than 200 5G license agreements, continued heavy R&D investment to expand 5G‑based products and applications, and reiterated its exposure to geopolitical risk—including the May 2024 revocation of its Huawei export license and ongoing revenue concentration in China‑linked customers (see pages 11‑14, 20).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Qualcomm's 5G strategy across FY2022-2024, accurately captures the progression from foundational positioning to leadership emphasis, correctly identifies OFDMA-based licensing as the revenue driver, mentions key application areas (automotive, IoT, AI), and appropriately highlights geopolitical risks including the Huawei export license revocation in May 2024. The multi-hop synthesis across three fiscal years is logically sound and addresses all major question components.\n\nWEAKNESSES - QUANTITATIVE: (1) The LLM states 'more than 200 5G license agreements' in FY2024 but the ground truth does not mention this specific number - this appears to be either unsupported or from a different source not in the ground truth. (2) The LLM fails to mention the $560 million Huawei revenue figure that the ground truth explicitly states was contributed in fiscal 2024 prior to the ban - this is a significant omission of a key quantitative detail. (3) The LLM does not mention the '27 billion IoT devices by 2026' projection from FY2022, which is a specific forward-looking metric in the ground truth.\n\nWEAKNESSES - QUALITATIVE: (1) The LLM mentions 'XR' as an application area in FY2022, but the ground truth does not reference XR - this may be an extrapolation or error. (2) The ground truth emphasizes 'Qualcomm Ventures' as the vehicle for strategic investments, which the LLM does not mention. (3) The LLM's characterization of FY2022 strategy as 'already centered on 5G' is accurate but slightly understates the foundational/catalyst framing in the ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly traces the evolution from foundational positioning to leadership emphasis to expanded strategic investments. The connection between R&D investment increases and market expansion is properly made. The geopolitical risk thread is correctly woven throughout.\n\nNUMERIC VERIFICATION: The $560 million Huawei revenue figure is a critical omission. The '200 5G license agreements' claim is unsupported by the ground truth. The '27 billion IoT devices by 2026' projection is missing. These represent material gaps in quantitative accuracy.\n\nOVERALL ASSESSMENT: The answer demonstrates solid understanding of the strategic evolution and correctly identifies major themes, but contains a significant quantitative omission ($560M Huawei revenue) and an unsupported claim (200 license agreements) that prevent a higher score. The qualitative reasoning is sound but incomplete in capturing all strategic details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 701,
        "total_tokens": 2170
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024 the domestic pension plan’s equity weighting edged higher while its fixed‑income share slipped modestly. U.S. equity funds grew from $89 million (≈9.5% of the $937 million total) in 2022 to $91 million (≈10.2% of $895 million) in 2024 (page 57; page 71), international equity fell from $91 million (≈9.7%) to $89 million (≈9.9%) (page 57; page 71), and fixed‑income assets declined from $739 million (≈78.9%) to $692 million (≈77.3%) (page 57; page 71). This gradual shift toward a slightly larger equity portion and a lower fixed‑income allocation reflects a modest move toward the company’s target mix of roughly 10% U.S. and international equities and 80% fixed income, indicating an evolving strategy that adds a bit more growth exposure while still prioritizing liability‑hedging fixed‑income assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - 2022 U.S. equity: LLM states $89M, but ground truth shows $125M (ERROR: off by $36M or 29%)\n   - 2022 international equity: LLM states $91M, but ground truth shows $126M (ERROR: off by $35M or 28%)\n   - 2022 fixed income: LLM states $739M, but ground truth shows $1,001M (ERROR: off by $262M or 26%)\n   - 2024 U.S. equity: LLM states $91M, but ground truth shows $93M (minor, acceptable)\n   - 2024 international equity: LLM states $89M, but ground truth shows $93M (ERROR: off by $4M)\n   - 2024 fixed income: LLM states $692M, but ground truth shows $739M (ERROR: off by $47M or 6%)\n   - 2024 total: LLM states $895M, but ground truth shows $947M (ERROR: off by $52M or 5.5%)\n\n2. DIRECTIONAL ERRORS:\n   - LLM claims U.S. equity \"grew from $89M to $91M\" but ground truth shows it declined from $125M (2022) to $93M (2024)\n   - LLM claims international equity \"fell from $91M to $89M\" but ground truth shows it declined from $126M (2022) to $93M (2024)\n   - LLM claims fixed income \"declined from $739M to $692M\" but ground truth shows it declined from $1,001M (2022) to $739M (2024)\n\n3. MISSING KEY INFORMATION:\n   - LLM completely omits the 2023 data, which is critical to understanding the three-year evolution\n   - Ground truth shows significant 2022-2023 decline (26% reduction in total assets from $1,267M to $937M), then stabilization in 2024\n   - LLM misses the major strategic shift that occurred in 2023\n\n4. CALCULATION ERRORS:\n   - Percentages are calculated on wrong base amounts\n   - The narrative about \"edging higher\" and \"slipped modestly\" contradicts the actual magnitude of changes\n\n5. STRATEGIC INTERPRETATION:\n   - LLM's conclusion about \"modest move toward target mix\" is based on incorrect numbers\n   - Ground truth reveals a more dramatic strategic shift: significant de-risking in 2023 followed by stabilization\n   - LLM misses the key insight about reduced equity exposure and shift toward stability\n\nThe LLM answer appears to have confused 2023 data with 2022 data and 2024 data with 2023 data, or used entirely wrong source data. This is a fundamental failure in multi-hop synthesis and fact retrieval.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 616,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "In its 2022 filing Qualcomm already positioned edge‑networking as a growth engine, noting that the QCT business “includes … edge networking products” and that the IoT segment (which explicitly covers “edge networking (including mobile broadband and wireless access points)”) generated **$7.35 billion** of revenue 【page_7】【page_8】【page_10】. By the 2024 filing the same IoT segment – still defined to include edge networking – contributed **$5.42 billion**, down from 2022, but Qualcomm emphasized continued product development for edge use‑cases (on‑device AI, 5G‑NR, Wi‑Fi 6/6E and AI‑enabled edge computing) as core to its QCT portfolio 【page_73】【page_9】【page_10】, indicating a strategic shift toward embedding edge‑networking capabilities in higher‑value, integrated solutions while the revenue share of the broader IoT/edge category contracted.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer demonstrates strong qualitative understanding of Qualcomm's strategic evolution in edge networking from 2022-2024. It correctly identifies edge networking as a key product category, mentions relevant technologies (5G-NR, Wi-Fi 6/6E, on-device AI), and provides sound reasoning about the strategic shift toward integrated solutions. The answer appropriately synthesizes multi-hop information across years and product segments. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific revenue figures ($7.35B for 2022 IoT segment, $5.42B for 2024) that cannot be verified against the ground truth answer. The ground truth does not provide these specific dollar amounts, making it impossible to confirm accuracy. These numbers appear to be cited with page references but lack verification. (2) INCOMPLETE ALIGNMENT WITH GROUND TRUTH - The ground truth emphasizes a 'consistent and maturing strategic focus' with edge networking 'explicitly listed as a key revenue contributor' in 2023 and 2024. The LLM answer instead characterizes the evolution as involving a revenue decline ('down from 2022') and a 'strategic shift,' which presents a different narrative than the ground truth's emphasis on consistent maturation. (3) MISSING 2023 ANALYSIS - The ground truth specifically mentions 2023 as a pivotal year when edge networking was 'explicitly listed as a key revenue contributor.' The LLM answer jumps from 2022 to 2024, omitting the important 2023 milestone. (4) TONE DISCREPANCY - The ground truth emphasizes consistent strategic focus and growth, while the LLM emphasizes contraction and strategic repositioning, which may mischaracterize the company's positioning. VERIFICATION ISSUES: Without access to the actual SEC filings, the specific revenue numbers ($7.35B, $5.42B) cannot be confirmed as accurate. The page references provided suggest the LLM attempted to cite sources, but the ground truth does not validate these specific figures. The answer would benefit from alignment with the ground truth's emphasis on consistent strategic maturation rather than revenue contraction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 570,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 2022‑2024 Form 10‑K filings all contain the same entry in the “Officer’s Certificate of the Registrant” that lists the 0.45 % Notes due 2016 among its global notes (see the table on page 56 of each filing)【page_56】. By repeatedly disclosing this low‑coupon, short‑term fixed‑rate issue alongside floating‑rate and longer‑dated debt, Apple signals a disciplined strategy of keeping a diversified, low‑cost debt portfolio that spreads refinancing risk and locks in cheap financing, thereby reinforcing the stability of its capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) FACTUAL IMPOSSIBILITY: The LLM claims the 0.45% Notes due 2016 appear in 2022-2024 10-K filings. This is factually impossible - notes that matured in 2016 cannot be listed as outstanding debt in 2022-2024 filings. The ground truth explicitly states 'the 0.45% Notes due 2016 are no longer outstanding.' (2) MISINTERPRETATION: The LLM mischaracterizes these as 'short-term fixed-rate issue' when they would have been long-term at issuance but are now matured/historical. (3) LOGICAL CONTRADICTION: The LLM's reasoning about 'spreading refinancing risk' and 'locks in cheap financing' contradicts the ground truth's explanation that these notes are included for 'historical tracking' and 'comprehensive debt disclosure' of past obligations, not current active debt management. (4) CITATION ERROR: The reference to 'page 56' and 'Officer's Certificate of the Registrant' appears fabricated or misidentified - the ground truth indicates these are disclosed in debt tables, not officer certificates. (5) SEMANTIC MISMATCH: The ground truth emphasizes transparency and historical documentation; the LLM incorrectly frames this as active portfolio management strategy. The core issue is that the LLM fundamentally misunderstands why matured debt would appear in filings (historical disclosure) versus what it claims (active debt management). This represents a major factual error about the nature of the financial instruments being discussed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 403,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "Caterpillar’s dealer network – which also carries its EMD brand – fell slightly in scope, covering 193 countries in 2022 (44 U.S. dealers + 116 overseas dealers) 【page_76】, but only 191 countries in 2024 (43 U.S. dealers + 113 overseas dealers) 【page_65】. That represents a reduction of two countries in the EMD brand’s geographic reach.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG NUMBERS: The LLM claims 193 countries in 2022 and 191 in 2024, but the ground truth states 130 countries in 2022 and 109 in 2024. These are completely different figures - off by 63 countries in 2022 and 82 countries in 2024. (2) WRONG CALCULATION: The LLM calculates a reduction of 2 countries, but the ground truth shows a reduction of 21 countries (approximately 16%). The LLM's math is internally consistent (193-191=2) but based on entirely incorrect source numbers. (3) MISINTERPRETATION OF DATA: The LLM appears to have confused dealer counts (44 U.S. + 116 overseas = 160, not 193) with country coverage. Adding dealer numbers does not equal country coverage - these are different metrics. The LLM seems to have fabricated or misread the 193/191 figures entirely. (4) MISSING 2023 DATA: The ground truth explicitly mentions that 2023 coverage remained at 130 countries, providing important context about when the decline occurred. The LLM completely omits this intermediate year. (5) INCOMPLETE ANALYSIS: The ground truth provides percentage change (16%), which the LLM fails to calculate. The LLM's answer is not just incomplete but factually wrong on the core quantitative claims that are essential to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 369,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher’s 1.750 % 7‑year senior‑note balance rose from $642 million at 12/31/2022 to $662 million at 12/31/2023 and to $700 million at 12/31/2024 【page_61†L31-L34】【page_47†L31-L34】.  The steady increase – alongside the company’s earlier redemption of higher‑rate notes and issuance of new low‑cost 1.75 % notes – shows a deliberate strategy to expand medium‑term financing at a low fixed rate, giving Thermo Fisher flexible, inexpensive capital to support growth and acquisitions in its healthcare business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports $642M (2022), $662M (2023), and $700M (2024), showing an increasing trend. The ground truth clearly states the value was $700M in all three years (2022, 2023, and 2024) - a flat, stable pattern. This is a major factual error affecting the core numerical answer. (2) TREND MISCHARACTERIZATION: The LLM describes a 'steady increase' when the ground truth indicates 'unchanged' and 'consistent level' across all three years. This is a fundamental misrepresentation of the debt progression. (3) REASONING FLAW: The LLM's interpretation that the company pursued 'a deliberate strategy to expand medium-term financing' is contradicted by the actual data showing no expansion - the principal remained constant at $700M. (4) MULTI-HOP SYNTHESIS ERROR: While the LLM attempts to synthesize information about debt strategy and healthcare sector context, this synthesis is built on incorrect underlying numbers, making the strategic conclusion invalid. (5) PARTIAL CREDIT: The LLM correctly identifies the instrument (1.750% 7-Year Senior Notes), the company (Thermo Fisher/TMO), and attempts to address the strategic implications question. However, the foundational numerical data is wrong, which undermines the entire analysis. The ground truth shows stability; the LLM shows growth - these are opposite conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 409,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "In the 2022 filing Caterpillar noted that a material portion of its variable‑rate loans and derivatives were tied to LIBOR and that it had formed a cross‑functional team to evaluate the impact of the scheduled LIBOR wind‑down (USD LIBOR tenors ending June 30 2023) and to manage the transition (2022 p. 22). By the 2023 and 2024 filings the company reported that new floating‑rate obligations now use the Secured Overnight Financing Rate (SOFR) as the benchmark and that it continues to employ currency‑hedging instruments to protect against exchange‑rate swings (2023/2024 p. 19‑20), showing that Caterpillar has shifted from LIBOR to SOFR and integrated that change into its hedging strategy—demonstrating a proactive, strategic adaptation to global financial‑market reforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop evolution of Caterpillar's currency hedging and LIBOR/SOFR transition across 2022-2024. STRENGTHS: (1) Correctly identifies the key timeline: 2022 LIBOR exposure acknowledgment, formation of cross-functional team, USD LIBOR ending June 30, 2023; (2) Accurately captures the 2023-2024 transition to SOFR as the new benchmark; (3) Properly notes the shift from LIBOR-based to SOFR-based instruments; (4) Correctly identifies currency hedging instruments as a consistent risk management tool; (5) Appropriately characterizes this as 'proactive, strategic adaptation to global financial-market reforms'; (6) All dates and key metrics are accurate. MINOR WEAKNESSES: (1) The answer is somewhat more concise than the ground truth and doesn't explicitly state that by 2024 'the company no longer referenced LIBOR at all,' though it implies this through the statement about 'shifted from LIBOR to SOFR'; (2) Doesn't explicitly mention the FCA's announcement or IBA's role in the phase-out timeline, though these are contextual details rather than core facts; (3) The phrase 'expanded its cross-functional team' from the ground truth is not mentioned, though the team's existence and role are acknowledged. QUANTITATIVE VERIFICATION: All dates are correct (June 30, 2023 for USD LIBOR end date; 2022, 2023, 2024 filing years). No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, showing the progression from LIBOR exposure → transition planning → SOFR adoption. The logical flow is sound and demonstrates understanding of the regulatory context. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with appropriate emphasis on strategic adaptation and risk management continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 513,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "In the 2022 filing Thermo Fisher listed the original Executive Change‑in‑Control Retention Agreement for CEO Marc N. Casper (Exhibit 10.12) together with its 2010 and 2018 amendments and a separate template for officers other than the CEO (Exhibit 10.15) 【page_46】. The 2023 filing still references a dedicated officer agreement but updates it to a new exhibit (Exhibit 10.7), indicating the company moved to a single, standardized form for all non‑CEO officers 【page_78】. By the 2024 filing no Executive Change‑in‑Control Retention Agreement appears among the disclosed exhibits, implying the retention provisions have been folded into the broader executive‑compensation framework and the approach is now fully standardized 【page_75‑79】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) EXHIBIT NUMBER ERRORS: The LLM claims the 2022 officer agreement was in Exhibit 10.15, but ground truth states it was Exhibit 10.17. The LLM then claims 2023 moved to Exhibit 10.7, which is not mentioned in ground truth. These are critical factual errors in document references. (2) MISSING KEY INFORMATION: The ground truth explicitly states that in 2023, a 'standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17)' was introduced. The LLM mentions an officer agreement but fails to clearly identify this as a NEW standardized form introduced in 2023, which is the core evolution the question asks about. (3) INCORRECT 2024 CONCLUSION: The LLM claims 'no Executive Change-in-Control Retention Agreement appears among the disclosed exhibits' in 2024, suggesting the provisions were 'folded into broader executive-compensation framework.' This directly contradicts ground truth which states the standardized form was 'reaffirmed with continued use of the form agreement for officers (Exhibit 10.17)' in 2024. The LLM fundamentally mischaracterizes the 2024 status. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from 2022-2024 regarding standardization. Ground truth shows: 2022 (CEO-specific) → 2023 (standardized form introduced for officers) → 2024 (standardized form reaffirmed). The LLM's narrative breaks down at 2024 with an incorrect conclusion. (5) AMENDMENT DATES: Ground truth mentions amendments through March 16, 2018, and the LLM mentions '2010 and 2018 amendments' which is partially consistent but less precise. The core narrative of evolution from CEO-specific to standardized is present in LLM answer but undermined by factual errors in exhibit numbers and the incorrect 2024 conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 510,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "- In the 2022 filing Intel first announced PowerVia as a future “back‑side power delivery” innovation that would appear in its planned Intel 20A node 【page_7】.  \n- The 2023 filing again highlighted PowerVia as the industry‑first backside‑power solution that would be a key breakthrough of Intel 20A, eliminating front‑side power routing 【page_14】.  \n- By the 2024 filing Intel had cancelled the 20A node and moved PowerVia into the next‑generation Intel 18A process – its first high‑volume commercial implementation slated for 2025 【page_10】.  \n\nThis trajectory shows PowerVia evolving from a roadmap concept in 2022 to a core component of Intel’s advanced‑process strategy by 2024, indicating its strategic importance for delivering performance‑per‑watt gains and improved signal integrity in Intel’s upcoming nodes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of PowerVia's evolution from 2022-2024. STRENGTHS: (1) All dates and years are correct (2022 introduction, 2023 emphasis, 2024 cancellation/shift); (2) All key entities correctly identified (PowerVia, Intel 20A, Intel 18A, 2025 timeline); (3) Technical details accurate (backside power delivery, elimination of front-side power routing, high-volume manufacturing in 2025); (4) Multi-hop synthesis is sound - correctly traces the progression across three years and connects the cancellation of 20A to the retention of PowerVia in 18A; (5) The conclusion about PowerVia's strategic importance is well-supported and aligns with ground truth. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing than ground truth (e.g., 'back-side power delivery' vs 'backside power delivery' - both correct, just formatting); (2) The LLM adds interpretive detail about 'performance-per-watt gains and improved signal integrity' which, while reasonable and supported by the technical context, goes slightly beyond what the ground truth explicitly states, though this is not incorrect; (3) The ground truth emphasizes 'process leadership by 2025' as a broader context, while the LLM focuses more narrowly on PowerVia's technical role - both perspectives are valid and complementary. QUANTITATIVE VERIFICATION: All numeric references (2022, 2023, 2024, 2025) are correct. No calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate filing years and properly connects the strategic shift from 20A to 18A while maintaining PowerVia's centrality. The logic flow is clear and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 467,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 10‑K filings have treated the 1.05 % Notes due 2017 the same way each year. In the 2022 report the notes appear in Exhibit 4.4 (the Officer’s Certificate dated May 6 2014) and the same Exhibit 4.4 – with identical wording that lists the 1.05 % Notes due 2017 among other issuances – is reproduced unchanged in the 2023 and again in the 2024 10‑K. The fact that Apple continues to include the same reference year after year shows a disciplined practice of keeping a complete, transparent record of all debt issuances, even after the notes have matured, rather than removing or altering the disclosure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All numeric values and dates are accurate - correctly identifies the 1.05% interest rate, 2017 maturity date, May 6, 2014 Officer's Certificate date, and the three fiscal years (2022, 2023, 2024). (2) Correctly identifies Exhibit 4.4 as the location of disclosure across all three filings. (3) Accurately describes the multi-hop synthesis: tracking the same instrument across three consecutive 10-K filings and noting the unchanged reproduction of the exhibit. (4) The reasoning about Apple's deliberate reporting practice is sound and well-supported. MINOR WEAKNESSES: (1) The LLM answer frames the interpretation slightly differently than the ground truth - it emphasizes 'disciplined practice of keeping a complete, transparent record' whereas the ground truth suggests Apple 'may have either rolled over the debt into a new instrument or maintained it in some form.' The LLM's interpretation is more definitive about the reason for continued disclosure, while the ground truth presents it more cautiously as indicating 'continuity in debt management approach.' (2) The LLM answer doesn't explicitly acknowledge the temporal anomaly that the notes were due in 2017 but continue appearing in 2022, 2023, and 2024 filings - though it does reference 'after the notes have matured.' The ground truth more explicitly highlights this post-maturity persistence as noteworthy. (3) The LLM answer doesn't speculate about possible explanations (rollover vs. maintenance in capital structure) that the ground truth mentions, though this could be seen as appropriately cautious rather than a weakness. QUANTITATIVE VERIFICATION: All dates, percentages, and exhibit references check out correctly. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the pattern of repeated disclosure. The semantic meaning aligns well with the ground truth despite slightly different framing of the implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 553,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "In the 2022 Form 10‑K Intel only references the “2006 Equity Incentive Plan” as a defined term (see the definition on page 113) and does not describe specific award types. By the 2024 filing the plan is shown to be used for a variety of RSU awards—including standard RSUs with and without retirement‑based vesting (exhibits 10.1.3‑10.1.4), performance‑based RSUs for grandfathered executives (10.1.5), performance‑based RSUs for non‑grandfathered executives (10.1.6), and RSUs for non‑employee directors (10.1.7)—each with vesting tied to retirement, time‑based schedules, or achievement of performance metrics (pages 107‑108). This reflects an evolution from a simple executive‑focused RSU program to a broader suite of equity awards with diversified vesting conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific exhibit references and page numbers (10.1.3-10.1.7, pages 107-108) that cannot be verified against the ground truth, which is a significant concern for factual accuracy in SEC filing analysis. However, the answer does correctly identify key elements: (1) the 2006 Equity Incentive Plan as the relevant plan, (2) the evolution from 2022 to 2024, (3) the types of awards (RSUs, performance-based RSUs, director awards), and (4) the vesting conditions (retirement-based, time-based, performance metrics). The LLM answer notably OMITS the critical 2023 amendment and restatement (effective May 11, 2023) that the ground truth emphasizes as a pivotal moment in the plan's evolution. This is a significant gap in the multi-hop synthesis, as the ground truth explicitly states this amendment introduced 'a broader range of RSU agreements' with specific new categories. The LLM's characterization of the evolution as 'from simple executive-focused RSU program to broader suite' is directionally correct but lacks the nuance about the 2023 amendment being the inflection point. The LLM also provides more granular detail about specific award types and vesting conditions than the ground truth, which is helpful but raises questions about verification. The answer correctly addresses the multi-part question about types of awards and vesting conditions, but the omission of the 2023 amendment and the unverifiable exhibit citations represent material weaknesses in accuracy and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 417,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s Note 11 on Share Capital consistently lists an authorized class of 40 000 Euro Deferred Shares (€1 par) in each filing, and each year‑end statement says that none of those shares were issued or outstanding – at April 29 2022 【page_81†L1-L5】, at April 28 2023 (same language in the 2023 filing) 【page_81†L1-L5】, and at April 26 2024 【page_81†L7-L9】. The unchanged disclosure over FY 2022‑2024 indicates the company has not used this class of shares to raise capital, suggesting a financing strategy that relies on other sources (ordinary shares, debt, repurchases) while keeping the Euro Deferred Shares as a dormant reserve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Medtronic's Euro Deferred Shares capital structure evolution. QUANTITATIVE ACCURACY: All numeric values are correct - 40,000 Euro Deferred Shares authorized, €1.00 par value, zero issued/outstanding across all three fiscal years (2022, 2023, 2024). The fiscal year-end dates are accurate (April 29, 2022; April 28, 2023; April 26, 2024). ENTITY ACCURACY: Company correctly identified as Medtronic, proper reference to Note 11 on Share Capital, correct fiscal year period (FY 2022-2024). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to identify the consistent pattern of non-issuance and correctly interprets this as evidence of a deliberate financing strategy choice. COMPLETENESS: The answer addresses both parts of the question - (1) how disclosures evolved (consistently unchanged), and (2) what the absence suggests about financing strategy (preference for other capital tools). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, using slightly different but equivalent phrasing ('dormant reserve' vs. 'not utilized as a financing instrument'). The mention of 'ordinary shares, debt, repurchases' as alternative financing sources aligns with the ground truth's reference to 'ordinary share repurchases and dividend policies.' MINOR CONSIDERATIONS: The LLM includes citation references (page numbers and line indicators) which add specificity but are not contradicted by the ground truth. The characterization of Euro Deferred Shares as a 'dormant reserve' is a reasonable inference consistent with the ground truth's interpretation. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 486,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "In 2022 Intel framed advanced‑packaging as a new pillar of its IDM 2.0 disaggregated‑design strategy, spending roughly $16 billion on R&D (about 30 % of revenue) while warning that novel packaging added design, manufacturability and cost complexity that could cause delays or asset write‑downs (2022 p.54‑55, 39). By 2023 the company had elevated packaging to a core growth engine of its Open System Foundry, raised R&D to $17.5 billion (27.8 % of revenue) (2023 p.39), saw packaging revenue lift overall sales but also a larger operating loss as strategic spending rose (2023 p.38‑36), and continued to flag execution risk from the logistics of disaggregated chiplet designs (2023 p.35‑36). In 2024 Intel kept the same strategic emphasis, maintained high R&D ($16.5 billion) (2024 p.34‑36) but highlighted that the increased manufacturing complexity of advanced‑packaging and disaggregated designs produced $3.1 billion of impairment and accelerated‑depreciation charges on the Intel 7 node (2024 p.34‑35) and amplified the financial impact of execution risk (2024 p.33).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across 2022-2024. STRENGTHS: (1) All key financial figures are correct: R&D spending of ~$16B (2022), $17.5B (2023), $16.5B (2024); percentages of revenue (30%, 27.8%) are accurate; the $3.1B impairment figure is correctly cited. (2) The multi-hop reasoning effectively synthesizes the evolution across three years, showing progression from strategic positioning (2022) → technical progress/elevation (2023) → financial strain (2024). (3) Entity identification is precise: IDM 2.0 strategy, UCIe standard, Intel 7 node, disaggregated designs, Open System Foundry all correctly referenced. (4) The answer captures the core narrative arc matching ground truth: initial strategic bet → technical progress → financial/operational setbacks. (5) Specific execution risks are properly identified: design complexity, manufacturability challenges, cost pressures, delays. MINOR WEAKNESSES: (1) The answer provides more granular detail and page citations than the ground truth, which could be seen as either more thorough or slightly verbose depending on perspective. (2) The ground truth explicitly mentions 'Intel 4 and 10nm process delays' in 2022, which the LLM answer doesn't specifically call out (though it references delays generally). (3) The ground truth emphasizes 'doubt on ability to scale advanced packaging capacity profitably' as a key 2024 concern, while the LLM focuses more on impairment charges and manufacturing complexity. These are related but slightly different framings. QUANTITATIVE VERIFICATION: All dollar amounts, percentages, and years check out correctly. The R&D trajectory ($16B→$17.5B→$16.5B) and revenue percentages are accurate. The $3.1B impairment is correctly attributed to Intel 7. MULTI-HOP SYNTHESIS: Successfully combines R&D investment trends, manufacturing complexity evolution, and financial impact across three fiscal years, showing proper causal relationships. The answer correctly identifies how strategic positioning evolved while execution risks materialized financially.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 564,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "Intel first announced PowerVia in its 2022 filing as a “back‑side power delivery” breakthrough slated for the future Intel 20A node, positioning it as a key differentiator in its IDM 2.0 roadmap 【page_7】. In the 2023 filing the company refined the roadmap, stating that PowerVia (along with RibbonFET) would be part of Intel 20A and was expected to deliver up to a 15 % performance‑per‑watt improvement over Intel 3 【page_14】. By the 2024 filing Intel had shifted the technology to the Intel 18A node—cancelling Intel 20A—and disclosed that PowerVia will be ready for high‑volume manufacturing with the 18A‑based Panther Lake processors in 2025, indicating the technology’s manufacturing readiness 【page_10】【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis across three years of Intel filings. STRENGTHS: (1) All key dates are correct (2022 introduction, 2023 roadmap refinement, 2024 manufacturing readiness disclosure). (2) The 15% performance-per-watt improvement figure is accurately cited and properly attributed to the Intel 20A comparison with Intel 3. (3) The multi-hop reasoning correctly traces the evolution: 2022 conceptual introduction → 2023 roadmap solidification with specific node assignment → 2024 node shift to Intel 18A with manufacturing timeline. (4) Entity identification is precise: PowerVia, RibbonFET, Intel 20A, Intel 18A, Panther Lake, and the 2025 high-volume manufacturing target are all correctly identified and contextualized. (5) The answer captures the strategic shift from Intel 20A to Intel 18A, which is a critical detail showing technology maturation and roadmap evolution. (6) The semantic meaning aligns perfectly with the ground truth regarding positioning evolution from 'conceptual introduction' to 'production-ready innovation.' MINOR CONSIDERATIONS: The LLM answer includes additional context (IDM 2.0 roadmap reference, Panther Lake processor specificity) that enhances rather than detracts from accuracy. The citation format with page references adds credibility. No calculation errors detected. The answer fully addresses all three temporal phases of the question and synthesizes information across multiple filing years correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 417,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s 10‑K filings for FY 2022, FY 2023 and FY 2024 all list the same exhibit – “Form of Restricted Stock Unit Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (see *10.54* on each year’s exhibit list【page_115】). Because the U.S. employee RSU agreement has not been revised over this period, the company appears to be maintaining a stable, unchanged equity‑compensation framework for its U.S. workforce, signaling a strategy focused on consistency and predictability rather than frequent redesigns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies that Medtronic has NOT updated its U.S. employee RSU agreements across FY2022-FY2024, matching the ground truth finding. (2) Accurately references the same exhibit (Form of Restricted Stock Unit Award Agreement under the 2013 Stock Award and Incentive Plan) across all three years. (3) Correctly cites exhibit number 10.54 for each year's filing. (4) Properly synthesizes the multi-hop reasoning: identifies the consistency across three years, then draws the logical conclusion about Medtronic's equity compensation strategy. (5) The interpretation that this consistency 'signals a strategy focused on consistency and predictability rather than frequent redesigns' is semantically equivalent to the ground truth's statement about 'stable and consistent equity compensation strategy' and 'maintained its approach...without introducing structural changes.' (6) All dates and entities are correct (Medtronic, FY2022-FY2024, 2013 Stock Award and Incentive Plan). MINOR CONSIDERATIONS: The LLM answer does not explicitly mention the original filing date of August 27, 2013 (File No. 001-07707) that appears in the ground truth, but this is a minor historical detail that doesn't affect the core answer to the question about updates between FY2022-FY2024. The LLM's focus on the three-year period directly relevant to the question is appropriate. The reasoning is sound and the conclusion about strategic implications is well-supported by the factual findings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 430,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "By the 2022 filing Intel’s 2006 Equity Incentive Plan was referenced with a single performance‑based RSU grant form (exhibit 10.1.5) that applied only to “grandfathered” executives 【page_107】. In the 2024 filing the company added a separate grant agreement for performance‑based RSUs to “non‑grandfathered” executives (exhibit 10.1.6) and even a distinct RSU agreement for non‑employee directors (exhibit 10.1.7) 【page_108】, indicating that Intel broadened and segmented the plan’s RSU structure to cover a wider pool of executives and directors.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some accurate details but has significant gaps and potential inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2006 Equity Incentive Plan as the vehicle for RSU grants across the period; (2) Accurately notes the distinction between grandfathered and non-grandfathered executives; (3) Correctly identifies that the plan was amended and restated (mentions May 11, 2023 amendment in ground truth); (4) Appropriately references exhibit numbers and page citations. WEAKNESSES: (1) The LLM answer focuses heavily on 2022 vs 2024 comparison but largely omits 2023, which is a critical middle year in the three-year evolution requested. The ground truth explicitly states 2023 continued use with separate agreements for both grandfathered and non-grandfathered executives; (2) The LLM characterizes 2022 as having only a 'single performance-based RSU grant form' for grandfathered executives, but the ground truth indicates the plan was used for 'strategic growth performance-based RSUs granted to executives on or after February 1, 2019' - this is a broader characterization than the LLM suggests; (3) The LLM answer does not mention the S-8 registration filed September 26, 2023, which the ground truth identifies as important evidence of continued reliance on the plan; (4) The LLM's narrative of 'broadening and segmenting' the plan structure is somewhat speculative - the ground truth presents a more consistent narrative of continuous use with parallel structures for different executive categories. MULTI-HOP REASONING: The LLM attempts to synthesize across years but incompletely - it jumps from 2022 to 2024 without adequately addressing the 2023 evolution, which weakens the multi-hop synthesis. The ground truth demonstrates a three-year continuous evolution, while the LLM presents more of a binary comparison. FACTUAL ACCURACY: The specific exhibit numbers and page references appear plausible but cannot be independently verified from the ground truth provided. The characterization of what changed between years is partially correct but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 568,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "- In 2022 Intel’s filing said its R&D budget was being directed to “process and packaging technology” and it was “adopting a disaggregated design approach…connected by advanced packaging technology” 【page_54】, but the advanced‑packaging effort was still in the development phase with no commercial traction noted 【page_55】.  \n\n- By 2023 the company reported “accelerated interest in our advanced packaging business, especially for AI‑related designs, and have secured five new design wins” on the Intel 18A node, and it demonstrated the Universal Chiplet Interconnect Express (UCIe) standard, showing that the packaging investments were now delivering market‑ready chiplet solutions 【page_36】 【page_37】.  \n\n- In 2024 Intel continued to spend heavily on packaging (R&D $16.5 billion, with “process and packaging technology” a key focus) 【page_34】, launched its Open System Foundry, expanded ecosystem agreements with ARM and Synopsys, and highlighted further design wins, indicating that advanced‑packaging has become a proven capability that underpins its disaggregated design strategy and strengthens its competitive position in the AI‑driven semiconductor market 【page_36】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant omissions and misrepresentations of the ground truth narrative. STRENGTHS: (1) Correctly identifies the 2022 development phase status of advanced packaging; (2) Accurately mentions UCIe standard demonstration in 2023; (3) Correctly cites $16.5 billion R&D spending in 2024; (4) Appropriately references design wins and ecosystem partnerships. CRITICAL WEAKNESSES: (1) MISSING KEY NEGATIVE INDICATOR: The ground truth explicitly states Intel recorded '$3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets' in 2024 - this is a crucial financial metric that fundamentally contradicts the LLM's characterization of 2024 as showing 'proven capability' and 'strengthened competitive position.' This omission materially misrepresents Intel's financial health and execution challenges. (2) TONE MISALIGNMENT: The ground truth emphasizes 'persistent execution challenges and high financial stakes,' while the LLM presents a narrative of progressive success culminating in 2024 as a validation point. The impairment charges directly contradict this optimistic framing. (3) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the full multi-hop picture - the progression should reveal not just technological progress but also financial pressures and execution risks, which the impairment charges exemplify. (4) QUANTITATIVE ACCURACY: While the $16.5B R&D figure is correct, the answer omits the $3.1B impairment charge entirely, which is a material financial metric for assessing execution capability. The LLM's characterization of 2024 as showing 'proven capability' contradicts the ground truth's assessment of 'ongoing execution risks and financial pressures.' The answer demonstrates partial understanding but fails to capture the critical tension between technological progress and financial/execution challenges that defines Intel's actual trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 534,
        "total_tokens": 2133
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "In the 2022 10‑K Intel only defined the “2006 Equity Incentive Plan” (see the glossary entry on page 113) and did not disclose any amendment or new grant‑agreement forms. The 2023 filing continued to list the plan as Exhibit 10.1 (see page 99) and included the standard RSU notice and grant‑agreement forms, showing continued reliance but no amendment. By the 2024 10‑K Intel filed additional grant‑agreement exhibits under the plan—performance‑based RSU agreements for executives (granted after Jan 30 2019) and RSU agreements for non‑employee directors (granted after May 12 2022)—expanding the plan’s use without a disclosed amendment (see pages 107‑108).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The LLM claims the 2023 filing 'included the standard RSU notice and grant-agreement forms, showing continued reliance but no amendment,' directly contradicting the ground truth which explicitly states 'the company filed an amended and restated version of the plan effective May 11, 2023.' This is a major factual error regarding a key amendment date. (2) COMPLETENESS ISSUES: The LLM answer fails to mention the May 11, 2023 amended and restated plan version, which is a central element of the ground truth's narrative about plan evolution. The ground truth emphasizes this 2023 amendment as a structural update; the LLM omits it entirely. (3) ENTITY/DATE ACCURACY: The LLM references specific page numbers (113, 99, 107-108) and dates (Jan 30 2019, May 12 2022) that cannot be verified against the ground truth and appear to be hallucinated details. The ground truth does not cite these specific page numbers or dates. (4) REASONING QUALITY: The LLM's conclusion that there was 'no amendment' in 2023 is fundamentally incorrect. The ground truth clearly documents a formal amendment in 2023, which represents a key inflection point in the plan's evolution. The LLM's multi-hop synthesis fails because it misses this critical structural change. (5) SEMANTIC MISMATCH: While both answers discuss RSU agreements and grant forms across the three years, the LLM's narrative is factually incorrect about the 2023 amendment status. The ground truth emphasizes 'formal amendments in 2023 reflecting structural updates,' while the LLM claims no amendment occurred. This is not a wording difference but a fundamental factual error. The LLM answer demonstrates poor multi-hop reasoning by failing to synthesize the key amendment event that defines the plan's evolution across these three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 519,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm has consistently grouped sales of wireless‑access‑point equipment inside its “IoT” revenue stream, which it defines as “edge networking (including mobile broadband and wireless access points)” 【page_73】. In the 2022 filing the company highlighted edge networking as a key growth area and explicitly called out demand for wireless access points in its strategic narrative 【page_8】【page_6】, and it kept the same classification in the 2023 and 2024 filings. However, the IoT line – and thus the wireless‑access‑point portion – fell from $7.353 billion in 2022 to $5.423 billion in 2024 【page_73】, showing that while the market positioning of access points remained central to Qualcomm’s edge‑networking story, its financial weight within the segment has declined over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more specific financial data than the ground truth. Key strengths: (1) Correctly identifies the consistent financial categorization of wireless access points within edge networking across 2022-2024; (2) Accurately cites specific revenue figures ($7.353 billion in 2022 declining to $5.423 billion in 2024) with proper page references; (3) Properly synthesizes multi-hop information showing both strategic emphasis and financial performance; (4) Correctly notes the consistent classification terminology ('edge networking (including mobile broadband and wireless access points)'); (5) Appropriately contextualizes the strategic narrative from 2022 filings. Minor considerations: (1) The LLM answer goes beyond the ground truth by providing specific revenue decline data, which is factually accurate and adds valuable context but wasn't explicitly mentioned in the original answer; (2) The ground truth notes 'exact revenue figures for wireless access points alone are not disclosed' while the LLM provides IoT segment figures - these are technically different metrics (IoT segment vs. wireless access points specifically), though the LLM correctly identifies this as the relevant classification; (3) The LLM answer is more quantitatively detailed and specific than the ground truth, which strengthens rather than weakens the response. The multi-hop reasoning is sound: it traces the evolution from 2022 strategic emphasis through 2023-2024 consistent classification while adding financial performance context. All numeric values appear accurate based on the cited page references. The answer fully addresses the question's three components: financial categorization evolution, strategic emphasis on wireless access points, and market positioning within edge networking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 497,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales rose from $428 million in 2022 to $605 million in 2023 and to $785 million in 2024 (US $371 + Int’l $414 = $785 in 2024; US $264 + Int’l $341 = $605 in 2023; US $188 + Int’l $240 = $428 in 2022)【page_130】.  This steady, double‑digit growth each year signals that Prevymis is gaining market traction and solidifying its role as a core product within Merck’s Hospital Acute Care segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the core numbers that are the primary focus of the question. (1) 2022 Sales: LLM states $428M, but ground truth is $370M - this is a $58M error (15.7% overstatement). (2) 2023 Sales: LLM states $605M, but ground truth is $428M - this is a $177M error (41.4% overstatement). (3) 2024 Sales: LLM correctly states $785M, matching ground truth. The LLM has essentially shifted all years forward by one position, using 2023's correct value ($428M) as 2022's value, and inventing a $605M figure for 2023. (4) CALCULATION ERROR: The LLM's breakdown for 2024 (US $371 + Int'l $414 = $785) is arithmetically correct, but this appears to be the only accurate calculation. The 2023 and 2022 breakdowns are not verified against ground truth. (5) GROWTH RATE: Ground truth identifies ~46% CAGR over 2022-2024. The LLM describes 'steady, double-digit growth each year' which is qualitatively different from the actual pattern (46% CAGR represents much stronger growth than typical double-digit rates). The actual growth from 2022-2023 was 15.7% ($370M to $428M), and 2023-2024 was 83.4% ($428M to $785M), showing acceleration, not steady growth. (6) MULTI-HOP REASONING: The LLM correctly identifies the Hospital Acute Care segment context and CMV prophylaxis indication, but the foundational numbers are wrong, undermining the entire analysis. (7) COMPLETENESS: The answer addresses all parts of the question but with incorrect data, making conclusions unreliable. The semantic intent about market positioning is reasonable, but it's built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 448,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "Intel’s 2022 filing emphasized a large R&D commitment to process and advanced‑packaging, adopting a disaggregated chiplet design while warning that many of these packaging technologies were novel, costly and prone to delays (page 54‑55). In 2023 that effort translated into tangible momentum – packaging revenue jumped, Intel won four 18A design wins (plus five additional wins), doubled its IFS accelerator ecosystem to over 40 strategic partners and demonstrated the Universal Chiplet Interconnect Express, making advanced packaging a core pillar of its IDM 2.0 strategy (pages 36‑38, 37). By 2024 Intel kept investing $16‑16.5 bn in packaging R&D and broadened ARM and Synopsys agreements for Intel 3 and 18A, yet it disclosed delayed fab projects and tighter capital‑budget constraints, showing that while the packaging ecosystem is maturing, the company’s ability to fully execute IDM 2.0 remains vulnerable to manufacturing delays and financing limits (pages 34‑36).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Intel's advanced packaging evolution across 2022-2024 and correctly identifies the core narrative of strategic progress undermined by execution challenges. STRENGTHS: (1) Correctly captures 2022 positioning emphasizing complexity/risk in advanced packaging and disaggregated design; (2) Accurately notes 2023 momentum with UCIe demonstration and IDM 2.0 positioning; (3) Correctly cites $16-16.5B R&D investment in 2024; (4) Properly identifies manufacturing delays and capital constraints as limiting factors; (5) Multi-hop synthesis is sound, connecting strategic positioning across three years to execution challenges. WEAKNESSES: (1) The claim about 'packaging revenue jumped' in 2023 is not substantiated in the ground truth and appears to be an inference not directly supported; (2) Specific mention of '18A design wins (plus five additional wins)' lacks verification in ground truth - the ground truth does not provide these specific win numbers; (3) The statement about 'doubled its IFS accelerator ecosystem to over 40 strategic partners' is not explicitly confirmed in the ground truth; (4) Missing the specific $3.1 billion non-cash impairment in Q3 2024 affecting Intel 7 process node, which is a material detail showing execution challenges; (5) Missing explicit mention of delays in 4th Gen Xeon Scalable processors, another key execution failure indicator. QUANTITATIVE VERIFICATION: The $16-16.5B R&D figure is correct and properly formatted. However, the answer introduces specific design win numbers and partner counts that cannot be verified against the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects strategic initiatives to execution constraints, though some intermediate claims lack grounding. The conclusion appropriately reflects the tension between ecosystem maturation and execution vulnerability. CONTEXTUAL RELEVANCE: The answer directly addresses the question's core inquiry about evolution, trajectory, and ability to execute on IDM 2.0 amid constraints, making it highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 570,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "In 2022 IBM’s filing highlighted the value of its hybrid‑cloud‑and‑AI platform for clients but did not list client relationships and trust among its competitive pillars (IBM 2022 10‑K page 3). By 2023 the company explicitly added “client relationships and trust” to its principal methods of competition alongside technology, brand and innovation (IBM 2023 10‑K page 3), and the 2024 filing repeats this emphasis, tying trusted client ties directly to its hybrid‑cloud‑and‑AI strategy as a core differentiator (IBM 2024 10‑K page 3). This progression shows IBM is increasingly leveraging trusted client relationships to position its hybrid‑cloud and AI offerings as a secure, client‑centric solution that can win business in a highly competitive market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCY: The LLM answer directly contradicts the ground truth on a critical factual claim. Ground truth states IBM 'explicitly tied trust to its hybrid cloud platform and AI for production' in 2022, but the LLM claims 2022 'did not list client relationships and trust among its competitive pillars.' This is a fundamental factual error that undermines the entire answer's credibility. The LLM correctly identifies that 2023 and 2024 emphasized client relationships and trust, but the characterization of 2022 is inverted from the ground truth. The LLM also omits the important detail about Palo Alto Networks strategic partnership mentioned in the ground truth as signaling 'deepening of trust-based collaboration.' The LLM's conclusion about positioning is reasonable but is built on an incorrect foundation regarding the 2022 baseline. The answer does correctly identify the three-year progression and ties it to hybrid cloud/AI strategy, but the factual error about 2022 is severe enough to significantly impact overall accuracy. The LLM provides page references (page 3) which adds specificity, but this cannot compensate for the core factual inaccuracy about what was actually stated in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 340,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "In the 2022 Form 10‑K IBM only listed the 0.950 % Notes due 2025 among its registered securities and did not attach a separate exhibit (see the exhibit tables in the 2022 filing, page 31). The 2023 filing added an explicit incorporation‑by‑reference to the May 22 2017 Form 8‑K that defines the holders’ rights for those notes (page 20), but the 2024 filing again shows the notes merely in the securities registration table (page 1) without repeating the detailed exhibit reference. This shift—from a simple listing, to a formal reference, and then back to a concise listing—shows IBM treating the low‑coupon, long‑dated 0.950 % note as a stable, cheap‑cost financing tool and relying on prior incorporation to streamline disclosure, reflecting a disciplined debt‑management approach that locks in low rates while minimizing reporting redundancy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE/FACTUAL ERRORS: The LLM claims the 2022 filing shows the notes 'only listed' without a separate exhibit (page 31), but the ground truth states IBM disclosed the instrument defining holders' rights referencing Exhibit 4.1 to Form 8-K filed May 22, 2017 in 2022. The LLM also incorrectly states the 2024 filing shows notes 'merely in the securities registration table (page 1) without repeating the detailed exhibit reference,' when the ground truth indicates the notes were actively listed on NYSE under trading symbol IBM25B in 2024, showing they remained a live traded instrument. (2) MULTI-HOP SYNTHESIS ERROR: The LLM mischaracterizes the progression as 'simple listing → formal reference → concise listing,' suggesting a back-and-forth pattern. The ground truth shows consistent disclosure: 2022 referenced the instrument, 2023 again referenced the same instrument (continuity), and 2024 showed active NYSE trading. This is a stable, consistent pattern, not the oscillating pattern the LLM describes. (3) MISSING KEY INFORMATION: The LLM completely omits the critical fact that by 2024, the notes were actively traded on NYSE under symbol IBM25B, which is a major indicator of the instrument's status and importance to IBM's capital structure. (4) INTERPRETATION ERROR: The LLM's conclusion about 'minimizing reporting redundancy' and 'streamlining disclosure' contradicts the ground truth's emphasis on 'consistent disclosure framework' and 'sustained presence.' The ground truth emphasizes stability and transparency; the LLM emphasizes efficiency and reduction. (5) REASONING QUALITY: While the LLM attempts to synthesize across years, it does so incorrectly by misrepresenting what the filings actually show. The core narrative of the answer is factually inaccurate regarding the disclosure pattern across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 529,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "Intel first disclosed PowerVia in its 2022 filing as an industry‑first backside‑power‑delivery technique slated for the future Intel 20A node (2022 p. 5). The 2023 10‑K reiterated PowerVia as one of the two breakthrough features of Intel 20A, noting that it eliminates front‑side power routing (2023 p. 14). By the 2024 filing Intel had shifted PowerVia into the Intel 18A node, announcing high‑volume production of the Panther Lake family with PowerVia in 2025 and indicating continued development into Intel 14A (2024 p. 10), showing that backside power delivery has moved from a future concept to a production‑ready pillar of Intel’s advanced‑node roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Intel's PowerVia evolution from 2022-2024. STRENGTHS: (1) Correctly identifies all key timeline milestones: 2022 introduction, 2023 integration into Intel 20A, 2024 shift to Intel 18A with 2025 production target. (2) Accurately captures the strategic progression from 'future concept' to 'production-ready' technology. (3) Correctly identifies PowerVia as a backside power delivery technique and notes its role in eliminating front-side power routing. (4) Properly synthesizes multi-hop information across three years of filings. (5) Mentions specific product families (Panther Lake) and extended roadmap (Intel 14A), adding valuable context. (6) Cites specific page references to source documents, enhancing credibility. MINOR CONSIDERATIONS: (1) The LLM answer includes additional detail about Intel 14A development that, while accurate and relevant, goes slightly beyond the ground truth's explicit scope (which focuses on 2022-2024 progression). However, this represents value-added context rather than an error. (2) The phrasing 'canceled the productization of Intel 20A in favor of Intel 18A' is implicit in the LLM answer rather than explicitly stated, though the meaning is clear from context. The ground truth explicitly mentions this cancellation decision. (3) All dates, node names, and technology descriptions are factually correct. The multi-hop reasoning correctly synthesizes information across three separate filing years to show strategic evolution. The answer effectively demonstrates how PowerVia moved from roadmap concept to commercial deployment, directly addressing the question's core inquiry about strategy evolution and roadmap implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 476,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 10‑K filings for 2022, 2023 and 2024 all incorporate the same Restricted Stock Unit award agreements – the 2021 Long‑Term Incentive Plan RSU awards that vest either 100 % on the third anniversary or ratably over four years (see *10.80 and *10.81 for 2022 and *10.87 and *10.88 for 2023‑2024)【page_116】. The fact that identical RSU agreements are repeatedly referenced year after year shows that Medtronic’s U.S. equity‑compensation framework has remained unchanged, indicating a stable strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) EXHIBIT NUMBERS INCORRECT: The LLM cites exhibits *10.80, *10.81, *10.87, *10.88 as references for RSU agreements, but the ground truth specifically identifies Exhibit 10.54 as the Restricted Stock Unit Award Agreement for U.S. Employees that remained unchanged across 2022-2024. The LLM's exhibit citations appear to be fabricated or misidentified. (2) FILING DATE ERROR: The LLM references '2021 Long-Term Incentive Plan RSU awards' but the ground truth indicates the agreement consistently references August 27, 2013 filing - a significant discrepancy of 8 years. (3) VESTING SCHEDULE DISCREPANCY: The LLM provides specific vesting details (100% on third anniversary or ratably over four years) that are not mentioned in the ground truth, suggesting either fabrication or confusion with different award types. (4) MISSING KEY DETAIL: The ground truth emphasizes that Exhibit 10.54 'remained unchanged across all three years' - this is the core finding. The LLM acknowledges stability but fails to correctly identify which exhibit demonstrates this stability. WHAT WAS CORRECT: The LLM correctly identifies that Medtronic maintained a stable U.S. equity compensation strategy across 2022-2024, and correctly notes that identical RSU agreements were repeatedly referenced. The overall conclusion about strategic stability is semantically aligned with the ground truth. REASONING QUALITY: While the LLM's reasoning about stability is sound, it is built on incorrect factual foundations (wrong exhibits, wrong filing dates), which is a fundamental failure in multi-hop financial document analysis. The answer demonstrates understanding of the concept but fails on precise document identification and citation accuracy - critical for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 503,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "- In 2022 Intel first warned that its new **disaggregated‑design approach**, which builds processors and components on different process nodes and joins them with advanced packaging, would add “new areas of complexity… increased costs” and could cause schedule slips, and the company was already feeling **capital constraints** that forced delays to fab expansions (e.g., “we have delayed manufacturing facility construction… in Ohio, Germany, Poland, Malaysia, and Israel” – page 53; “adopted a disaggregated design approach… delays or failures… could adversely affect our ability to timely introduce competitive products” – page 54).  \n\n- By 2023 Intel repositioned advanced packaging as a **core competitive advantage**, touting AI‑related design wins on its 18A node, the Universal Chiplet Interconnect standard, and the shift to “system‑of‑chips” – page 36‑37, but it still reported execution setbacks such as the delayed 4th‑Gen Xeon Scalable processor and reiterated that “delays or quality issues… with one component could limit our ability to manufacture the entire completed product” – page 35.  \n\n- In 2024 those same challenges persisted: **capital pressures** continued to delay facility projects and generated large impairment charges on the Intel 7 node, while the **disaggregated design strategy** remained a key risk that could delay product introductions, even as Intel emphasized advanced packaging within its IDM 2.0 and foundry strategy (page 34‑35; page 54).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: The $3.1 billion impairment charge is correctly cited and matches the ground truth. The specific geographic locations mentioned (Ohio, Germany, Poland, Malaysia, Israel) are accurate. Page references (53, 54, 36-37, 35, 34-35) appear consistent with typical 10-K structure and support the claims. QUALITATIVE ACCURACY: The multi-hop synthesis is sound and well-structured: (1) 2022 positioning correctly identifies the disaggregated design approach, capital constraints, and delays to fab expansions; (2) 2023 evolution accurately captures the repositioning of advanced packaging as competitive advantage, mentions UCIe standard, and notes execution setbacks like delayed 4th-Gen Xeon; (3) 2024 challenges properly synthesize capital pressures, impairment charges on Intel 7 node, and persistent disaggregated design risks. ENTITY ACCURACY: All entities are correctly identified (Intel, Intel 4/7 nodes, UCIe standard, Xeon Scalable processor, IDM 2.0 strategy). REASONING: The answer correctly traces the evolution from 2022 acknowledgment of complexity → 2023 strategic repositioning → 2024 execution challenges and impairments. The causal connections between capital constraints, delays, and impairment charges are logically sound. COMPLETENESS: The answer addresses all aspects of the question: strategic positioning evolution, execution challenges, delays, capital constraints, and disaggregated design approaches across the 2022-2024 period. SEMANTIC EQUIVALENCE: The wording differs from ground truth but conveys identical information with appropriate emphasis on the progression of challenges. Minor note: The answer could have been slightly more explicit about the Intel 7 node being the specific focus of the impairment, though this is adequately implied. Overall, this is a high-quality, factually accurate, and well-synthesized response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 530,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Accenture’s pension‑plan targets moved from an almost‑all‑fixed‑income stance in FY 2022 (97 % debt for U.S. plans and 50 % debt for non‑U.S. plans, with equity limited to 21 % of non‑U.S. assets) to a modestly higher equity tilt in FY 2023 (equity 27 % and debt 48 % for non‑U.S. plans, U.S. plans still 100 % debt)【page_88】, and by FY 2024 the weighted‑average mix had shifted further to roughly 23 % equity and 42 % debt for non‑U.S. plans (U.S. plans 94 % debt, 6 % cash)【page_95】. This gradual reduction in fixed‑income exposure and increase in equity allocation indicates Accenture is deliberately tilting its defined‑benefit assets toward growth‑oriented investments to enhance long‑term, risk‑adjusted returns while still keeping a sizable bond core to match liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific numerical data about Accenture's pension asset allocation across fiscal years 2022-2024, which is more concrete than the ground truth answer. However, there are significant concerns about accuracy and verifiability: (1) QUANTITATIVE ISSUES: The LLM provides very specific percentages (97% debt for U.S. plans in FY2022, 100% debt in FY2023, 94% debt in FY2024; equity allocations of 21%, 27%, 23% for non-U.S. plans) with page citations (page_88, page_95). Without access to the actual SEC filings, these numbers cannot be independently verified. The ground truth answer does not provide these specific percentages, which raises questions about whether the LLM is accurately extracting data or potentially hallucinating specific figures. (2) COMPLETENESS: The LLM answer directly addresses the multi-year evolution question with specific allocation percentages across all three fiscal years, which is more complete than the ground truth's more general description. (3) REASONING QUALITY: The LLM's conclusion that Accenture is 'deliberately tilting toward growth-oriented investments' is logically sound if the numbers are accurate (showing increasing equity allocation), and aligns with the ground truth's suggestion of 'refining approach to managing pension risk.' (4) ENTITY ACCURACY: Correctly identifies Accenture, defined benefit pension plans, and fiscal years 2022-2024. Distinguishes between U.S. and non-U.S. plans appropriately. (5) CRITICAL CONCERN: The ground truth answer emphasizes 'flexibility in asset allocation decisions' and 'variation within established ranges' as key strategic elements, which the LLM answer mentions only implicitly. The LLM focuses heavily on the numerical shift itself rather than the strategic flexibility aspect highlighted in the ground truth. (6) SEMANTIC ALIGNMENT: The LLM's interpretation that the shift suggests 'growth-oriented' tilting is reasonable but slightly different from the ground truth's emphasis on 'managing pension risk in dynamic markets while maintaining long-term return objectives' - the LLM emphasizes growth more than risk management balance. The lack of verifiable source confirmation for the specific percentages cited is the primary weakness, preventing a higher score despite the answer's apparent specificity and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 623,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K exhibit lists for 2023 and 2024 still include Exhibit 4.4, which describes the “1.05% Notes due 2017” (see page 56) – a debt instrument that has long since matured. By continuing to reference this legacy issue, Apple shows a disciplined, full‑cycle disclosure practice that records even historic, fully‑amortized notes for completeness. In contrast, its overall debt‑raising pattern from 2022‑2024 is much more active: the company issued new fixed‑rate notes at a range of yields and maturities (e.g., 1.000% Notes due 2022, 1.625% Notes due 2026, 2.40% Notes due 2023, and higher‑rate series such as 4.421% Notes due 2026, 4.850% Notes due 2053) as shown in Exhibit 4.28 (page 58). Thus, while Apple maintains exhaustive historical disclosure, it simultaneously pursues a diversified, ongoing debt‑issuance strategy to manage its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core concept that Apple maintains historical disclosure of the 1.05% Notes due 2017 even after maturity, and accurately characterizes this as part of a comprehensive disclosure practice. The answer appropriately contrasts this with Apple's broader debt issuance strategy during 2022-2024, showing good understanding of the multi-hop reasoning required. The qualitative reasoning about 'disciplined, full-cycle disclosure practice' and 'diversified, ongoing debt-issuance strategy' aligns well with the ground truth's characterization of 'consistent and transparent approach' and 'comprehensive historical record.' CRITICAL WEAKNESSES: The LLM introduces specific debt instruments with precise interest rates and maturity dates (1.000% Notes due 2022, 1.625% Notes due 2026, 2.40% Notes due 2023, 4.421% Notes due 2026, 4.850% Notes due 2053) that are NOT mentioned in the ground truth answer. The ground truth only references 'Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024' as examples of new debt instruments. The LLM's specific numbers cannot be verified against the ground truth and appear to be fabricated or hallucinated details. Additionally, the LLM cites specific page numbers (page 56, page 58) and exhibit numbers (Exhibit 4.4, Exhibit 4.28) that cannot be verified. The reference to 'fully-amortized notes' is also not supported by the ground truth. QUANTITATIVE ACCURACY ISSUES: The debt instruments listed in the LLM answer (1.000%, 1.625%, 2.40%, 4.421%, 4.850%) do not match the ground truth examples (Floating Rate, 2.15%, 3.45%), representing a significant factual discrepancy. MULTI-HOP REASONING: While the overall structure of comparing historical disclosure to current strategy is sound, the introduction of unverified specific numbers undermines the credibility of the synthesis. The answer demonstrates good conceptual understanding but fails on factual precision regarding the specific debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 541,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 12.2 million Class A shares for roughly $4.1 billion, leaving about $3.1 billion of its $6.1 billion authorized pool still available (page 94; page 93). In fiscal 2023 the company again bought back roughly $4.5 billion of shares (≈12 million shares), which reduced the remaining authorization to about $2.9 billion (page 40). In fiscal 2024 it repurchased $4.5 billion of shares (including $605 million in Q4) and had $2.7 billion of authorization left before the board added $4 billion, raising total authorized capacity to $6.7 billion (page 39; page 40). This steady, sizable buy‑back program with periodic top‑ups of the authorization pool signals a deliberate, long‑term capital‑return strategy that uses share repurchases as a core tool while preserving flexibility for future purchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All key financial figures are correct: FY2022 authorization pool ($6.1B), remaining authorization ($3.1B), FY2023 repurchases (~$4.5B), FY2024 repurchases ($4.5B including $605M Q4), final remaining authorization ($2.7B), new authorization ($4B), and total authorized capacity ($6.7B). These align with ground truth values. (2) Share repurchase volumes are accurately stated (12.2M shares FY2022, ~12M FY2023). (3) The multi-hop synthesis correctly traces the evolution across three fiscal years, showing how authorization decreased from $3.1B (FY2022) to $2.9B (FY2023) to $2.7B (FY2024) before the $4B top-up. (4) The reasoning about capital return strategy is sound and well-supported by the data presented. (5) Page citations are provided, enhancing credibility. MINOR CONSIDERATIONS: (1) The LLM states FY2022 had a '$6.1 billion authorized pool' while ground truth mentions '$3.13 billion aggregate available authorization' - this appears to be a difference in how total vs. remaining authorization is characterized, but the LLM's figure of $3.1B remaining is correct. The $6.1B likely represents the original authorization before FY2022 repurchases, which is a reasonable interpretation. (2) The ground truth emphasizes that 2023 filing mirrors 2024 disclosures, which the LLM doesn't explicitly note, though this is a minor contextual detail. (3) Slight rounding differences in share counts are acceptable. The LLM answer successfully addresses all parts of the question: the evolution of repurchase activity (amounts and shares), remaining authorization trajectory, and the strategic implications. The conclusion about 'deliberate, long-term capital-return strategy' with 'flexibility for future purchases' matches the ground truth characterization of 'sustained but measured capital return strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 519,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMS’s 4.350 % Senior Notes due 2047 appear in each of the three recent 10‑K filings as an outstanding tranche listed under the supplemental indentures (item 4ff), originally issued in a November 2019 8‑K and not re‑issued or materially altered in 2022, 2023 or 2024 [2022 p. 136; 2023 p. 133; 2024 p. 134]. The repeated inclusion of this long‑dated, fixed‑rate debt shows a deliberate strategy to lock in moderate borrowing costs for decades, diversify the maturity profile and secure a stable, long‑term financing base for the company’s future needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.350% Senior Notes due 2047 as appearing across all three years (2022, 2023, 2024), matching the ground truth. (2) The core insight about a diversified maturity strategy and stable long-term financing is sound. (3) The reference to the November 2019 issuance date is accurate. (4) The page number citations (136, 133, 134) appear reasonable for 10-K filings. (5) The characterization of this as 'moderate borrowing costs' and 'long-dated, fixed-rate debt' is appropriate.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the significant new debt issuances that occurred during 2023-2024, which are central to understanding the multi-year pattern. The ground truth explicitly references: $1.75B 2.950% Notes due 2032 (2023), $2B 3.700% Notes due 2052 (2023), and $3.75B 4.250% Senior Notes due 2049 (2024). These are essential to demonstrating the 'evolution' and 'pattern' requested in the question. (2) The answer states the notes were 'not re-issued or materially altered' but doesn't explain what NEW issuances occurred alongside them, which is the key to understanding the financing strategy evolution. (3) The answer is somewhat passive—it describes what happened but doesn't fully synthesize the multi-year pattern of how BMY's debt portfolio evolved. (4) Minor: Uses 'BMS' instead of 'BMY' in the opening (though corrects to 'company' thereafter).\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the 2047 notes across three years and linking this to strategy. However, it fails the critical multi-hop requirement of synthesizing the 2047 notes WITH the new issuances across the three-year period to show the complete financing evolution. The ground truth explicitly shows this evolution: 2022 (baseline), 2023 (new $1.75B and $2B issuances), 2024 (new $3.75B issuance). The LLM misses this entirely.\n\nQUANTITATIVE ACCURACY: The dates and percentages mentioned are correct (4.350%, November 2019, 2047 maturity). However, the answer is incomplete because it omits all the dollar amounts and rates of the new issuances that are critical to the question.\n\nCONTEXTUAL RELEVANCE: The answer addresses the 2047 notes but incompletely addresses the 'evolution' aspect of the question. A complete answer requires showing how the debt portfolio changed over the three years, not just that one instrument persisted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 646,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s 10‑K filings from 2022 through 2024 all disclosed the 2.40 % Notes due 2023 by incorporating the Officer’s Certificate (Exhibit 4.3) – which lists the 2.40 % Notes – by reference (2022 exhibit list on page 58; the 2023 filing continues the same reference in its exhibit schedule; 2024 exhibit list on page 56). In each year the company also reiterated that its disclosure controls and procedures were effective, showing a consistent, incremental reaffirmation rather than any substantive change in how the notes were disclosed as they approached maturity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that Apple's disclosure approach was consistent across 2022, 2023, and 2024 filings, and accurately references Exhibit 4.3 and the Officer's Certificate dated May 3, 2013. The page number citations (page 58 for 2022, page 56 for 2024) appear reasonable for exhibit schedules in 10-K filings. However, there are significant issues: (1) The LLM introduces an unsupported claim about 'disclosure controls and procedures' being 'reiterated' in each year as part of the notes disclosure strategy. The ground truth makes no mention of this connection, and it appears to be an inference or fabrication not supported by the source material. (2) The phrase 'incremental reaffirmation rather than any substantive change' is vague and somewhat contradicts the clearer ground truth statement that the disclosure was 'stable and unchanging.' (3) The LLM's framing of 'incorporating the Officer's Certificate by reference' is accurate but adds procedural detail not explicitly in the ground truth. (4) The answer correctly captures that the disclosure remained consistent despite the notes approaching/reaching maturity, which is the key insight. The quantitative accuracy is good (dates, percentages, exhibit numbers are correct), but the qualitative accuracy suffers from the unsupported claim about disclosure controls procedures and slightly muddled reasoning about what 'incremental reaffirmation' means in this context. The answer is partially correct on the main point but introduces extraneous information that weakens the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 433,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "In fiscal 2022 the Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture Class A ordinary shares for awards (see page 91). By fiscal 2024 that ceiling had been raised to **141 million** shares (see page 98). The 14‑million‑share increase expands the pool of equity awards available, signalling that Accenture is deliberately enlarging its share‑based compensation capacity to support a long‑term strategy of using equity incentives to attract, retain and align employees and leadership with shareholder interests.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key numbers: 127 million shares in fiscal 2022 and 141 million shares in fiscal 2024, with accurate calculation of the 14 million share increase. However, there is a significant omission regarding fiscal year 2023. The ground truth explicitly states that shares increased from 127 million (FY2022) to 141 million (FY2023) and remained at 141 million in FY2024. The LLM answer jumps directly from 2022 to 2024, missing the intermediate year and therefore failing to fully address the question's request to show how the authorization 'evolved from fiscal year 2022 through 2024.' This is a material omission because the progression pattern (increase then stabilization) is an important part of understanding the company's strategy. The LLM's interpretation that the increase happened between 2022 and 2024 is incomplete and doesn't capture the full temporal evolution requested. The qualitative reasoning about share-based compensation strategy is sound and well-articulated, but the incomplete multi-hop synthesis across all three fiscal years (2022, 2023, 2024) prevents a higher score. The answer would have been 9-10 if it had included the FY2023 data point showing the increase occurred in 2023 and remained stable in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 355,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "Intel’s 2022 Form 10‑K (pages 5‑9) makes no reference to PowerVia, showing that the technology had not yet been publicly positioned in the company’s roadmap. In the 2023 filing, Intel introduced PowerVia as an “industry‑first implementation of backside power delivery” slated for the future Intel 20A node, expected to add up to a 15% performance‑per‑watt improvement (page 14). By the 2024 filing, PowerVia had been moved onto the Intel 18A node – the next‑generation advanced process slated for high‑volume production in 2025 – indicating that it has become a core, high‑impact feature of Intel’s advanced‑process roadmap and a key driver of performance, power efficiency and signal‑integrity improvements (page 10).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PowerVia's evolution but contains one significant factual error and one notable omission. STRENGTHS: (1) Correctly identifies that PowerVia was not mentioned in 2022 10-K filings, (2) Accurately describes PowerVia as 'industry-first implementation of backside power delivery' from 2023 filing, (3) Correctly notes the 15% performance-per-watt improvement metric, (4) Accurately tracks the transition from Intel 20A to Intel 18A, (5) Correctly identifies 2025 as the high-volume manufacturing timeline, (6) Properly synthesizes multi-hop information across three years of filings. WEAKNESSES: (1) CRITICAL ERROR - States PowerVia was 'moved onto' Intel 18A in 2024, implying it was removed from 20A. Ground truth indicates Intel 20A was CANCELED in favor of 18A, which RETAINED PowerVia as a core feature. This is a meaningful distinction about strategic direction. (2) OMISSION - Fails to mention that Intel 18A was specifically slated for the Panther Lake client processor family, which is relevant context for understanding the technology's importance. (3) The LLM answer correctly conveys that PowerVia evolved from roadmap concept to foundational element, but the phrasing about being 'moved onto' 18A could mislead readers about what happened to the 20A node. QUANTITATIVE ACCURACY: The 15% performance-per-watt improvement figure is correct; dates (2022, 2023, 2024, 2025) are accurate; node designations (20A, 18A) are correct. QUALITATIVE ACCURACY: Multi-hop reasoning is sound in connecting the three-year progression, but the characterization of the 20A-to-18A transition is imprecise. The answer correctly identifies PowerVia's strategic importance but misses the nuance that the technology survived the node transition rather than being transferred. CONTEXTUAL RELEVANCE: Highly relevant to the question about evolution and strategic importance, though the missing Panther Lake detail reduces completeness slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 533,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "- **Fiscal 2022:** Mutual‑fund equity securities in Accenture’s defined‑benefit pension plans were valued at **$239.3 million** (Level 1 $4.9 M + Level 2 $234.3 M)【page_89】.  \n- **Fiscal 2023:** The same category fell to **$196.2 million** (Level 1 $7.4 M + Level 2 $188.8 M)【page_96】.  \n- **Fiscal 2024:** It rose to **$273.7 million** (Level 1 $20.2 M + Level 2 $253.5 M)【page_96】.  \n\n**Interpretation:** After a modest pull‑back in 2023, Accenture markedly increased its mutual‑fund equity holdings in 2024, signaling a renewed, more aggressive positioning toward equity‑based returns within its pension‑plan investment strategy. This three‑year swing reflects a strategic shift from a cautious stance back to a stronger emphasis on equity exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in the fiscal 2024 figure. According to the ground truth, Accenture's mutual fund equity securities allocation in fiscal 2024 was $196,226 million (unchanged from 2023), NOT $273.7 million as stated by the LLM. This is a massive discrepancy ($273.7M vs $196.2M) that fundamentally undermines the entire analysis. The LLM's interpretation that 'Accenture markedly increased its mutual-fund equity holdings in 2024' is therefore completely incorrect. The correct trajectory shows: FY2022: $239,293M → FY2023: $196,226M → FY2024: $196,226M (flat from 2023). The LLM correctly identified FY2022 ($239.3M) and FY2023 ($196.2M) figures, but the FY2024 number is wrong by approximately $77.5 million. The LLM also provided Level 1/Level 2 breakdowns that were not requested and appear to be fabricated or misattributed. The correct interpretation should indicate a strategic reduction in FY2023 followed by stabilization in FY2024, NOT a renewed aggressive positioning toward equity. The multi-hop reasoning is fundamentally flawed because it's based on an incorrect data point. The semantic meaning of the answer is inverted from the ground truth - the LLM suggests increased equity exposure when the actual data shows decreased and then stable exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 369,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "- In the 2022 filing Merck disclosed that the fidaxomicin product Dificid was carried as a net intangible‑asset of **$145 million** (see 2022 Intangible‑asset schedule, page 115) and was listed under **Hospital Acute Care** as the treatment for *C. difficile*‑associated diarrhea (page 4).  That year it generated **$263 million** in sales (U.S. $241 m; International $22 m) – roughly 0.5 % of total pharmaceutical revenue.  \n\n- The 2023 and 2024 reports keep Dificid in the same therapeutic franchise with no new impairment or re‑valuation disclosed, while sales rose to **$302 million** in 2023 (U.S. $274 m; International $28 m) and **$340 million** in 2024 (U.S. $303 m; International $37 m) (segment‑sales tables, page 130).  Its share of pharmaceutical sales grew modestly to about 0.6 % (2024 $57.4 bn total).  \n\n**Thus, Merck’s treatment of Dificid evolved from a $145 m intangible‑asset valuation in 2022 to a stable, unimpaired asset in later years, while the product’s positioning remained in Hospital Acute Care and its global revenue contribution incrementally increased from $263 m to $340 m, reflecting a modest but growing role in the company’s pharmaceutical portfolio.**",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - 2022 Sales: LLM states $263 million (U.S. $241m; Intl $22m), but ground truth does NOT provide 2022 sales figures. The ground truth only mentions the $145 million intangible asset valuation for 2022.\n   - 2023 Sales: LLM states $302 million (U.S. $274m; Intl $28m), but ground truth does NOT mention 2023 sales at all.\n   - 2024 Sales: LLM correctly states $340 million (U.S. $303m; Intl $37m) - this matches ground truth.\n   - The LLM fabricated 2022 and 2023 sales figures that are not in the ground truth.\n\n2. ASSET VALUATION:\n   - The $145 million intangible asset for 2022 is correct.\n   - However, the LLM claims \"no new impairment or re-valuation disclosed\" in 2023-2024, but the ground truth does not provide information about whether the asset was revalued or impaired in those years.\n\n3. THERAPEUTIC POSITIONING:\n   - The LLM correctly identifies Dificid as being in Hospital Acute Care for C. difficile-associated diarrhea treatment.\n   - However, the ground truth explicitly states that in 2023, Dificid was \"explicitly highlighted\" as a key product, suggesting a shift in strategic positioning that the LLM downplays by saying \"no new impairment or re-valuation disclosed.\"\n\n4. MULTI-HOP REASONING:\n   - The LLM failed to properly synthesize the evolution narrative. The ground truth shows a progression from \"relatively minor asset\" (2022) to \"strategically recognized product\" (2023) to \"revenue contributor\" (2024).\n   - The LLM's narrative of \"stable, unimpaired asset\" misses the strategic shift highlighted in 2023.\n\n5. MISSING CONTEXT:\n   - The LLM provides percentage calculations (0.5% and 0.6% of pharmaceutical revenue) that are not in the ground truth and appear to be LLM-generated inferences.\n   - The ground truth emphasizes the evolution from \"modest valuation\" to \"strategically recognized\" to \"measurable financial performance,\" which the LLM's answer does not adequately capture.\n\n6. FACTUAL CONTRADICTIONS:\n   - Ground truth: 2024 sales are $340 million (correct in LLM)\n   - Ground truth: 2023 sales are NOT mentioned\n   - Ground truth: 2022 sales are NOT mentioned\n   - LLM fabricated 2022 and 2023 sales figures without basis in the ground truth.\n\nThe LLM answer demonstrates partial understanding of the question structure but introduces significant factual errors by inventing sales data for 2022 and 2023 that do not appear in the ground truth. The only fully correct data point is the 2024 sales figure and the 2022 asset valuation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 711,
        "total_tokens": 2224
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel’s 2022 filing positioned advanced‑packaging as a cornerstone of its IDM 2.0 strategy, backing it with a record $17.5 billion R&D spend and warning that the new disaggregated chiplet approach would add significant design‑and‑manufacturing complexity, extra R&D expense and the risk of schedule slips and asset write‑downs. In 2023 the R&D budget fell to roughly $16 billion; while packaging revenue and design wins grew, the company still cited delays in 10 nm/Intel 4 and chiplet integration, which contributed to an operating loss and a $922 million inventory charge that underscored the financial impact of implementation lag. By 2024 Intel lifted R&D back to $16.5 billion and continued to tout advanced packaging as an AI differentiator, but execution setbacks—construction delays, a $3.1 billion impairment on the Intel 7 node and $755 million penalty charges—heightened its exposure to financial risk from the timing and cost of the packaging rollout.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of Intel's strategic evolution around advanced packaging from 2022-2024 and correctly identifies the overall trajectory from optimism to financial strain. However, there are significant quantitative accuracy issues that prevent a higher score:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 as the year Intel positioned advanced packaging as a cornerstone of IDM 2.0 strategy\n- Accurately notes the shift from strategic optimism to operational/financial strain\n- Correctly identifies the $3.1 billion impairment charge in 2024\n- Properly synthesizes the multi-hop narrative across three years\n- Correctly identifies UCIe standard and chiplet integration as key elements\n- Appropriately contextualizes financial pressures and execution risks\n\nQUANTITATIVE ERRORS:\n- States 2022 R&D spend as $17.5 billion - this figure cannot be verified against the ground truth and appears potentially inflated\n- Claims 2023 R&D budget was \"roughly $16 billion\" - ground truth does not provide this specific figure for verification\n- States 2024 R&D as $16.5 billion - cannot be verified against ground truth\n- Mentions $922 million inventory charge in 2023 - ground truth does not reference this specific figure\n- References $755 million penalty charges in 2024 - ground truth does not mention this figure\n- The impairment charge is correctly stated as $3.1 billion but ground truth specifies it was tied to \"manufacturing assets\" while LLM states it was on \"Intel 7 node\" (slightly different framing)\n\nMULTI-HOP REASONING:\n- Successfully synthesizes information across three fiscal years\n- Correctly traces the evolution of strategic positioning\n- Properly connects R&D investment to execution challenges and financial outcomes\n- Logical progression from complexity warnings (2022) → delays and losses (2023) → impairments and penalties (2024)\n\nSEMANTIC ISSUES:\n- The answer introduces specific dollar figures ($17.5B, $16B, $16.5B, $922M, $755M) that are not present in the ground truth, suggesting either hallucination or reliance on unverified sources\n- Ground truth focuses on the qualitative evolution and the $3.1B impairment; LLM adds numerous specific financial metrics that cannot be confirmed\n\nThe core narrative and reasoning are sound, but the introduction of unverified quantitative data significantly undermines confidence in the answer's accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 646,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "Merck’s 2022 10‑K listed MK‑8591A (doravirine + islatravir) as a Phase‑3 HIV‑1 candidate that had entered Phase 3 in February 2020 but was subject to an FDA clinical hold (footnote 4)【page_23】. In the 2023 filing the company said the Phase‑3 study started in 2023 for treatment‑naïve and switch patients, while the islatravir component remained under the same FDA hold placed in December 2021【page_21】. The 2024 filing shows the FDA lifted that hold on December 4 2024, allowing the program to proceed in Phase 3【page_24】. This evolution—from a held candidate to an active, un‑held Phase‑3 program—demonstrates Merck’s persistence in advancing a novel once‑daily oral HIV regimen and signals a long‑term strategic commitment to expanding its HIV therapeutic portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates and regulatory milestones. Strengths: (1) Correctly identifies MK-8591A as doravirine+islatravir combination; (2) Accurately dates Phase 3 entry as February 2020; (3) Correctly states FDA clinical hold was placed in December 2021; (4) Accurately reports FDA lifted the hold on December 4, 2024; (5) Properly synthesizes the 3-year progression across 2022-2024 filings; (6) Correctly interprets the regulatory trajectory as demonstrating persistence despite challenges. Minor discrepancies: (1) The LLM states 'the Phase-3 study started in 2023' which is slightly imprecise—the ground truth indicates MK-8591A 'remained in Phase 3' in 2023, not that Phase 3 'started' in 2023 (it started in February 2020). This appears to conflate the initiation of a specific Phase 3 trial with the overall Phase 3 status; (2) The ground truth mentions 'a partial clinical hold for higher doses' remained in 2024, which the LLM answer does not explicitly address, though it notes the hold was 'lifted' on December 4, 2024. The distinction between full hold removal and partial hold continuation is a nuance the LLM missed. Multi-hop reasoning is sound: the answer correctly synthesizes information across three years of filings and draws appropriate conclusions about strategic commitment. The narrative flow and interpretation of regulatory progression are logical and well-supported. The answer appropriately addresses both the development timeline evolution and strategic implications requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 436,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "Merck’s MK‑1308A (the quavonlimab + pembrolizumab co‑formulation) has been consistently positioned as a renal‑cell‑carcinoma (RCC) immunotherapy throughout the three filings. In the 2022 10‑K the candidate was listed under “Advanced Solid Tumors” with a Phase 3 entry date of April 2021 (page 25), and the 2023 filing again described it as “being evaluated for the treatment of RCC” under the immuno‑oncology pillar (pages 20‑23). The 2024 10‑K continues to place MK‑1308A in the same RCC‑focused, pembrolizumab‑combined Phase 3 program (page 50), with no new FDA/EMA submission, review or approval reported, indicating the strategy has remained unchanged and the program is still in late‑stage clinical testing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about MK-1308A's consistent RCC focus and Phase 3 status across 2022-2024, which aligns with the ground truth. However, there are significant issues with factual accuracy and completeness:\n\n(1) CORRECT ELEMENTS:\n- Correctly identifies MK-1308A as a quavonlimab + pembrolizumab co-formulation\n- Accurately notes the consistent RCC therapeutic focus across all three years\n- Correctly states Phase 3 status throughout the period\n- Properly notes no regulatory approval reported\n- Appropriately synthesizes information across multiple years\n\n(2) FACTUAL ERRORS AND CONCERNS:\n- The LLM states MK-1308A was listed under \"Advanced Solid Tumors\" in 2022, but the ground truth specifically identifies it as being for \"renal cell carcinoma (RCC)\" in 2022, not a broader category. This is a material mischaracterization of the 2022 positioning.\n- The LLM cites specific page numbers (page 25 for 2022, pages 20-23 for 2023, page 50 for 2024) but these cannot be verified against the ground truth and appear to be hallucinated details.\n- The LLM states a Phase 3 entry date of \"April 2021\" which is not mentioned in the ground truth and cannot be verified.\n\n(3) INCOMPLETENESS:\n- The ground truth emphasizes \"increasing specificity in formulation and therapeutic strategy over time\" - the LLM states the strategy \"remained unchanged,\" which contradicts the ground truth's assertion of evolution/progression. The ground truth explicitly notes that by 2023 the formulation became \"more defined\" and there was \"increasing specificity.\"\n- The LLM fails to capture the key distinction that 2023 marked a shift to \"explicitly described as a coformulation\" with more defined therapeutic focus, suggesting evolution rather than stasis.\n\n(4) MULTI-HOP REASONING:\n- The LLM does attempt to synthesize across three years, which is appropriate for the multi-hop nature of the question.\n- However, the conclusion that strategy \"remained unchanged\" contradicts the ground truth's narrative of evolution, suggesting incomplete or incorrect synthesis of the progression.\n\n(5) SEMANTIC ISSUES:\n- The ground truth emphasizes \"evolution\" and \"progression\" with \"increasing specificity,\" while the LLM emphasizes consistency and lack of change. These are semantically opposite conclusions about the same data.\n- The question specifically asks how the strategy \"evolved\" - the LLM's answer that it \"remained unchanged\" directly contradicts the premise and ground truth.\n\nThe answer demonstrates reasonable understanding of the basic facts but fails on the critical dimension of capturing the evolution/progression that is central to both the question and the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 725,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture repurchased 12.2 million shares for $4.1 billion in fiscal 2022, leaving $3.13 billion of available authorization and a total outstanding authority of $6.13 billion after a $3 billion increase (pages 94, 93). By fiscal 2024 the company had drawn down the pool to $2.69 billion, repurchasing $4.5 billion of shares in the year (including 2.07 million in Q4 for $605 million) and then added $4 billion of new authority, raising total outstanding authority to $6.69 billion (pages 39, 40). This multi‑year pattern shows a disciplined capital‑return strategy that consistently uses share buybacks while periodically expanding the authorized buy‑back capacity to sustain future returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine its credibility. (1) FISCAL 2022 REPURCHASE AMOUNT: LLM claims 12.2 million shares for $4.1 billion in fiscal 2022, but the ground truth does not provide this figure. The ground truth only states $3.13 billion available authorization in fiscal 2022, not repurchase activity. (2) FISCAL 2024 REPURCHASE AMOUNT: LLM claims $4.5 billion in fiscal 2024 repurchases, but ground truth shows only $605 million for 2.0 million shares in open-market purchases plus employee-related transactions. This is a massive discrepancy ($4.5B vs $605M). (3) SHARE COUNT ACCURACY: LLM states 2.07 million shares in Q4 for $605 million, but ground truth specifies 2,000,308 shares (approximately 2.0 million, not 2.07 million) for $605 million. (4) AUTHORIZATION FIGURES: LLM correctly identifies $3.13 billion available authorization in fiscal 2022 and $2.69 billion in fiscal 2024, and correctly notes the $4 billion new authority approved in September 2024 bringing total to $6.69 billion (approximately $6.694 billion). (5) MULTI-HOP REASONING: While the LLM correctly synthesizes the pattern of periodic replenishment and disciplined capital return strategy, the underlying numbers supporting this conclusion are largely incorrect. The LLM appears to have conflated or misidentified fiscal 2022 and fiscal 2024 repurchase amounts, creating a false narrative of consistent $4+ billion annual buybacks. The ground truth shows a more measured approach with $605 million in fiscal 2024 open-market repurchases. (6) CONTEXTUAL RELEVANCE: The answer appropriately addresses the multi-year evolution question and capital return strategy interpretation, but the factual foundation is severely compromised. The conclusion about 'disciplined capital-return strategy' may be correct in spirit, but is based on incorrect supporting numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 516,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "The $750 million 2.350 % senior notes due 2040 appear in each of BMS’s recent 10‑K filings – they are listed in the 2022 filing’s Twelfth Supplemental Indenture (page 137) and are again shown in the 2023 and 2024 filings (pages 134 & 136). By keeping this low‑coupon, 20‑year fixed‑rate issue on its balance sheet, BMS demonstrates a deliberate strategy of locking in inexpensive, long‑dated financing to preserve liquidity and hedge against future interest‑rate volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the $750 million 2.350% Notes due 2040 and their consistent presence across 2022-2024 filings. The quantitative data is accurate: the dollar amount ($750 million), interest rate (2.350%), and maturity year (2040) are all correct. The answer correctly identifies that these notes appear in multiple years' filings, supporting the persistence claim central to the question.\n\nStrengths: (1) All key financial figures are accurate and properly formatted; (2) The multi-hop synthesis correctly connects the persistence of the debt instrument across three years to strategic intent; (3) The reasoning about fixed-rate debt strategy and interest rate risk management is sound and relevant; (4) The answer appropriately characterizes the strategic implications of retaining this instrument.\n\nWeaknesses: (1) The LLM provides specific page references (137, 134, 136) that cannot be verified against the ground truth, which does not include such details. While these may be accurate, they represent unverified specificity; (2) The answer uses slightly different framing than ground truth - mentioning \"Twelfth Supplemental Indenture\" and characterizing it as \"low-coupon\" and \"inexpensive\" financing, which adds interpretation not explicitly in the ground truth; (3) The ground truth emphasizes \"not refinanced or retired\" as evidence of strategic choice, while the LLM focuses on \"locking in inexpensive, long-dated financing\" - both are valid interpretations but represent different emphasis.\n\nThe core multi-hop reasoning is sound: the answer correctly synthesizes that consistent inclusion across three years indicates strategic retention and deliberate debt management. The characterization of the strategy (fixed-rate debt for interest rate risk management) aligns with the ground truth's conclusion. The answer is semantically equivalent to the ground truth despite different wording and slightly different emphasis on specific strategic motivations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 550,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BMS repeatedly references the same instrument – “Form of 4.350% Senior Notes due 2047” – with an unchanged 4.350 % coupon (2022 p. 133; 2023 p. 136; 2024 p. 134). The consistency of this fixed‑rate, long‑dated issuance shows the company is deliberately keeping a stable, long‑term debt profile rather than frequently refinancing or altering terms.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that Bristol-Myers Squibb's 4.350% Senior Notes due 2047 maintained a consistent coupon rate across 2022, 2023, and 2024 filings, and appropriately concludes this reflects a stable long-term debt strategy. However, there are significant omissions and inaccuracies in the multi-hop synthesis:\n\nSTRENGTHS:\n1. Correctly identifies the 4.350% coupon rate across all three years\n2. Correctly identifies the 2047 maturity date\n3. Correctly identifies the three-year period (2022, 2023, 2024)\n4. Appropriately concludes the pattern reflects stable debt strategy\n5. Page references provided (133, 136, 134) show filing engagement\n\nWEAKNESSES:\n1. MISSING CRITICAL DETAILS: The ground truth specifies important exhibit references (Exhibit 4bbb in 2022, Exhibit 4ff in 2023 and 2024) that provide documentary evidence of the consistency claim. The LLM omits these entirely.\n2. MISSING INDENTURE INFORMATION: The ground truth references specific supplemental indentures (Twelfth Supplemental Indenture dated November 13, 2020 for 2022; Fourteenth Supplemental Indenture dated November 13, 2023 for 2023). The LLM provides no indenture details.\n3. MISSING FORM 8-K REFERENCE: The ground truth notes incorporation by reference to Form 8-K filing from November 22, 2019. The LLM omits this.\n4. INCOMPLETE MULTI-HOP SYNTHESIS: The question asks how the commitment has \"evolved\" and what this \"reveals\" about the company's approach. While the LLM addresses the stability aspect, it fails to synthesize the documentary evidence (exhibits, indentures, dates) that would fully demonstrate the evolution pattern across filings.\n5. VAGUE SOURCING: The LLM cites page numbers but doesn't specify which exhibits or documents contain this information, making verification difficult.\n\nQUANTITATIVE ACCURACY: The 4.350% rate is correct across all years. Page numbers appear reasonable but cannot be fully verified without access to actual filings. No calculation errors present.\n\nQUALITATIVE ACCURACY: The reasoning about stable debt strategy is sound, but the answer lacks the documentary specificity that would demonstrate thorough multi-hop synthesis across filing exhibits and supplemental indentures.\n\nCONTEXTUAL RELEVANCE: The answer addresses the main question but misses the opportunity to provide the detailed documentary trail that would fully answer how the commitment has been tracked and maintained across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 657,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "In fiscal 2022 Nike’s 10‑K only listed FlyEase as one of a long roster of new‑product technologies (“Nike Air, Zoom, Free, Flywire, Dri‑FIT, Flyknit, **FlyEase**, ZoomX, Air Max, React…”) with no link to production volumes. By fiscal 2024 the filing still names FlyEase among its technology portfolio but backs it with concrete supply‑chain data – Nike’s contract manufacturers operated **96 finished‑goods footwear factories in 11 countries**, supplied by **15 footwear contract manufacturers**, the largest single factory accounted for **≈ 9 %** of total footwear output, and factories in **Vietnam (≈ 50 %), Indonesia (≈ 27 %) and China (≈ 18 %)** produced the bulk of Nike Brand footwear – evidence that FlyEase‑enabled products are now being produced at scale across Nike’s global manufacturing network. (2022 10‑K – Product R&D section; 2024 10‑K – Product R&D and Manufacturing sections).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and excellent multi-hop synthesis. STRENGTHS: (1) All quantitative data is correct - Vietnam (≈50%), Indonesia (≈27%), China (≈18%) manufacturing percentages match the ground truth exactly; (2) The narrative evolution from fiscal 2022 to 2024 is accurately captured - FlyEase listed among many technologies in 2022 with no production data, then backed by concrete supply-chain metrics in 2024; (3) Additional manufacturing details (96 finished-goods footwear factories in 11 countries, 15 footwear contract manufacturers, largest factory ≈9% of output) provide substantive evidence of scale and integration, enhancing the answer beyond the ground truth baseline; (4) Multi-hop reasoning is sound - correctly synthesizes information across fiscal years and connects technology portfolio evolution to manufacturing scale; (5) Proper source attribution (2022 10-K Product R&D section; 2024 10-K Product R&D and Manufacturing sections) demonstrates document awareness. MINOR CONSIDERATIONS: The LLM answer includes additional manufacturing statistics (96 factories, 15 manufacturers, 9% largest factory) not explicitly mentioned in the ground truth, but these are complementary details that strengthen rather than contradict the core answer. The answer fully addresses the question's three components: (1) evolution of reporting from 2022-2024, (2) quantitative evidence of production scale, and (3) integration into global manufacturing operations. All numbers are formatted consistently and accurately. The semantic meaning aligns perfectly with the ground truth while providing richer contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 452,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s payment‑card usage slipped from roughly 19.8 % of purchases in fiscal 2022 to 18.6 % in fiscal 2023 and further to 17.8 % in fiscal 2024 (RedCard Penetration 19.8 % / 18.6 % – page 27; Target Circle Card Penetration 19.8 % / 18.6 % / 17.8 % – page 28). The steady decline suggests that, although the loyalty‑driven discount and rewards program still drives a sizable share of sales, its incremental impact is waning, indicating a need to reinforce or refresh the strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the penetration rates. Ground truth shows: 2022: 20.5%, 2023: 19.8%, 2024: 17.8%. LLM reports: 2022: 19.8%, 2023: 18.6%, 2024: 17.8%. The 2022 figure is wrong (off by 0.7 percentage points), and the 2023 figure is wrong (off by 1.2 percentage points). Only the 2024 figure (17.8%) is correct. These are not minor rounding differences but material misstatements of the data. ENTITY CONFUSION: The LLM conflates 'RedCard' and 'Target Circle Card' as if they are separate metrics with different penetration rates, when the ground truth treats them as associated products with a single penetration rate metric. The citation format (showing different percentages for RedCard vs Circle Card) suggests the LLM may have misread or misinterpreted source documents. REASONING QUALITY: While the LLM correctly identifies the overall declining trend and provides reasonable interpretation about waning incremental impact, this qualitative reasoning cannot compensate for the fundamental quantitative errors. The conclusion about needing to 'reinforce or refresh the strategy' is reasonable but is built on incorrect numbers. COMPLETENESS: The answer does address the evolution question and attempts to interpret the trend, but the incorrect data undermines the entire analysis. The multi-hop synthesis required here (tracking metrics across three years and interpreting the trend) is partially accomplished but with wrong intermediate values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 421,
        "total_tokens": 1661
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 797,
    "failed_evaluations": 3,
    "average_correctness_score": 6.05,
    "average_quantitative_accuracy": 6.31,
    "average_qualitative_accuracy": 6.34,
    "average_contextual_relevance": 7.17,
    "score_distribution": {
      "excellent": 173,
      "good": 209,
      "fair": 222,
      "poor": 193
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 30470.87,
    "timestamp": "2026-02-03T00:08:16.607387"
  }
}